23069	HMR136_T09094_14_tr0_r1_1_gPRT		Comparison report between T09094_P14 and PEL1_HUMANpartial   	Sequence name: PEL1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09094_P14, comprising a first amino	Sequence documentation:                                      
						MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGPVEVSTLQCLA 	                                                            
						NATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIPTIIRDEELKTRGFGGIYGVG 	Alignment of: 23069 x PEL1_HUMAN   ..                        
						KAALHPPALAVLSHTPDGATQTIAWVGKGIVYDTGGLSIKGKTTMPGMKRDCGGAAAVLG 	                                                            
						AFRAAIKQGFKDNLHAVFCLAENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADG 	Alignment segment 1/1:                                       
						VSYACKDLGADIILDMATLTGAQ                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2508.00                      Escore:       0                                               
						to amino acids 1 - 263 of PEL1_HUMAN, which also corresponds 	             Matching length:     263                Total length:     263                                               
						to amino acids 1 - 263 of T09094_P14, and a second amino acid	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VSAPWIHPLAVVPGNPTPLLTSRWGRQRVGAAVRKFS    	Alignment:                                                   
						corresponding to amino acids 264 - 300 of T09094_P14, wherein	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09094_P14, comprising a  	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSAPWIHPLAVVPGNPTPLLTSRWGRQRVGAAVRKFS in     	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						T09094_P14.                                                  	                  .         .         .         .         .  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	                  .                                          
						                                                            	     251 DIILDMATLTGAQ                                      263                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     251 DIILDMATLTGAQ                                      263                                                          

23079	HMR136_T09094_15_tr0_r1_1_gPRT		Comparison report between T09094_P15 and PEL1_HUMANpartial   	Sequence name: PEL1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09094_P15, comprising a first amino	Sequence documentation:                                      
						MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGPVEVSTLQCLA 	                                                            
						NATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIPTIIRDEELKTRGFGGIYGVG 	Alignment of: 23079 x PEL1_HUMAN   ..                        
						KAALHPPALAVLSHTPDGATQTIAWVGKGIVYDTGGLSIKGKTTMPGMKRDCGGAAAVLG 	                                                            
						AFRAAIKQGFKDNLHAVFCLAENSVGPNATRPDDIHLLYSGK                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 222 of PEL1_HUMAN, which also corresponds 	                     Quality: 2133.00                      Escore:       0                                               
						to amino acids 1 - 222 of T09094_P15, and a second amino acid	             Matching length:     224                Total length:     224                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:   99.55   Matching Percent Identity:   99.55                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   99.55      Total Percent Identity:   99.55                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence                                          	                                                            
						YVWPSHSFLPTVGTRDPSRPAMPAHSRHIGRALSVGVPWAAGSLLPGGLGSFGSRRTSR  	Alignment:                                                   
						corresponding to amino acids 223 - 281 of T09094_P15, wherein	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09094_P15, comprising a  	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						YVWPSHSFLPTVGTRDPSRPAMPAHSRHIGRALSVGVPWAAGSLLPGGLGSFGSRRTSR  	                  .         .         .         .         .  
						in T09094_P15.                                               	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKYV                           224                                                          
						                                                            	         |||||||||||||||||||||| |                            
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTV                           224                                                          

23099	HMR136_T09094_2_tr0_r1_1_gPRT		Comparison report between T09094_P2 and PEL1_HUMANpartial WT 	Sequence name: PEL1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09094_P2, comprising a first amino 	Sequence documentation:                                      
						MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGPVEVSTLQCLA 	                                                            
						NATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIPTIIRDEELKTRGFGGIYGVG 	Alignment of: 23099 x PEL1_HUMAN   ..                        
						KAALHPPALAVLSHTPDGATQTIAWVGKGIVYDTGGLSIKGKTTMPGMKRDCGGAAAVLG 	                                                            
						AFRAAIKQGFKDNLHAVFCLAENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADG 	Alignment segment 1/1:                                       
						VSYACKDLGADIILDMATLTGAQ                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2508.00                      Escore:       0                                               
						to amino acids 1 - 263 of PEL1_HUMAN, which also corresponds 	             Matching length:     263                Total length:     263                                               
						to amino acids 1 - 263 of T09094_P2, and a second amino acid 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence VSAPWIHPLAVVPGNPTPLLTSRWGRQRVGAAVRKFS    	Alignment:                                                   
						corresponding to amino acids 264 - 300 of T09094_P2, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09094_P2, comprising a   	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSAPWIHPLAVVPGNPTPLLTSRWGRQRVGAAVRKFS in     	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						T09094_P2.                                                   	                  .         .         .         .         .  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	                  .                                          
						                                                            	     251 DIILDMATLTGAQ                                      263                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     251 DIILDMATLTGAQ                                      263                                                          

23101	HMR136_T09094_4_tr0_r1_1_gPRT		Comparison report between T09094_P4 and PEL1_HUMANpartial WT 	Sequence name: PEL1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09094_P4, comprising a first amino 	Sequence documentation:                                      
						MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGPVEVSTLQCLA 	                                                            
						NATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIPTIIRDEELKTRGFGGIYGVG 	Alignment of: 23101 x PEL1_HUMAN   ..                        
						KAALHPPALAVLSHTPDGATQTIAWVGKGIVYDTGGLSIKGKTTMPGMKRDCGGAAAVLG 	                                                            
						AFRAAIKQGFKDNLHAVFCLAENSVGPNATRPDDIHLLYSGK                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 222 of PEL1_HUMAN, which also corresponds 	                     Quality: 2133.00                      Escore:       0                                               
						to amino acids 1 - 222 of T09094_P4, and a second amino acid 	             Matching length:     224                Total length:     224                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:   99.55   Matching Percent Identity:   99.55                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   99.55      Total Percent Identity:   99.55                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence                                          	                                                            
						YVWPSHSFLPTVGTRDPSRPAMPAHSRHIGRALSVGVPWAAGSLLPGGLGSFGSRRTSR  	Alignment:                                                   
						corresponding to amino acids 223 - 281 of T09094_P4, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09094_P4, comprising a   	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						YVWPSHSFLPTVGTRDPSRPAMPAHSRHIGRALSVGVPWAAGSLLPGGLGSFGSRRTSR  	                  .         .         .         .         .  
						in T09094_P4.                                                	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKYV                           224                                                          
						                                                            	         |||||||||||||||||||||| |                            
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTV                           224                                                          

23081	HMR136_T09094_6_tr0_r1_1_gPRT		Comparison report between T09094_P6 and PEL1_HUMANpartial WT 	Sequence name: PEL1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09094_P6, comprising a first amino 	Sequence documentation:                                      
						MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGPVEVSTLQCLA 	                                                            
						NATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIPTIIRDEELKTRGFGGIYGVG 	Alignment of: 23081 x PEL1_HUMAN   ..                        
						KAALHPPALAVLSHTPDGATQTIAWVGKGIVYDTGGLSIKGKTTMPGMKRDCGGAAAVLG 	                                                            
						AFRAAIKQGFKDNLHAVFCLAENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADG 	Alignment segment 1/1:                                       
						VSYACKDLGADIILDMATLTGAQGIATGKYHAAVLTNSAEWEAACVKAGRKCGDLVHPLV 	                                                            
						YCPELHFSEFTSAVADMKNSVADRDNSPSSCAGLFIASHIGFDWPGVWVHLDIAAPVHA  	                     Quality: 3460.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     359                Total length:     359                                               
						to amino acids 1 - 359 of PEL1_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 359 of T09094_P6, and a second amino acid 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence VSVSPPHWPWLLPPACPNSAPLALELLAELIRNFCL     	                  .         .         .         .         .  
						corresponding to amino acids 360 - 395 of T09094_P6, wherein 	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	       1 MVCEQPEVFASACALARAFPLFTHRSGASRRLEKKTVTVEFFLVGQDNGP 50                                                           
						polypeptide encoding for a tail of T09094_P6, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 VEVSTLQCLANATDGVRLAARIVDTPCNEMNTDTFLEEINKVGKELGIIP 100                                                          
						to the sequence VSVSPPHWPWLLPPACPNSAPLALELLAELIRNFCL in      	                  .         .         .         .         .  
						T09094_P6.                                                   	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TIIRDEELKTRGFGGIYGVGKAALHPPALAVLSHTPDGATQTIAWVGKGI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VYDTGGLSIKGKTTMPGMKRDCGGAAAVLGAFRAAIKQGFKDNLHAVFCL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AENSVGPNATRPDDIHLLYSGKTVEINNTDAEGRLVLADGVSYACKDLGA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DIILDMATLTGAQGIATGKYHAAVLTNSAEWEAACVKAGRKCGDLVHPLV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DIILDMATLTGAQGIATGKYHAAVLTNSAEWEAACVKAGRKCGDLVHPLV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YCPELHFSEFTSAVADMKNSVADRDNSPSSCAGLFIASHIGFDWPGVWVH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YCPELHFSEFTSAVADMKNSVADRDNSPSSCAGLFIASHIGFDWPGVWVH 350                                                          
						                                                            	                                                             
						                                                            	     351 LDIAAPVHA                                          359                                                          
						                                                            	         |||||||||                                           
						                                                            	     351 LDIAAPVHA                                          359                                                          

23275	HMR136_T09097_7_tr0_r1_1_gPRT		Comparison report between T09097_P7 and O95900partial WT     	Sequence name: O95900                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09097_P7, comprising a first amino 	Sequence documentation:                                      
						MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRVRFLLGPMEGS 	                                                            
						EEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQASGVLVLGVGHGCRLLTDMY 	Alignment of: 23275 x O95900   ..                            
						NAHLTKDYTVRGLLGKATDDFREDGRLVEKTTYDHVTREKLDRILAVIQGSHQKALV    	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 177 of O95900, which also corresponds to  	                                                            
						amino acids 1 - 177 of T09097_P7, and a second amino acid    	                     Quality: 1706.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     178                Total length:     178                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.44                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.44                                               
						having the sequence IGAVHA corresponding to amino acids 178 -	                        Gaps:       0                        
						183 of T09097_P7, wherein said first amino acid sequence and 	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09097_P7, comprising a polypeptide being at least 70%,      	       1 MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRV 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRV 50                                                           
						least about 95% homologous to the sequence IGAVHA in         	                  .         .         .         .         .  
						T09097_P7.                                                   	      51 RFLLGPMEGSEEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RFLLGPMEGSEEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQ 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASGVLVLGVGHGCRLLTDMYNAHLTKDYTVRGLLGKATDDFREDGRLVEK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ASGVLVLGVGHGCRLLTDMYNAHLTKDYTVRGLLGKATDDFREDGRLVEK 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 TTYDHVTREKLDRILAVIQGSHQKALVI                       178                                                          
						                                                            	         |||||||||||||||||||||||||||:                        
						                                                            	     151 TTYDHVTREKLDRILAVIQGSHQKALVM                       178                                                          

23277	HMR136_T09097_9_tr0_r1_1_gPRT		Comparison report between T09097_P9 and O95900partial WT     	Sequence name: O95900                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09097_P9, comprising a first amino 	Sequence documentation:                                      
						MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRVRFLLGPMEGS 	                                                            
						EEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQASGVL                	Alignment of: 23277 x O95900   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 105 of O95900, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 105 of T09097_P9, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1018.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     105                Total length:     105                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence GLHSAWPPGQSYR corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 106 - 118 of T09097_P9, wherein said first amino acid  	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of T09097_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRV 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence GLHSAWPPGQSYR  	       1 MGSAGLSRLHGLFAVYKPPGLKWKHLRDTVELQLLKGLNARKPPAPKQRV 50                                                           
						in T09097_P9.                                                	                  .         .         .         .         .  
						                                                            	      51 RFLLGPMEGSEEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 RFLLGPMEGSEEKELTLTATSVPSFINHPLVCGPAFAHLKVGVGHRLDAQ 100                                                          
						                                                            	                                                             
						                                                            	     101 ASGVL                                              105                                                          
						                                                            	         |||||                                               
						                                                            	     101 ASGVL                                              105                                                          

23858	HMR136_T09103_15_tr0_r1_1_gPRT		Comparison report between T09103_P15 and Q9UL65partial WT    	Sequence name: Q9UL65                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09103_P15, comprising a first amino acid       	                                                            
						MILSKPTAPQRALVITHFVHVAEKLLQLQNFNTLMAVVGGLSHSSISRLKETHSHVSPET 	Alignment of: 23858 x Q9UL65   ..                            
						IKLWEGLTELVTATGNYGNYRRRLAACVGFRFPILGVHLKDLVALQLALPDWLDPARTRL 	                                                            
						NGAKMKQLFSILEELAMVTSLRPPVQANPDLLSLLTVSLDQYQTEDELYQLSLQREPRSK 	Alignment segment 1/1:                                       
						SSPTSPTSCTPPPRPPVLEEWTSAAKPKLDQALVVEHIEKMVESVFRNFDVDGDGHISQE 	                                                            
						EFQIIRGNFPYLSAFGDLDQNQDGCISREEMVSYFLRSSSVLGGRMGFVHNFQESNSLRP 	                     Quality: 3935.00                      Escore:       0                                               
						VACRHCKALILGIYKQGLKCRACGVNCHKQCKDRLSVECRRRAQSVSLEGSAPSPSPMHS 	             Matching length:     400                Total length:     400                                               
						HHHRAFSFSLPRPGRRGSRPPEIREEEVQTVEDGVFDIHL                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 272 - 671 of Q9UL65, which also corresponds to   	                        Gaps:       0                        
						amino acids 1 - 400 of T09103_P15.                           	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MILSKPTAPQRALVITHFVHVAEKLLQLQNFNTLMAVVGGLSHSSISRLK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 MILSKPTAPQRALVITHFVHVAEKLLQLQNFNTLMAVVGGLSHSSISRLK 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ETHSHVSPETIKLWEGLTELVTATGNYGNYRRRLAACVGFRFPILGVHLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 ETHSHVSPETIKLWEGLTELVTATGNYGNYRRRLAACVGFRFPILGVHLK 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DLVALQLALPDWLDPARTRLNGAKMKQLFSILEELAMVTSLRPPVQANPD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 DLVALQLALPDWLDPARTRLNGAKMKQLFSILEELAMVTSLRPPVQANPD 421                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLSLLTVSLDQYQTEDELYQLSLQREPRSKSSPTSPTSCTPPPRPPVLEE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     422 LLSLLTVSLDQYQTEDELYQLSLQREPRSKSSPTSPTSCTPPPRPPVLEE 471                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WTSAAKPKLDQALVVEHIEKMVESVFRNFDVDGDGHISQEEFQIIRGNFP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     472 WTSAAKPKLDQALVVEHIEKMVESVFRNFDVDGDGHISQEEFQIIRGNFP 521                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YLSAFGDLDQNQDGCISREEMVSYFLRSSSVLGGRMGFVHNFQESNSLRP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     522 YLSAFGDLDQNQDGCISREEMVSYFLRSSSVLGGRMGFVHNFQESNSLRP 571                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VACRHCKALILGIYKQGLKCRACGVNCHKQCKDRLSVECRRRAQSVSLEG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     572 VACRHCKALILGIYKQGLKCRACGVNCHKQCKDRLSVECRRRAQSVSLEG 621                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SAPSPSPMHSHHHRAFSFSLPRPGRRGSRPPEIREEEVQTVEDGVFDIHL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     622 SAPSPSPMHSHHHRAFSFSLPRPGRRGSRPPEIREEEVQTVEDGVFDIHL 671                                                          

23860	HMR136_T09103_17_tr0_r1_1_gPRT		Comparison report between T09103_P17 and Q9UL65partial WT    	Sequence name: Q9UL65                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09103_P17, comprising a first amino acid       	                                                            
						MAGTLDLDKGCTVEELLRGCIEAFDDSGKVRDPQLVRMFLMMHPWYIPSSQLAAKLLHIY 	Alignment of: 23860 x Q9UL65   ..                            
						QQSRKDNSNSLQVKTCHLVRYWISAFPAEFDLNPELAEQIKELKALLDQEGNRRHSSLID 	                                                            
						IDSVPTYKWKRQVTQRNPVGQKKRKMSLLFDHLEPMELAEHLTYLEYRSFCKILFQDYHS 	Alignment segment 1/1:                                       
						FVTHGCTVDNPVLERFISLFNSVSQWVQLMILSKPTAPQRALVITHFVHVAEKLLQLQNF 	                                                            
						NTLMAVVGGLSHSSISRLKETHSHVSPETIKLWEGLTELVTATGNYGNYRRRLAACVGFR 	                     Quality: 4639.00                      Escore:       0                                               
						FPILGVHLKDLVALQLALPDWLDPARTRLNGAKMKQLFSILEELAMVTSLRPPVQANPDL 	             Matching length:     471                Total length:     471                                               
						LSLLTVSLDQYQTEDELYQLSLQREPRSKSSPTSPTSCTPPPRPPVLEEWTSAAKPKLDQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALVVEHIEKMVESVFRNFDVDGDGHISQEEFQIIRGNFPYLSAFGDLDQNQ          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 63 - 533 of Q9UL65, which also corresponds to    	                                                            
						amino acids 1 - 471 of T09103_P17.                           	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAGTLDLDKGCTVEELLRGCIEAFDDSGKVRDPQLVRMFLMMHPWYIPSS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      63 MAGTLDLDKGCTVEELLRGCIEAFDDSGKVRDPQLVRMFLMMHPWYIPSS 112                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QLAAKLLHIYQQSRKDNSNSLQVKTCHLVRYWISAFPAEFDLNPELAEQI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     113 QLAAKLLHIYQQSRKDNSNSLQVKTCHLVRYWISAFPAEFDLNPELAEQI 162                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KELKALLDQEGNRRHSSLIDIDSVPTYKWKRQVTQRNPVGQKKRKMSLLF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     163 KELKALLDQEGNRRHSSLIDIDSVPTYKWKRQVTQRNPVGQKKRKMSLLF 212                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DHLEPMELAEHLTYLEYRSFCKILFQDYHSFVTHGCTVDNPVLERFISLF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     213 DHLEPMELAEHLTYLEYRSFCKILFQDYHSFVTHGCTVDNPVLERFISLF 262                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NSVSQWVQLMILSKPTAPQRALVITHFVHVAEKLLQLQNFNTLMAVVGGL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     263 NSVSQWVQLMILSKPTAPQRALVITHFVHVAEKLLQLQNFNTLMAVVGGL 312                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SHSSISRLKETHSHVSPETIKLWEGLTELVTATGNYGNYRRRLAACVGFR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     313 SHSSISRLKETHSHVSPETIKLWEGLTELVTATGNYGNYRRRLAACVGFR 362                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 FPILGVHLKDLVALQLALPDWLDPARTRLNGAKMKQLFSILEELAMVTSL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     363 FPILGVHLKDLVALQLALPDWLDPARTRLNGAKMKQLFSILEELAMVTSL 412                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RPPVQANPDLLSLLTVSLDQYQTEDELYQLSLQREPRSKSSPTSPTSCTP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     413 RPPVQANPDLLSLLTVSLDQYQTEDELYQLSLQREPRSKSSPTSPTSCTP 462                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PPRPPVLEEWTSAAKPKLDQALVVEHIEKMVESVFRNFDVDGDGHISQEE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     463 PPRPPVLEEWTSAAKPKLDQALVVEHIEKMVESVFRNFDVDGDGHISQEE 512                                                          
						                                                            	                  .         .                                
						                                                            	     451 FQIIRGNFPYLSAFGDLDQNQ                              471                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     513 FQIIRGNFPYLSAFGDLDQNQ                              533                                                          

23982	HMR136_T09104_21_tr0_r1_1_gPRT		Comparison report between T09104_P21 and STKG_HUMAN_V1unique 	Sequence name: STKG_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09104_P21, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 23982 x STKG_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence GIPAFLSRDAHRSLLLLY corresponding to amino	Alignment segment 1/1:                                       
						acids 1 - 18 of T09104_P21, and a second amino acid sequence 	                                                            
						RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 	                     Quality: 1581.00                      Escore:       0                                               
						QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALR 	             Matching length:     160                Total length:     160                                               
						QLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQI                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.38                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.38                                               
						acids 147 - 305 of STKG_HUMAN_V1, which also corresponds to  	                        Gaps:       0                        
						amino acids 19 - 177 of T09104_P21, wherein said first amino 	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of T09104_P21, comprising a polypeptide being at  	      18 YRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 67                                                           
						least 70%, optionally at least about 80%, preferably at least	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     146 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 195                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						GIPAFLSRDAHRSLLLLY of T09104_P21.                            	      68 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 117                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     196 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 245                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     118 ALAVQNQLSIPQSPRHSSALRQLLNSMMTVDPHQRPHIPLLLSQLEALQP 167                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 ALAVQNQLSIPQSPRHSSALRQLLNSMMTVDPHQRPHIPLLLSQLEALQP 295                                                          
						                                                            	                  .                                          
						                                                            	     168 PAPGQHTTQI                                         177                                                          
						                                                            	         ||||||||||                                          
						                                                            	     296 PAPGQHTTQI                                         305                                                          

23978	HMR136_T09104_23_tr0_r1_1_gPRT		Comparison report between T09104_P23 and                     	Sequence name: STKG_HUMAN_V2                                 
						STKG_HUMAN_V2partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for T09104_P23, comprising a   	                                                            
						MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDPHQRPHIPLLL 	Alignment of: 23978 x STKG_HUMAN_V2   ..                     
						SQLEALQPPAPGQHTTQI                                           	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 228 - 305 of STKG_HUMAN_V2,     	                                                            
						which also corresponds to amino acids 1 - 78 of T09104_P23.  	                     Quality:  778.00                      Escore:       0                                               
						                                                            	             Matching length:      78                Total length:      78                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDP 277                                                          
						                                                            	                  .         .                                
						                                                            	      51 HQRPHIPLLLSQLEALQPPAPGQHTTQI                       78                                                           
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     278 HQRPHIPLLLSQLEALQPPAPGQHTTQI                       305                                                          

23980	HMR136_T09104_24_tr0_r1_1_gPRT		Comparison report between T09104_P24 and                     	Sequence name: STKG_HUMAN_V2                                 
						STKG_HUMAN_V2partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for T09104_P24, comprising a   	                                                            
						MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDPHQRPHIPLLL 	Alignment of: 23980 x STKG_HUMAN_V2   ..                     
						SQLEALQPPAPGQHTTQI                                           	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 228 - 305 of STKG_HUMAN_V2,     	                                                            
						which also corresponds to amino acids 1 - 78 of T09104_P24.  	                     Quality:  778.00                      Escore:       0                                               
						                                                            	             Matching length:      78                Total length:      78                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDP 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALRQLLNSMMTVDP 277                                                          
						                                                            	                  .         .                                
						                                                            	      51 HQRPHIPLLLSQLEALQPPAPGQHTTQI                       78                                                           
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     278 HQRPHIPLLLSQLEALQPPAPGQHTTQI                       305                                                          

24096	HMR136_T09106_2_tr0_r1_1_gPRT		Comparison report between T09106_P2 and Q96GF8short unique   	Sequence name: Q96GF8                                        
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09106_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24096 x Q96GF8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of T09106_P2, a second    	                                                            
						AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTIS 	                     Quality: 2143.00                      Escore:       0                                               
						FLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPSSHSQFMWFFSVYSFLFLYL  	             Matching length:     229                Total length:     237                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 4 - 122 of Q96GF8, which also   	    Total Percent Similarity:   96.62      Total Percent Identity:   96.62                                               
						corresponds to amino acids 2 - 120 of T09106_P2, and a third 	                        Gaps:       1                        
						RFLDLLWRHVLSLGLLAVAFLVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLT 	                                                            
						PLFPRIAAWPVSEFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ           	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 131 - 240 of Q96GF8, which also 	       2 AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLI 51                                                           
						corresponds to amino acids 121 - 230 of T09106_P2, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       4 AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLI 53                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated chimeric polypeptide encoding 	      52 IFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPS 101                                                          
						for an edge portion of T09106_P2, comprising a polypeptide   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having a length "n", wherein n is at least about 10 amino    	      54 IFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPS 103                                                          
						acids in length, optionally at least about 20 amino acids in 	                  .         .         .         .         .  
						length, preferably at least about 30 amino acids in length,  	     102 SHSQFMWFFSVYSFLFLYL........RFLDLLWRHVLSLGLLAVAFLVS 143                                                          
						more preferably at least about 40 amino acids in length and  	         |||||||||||||||||||        |||||||||||||||||||||||  
						most preferably at least about 50 amino acids in length,     	     104 SHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLVS 153                                                          
						wherein at least two amino acids comprise LR, having a       	                  .         .         .         .         .  
						structure as follows: a sequence starting from any of amino  	     144 YSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVSE 193                                                          
						acid numbers 120-x to 121; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 121+ ((n-2) - x), in which x varies from 0 to n-2.   	     154 YSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVSE 203                                                          
						                                                            	                  .         .         .                      
						                                                            	     194 FFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ              230                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     204 FFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ              240                                                          

						Comparison report between T09106_P2 and AAO34712partial WT   	Sequence name: AAO34712                                      
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09106_P2, comprising a first amino 	Sequence documentation:                                      
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	                                                            
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPSSHSQFMWFFSVYSFLFLYL 	Alignment of: 24096 x AAO34712   ..                          
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 120 of AAO34712, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 120 of T09106_P2, and a second amino acid    	                                                            
						RFLDLLWRHVLSLGLLAVAFLVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLT 	                     Quality: 2155.00                      Escore:       0                                               
						PLFPRIAAWPVSEFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ           	             Matching length:     230                Total length:     238                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 129 - 238 of AAO34712, which also corresponds to 	    Total Percent Similarity:   96.64      Total Percent Identity:   96.64                                               
						amino acids 121 - 230 of T09106_P2, wherein said first amino 	                        Gaps:       1                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated chimeric polypeptide 	Alignment:                                                   
						encoding for an edge portion of T09106_P2, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	       1 MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTL 50                                                           
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	       1 MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTL 50                                                           
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      51 IIFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMP 100                                                          
						length, wherein at least two amino acids comprise LR, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	      51 IIFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMP 100                                                          
						acid numbers 120-x to 121; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 121+ ((n-2) - x), in which x varies from 0 to n-2.   	     101 SSHSQFMWFFSVYSFLFLYL........RFLDLLWRHVLSLGLLAVAFLV 142                                                          
						                                                            	         ||||||||||||||||||||        ||||||||||||||||||||||  
						                                                            	     101 SSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     143 SYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVS 192                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVS 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     193 EFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ             230                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     201 EFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ             238                                                          

						Comparison report between T09106_P2 and Q8IUV4unique head    	Sequence name: Q8IUV4                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique insertion.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for T09106_P2, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 24096 x Q8IUV4   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	                                                            
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYG                       	                     Quality:  676.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 98 of   	             Matching length:      89                Total length:     140                                               
						T09106_P2, a second amino acid sequence being at least 90 %  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to MPSSHSQFMWFFSVYSFLFLYL corresponding to amino  	    Total Percent Similarity:   63.57      Total Percent Identity:   63.57                                               
						acids 1 - 22 of Q8IUV4, which also corresponds to amino acids	                        Gaps:       2                        
						99 - 120 of T09106_P2, a third amino acid sequence being at  	                                                            
						least 90 % homologous to RFLDLLWRHVLSLGLLAVAFLVSYSR          	Alignment:                                                   
						corresponding to amino acids 31 - 56 of Q8IUV4, which also   	                  .         .         .         .         .  
						corresponds to amino acids 121 - 146 of T09106_P2, a fourth  	      99 MPSSHSQFMWFFSVYSFLFLYL........RFLDLLWRHVLSLGLLAVAF 140                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||        ||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MPSSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAF 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence                                          	     141 LVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWP 190                                                          
						VYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAW corresponding to 	         ||||||                                           |  
						amino acids 147 - 189 of T09106_P2, and a fifth amino acid   	      51 LVSYSR...........................................P 57                                                           
						sequence being at least 90 % homologous to                   	                  .         .         .         .            
						PVSEFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ corresponding to   	     191 VSEFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ           230                                                          
						amino acids 57 - 97 of Q8IUV4, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||            
						amino acids 190 - 230 of T09106_P2, wherein said first amino 	      58 VSEFFLIRDTSLIPNVLWFEYTVTRAEARNRQRKLGTKLQ           97                                                           
						acid sequence, second amino acid sequence, third amino acid  	                                                            
						sequence, fourth amino acid sequence and fifth amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of T09106_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	                                                            
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYG                       	                                                            
						about 95% homologous to the sequence of T09106_P2.3.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						T09106_P2, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LR, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						120-x to 121; and ending at any of amino acid numbers 121+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for an edge portion of T09106_P2,       	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						VYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAW, corresponding to	                                                            
						T09106_P2.                                                   	                                                            

24092	HMR136_T09106_8_tr0_r1_1_gPRT		Comparison report between T09106_P8 and Q96GF8short unique   	Sequence name: Q96GF8                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09106_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 24092 x Q96GF8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence M corresponding to amino acids 1 - 1 of  	Alignment segment 1/1:                                       
						T09106_P8, and a second amino acid sequence being at least 90	                                                            
						AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTIS 	                     Quality: 2221.00                      Escore:       0                                               
						FLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPSSHSQFMWFFSVYSFLFLYLR 	             Matching length:     226                Total length:     226                                               
						MHQTNNARFLDLLWRHVLSLGLLAVAFLVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWFI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FTQEVLTPLFPRIAAWPVSEFFLIRDTSLIPNVLWFEYTVTRAEAR               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						% homologous to corresponding to amino acids 4 - 229 of      	                        Gaps:       0                        
						Q96GF8, which also corresponds to amino acids 2 - 227 of     	                                                            
						T09106_P8, wherein said first amino acid sequence and second 	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential order.	                  .         .         .         .         .  
						                                                            	       2 AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLI 51                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       4 AADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLI 53                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      52 IFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPS 101                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      54 IFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPS 103                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     102 SHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLVS 151                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     104 SHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLVS 153                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     152 YSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVSE 201                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     154 YSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVSE 203                                                          
						                                                            	                  .         .                                
						                                                            	     202 FFLIRDTSLIPNVLWFEYTVTRAEAR                         227                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     204 FFLIRDTSLIPNVLWFEYTVTRAEAR                         229                                                          

						Comparison report between T09106_P8 and AAO34712partial WT   	Sequence name: AAO34712                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09106_P8, comprising a first amino acid        	                                                            
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	Alignment of: 24092 x AAO34712   ..                          
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMPSSHSQFMWFFSVYSFLFLYL 	                                                            
						RMHQTNNARFLDLLWRHVLSLGLLAVAFLVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWF 	Alignment segment 1/1:                                       
						IFTQEVLTPLFPRIAAWPVSEFFLIRDTSLIPNVLWFEYTVTRAEAR              	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2233.00                      Escore:       0                                               
						amino acids 1 - 227 of AAO34712, which also corresponds to   	             Matching length:     227                Total length:     227                                               
						amino acids 1 - 227 of T09106_P8.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTL 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IIFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 IIFKRELHTISFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYGMP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWPVS 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 EFFLIRDTSLIPNVLWFEYTVTRAEAR                        227                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     201 EFFLIRDTSLIPNVLWFEYTVTRAEAR                        227                                                          

						Comparison report between T09106_P8 and Q8IUV4unique head    	Sequence name: Q8IUV4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09106_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24092 x Q8IUV4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	Alignment segment 1/1:                                       
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYG                       	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality:  754.00                      Escore:       0                                               
						to amino acids 1 - 98 of T09106_P8, a second amino acid      	             Matching length:      86                Total length:     129                                               
						sequence being at least 90 % homologous to                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MPSSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAFLVSYSR     	    Total Percent Similarity:   66.67      Total Percent Identity:   66.67                                               
						corresponding to amino acids 1 - 56 of Q8IUV4, which also    	                        Gaps:       1                        
						corresponds to amino acids 99 - 154 of T09106_P8, a third    	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	      99 MPSSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAF 148                                                          
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAW corresponding to 	       1 MPSSHSQFMWFFSVYSFLFLYLRMHQTNNARFLDLLWRHVLSLGLLAVAF 50                                                           
						amino acids 155 - 197 of T09106_P8, and a fourth amino acid  	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     149 LVSYSRVYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAWP 198                                                          
						PVSEFFLIRDTSLIPNVLWFEYTVTRAEAR corresponding to amino acids  	         ||||||                                           |  
						57 - 86 of Q8IUV4, which also corresponds to amino acids 198 	      51 LVSYSR...........................................P 57                                                           
						- 227 of T09106_P8, wherein said first amino acid sequence,  	                  .         .                                
						second amino acid sequence, third amino acid sequence and    	     199 VSEFFLIRDTSLIPNVLWFEYTVTRAEAR                      227                                                          
						fourth amino acid sequence are contiguous and in a sequential	         |||||||||||||||||||||||||||||                       
						order.2.An isolated polypeptide encoding for a head of       	      58 VSEFFLIRDTSLIPNVLWFEYTVTRAEAR                      86                                                           
						T09106_P8, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MAADGQCSLPASWRPVTLTHVEYPAGDLSGHLLAYLSLSPVFVIVGFVTLIIFKRELHTI 	                                                            
						SFLGGLALNEGVNWLIKNVIQEPRPCGGPHTAVGTKYG                       	                                                            
						least about 95% homologous to the sequence of T09106_P8.3.An 	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T09106_P8, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VYLLYHTWSQVLYGGIAGGLMAIAWFIFTQEVLTPLFPRIAAW, corresponding to	                                                            
						T09106_P8.                                                   	                                                            

24754	HMR136_T09114_9_tr0_r1_1_gPRT		Comparison report between T09114_P9 and Q9HBX5partial WT     	Sequence name: Q9HBX5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09114_P9, comprising a first amino 	Sequence documentation:                                      
						MGGIMAPKDIMTNTHAKSILNSMNSLRKSNTLCDVTLRVEQKDFPAHRIVLAACSDYFCA 	                                                            
						MFTSELSEKGKPYVDIQGLTASTMEILLDFVYTETVHVTVENVQELLPAACLLQLKG    	Alignment of: 24754 x Q9HBX5   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 117 of Q9HBX5, which also corresponds to  	Alignment segment 1/1:                                       
						amino acids 1 - 117 of T09114_P9, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1135.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     117                Total length:     117                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence TDIKTCYCLCQNSPG corresponding to amino   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acids 118 - 132 of T09114_P9, wherein said first amino acid  	                        Gaps:       0                        
						sequence and second amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	Alignment:                                                   
						tail of T09114_P9, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	       1 MGGIMAPKDIMTNTHAKSILNSMNSLRKSNTLCDVTLRVEQKDFPAHRIV 50                                                           
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence TDIKTCYCLCQNSPG	       1 MGGIMAPKDIMTNTHAKSILNSMNSLRKSNTLCDVTLRVEQKDFPAHRIV 50                                                           
						in T09114_P9.                                                	                  .         .         .         .         .  
						                                                            	      51 LAACSDYFCAMFTSELSEKGKPYVDIQGLTASTMEILLDFVYTETVHVTV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LAACSDYFCAMFTSELSEKGKPYVDIQGLTASTMEILLDFVYTETVHVTV 100                                                          
						                                                            	                  .                                          
						                                                            	     101 ENVQELLPAACLLQLKG                                  117                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     101 ENVQELLPAACLLQLKG                                  117                                                          

2994	HMR136_T09123_11_tr0_r1_1_gPRT		Comparison report between T09123_P11 and BAT5_HUMANpartial   	Sequence name: BAT5_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T09123_P11, comprising a first amino	                                                            
						MLYPGSVYLLQKALMPVLLQGQARLVEECNGRRAKLLACDGNEIDTMFVDRRGTAEPQGQ 	Alignment of: 2994 x BAT5_HUMAN   ..                         
						KLVICCEGNAGFYEVGCVSTPLEAGYSVLGWNHPGFAGSTGVPFPQNEANAMDVVVQFAI 	                                                            
						HRLGFQPQDIIIYAWSIGGFTATWAAMSYPDVSAMILDASFDDLVPLALKVMPDSWRGLV 	Alignment segment 1/1:                                       
						TRTVRQHLNLNNAEQLCRYQGPVLLIRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYP 	                                                            
						RVMAEEGLRVVRQWLEASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDM 	                     Quality: 3370.00                      Escore:       0                                               
						SADGRRQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL                      	             Matching length:     339                Total length:     339                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 220 - 558 of BAT5_HUMAN, which also           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 339 of T09123_P11.            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLYPGSVYLLQKALMPVLLQGQARLVEECNGRRAKLLACDGNEIDTMFVD 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     220 MLYPGSVYLLQKALMPVLLQGQARLVEECNGRRAKLLACDGNEIDTMFVD 269                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 RRGTAEPQGQKLVICCEGNAGFYEVGCVSTPLEAGYSVLGWNHPGFAGST 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     270 RRGTAEPQGQKLVICCEGNAGFYEVGCVSTPLEAGYSVLGWNHPGFAGST 319                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GVPFPQNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     320 GVPFPQNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYP 369                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DVSAMILDASFDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 DVSAMILDASFDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQ 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GPVLLIRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 GPVLLIRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRV 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VRQWLEASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDM 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     470 VRQWLEASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDM 519                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 SADGRRQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL            339                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     520 SADGRRQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL            558                                                          

2992	HMR136_T09123_6_tr0_r1_1_gPRT		Comparison report between T09123_P6 and BAT5_HUMANunique     	Sequence name: BAT5_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09123_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 2992 x BAT5_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						LKMSQLARRRSRYGLTSRAHNTSEAGRAGPAGGPAAGRAAARAGA corresponding  	                                                            
						to amino acids 1 - 45 of T09123_P6, a second amino acid      	                     Quality: 5437.00                      Escore:       0                                               
						MAKLLSCVLGPRLYKIYRERDSERAPASVPETPTAVTAPHSSSWDTYYQPRALEKHADSI 	             Matching length:     558                Total length:     584                                               
						LALASVFWSISYYSSPFAFFYLYRKGYLSLSKVVPFSHYAGTLLLLLAGVACLRGIGRWT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NPQYRQFITILEATHRNQSSENKRQLANYNFDFRSWPVDFHWEEPSSRKESRGGPSRRGV 	    Total Percent Similarity:   95.55      Total Percent Identity:   95.55                                               
						ALLRPEPLHRGTADTLLNRVKKLPCQITSYLVAHTLGRRMLYPGSVYLLQKALMPVLLQG 	                        Gaps:       1                        
						QARLVEECNGRRAKLLACDGNEIDTMFVDRRGTAEPQGQKLVICCEGNAGFYEVGCVSTP 	                                                            
						LEAGYSVLGWNHPGFAGST                                          	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 319 of BAT5_HUMAN, which also corresponds to 	      46 MAKLLSCVLGPRLYKIYRERDSERAPASVPETPTAVTAPHSSSWDTYYQP 95                                                           
						amino acids 46 - 364 of T09123_P6, a third amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MAKLLSCVLGPRLYKIYRERDSERAPASVPETPTAVTAPHSSSWDTYYQP 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      96 RALEKHADSILALASVFWSISYYSSPFAFFYLYRKGYLSLSKVVPFSHYA 145                                                          
						having the sequence EGSTLGGTGELAFGADTLLTLPFLLQ corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 365 - 390 of T09123_P6, and a fourth amino    	      51 RALEKHADSILALASVFWSISYYSSPFAFFYLYRKGYLSLSKVVPFSHYA 100                                                          
						GVPFPQNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYPDVSAMILDAS 	                  .         .         .         .         .  
						FDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQGPVLLIRRTKDEIITTTVPE 	     146 GTLLLLLAGVACLRGIGRWTNPQYRQFITILEATHRNQSSENKRQLANYN 195                                                          
						DIMSNRGNDLLLKLLQHRYPRVMAEEGLRVVRQWLEASSQLEEASIYSRWEVEEDWCLSV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRSYQAEHGPDFPWSVGEDMSADGRRQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL  	     101 GTLLLLLAGVACLRGIGRWTNPQYRQFITILEATHRNQSSENKRQLANYN 150                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 320 - 558 of BAT5_HUMAN, which also           	     196 FDFRSWPVDFHWEEPSSRKESRGGPSRRGVALLRPEPLHRGTADTLLNRV 245                                                          
						corresponds to amino acids 391 - 629 of T09123_P6, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 FDFRSWPVDFHWEEPSSRKESRGGPSRRGVALLRPEPLHRGTADTLLNRV 200                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     246 KKLPCQITSYLVAHTLGRRMLYPGSVYLLQKALMPVLLQGQARLVEECNG 295                                                          
						polypeptide encoding for a head of T09123_P6, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     201 KKLPCQITSYLVAHTLGRRMLYPGSVYLLQKALMPVLLQGQARLVEECNG 250                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     296 RRAKLLACDGNEIDTMFVDRRGTAEPQGQKLVICCEGNAGFYEVGCVSTP 345                                                          
						to the sequence LKMSQLARRRSRYGLTSRAHNTSEAGRAGPAGGPAAGRAAARAGA	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09123_P6.3.An isolated polypeptide encoding for an edge  	     251 RRAKLLACDGNEIDTMFVDRRGTAEPQGQKLVICCEGNAGFYEVGCVSTP 300                                                          
						portion of T09123_P6, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     346 LEAGYSVLGWNHPGFAGSTEGSTLGGTGELAFGADTLLTLPFLLQGVPFP 395                                                          
						least about 85%, more preferably at least about 90% and most 	         |||||||||||||||||||                          |||||  
						preferably at least about 95% homologous to the sequence     	     301 LEAGYSVLGWNHPGFAGST..........................GVPFP 324                                                          
						encoding for EGSTLGGTGELAFGADTLLTLPFLLQ, corresponding to    	                  .         .         .         .         .  
						T09123_P6.                                                   	     396 QNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYPDVSAM 445                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 QNEANAMDVVVQFAIHRLGFQPQDIIIYAWSIGGFTATWAAMSYPDVSAM 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     446 ILDASFDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQGPVLL 495                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 ILDASFDDLVPLALKVMPDSWRGLVTRTVRQHLNLNNAEQLCRYQGPVLL 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     496 IRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRVVRQWL 545                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 IRRTKDEIITTTVPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRVVRQWL 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     546 EASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDMSADGR 595                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 EASSQLEEASIYSRWEVEEDWCLSVLRSYQAEHGPDFPWSVGEDMSADGR 524                                                          
						                                                            	                  .         .         .                      
						                                                            	     596 RQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL                 629                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     525 RQLALFLARKHLHNFEATHCTPLPAQNFQMPWHL                 558                                                          

25581	HMR136_T09132_34_tr0_r1_1_gPRT		Comparison report between T09132_P34 and UNR_HUMANpartial WT 	Sequence name: UNR_HUMAN                                     
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09132_P34, comprising a first amino acid sequence being at  	                                                            
						MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLFFHCSQYNGNL 	Alignment of: 25581 x UNR_HUMAN   ..                         
						QDLKVGDDVEFEVSSDRRTGKPIAVKLVKIKQEILPEERMNGQ                  	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 103	Alignment segment 1/1:                                       
						of UNR_HUMAN, which also corresponds to amino acids 1 - 103  	                                                            
						of T09132_P34, a second amino acid sequence being at least 90	                     Quality: 2319.00                      Escore: 1.46e-09                                              
						EVFYLTYTPEDVEGNVQLETGDKINFVIDNNKHTGAVSARNIMLLKKKQARCQGVVCAMK 	             Matching length:     248                Total length:     279                                               
						EAFGFIERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKEVATDVRLLPQGTVI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FEDISIEHFEGTVTKVIPKVPSKNQ                                    	    Total Percent Similarity:   88.89      Total Percent Identity:   88.89                                               
						% homologous to corresponding to amino acids 135 - 279 of    	                        Gaps:       1                        
						UNR_HUMAN, which also corresponds to amino acids 104 - 248 of	                                                            
						T09132_P34, and a third amino acid sequence being at least   	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       1 MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLF 50                                                           
						homologous to a polypeptide having the sequence VNNLFQESPISPQ	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 249 - 261 of T09132_P34, wherein	       1 MSFDPNLLHNNGHNGYPNGTSAALRETGVIEKLLTSYGFIQCSERQARLF 50                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      51 FHCSQYNGNLQDLKVGDDVEFEVSSDRRTGKPIAVKLVKIKQEILPEERM 100                                                          
						sequential order.2.An isolated chimeric polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of T09132_P34, comprising a polypeptide  	      51 FHCSQYNGNLQDLKVGDDVEFEVSSDRRTGKPIAVKLVKIKQEILPEERM 100                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     101 NGQ...............................EVFYLTYTPEDVEGNV 119                                                          
						length, preferably at least about 30 amino acids in length,  	         |||                               ||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     101 NGQVVCAVPHNLESKSPAAPGQSPTGSVCYERNGEVFYLTYTPEDVEGNV 150                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise QE, having a       	     120 QLETGDKINFVIDNNKHTGAVSARNIMLLKKKQARCQGVVCAMKEAFGFI 169                                                          
						structure as follows: a sequence starting from any of amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 103-x to 104; and ending at any of amino acid   	     151 QLETGDKINFVIDNNKHTGAVSARNIMLLKKKQARCQGVVCAMKEAFGFI 200                                                          
						numbers 104+ ((n-2) - x), in which x varies from 0 to        	                  .         .         .         .         .  
						n-2.3.An isolated polypeptide encoding for a tail of         	     170 ERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKEVATDVRLLPQ 219                                                          
						T09132_P34, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 ERGDVVKEIFFHYSEFKGDLETLQPGDDVEFTIKDRNGKEVATDVRLLPQ 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						least about 95% homologous to the sequence VNNLFQESPISPQ in  	     220 GTVIFEDISIEHFEGTVTKVIPKVPSKNQ                      248                                                          
						T09132_P34.                                                  	         |||||||||||||||||||||||||||||                       
						                                                            	     251 GTVIFEDISIEHFEGTVTKVIPKVPSKNQ                      279                                                          

26053	HMR136_T09141_9_tr0_r1_1_gPRT		Comparison report between T09141_P9 and MDC2_HUMANpartial WT 	Sequence name: MDC2_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09141_P9, comprising a first amino acid        	                                                            
						MTKKGKTLMMFVTVSGSPTEKETEEITSLWQGSLFNANYDVQRFIVGSDRAIFMLRDGSY 	Alignment of: 26053 x MDC2_HUMAN   ..                        
						AWEIKDFLVGQDRCADVTLEGQVYPGKGGGSKEKNKTKQDKGKKKKEGDLKSRSSKEENR 	                                                            
						AGNKREDL                                                     	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 107 - 234 of MDC2_HUMAN, which also corresponds  	                     Quality: 1251.00                      Escore:       0                                               
						to amino acids 1 - 128 of T09141_P9.                         	             Matching length:     128                Total length:     128                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MTKKGKTLMMFVTVSGSPTEKETEEITSLWQGSLFNANYDVQRFIVGSDR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     107 MTKKGKTLMMFVTVSGSPTEKETEEITSLWQGSLFNANYDVQRFIVGSDR 156                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 AIFMLRDGSYAWEIKDFLVGQDRCADVTLEGQVYPGKGGGSKEKNKTKQD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 AIFMLRDGSYAWEIKDFLVGQDRCADVTLEGQVYPGKGGGSKEKNKTKQD 206                                                          
						                                                            	                  .         .                                
						                                                            	     101 KGKKKKEGDLKSRSSKEENRAGNKREDL                       128                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     207 KGKKKKEGDLKSRSSKEENRAGNKREDL                       234                                                          

26666	HMR136_T09153_4_tr0_r1_1_gPRT		Comparison report between T09153_P4 and ATY1_HUMANpartial WT 	Sequence name: ATY1_HUMAN                                    
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09153_P4, comprising a first amino acid sequence being at   	                                                            
						MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGYHVVVWMMAGI 	Alignment of: 26666 x ATY1_HUMAN   ..                        
						PLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSWQLFTVQVQTEAIGEGSLEPS 	                                                            
						PQSQAEDGRSQAAVGAVPEGAWKDTAQLHKSEEA                           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 154	                                                            
						of ATY1_HUMAN, which also corresponds to amino acids 1 - 154 	                     Quality: 10161.00                      Escore:       0                                              
						of T09153_P4, a second amino acid sequence being at least 90 	             Matching length:    1069                Total length:    1078                                               
						KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRSRHGLSLQDQMVRKAIYGPN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VISIPVKSYPQLLVDEALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTR 	    Total Percent Similarity:   99.17      Total Percent Identity:   99.17                                               
						KQSQTLRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECM 	                        Gaps:       2                        
						VNESSLTGESIPVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTG 	                                                            
						FCTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRNRVPLNEIVI 	Alignment:                                                   
						RALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLT 	                  .         .         .         .         .  
						EDGLDVMGVVPLKGQAFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVE 	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						STGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVP 	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						SLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVTGDNLQTAVT 	                  .         .         .         .         .  
						VARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAVNGVK                	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						% homologous to corresponding to amino acids 160 - 804 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATY1_HUMAN, which also corresponds to amino acids 155 - 799  	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						of T09153_P4, a third amino acid sequence being at least 90 %	                  .         .         .         .         .  
						AASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTVFARMAPEQKTELVCELQK 	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						LQYCVGMCGDGANDCGALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSFSVFKYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLG 	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						RVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENT 	                  .         .         .         .         .  
						VVFSLSSFQYLILAAAVSKGAPFRRPLYTN                               	     151 SEEA.....KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 195                                                          
						homologous to corresponding to amino acids 809 - 1078 of     	         ||||     |||||||||||||||||||||||||||||||||||||||||  
						ATY1_HUMAN, which also corresponds to amino acids 800 - 1069 	     151 SEEAVSVGQKRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 200                                                          
						of T09153_P4, and a fourth amino acid sequence being at least	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     196 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 245                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence GAAGAEEHH    	     201 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 250                                                          
						corresponding to amino acids 1070 - 1078 of T09153_P4,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     246 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 295                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     251 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 300                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						T09153_P4, comprising a polypeptide having a length "n",     	     296 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 345                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     301 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 350                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     346 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 395                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise AK, having a structure as  	     351 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 400                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						154-x to 155; and ending at any of amino acid numbers 155+   	     396 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 445                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     401 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 450                                                          
						T09153_P4, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     446 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 495                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     451 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 500                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     496 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 545                                                          
						at least two amino acids comprise KA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     501 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 550                                                          
						799-x to 800; and ending at any of amino acid numbers 800+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     546 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 595                                                          
						polypeptide encoding for a tail of T09153_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     551 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 600                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     596 AVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPE 645                                                          
						to the sequence GAAGAEEHH in T09153_P4.                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     646 AYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPS 695                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 AYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     696 LEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVT 745                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     746 GDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAV 795                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 GDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     796 NGVK....AASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTV 841                                                          
						                                                            	         ||||    ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     842 FARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEA 891                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     892 SVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLI 941                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 SVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLI 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     942 LYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVP 991                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 LYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     992 VLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENTVV 1041                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 VLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENTVV 1050                                                         
						                                                            	                  .         .                                
						                                                            	    1042 FSLSSFQYLILAAAVSKGAPFRRPLYTN                       1069                                                         
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	    1051 FSLSSFQYLILAAAVSKGAPFRRPLYTN                       1078                                                         

26670	HMR136_T09153_6_tr0_r1_1_gPRT		Comparison report between T09153_P6 and ATY1_HUMANunique     	Sequence name: ATY1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09153_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26670 x ATY1_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence CLPPLPQ corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of T09153_P6, and a second amino acid sequence being at    	                                                            
						ALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRV 	                     Quality: 9111.00                      Escore:       0                                               
						CVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESIPVLKT 	             Matching length:     946                Total length:     946                                               
						ALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGFCTAKGGLVSSILHPR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.89                                               
						PINFKFYKHSMKFVAALSVLALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPA 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.89                                               
						AMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQA 	                        Gaps:       0                        
						FLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAF 	                                                            
						GTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPEAYVKG 	Alignment:                                                   
						SPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPSLEAAQQLTRDTVEGD 	                  .         .         .         .         .  
						LSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVTGDNLQTAVTVARGCGMVAPQEHLII 	       7 QALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTRKQSQT 56                                                           
						VHATHPERGQPASLEFLPMESPTAVNGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIVK 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						HFPKLLPKVLVQGTVFARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISL 	     235 EALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTRKQSQT 284                                                          
						SQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLILYTIN 	                  .         .         .         .         .  
						TNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVPVLSSLLLQMVLVTGV 	      57 LRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALV 106                                                          
						QLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENTVVFSLSSFQYLILAAAVSKGAPFRRPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YTNVPFLVALALLSSVLVGLVLVPGLLQGPLALRNITDTGFKLLLLGLVTLNFVGAFMLE 	     285 LRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALV 334                                                          
						SVLDQCLPACLRRLRPKRASKKRFKQLERELAEQPWPPLPAGPLR                	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 236 -  	     107 AGECMVNESSLTGESIPVLKTALPEGLGPYCAETHRRHTLFCGTLILQAR 156                                                          
						1180 of ATY1_HUMAN, which also corresponds to amino acids 8 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						952 of T09153_P6, wherein said first amino acid sequence and 	     335 AGECMVNESSLTGESIPVLKTALPEGLGPYCAETHRRHTLFCGTLILQAR 384                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     157 AYVGPHVLAVVTRTGFCTAKGGLVSSILHPRPINFKFYKHSMKFVAALSV 206                                                          
						T09153_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     385 AYVGPHVLAVVTRTGFCTAKGGLVSSILHPRPINFKFYKHSMKFVAALSV 434                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence CLPPLPQ of        	     207 LALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYA 256                                                          
						T09153_P6.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     435 LALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYA 484                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     257 QSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQ 306                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     485 QSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQ 534                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     307 AFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVESTGWV 356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     535 AFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVESTGWV 584                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     357 LEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSAL 406                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     585 LEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSAL 634                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     407 QRMSVVVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAG 456                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     635 QRMSVVVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAG 684                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     457 YRVVALASKPLPTVPSLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTP 506                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     685 YRVVALASKPLPTVPSLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTP 734                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     507 VIQALRRTRIRAVMVTGDNLQTAVTVARGCGMVAPQEHLIIVHATHPERG 556                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     735 VIQALRRTRIRAVMVTGDNLQTAVTVARGCGMVAPQEHLIIVHATHPERG 784                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     557 QPASLEFLPMESPTAVNGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIV 606                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     785 QPASLEFLPMESPTAVNGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIV 834                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     607 KHFPKLLPKVLVQGTVFARMAPEQKTELVCELQKLQYCVGMCGDGANDCG 656                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     835 KHFPKLLPKVLVQGTVFARMAPEQKTELVCELQKLQYCVGMCGDGANDCG 884                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     657 ALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVF 706                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     885 ALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVF 934                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     707 KYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPA 756                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     935 KYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPA 984                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     757 LVLGRVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNR 806                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     985 LVLGRVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNR 1034                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     807 TVAAPDNLPNYENTVVFSLSSFQYLILAAAVSKGAPFRRPLYTNVPFLVA 856                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1035 TVAAPDNLPNYENTVVFSLSSFQYLILAAAVSKGAPFRRPLYTNVPFLVA 1084                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     857 LALLSSVLVGLVLVPGLLQGPLALRNITDTGFKLLLLGLVTLNFVGAFML 906                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1085 LALLSSVLVGLVLVPGLLQGPLALRNITDTGFKLLLLGLVTLNFVGAFML 1134                                                         
						                                                            	                  .         .         .         .            
						                                                            	     907 ESVLDQCLPACLRRLRPKRASKKRFKQLERELAEQPWPPLPAGPLR     952                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	    1135 ESVLDQCLPACLRRLRPKRASKKRFKQLERELAEQPWPPLPAGPLR     1180                                                         

26664	HMR136_T09153_7_tr0_r1_1_gPRT		Comparison report between T09153_P7 and ATY1_HUMANpartial WT 	Sequence name: ATY1_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09153_P7, comprising a first amino 	Sequence documentation:                                      
						MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGYHVVVWMMAGI 	                                                            
						PLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSWQLFTVQVQTEAIGEGSLEPS 	Alignment of: 26664 x ATY1_HUMAN   ..                        
						PQSQAEDGRSQAAVGAVPEGAWKDTAQLHKSEEA                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 154 of ATY1_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 154 of T09153_P7, a second amino acid     	                     Quality: 9679.00                      Escore:       0                                               
						KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRSRHGLSLQDQMVRKAIYGPN 	             Matching length:    1019                Total length:    1028                                               
						VISIPVKSYPQLLVDEALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KQSQTLRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECM 	    Total Percent Similarity:   99.12      Total Percent Identity:   99.12                                               
						VNESSLTGESIPVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTG 	                        Gaps:       2                        
						FCTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRNRVPLNEIVI 	                                                            
						RALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLT 	Alignment:                                                   
						EDGLDVMGVVPLKGQAFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVE 	                  .         .         .         .         .  
						STGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSV 	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						VVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVTGDNLQTAVT 	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						VARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAVNGVK                	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						amino acids 160 - 804 of ATY1_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 155 - 799 of T09153_P7, and a third amino acid	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						AASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTVFARMAPEQKTELVCELQK 	                  .         .         .         .         .  
						LQYCVGMCGDGANDCGALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLD 	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						TSFSVFKYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPW                     	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 809 - 1028 of ATY1_HUMAN, which also corresponds 	     151 SEEA.....KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 195                                                          
						to amino acids 800 - 1019 of T09153_P7, wherein said first   	         ||||     |||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 SEEAVSVGQKRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	     196 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 245                                                          
						portion of T09153_P7, comprising a polypeptide having a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length "n", wherein n is at least about 10 amino acids in    	     201 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 250                                                          
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     246 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 295                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     251 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 300                                                          
						at least two amino acids comprise AK, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     296 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 345                                                          
						154-x to 155; and ending at any of amino acid numbers 155+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     301 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 350                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09153_P7, comprising a polypeptide having a length "n",     	     346 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 395                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     351 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     396 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 445                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise KA, having a structure as  	     401 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						799-x to 800; and ending at any of amino acid numbers 800+   	     446 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 495                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     496 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 545                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     546 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 595                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     596 AVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPE 645                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPE 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     646 AYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPS 695                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 AYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     696 LEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVT 745                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 LEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVT 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     746 GDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAV 795                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 GDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     796 NGVK....AASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTV 841                                                          
						                                                            	         ||||    ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 NGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     842 FARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEA 891                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEA 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     892 SVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLI 941                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 SVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLI 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     942 LYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVP 991                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 LYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVP 1000                                                         
						                                                            	                  .         .                                
						                                                            	     992 VLSSLLLQMVLVTGVQLGGYFLTLAQPW                       1019                                                         
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	    1001 VLSSLLLQMVLVTGVQLGGYFLTLAQPW                       1028                                                         

26668	HMR136_T09153_8_tr0_r1_1_gPRT		Comparison report between T09153_P8 and ATY1_HUMANpartial WT 	Sequence name: ATY1_HUMAN                                    
						sequence featuring skipped exon and a followed by a short    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						T09153_P8, comprising a first amino acid sequence being at   	                                                            
						MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGYHVVVWMMAGI 	Alignment of: 26668 x ATY1_HUMAN   ..                        
						PLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSWQLFTVQVQTEAIGEGSLEPS 	                                                            
						PQSQAEDGRSQAAVGAVPEGAWKDTAQLHKSEEA                           	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 154	                                                            
						of ATY1_HUMAN, which also corresponds to amino acids 1 - 154 	                     Quality: 5867.00                      Escore:       0                                               
						of T09153_P8, a second amino acid sequence being at least 90 	             Matching length:     610                Total length:     615                                               
						KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRSRHGLSLQDQMVRKAIYGPN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VISIPVKSYPQLLVDEALNPYYGFQAFSIALWLADHYYWYALCIFLISSISICLSLYKTR 	    Total Percent Similarity:   99.19      Total Percent Identity:   99.19                                               
						KQSQTLRDMVKLSMRVCVCRPGGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECM 	                        Gaps:       1                        
						VNESSLTGESIPVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTG 	                                                            
						FCTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRNRVPLNEIVI 	Alignment:                                                   
						RALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLT 	                  .         .         .         .         .  
						EDGLDVMGVVPLKGQAFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVE 	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						STGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAM                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 160 - 615 of    	       1 MSADSSPLVGSTPTGYGTLTIGTSIDPLSSSVSSVRLSGYCGSPWRVIGY 50                                                           
						ATY1_HUMAN, which also corresponds to amino acids 155 - 610  	                  .         .         .         .         .  
						of T09153_P8, and a third amino acid sequence being at least 	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 HVVVWMMAGIPLLLFRWKPLWGVRLRLRPCNLAHAETLVIEIRDKEDSSW 100                                                          
						homologous to a polypeptide having the sequence VS           	                  .         .         .         .         .  
						corresponding to amino acids 611 - 612 of T09153_P8, wherein 	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and third amino acid sequence are contiguous and in a        	     101 QLFTVQVQTEAIGEGSLEPSPQSQAEDGRSQAAVGAVPEGAWKDTAQLHK 150                                                          
						sequential order.2.An isolated chimeric polypeptide encoding 	                  .         .         .         .         .  
						for an edge portion of T09153_P8, comprising a polypeptide   	     151 SEEA.....KRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 195                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||     |||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     151 SEEAVSVGQKRVLRYYLFQGQRYIWIETQQAFYQVSLLDHGRSCDDVHRS 200                                                          
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	     196 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 245                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein at least two amino acids comprise AK, having a       	     201 RHGLSLQDQMVRKAIYGPNVISIPVKSYPQLLVDEALNPYYGFQAFSIAL 250                                                          
						structure as follows: a sequence starting from any of amino  	                  .         .         .         .         .  
						acid numbers 154-x to 155; and ending at any of amino acid   	     246 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 295                                                          
						numbers 155+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WLADHYYWYALCIFLISSISICLSLYKTRKQSQTLRDMVKLSMRVCVCRP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     296 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 345                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GGEEEWVDSSELVPGDCLVLPQEGGLMPCDAALVAGECMVNESSLTGESI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     346 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 395                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PVLKTALPEGLGPYCAETHRRHTLFCGTLILQARAYVGPHVLAVVTRTGF 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     396 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 445                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 CTAKGGLVSSILHPRPINFKFYKHSMKFVAALSVLALLGTIYSIFILYRN 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     446 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 495                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     496 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 545                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 INLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGP 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     546 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 595                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVL 600                                                          
						                                                            	                  .                                          
						                                                            	     596 AVMRPPLWEPQLQAM                                    610                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 AVMRPPLWEPQLQAM                                    615                                                          

26993	HMR136_T09157_7_tr0_r1_1_gPRT		Comparison report between T09157_P7 and Q9H0R3unique head    	Sequence name: Q9H0R3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09157_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26993 x Q9H0R3   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LTYPLLSHCTSATYPGLSSGPNVSSSLTSAFVPQQ      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 35 of T09157_P7, and a      	                                                            
						EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDNCHSHVALALN 	                     Quality: 1168.00                      Escore:       0                                               
						LMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFILLLGIILTVSLVFNLR      	             Matching length:     115                Total length:     115                                               
						second amino acid sequence being at least 90 % homologous to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 74 - 188 of Q9H0R3, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 36 - 150 of T09157_P7, wherein    	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a head of T09157_P7, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      36 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 85                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      74 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 123                                                          
						to the sequence LTYPLLSHCTSATYPGLSSGPNVSSSLTSAFVPQQ of       	                  .         .         .         .         .  
						T09157_P7.                                                   	      86 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 135                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     124 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 173                                                          
						                                                            	                  .                                          
						                                                            	     136 LLGIILTVSLVFNLR                                    150                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     174 LLGIILTVSLVFNLR                                    188                                                          

						Comparison report between T09157_P7 and Q8TDQ4unique head    	Sequence name: Q8TDQ4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09157_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26993 x Q8TDQ4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence LTYPLLSHCTSATYPGLSSGPNVSSSLTSAFVPQQ      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 35 of T09157_P7, and a      	                                                            
						EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDNCHSHVALALN 	                     Quality: 1168.00                      Escore:       0                                               
						LMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFILLLGIILTVSLVFNLR      	             Matching length:     115                Total length:     115                                               
						second amino acid sequence being at least 90 % homologous to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 61 - 175 of Q8TDQ4, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 36 - 150 of T09157_P7, wherein    	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a head of T09157_P7, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      36 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 85                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      61 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 110                                                          
						to the sequence LTYPLLSHCTSATYPGLSSGPNVSSSLTSAFVPQQ of       	                  .         .         .         .         .  
						T09157_P7.                                                   	      86 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 135                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     111 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 160                                                          
						                                                            	                  .                                          
						                                                            	     136 LLGIILTVSLVFNLR                                    150                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     161 LLGIILTVSLVFNLR                                    175                                                          

26991	HMR136_T09157_8_tr0_r1_1_gPRT		Comparison report between T09157_P8 and Q9H0R3unique head    	Sequence name: Q9H0R3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09157_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26991 x Q9H0R3   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						PVGAGRAPHGGSGREFSALVAAAATPAQDGGSGGADGGRDGHEAISRLRRRRHGCGTESL 	Alignment segment 1/1:                                       
						PLLRGVDAHPGAH                                                	                                                            
						having the sequence corresponding to amino acids 1 - 73 of   	                     Quality: 1168.00                      Escore:       0                                               
						T09157_P8, and a second amino acid sequence being at least 90	             Matching length:     115                Total length:     115                                               
						EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDNCHSHVALALN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFILLLGIILTVSLVFNLR      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						% homologous to corresponding to amino acids 74 - 188 of     	                        Gaps:       0                        
						Q9H0R3, which also corresponds to amino acids 74 - 188 of    	                                                            
						T09157_P8, wherein said first amino acid sequence and second 	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      74 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 123                                                          
						T09157_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      74 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 123                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						PVGAGRAPHGGSGREFSALVAAAATPAQDGGSGGADGGRDGHEAISRLRRRRHGCGTESL 	     124 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 173                                                          
						PLLRGVDAHPGAH                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of T09157_P8.     	     124 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 173                                                          
						                                                            	                  .                                          
						                                                            	     174 LLGIILTVSLVFNLR                                    188                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     174 LLGIILTVSLVFNLR                                    188                                                          

						Comparison report between T09157_P8 and Q8TDQ4unique head    	Sequence name: Q8TDQ4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09157_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 26991 x Q8TDQ4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						PVGAGRAPHGGSGREFSALVAAAATPAQDGGSGGADGGRDGHEAISRLRRRRHGCGTESL 	Alignment segment 1/1:                                       
						PLLRGVDAHPGAH                                                	                                                            
						having the sequence corresponding to amino acids 1 - 73 of   	                     Quality: 1168.00                      Escore:       0                                               
						T09157_P8, and a second amino acid sequence being at least 90	             Matching length:     115                Total length:     115                                               
						EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDNCHSHVALALN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFILLLGIILTVSLVFNLR      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						% homologous to corresponding to amino acids 61 - 175 of     	                        Gaps:       0                        
						Q8TDQ4, which also corresponds to amino acids 74 - 188 of    	                                                            
						T09157_P8, wherein said first amino acid sequence and second 	Alignment:                                                   
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      74 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 123                                                          
						T09157_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      61 EDNMAFGKPAKYWKLDPAQVYASGPNAWDTAVHDASEEYKHRMHNLCCDN 110                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						PVGAGRAPHGGSGREFSALVAAAATPAQDGGSGGADGGRDGHEAISRLRRRRHGCGTESL 	     124 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 173                                                          
						PLLRGVDAHPGAH                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of T09157_P8.     	     111 CHSHVALALNLMRYNNSTNWNMVTLCFFCLLYGKYVSVGAFVKTWLPFIL 160                                                          
						                                                            	                  .                                          
						                                                            	     174 LLGIILTVSLVFNLR                                    188                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     161 LLGIILTVSLVFNLR                                    175                                                          

27122	HMR136_T09158_10_tr0_r1_1_gPRT		Comparison report between T09158_P10 and                     	Sequence name: RFC1_HUMAN_V5                                 
						RFC1_HUMAN_V5partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09158_P10, comprising a first amino acid sequence being at  	                                                            
						MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQR 	Alignment of: 27122 x RFC1_HUMAN_V5   ..                     
						SNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLDEEP 	                                                            
						KTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKYESSKES 	Alignment segment 1/1:                                       
						QQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK 	                                                            
						TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 	                     Quality: 4972.00                      Escore:       0                                               
						VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLL 	             Matching length:     514                Total length:     514                                               
						NLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.61                                               
						SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.61                                               
						TIIGQQGDQSCANKLLRWLRNWQKSSSEDKKH                             	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 117 -  	                                                            
						628 of RFC1_HUMAN_V5, which also corresponds to amino acids 1	Alignment:                                                   
						- 512 of T09158_P10, and a second amino acid sequence being  	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	       1 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 50                                                           
						85%, more preferably at least 90% and most preferably at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	     117 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 166                                                          
						AQSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding 	                  .         .         .         .         .  
						to amino acids 513 - 558 of T09158_P10, wherein said first   	      51 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 100                                                          
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     167 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 216                                                          
						polypeptide encoding for a tail of T09158_P10, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     101 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 150                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     217 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 266                                                          
						to the sequence                                              	                  .         .         .         .         .  
						AQSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN in T09158_P10.	     151 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 SKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 616                                                          
						                                                            	                  .                                          
						                                                            	     501 NWQKSSSEDKKHAQ                                     514                                                          
						                                                            	         ||||||||||||::                                      
						                                                            	     617 NWQKSSSEDKKHSK                                     630                                                          

						Comparison report between T09158_P10 and AAH51751partial WT  	Sequence name: AAH51751                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09158_P10, comprising a first amino	Sequence documentation:                                      
						MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQR 	                                                            
						SNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLDEEP 	Alignment of: 27122 x AAH51751   ..                          
						KTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKYESSKES 	                                                            
						QQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK 	Alignment segment 1/1:                                       
						TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 	                                                            
						VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLL 	                     Quality: 4979.00                      Escore:       0                                               
						NLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD 	             Matching length:     514                Total length:     514                                               
						SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						TIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHA                            	    Total Percent Similarity:  100.00      Total Percent Identity:   99.81                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 117 - 629 of AAH51751, which also corresponds 	                                                            
						to amino acids 1 - 513 of T09158_P10, and a second amino acid	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence                                          	     117 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 166                                                          
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	                  .         .         .         .         .  
						to amino acids 514 - 558 of T09158_P10, wherein said first   	      51 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 100                                                          
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     167 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 216                                                          
						polypeptide encoding for a tail of T09158_P10, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     101 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 150                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     217 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 266                                                          
						to the sequence QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN	                  .         .         .         .         .  
						in T09158_P10.                                               	     151 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 SKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 616                                                          
						                                                            	                  .                                          
						                                                            	     501 NWQKSSSEDKKHAQ                                     514                                                          
						                                                            	         |||||||||||||:                                      
						                                                            	     617 NWQKSSSEDKKHAK                                     630                                                          

						Comparison report between T09158_P10 and AAH51786partial WT  	Sequence name: AAH51786                                      
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09158_P10, comprising a first amino acid sequence being at  	                                                            
						MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQR 	Alignment of: 27122 x AAH51786   ..                          
						SNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLDEEP 	                                                            
						KTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKYESSKES 	Alignment segment 1/1:                                       
						QQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK 	                                                            
						TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 	                     Quality: 4972.00                      Escore:       0                                               
						VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLL 	             Matching length:     522                Total length:     522                                               
						NLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD 	 Matching Percent Similarity:   98.85   Matching Percent Identity:   98.47                                               
						SLAKTIKKETDVFWKSLDFKEQVAEETSGD                               	    Total Percent Similarity:   98.85      Total Percent Identity:   98.47                                               
						least 90 % homologous to corresponding to amino acids 117 -  	                        Gaps:       0                        
						566 of AAH51786, which also corresponds to amino acids 1 -   	                                                            
						450 of T09158_P10, a bridging amino acid S corresponding to  	Alignment:                                                   
						amino acid 451 of T09158_P10, a second amino acid sequence   	                  .         .         .         .         .  
						KARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKK 	       1 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 50                                                           
						HA                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     117 MCKKAASKSKENGRSTNSHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVL 166                                                          
						acids 568 - 629 of AAH51786, which also corresponds to amino 	                  .         .         .         .         .  
						acids 452 - 513 of T09158_P10, and a third amino acid        	      51 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 100                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     167 DYFGTGSVQRSNKKMVASKRKELSQNTDESGLNDEAIAKQLQLDEDAELE 216                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	     101 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 150                                                          
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 514 - 558 of T09158_P10, wherein said first   	     217 RQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKY 266                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     151 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 200                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T09158_P10, comprising a polypeptide being at least  	     267 PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKAS 316                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     201 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 250                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN in T09158_P10. 	     317 SKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKES 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 VSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITG 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 VLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALG 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 TKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRK 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 ISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 500                                                          
						                                                            	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 NKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLR 616                                                          
						                                                            	                  .         .                                
						                                                            	     501 NWQKSSSEDKKHAQSLVNFPAK                             522                                                          
						                                                            	         |||||||||||||  :  |  |                              
						                                                            	     617 NWQKSSSEDKKHAAKFGKFSGK                             638                                                          

						Comparison report between T09158_P10 and Q14756unique head   	Sequence name: Q14756                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09158_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27122 x Q14756   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MCKKAASKSKENGRSTN corresponding to amino acids 1 - 17 of     	                                                            
						T09158_P10, a second amino acid sequence being at least 90 % 	                     Quality: 4810.00                      Escore:       0                                               
						SHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQRSNKKMVASKRKELSQNT 	             Matching length:     497                Total length:     497                                               
						DESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLDEEPKTKKARKDTEAGETFSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						VQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.80                                               
						KASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSE 	                        Gaps:       0                        
						KKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERY 	                                                            
						GGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMPGKKSKYEIAV 	Alignment:                                                   
						ETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRDSLAKTIKKETDVFWKSL 	                  .         .         .         .         .  
						DFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLR 	      18 SHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQRSNKKMVA 67                                                           
						WLRNWQKSSSEDKKHA                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 23 - 518 of       	      23 SHLGTSNMKKNEENTKTKNKPLSPIKLTPTSVLDYFGTGSVQRSNKKMVA 72                                                           
						Q14756, which also corresponds to amino acids 18 - 513 of    	                  .         .         .         .         .  
						T09158_P10, and a third amino acid sequence being at least   	      68 SKRKELSQNTDESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLD 117                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      73 SKRKELSQNTDESGLNDEAIAKQLQLDEDAELERQLHEDEEFARTLAMLD 122                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	     118 EEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYS 167                                                          
						to amino acids 514 - 558 of T09158_P10, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     123 EEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYS 172                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     168 PRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEI 217                                                          
						T09158_P10, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     173 PRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEI 222                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MCKKAASKSKENGRSTN 	     218 EPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYR 267                                                          
						of T09158_P10.3.An isolated polypeptide encoding for a tail  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09158_P10, comprising a polypeptide being at least 70%,  	     223 EPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYR 272                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     268 SYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERY 317                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN in T09158_P10. 	     273 SYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERY 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     318 GGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMP 367                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 GGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMP 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     368 GKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTS 417                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 GKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTS 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     418 KRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVEN 467                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 KRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVEN 472                                                          
						                                                            	                  .         .         .         .            
						                                                            	     468 LLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAQ    514                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||:     
						                                                            	     473 LLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAK    519                                                          

27124	HMR136_T09158_11_tr0_r1_1_gPRT		Comparison report between T09158_P11 and                     	Sequence name: RFC1_HUMAN_V5                                 
						RFC1_HUMAN_V5partial WT sequence followed by a unique        	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09158_P11, comprising a first amino acid sequence being at  	                                                            
						MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKY 	Alignment of: 27124 x RFC1_HUMAN_V5   ..                     
						ESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGE 	                                                            
						TKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGL 	Alignment segment 1/1:                                       
						IFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKII 	                                                            
						DEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 	                     Quality: 3866.00                      Escore:       0                                               
						PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKY 	             Matching length:     400                Total length:     400                                               
						KPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKH                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.50                                               
						least 90 % homologous to corresponding to amino acids 231 -  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.50                                               
						628 of RFC1_HUMAN_V5, which also corresponds to amino acids 1	                        Gaps:       0                        
						- 398 of T09158_P11, and a second amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment:                                                   
						85%, more preferably at least 90% and most preferably at     	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	       1 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 50                                                           
						AQSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 399 - 444 of T09158_P11, wherein said first   	     231 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 280                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 100                                                          
						polypeptide encoding for a tail of T09158_P11, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     281 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 330                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 150                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AQSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN in T09158_P11.	     331 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 430                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     531 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||::  
						                                                            	     581 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHSK 630                                                          

						Comparison report between T09158_P11 and AAH51751partial WT  	Sequence name: AAH51751                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09158_P11, comprising a first amino	Sequence documentation:                                      
						MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKY 	                                                            
						ESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGE 	Alignment of: 27124 x AAH51751   ..                          
						TKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGL 	                                                            
						IFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKII 	Alignment segment 1/1:                                       
						DEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 	                                                            
						PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKY 	                     Quality: 3873.00                      Escore:       0                                               
						KPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHA                      	             Matching length:     400                Total length:     400                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.75                                               
						to amino acids 231 - 629 of AAH51751, which also corresponds 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.75                                               
						to amino acids 1 - 399 of T09158_P11, and a second amino acid	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	       1 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 50                                                           
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 400 - 444 of T09158_P11, wherein said first   	     231 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 280                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 100                                                          
						polypeptide encoding for a tail of T09158_P11, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     281 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 330                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 150                                                          
						to the sequence QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in T09158_P11.                                               	     331 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 430                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     531 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAQ 400                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     581 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAK 630                                                          

						Comparison report between T09158_P11 and AAH51786partial WT  	Sequence name: AAH51786                                      
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09158_P11, comprising a first amino acid sequence being at  	                                                            
						MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKY 	Alignment of: 27124 x AAH51786   ..                          
						ESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGE 	                                                            
						TKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGL 	Alignment segment 1/1:                                       
						IFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKII 	                                                            
						DEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 	                     Quality: 3866.00                      Escore:       0                                               
						PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGD                         	             Matching length:     408                Total length:     408                                               
						least 90 % homologous to corresponding to amino acids 231 -  	 Matching Percent Similarity:   98.53   Matching Percent Identity:   98.04                                               
						566 of AAH51786, which also corresponds to amino acids 1 -   	    Total Percent Similarity:   98.53      Total Percent Identity:   98.04                                               
						336 of T09158_P11, a bridging amino acid S corresponding to  	                        Gaps:       0                        
						amino acid 337 of T09158_P11, a second amino acid sequence   	                                                            
						KARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKK 	Alignment:                                                   
						HA                                                           	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	       1 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 50                                                           
						acids 568 - 629 of AAH51786, which also corresponds to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 338 - 399 of T09158_P11, and a third amino acid        	     231 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 280                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      51 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 100                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence                                          	     281 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 330                                                          
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	                  .         .         .         .         .  
						to amino acids 400 - 444 of T09158_P11, wherein said first   	     101 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     331 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 380                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of T09158_P11, comprising a polypeptide being at least  	     151 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     381 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 430                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN in T09158_P11. 	     201 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 530                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||:|||||||||||||  
						                                                            	     531 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDNKARNLADDSSENK 580                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAQ 400                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     581 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAA 630                                                          
						                                                            	                                                             
						                                                            	     401 SLVNFPAK                                           408                                                          
						                                                            	          :  |  |                                            
						                                                            	     631 KFGKFSGK                                           638                                                          

						Comparison report between T09158_P11 and Q14756partial WT    	Sequence name: Q14756                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09158_P11, comprising a first amino	Sequence documentation:                                      
						MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERKSYSPRKQSKY 	                                                            
						ESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGE 	Alignment of: 27124 x Q14756   ..                            
						TKTPKKTKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGL 	                                                            
						IFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKII 	Alignment segment 1/1:                                       
						DEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 	                                                            
						PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKY 	                     Quality: 3873.00                      Escore:       0                                               
						KPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHA                      	             Matching length:     400                Total length:     400                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.75                                               
						to amino acids 120 - 518 of Q14756, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:   99.75                                               
						amino acids 1 - 399 of T09158_P11, and a second amino acid   	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence                                          	       1 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 50                                                           
						QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN corresponding  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 400 - 444 of T09158_P11, wherein said first   	     120 MLDEEPKTKKARKDTEAGETFSSVQANLSKAEKHKYPHKVKTAQVSDERK 169                                                          
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 100                                                          
						polypeptide encoding for a tail of T09158_P11, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     170 SYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSY 219                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 150                                                          
						to the sequence QSLVNFPAKMMALVLKQRCCQALLVLAKPPQLPWCVRSWDTATWN	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in T09158_P11.                                               	     220 KEIEPVASKRKENAIKLKGETKTPKKTKSSPAKKESVSPEDSEKKRTNYQ 269                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     270 AYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLI 319                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     320 ERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIR 369                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     370 TMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSR 419                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     420 PTSKRDSLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENK 469                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAQ 400                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						                                                            	     470 VENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDKKHAK 519                                                          

27191	HMR136_T09168_1_tr0_r1_1_gPRT		Comparison report between T09168_P1 and Q9H7V7partial WT     	Sequence name: Q9H7V7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09168_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCN corresponding to     	Alignment of: 27191 x Q9H7V7   ..                            
						amino acids 125 - 163 of Q9H7V7, which also corresponds to   	                                                            
						amino acids 1 - 39 of T09168_P1, a bridging amino acid L     	Alignment segment 1/1:                                       
						corresponding to amino acid 40 of T09168_P1, and a second    	                                                            
						AVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 	                     Quality: 4165.00                      Escore:       0                                               
						VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSL 	             Matching length:     423                Total length:     423                                               
						GTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYAT 	 Matching Percent Similarity:   99.76   Matching Percent Identity:   99.76                                               
						RQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSW 	    Total Percent Similarity:   99.76      Total Percent Identity:   99.76                                               
						QRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTE 	                        Gaps:       0                        
						PDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 	                                                            
						MGVHHLHRKDSLTQAQEQGNLLN                                      	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 165 - 547 of Q9H7V7, which also 	       1 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNLAVQLLKCNKS 50                                                           
						corresponds to amino acids 41 - 423 of T09168_P1, wherein    	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						said first amino acid sequence, bridging amino acid and      	     125 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNPAVQLLKCNKS 174                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     175 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 524                                                          
						                                                            	                  .         .                                
						                                                            	     401 MGVHHLHRKDSLTQAQEQGNLLN                            423                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     525 MGVHHLHRKDSLTQAQEQGNLLN                            547                                                          

27173	HMR136_T09168_3_tr0_r1_1_gPRT		Comparison report between T09168_P3 and Q9H7V7partial WT     	Sequence name: Q9H7V7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09168_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCN corresponding to     	Alignment of: 27173 x Q9H7V7   ..                            
						amino acids 125 - 163 of Q9H7V7, which also corresponds to   	                                                            
						amino acids 1 - 39 of T09168_P3, a bridging amino acid L     	Alignment segment 1/1:                                       
						corresponding to amino acid 40 of T09168_P3, and a second    	                                                            
						AVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 	                     Quality: 4165.00                      Escore:       0                                               
						VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSL 	             Matching length:     423                Total length:     423                                               
						GTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYAT 	 Matching Percent Similarity:   99.76   Matching Percent Identity:   99.76                                               
						RQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSW 	    Total Percent Similarity:   99.76      Total Percent Identity:   99.76                                               
						QRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTE 	                        Gaps:       0                        
						PDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 	                                                            
						MGVHHLHRKDSLTQAQEQGNLLN                                      	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 165 - 547 of Q9H7V7, which also 	       1 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNLAVQLLKCNKS 50                                                           
						corresponds to amino acids 41 - 423 of T09168_P3, wherein    	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						said first amino acid sequence, bridging amino acid and      	     125 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNPAVQLLKCNKS 174                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     175 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 524                                                          
						                                                            	                  .         .                                
						                                                            	     401 MGVHHLHRKDSLTQAQEQGNLLN                            423                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     525 MGVHHLHRKDSLTQAQEQGNLLN                            547                                                          

27177	HMR136_T09168_5_tr0_r1_1_gPRT		Comparison report between T09168_P5 and Q9H7V7partial WT     	Sequence name: Q9H7V7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09168_P5, comprising a first amino 	Sequence documentation:                                      
						MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKFKDKFRRLQNS 	                                                            
						YTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLD 	Alignment of: 27177 x Q9H7V7   ..                            
						CN                                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 42 - 163 of Q9H7V7, which also corresponds to 	                                                            
						amino acids 1 - 122 of T09168_P5, a bridging amino acid L    	                     Quality: 4964.00                      Escore:       0                                               
						corresponding to amino acid 123 of T09168_P5, and a second   	             Matching length:     506                Total length:     506                                               
						AVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.80                                               
						VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSL 	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						GTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYAT 	                        Gaps:       0                        
						RQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSW 	                                                            
						QRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTE 	Alignment:                                                   
						PDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 	                  .         .         .         .         .  
						MGVHHLHRKDSLTQAQEQGNLLN                                      	       1 MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKF 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 165 - 547 of Q9H7V7, which also 	      42 MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKF 91                                                           
						corresponds to amino acids 124 - 506 of T09168_P5, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	      51 KDKFRRLQNSYTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKL 100                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	      92 KDKFRRLQNSYTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKL 141                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LDAKNTINKLEELNERYRLDCNLAVQLLKCNKSHFRNHKFADLPCELQDM 150                                                          
						                                                            	         |||||||||||||||||||||| |||||||||||||||||||||||||||  
						                                                            	     142 LDAKNTINKLEELNERYRLDCNPAVQLLKCNKSHFRNHKFADLPCELQDM 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VRKHLHSGQEAASPGPAPSLAPGAVVPTSVIARVLEKPESLLLNSAQSGS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 VRKHLHSGQEAASPGPAPSLAPGAVVPTSVIARVLEKPESLLLNSAQSGS 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSLGTARGSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 AGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSLGTARGSP 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 EEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCT 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YATRQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 YATRQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPA 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 SSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPA 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DRDEVVQAPSARPEESELLLPTEPDSGFPREEEELNLPISPEEERQSLLP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 DRDEVVQAPSARPEESELLLPTEPDSGFPREEEELNLPISPEEERQSLLP 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 INRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKRMGVHHLHRKDSLTQAQE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 INRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKRMGVHHLHRKDSLTQAQE 541                                                          
						                                                            	                                                             
						                                                            	     501 QGNLLN                                             506                                                          
						                                                            	         ||||||                                              
						                                                            	     542 QGNLLN                                             547                                                          

27193	HMR136_T09168_6_tr0_r1_1_gPRT		Comparison report between T09168_P6 and Q9H7V7partial WT     	Sequence name: Q9H7V7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09168_P6, comprising a first amino 	Sequence documentation:                                      
						MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKFKDKFRRLQNS 	                                                            
						YTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLD 	Alignment of: 27193 x Q9H7V7   ..                            
						CN                                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 42 - 163 of Q9H7V7, which also corresponds to 	                                                            
						amino acids 1 - 122 of T09168_P6, a bridging amino acid L    	                     Quality: 4964.00                      Escore:       0                                               
						corresponding to amino acid 123 of T09168_P6, and a second   	             Matching length:     506                Total length:     506                                               
						AVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.80                                               
						VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSL 	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						GTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYAT 	                        Gaps:       0                        
						RQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSW 	                                                            
						QRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTE 	Alignment:                                                   
						PDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 	                  .         .         .         .         .  
						MGVHHLHRKDSLTQAQEQGNLLN                                      	       1 MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKF 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 165 - 547 of Q9H7V7, which also 	      42 MKLLQEENEELRRRLASATRRTEALERELEIGQDCLELELGQSREELDKF 91                                                           
						corresponds to amino acids 124 - 506 of T09168_P6, wherein   	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	      51 KDKFRRLQNSYTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKL 100                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	      92 KDKFRRLQNSYTASQRTNQELEDKLHTLIKKAEMDRKTLDWEIVELTNKL 141                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LDAKNTINKLEELNERYRLDCNLAVQLLKCNKSHFRNHKFADLPCELQDM 150                                                          
						                                                            	         |||||||||||||||||||||| |||||||||||||||||||||||||||  
						                                                            	     142 LDAKNTINKLEELNERYRLDCNPAVQLLKCNKSHFRNHKFADLPCELQDM 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VRKHLHSGQEAASPGPAPSLAPGAVVPTSVIARVLEKPESLLLNSAQSGS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 VRKHLHSGQEAASPGPAPSLAPGAVVPTSVIARVLEKPESLLLNSAQSGS 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSLGTARGSP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 AGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSLGTARGSP 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 EEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCT 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YATRQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 YATRQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPA 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 SSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPA 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DRDEVVQAPSARPEESELLLPTEPDSGFPREEEELNLPISPEEERQSLLP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 DRDEVVQAPSARPEESELLLPTEPDSGFPREEEELNLPISPEEERQSLLP 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 INRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKRMGVHHLHRKDSLTQAQE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 INRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKRMGVHHLHRKDSLTQAQE 541                                                          
						                                                            	                                                             
						                                                            	     501 QGNLLN                                             506                                                          
						                                                            	         ||||||                                              
						                                                            	     542 QGNLLN                                             547                                                          

27175	HMR136_T09168_8_tr0_r1_1_gPRT		Comparison report between T09168_P8 and Q9H7V7partial WT     	Sequence name: Q9H7V7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09168_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCN corresponding to     	Alignment of: 27175 x Q9H7V7   ..                            
						amino acids 125 - 163 of Q9H7V7, which also corresponds to   	                                                            
						amino acids 1 - 39 of T09168_P8, a bridging amino acid L     	Alignment segment 1/1:                                       
						corresponding to amino acid 40 of T09168_P8, and a second    	                                                            
						AVQLLKCNKSHFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 	                     Quality: 4165.00                      Escore:       0                                               
						VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPTPQPNGECHSL 	             Matching length:     423                Total length:     423                                               
						GTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEFSEDKVRIPRNSPLPNCTYAT 	 Matching Percent Similarity:   99.76   Matching Percent Identity:   99.76                                               
						RQAISLSLVEEGSERARPSPVPSTPASAQASPHHQPSPAPLTLSAPASSASSEEDLLVSW 	    Total Percent Similarity:   99.76      Total Percent Identity:   99.76                                               
						QRAFVDRTPPPAAVAQRTAFGRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTE 	                        Gaps:       0                        
						PDSGFPREEEELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 	                                                            
						MGVHHLHRKDSLTQAQEQGNLLN                                      	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 165 - 547 of Q9H7V7, which also 	       1 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNLAVQLLKCNKS 50                                                           
						corresponds to amino acids 41 - 423 of T09168_P8, wherein    	         ||||||||||||||||||||||||||||||||||||||| ||||||||||  
						said first amino acid sequence, bridging amino acid and      	     125 MDRKTLDWEIVELTNKLLDAKNTINKLEELNERYRLDCNPAVQLLKCNKS 174                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     175 HFRNHKFADLPCELQDMVRKHLHSGQEAASPGPAPSLAPGAVVPTSVIAR 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 VLEKPESLLLNSAQSGSAGRPLAEDVFVHVDMSEGVPGDPASPPAPGSPT 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 PQPNGECHSLGTARGSPEEELPLPAFEKLNPYPTPSPPHPLYPGRRVIEF 324                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     325 SEDKVRIPRNSPLPNCTYATRQAISLSLVEEGSERARPSPVPSTPASAQA 374                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     375 SPHHQPSPAPLTLSAPASSASSEEDLLVSWQRAFVDRTPPPAAVAQRTAF 424                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 GRDALPELQRHFAHSPADRDEVVQAPSARPEESELLLPTEPDSGFPREEE 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 ELNLPISPEEERQSLLPINRGTEEGPGTSHTEGRAWPLPSSSRPQRSPKR 524                                                          
						                                                            	                  .         .                                
						                                                            	     401 MGVHHLHRKDSLTQAQEQGNLLN                            423                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     525 MGVHHLHRKDSLTQAQEQGNLLN                            547                                                          

3795	HMR136_T09174_15_tr0_r1_1_gPRT		Comparison report between T09174_P15 and Q13025partial WT    	Sequence name: Q13025                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09174_P15, comprising a first amino acid       	                                                            
						MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNLVLYVCETVDP 	Alignment of: 3795 x Q13025   ..                             
						AQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEEAVMHLDHSDPITRDHMGSVM 	                                                            
						AQVRQKLFQFLQAEPHNSLGKAARRLSLMLHGLVTPSLP                      	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 810 - 968 of Q13025, which also corresponds to   	                     Quality: 1551.00                      Escore:       0                                               
						amino acids 1 - 159 of T09174_P15.                           	             Matching length:     159                Total length:     159                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     810 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 859                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     860 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 909                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     910 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 959                                                          
						                                                            	                                                             
						                                                            	     151 HGLVTPSLP                                          159                                                          
						                                                            	         |||||||||                                           
						                                                            	     960 HGLVTPSLP                                          968                                                          

						Comparison report between T09174_P15 and AAH53598partial WT  	Sequence name: AAH53598                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09174_P15, comprising a first amino acid       	                                                            
						MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNLVLYVCETVDP 	Alignment of: 3795 x AAH53598   ..                           
						AQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEEAVMHLDHSDPITRDHMGSVM 	                                                            
						AQVRQKLFQFLQAEPHNSLGKAARRLSLMLHGLVTPSLP                      	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1036 - 1194 of AAH53598, which also corresponds  	                     Quality: 1551.00                      Escore:       0                                               
						to amino acids 1 - 159 of T09174_P15.                        	             Matching length:     159                Total length:     159                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1036 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 1085                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1086 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 1135                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1136 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 1185                                                         
						                                                            	                                                             
						                                                            	     151 HGLVTPSLP                                          159                                                          
						                                                            	         |||||||||                                           
						                                                            	    1186 HGLVTPSLP                                          1194                                                         

3799	HMR136_T09174_2_tr0_r1_1_gPRT		Comparison report between T09174_P2 and Q13025partial WT     	Sequence name: Q13025                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09174_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MTPDAFMTPSASLQQITASPSSSSSGSS corresponding to amino acids 160	Alignment of: 3799 x Q13025   ..                             
						- 187 of Q13025, which also corresponds to amino acids 1 - 28	                                                            
						of T09174_P2, a bridging amino acid S corresponding to amino 	Alignment segment 1/1:                                       
						acid 29 of T09174_P2, and a second amino acid sequence being 	                                                            
						SSSSSSSSLTAVSAMSSTSAVDPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLL 	                     Quality: 7772.00                      Escore:       0                                               
						PGLLPAPADKLTPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALS 	             Matching length:     809                Total length:     809                                               
						QDIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQLGLDGGPGD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.88                                               
						GDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLAESPRNGLQEKHKSLAFHRP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.88                                               
						PYHLLQQRDSQDASAEQSDHDDEVASLASASGGFGTKVPAPRLPAKDWKTKGSPRTSPKL 	                        Gaps:       0                        
						KRKSKKDDGDAAMGSRLTEHQVAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEG 	                                                            
						LQSTVTGHVERALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLER 	Alignment:                                                   
						SIRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSKNLTDAIARA 	                  .         .         .         .         .  
						AADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFRLGTQEYLQQLESHMKSRKA 	       1 MTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAV 50                                                           
						REQEAREPVLAQLRGLVSTLQSATEQMAATVAGSVRAEVQHQLHVAVGSLQESILAQVQR 	         ||||||||||||||||||||||||||||:|||||||||||||||||||||  
						IVKGEVSVALKEQQAAVTSSIMQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAF 	     160 MTPDAFMTPSASLQQITASPSSSSSGSSNSSSSSSSSLTAVSAMSSTSAV 209                                                          
						QQALTAADLNLVLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLE 	                  .         .         .         .         .  
						EAVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLMLHGLVTPSLP 	      51 DPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKL 100                                                          
						at least 90 % homologous to corresponding to amino acids 189 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 968 of Q13025, which also corresponds to amino acids 30 -  	     210 DPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKL 259                                                          
						809 of T09174_P2, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						bridging amino acid and second amino acid sequence are       	     101 TPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQ 150                                                          
						contiguous and in a sequential order.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     260 TPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQ 309                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     310 DIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQ 359                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     360 LGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLA 409                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASAS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 ESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASAS 459                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     460 GGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQ 509                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVER 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     510 VAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVER 559                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     560 ALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERS 609                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     610 IRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSK 659                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     660 NLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFR 709                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     710 LGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATV 759                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     760 AGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSI 809                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     810 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 859                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     860 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 909                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     910 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 959                                                          
						                                                            	                                                             
						                                                            	     801 HGLVTPSLP                                          809                                                          
						                                                            	         |||||||||                                           
						                                                            	     960 HGLVTPSLP                                          968                                                          

						Comparison report between T09174_P2 and AAH53598partial WT   	Sequence name: AAH53598                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09174_P2, comprising a first amino acid        	                                                            
						MTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAVDPSLTRPPEE 	Alignment of: 3799 x AAH53598   ..                           
						LTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKLTPKGPGQVPTATSALSLELQ 	                                                            
						EVEPLGLPQASPSRTRSPDVISSASTALSQDIPEIASEALSRGFGSSAPEGLEPDSMASA 	Alignment segment 1/1:                                       
						ASALHLLSPRPRPGPELGPQLGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPD 	                                                            
						ITRETCSTLAESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASAS 	                     Quality: 7781.00                      Escore:       0                                               
						GGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQVAEPPEDWPA 	             Matching length:     809                Total length:     809                                               
						LIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVERALETRHEQEQRRLERALAEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QQRGGQLQEQLTQQLSQALSSAVAGRLERSIRDEIKKTVPPCVSRSLEPMAGQLSNSVAT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KLTAVEGSMKENISKLLKSKNLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQA 	                        Gaps:       0                        
						MFQQINDSFRLGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATV 	                                                            
						AGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSIMQAMRSAAGT 	Alignment:                                                   
						PVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNLVLYVCETVDPAQVFGQPPCP 	                  .         .         .         .         .  
						LSQPVLLSLIQQLASDLGTRTDLKLSYLEEAVMHLDHSDPITRDHMGSVMAQVRQKLFQF 	       1 MTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAV 50                                                           
						LQAEPHNSLGKAARRLSLMLHGLVTPSLP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     386 MTPDAFMTPSASLQQITASPSSSSSGSSSSSSSSSSSLTAVSAMSSTSAV 435                                                          
						amino acids 386 - 1194 of AAH53598, which also corresponds to	                  .         .         .         .         .  
						amino acids 1 - 809 of T09174_P2.                            	      51 DPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     436 DPSLTRPPEELTLSPKLQLDGSLTMSSSGSLQASPRGLLPGLLPAPADKL 485                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     486 TPKGPGQVPTATSALSLELQEVEPLGLPQASPSRTRSPDVISSASTALSQ 535                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     536 DIPEIASEALSRGFGSSAPEGLEPDSMASAASALHLLSPRPRPGPELGPQ 585                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     586 LGLDGGPGDGDRHNTPSLLEAALTQEASTPDSQVWPTAPDITRETCSTLA 635                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASAS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     636 ESPRNGLQEKHKSLAFHRPPYHLLQQRDSQDASAEQSDHDDEVASLASAS 685                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     686 GGFGTKVPAPRLPAKDWKTKGSPRTSPKLKRKSKKDDGDAAMGSRLTEHQ 735                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVER 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     736 VAEPPEDWPALIWQQQRELAELRHSQEELLQRLCTQLEGLQSTVTGHVER 785                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     786 ALETRHEQEQRRLERALAEGQQRGGQLQEQLTQQLSQALSSAVAGRLERS 835                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 IRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     836 IRDEIKKTVPPCVSRSLEPMAGQLSNSVATKLTAVEGSMKENISKLLKSK 885                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     886 NLTDAIARAAADTLQGPMQAAYREAFQSVVLPAFEKSCQAMFQQINDSFR 935                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     936 LGTQEYLQQLESHMKSRKAREQEAREPVLAQLRGLVSTLQSATEQMAATV 985                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     986 AGSVRAEVQHQLHVAVGSLQESILAQVQRIVKGEVSVALKEQQAAVTSSI 1035                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1036 MQAMRSAAGTPVPSAHLDCQAQQAHILQLLQQGHLNQAFQQALTAADLNL 1085                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1086 VLYVCETVDPAQVFGQPPCPLSQPVLLSLIQQLASDLGTRTDLKLSYLEE 1135                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1136 AVMHLDHSDPITRDHMGSVMAQVRQKLFQFLQAEPHNSLGKAARRLSLML 1185                                                         
						                                                            	                                                             
						                                                            	     801 HGLVTPSLP                                          809                                                          
						                                                            	         |||||||||                                           
						                                                            	    1186 HGLVTPSLP                                          1194                                                         

27944	HMR136_T09175_10_tr0_r1_1_gPRT		Comparison report between T09175_P10 and Q9UPF5partial WT    	Sequence name: Q9UPF5                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09175_P10, comprising a first amino acid sequence being at  	                                                            
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	Alignment of: 27944 x Q9UPF5   ..                            
						LEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGS 	                                                            
						ILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQS 	Alignment segment 1/1:                                       
						QI                                                           	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 182	                     Quality: 4501.00                      Escore:       0                                               
						of Q9UPF5, which also corresponds to amino acids 1 - 182 of  	             Matching length:     459                Total length:     459                                               
						T09175_P10, a bridging amino acid A corresponding to amino   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						acid 183 of T09175_P10, a second amino acid sequence being at	    Total Percent Similarity:  100.00      Total Percent Identity:   99.78                                               
						VFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPL 	                        Gaps:       0                        
						IFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKI 	                                                            
						TVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKK 	Alignment:                                                   
						PDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEYERDTLLVE 	                  .         .         .         .         .  
						PEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA                         	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						least 90 % homologous to corresponding to amino acids 184 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						459 of Q9UPF5, which also corresponds to amino acids 184 -   	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						459 of T09175_P10, and a third amino acid sequence being at  	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence NTLFTQGI     	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						corresponding to amino acids 460 - 467 of T09175_P10, wherein	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid, second  	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						polypeptide encoding for a tail of T09175_P10, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQM 200                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||:|||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQISVFKEFLLRATKYNKLQM 200                                                          
						to the sequence NTLFTQGI in T09175_P10.                      	                  .         .         .         .         .  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	                                                             
						                                                            	     451 MEIDDIVRA                                          459                                                          
						                                                            	         |||||||||                                           
						                                                            	     451 MEIDDIVRA                                          459                                                          

						Comparison report between T09175_P10 and Q9UNR8unique head   	Sequence name: Q9UNR8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09175_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27944 x Q9UNR8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	Alignment segment 1/1:                                       
						LEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGS 	                                                            
						ILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKG                	                     Quality: 2872.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     294                Total length:     294                                               
						to amino acids 1 - 165 of T09175_P10, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMM 	                        Gaps:       0                        
						KFLNRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKK 	                                                            
						GMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDS 	Alignment:                                                   
						PRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     166 MFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVE 215                                                          
						amino acids 1 - 294 of Q9UNR8, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 166 - 459 of T09175_P10, and a third amino acid  	       1 MFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVE 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     216 DLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEI 265                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence NTLFTQGI corresponding to amino acids 460	      51 DLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEI 100                                                          
						- 467 of T09175_P10, wherein said first amino acid sequence, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     266 QEECSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKITVPDKTSLELLC 315                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T09175_P10, comprising a  	     101 QEECSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKITVPDKTSLELLC 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     316 QGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKKPD 365                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	     151 QGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKKPD 200                                                          
						LEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGS 	                  .         .         .         .         .  
						ILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKG                	     366 RVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEY 415                                                          
						to the sequence of T09175_P10.3.An isolated polypeptide      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of T09175_P10, comprising a polypeptide  	     201 RVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEY 250                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .            
						at least about 85%, more preferably at least about 90% and   	     416 ERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA       459                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||        
						NTLFTQGI in T09175_P10.                                      	     251 ERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA       294                                                          

						Comparison report between T09175_P10 and Q9UNR7unique head   	Sequence name: Q9UNR7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09175_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27944 x Q9UNR7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	Alignment segment 1/1:                                       
						LEQIYGLENSKEYLSENEPWVDKYKPET                                 	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3633.00                      Escore:       0                                               
						to amino acids 1 - 88 of T09175_P10, a second amino acid     	             Matching length:     371                Total length:     371                                               
						QHELAVHKKKIEEVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EWINPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEIQEE 	                        Gaps:       0                        
						CSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINS 	                                                            
						LQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRA 	Alignment:                                                   
						LGKILYCKRASLTELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYID 	                  .         .         .         .         .  
						FFMEIDDIVRA                                                  	      89 QHELAVHKKKIEEVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKI 138                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 3 - 373 of Q9UNR7, which also corresponds to     	       3 QHELAVHKKKIEEVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKI 52                                                           
						amino acids 89 - 459 of T09175_P10, and a third amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     139 LSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEF 188                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      53 LSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEF 102                                                          
						having the sequence NTLFTQGI corresponding to amino acids 460	                  .         .         .         .         .  
						- 467 of T09175_P10, wherein said first amino acid sequence, 	     189 LLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRI 238                                                          
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     103 LLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRI 152                                                          
						polypeptide encoding for a head of T09175_P10, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     239 GRCPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFL 288                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     153 GRCPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFL 202                                                          
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	                  .         .         .         .         .  
						LEQIYGLENSKEYLSENEPWVDKYKPET                                 	     289 NRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGEN 338                                                          
						to the sequence of T09175_P10.3.An isolated polypeptide      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of T09175_P10, comprising a polypeptide  	     203 NRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGEN 252                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     339 NLRPRKKGMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRA 388                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NTLFTQGI in T09175_P10.                                      	     253 NLRPRKKGMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRA 302                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     389 LGKILYCKRASLTELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLF 438                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 LGKILYCKRASLTELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLF 352                                                          
						                                                            	                  .         .                                
						                                                            	     439 NLYLHQNYIDFFMEIDDIVRA                              459                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     353 NLYLHQNYIDFFMEIDDIVRA                              373                                                          

						Comparison report between T09175_P10 and Q9UNK7partial WT    	Sequence name: Q9UNK7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09175_P10, comprising a first amino	Sequence documentation:                                      
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	                                                            
						LEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGS 	Alignment of: 27944 x Q9UNK7   ..                            
						ILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQS 	                                                            
						QIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGR 	Alignment segment 1/1:                                       
						CPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 	                                                            
						GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKR 	                     Quality: 4508.00                      Escore:       0                                               
						RKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEYERDTL 	             Matching length:     459                Total length:     459                                               
						LVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 459 of Q9UNK7, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 459 of T09175_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						having the sequence NTLFTQGI corresponding to amino acids 460	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 467 of T09175_P10, wherein said first amino acid sequence  	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						tail of T09175_P10, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence NTLFTQGI in    	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						T09175_P10.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	                                                             
						                                                            	     451 MEIDDIVRA                                          459                                                          
						                                                            	         |||||||||                                           
						                                                            	     451 MEIDDIVRA                                          459                                                          

						Comparison report between T09175_P10 and O75714partial WT    	Sequence name: O75714                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09175_P10, comprising a first amino	Sequence documentation:                                      
						MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSS 	                                                            
						LEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGS 	Alignment of: 27944 x O75714   ..                            
						ILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQS 	                                                            
						QIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGR 	Alignment segment 1/1:                                       
						CPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 	                                                            
						GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKR 	                     Quality: 4508.00                      Escore:       0                                               
						RKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEYERDTL 	             Matching length:     459                Total length:     459                                               
						LVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRA                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 459 of O75714, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 459 of T09175_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						having the sequence NTLFTQGI corresponding to amino acids 460	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 467 of T09175_P10, wherein said first amino acid sequence  	       1 MNQVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRF 50                                                           
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						tail of T09175_P10, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 PARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIE 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence NTLFTQGI in    	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						T09175_P10.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEW 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 INPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQM 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFF 450                                                          
						                                                            	                                                             
						                                                            	     451 MEIDDIVRA                                          459                                                          
						                                                            	         |||||||||                                           
						                                                            	     451 MEIDDIVRA                                          459                                                          

28324	HMR136_T09196_7_tr0_r1_1_gPRT		Comparison report between T09196_P7 and KAD4_HUMANpartial WT 	Sequence name: KAD4_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09196_P7, comprising a first amino 	Sequence documentation:                                      
						MASKLLRAVILGPPGSGKGTVCQRIAQNFGLQHLSSGHFLRENIKASTEVGEMAKQYIEK 	                                                            
						SLLVPDHVITRLMMSELENRRGQHWLLDGFPRTLGQAEALDKICEVDLVISLNIPFETLK 	Alignment of: 28324 x KAD4_HUMAN   ..                        
						DRLSRRWIHPPSGRVYNLDFNPPHVH                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 146 of KAD4_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 146 of T09196_P7, and a second amino acid 	                     Quality: 1965.00                      Escore:       0                                               
						EDDKPEAVAARLRQYKDVAKPVIELYKSRGVLHQFSGTETNKIWPYVYTLFSNKITPIQS 	             Matching length:     210                Total length:     223                                               
						KEAY                                                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:   94.17      Total Percent Identity:   94.17                                               
						amino acids 160 - 223 of KAD4_HUMAN, which also corresponds  	                        Gaps:       1                        
						to amino acids 147 - 210 of T09196_P7, wherein said first    	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T09196_P7,       	       1 MASKLLRAVILGPPGSGKGTVCQRIAQNFGLQHLSSGHFLRENIKASTEV 50                                                           
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	       1 MASKLLRAVILGPPGSGKGTVCQRIAQNFGLQHLSSGHFLRENIKASTEV 50                                                           
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	      51 GEMAKQYIEKSLLVPDHVITRLMMSELENRRGQHWLLDGFPRTLGQAEAL 100                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	      51 GEMAKQYIEKSLLVPDHVITRLMMSELENRRGQHWLLDGFPRTLGQAEAL 100                                                          
						comprise HE, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 146-x to 147; and    	     101 DKICEVDLVISLNIPFETLKDRLSRRWIHPPSGRVYNLDFNPPHVH.... 146                                                          
						ending at any of amino acid numbers 147+ ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||      
						which x varies from 0 to n-2.                                	     101 DKICEVDLVISLNIPFETLKDRLSRRWIHPPSGRVYNLDFNPPHVHGIDD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     147 .........EDDKPEAVAARLRQYKDVAKPVIELYKSRGVLHQFSGTETN 187                                                          
						                                                            	                  |||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VTGEPLVQQEDDKPEAVAARLRQYKDVAKPVIELYKSRGVLHQFSGTETN 200                                                          
						                                                            	                  .         .                                
						                                                            	     188 KIWPYVYTLFSNKITPIQSKEAY                            210                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     201 KIWPYVYTLFSNKITPIQSKEAY                            223                                                          

28715	HMR136_T09205_7_tr0_r1_1_gPRT		Comparison report between T09205_P7 and Q96RI2unique head    	Sequence name: Q96RI2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09205_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28715 x Q96RI2   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	Alignment segment 1/1:                                       
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	                                                            
						LPVHQLSSPFYTKTT                                              	                     Quality: 5351.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 135 of  	             Matching length:     541                Total length:     541                                               
						T09205_P7, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAANGQGQQRRRIT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPK 	                        Gaps:       0                        
						ELALYVLSFLEPKDLLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGF 	                                                            
						IHSPWKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVW 	Alignment:                                                   
						SAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 	                  .         .         .         .         .  
						MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVW 	     136 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 185                                                          
						DPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTV 	      21 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 70                                                           
						KLWDLKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDM 	                  .         .         .         .         .  
						K                                                            	     186 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 235                                                          
						% homologous to corresponding to amino acids 21 - 561 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q96RI2, which also corresponds to amino acids 136 - 676 of   	      71 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 120                                                          
						T09205_P7, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     236 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 285                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09205_P7, comprising a polypeptide being at least 70%,      	     121 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 170                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     286 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 335                                                          
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	     171 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 220                                                          
						LPVHQLSSPFYTKTT                                              	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T09205_P7.     	     336 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 270                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     271 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 320                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     486 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 535                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 420                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     536 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 585                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     586 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 635                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 520                                                          
						                                                            	                  .         .         .         .            
						                                                            	     636 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          676                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     521 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          561                                                          

						Comparison report between T09205_P7 and Q96A16unique head    	Sequence name: Q96A16                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09205_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28715 x Q96A16   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	Alignment segment 1/1:                                       
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	                                                            
						LPVHQLSSPFYTKTT                                              	                     Quality: 5351.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 135 of  	             Matching length:     541                Total length:     541                                               
						T09205_P7, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAANGQGQQRRRIT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPK 	                        Gaps:       0                        
						ELALYVLSFLEPKDLLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGF 	                                                            
						IHSPWKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVW 	Alignment:                                                   
						SAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 	                  .         .         .         .         .  
						MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVW 	     136 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 185                                                          
						DPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTV 	      87 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 136                                                          
						KLWDLKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDM 	                  .         .         .         .         .  
						K                                                            	     186 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 235                                                          
						% homologous to corresponding to amino acids 87 - 627 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q96A16, which also corresponds to amino acids 136 - 676 of   	     137 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 186                                                          
						T09205_P7, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     236 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 285                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09205_P7, comprising a polypeptide being at least 70%,      	     187 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 236                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     286 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 335                                                          
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	     237 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 286                                                          
						LPVHQLSSPFYTKTT                                              	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T09205_P7.     	     336 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 436                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     486 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 535                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     437 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 486                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     536 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 585                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     487 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 536                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     586 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 635                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     537 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 586                                                          
						                                                            	                  .         .         .         .            
						                                                            	     636 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          676                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     587 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          627                                                          

						Comparison report between T09205_P7 and Q9NUX6unique head    	Sequence name: Q9NUX6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09205_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28715 x Q9NUX6   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	Alignment segment 1/1:                                       
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	                                                            
						LPVHQLSSPFYTKTT                                              	                     Quality: 5351.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 135 of  	             Matching length:     541                Total length:     541                                               
						T09205_P7, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAANGQGQQRRRIT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPK 	                        Gaps:       0                        
						ELALYVLSFLEPKDLLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGF 	                                                            
						IHSPWKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVW 	Alignment:                                                   
						SAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 	                  .         .         .         .         .  
						MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVW 	     136 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 185                                                          
						DPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTV 	      13 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 62                                                           
						KLWDLKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDM 	                  .         .         .         .         .  
						K                                                            	     186 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 235                                                          
						% homologous to corresponding to amino acids 13 - 553 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9NUX6, which also corresponds to amino acids 136 - 676 of   	      63 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 112                                                          
						T09205_P7, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     236 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 285                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09205_P7, comprising a polypeptide being at least 70%,      	     113 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 162                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     286 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 335                                                          
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	     163 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 212                                                          
						LPVHQLSSPFYTKTT                                              	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T09205_P7.     	     336 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     213 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 262                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     263 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 312                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     313 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 362                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     486 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 535                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     363 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 412                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     536 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 585                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     413 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 462                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     586 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 635                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     463 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 512                                                          
						                                                            	                  .         .         .         .            
						                                                            	     636 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          676                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     513 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          553                                                          

						Comparison report between T09205_P7 and Q969H0partial WT     	Sequence name: Q969H0                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09205_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARN     	Alignment of: 28715 x Q969H0   ..                            
						corresponding to amino acids 1 - 56 of Q969H0, which also    	                                                            
						corresponds to amino acids 1 - 56 of T09205_P7, and a second 	Alignment segment 1/1:                                       
						DEDSSGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSS 	                                                            
						SIVDLPVHQLSSPFYTKTTKMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPT 	                     Quality: 6590.00                      Escore:       0                                               
						TFGDLRAANGQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVKH 	             Matching length:     676                Total length:     707                                               
						MMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAEDNLLWREKCKE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCL 	    Total Percent Similarity:   95.62      Total Percent Identity:   95.62                                               
						QFCGNRIVSGSDDNTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWN 	                        Gaps:       1                        
						AETGECIHTLYGHTSTVRCMHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCV 	                                                            
						QYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWD 	Alignment:                                                   
						VETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAV 	                  .         .         .         .         .  
						TCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVG 	       1 MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEE 50                                                           
						SRNGTEETKLLVLDFDVDMK                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEE 50                                                           
						corresponding to amino acids 88 - 707 of Q969H0, which also  	                  .         .         .         .         .  
						corresponds to amino acids 57 - 676 of T09205_P7, wherein    	      51 EHTARN...............................DEDSSGNQEEQEE 69                                                           
						said first amino acid sequence and second amino acid sequence	         ||||||                               |||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	      51 EHTARNGEVVGVEPRPGGQNDSQQGQLEENNNRFISVDEDSSGNQEEQEE 100                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09205_P7, comprising a polypeptide having a length "n",     	      70 DEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIV 119                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     101 DEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIV 150                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     120 DLPVHQLSSPFYTKTTKMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLV 169                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise ND, having a structure as  	     151 DLPVHQLSSPFYTKTTKMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLV 200                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						56-x to 57; and ending at any of amino acid numbers 57+      	     170 PCSATPTTFGDLRAANGQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKL 219                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PCSATPTTFGDLRAANGQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     220 LALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPKELALYVLSFLEPKD 269                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPKELALYVLSFLEPKD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     270 LLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSP 319                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     320 WKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDD 369                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 WKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     370 NTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAET 419                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAET 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     420 GECIHTLYGHTSTVRCMHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGH 469                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GECIHTLYGHTSTVRCMHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGH 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     470 VAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFD 519                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFD 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     520 GIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNILVSGNAD 569                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 GIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNILVSGNAD 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     570 STVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWD 619                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 STVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWD 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     620 LKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVL 669                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVL 700                                                          
						                                                            	                                                             
						                                                            	     670 DFDVDMK                                            676                                                          
						                                                            	         |||||||                                             
						                                                            	     701 DFDVDMK                                            707                                                          

						Comparison report between T09205_P7 and Q96LE0unique head    	Sequence name: Q96LE0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09205_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 28715 x Q96LE0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	Alignment segment 1/1:                                       
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	                                                            
						LPVHQLSSPFYTKTTK                                             	                     Quality: 5344.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 136 of  	             Matching length:     541                Total length:     541                                               
						T09205_P7, and a second amino acid sequence being at least 90	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.82                                               
						MKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAANGQGQQRRRITS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.82                                               
						VQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPKE 	                        Gaps:       0                        
						LALYVLSFLEPKDLLQAAQTCRYWRILAEDNLLWREKCKEEGIDEPLHIKRRKVIKPGFI 	                                                            
						HSPWKSAYIRQHRIDTNWRRGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWS 	Alignment:                                                   
						AVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRCM 	                  .         .         .         .         .  
						HLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWD 	     136 KMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 185                                                          
						PETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGM 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						ELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSDDGTVK 	      49 RMKRKLDHGSEVRSFSLGKKPCKVSEYTSTTGLVPCSATPTTFGDLRAAN 98                                                           
						LWDLKTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK 	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 50 - 589 of     	     186 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 235                                                          
						Q96LE0, which also corresponds to amino acids 137 - 676 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09205_P7, wherein said first amino acid sequence and second 	      99 GQGQQRRRITSVQPPTGLQEWLKMFQSWSGPEKLLALDELIDSCEPTQVK 148                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     236 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 285                                                          
						T09205_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     149 HMMQVIEPQFQRDFISLLPKELALYVLSFLEPKDLLQAAQTCRYWRILAE 198                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MNQELLSVGSKRRRTGGSLRGNPSSSQVDEEQMNRVVEEEQQQQLRQQEEEHTARNDEDS 	     286 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 335                                                          
						SGNQEEQEEDEEHAGEQDEEDEEEEEMDQESDDFDQSDDSSREDEHTHTNSVTNSSSIVD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPVHQLSSPFYTKTTK                                             	     199 DNLLWREKCKEEGIDEPLHIKRRKVIKPGFIHSPWKSAYIRQHRIDTNWR 248                                                          
						least about 95% homologous to the sequence of T09205_P7.     	                  .         .         .         .         .  
						                                                            	     336 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     249 RGELKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRT 298                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     386 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 435                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     299 LVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRC 348                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     436 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 485                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     349 MHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVS 398                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     486 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 535                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     399 GAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVW 448                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     536 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 585                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     449 DVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQT 498                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     586 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 635                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     499 LQGPNKHQSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNLVTLESG 548                                                          
						                                                            	                  .         .         .         .            
						                                                            	     636 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          676                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     549 GSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK          589                                                          

28978	HMR136_T09214_5_tr0_r1_1_gPRT		Comparison report between T09214_P5 and COQ4_HUMANpartial WT 	Sequence name: COQ4_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09214_P5, comprising a first amino 	Sequence documentation:                                      
						MATLLRPVLRRLCGLPGLQRPAAEMPLRARSDGAGPLYSHHLPTSPLQKALLAAGSAAMA 	                                                            
						LYNPYRHDMVAVLGETTGHRTLKVLRDQMRRDPEGAQILQERPRISTSTLDLGKLQSLPE 	Alignment of: 28978 x COQ4_HUMAN   ..                        
						GSLG                                                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 124 of COQ4_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 124 of T09214_P5, and a second amino acid 	                     Quality: 1193.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     124                Total length:     124                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence QGLPRHPSTHPLRG corresponding to amino    	                        Gaps:       0                        
						acids 125 - 138 of T09214_P5, wherein said first amino acid  	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of T09214_P5, comprising a polypeptide being at least   	       1 MATLLRPVLRRLCGLPGLQRPAAEMPLRARSDGAGPLYSHHLPTSPLQKA 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       1 MATLLRPVLRRLCGLPGLQRPAAEMPLRARSDGAGPLYSHHLPTSPLQKA 50                                                           
						at least about 95% homologous to the sequence QGLPRHPSTHPLRG 	                  .         .         .         .         .  
						in T09214_P5.                                                	      51 LLAAGSAAMALYNPYRHDMVAVLGETTGHRTLKVLRDQMRRDPEGAQILQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 LLAAGSAAMALYNPYRHDMVAVLGETTGHRTLKVLRDQMRRDPEGAQILQ 100                                                          
						                                                            	                  .         .                                
						                                                            	     101 ERPRISTSTLDLGKLQSLPEGSLG                           124                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     101 ERPRISTSTLDLGKLQSLPEGSLG                           124                                                          

4390	HMR136_T09218_11_tr0_r1_1_gPRT		Comparison report between T09218_P11 and Q9BVQ3partial WT    	Sequence name: Q9BVQ3                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09218_P11, comprising a first amino acid       	                                                            
						MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAE 	Alignment of: 4390 x Q9BVQ3   ..                             
						FAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAA 	                                                            
						LKEIVA                                                       	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 168 - 293 of Q9BVQ3, which also corresponds to   	                     Quality: 1206.00                      Escore:       0                                               
						amino acids 1 - 126 of T09218_P11.                           	             Matching length:     126                Total length:     126                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     168 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 217                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     218 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 267                                                          
						                                                            	                  .         .                                
						                                                            	     101 IPRRTLATGYQYSFPELGAALKEIVA                         126                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     268 IPRRTLATGYQYSFPELGAALKEIVA                         293                                                          

4396	HMR136_T09218_13_tr0_r1_1_gPRT		Comparison report between T09218_P13 and Q9BVQ3unique head   	Sequence name: Q9BVQ3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09218_P13, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4396 x Q9BVQ3   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MKPS         	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 4 of T09218_P13, a second   	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 1815.00                      Escore:       0                                               
						KAPQPPKAWVLVTGV corresponding to amino acids 95 - 109 of     	             Matching length:     200                Total length:     231                                               
						Q9BVQ3, which also corresponds to amino acids 5 - 19 of      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.50                                               
						T09218_P13, a third amino acid sequence being at least 70%,  	    Total Percent Similarity:   86.58      Total Percent Identity:   86.15                                               
						optionally at least 80%, preferably at least 85%, more       	                        Gaps:       1                        
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						GPEKVRPRGASTTESQAGPRTPRANDCVPPA corresponding to amino acids 	                  .         .         .         .         .  
						20 - 50 of T09218_P13, and a fourth amino acid sequence being	       4 SKAPQPPKAWVLVTGVGPEKVRPRGASTTESQAGPRTPRANDCVPPAAYY 53                                                           
						AYYQPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSGVVLGRGGGAMG 	         :|||||||||||||||                               |||  
						HMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAEFA 	      94 TKAPQPPKAWVLVTGV...............................AYY 112                                                          
						QTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAALK 	                  .         .         .         .         .  
						EIVA                                                         	      54 QPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSGVVLG 103                                                          
						at least 90 % homologous to corresponding to amino acids 110 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 293 of Q9BVQ3, which also corresponds to amino acids 51 -  	     113 QPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSGVVLG 162                                                          
						234 of T09218_P13, wherein said first amino acid sequence,   	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence and    	     104 RGGGAMGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVH 153                                                          
						fourth amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     163 RGGGAMGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVH 212                                                          
						T09218_P13, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     154 GVLNGVAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLL 203                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence MKPS of           	     213 GVLNGVAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLL 262                                                          
						T09218_P13.3.An isolated polypeptide encoding for an edge    	                  .         .         .                      
						portion of T09218_P13, comprising an amino acid sequence     	     204 EGQKVIPRRTLATGYQYSFPELGAALKEIVA                    234                                                          
						being at least 70%, optionally at least about 80%, preferably	         |||||||||||||||||||||||||||||||                     
						at least about 85%, more preferably at least about 90% and   	     263 EGQKVIPRRTLATGYQYSFPELGAALKEIVA                    293                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for GPEKVRPRGASTTESQAGPRTPRANDCVPPA, corresponding  	                                                            
						to T09218_P13.                                               	                                                            

4388	HMR136_T09218_18_tr0_r1_1_gPRT		Comparison report between T09218_P18 and Q9BVQ3partial WT    	Sequence name: Q9BVQ3                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09218_P18, comprising a first amino acid       	                                                            
						MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAE 	Alignment of: 4388 x Q9BVQ3   ..                             
						FAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAA 	                                                            
						LKEIVA                                                       	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 168 - 293 of Q9BVQ3, which also corresponds to   	                     Quality: 1206.00                      Escore:       0                                               
						amino acids 1 - 126 of T09218_P18.                           	             Matching length:     126                Total length:     126                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     168 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 217                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     218 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 267                                                          
						                                                            	                  .         .                                
						                                                            	     101 IPRRTLATGYQYSFPELGAALKEIVA                         126                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     268 IPRRTLATGYQYSFPELGAALKEIVA                         293                                                          

4398	HMR136_T09218_21_tr0_r1_1_gPRT		Comparison report between T09218_P21 and Q9BVQ3partial WT    	Sequence name: Q9BVQ3                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09218_P21, comprising a first amino acid       	                                                            
						MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAE 	Alignment of: 4398 x Q9BVQ3   ..                             
						FAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAA 	                                                            
						LKEIVA                                                       	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 168 - 293 of Q9BVQ3, which also corresponds to   	                     Quality: 1206.00                      Escore:       0                                               
						amino acids 1 - 126 of T09218_P21.                           	             Matching length:     126                Total length:     126                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     168 MGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNG 217                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     218 VAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKV 267                                                          
						                                                            	                  .         .                                
						                                                            	     101 IPRRTLATGYQYSFPELGAALKEIVA                         126                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     268 IPRRTLATGYQYSFPELGAALKEIVA                         293                                                          

4392	HMR136_T09218_26_tr0_r1_1_gPRT		Comparison report between T09218_P26 and Q9NRG7unique head   	Sequence name: Q9NRG7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T09218_P26, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 4392 x Q9NRG7   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MYLVAFYFPCFSC corresponding  	                                                            
						to amino acids 1 - 13 of T09218_P26, a second amino acid     	                     Quality:  778.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:      90                Total length:     121                                               
						RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV corresponding to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 95 - 135 of Q9NRG7, which also corresponds to    	    Total Percent Similarity:   74.38      Total Percent Identity:   74.38                                               
						amino acids 14 - 54 of T09218_P26, a third amino acid        	                        Gaps:       1                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GPEKVRPRGASTTESQAGPRTPRANDCVPPA          	      14 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGVGPEKVRPRG 63                                                           
						corresponding to amino acids 55 - 85 of T09218_P26, a fourth 	         |||||||||||||||||||||||||||||||||||||||||           
						amino acid sequence being at least 90 % homologous to        	      95 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV......... 135                                                          
						AYYQPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSG            	                  .         .         .         .         .  
						corresponding to amino acids 136 - 184 of Q9NRG7, which also 	      64 ASTTESQAGPRTPRANDCVPPAAYYQPSLTAEYDEDSPGGDFDFFSNLVT 113                                                          
						corresponds to amino acids 86 - 134 of T09218_P26, and a     	                               ||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     136 ......................AYYQPSLTAEYDEDSPGGDFDFFSNLVT 163                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .                                
						90% and most preferably at least 95% homologous to a         	     114 KWEAAARLPGDSTRQVVVRSG                              134                                                          
						polypeptide having the sequence EKRAWVS corresponding to     	         |||||||||||||||||||||                               
						amino acids 135 - 141 of T09218_P26, wherein said first amino	     164 KWEAAARLPGDSTRQVVVRSG                              184                                                          
						acid sequence, second amino acid sequence, third amino acid  	                                                            
						sequence, fourth amino acid sequence and fifth amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of T09218_P26,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MYLVAFYFPCFSC of        	                                                            
						T09218_P26.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09218_P26, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for GPEKVRPRGASTTESQAGPRTPRANDCVPPA, corresponding  	                                                            
						to T09218_P26.4.An isolated polypeptide encoding for a tail  	                                                            
						of T09218_P26, comprising a polypeptide being at least 70%,  	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence EKRAWVS in        	                                                            
						T09218_P26.                                                  	                                                            

						Comparison report between T09218_P26 and Q9BVQ3unique head   	Sequence name: Q9BVQ3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T09218_P26, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 4392 x Q9BVQ3   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MYLVAFYFPCFSC corresponding  	                                                            
						to amino acids 1 - 13 of T09218_P26, a second amino acid     	                     Quality:  778.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:      90                Total length:     121                                               
						RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV corresponding to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 69 - 109 of Q9BVQ3, which also corresponds to    	    Total Percent Similarity:   74.38      Total Percent Identity:   74.38                                               
						amino acids 14 - 54 of T09218_P26, a third amino acid        	                        Gaps:       1                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GPEKVRPRGASTTESQAGPRTPRANDCVPPA          	      14 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGVGPEKVRPRG 63                                                           
						corresponding to amino acids 55 - 85 of T09218_P26, a fourth 	         |||||||||||||||||||||||||||||||||||||||||           
						amino acid sequence being at least 90 % homologous to        	      69 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV......... 109                                                          
						AYYQPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSG            	                  .         .         .         .         .  
						corresponding to amino acids 110 - 158 of Q9BVQ3, which also 	      64 ASTTESQAGPRTPRANDCVPPAAYYQPSLTAEYDEDSPGGDFDFFSNLVT 113                                                          
						corresponds to amino acids 86 - 134 of T09218_P26, and a     	                               ||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     110 ......................AYYQPSLTAEYDEDSPGGDFDFFSNLVT 137                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .                                
						90% and most preferably at least 95% homologous to a         	     114 KWEAAARLPGDSTRQVVVRSG                              134                                                          
						polypeptide having the sequence EKRAWVS corresponding to     	         |||||||||||||||||||||                               
						amino acids 135 - 141 of T09218_P26, wherein said first amino	     138 KWEAAARLPGDSTRQVVVRSG                              158                                                          
						acid sequence, second amino acid sequence, third amino acid  	                                                            
						sequence, fourth amino acid sequence and fifth amino acid    	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of T09218_P26,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MYLVAFYFPCFSC of        	                                                            
						T09218_P26.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09218_P26, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for GPEKVRPRGASTTESQAGPRTPRANDCVPPA, corresponding  	                                                            
						to T09218_P26.4.An isolated polypeptide encoding for a tail  	                                                            
						of T09218_P26, comprising a polypeptide being at least 70%,  	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence EKRAWVS in        	                                                            
						T09218_P26.                                                  	                                                            

4394	HMR136_T09218_5_tr0_r1_1_gPRT		Comparison report between T09218_P5 and Q9BVQ3unique head    	Sequence name: Q9BVQ3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09218_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4394 x Q9BVQ3   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MYLVAFYFPCFSC	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of T09218_P5, a second   	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2062.00                      Escore:       0                                               
						RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV corresponding to   	             Matching length:     225                Total length:     256                                               
						amino acids 69 - 109 of Q9BVQ3, which also corresponds to    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 14 - 54 of T09218_P5, a third amino acid sequence	    Total Percent Similarity:   87.89      Total Percent Identity:   87.89                                               
						being at least 70%, optionally at least 80%, preferably at   	                        Gaps:       1                        
						least 85%, more preferably at least 90% and most preferably  	                                                            
						at least 95% homologous to a polypeptide having the sequence 	Alignment:                                                   
						GPEKVRPRGASTTESQAGPRTPRANDCVPPA corresponding to amino acids 	                  .         .         .         .         .  
						55 - 85 of T09218_P5, and a fourth amino acid sequence being 	      14 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGVGPEKVRPRG 63                                                           
						AYYQPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSGVVLGRGGGAMG 	         |||||||||||||||||||||||||||||||||||||||||           
						HMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAEFA 	      69 RWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGV......... 109                                                          
						QTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAALK 	                  .         .         .         .         .  
						EIVA                                                         	      64 ASTTESQAGPRTPRANDCVPPAAYYQPSLTAEYDEDSPGGDFDFFSNLVT 113                                                          
						at least 90 % homologous to corresponding to amino acids 110 	                               ||||||||||||||||||||||||||||  
						- 293 of Q9BVQ3, which also corresponds to amino acids 86 -  	     110 ......................AYYQPSLTAEYDEDSPGGDFDFFSNLVT 137                                                          
						269 of T09218_P5, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence and    	     114 KWEAAARLPGDSTRQVVVRSGVVLGRGGGAMGHMLLPFRLGLGGPIGSGH 163                                                          
						fourth amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     138 KWEAAARLPGDSTRQVVVRSGVVLGRGGGAMGHMLLPFRLGLGGPIGSGH 187                                                          
						T09218_P5, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     164 QFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAEFAQTFGAALG 213                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence MYLVAFYFPCFSC of  	     188 QFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAEFAQTFGAALG 237                                                          
						T09218_P5.3.An isolated polypeptide encoding for an edge     	                  .         .         .         .         .  
						portion of T09218_P5, comprising an amino acid sequence being	     214 RRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAA 263                                                          
						at least 70%, optionally at least about 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 85%, more preferably at least about 90% and most 	     238 RRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAA 287                                                          
						preferably at least about 95% homologous to the sequence     	                                                             
						encoding for GPEKVRPRGASTTESQAGPRTPRANDCVPPA, corresponding  	     264 LKEIVA                                             269                                                          
						to T09218_P5.                                                	         ||||||                                              
						                                                            	     288 LKEIVA                                             293                                                          

8359	HMR136_T09233_23_tr0_r1_1_gPRT		Comparison report between T09233_P23 and A2M1_HUMANpartial   	Sequence name: A2M1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09233_P23, comprising a first amino	Sequence documentation:                                      
						MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKR 	                                                            
						SNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGY 	Alignment of: 8359 x A2M1_HUMAN   ..                         
						PQNSETGALKTFITQQGIKSQHQTKEEQSQITSQVTGQIGWRREGIKYRRNELFLDVLES 	                                                            
						VNLLMSPQGQVLSAHVSGRVVMKSYLSGMPECKFGMNDKIVIEKQGKGTADETSKSGKQS 	Alignment segment 1/1:                                       
						IAIDDCTFHQCVRLSKFDSERSISFIPPDGEFELMR                         	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2696.00                      Escore:       0                                               
						to amino acids 1 - 276 of A2M1_HUMAN, which also corresponds 	             Matching length:     276                Total length:     276                                               
						to amino acids 1 - 276 of T09233_P23, and a second amino acid	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence CHWGVRRQLVLLA corresponding to amino     	Alignment:                                                   
						acids 277 - 289 of T09233_P23, wherein said first amino acid 	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNI 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T09233_P23, comprising a polypeptide being at least  	       1 MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNI 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 ARTSFFHVKRSNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEEN 100                                                          
						at least about 95% homologous to the sequence CHWGVRRQLVLLA  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in T09233_P23.                                               	      51 ARTSFFHVKRSNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEEN 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IKNNFVLIYELLDEILDFGYPQNSETGALKTFITQQGIKSQHQTKEEQSQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IKNNFVLIYELLDEILDFGYPQNSETGALKTFITQQGIKSQHQTKEEQSQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ITSQVTGQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVSGRV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ITSQVTGQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVSGRV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VMKSYLSGMPECKFGMNDKIVIEKQGKGTADETSKSGKQSIAIDDCTFHQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VMKSYLSGMPECKFGMNDKIVIEKQGKGTADETSKSGKQSIAIDDCTFHQ 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 CVRLSKFDSERSISFIPPDGEFELMR                         276                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     251 CVRLSKFDSERSISFIPPDGEFELMR                         276                                                          

4717	HMR136_T09244_8_tr0_r1_1_gPRT		Comparison report between T09244_P8 and MK07_HUMAN_V1unique  	Sequence name: MK07_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09244_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 4717 x MK07_HUMAN_V1   ..                      
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence GILWYVPFPCSS corresponding to amino acids	Alignment segment 1/1:                                       
						1 - 12 of T09244_P8, and a second amino acid sequence being  	                                                            
						GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 	                     Quality: 7313.00                      Escore:       0                                               
						DLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELK 	             Matching length:     740                Total length:     740                                               
						IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						RRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGAD 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						RQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERI 	                        Gaps:       0                        
						KEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPSGDCAMESPPPA 	                                                            
						PPPCPGPAPDTIDLTLQPPPPVSEPAPPKKDGAISDNTKAALKAALLKSLRSRLRDGPSA 	Alignment:                                                   
						PLEAPEPRKPVTAQERQREREEKRRRRQERAKEREKRRQERERKERGAGASGGPSTDPLA 	                  .         .         .         .         .  
						GLVLSDNDRSLLERWTRMARPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQ 	      12 SGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 61                                                           
						PQSAGSTSGPVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLPG 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						SSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPLPPVFSGTPKGS 	      76 TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 125                                                          
						GAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSASLLADWLEGHGMNPADIESLQR 	                  .         .         .         .         .  
						EIQMDSPMLLADLPDLQDP                                          	      62 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 111                                                          
						at least 90 % homologous to corresponding to amino acids 77 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						815 of MK07_HUMAN_V1, which also corresponds to amino acids  	     126 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 175                                                          
						13 - 751 of T09244_P8, wherein said first amino acid sequence	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	     112 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 161                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of T09244_P8, comprising a polypeptide being at least   	     176 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 225                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     162 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 211                                                          
						at least about 95% homologous to the sequence GILWYVPFPCSS of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09244_P8.                                                   	     226 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 275                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     212 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 261                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     276 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 325                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     262 MLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRER 311                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     326 MLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRER 375                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     312 IKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPS 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     376 IKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPS 425                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     362 GDCAMESPPPAPPPCPGPAPDTIDLTLQPPPPVSEPAPPKKDGAISDNTK 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     426 GDCAMESPPPAPPPCPGPAPDTIDLTLQPPPPVSEPAPPKKDGAISDNTK 475                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 AALKAALLKSLRSRLRDGPSAPLEAPEPRKPVTAQERQREREEKRRRRQE 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     476 AALKAALLKSLRSRLRDGPSAPLEAPEPRKPVTAQERQREREEKRRRRQE 525                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 RAKEREKRRQERERKERGAGASGGPSTDPLAGLVLSDNDRSLLERWTRMA 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     526 RAKEREKRRQERERKERGAGASGGPSTDPLAGLVLSDNDRSLLERWTRMA 575                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     512 RPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQPQSAGSTSG 561                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     576 RPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQPQSAGSTSG 625                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     562 PVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLP 611                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     626 PVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLP 675                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     612 GSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPL 661                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     676 GSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPL 725                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     662 PPVFSGTPKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSAS 711                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     726 PPVFSGTPKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSAS 775                                                          
						                                                            	                  .         .         .         .            
						                                                            	     712 LLADWLEGHGMNPADIESLQREIQMDSPMLLADLPDLQDP           751                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     776 LLADWLEGHGMNPADIESLQREIQMDSPMLLADLPDLQDP           815                                                          

4715	HMR136_T09244_9_tr0_r1_1_gPRT		Comparison report between T09244_P9 and MK07_HUMAN_V1unique  	Sequence name: MK07_HUMAN_V1                                 
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids.1.An isolated chimeric polypeptide    	Sequence documentation:                                      
						encoding for T09244_P9, comprising a first amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 4715 x MK07_HUMAN_V1   ..                      
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence GILWYVPFPCSS corresponding to amino acids	                                                            
						1 - 12 of T09244_P9, a second amino acid sequence being at   	                     Quality: 6897.00                      Escore:       0                                               
						GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 	             Matching length:     707                Total length:     740                                               
						DLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.72                                               
						IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 	    Total Percent Similarity:   95.54      Total Percent Identity:   95.27                                               
						RRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGAD 	                        Gaps:       1                        
						RQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERI 	                                                            
						KEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPSGDCAMESPPPA 	Alignment:                                                   
						PPPCPGPAPDTIDLTLQPPPPV                                       	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 77 -   	      12 SGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 61                                                           
						458 of MK07_HUMAN_V1, which also corresponds to amino acids  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						13 - 394 of T09244_P9, a third amino acid sequence bridging  	      76 TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 125                                                          
						amino acid sequence comprising of N, and a fourth amino acid 	                  .         .         .         .         .  
						GPSAPLEAPEPRKPVTAQERQREREEKRRRRQERAKEREKRRQERERKERGAGASGGPST 	      62 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 111                                                          
						DPLAGLVLSDNDRSLLERWTRMARPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGPQPQSAGSTSGPVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPP 	     126 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 175                                                          
						GLPGSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPLPPVFSGT 	                  .         .         .         .         .  
						PKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSASLLADWLEGHGMNPADIE 	     112 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 161                                                          
						SLQREIQMDSPMLLADLPDLQDP                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     176 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 225                                                          
						amino acids 493 - 815 of MK07_HUMAN_V1, which also           	                  .         .         .         .         .  
						corresponds to amino acids 396 - 718 of T09244_P9, wherein   	     162 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 211                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     226 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 275                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09244_P9, comprising a   	     212 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 261                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     276 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 325                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence GILWYVPFPCSS of T09244_P9.3.An isolated      	     262 MLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRER 311                                                          
						polypeptide encoding for an edge portion of T09244_P9,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     326 MLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRER 375                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     312 IKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPS 361                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     376 IKEAIVAEIEDFHARREGIRQQIRFQPSLQPVASEPGCPDVEMPSPWAPS 425                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise VNG having a structure as follows (numbering        	     362 GDCAMESPPPAPPPCPGPAPDTIDLTLQPPPPV................. 394                                                          
						according to T09244_P9): a sequence starting from any of     	         |||||||||||||||||||||||||||||||||                   
						amino acid numbers 394-x to 394; and ending at any of amino  	     426 GDCAMESPPPAPPPCPGPAPDTIDLTLQPPPPVSEPAPPKKDGAISDNTK 475                                                          
						acid numbers 396 + ((n-2) - x), in which x varies from 0 to  	                  .         .         .         .         .  
						n-2.                                                         	     395 ................NGPSAPLEAPEPRKPVTAQERQREREEKRRRRQE 428                                                          
						                                                            	                         :|||||||||||||||||||||||||||||||||  
						                                                            	     476 AALKAALLKSLRSRLRDGPSAPLEAPEPRKPVTAQERQREREEKRRRRQE 525                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     429 RAKEREKRRQERERKERGAGASGGPSTDPLAGLVLSDNDRSLLERWTRMA 478                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     526 RAKEREKRRQERERKERGAGASGGPSTDPLAGLVLSDNDRSLLERWTRMA 575                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     479 RPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQPQSAGSTSG 528                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     576 RPAAPALTSVPAPAPAPTPTPTPVQPTSPPPGPVAQPTGPQPQSAGSTSG 625                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     529 PVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLP 578                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     626 PVPQPACPPPGPAPHPTGPPGPIPVPAPPQIATSTSLLAAQSLVPPPGLP 675                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     579 GSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPL 628                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     676 GSSTPGVLPYFPPGLPPPDAGGAPQSSMSESPDVNLVTQQLSKSQVEDPL 725                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     629 PPVFSGTPKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSAS 678                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     726 PPVFSGTPKGSGAGYGVGFDLEEFLNQSFDMGVADGPQDGQADSASLSAS 775                                                          
						                                                            	                  .         .         .         .            
						                                                            	     679 LLADWLEGHGMNPADIESLQREIQMDSPMLLADLPDLQDP           718                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     776 LLADWLEGHGMNPADIESLQREIQMDSPMLLADLPDLQDP           815                                                          

4771	HMR136_T09246_10_tr0_r1_1_gPRT		Comparison report between T09246_P10 and DVL1_HUMANshort     	Sequence name: DVL1_HUMAN                                    
						unique head followed by partial WT sequence a mismatch,      	                                                            
						followed by a unique insertion, followed by a unique         	Sequence documentation:                                      
						insertion with extra amino acids and a followed by a short   	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Alignment of: 4771 x DVL1_HUMAN   ..                         
						T09246_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment segment 1/1:                                       
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MA           	                     Quality: 5123.00                      Escore:       0                                               
						corresponding to amino acids 1 - 2 of T09246_P10, a second   	             Matching length:     546                Total length:     594                                               
						ETKIIYHMDEEETPYLVKLPVAPERVTLADFKNVLSNRPVHAYKFFFKSMDQDFGVVKEE 	 Matching Percent Similarity:   99.63   Matching Percent Identity:   99.45                                               
						IFDDNAKLPCFNGRVVSWLVLAEGAHSDAGSQGTDSHTDLPPPLERTGGIGDSRPPSFHP 	    Total Percent Similarity:   91.58      Total Percent Identity:   91.41                                               
						NVASSRDGMDNETGTESMVSHRRERARRRNREEA                           	                        Gaps:       2                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 3 - 156 of DVL1_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 3 - 156 of T09246_P10, a     	                  .         .         .         .         .  
						bridging amino acid A corresponding to amino acid 157 of     	       1 MAETKIIYHMDEEETPYLVKLPVAPERVTLADFKNVLSNRPVHAYKFFFK 50                                                           
						T09246_P10, a third amino acid sequence being at least 90 %  	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						RTNGHPRGDRRRDVGLPPDSASTALSSELESSSFVDSDEDGSTSRLSSSTEQSTSSRLIR 	       1 MGETKIIYHMDEEETPYLVKLPVAPERVTLADFKNVLSNRPVHAYKFFFK 50                                                           
						KHKRRRRKQRLRQADRASSFSSITDSTMSLNIVTVTLNM                      	                  .         .         .         .         .  
						homologous to corresponding to amino acids 158 - 256 of      	      51 SMDQDFGVVKEEIFDDNAKLPCFNGRVVSWLVLAEGAHSDAGSQGTDSHT 100                                                          
						DVL1_HUMAN, which also corresponds to amino acids 158 - 256  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09246_P10, a fourth amino acid sequence being at least   	      51 SMDQDFGVVKEEIFDDNAKLPCFNGRVVSWLVLAEGAHSDAGSQGTDSHT 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     101 DLPPPLERTGGIGDSRPPSFHPNVASSRDGMDNETGTESMVSHRRERARR 150                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEASGRGLGAGAGAWPRLMALPA corresponding to amino acids 257 -   	     101 DLPPPLERTGGIGDSRPPSFHPNVASSRDGMDNETGTESMVSHRRERARR 150                                                          
						279 of T09246_P10, a fifth amino acid sequence being at least	                  .         .         .         .         .  
						ERHHFLGISIVGQSNDRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDD 	     151 RNREEAARTNGHPRGDRRRDVGLPPDSASTALSSELESSSFVDSDEDGST 200                                                          
						AVRVLREIVSQTGPISLTVAKCWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALTGALPR 	         |||||| |||||||||||||||||||||||||||||||||||||||||||  
						Y                                                            	     151 RNREEAPRTNGHPRGDRRRDVGLPPDSASTALSSELESSSFVDSDEDGST 200                                                          
						90 % homologous to corresponding to amino acids 257 - 377 of 	                  .         .         .         .         .  
						DVL1_HUMAN, which also corresponds to amino acids 280 - 400  	     201 SRLSSSTEQSTSSRLIRKHKRRRRKQRLRQADRASSFSSITDSTMSLNIV 250                                                          
						of T09246_P10, a sixth amino acid sequence being at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     201 SRLSSSTEQSTSSRLIRKHKRRRRKQRLRQADRASSFSSITDSTMSLNIV 250                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     251 TVTLNMGEASGRGLGAGAGAWPRLMALPAERHHFLGISIVGQSNDRGDGG 300                                                          
						GTSPCSSAVTRTSSSSLTSSVPGAPQ corresponding to amino acids 401 -	         ||||||                       |||||||||||||||||||||  
						426 of T09246_P10, a seventh amino acid sequence being at    	     251 TVTLNM.......................ERHHFLGISIVGQSNDRGDGG 277                                                          
						LEEAPLTVKSDMSAVVRVMQLPDSGLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKE 	                  .         .         .         .         .  
						RREARKYASSLLKHGFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDTLA 	     301 IYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVLREIVSQ 350                                                          
						PLPHPAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSE             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 379 -  	     278 IYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVLREIVSQ 327                                                          
						546 of DVL1_HUMAN, which also corresponds to amino acids 427 	                  .         .         .         .         .  
						- 594 of T09246_P10, and a eight amino acid sequence being at	     351 TGPISLTVAKCWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALTGALPRY 400                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     328 TGPISLTVAKCWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALTGALPRY 377                                                          
						homologous to a polypeptide having the sequence ALD          	                  .         .         .         .         .  
						corresponding to amino acids 595 - 597 of T09246_P10, wherein	     401 GTSPCSSAVTRTSSSSLTSSVPGAPQLEEAPLTVKSDMSAVVRVMQLPDS 450                                                          
						said first amino acid sequence, second amino acid sequence,  	                                  :||||||||||||||||||||||||  
						bridging amino acid, third amino acid sequence, fourth amino 	     378 .........................ELEEAPLTVKSDMSAVVRVMQLPDS 402                                                          
						acid sequence, fifth amino acid sequence, sixth amino acid   	                  .         .         .         .         .  
						sequence, seventh amino acid sequence and eight amino acid   	     451 GLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKERREARKYASSLLKH 500                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for an edge portion of         	     403 GLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKERREARKYASSLLKH 452                                                          
						T09246_P10, comprising an amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     501 GFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDTLAPLPH 550                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     453 GFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDTLAPLPH 502                                                          
						GEASGRGLGAGAGAWPRLMALPA, corresponding to T09246_P10.3.An    	                  .         .         .         .            
						isolated polypeptide encoding for an edge portion of         	     551 PAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSE       594                                                          
						T09246_P10, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||        
						70%, optionally at least about 80%, preferably at least about	     503 PAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSE       546                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						GTSPCSSAVTRTSSSSLTSSVPGAPQ, corresponding to T09246_P10.4.A  	                                                            
						bridge portion of T09246_P10, comprising a polypeptide having	                                                            
						a length "n", wherein n is at least about 10 amino acids in  	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise Y, having a structure as   	                                                            
						follows (numbering according to T09246_P10): a sequence      	                                                            
						starting from any of amino acid numbers 377-x to 377; and    	                                                            
						ending at any of amino acid numbers 401 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

4773	HMR136_T09246_3_tr0_r1_1_gPRT		Comparison report between T09246_P3 and DVL1_HUMANunique     	Sequence name: DVL1_HUMAN                                    
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique insertion with extra amino acids.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T09246_P3,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 4773 x DVL1_HUMAN   ..                         
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MPSFPASTAAWSPG corresponding to amino acids 1 - 14 of        	                     Quality: 5245.00                      Escore:       0                                               
						T09246_P3, a second amino acid sequence being at least 90 %  	             Matching length:     549                Total length:     574                                               
						homologous to PNVASSRDGMDNETGTESMVSHRRERARRRNREEA            	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.64                                               
						corresponding to amino acids 122 - 156 of DVL1_HUMAN, which  	    Total Percent Similarity:   95.47      Total Percent Identity:   95.30                                               
						also corresponds to amino acids 15 - 49 of T09246_P3, a      	                        Gaps:       1                        
						bridging amino acid A corresponding to amino acid 50 of      	                                                            
						T09246_P3, a third amino acid sequence being at least 90 %   	Alignment:                                                   
						RTNGHPRGDRRRDVGLPPDSASTALSSELESSSFVDSDEDGSTSRLSSSTEQSTSSRLIR 	                  .         .         .         .         .  
						KHKRRRRKQRLRQADRASSFSSITDSTMSLNIVTVTLNMERHHFLGISIVGQSNDRGDGG 	      15 PNVASSRDGMDNETGTESMVSHRRERARRRNREEAARTNGHPRGDRRRDV 64                                                           
						IYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVLREIVSQTGPISLTVAK 	         ||||||||||||||||||||||||||||||||||| ||||||||||||||  
						CWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALTGALPRY                     	     122 PNVASSRDGMDNETGTESMVSHRRERARRRNREEAPRTNGHPRGDRRRDV 171                                                          
						homologous to corresponding to amino acids 158 - 377 of      	                  .         .         .         .         .  
						DVL1_HUMAN, which also corresponds to amino acids 51 - 270 of	      65 GLPPDSASTALSSELESSSFVDSDEDGSTSRLSSSTEQSTSSRLIRKHKR 114                                                          
						T09246_P3, a fourth amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     172 GLPPDSASTALSSELESSSFVDSDEDGSTSRLSSSTEQSTSSRLIRKHKR 221                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     115 RRRKQRLRQADRASSFSSITDSTMSLNIVTVTLNMERHHFLGISIVGQSN 164                                                          
						GTSPCSSAVTRTSSSSLTSSVPGAPQ corresponding to amino acids 271 -	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						296 of T09246_P3, and a fifth amino acid sequence being at   	     222 RRRKQRLRQADRASSFSSITDSTMSLNIVTVTLNMERHHFLGISIVGQSN 271                                                          
						LEEAPLTVKSDMSAVVRVMQLPDSGLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKE 	                  .         .         .         .         .  
						RREARKYASSLLKHGFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDTLA 	     165 DRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVL 214                                                          
						PLPHPAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSEGSKSSGSTRSSR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RAPGREKERRAAGAGGSGSESDHTAPSGVGSSWRERPAGQLSRGSSPRSQASATAPGLPP 	     272 DRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVL 321                                                          
						PHPTTKAYTVVGGPPGGPPVRELAAVPPELTGSRQSFQKAMGNPCEFFVDIM         	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 379 -  	     215 REIVSQTGPISLTVAKCWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALT 264                                                          
						670 of DVL1_HUMAN, which also corresponds to amino acids 297 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 588 of T09246_P3, wherein said first amino acid sequence,  	     322 REIVSQTGPISLTVAKCWDPTPRSYFTVPRADPVRPIDPAAWLSHTAALT 371                                                          
						second amino acid sequence, bridging amino acid, third amino 	                  .         .         .         .         .  
						acid sequence, fourth amino acid sequence and fifth amino    	     265 GALPRYGTSPCSSAVTRTSSSSLTSSVPGAPQLEEAPLTVKSDMSAVVRV 314                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||                         :||||||||||||||||||  
						isolated polypeptide encoding for a head of T09246_P3,       	     372 GALPRY.........................ELEEAPLTVKSDMSAVVRV 396                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     315 MQLPDSGLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKERREARKYA 364                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence MPSFPASTAAWSPG of       	     397 MQLPDSGLEIRDRMWLKITIANAVIGADVVDWLYTHVEGFKERREARKYA 446                                                          
						T09246_P3.3.An isolated polypeptide encoding for an edge     	                  .         .         .         .         .  
						portion of T09246_P3, comprising an amino acid sequence being	     365 SSLLKHGFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDT 414                                                          
						at least 70%, optionally at least about 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 85%, more preferably at least about 90% and most 	     447 SSLLKHGFLRHTVNKITFSEQCYYVFGDLCSNLATLNLNSGSSGTSDQDT 496                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for GTSPCSSAVTRTSSSSLTSSVPGAPQ, corresponding to    	     415 LAPLPHPAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSE 464                                                          
						T09246_P3.4.A bridge portion of T09246_P3, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     497 LAPLPHPAAPWPLGQGYPYQYPGPPPCFPPAYQDPGFSYGSGSTGSQQSE 546                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     465 GSKSSGSTRSSRRAPGREKERRAAGAGGSGSESDHTAPSGVGSSWRERPA 514                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     547 GSKSSGSTRSSRRAPGREKERRAAGAGGSGSESDHTAPSGVGSSWRERPA 596                                                          
						length, wherein at least two amino acids comprise Y, having a	                  .         .         .         .         .  
						structure as follows (numbering according to T09246_P3): a   	     515 GQLSRGSSPRSQASATAPGLPPPHPTTKAYTVVGGPPGGPPVRELAAVPP 564                                                          
						sequence starting from any of amino acid numbers 377-x to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						377; and ending at any of amino acid numbers 271 + ((n-2) -  	     597 GQLSRGSSPRSQASATAPGLPPPHPTTKAYTVVGGPPGGPPVRELAAVPP 646                                                          
						x), in which x varies from 0 to n-2.                         	                  .         .                                
						                                                            	     565 ELTGSRQSFQKAMGNPCEFFVDIM                           588                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     647 ELTGSRQSFQKAMGNPCEFFVDIM                           670                                                          

5003	HMR136_T09253_1_tr0_r1_1_gPRT		Comparison report between T09253_P1 and Q99779partial WT     	Sequence name: Q99779                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09253_P1, comprising a first amino acid        	                                                            
						MGAFGEPLSLWQGRRTDTEAHRPLTAEASLPSCSALSVPWRGRKRGLRAEGVWGSHFAGQ 	Alignment of: 5003 x Q99779   ..                             
						SLLLSLAVALGSFPWAVLSRAQGFAEGGGPSLQLGCRPPLP                    	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 35 - 135 of Q99779, which also corresponds to    	                                                            
						amino acids 1 - 101 of T09253_P1.                            	                     Quality:  990.00                      Escore:       0                                               
						                                                            	             Matching length:     101                Total length:     101                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGAFGEPLSLWQGRRTDTEAHRPLTAEASLPSCSALSVPWRGRKRGLRAE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      35 MGAFGEPLSLWQGRRTDTEAHRPLTAEASLPSCSALSVPWRGRKRGLRAE 84                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GVWGSHFAGQSLLLSLAVALGSFPWAVLSRAQGFAEGGGPSLQLGCRPPL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      85 GVWGSHFAGQSLLLSLAVALGSFPWAVLSRAQGFAEGGGPSLQLGCRPPL 134                                                          
						                                                            	                                                             
						                                                            	     101 P                                                  101                                                          
						                                                            	         |                                                   
						                                                            	     135 P                                                  135                                                          

5005	HMR136_T09259_12_tr0_r1_1_gPRT		Comparison report between T09259_P12 and SMCX_HUMANpartial   	Sequence name: SMCX_HUMAN                                    
						WT sequence featuring skipped exon and a mismatch.1.An       	                                                            
						isolated chimeric polypeptide encoding for T09259_P12,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPADWQPPFAVEV 	Alignment of: 5005 x SMCX_HUMAN   ..                         
						DNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSLKIPNVERRILDLYSLSKIVV 	                                                            
						EEGGYEAICKDRRWARVAQRLNYPPGKNIGSLLRSHYERIVYPYEMYQSGANLVQCNTRP 	Alignment segment 1/1:                                       
						FDNEEKDKEYKPHSIPLRQSVQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYG 	                                                            
						AGPKMMGLGLMAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 	                     Quality: 14760.00                      Escore:       0                                              
						SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPPLPE 	             Matching length:    1511                Total length:    1560                                               
						IPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKADYFNMPVHMVPTEL 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						VEKEFWRLVNSIEEDVTVEYGADIHSKEFGSGFPVSDSKRHLTPEEEEYATSGWNLNVMP 	    Total Percent Similarity:   96.79      Total Percent Identity:   96.79                                               
						VLEQSVLCHINADISGMKVPWLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSL 	                        Gaps:       2                        
						AAEHLEEVMKKLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 	                                                            
						YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEKLDL 	Alignment:                                                   
						NLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQCIKCKTTCFLSALA 	                  .         .         .         .         .  
						CYDCPDGLVCLSHINDLCKCSSSRQYLRYRYTLDELPAMLHKLKVRAESFDTWANKVRVA 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						LEVEDGRKRSLEELRALESEARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HRVAGLQMTLTELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAGASV 	                  .         .         .         .         .  
						APSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIREAENIPVHLPNIQ 	      51 DWQPPFAVEVDNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSL 100                                                          
						ALKEALAKARAWIADVDEIQNGDHYPCLDDLEGLVAVGRDLPVGLEELRQLELQVLTAHS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WREKASKTFLKKNSCYTLLE                                         	      51 DWQPPFAVEVDNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSL 100                                                          
						homologous to corresponding to amino acids 1 - 1100 of       	                  .         .         .         .         .  
						SMCX_HUMAN, which also corresponds to amino acids 1 - 1100 of	     101 KIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 150                                                          
						T09259_P12, a second amino acid sequence being at least 90 % 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to                                                	     101 KIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 150                                                          
						IVAFKEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAG         	                  .         .         .         .         .  
						corresponding to amino acids 1147 - 1198 of SMCX_HUMAN, which	     151 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 200                                                          
						also corresponds to amino acids 1101 - 1152 of T09259_P12, a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid A corresponding to amino acid 1153 of    	     151 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 200                                                          
						T09259_P12, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						LQCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRSRRPRLETIL 	     201 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 250                                                          
						ALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASEDVTALLGRLAELRQRLQAEP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPEEPPNYPAAPASDPLREGSGKDMPKVQGLLENGDSVTSPEKVAPEEGS           	     201 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 250                                                          
						homologous to corresponding to amino acids 1200 - 1369 of    	                  .         .         .         .         .  
						SMCX_HUMAN, which also corresponds to amino acids 1154 - 1323	     251 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 300                                                          
						of T09259_P12, and a fourth amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLELLSSLLPQLTGPVLELPEATRAPLEELMMEGDLLEVTLDENHSIWQLLQAGQPPDLE 	     251 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 300                                                          
						RIRTLLELEKAERHGSRARGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEV 	                  .         .         .         .         .  
						QEEEELEEETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLPCP 	     301 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 350                                                          
						QQPPQQQL                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1373 - 	     301 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 350                                                          
						1560 of SMCX_HUMAN, which also corresponds to amino acids    	                  .         .         .         .         .  
						1324 - 1511 of T09259_P12, wherein said first amino acid     	     351 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 400                                                          
						sequence, second amino acid sequence, bridging amino acid,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     351 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 400                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T09259_P12,      	     401 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 450                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     401 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 450                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     451 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 500                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     451 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 500                                                          
						comprise EI, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 1100-x to 1101; and  	     501 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 550                                                          
						ending at any of amino acid numbers 1101+ ((n-2) - x), in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.3.An isolated chimeric          	     501 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 550                                                          
						polypeptide encoding for an edge portion of T09259_P12,      	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     551 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 600                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     551 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 600                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     601 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 650                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise SD, having a structure as follows: a sequence       	     601 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 650                                                          
						starting from any of amino acid numbers 1323-x to 1324; and  	                  .         .         .         .         .  
						ending at any of amino acid numbers 1324+ ((n-2) - x), in    	     651 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 700                                                          
						which x varies from 0 to n-2.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ..............................................IVAF 1104                                                         
						                                                            	                                                       ||||  
						                                                            	    1101 VLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAF 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1105 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGAL 1154                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						                                                            	    1151 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGRL 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1155 QCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRS 1204                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 QCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRS 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1205 RRPRLETILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASED 1254                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 RRPRLETILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASED 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1255 VTALLGRLAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGL 1304                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 VTALLGRLAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGL 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1305 LENGDSVTSPEKVAPEEGS...DLELLSSLLPQLTGPVLELPEATRAPLE 1351                                                         
						                                                            	         |||||||||||||||||||   ||||||||||||||||||||||||||||  
						                                                            	    1351 LENGDSVTSPEKVAPEEGSGKRDLELLSSLLPQLTGPVLELPEATRAPLE 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1352 ELMMEGDLLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRA 1401                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 ELMMEGDLLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1402 RGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEE 1451                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 RGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEE 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1452 ETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLP 1501                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 ETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLP 1550                                                         
						                                                            	                  .                                          
						                                                            	    1502 CPQQPPQQQL                                         1511                                                         
						                                                            	         ||||||||||                                          
						                                                            	    1551 CPQQPPQQQL                                         1560                                                         

5007	HMR136_T09259_13_tr0_r1_1_gPRT		Comparison report between T09259_P13 and SMCX_HUMANpartial   	Sequence name: SMCX_HUMAN                                    
						WT sequence followed by mismatch and a featuring a skipped   	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09259_P13, comprising a first amino acid sequence being at  	                                                            
						MTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPPLPEIPKGVWR 	Alignment of: 5007 x SMCX_HUMAN   ..                         
						CPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKADYFNMPVHMVPTELVEKEFWR 	                                                            
						LVNSIEEDVTVEYGADIHSKEFGSGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVL 	Alignment segment 1/1:                                       
						CHINADISGMKVPWLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEE 	                                                            
						VMKKLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRAYHSGFNQ 	                     Quality: 12233.00                      Escore:       0                                              
						GYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEKLDLNLAAAVH 	             Matching length:    1250                Total length:    1253                                               
						KEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQCIKCKTTCFLSALACYDCPDG 	 Matching Percent Similarity:   99.92   Matching Percent Identity:   99.92                                               
						LVCLSHINDLCKCSSSRQYLRYRYTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGR 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						KRSLEELRALESEARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQ 	                        Gaps:       1                        
						MTLTELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGLLQSLLER 	                                                            
						GRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAGASVAPSPAVD 	Alignment:                                                   
						KAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIREAENIPVHLPNIQALKEALA 	                  .         .         .         .         .  
						KARAWIADVDEIQNGDHYPCLDDLEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASK 	       1 MTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPP 50                                                           
						TFLKKNSCYTLLEVLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VAFKEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAG          	     308 MTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPP 357                                                          
						least 90 % homologous to corresponding to amino acids 308 -  	                  .         .         .         .         .  
						1198 of SMCX_HUMAN, which also corresponds to amino acids 1 -	      51 LPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKAD 100                                                          
						891 of T09259_P13, a bridging amino acid A corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid 892 of T09259_P13, a second amino acid sequence   	     358 LPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKAD 407                                                          
						LQCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRSRRPRLETIL 	                  .         .         .         .         .  
						ALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASEDVTALLGRLAELRQRLQAEP 	     101 YFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFGSGFPVSD 150                                                          
						RPEEPPNYPAAPASDPLREGSGKDMPKVQGLLENGDSVTSPEKVAPEEGS           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     408 YFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFGSGFPVSD 457                                                          
						acids 1200 - 1369 of SMCX_HUMAN, which also corresponds to   	                  .         .         .         .         .  
						amino acids 893 - 1062 of T09259_P13, and a third amino acid 	     151 SKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVPWLYVGMV 200                                                          
						DLELLSSLLPQLTGPVLELPEATRAPLEELMMEGDLLEVTLDENHSIWQLLQAGQPPDLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RIRTLLELEKAERHGSRARGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEV 	     458 SKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVPWLYVGMV 507                                                          
						QEEEELEEETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLPCP 	                  .         .         .         .         .  
						QQPPQQQL                                                     	     201 FSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMKKLTPELF 250                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1373 - 1560 of SMCX_HUMAN, which also corresponds	     508 FSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMKKLTPELF 557                                                          
						to amino acids 1063 - 1250 of T09259_P13, wherein said first 	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     251 DSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRAYHSGFNQ 300                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated chimeric polypeptide        	     558 DSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRAYHSGFNQ 607                                                          
						encoding for an edge portion of T09259_P13, comprising a     	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	     301 GYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEK 350                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     608 GYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEK 657                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     351 LDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQC 400                                                          
						length, wherein at least two amino acids comprise SD, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     658 LDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQC 707                                                          
						acid numbers 1062-x to 1063; and ending at any of amino acid 	                  .         .         .         .         .  
						numbers 1063+ ((n-2) - x), in which x varies from 0 to n-2.  	     401 IKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYRYTLDELP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     708 IKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYRYTLDELP 757                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 AMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESEARERRFP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     758 AMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESEARERRFP 807                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTLTELRAFL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     808 NSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTLTELRAFL 857                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGLLQSLLER 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     858 DQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGLLQSLLER 907                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     908 GRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAG 957                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     958 ASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIR 1007                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 EAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDDLEGLVAV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1008 EAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDDLEGLVAV 1057                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLEVLCPCAD 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1058 GRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLEVLCPCAD 1107                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 AGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAFKEGEQKE 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1108 AGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAFKEGEQKE 1157                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 KEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGALQCDLCQD 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||| ||||||||  
						                                                            	    1158 KEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGRLQCDLCQD 1207                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 WFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRSRRPRLET 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1208 WFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRSRRPRLET 1257                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 ILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASEDVTALLGR 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1258 ILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASEDVTALLGR 1307                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 LAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGLLENGDSV 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1308 LAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGLLENGDSV 1357                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 TSPEKVAPEEGS...DLELLSSLLPQLTGPVLELPEATRAPLEELMMEGD 1097                                                         
						                                                            	         ||||||||||||   |||||||||||||||||||||||||||||||||||  
						                                                            	    1358 TSPEKVAPEEGSGKRDLELLSSLLPQLTGPVLELPEATRAPLEELMMEGD 1407                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1098 LLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRARGRALER 1147                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1408 LLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRARGRALER 1457                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1148 RRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEEETGGEGP 1197                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1458 RRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEEETGGEGP 1507                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1198 PAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLPCPQQPPQ 1247                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1508 PAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLPCPQQPPQ 1557                                                         
						                                                            	                                                             
						                                                            	    1248 QQL                                                1250                                                         
						                                                            	         |||                                                 
						                                                            	    1558 QQL                                                1560                                                         

5009	HMR136_T09259_18_tr0_r1_1_gPRT		Comparison report between T09259_P18 and SMCX_HUMANpartial   	Sequence name: SMCX_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09259_P18, comprising a first amino	Sequence documentation:                                      
						MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPADWQPPFAVEV 	                                                            
						DNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSLKIPNVERRILDLYSLSKIVV 	Alignment of: 5009 x SMCX_HUMAN   ..                         
						EEGGYEAICKDRRWARVAQRLNYPPGKNIGSLLRSHYERIVYPYEMYQSGANLVQCNTRP 	                                                            
						FDNEEKDKEYKPHSIPLRQSVQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYG 	Alignment segment 1/1:                                       
						AGPKMMGLGLMAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 	                                                            
						SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPPLPE 	                     Quality: 11839.00                      Escore:       0                                              
						IPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKADYFNMPVHMVPTEL 	             Matching length:    1196                Total length:    1196                                               
						VEKEFWRLVNSIEEDVTVEYGADIHSKEFGSGFPVSDSKRHLTPEEEEYATSGWNLNVMP 	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						VLEQSVLCHINADISGMKVPWLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSL 	    Total Percent Similarity:   99.75      Total Percent Identity:   99.75                                               
						AAEHLEEVMKKLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 	                        Gaps:       0                        
						YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEKLDL 	                                                            
						NLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQCIKCKTTCFLSALA 	Alignment:                                                   
						CYDCPDGLVCLSHINDLCKCSSSRQYLRYRYTLDELPAMLHKLKVRAESFDTWANKVRVA 	                  .         .         .         .         .  
						LEVEDGRKRSLEELRALESEARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGP 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						HRVAGLQMTLTELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAGASV 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						APSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIREAENIPVHLPNIQ 	                  .         .         .         .         .  
						ALKEALAKARAWIADVDEIQNGDHYPCLDDLEGLVAVGRDLPVGLEELRQLELQVLTAHS 	      51 DWQPPFAVEVDNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSL 100                                                          
						WREKASKTFLKKNSCYTLLEVLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDPGSVIVAFKEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQ         	      51 DWQPPFAVEVDNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSL 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1192 of SMCX_HUMAN, which also corresponds	     101 KIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 150                                                          
						to amino acids 1 - 1192 of T09259_P18, and a second amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 70%, optionally at least 80%,   	     101 KIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     151 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 200                                                          
						having the sequence AAPGRLWPLKM corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1193 - 1203 of T09259_P18, wherein said first amino acid     	     151 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 200                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     201 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 250                                                          
						tail of T09259_P18, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     201 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 250                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence AAPGRLWPLKM in 	     251 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 300                                                          
						T09259_P18.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 VLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAF 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 VLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAF 1150                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1151 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQAAPG     1196                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||   |      
						                                                            	    1151 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAG     1196                                                         

5011	HMR136_T09259_19_tr0_r1_1_gPRT		Comparison report between T09259_P19 and SMCX_HUMANpartial   	Sequence name: SMCX_HUMAN                                    
						WT sequence featuring skipped exon and a mismatch.1.An       	                                                            
						isolated chimeric polypeptide encoding for T09259_P19,       	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPADWQPPFAVEV 	Alignment of: 5011 x SMCX_HUMAN   ..                         
						DNFRFTPRIQRLNELE                                             	                                                            
						homologous to corresponding to amino acids 1 - 76 of         	Alignment segment 1/1:                                       
						SMCX_HUMAN, which also corresponds to amino acids 1 - 76 of  	                                                            
						T09259_P19, a second amino acid sequence being at least 90 % 	                     Quality: 14813.00                      Escore:       0                                              
						IVVEEGGYEAICKDRRWARVAQRLNYPPGKNIGSLLRSHYERIVYPYEMYQSGANLVQCN 	             Matching length:    1516                Total length:    1560                                               
						TRPFDNEEKDKEYKPHSIPLRQSVQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQ 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						IYGAGPKMMGLGLMAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEE 	    Total Percent Similarity:   97.12      Total Percent Identity:   97.12                                               
						LSHSPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYHIFCLLPP 	                        Gaps:       2                        
						LPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEMADSFKADYFNMPVHMVP 	                                                            
						TELVEKEFWRLVNSIEEDVTVEYGADIHSKEFGSGFPVSDSKRHLTPEEEEYATSGWNLN 	Alignment:                                                   
						VMPVLEQSVLCHINADISGMKVPWLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGV 	                  .         .         .         .         .  
						PSLAAEHLEEVMKKLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITF 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						PRAYHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICKMAACPEK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELLPDDERQCIKCKTTCFLS 	       1 MEPGSDDFLPPPECPVFEPSWAEFRDPLGYIAKIRPIAEKSGICKIRPPA 50                                                           
						ALACYDCPDGLVCLSHINDLCKCSSSRQYLRYRYTLDELPAMLHKLKVRAESFDTWANKV 	                  .         .         .         .         .  
						RVALEVEDGRKRSLEELRALESEARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQE 	      51 DWQPPFAVEVDNFRFTPRIQRLNELE........................ 76                                                           
						AGPHRVAGLQMTLTELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSS 	         ||||||||||||||||||||||||||                          
						PGLLQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVMRGLLVAG 	      51 DWQPPFAVEVDNFRFTPRIQRLNELEAQTRVKLNYLDQIAKFWEIQGSSL 100                                                          
						ASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPATLEAIIREAENIPVHLP 	                  .         .         .         .         .  
						NIQALKEALAKARAWIADVDEIQNGDHYPCLDDLEGLVAVGRDLPVGLEELRQLELQVLT 	      77 .................IVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 109                                                          
						AHSWREKASKTFLKKNSCYTLLEVLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSA 	                          |||||||||||||||||||||||||||||||||  
						QDLRDPGSVIVAFKEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGA 	     101 KIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIG 150                                                          
						G                                                            	                  .         .         .         .         .  
						homologous to corresponding to amino acids 118 - 1198 of     	     110 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 159                                                          
						SMCX_HUMAN, which also corresponds to amino acids 77 - 1157  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09259_P19, a bridging amino acid A corresponding to amino	     151 SLLRSHYERIVYPYEMYQSGANLVQCNTRPFDNEEKDKEYKPHSIPLRQS 200                                                          
						acid 1158 of T09259_P19, a third amino acid sequence being at	                  .         .         .         .         .  
						LQCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRSRRPRLETIL 	     160 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 209                                                          
						ALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASEDVTALLGRLAELRQRLQAEP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPEEPPNYPAAPASDPLREGSGKDMPKVQGLLENGDSVTSPEKVAPEEGS           	     201 VQPSKFNSYGRRAKRLQPDPEPTEEDIEKNPELKKLQIYGAGPKMMGLGL 250                                                          
						least 90 % homologous to corresponding to amino acids 1200 - 	                  .         .         .         .         .  
						1369 of SMCX_HUMAN, which also corresponds to amino acids    	     210 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 259                                                          
						1159 - 1328 of T09259_P19, and a fourth amino acid sequence  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DLELLSSLLPQLTGPVLELPEATRAPLEELMMEGDLLEVTLDENHSIWQLLQAGQPPDLE 	     251 MAKDKTLRKKDKEGPECPPTVVVKEELGGDVKVESTSPKTFLESKEELSH 300                                                          
						RIRTLLELEKAERHGSRARGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEV 	                  .         .         .         .         .  
						QEEEELEEETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLPCP 	     260 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 309                                                          
						QQPPQQQL                                                     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     301 SPEPCTKMTMRLRRNHSNAQFIESYVCRMCSRGDEDDKLLLCDGCDDNYH 350                                                          
						acids 1373 - 1560 of SMCX_HUMAN, which also corresponds to   	                  .         .         .         .         .  
						amino acids 1329 - 1516 of T09259_P19, wherein said first    	     310 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 359                                                          
						amino acid sequence, second amino acid sequence, bridging    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid, third amino acid sequence and fourth amino acid  	     351 IFCLLPPLPEIPKGVWRCPKCVMAECKRPPEAFGFEQATREYTLQSFGEM 400                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     360 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 409                                                          
						T09259_P19, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     401 ADSFKADYFNMPVHMVPTELVEKEFWRLVNSIEEDVTVEYGADIHSKEFG 450                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     410 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 459                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     451 SGFPVSDSKRHLTPEEEEYATSGWNLNVMPVLEQSVLCHINADISGMKVP 500                                                          
						at least two amino acids comprise EI, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     460 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 509                                                          
						76-x to 77; and ending at any of amino acid numbers 77+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     501 WLYVGMVFSAFCWHIEDHWSYSINYLHWGEPKTWYGVPSLAAEHLEEVMK 550                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09259_P19, comprising a polypeptide having a length "n",    	     510 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 559                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     551 KLTPELFDSQPDLLHQLVTLMNPNTLMSHGVPVVRTNQCAGEFVITFPRA 600                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     560 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 609                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise SD, having a structure as  	     601 YHSGFNQGYNFAEAVNFCTADWLPAGRQCIEHYRRLRRYCVFSHEELICK 650                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						1328-x to 1329; and ending at any of amino acid numbers 1329+	     610 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 659                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 MAACPEKLDLNLAAAVHKEMFIMVQEERRLRKALLEKGITEAEREAFELL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     660 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 709                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PDDERQCIKCKTTCFLSALACYDCPDGLVCLSHINDLCKCSSSRQYLRYR 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     710 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 759                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 YTLDELPAMLHKLKVRAESFDTWANKVRVALEVEDGRKRSLEELRALESE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     760 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 809                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ARERRFPNSELLQQLKNCLSEAEACVSRALGLVSGQEAGPHRVAGLQMTL 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     810 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 859                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 TELRAFLDQMNNLPCAMHQIGDVKGVLEQVEAYQAEAREALASLPSSPGL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     860 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 909                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 LQSLLERGRQLGVEVPEAQQLQRQVEQARWLDEVKRTLAPSARRGTLAVM 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     910 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 959                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 RGLLVAGASVAPSPAVDKAQAELQELLTIAERWEEKAHLCLEARQKHPPA 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     960 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1009                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 TLEAIIREAENIPVHLPNIQALKEALAKARAWIADVDEIQNGDHYPCLDD 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1010 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1059                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LEGLVAVGRDLPVGLEELRQLELQVLTAHSWREKASKTFLKKNSCYTLLE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1060 VLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAF 1109                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 VLCPCADAGSDSTKRSRWMEKELGLYKSDTELLGLSAQDLRDPGSVIVAF 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1110 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGAL 1159                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						                                                            	    1151 KEGEQKEKEGILQLRRTNSAKPSPLASSSTASSTTSICVCGQVLAGAGRL 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1160 QCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRS 1209                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 QCDLCQDWFHGRCVSVPRLLSSPRPNPTSSPLLAWWEWDTKFLCPLCMRS 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1210 RRPRLETILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASED 1259                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 RRPRLETILALLVALQRLPVRLPEGEALQCLTERAISWQGRARQALASED 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1260 VTALLGRLAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGL 1309                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 VTALLGRLAELRQRLQAEPRPEEPPNYPAAPASDPLREGSGKDMPKVQGL 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1310 LENGDSVTSPEKVAPEEGS...DLELLSSLLPQLTGPVLELPEATRAPLE 1356                                                         
						                                                            	         |||||||||||||||||||   ||||||||||||||||||||||||||||  
						                                                            	    1351 LENGDSVTSPEKVAPEEGSGKRDLELLSSLLPQLTGPVLELPEATRAPLE 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1357 ELMMEGDLLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRA 1406                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 ELMMEGDLLEVTLDENHSIWQLLQAGQPPDLERIRTLLELEKAERHGSRA 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1407 RGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEE 1456                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 RGRALERRRRRKVDRGGEGDDPAREELEPKRVRSSGPEAEEVQEEEELEE 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1457 ETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLP 1506                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 ETGGEGPPAPIPTTGSPSTQENQNGLEPAEGTTSGPSAPFSTLTPRLHLP 1550                                                         
						                                                            	                  .                                          
						                                                            	    1507 CPQQPPQQQL                                         1516                                                         
						                                                            	         ||||||||||                                          
						                                                            	    1551 CPQQPPQQQL                                         1560                                                         

9893	HMR136_T09261_0_tr0_r1_1_gPRT		Comparison report between T09261_P0 and O15048unique head    	Sequence name: O15048                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9893 x O15048   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P0, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5365.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     544                Total length:     544                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTT                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     509 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 558                                                          
						corresponding to amino acids 509 - 1052 of O15048, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 555 of T09261_P0, and a third	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     559 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 608                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQR 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						SPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSER 	     609 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 658                                                          
						PRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRR 	                  .         .         .         .         .  
						SSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD 	     659 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 708                                                          
						ESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTP 	                  .         .         .         .         .  
						LTRRASQSSLESSTGPPCIRS                                        	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						having the sequence corresponding to amino acids 556 - 1056  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09261_P0, wherein said first amino acid sequence, second 	     709 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 758                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						polypeptide encoding for a head of T09261_P0, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     759 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 808                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						to the sequence MRKAKREKVET of T09261_P0.3.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09261_P0, comprising a   	     809 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 858                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQR 	     859 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 908                                                          
						SPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSS 	                  .         .         .         .         .  
						QELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSER 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						PRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 	     909 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 958                                                          
						GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKG 	                  .         .         .         .         .  
						QLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD 	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						ESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTRRASQSSLESSTGPPCIRS                                        	     959 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 1008                                                         
						to the sequence in T09261_P0.                                	                  .         .         .         .            
						                                                            	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	    1009 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       1052                                                         

						Comparison report between T09261_P0 and Q9HBA1unique head    	Sequence name: Q9HBA1                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9893 x Q9HBA1   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 4795.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     516                Total length:     764                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   67.54      Total Percent Identity:   67.54                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P0, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P0,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P0, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD                            	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						being at least 90 % homologous to corresponding to amino     	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						acids 149 - 241 of Q9HBA1, which also corresponds to amino   	                  .         .         .         .         .  
						acids 442 - 534 of T09261_P0, a fifth amino acid sequence    	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	                  .         .         .         .         .  
						SIQKQTRKGTASDAE                                              	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||          
						corresponding to amino acids 535 - 609 of T09261_P0, a sixth 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD........ 241                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						acids 242 - 279 of Q9HBA1, which also corresponds to amino   	                                                            
						acids 610 - 647 of T09261_P0, a seventh amino acid sequence  	     241 .................................................. 241                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     593 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 642                                                          
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                          |||||||||||||||||||||||||||||||||  
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	     242 .................RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 274                                                          
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     643 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 692                                                          
						corresponding to amino acids 648 - 819 of T09261_P0, and a   	         |||||                                               
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	     275 GSIEQ............................................. 279                                                          
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	                  .         .         .         .         .  
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	     693 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 742                                                          
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	                                                            
						eight amino acid sequence being at least 90 % homologous to  	     279 .................................................. 279                                                          
						corresponding to amino acids 280 - 516 of Q9HBA1, which also 	                  .         .         .         .         .  
						corresponds to amino acids 820 - 1056 of T09261_P0, wherein  	     743 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 792                                                          
						said first amino acid sequence, second amino acid sequence,  	                                                            
						third amino acid sequence, fourth amino acid sequence, fifth 	     279 .................................................. 279                                                          
						amino acid sequence, sixth amino acid sequence, seventh amino	                  .         .         .         .         .  
						acid sequence and eight amino acid sequence are contiguous   	     793 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 842                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                                    |||||||||||||||||||||||  
						for a head of T09261_P0, comprising a polypeptide being at   	     280 ...........................ESGHKKLKSTIQRSTETGMAAEM 302                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     843 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 892                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     303 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 352                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                  .         .         .         .         .  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     893 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 942                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     353 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 402                                                          
						T09261_P0.3.An isolated polypeptide encoding for an edge     	                  .         .         .         .         .  
						portion of T09261_P0, comprising an amino acid sequence being	     943 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 992                                                          
						at least 70%, optionally at least about 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 85%, more preferably at least about 90% and most 	     403 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 452                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for V, corresponding to T09261_P0.4.An isolated     	     993 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 1042                                                         
						polypeptide encoding for an edge portion of T09261_P0,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     453 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 502                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .                                          
						more preferably at least about 90% and most preferably at    	    1043 SSLESSTGPPCIRS                                     1056                                                         
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	         ||||||||||||||                                      
						SIQKQTRKGTASDAE,                                             	     503 SSLESSTGPPCIRS                                     516                                                          
						least about 95% homologous to the sequence encoding for      	                                                            
						corresponding to T09261_P0.5.An isolated polypeptide encoding	                                                            
						for an edge portion of T09261_P0, comprising an amino acid   	                                                            
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						sequence encoding for corresponding to T09261_P0.            	                                                            

						Comparison report between T09261_P0 and Q9HBA6unique head    	Sequence name: Q9HBA6                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique insertion.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for T09261_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9893 x Q9HBA6   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 7054.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     740                Total length:     790                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   93.67      Total Percent Identity:   93.67                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       2                        
						T09261_P0, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QDSELLMLPRAKRGRSAECLHTT                                      	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						homologous to corresponding to amino acids 1 - 263 of Q9HBA6,	                  .         .         .         .         .  
						which also corresponds to amino acids 293 - 555 of T09261_P0,	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						a third amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELQPFLDRARSASTNCLRPDTSLHSPER corresponding to amino acids   	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						290 - 318 of Q9HBA6, which also corresponds to amino acids   	                  .         .         .         .         .  
						556 - 584 of T09261_P0, a fourth amino acid sequence being at	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						ERHSRKSERSSIQKQTRKGTASDA corresponding to amino acids 585 -  	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						608 of T09261_P0, and a fifth amino acid sequence being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	                  .         .         .         .         .  
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQI 	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						GMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLY 	                  .         .         .         .         .  
						QQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSL 	     543 AKRGRSAECLHTT..........................SELQPFLDRAR 566                                                          
						VDPTLTPLTRRASQSSLESSTGPPCIRS                                 	         |||||||||||||                          |||||||||||  
						least 90 % homologous to corresponding to amino acids 319 -  	     251 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSELQPFLDRAR 300                                                          
						766 of Q9HBA6, which also corresponds to amino acids 609 -   	                  .         .         .         .         .  
						1056 of T09261_P0, wherein said first amino acid sequence,   	     567 SASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQRS 616                                                          
						second amino acid sequence, third amino acid sequence, fourth	         ||||||||||||||||||                        ||||||||  
						amino acid sequence and fifth amino acid sequence are        	     301 SASTNCLRPDTSLHSPER........................ERMHRQRS 326                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09261_P0, comprising a   	     617 PTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRF 666                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     327 PTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRF 376                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	     667 KQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISR 716                                                          
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	     377 KQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISR 426                                                          
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                  .         .         .         .         .  
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	     717 TSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVS 766                                                          
						to the sequence of T09261_P0.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P0,       	     427 TSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVS 476                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     767 GEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQL 816                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     477 GEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQL 526                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     817 SQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGN 866                                                          
						comprise TS, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 555-x to 556; and    	     527 SQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGN 576                                                          
						ending at any of amino acid numbers 556+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     867 LIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQ 916                                                          
						encoding for an edge portion of T09261_P0, comprising an     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	     577 LIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQ 626                                                          
						about 80%, preferably at least about 85%, more preferably at 	                  .         .         .         .         .  
						least about 90% and most preferably at least about 95%       	     917 LEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDP 966                                                          
						homologous to the sequence encoding for                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERHSRKSERSSIQKQTRKGTASDA, corresponding to T09261_P0.        	     627 LEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDP 676                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     967 LYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMV 1016                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     677 LYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMV 726                                                          
						                                                            	                  .         .         .         .            
						                                                            	    1017 IGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS           1056                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     727 IGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS           766                                                          

						Comparison report between T09261_P0 and Q9HBA4unique head    	Sequence name: Q9HBA4                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9893 x Q9HBA4   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 6557.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     700                Total length:     764                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   91.62      Total Percent Identity:   91.62                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P0, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA4,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P0,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P0, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						being at least 90 % homologous to corresponding to amino     	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						acids 149 - 262 of Q9HBA4, which also corresponds to amino   	                  .         .         .         .         .  
						acids 442 - 555 of T09261_P0, a fifth amino acid sequence    	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAE       	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						corresponding to amino acids 556 - 609 of T09261_P0, a sixth 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	                  .         .         .         .         .  
						SEQSERPRGRI                                                  	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						amino acid sequence being at least 90 % homologous to        	         |||||||||||||                                       
						corresponding to amino acids 263 - 393 of Q9HBA4, which also 	     250 AKRGRSAECLHTT..................................... 262                                                          
						corresponds to amino acids 610 - 740 of T09261_P0, a seventh 	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     593 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 642                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                          |||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     263 .................RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 295                                                          
						having the sequence SSFTPKMQG corresponding to amino acids   	                  .         .         .         .         .  
						741 - 749 of T09261_P0, and a eight amino acid sequence being	     643 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 692                                                          
						RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIF 	     296 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 345                                                          
						PGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQ 	                  .         .         .         .         .  
						KPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWG 	     693 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 742                                                          
						DYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESST 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						GPPCIRS                                                      	     346 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRI.. 393                                                          
						at least 90 % homologous to corresponding to amino acids 394 	                  .         .         .         .         .  
						- 700 of Q9HBA4, which also corresponds to amino acids 750 - 	     743 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 792                                                          
						1056 of T09261_P0, wherein said first amino acid sequence,   	                |||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence, fourth	     394 .......RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 436                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                  .         .         .         .         .  
						acid sequence, seventh amino acid sequence and eight amino   	     793 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 842                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of T09261_P0,       	     437 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 486                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     843 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 892                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	     487 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 536                                                          
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                  .         .         .         .         .  
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	     893 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 942                                                          
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	     537 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 586                                                          
						about 95% homologous to the sequence of T09261_P0.3.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     943 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 992                                                          
						T09261_P0, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     587 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 636                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for V,	     993 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 1042                                                         
						corresponding to T09261_P0.4.An isolated polypeptide encoding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of T09261_P0, comprising an amino acid   	     637 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 686                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .                                          
						preferably at least about 85%, more preferably at least about	    1043 SSLESSTGPPCIRS                                     1056                                                         
						90% and most preferably at least about 95% homologous to the 	         ||||||||||||||                                      
						sequence encoding for                                        	     687 SSLESSTGPPCIRS                                     700                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAE,      	                                                            
						corresponding to T09261_P0.5.An isolated polypeptide encoding	                                                            
						for an edge portion of T09261_P0, comprising an amino acid   	                                                            
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						sequence encoding for SSFTPKMQG, corresponding to T09261_P0. 	                                                            

						Comparison report between T09261_P0 and Q9HBA2unique head    	Sequence name: Q9HBA2                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9893 x Q9HBA2   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 5296.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     567                Total length:     764                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   74.21      Total Percent Identity:   74.21                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P0, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA2,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P0,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P0, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						LDRARSASTNCLRPDTSLHSPER                                      	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 149 - 291 of Q9HBA2, which also corresponds to amino   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						acids 442 - 584 of T09261_P0, a fifth amino acid sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least 80%, preferably at   	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						at least 95% homologous to a polypeptide having the sequence 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						ERHSRKSERSSIQKQTRKGTASDA corresponding to amino acids 585 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						608 of T09261_P0, a sixth amino acid sequence being at least 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						90 % homologous to ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ   	                  .         .         .         .         .  
						corresponding to amino acids 292 - 330 of Q9HBA2, which also 	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						corresponds to amino acids 609 - 647 of T09261_P0, a seventh 	         ||||||||||||||||||||||||||||||||||||||||||          
						amino acid sequence being at least 70%, optionally at least  	     250 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER........ 291                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     593 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 642                                                          
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                         ||||||||||||||||||||||||||||||||||  
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	     292 ................ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 325                                                          
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 648 - 819 of	     643 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 692                                                          
						T09261_P0, and a eight amino acid sequence being at least 90 	         |||||                                               
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	     326 GSIEQ............................................. 330                                                          
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	                  .         .         .         .         .  
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	     693 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 742                                                          
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	                                                            
						% homologous to corresponding to amino acids 331 - 567 of    	     330 .................................................. 330                                                          
						Q9HBA2, which also corresponds to amino acids 820 - 1056 of  	                  .         .         .         .         .  
						T09261_P0, wherein said first amino acid sequence, second    	     743 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 792                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence, fifth amino acid sequence, sixth amino acid   	     330 .................................................. 330                                                          
						sequence, seventh amino acid sequence and eight amino acid   	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     793 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 842                                                          
						isolated polypeptide encoding for a head of T09261_P0,       	                                    |||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     331 ...........................ESGHKKLKSTIQRSTETGMAAEM 353                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     843 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 892                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     354 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 403                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                  .         .         .         .         .  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     893 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 942                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of T09261_P0.3.An       	     404 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 453                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09261_P0, comprising an amino acid sequence being at least  	     943 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 992                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     454 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 503                                                          
						at least about 95% homologous to the sequence encoding for V,	                  .         .         .         .         .  
						corresponding to T09261_P0.4.An isolated polypeptide encoding	     993 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 1042                                                         
						for an edge portion of T09261_P0, comprising an amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	     504 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 553                                                          
						preferably at least about 85%, more preferably at least about	                  .                                          
						90% and most preferably at least about 95% homologous to the 	    1043 SSLESSTGPPCIRS                                     1056                                                         
						sequence encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding	         ||||||||||||||                                      
						to T09261_P0.5.An isolated polypeptide encoding for an edge  	     554 SSLESSTGPPCIRS                                     567                                                          
						portion of T09261_P0, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						encoding for corresponding to T09261_P0.                     	                                                            

						Comparison report between T09261_P0 and Q9HBA5unique head    	Sequence name: Q9HBA5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09261_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9893 x Q9HBA5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	Alignment segment 1/1:                                       
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                     Quality: 7154.00                      Escore:       0                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	             Matching length:     740                Total length:     764                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   96.86      Total Percent Identity:   96.86                                               
						to amino acids 1 - 292 of T09261_P0, a second amino acid     	                        Gaps:       1                        
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                                                            
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	Alignment:                                                   
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	                  .         .         .         .         .  
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						QDSELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						amino acids 1 - 292 of Q9HBA5, which also corresponds to     	                  .         .         .         .         .  
						amino acids 293 - 584 of T09261_P0, a third amino acid       	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence ERHSRKSERSSIQKQTRKGTASDA corresponding to	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						amino acids 585 - 608 of T09261_P0, and a fourth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	                  .         .         .         .         .  
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQI 	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						GMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLY 	                  .         .         .         .         .  
						QQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSL 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						VDPTLTPLTRRASQSSLESSTGPPCIRS                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						amino acids 293 - 740 of Q9HBA5, which also corresponds to   	                  .         .         .         .         .  
						amino acids 609 - 1056 of T09261_P0, wherein said first amino	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						acid sequence, second amino acid sequence, third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||          
						sequence and fourth amino acid sequence are contiguous and in	     251 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER........ 292                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of T09261_P0, comprising a polypeptide being at least   	     593 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 642                                                          
						70%, optionally at least about 80%, preferably at least about	                         ||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     293 ................ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 326                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                  .         .         .         .         .  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     643 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 692                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     327 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 376                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     693 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 742                                                          
						T09261_P0.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T09261_P0, comprising an amino acid sequence being	     377 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 426                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     743 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 792                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding to      	     427 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 476                                                          
						T09261_P0.                                                   	                  .         .         .         .         .  
						                                                            	     793 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 842                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     477 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 526                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     843 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 892                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     527 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 576                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     893 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 942                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     577 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 626                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     943 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 992                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     627 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 676                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     993 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 1042                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     677 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 726                                                          
						                                                            	                  .                                          
						                                                            	    1043 SSLESSTGPPCIRS                                     1056                                                         
						                                                            	         ||||||||||||||                                      
						                                                            	     727 SSLESSTGPPCIRS                                     740                                                          

						Comparison report between T09261_P0 and Q8TDY9unique head    	Sequence name: Q8TDY9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09261_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9893 x Q8TDY9   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P0, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 9465.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     987                Total length:    1045                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:   94.45      Total Percent Identity:   94.45                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       2                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTTSELQPFLDRARSASTNCLRPDTSLHSPER                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						corresponding to amino acids 484 - 1056 of Q8TDY9, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 584 of T09261_P0, a third    	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence ERHSRKSERSSIQKQTRKGTASDA corresponding to	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						amino acids 585 - 608 of T09261_P0, a fourth amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	                  .         .         .         .         .  
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAM      	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1057 - 1351 of Q8TDY9, which also corresponds to 	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						amino acids 609 - 903 of T09261_P0, a fifth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						having the sequence GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 904 - 937 of T09261_P0, and a   	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						APYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 	                  .         .         .         .         .  
						CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS  	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						sixth amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1352 - 1470 of Q8TDY9, which    	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						also corresponds to amino acids 938 - 1056 of T09261_P0,     	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T09261_P0,       	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MRKAKREKVET of          	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						T09261_P0.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T09261_P0, comprising an amino acid sequence being	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 561                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding to      	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 1033                                                         
						T09261_P0.4.An isolated polypeptide encoding for an edge     	                  .         .         .         .         .  
						portion of T09261_P0, comprising an amino acid sequence being	     562 LDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERM 611                                                          
						at least 70%, optionally at least about 80%, preferably at   	         |||||||||||||||||||||||                        |||  
						least about 85%, more preferably at least about 90% and most 	    1034 LDRARSASTNCLRPDTSLHSPER........................ERM 1059                                                         
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP,             	     612 HRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKM 661                                                          
						corresponding to T09261_P0.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1060 HRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKM 1109                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     662 KVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDV 711                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1110 KVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDV 1159                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     712 SAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMK 761                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1160 SAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMK 1209                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     762 STSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSR 811                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1210 STSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSR 1259                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     812 STSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSY 861                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1260 STSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSY 1309                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     862 SSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGME 911                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	    1310 SSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAM........ 1351                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     912 DKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIAR 961                                                          
						                                                            	                                   ||||||||||||||||||||||||  
						                                                            	    1352 ..........................APYVKVYLLENGACIAKKKTRIAR 1375                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     962 KTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELD 1011                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1376 KTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELD 1425                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1012 LSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS      1056                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1426 LSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS      1470                                                         

						Comparison report between T09261_P0 and AAO38848partial WT   	Sequence name: AAO38848                                      
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09261_P0, comprising a first amino 	Sequence documentation:                                      
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	Alignment of: 9893 x AAO38848   ..                           
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	Alignment segment 1/1:                                       
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 	                                                            
						MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEES 	                     Quality: 10027.00                      Escore:       0                                              
						EFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQR 	             Matching length:    1056                Total length:    1209                                               
						ISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLML 	    Total Percent Similarity:   87.34      Total Percent Identity:   87.34                                               
						PRAKRGRSAECLHTT                                              	                        Gaps:       3                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 484 - 1038 of AAO38848, which also corresponds	Alignment:                                                   
						to amino acids 1 - 555 of T09261_P0, a second amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	       1 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 50                                                           
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1103 - 1132 of AAO38848, which also corresponds to amino     	     484 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 533                                                          
						acids 556 - 585 of T09261_P0, a third amino acid sequence    	                  .         .         .         .         .  
						being at least 90 % homologous to RHSRKSERSSIQKQTRKGTASDAE   	      51 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 100                                                          
						corresponding to amino acids 1161 - 1184 of AAO38848, which  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 586 - 609 of T09261_P0, and a	     534 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 583                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	                  .         .         .         .         .  
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	     101 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 150                                                          
						SEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQP 	     584 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 633                                                          
						SRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIG 	                  .         .         .         .         .  
						MEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQ 	     151 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 200                                                          
						QSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DPTLTPLTRRASQSSLESSTGPPCIRS                                  	     634 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 683                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 1246 - 1692 of AAO38848, which  	     201 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 250                                                          
						also corresponds to amino acids 610 - 1056 of T09261_P0,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     684 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 733                                                          
						sequence, third amino acid sequence and fourth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     251 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 300                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09261_P0, comprising a polypeptide having a length "n",     	     734 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 783                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     301 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 350                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     784 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 833                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise TS, having a structure as  	     351 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 400                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						555-x to 556; and ending at any of amino acid numbers 556+   	     834 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 883                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     401 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 450                                                          
						T09261_P0, comprising a polypeptide having a length "n",     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     884 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 933                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     451 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 500                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     934 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 983                                                          
						at least two amino acids comprise ER, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     501 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 550                                                          
						585-x to 586; and ending at any of amino acid numbers 586+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     984 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 1033                                                         
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09261_P0, comprising a polypeptide having a length "n",     	     551 CLHTT............................................. 555                                                          
						wherein n is at least about 10 amino acids in length,        	         |||||                                               
						optionally at least about 20 amino acids in length,          	    1034 CLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDIS 1083                                                         
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     556 ...................SELQPFLDRARSASTNCLRPDTSLHSPERE. 585                                                          
						preferably at least about 50 amino acids in length, wherein  	                            ||||||||||||||||||||||||||||||   
						at least two amino acids comprise ER, having a structure as  	    1084 LHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERER 1133                                                         
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						609-x to 610; and ending at any of amino acid numbers 610+   	     586 ...........................RHSRKSERSSIQKQTRKGTASDA 608                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                                    |||||||||||||||||||||||  
						                                                            	    1134 GRWSPSLDRRRPPSPRIQIQHASPENDRHSRKSERSSIQKQTRKGTASDA 1183                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     609 E................................................. 609                                                          
						                                                            	         |                                                   
						                                                            	    1184 ERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLV 1233                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     610 ............RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 647                                                          
						                                                            	                     ||||||||||||||||||||||||||||||||||||||  
						                                                            	    1234 PGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 1283                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     648 ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCD 697                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1284 ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCD 1333                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     698 NVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKM 747                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1334 NVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKM 1383                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     748 QGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSS 797                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1384 QGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSS 1433                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     798 LSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVR 847                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1434 LSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVR 1483                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     848 QPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQT 897                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1484 QPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQT 1533                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     898 LATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLE 947                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1534 LATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLE 1583                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     948 NGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 997                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1584 NGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 1633                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     998 CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLES 1047                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1634 CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLES 1683                                                         
						                                                            	                                                             
						                                                            	    1048 STGPPCIRS                                          1056                                                         
						                                                            	         |||||||||                                           
						                                                            	    1684 STGPPCIRS                                          1692                                                         

						Comparison report between T09261_P0 and Q8TDZ5unique head    	Sequence name: Q8TDZ5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9893 x Q8TDZ5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P0, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5365.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     544                Total length:     544                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTT                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						corresponding to amino acids 484 - 1027 of Q8TDZ5, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 555 of T09261_P0, and a third	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQR 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						SPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSER 	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						PRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRR 	                  .         .         .         .         .  
						SSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD 	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						ESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTP 	                  .         .         .         .         .  
						LTRRASQSSLESSTGPPCIRS                                        	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						having the sequence corresponding to amino acids 556 - 1056  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T09261_P0, wherein said first amino acid sequence, second 	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						polypeptide encoding for a head of T09261_P0, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						to the sequence MRKAKREKVET of T09261_P0.3.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09261_P0, comprising a   	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQR 	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						SPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSS 	                  .         .         .         .         .  
						QELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSER 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						PRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKG 	                  .         .         .         .         .  
						QLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD 	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						ESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTRRASQSSLESSTGPPCIRS                                        	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						to the sequence in T09261_P0.                                	                  .         .         .         .            
						                                                            	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       1027                                                         

9889	HMR136_T09261_14_tr0_r1_1_gPRT		Comparison report between T09261_P14 and O15048unique head   	Sequence name: O15048                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9889 x O15048   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P14, a second  	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5375.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     545                Total length:     545                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTTR                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     509 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 558                                                          
						corresponding to amino acids 509 - 1053 of O15048, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 556 of T09261_P14, and a     	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						third amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     559 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 608                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						HLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDE 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						ILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQGIR                   	     609 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 658                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						557 - 718 of T09261_P14, wherein said first amino acid       	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     659 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 708                                                          
						isolated polypeptide encoding for a head of T09261_P14,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     709 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 758                                                          
						about 95% homologous to the sequence MRKAKREKVET of          	                  .         .         .         .         .  
						T09261_P14.3.An isolated polypeptide encoding for a tail of  	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						T09261_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     759 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 808                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						HLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDE 	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						ILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQGIR                   	     809 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 858                                                          
						least about 95% homologous to the sequence in T09261_P14.    	                  .         .         .         .         .  
						                                                            	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     859 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 908                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     909 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 958                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     959 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 1008                                                         
						                                                            	                  .         .         .         .            
						                                                            	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTR      556                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1009 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTR      1053                                                         

						Comparison report between T09261_P14 and Q9HBA1unique head   	Sequence name: Q9HBA1                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, followed by a unique insertion and a followed by a	Sequence documentation:                                      
						short unique tail.1.An isolated chimeric polypeptide encoding	                                                            
						for T09261_P14, comprising a first amino acid sequence being 	Alignment of: 9889 x Q9HBA1   ..                             
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 2598.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     279                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   65.96      Total Percent Identity:   65.96                                               
						least 95% homologous to a polypeptide having the sequence    	                        Gaps:       2                        
						corresponding to amino acids 1 - 292 of T09261_P14, a second 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 148 of Q9HBA1, which also   	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						corresponds to amino acids 293 - 440 of T09261_P14, a third  	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						having the sequence V corresponding to amino acids 441 - 441 	                  .         .         .         .         .  
						of T09261_P14, a fourth amino acid sequence being at least 90	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQ                             	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						% homologous to corresponding to amino acids 149 - 240 of    	                  .         .         .         .         .  
						Q9HBA1, which also corresponds to amino acids 442 - 533 of   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						T09261_P14, a fifth amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						DSELLMLPRAKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKS 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						VTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRW 	         |||||||||||||||||||||||||||||||||||||||||           
						SPSLDRRRPPSPRIQIQHASPEN                                      	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQ......... 240                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 534 - 676 of T09261_P14, a sixth amino acid   	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						sequence being at least 90 % homologous to                   	                                                            
						DRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to     	     240 .................................................. 240                                                          
						amino acids 241 - 279 of Q9HBA1, which also corresponds to   	                  .         .         .         .         .  
						amino acids 677 - 715 of T09261_P14, and a seventh amino acid	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	     240 .................................................. 240                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GIR corresponding to amino acids 716 -   	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	                                           ||||||||||||||||  
						second amino acid sequence, third amino acid sequence, fourth	     241 ..................................DRMHRQRSPTQSPPAD 256                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                  .         .                                
						acid sequence and seventh amino acid sequence are contiguous 	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         |||||||||||||||||||||||                             
						for a head of T09261_P14, comprising a polypeptide being at  	     257 TSFSSRRGRQLPQVPVRSGSIEQ                            279                                                          
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						T09261_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09261_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for V, corresponding to T09261_P14.4.An isolated    	                                                            
						polypeptide encoding for an edge portion of T09261_P14,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						DSELLMLPRAKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKS 	                                                            
						VTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRW 	                                                            
						SPSLDRRRPPSPRIQIQHASPEN,                                     	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						corresponding to T09261_P14.                                 	                                                            

						Comparison report between T09261_P14 and Q9HBA6unique head   	Sequence name: Q9HBA6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a short unique tail.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for T09261_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 9889 x Q9HBA6   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 3381.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     357                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   84.40      Total Percent Identity:   84.40                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       2                        
						1 - 292 of T09261_P14, a second amino acid sequence being at 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QDSELLMLPRAKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIY            	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 289	                  .         .         .         .         .  
						of Q9HBA6, which also corresponds to amino acids 293 - 581 of	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						T09261_P14, a third amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						SSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDEILV corresponding to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 582 - 619 of T09261_P14, a fourth amino acid sequence  	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						being at least 90 % homologous to                            	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						290 - 319 of Q9HBA6, which also corresponds to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						620 - 649 of T09261_P14, a fifth amino acid sequence being at	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGRWSPSLDRRRPPSPRIQIQHASPEND corresponding to amino acids 650	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						- 677 of T09261_P14, a sixth amino acid sequence being at    	                  .         .         .         .         .  
						least 90 % homologous to                                     	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	         |||||||||||||||||||||||||||||||||||||||             
						acids 320 - 357 of Q9HBA6, which also corresponds to amino   	     251 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIY........... 289                                                          
						acids 678 - 715 of T09261_P14, and a seventh amino acid      	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						preferably at least 85%, more preferably at least 90% and    	                                    |||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     290 ...........................SELQPFLDRARSASTNCLRPDTS 312                                                          
						having the sequence GIR corresponding to amino acids 716 -   	                  .         .         .         .         .  
						718 of T09261_P14, wherein said first amino acid sequence,   	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						second amino acid sequence, third amino acid sequence, fourth	         |||||||                            |||||||||||||||  
						amino acid sequence, fifth amino acid sequence, sixth amino  	     313 LHSPERE............................RMHRQRSPTQSPPAD 334                                                          
						acid sequence and seventh amino acid sequence are contiguous 	                  .         .                                
						and in a sequential order.2.An isolated polypeptide encoding 	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						for a head of T09261_P14, comprising a polypeptide being at  	         |||||||||||||||||||||||                             
						least 70%, optionally at least about 80%, preferably at least	     335 TSFSSRRGRQLPQVPVRSGSIEQ                            357                                                          
						about 85%, more preferably at least about 90% and most       	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						T09261_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09261_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for SSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDEILV,         	                                                            
						corresponding to T09261_P14.4.An isolated polypeptide        	                                                            
						encoding for an edge portion of T09261_P14, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						RGRWSPSLDRRRPPSPRIQIQHASPEND, corresponding to T09261_P14.   	                                                            

						Comparison report between T09261_P14 and Q9HBA4unique head   	Sequence name: Q9HBA4                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, followed by a unique insertion and a followed by a	Sequence documentation:                                      
						short unique tail.1.An isolated chimeric polypeptide encoding	                                                            
						for T09261_P14, comprising a first amino acid sequence being 	Alignment of: 9889 x Q9HBA4   ..                             
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 2802.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     300                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   70.92      Total Percent Identity:   70.92                                               
						least 95% homologous to a polypeptide having the sequence    	                        Gaps:       2                        
						corresponding to amino acids 1 - 292 of T09261_P14, a second 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 148 of Q9HBA4, which also   	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						corresponds to amino acids 293 - 440 of T09261_P14, a third  	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						having the sequence V corresponding to amino acids 441 - 441 	                  .         .         .         .         .  
						of T09261_P14, a fourth amino acid sequence being at least 90	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						% homologous to corresponding to amino acids 149 - 262 of    	                  .         .         .         .         .  
						Q9HBA4, which also corresponds to amino acids 442 - 555 of   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						T09261_P14, a fifth amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						EILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ND                                                           	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 556 - 677 of T09261_P14, a sixth amino acid   	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						sequence being at least 90 % homologous to                   	         |||||||||||||                                       
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     250 AKRGRSAECLHTT..................................... 262                                                          
						acids 263 - 300 of Q9HBA4, which also corresponds to amino   	                  .         .         .         .         .  
						acids 678 - 715 of T09261_P14, and a seventh amino acid      	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	     262 .................................................. 262                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GIR corresponding to amino acids 716 -   	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	                                            |||||||||||||||  
						second amino acid sequence, third amino acid sequence, fourth	     263 ...................................RMHRQRSPTQSPPAD 277                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                  .         .                                
						acid sequence and seventh amino acid sequence are contiguous 	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         |||||||||||||||||||||||                             
						for a head of T09261_P14, comprising a polypeptide being at  	     278 TSFSSRRGRQLPQVPVRSGSIEQ                            300                                                          
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						T09261_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09261_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for V, corresponding to T09261_P14.4.An isolated    	                                                            
						polypeptide encoding for an edge portion of T09261_P14,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	                                                            
						EILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPE 	                                                            
						ND,                                                          	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						corresponding to T09261_P14.                                 	                                                            

						Comparison report between T09261_P14 and Q9HBA2unique head   	Sequence name: Q9HBA2                                        
						followed by partial WT sequence with a short unique          	                                                            
						insertion, followed by a unique insertion and a followed by a	Sequence documentation:                                      
						short unique tail.1.An isolated chimeric polypeptide encoding	                                                            
						for T09261_P14, comprising a first amino acid sequence being 	Alignment of: 9889 x Q9HBA2   ..                             
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 2999.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     330                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   78.01      Total Percent Identity:   78.01                                               
						least 95% homologous to a polypeptide having the sequence    	                        Gaps:       3                        
						corresponding to amino acids 1 - 292 of T09261_P14, a second 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 148 of Q9HBA2, which also   	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						corresponds to amino acids 293 - 440 of T09261_P14, a third  	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						having the sequence V corresponding to amino acids 441 - 441 	                  .         .         .         .         .  
						of T09261_P14, a fourth amino acid sequence being at least 90	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						% homologous to corresponding to amino acids 149 - 262 of    	                  .         .         .         .         .  
						Q9HBA2, which also corresponds to amino acids 442 - 555 of   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						T09261_P14, a fifth amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						EILV                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						to amino acids 556 - 619 of T09261_P14, a sixth amino acid   	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	         |||||||||||||                                       
						263 - 292 of Q9HBA2, which also corresponds to amino acids   	     250 AKRGRSAECLHTT..................................... 262                                                          
						620 - 649 of T09261_P14, a seventh amino acid sequence being 	                  .         .         .         .         .  
						at least 70%, optionally at least 80%, preferably at least   	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						85%, more preferably at least 90% and most preferably at     	                                    |||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	     263 ...........................SELQPFLDRARSASTNCLRPDTS 285                                                          
						RGRWSPSLDRRRPPSPRIQIQHASPEND corresponding to amino acids 650	                  .         .         .         .         .  
						- 677 of T09261_P14, a eight amino acid sequence being at    	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						least 90 % homologous to                                     	         |||||||                            |||||||||||||||  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     286 LHSPERE............................RMHRQRSPTQSPPAD 307                                                          
						acids 293 - 330 of Q9HBA2, which also corresponds to amino   	                  .         .                                
						acids 678 - 715 of T09261_P14, and a ninth amino acid        	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						sequence being at least 70%, optionally at least 80%,        	         |||||||||||||||||||||||                             
						preferably at least 85%, more preferably at least 90% and    	     308 TSFSSRRGRQLPQVPVRSGSIEQ                            330                                                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence GIR corresponding to amino acids 716 -   	                                                            
						718 of T09261_P14, wherein said first amino acid sequence,   	                                                            
						second amino acid sequence, third amino acid sequence, fourth	                                                            
						amino acid sequence, fifth amino acid sequence, sixth amino  	                                                            
						acid sequence, seventh amino acid sequence, eight amino acid 	                                                            
						sequence and ninth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of T09261_P14, comprising a polypeptide being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						T09261_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09261_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for V, corresponding to T09261_P14.4.An isolated    	                                                            
						polypeptide encoding for an edge portion of T09261_P14,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	                                                            
						EILV,                                                        	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						corresponding to T09261_P14.5.An isolated polypeptide        	                                                            
						encoding for an edge portion of T09261_P14, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						RGRWSPSLDRRRPPSPRIQIQHASPEND, corresponding to T09261_P14.   	                                                            

						Comparison report between T09261_P14 and Q9HBA5unique head   	Sequence name: Q9HBA5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a short unique tail.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for T09261_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 9889 x Q9HBA5   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 3107.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     331                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   78.25      Total Percent Identity:   78.25                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       2                        
						1 - 292 of T09261_P14, a second amino acid sequence being at 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QDSELLMLPRAKRGRSAECLHTT                                      	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 263	                  .         .         .         .         .  
						of Q9HBA5, which also corresponds to amino acids 293 - 555 of	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						T09261_P14, a third amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						EILV                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						to amino acids 556 - 619 of T09261_P14, a fourth amino acid  	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						264 - 293 of Q9HBA5, which also corresponds to amino acids   	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						620 - 649 of T09261_P14, a fifth amino acid sequence being at	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						RGRWSPSLDRRRPPSPRIQIQHASPEND corresponding to amino acids 650	                  .         .         .         .         .  
						- 677 of T09261_P14, a sixth amino acid sequence being at    	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						least 90 % homologous to                                     	         |||||||||||||                                       
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     251 AKRGRSAECLHTT..................................... 263                                                          
						acids 294 - 331 of Q9HBA5, which also corresponds to amino   	                  .         .         .         .         .  
						acids 678 - 715 of T09261_P14, and a seventh amino acid      	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						sequence being at least 70%, optionally at least 80%,        	                                    |||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     264 ...........................SELQPFLDRARSASTNCLRPDTS 286                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GIR corresponding to amino acids 716 -   	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	         |||||||                            |||||||||||||||  
						second amino acid sequence, third amino acid sequence, fourth	     287 LHSPERE............................RMHRQRSPTQSPPAD 308                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                  .         .                                
						acid sequence and seventh amino acid sequence are contiguous 	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         |||||||||||||||||||||||                             
						for a head of T09261_P14, comprising a polypeptide being at  	     309 TSFSSRRGRQLPQVPVRSGSIEQ                            331                                                          
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						T09261_P14.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09261_P14, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	                                                            
						EILV,                                                        	                                                            
						encoding for corresponding to T09261_P14.4.An isolated       	                                                            
						polypeptide encoding for an edge portion of T09261_P14,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						RGRWSPSLDRRRPPSPRIQIQHASPEND, corresponding to T09261_P14.   	                                                            

						Comparison report between T09261_P14 and Q8TDY9unique head   	Sequence name: Q8TDY9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a short unique tail.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for T09261_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 9889 x Q8TDY9   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence MRKAKREKVET corresponding to 	                                                            
						amino acids 1 - 11 of T09261_P14, a second amino acid        	                     Quality: 5842.00                      Escore:       0                                               
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	             Matching length:     612                Total length:     704                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	    Total Percent Similarity:   86.93      Total Percent Identity:   86.93                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	                        Gaps:       2                        
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                                                            
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	Alignment:                                                   
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	                  .         .         .         .         .  
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHTT                                                         	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 484 - 1027 of Q8TDY9, which also corresponds to  	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acids 12 - 555 of T09261_P14, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EILV                                                         	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						having the sequence corresponding to amino acids 556 - 619 of	                  .         .         .         .         .  
						T09261_P14, a fourth amino acid sequence being at least 90 % 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						homologous to SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1028 - 1057 of Q8TDY9, which also corresponds to 	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						amino acids 620 - 649 of T09261_P14, a fifth amino acid      	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						having the sequence RGRWSPSLDRRRPPSPRIQIQHASPEND             	                  .         .         .         .         .  
						corresponding to amino acids 650 - 677 of T09261_P14, a sixth	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						acids 1058 - 1095 of Q8TDY9, which also corresponds to amino 	                  .         .         .         .         .  
						acids 678 - 715 of T09261_P14, and a seventh amino acid      	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GIR corresponding to amino acids 716 -   	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence, fourth	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                  .         .         .         .         .  
						acid sequence and seventh amino acid sequence are contiguous 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of T09261_P14, comprising a polypeptide being at  	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MRKAKREKVET of T09261_P14.3.An isolated polypeptide encoding 	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						for an edge portion of T09261_P14, comprising an amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least about 80%,  	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTRHLVRH 561                                                          
						preferably at least about 85%, more preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||        
						90% and most preferably at least about 95% homologous to the 	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT...... 1027                                                         
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	                  .         .         .         .         .  
						EILV,                                                        	     562 YKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVL 611                                                          
						sequence encoding for corresponding to T09261_P14.4.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	    1027 .................................................. 1027                                                         
						T09261_P14, comprising an amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     612 RFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRR 661                                                          
						85%, more preferably at least about 90% and most preferably  	                 ||||||||||||||||||||||||||||||              
						at least about 95% homologous to the sequence encoding for   	    1028 ........SELQPFLDRARSASTNCLRPDTSLHSPERE............ 1057                                                         
						RGRWSPSLDRRRPPSPRIQIQHASPEND, corresponding to T09261_P14.   	                  .         .         .         .         .  
						                                                            	     662 PPSPRIQIQHASPENDRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSG 711                                                          
						                                                            	                         ||||||||||||||||||||||||||||||||||  
						                                                            	    1058 ................RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSG 1091                                                         
						                                                            	                                                             
						                                                            	     712 SIEQ                                               715                                                          
						                                                            	         ||||                                                
						                                                            	    1092 SIEQ                                               1095                                                         

						Comparison report between T09261_P14 and AAO38848partial WT  	Sequence name: AAO38848                                      
						sequence featuring skipped exon and a followed by a short    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						T09261_P14, comprising a first amino acid sequence being at  	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	Alignment of: 9889 x AAO38848   ..                           
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	Alignment segment 1/1:                                       
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	                                                            
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 	                     Quality: 6980.00                      Escore:       0                                               
						MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEES 	             Matching length:     715                Total length:     800                                               
						EFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQG 	    Total Percent Similarity:   89.38      Total Percent Identity:   89.38                                               
						KPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLML 	                        Gaps:       1                        
						PRAKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDIS 	                                                            
						LHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRR 	Alignment:                                                   
						RPPSPRIQIQHASPEND                                            	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 484 -  	       1 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 50                                                           
						1160 of AAO38848, which also corresponds to amino acids 1 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						677 of T09261_P14, a second amino acid sequence being at     	     484 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 533                                                          
						least 90 % homologous to                                     	                  .         .         .         .         .  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	      51 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 100                                                          
						acids 1246 - 1283 of AAO38848, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 678 - 715 of T09261_P14, and a third amino acid  	     534 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 583                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     101 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 150                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GIR corresponding to amino acids 716 -   	     584 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 633                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     151 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 200                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P14,      	     634 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 683                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     201 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 250                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     684 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 733                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     251 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 300                                                          
						comprise DR, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 677-x to 678; and    	     734 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 783                                                          
						ending at any of amino acid numbers 678+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     301 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     784 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 833                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     834 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 883                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     884 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 933                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     934 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 983                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     984 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 1033                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDIS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1034 CLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDIS 1083                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERER 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1084 LHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERER 1133                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 GRWSPSLDRRRPPSPRIQIQHASPEND....................... 677                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	    1134 GRWSPSLDRRRPPSPRIQIQHASPENDRHSRKSERSSIQKQTRKGTASDA 1183                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     677 .................................................. 677                                                          
						                                                            	                                                            
						                                                            	    1184 ERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLV 1233                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     678 ............RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 715                                                          
						                                                            	                     ||||||||||||||||||||||||||||||||||||||  
						                                                            	    1234 PGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 1283                                                         

						Comparison report between T09261_P14 and Q9HBA3unique head   	Sequence name: Q9HBA3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a short unique tail.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for T09261_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 9889 x Q9HBA3   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 3497.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     359                Total length:     423                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   84.87      Total Percent Identity:   84.87                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       1                        
						1 - 292 of T09261_P14, a second amino acid sequence being at 	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QDSELLMLPRAKRGRSAECLHTT                                      	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						least 90 % homologous to corresponding to amino acids 1 - 263	                  .         .         .         .         .  
						of Q9HBA3, which also corresponds to amino acids 293 - 555 of	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						T09261_P14, a third amino acid sequence being at least 70%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						EILV                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						to amino acids 556 - 619 of T09261_P14, a fourth amino acid  	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRM 	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						HRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						amino acids 264 - 359 of Q9HBA3, which also corresponds to   	                  .         .         .         .         .  
						amino acids 620 - 715 of T09261_P14, and a fifth amino acid  	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GIR corresponding to amino acids 716 -   	     543 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTK 592                                                          
						718 of T09261_P14, wherein said first amino acid sequence,   	         |||||||||||||                                       
						second amino acid sequence, third amino acid sequence, fourth	     251 AKRGRSAECLHTT..................................... 263                                                          
						amino acid sequence and fifth amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     593 SVTRQDISLHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTS 642                                                          
						polypeptide encoding for a head of T09261_P14, comprising a  	                                    |||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     264 ...........................SELQPFLDRARSASTNCLRPDTS 286                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     643 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 692                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     287 LHSPERERGRWSPSLDRRRPPSPRIQIQHASPENDRMHRQRSPTQSPPAD 336                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                  .         .                                
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     693 TSFSSRRGRQLPQVPVRSGSIEQ                            715                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	         |||||||||||||||||||||||                             
						to the sequence of T09261_P14.3.An isolated polypeptide      	     337 TSFSSRRGRQLPQVPVRSGSIEQ                            359                                                          
						encoding for an edge portion of T09261_P14, comprising an    	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						RHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTD 	                                                            
						EILV,                                                        	                                                            
						homologous to the sequence encoding for corresponding to     	                                                            
						T09261_P14.                                                  	                                                            

						Comparison report between T09261_P14 and Q8TDZ5unique head   	Sequence name: Q8TDZ5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9889 x Q8TDZ5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P14, a second  	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5375.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     545                Total length:     545                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTTR                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						corresponding to amino acids 484 - 1028 of Q8TDZ5, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 556 of T09261_P14, and a     	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						third amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						HLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDE 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						ILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQGIR                   	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						557 - 718 of T09261_P14, wherein said first amino acid       	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						isolated polypeptide encoding for a head of T09261_P14,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						about 95% homologous to the sequence MRKAKREKVET of          	                  .         .         .         .         .  
						T09261_P14.3.An isolated polypeptide encoding for a tail of  	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						T09261_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						HLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDE 	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						ILVSELQPFLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASPEN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQGIR                   	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						least about 95% homologous to the sequence in T09261_P14.    	                  .         .         .         .         .  
						                                                            	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						                                                            	                  .         .         .         .            
						                                                            	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTR      556                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTR      1028                                                         

9897	HMR136_T09261_15_tr0_r1_1_gPRT		Comparison report between T09261_P15 and O15048partial WT    	Sequence name: O15048                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09261_P15, comprising a first amino	Sequence documentation:                                      
						MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKEEAMLKCVVRD 	                                                            
						MAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGEEARRYQGEHKDDAPTCGICH 	Alignment of: 9897 x O15048   ..                             
						KTKFADGCGHLCSYCRTKFCARCGGRVSLRSNN                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 26 - 178 of O15048, which also corresponds to 	                                                            
						amino acids 1 - 153 of T09261_P15, and a second amino acid   	                     Quality: 1565.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     153                Total length:     153                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GGQSG corresponding to amino acids 154 - 	                        Gaps:       0                        
						158 of T09261_P15, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09261_P15, comprising a polypeptide being at least 70%,     	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      26 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 75                                                           
						least about 95% homologous to the sequence GGQSG in          	                  .         .         .         .         .  
						T09261_P15.                                                  	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      76 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 125                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     126 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 175                                                          
						                                                            	                                                             
						                                                            	     151 SNN                                                153                                                          
						                                                            	         |||                                                 
						                                                            	     176 SNN                                                178                                                          

						Comparison report between T09261_P15 and Q8TDY9partial WT    	Sequence name: Q8TDY9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09261_P15, comprising a first amino	Sequence documentation:                                      
						MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKEEAMLKCVVRD 	                                                            
						MAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGEEARRYQGEHKDDAPTCGICH 	Alignment of: 9897 x Q8TDY9   ..                             
						KTKFADGCGHLCSYCRTKFCARCGGRVSLRSNN                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 153 of Q8TDY9, which also corresponds to  	                                                            
						amino acids 1 - 153 of T09261_P15, and a second amino acid   	                     Quality: 1565.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     153                Total length:     153                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GGQSG corresponding to amino acids 154 - 	                        Gaps:       0                        
						158 of T09261_P15, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09261_P15, comprising a polypeptide being at least 70%,     	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						least about 95% homologous to the sequence GGQSG in          	                  .         .         .         .         .  
						T09261_P15.                                                  	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	                                                             
						                                                            	     151 SNN                                                153                                                          
						                                                            	         |||                                                 
						                                                            	     151 SNN                                                153                                                          

						Comparison report between T09261_P15 and AAO38848partial WT  	Sequence name: AAO38848                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09261_P15, comprising a first amino	Sequence documentation:                                      
						MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKEEAMLKCVVRD 	                                                            
						MAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGEEARRYQGEHKDDAPTCGICH 	Alignment of: 9897 x AAO38848   ..                           
						KTKFADGCGHLCSYCRTKFCARCGGRVSLRSNN                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 153 of AAO38848, which also corresponds to	                                                            
						amino acids 1 - 153 of T09261_P15, and a second amino acid   	                     Quality: 1565.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     153                Total length:     153                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GGQSG corresponding to amino acids 154 - 	                        Gaps:       0                        
						158 of T09261_P15, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09261_P15, comprising a polypeptide being at least 70%,     	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						least about 95% homologous to the sequence GGQSG in          	                  .         .         .         .         .  
						T09261_P15.                                                  	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	                                                             
						                                                            	     151 SNN                                                153                                                          
						                                                            	         |||                                                 
						                                                            	     151 SNN                                                153                                                          

						Comparison report between T09261_P15 and Q8TDZ5partial WT    	Sequence name: Q8TDZ5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09261_P15, comprising a first amino	Sequence documentation:                                      
						MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKEEAMLKCVVRD 	                                                            
						MAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGEEARRYQGEHKDDAPTCGICH 	Alignment of: 9897 x Q8TDZ5   ..                             
						KTKFADGCGHLCSYCRTKFCARCGGRVSLRSNN                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 153 of Q8TDZ5, which also corresponds to  	                                                            
						amino acids 1 - 153 of T09261_P15, and a second amino acid   	                     Quality: 1565.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     153                Total length:     153                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence GGQSG corresponding to amino acids 154 - 	                        Gaps:       0                        
						158 of T09261_P15, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09261_P15, comprising a polypeptide being at least 70%,     	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MSSAVGPRGPRPPTVPPPMQELPDLSHLTEEERNIIMAVMDRQKEEEEKE 50                                                           
						least about 95% homologous to the sequence GGQSG in          	                  .         .         .         .         .  
						T09261_P15.                                                  	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAMLKCVVRDMAKPAACKTPRNAENQPHQPSPRLHQQFESYKEQVRKIGE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EARRYQGEHKDDAPTCGICHKTKFADGCGHLCSYCRTKFCARCGGRVSLR 150                                                          
						                                                            	                                                             
						                                                            	     151 SNN                                                153                                                          
						                                                            	         |||                                                 
						                                                            	     151 SNN                                                153                                                          

9895	HMR136_T09261_3_tr0_r1_1_gPRT		Comparison report between T09261_P3 and Q9HBA1unique head    	Sequence name: Q9HBA1                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9895 x Q9HBA1   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                     Quality: 4795.00                      Escore:       0                                               
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	             Matching length:     516                Total length:     764                                               
						having the sequence corresponding to amino acids 1 - 168 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T09261_P3, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   67.54      Total Percent Identity:   67.54                                               
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                        Gaps:       3                        
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                                                            
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	Alignment:                                                   
						homologous to corresponding to amino acids 1 - 148 of Q9HBA1,	                  .         .         .         .         .  
						which also corresponds to amino acids 169 - 316 of T09261_P3,	     169 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 218                                                          
						a third amino acid sequence being at least 70%, optionally at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence V corresponding to amino     	     219 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 268                                                          
						acids 317 - 317 of T09261_P3, a fourth amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD                            	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     269 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 318                                                          
						acids 149 - 241 of Q9HBA1, which also corresponds to amino   	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						acids 318 - 410 of T09261_P3, a fifth amino acid sequence    	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     319 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 368                                                          
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIQKQTRKGTASDAE                                              	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						corresponding to amino acids 411 - 485 of T09261_P3, a sixth 	     369 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 418                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD........ 241                                                          
						acids 242 - 279 of Q9HBA1, which also corresponds to amino   	                  .         .         .         .         .  
						acids 486 - 523 of T09261_P3, a seventh amino acid sequence  	     419 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 468                                                          
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	     241 .................................................. 241                                                          
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                  .         .         .         .         .  
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	     469 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 518                                                          
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	                          |||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     242 .................RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 274                                                          
						corresponding to amino acids 524 - 695 of T09261_P3, and a   	                  .         .         .         .         .  
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	     519 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 568                                                          
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	         |||||                                               
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	     275 GSIEQ............................................. 279                                                          
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	                  .         .         .         .         .  
						eight amino acid sequence being at least 90 % homologous to  	     569 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 618                                                          
						corresponding to amino acids 280 - 516 of Q9HBA1, which also 	                                                            
						corresponds to amino acids 696 - 932 of T09261_P3, wherein   	     279 .................................................. 279                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence, fourth amino acid sequence, fifth 	     619 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 668                                                          
						amino acid sequence, sixth amino acid sequence, seventh amino	                                                            
						acid sequence and eight amino acid sequence are contiguous   	     279 .................................................. 279                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of T09261_P3, comprising a polypeptide being at   	     669 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 718                                                          
						least 70%, optionally at least about 80%, preferably at least	                                    |||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     280 ...........................ESGHKKLKSTIQRSTETGMAAEM 302                                                          
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                  .         .         .         .         .  
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	     719 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 768                                                          
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     303 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 352                                                          
						T09261_P3.3.An isolated polypeptide encoding for an edge     	                  .         .         .         .         .  
						portion of T09261_P3, comprising an amino acid sequence being	     769 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 818                                                          
						at least 70%, optionally at least about 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 85%, more preferably at least about 90% and most 	     353 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 402                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						encoding for V, corresponding to T09261_P3.4.An isolated     	     819 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 868                                                          
						polypeptide encoding for an edge portion of T09261_P3,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     403 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 452                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     869 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 918                                                          
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SIQKQTRKGTASDAE,                                             	     453 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 502                                                          
						least about 95% homologous to the sequence encoding for      	                  .                                          
						corresponding to T09261_P3.5.An isolated polypeptide encoding	     919 SSLESSTGPPCIRS                                     932                                                          
						for an edge portion of T09261_P3, comprising an amino acid   	         ||||||||||||||                                      
						sequence being at least 70%, optionally at least about 80%,  	     503 SSLESSTGPPCIRS                                     516                                                          
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						sequence encoding for corresponding to T09261_P3.            	                                                            

						Comparison report between T09261_P3 and Q9HBA6unique head    	Sequence name: Q9HBA6                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique insertion.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for T09261_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9895 x Q9HBA6   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                     Quality: 7054.00                      Escore:       0                                               
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	             Matching length:     740                Total length:     790                                               
						having the sequence corresponding to amino acids 1 - 168 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T09261_P3, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   93.67      Total Percent Identity:   93.67                                               
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                        Gaps:       2                        
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                                                            
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	Alignment:                                                   
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	                  .         .         .         .         .  
						QDSELLMLPRAKRGRSAECLHTT                                      	     169 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 218                                                          
						homologous to corresponding to amino acids 1 - 263 of Q9HBA6,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 169 - 431 of T09261_P3,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 90 % homologous to	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPER corresponding to amino acids   	     219 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 268                                                          
						290 - 318 of Q9HBA6, which also corresponds to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						432 - 460 of T09261_P3, a fourth amino acid sequence being at	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     269 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 318                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERHSRKSERSSIQKQTRKGTASDA corresponding to amino acids 461 -  	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						484 of T09261_P3, and a fifth amino acid sequence being at   	                  .         .         .         .         .  
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	     319 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 368                                                          
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	                  .         .         .         .         .  
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQI 	     369 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 418                                                          
						GMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSL 	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						VDPTLTPLTRRASQSSLESSTGPPCIRS                                 	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 319 -  	     419 AKRGRSAECLHTT..........................SELQPFLDRAR 442                                                          
						766 of Q9HBA6, which also corresponds to amino acids 485 -   	         |||||||||||||                          |||||||||||  
						932 of T09261_P3, wherein said first amino acid sequence,    	     251 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSELQPFLDRAR 300                                                          
						second amino acid sequence, third amino acid sequence, fourth	                  .         .         .         .         .  
						amino acid sequence and fifth amino acid sequence are        	     443 SASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQRS 492                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||                        ||||||||  
						polypeptide encoding for a head of T09261_P3, comprising a   	     301 SASTNCLRPDTSLHSPER........................ERMHRQRS 326                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     493 PTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRF 542                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	     327 PTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRF 376                                                          
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                  .         .         .         .         .  
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	     543 KQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISR 592                                                          
						to the sequence of T09261_P3.3.An isolated chimeric          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P3,       	     377 KQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISR 426                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     593 TSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVS 642                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     427 TSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVS 476                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     643 GEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQL 692                                                          
						comprise TS, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 431-x to 432; and    	     477 GEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQL 526                                                          
						ending at any of amino acid numbers 432+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     693 SQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGN 742                                                          
						encoding for an edge portion of T09261_P3, comprising an     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	     527 SQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGN 576                                                          
						about 80%, preferably at least about 85%, more preferably at 	                  .         .         .         .         .  
						least about 90% and most preferably at least about 95%       	     743 LIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQ 792                                                          
						homologous to the sequence encoding for                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERHSRKSERSSIQKQTRKGTASDA, corresponding to T09261_P3.        	     577 LIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQ 626                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     793 LEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDP 842                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     627 LEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDP 676                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     843 LYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMV 892                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     677 LYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMV 726                                                          
						                                                            	                  .         .         .         .            
						                                                            	     893 IGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS           932                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     727 IGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS           766                                                          

						Comparison report between T09261_P3 and Q9HBA4unique head    	Sequence name: Q9HBA4                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9895 x Q9HBA4   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                     Quality: 6557.00                      Escore:       0                                               
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	             Matching length:     700                Total length:     764                                               
						having the sequence corresponding to amino acids 1 - 168 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T09261_P3, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   91.62      Total Percent Identity:   91.62                                               
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                        Gaps:       3                        
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                                                            
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	Alignment:                                                   
						homologous to corresponding to amino acids 1 - 148 of Q9HBA4,	                  .         .         .         .         .  
						which also corresponds to amino acids 169 - 316 of T09261_P3,	     169 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 218                                                          
						a third amino acid sequence being at least 70%, optionally at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence V corresponding to amino     	     219 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 268                                                          
						acids 317 - 317 of T09261_P3, a fourth amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     269 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 318                                                          
						acids 149 - 262 of Q9HBA4, which also corresponds to amino   	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						acids 318 - 431 of T09261_P3, a fifth amino acid sequence    	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     319 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 368                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAE       	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						corresponding to amino acids 432 - 485 of T09261_P3, a sixth 	                  .         .         .         .         .  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	     369 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 418                                                          
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEQSERPRGRI                                                  	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 263 - 393 of Q9HBA4, which also 	     419 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 468                                                          
						corresponds to amino acids 486 - 616 of T09261_P3, a seventh 	         |||||||||||||                                       
						amino acid sequence being at least 70%, optionally at least  	     250 AKRGRSAECLHTT..................................... 262                                                          
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     469 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 518                                                          
						having the sequence SSFTPKMQG corresponding to amino acids   	                          |||||||||||||||||||||||||||||||||  
						617 - 625 of T09261_P3, and a eight amino acid sequence being	     263 .................RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 295                                                          
						RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRR 	                  .         .         .         .         .  
						SRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIF 	     519 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 568                                                          
						PGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWG 	     296 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 345                                                          
						DYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESST 	                  .         .         .         .         .  
						GPPCIRS                                                      	     569 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 618                                                          
						at least 90 % homologous to corresponding to amino acids 394 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						- 700 of Q9HBA4, which also corresponds to amino acids 626 - 	     346 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRI.. 393                                                          
						932 of T09261_P3, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence, fourth	     619 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 668                                                          
						amino acid sequence, fifth amino acid sequence, sixth amino  	                |||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, seventh amino acid sequence and eight amino   	     394 .......RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 436                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T09261_P3,       	     669 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 718                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     437 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 486                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	     719 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 768                                                          
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	     487 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 536                                                          
						about 95% homologous to the sequence of T09261_P3.3.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     769 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 818                                                          
						T09261_P3, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     537 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 586                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for V,	     819 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 868                                                          
						corresponding to T09261_P3.4.An isolated polypeptide encoding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for an edge portion of T09261_P3, comprising an amino acid   	     587 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 636                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .         .         .         .         .  
						preferably at least about 85%, more preferably at least about	     869 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 918                                                          
						90% and most preferably at least about 95% homologous to the 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence encoding for                                        	     637 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 686                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAE,      	                  .                                          
						corresponding to T09261_P3.5.An isolated polypeptide encoding	     919 SSLESSTGPPCIRS                                     932                                                          
						for an edge portion of T09261_P3, comprising an amino acid   	         ||||||||||||||                                      
						sequence being at least 70%, optionally at least about 80%,  	     687 SSLESSTGPPCIRS                                     700                                                          
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						sequence encoding for SSFTPKMQG, corresponding to T09261_P3. 	                                                            

						Comparison report between T09261_P3 and Q9HBA2unique head    	Sequence name: Q9HBA2                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P3, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9895 x Q9HBA2   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                     Quality: 5296.00                      Escore:       0                                               
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	             Matching length:     567                Total length:     764                                               
						having the sequence corresponding to amino acids 1 - 168 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T09261_P3, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   74.21      Total Percent Identity:   74.21                                               
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                        Gaps:       3                        
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                                                            
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	Alignment:                                                   
						homologous to corresponding to amino acids 1 - 148 of Q9HBA2,	                  .         .         .         .         .  
						which also corresponds to amino acids 169 - 316 of T09261_P3,	     169 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 218                                                          
						a third amino acid sequence being at least 70%, optionally at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence V corresponding to amino     	     219 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 268                                                          
						acids 317 - 317 of T09261_P3, a fourth amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 	                  .         .         .         .         .  
						LDRARSASTNCLRPDTSLHSPER                                      	     269 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 318                                                          
						being at least 90 % homologous to corresponding to amino     	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						acids 149 - 291 of Q9HBA2, which also corresponds to amino   	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						acids 318 - 460 of T09261_P3, a fifth amino acid sequence    	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     319 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 368                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						ERHSRKSERSSIQKQTRKGTASDA corresponding to amino acids 461 -  	                  .         .         .         .         .  
						484 of T09261_P3, a sixth amino acid sequence being at least 	     369 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 418                                                          
						90 % homologous to ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 292 - 330 of Q9HBA2, which also 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						corresponds to amino acids 485 - 523 of T09261_P3, a seventh 	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     419 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 468                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||          
						and most preferably at least 95% homologous to a polypeptide 	     250 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER........ 291                                                          
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                  .         .         .         .         .  
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	     469 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 518                                                          
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	                         ||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 524 - 695 of	     292 ................ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 325                                                          
						T09261_P3, and a eight amino acid sequence being at least 90 	                  .         .         .         .         .  
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	     519 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 568                                                          
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	         |||||                                               
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	     326 GSIEQ............................................. 330                                                          
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 331 - 567 of    	     569 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 618                                                          
						Q9HBA2, which also corresponds to amino acids 696 - 932 of   	                                                            
						T09261_P3, wherein said first amino acid sequence, second    	     330 .................................................. 330                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .         .         .         .  
						acid sequence, fifth amino acid sequence, sixth amino acid   	     619 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 668                                                          
						sequence, seventh amino acid sequence and eight amino acid   	                                                            
						sequence are contiguous and in a sequential order.2.An       	     330 .................................................. 330                                                          
						isolated polypeptide encoding for a head of T09261_P3,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     669 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 718                                                          
						least about 80%, preferably at least about 85%, more         	                                    |||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     331 ...........................ESGHKKLKSTIQRSTETGMAAEM 353                                                          
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                  .         .         .         .         .  
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	     719 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 768                                                          
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of T09261_P3.3.An       	     354 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 403                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09261_P3, comprising an amino acid sequence being at least  	     769 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 818                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     404 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 453                                                          
						at least about 95% homologous to the sequence encoding for V,	                  .         .         .         .         .  
						corresponding to T09261_P3.4.An isolated polypeptide encoding	     819 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 868                                                          
						for an edge portion of T09261_P3, comprising an amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	     454 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 503                                                          
						preferably at least about 85%, more preferably at least about	                  .         .         .         .         .  
						90% and most preferably at least about 95% homologous to the 	     869 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 918                                                          
						sequence encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to T09261_P3.5.An isolated polypeptide encoding for an edge  	     504 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 553                                                          
						portion of T09261_P3, comprising an amino acid sequence being	                  .                                          
						at least 70%, optionally at least about 80%, preferably at   	     919 SSLESSTGPPCIRS                                     932                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||                                      
						preferably at least about 95% homologous to the sequence     	     554 SSLESSTGPPCIRS                                     567                                                          
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						encoding for corresponding to T09261_P3.                     	                                                            

						Comparison report between T09261_P3 and Q9HBA5unique head    	Sequence name: Q9HBA5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09261_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9895 x Q9HBA5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	Alignment segment 1/1:                                       
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	                                                            
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	                     Quality: 7154.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     740                Total length:     764                                               
						to amino acids 1 - 168 of T09261_P3, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	    Total Percent Similarity:   96.86      Total Percent Identity:   96.86                                               
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                        Gaps:       1                        
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	                                                            
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	Alignment:                                                   
						QDSELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER         	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     169 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 218                                                          
						amino acids 1 - 292 of Q9HBA5, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 169 - 460 of T09261_P3, a third amino acid       	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     219 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 268                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence ERHSRKSERSSIQKQTRKGTASDA corresponding to	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						amino acids 461 - 484 of T09261_P3, and a fourth amino acid  	                  .         .         .         .         .  
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	     269 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 318                                                          
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	                  .         .         .         .         .  
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQI 	     319 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 368                                                          
						GMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSL 	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						VDPTLTPLTRRASQSSLESSTGPPCIRS                                 	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     369 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 418                                                          
						amino acids 293 - 740 of Q9HBA5, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 485 - 932 of T09261_P3, wherein said first amino 	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						acid sequence, second amino acid sequence, third amino acid  	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     419 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 468                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||          
						head of T09261_P3, comprising a polypeptide being at least   	     251 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER........ 292                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     469 RSSIQKQTRKGTASDAERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 518                                                          
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                         ||||||||||||||||||||||||||||||||||  
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	     293 ................ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRS 326                                                          
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG             	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     519 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 568                                                          
						T09261_P3.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T09261_P3, comprising an amino acid sequence being	     327 GSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQ 376                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     569 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 618                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding to      	     377 YRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISS 426                                                          
						T09261_P3.                                                   	                  .         .         .         .         .  
						                                                            	     619 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 668                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     427 FTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGK 476                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     669 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 718                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     477 KRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEM 526                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     719 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 768                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     527 RKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQL 576                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     769 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 818                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     577 VGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVK 626                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     819 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 868                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     627 VYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYG 676                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     869 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 918                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     677 RMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQ 726                                                          
						                                                            	                  .                                          
						                                                            	     919 SSLESSTGPPCIRS                                     932                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     727 SSLESSTGPPCIRS                                     740                                                          

						Comparison report between T09261_P3 and Q8TDY9partial WT     	Sequence name: Q8TDY9                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09261_P3, comprising a first amino 	Sequence documentation:                                      
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	Alignment of: 9895 x Q8TDY9   ..                             
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFL 	                                                            
						PDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLG 	Alignment segment 1/1:                                       
						EILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 	                                                            
						DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRS 	                     Quality: 8338.00                      Escore:       0                                               
						RLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAK 	             Matching length:     874                Total length:     932                                               
						RGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPER                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:   93.78      Total Percent Identity:   93.78                                               
						to amino acids 597 - 1056 of Q8TDY9, which also corresponds  	                        Gaps:       2                        
						to amino acids 1 - 460 of T09261_P3, a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVL 50                                                           
						having the sequence ERHSRKSERSSIQKQTRKGTASDA corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 461 - 484 of T09261_P3, a third amino acid       	     597 MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVL 646                                                          
						ERMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	                  .         .         .         .         .  
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	      51 EWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPL 100                                                          
						MSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQ 	     647 EWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPL 696                                                          
						PSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAM      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     101 ESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGH 150                                                          
						amino acids 1057 - 1351 of Q8TDY9, which also corresponds to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 485 - 779 of T09261_P3, a fourth amino acid      	     697 ESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGH 746                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     151 QLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKSKRRTKTVKKILEP 200                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP       	     747 QLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKSKRRTKTVKKILEP 796                                                          
						corresponding to amino acids 780 - 813 of T09261_P3, and a   	                  .         .         .         .         .  
						APYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 	     201 KWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELETAL 250                                                          
						CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 90 % homologous to  	     797 KWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELETAL 846                                                          
						corresponding to amino acids 1352 - 1470 of Q8TDY9, which    	                  .         .         .         .         .  
						also corresponds to amino acids 814 - 932 of T09261_P3,      	     251 LDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 300                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     847 LDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 896                                                          
						sequence and fifth amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for an 	     301 DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPH 350                                                          
						edge portion of T09261_P3, comprising an amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     897 DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPH 946                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     351 RGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRD 400                                                          
						encoding for ERHSRKSERSSIQKQTRKGTASDA, corresponding to      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09261_P3.3.An isolated polypeptide encoding for an edge     	     947 RGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRD 996                                                          
						portion of T09261_P3, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     401 VDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLR 450                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     997 VDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLR 1046                                                         
						encoding for GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP,             	                  .         .         .         .         .  
						corresponding to T09261_P3.                                  	     451 PDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERMHRQRSPTQSPPAD 500                                                          
						                                                            	         ||||||||||                        ||||||||||||||||  
						                                                            	    1047 PDTSLHSPER........................ERMHRQRSPTQSPPAD 1072                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 TSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1073 TSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 1122                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1123 SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLS 1172                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 STSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEH 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1173 STSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEH 1222                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 NDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1223 NDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHK 1272                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 KLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1273 KLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRL 1322                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRA 800                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	    1323 GADSQFSDFLDGLGPAQLVGRQTLATPAM..................... 1351                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 RSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 850                                                          
						                                                            	                      |||||||||||||||||||||||||||||||||||||  
						                                                            	    1352 .............APYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 1388                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFP 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1389 DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFP 1438                                                         
						                                                            	                  .         .         .                      
						                                                            	     901 PSSLVDPTLTPLTRRASQSSLESSTGPPCIRS                   932                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	    1439 PSSLVDPTLTPLTRRASQSSLESSTGPPCIRS                   1470                                                         

						Comparison report between T09261_P3 and AAO38848partial WT   	Sequence name: AAO38848                                      
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09261_P3, comprising a first amino 	Sequence documentation:                                      
						MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGA 	                                                            
						TNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVI 	Alignment of: 9895 x AAO38848   ..                           
						SPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFL 	                                                            
						PDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLG 	Alignment segment 1/1:                                       
						EILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 	                                                            
						DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRS 	                     Quality: 8793.00                      Escore:       0                                               
						RLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAK 	             Matching length:     932                Total length:    1085                                               
						RGRSAECLHTT                                                  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:   85.90      Total Percent Identity:   85.90                                               
						to amino acids 608 - 1038 of AAO38848, which also corresponds	                        Gaps:       3                        
						to amino acids 1 - 431 of T09261_P3, a second amino acid     	                                                            
						sequence being at least 90 % homologous to                   	Alignment:                                                   
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	                  .         .         .         .         .  
						1103 - 1132 of AAO38848, which also corresponds to amino     	       1 MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVL 50                                                           
						acids 432 - 461 of T09261_P3, a third amino acid sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to RHSRKSERSSIQKQTRKGTASDAE   	     608 MPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVL 657                                                          
						corresponding to amino acids 1161 - 1184 of AAO38848, which  	                  .         .         .         .         .  
						also corresponds to amino acids 462 - 485 of T09261_P3, and a	      51 EWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPL 100                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	     658 EWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPL 707                                                          
						SEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGA 	                  .         .         .         .         .  
						GGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQP 	     101 ESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGH 150                                                          
						SRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQ 	     708 ESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGH 757                                                          
						QSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLV 	                  .         .         .         .         .  
						DPTLTPLTRRASQSSLESSTGPPCIRS                                  	     151 QLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKSKRRTKTVKKILEP 200                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1246 - 1692 of AAO38848, which  	     758 QLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKSKRRTKTVKKILEP 807                                                          
						also corresponds to amino acids 486 - 932 of T09261_P3,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     201 KWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELETAL 250                                                          
						sequence, third amino acid sequence and fourth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     808 KWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELETAL 857                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						T09261_P3, comprising a polypeptide having a length "n",     	     251 LDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 300                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     858 LDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDS 907                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     301 DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPH 350                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TS, having a structure as  	     908 DISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPH 957                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						431-x to 432; and ending at any of amino acid numbers 432+   	     351 RGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRD 400                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     958 RGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRD 1007                                                         
						T09261_P3, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     401 VDSQYLSEQDSELLMLPRAKRGRSAECLHTT................... 431                                                          
						optionally at least about 20 amino acids in length,          	         |||||||||||||||||||||||||||||||                     
						preferably at least about 30 amino acids in length, more     	    1008 VDSQYLSEQDSELLMLPRAKRGRSAECLHTTRHLVRHYKTLPPKMPLLQS 1057                                                         
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     432 .............................................SELQP 436                                                          
						at least two amino acids comprise ER, having a structure as  	                                                      |||||  
						follows: a sequence starting from any of amino acid numbers  	    1058 SSHWNIYSSILPAHTKTKSVTRQDISLHHECFNSTVLRFTDEILVSELQP 1107                                                         
						461-x to 462; and ending at any of amino acid numbers 462+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     437 FLDRARSASTNCLRPDTSLHSPERE......................... 461                                                          
						chimeric polypeptide encoding for an edge portion of         	         |||||||||||||||||||||||||                           
						T09261_P3, comprising a polypeptide having a length "n",     	    1108 FLDRARSASTNCLRPDTSLHSPERERGRWSPSLDRRRPPSPRIQIQHASP 1157                                                         
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     462 ...RHSRKSERSSIQKQTRKGTASDAE....................... 485                                                          
						preferably at least about 30 amino acids in length, more     	            ||||||||||||||||||||||||                         
						preferably at least about 40 amino acids in length and most  	    1158 ENDRHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVI 1207                                                         
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise ER, having a structure as  	     486 ......................................RMHRQRSPTQSP 497                                                          
						follows: a sequence starting from any of amino acid numbers  	                                               ||||||||||||  
						485-x to 486; and ending at any of amino acid numbers 486+   	    1208 RGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSP 1257                                                         
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     498 PADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTG 547                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1258 PADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTG 1307                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     548 SGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSAS 597                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1308 SGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSAS 1357                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     598 RLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYT 647                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1358 RLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYT 1407                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     648 LEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTES 697                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1408 LEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTES 1457                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     698 GHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPG 747                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1458 GHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPG 1507                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     748 VRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEV 797                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1508 VRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEV 1557                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     798 IRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQS 847                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1558 IRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQS 1607                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     848 LVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYK 897                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1608 LVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYK 1657                                                         
						                                                            	                  .         .         .                      
						                                                            	     898 LFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS                932                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1658 LFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS                1692                                                         

9891	HMR136_T09261_4_tr0_r1_1_gPRT		Comparison report between T09261_P4 and O15048unique head    	Sequence name: O15048                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9891 x O15048   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P4, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5365.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     544                Total length:     544                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTT                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     509 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 558                                                          
						corresponding to amino acids 509 - 1052 of O15048, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 555 of T09261_P4, and a third	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     559 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 608                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPTC 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						LSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 	     609 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 658                                                          
						SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSE 	                  .         .         .         .         .  
						RPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKR 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						RSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSREST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKK 	     659 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 708                                                          
						GQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 	                  .         .         .         .         .  
						DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLT 	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						PLTRRASQSSLESSTGPPCIRS                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 556 - 1117  	     709 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 758                                                          
						of T09261_P4, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T09261_P4, comprising a   	     759 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 808                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MRKAKREKVET of T09261_P4.3.An isolated       	     809 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 858                                                          
						polypeptide encoding for a tail of T09261_P4, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     859 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 908                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPTC 	                  .         .         .         .         .  
						LSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQ 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						RSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSE 	     909 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 958                                                          
						RPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKR 	                  .         .         .         .         .  
						RSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSREST 	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						DGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 	     959 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 1008                                                         
						DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLT 	                  .         .         .         .            
						PLTRRASQSSLESSTGPPCIRS                                       	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       555                                                          
						to the sequence in T09261_P4.                                	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	    1009 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       1052                                                         

						Comparison report between T09261_P4 and Q9HBA1unique head    	Sequence name: Q9HBA1                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P4, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9891 x Q9HBA1   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 4795.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     516                Total length:     825                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   62.55      Total Percent Identity:   62.55                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P4, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P4,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P4, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD                            	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						being at least 90 % homologous to corresponding to amino     	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						acids 149 - 241 of Q9HBA1, which also corresponds to amino   	                  .         .         .         .         .  
						acids 442 - 534 of T09261_P4, a fifth amino acid sequence    	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	                  .         .         .         .         .  
						SIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSM 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						HHLVPGGSAPPSPLLT                                             	         ||||||||||||||||||||||||||||||||||||||||||          
						at least 95% homologous to a polypeptide having the sequence 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQD........ 241                                                          
						corresponding to amino acids 535 - 670 of T09261_P4, a sixth 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	                                                            
						acids 242 - 279 of Q9HBA1, which also corresponds to amino   	     241 .................................................. 241                                                          
						acids 671 - 708 of T09261_P4, a seventh amino acid sequence  	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     593 RSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRS 642                                                          
						least 85%, more preferably at least 90% and most preferably  	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	     241 .................................................. 241                                                          
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                  .         .         .         .         .  
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	     643 SEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRR 692                                                          
						at least 95% homologous to a polypeptide having the sequence 	                                     ||||||||||||||||||||||  
						corresponding to amino acids 709 - 880 of T09261_P4, and a   	     242 ............................RMHRQRSPTQSPPADTSFSSRR 263                                                          
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	                  .         .         .         .         .  
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	     693 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 742                                                          
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	         ||||||||||||||||                                    
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	     264 GRQLPQVPVRSGSIEQ.................................. 279                                                          
						eight amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 280 - 516 of Q9HBA1, which also 	     743 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 792                                                          
						corresponds to amino acids 881 - 1117 of T09261_P4, wherein  	                                                            
						said first amino acid sequence, second amino acid sequence,  	     279 .................................................. 279                                                          
						third amino acid sequence, fourth amino acid sequence, fifth 	                  .         .         .         .         .  
						amino acid sequence, sixth amino acid sequence, seventh amino	     793 QSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 842                                                          
						acid sequence and eight amino acid sequence are contiguous   	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	     279 .................................................. 279                                                          
						for a head of T09261_P4, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     843 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 892                                                          
						about 85%, more preferably at least about 90% and most       	                                               ||||||||||||  
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	     280 ......................................ESGHKKLKSTIQ 291                                                          
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                  .         .         .         .         .  
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	     893 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 942                                                          
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	     292 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 341                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						T09261_P4.3.An isolated polypeptide encoding for an edge     	     943 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 992                                                          
						portion of T09261_P4, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     342 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 391                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     993 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 1042                                                         
						encoding for V, corresponding to T09261_P4.4.An isolated     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P4,       	     392 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 441                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1043 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 1092                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERS 	     442 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 491                                                          
						SIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSM 	                  .         .                                
						HHLVPGGSAPPSPLLT,                                            	    1093 TLTPLTRRASQSSLESSTGPPCIRS                          1117                                                         
						least about 95% homologous to the sequence encoding for      	         |||||||||||||||||||||||||                           
						corresponding to T09261_P4.5.An isolated polypeptide encoding	     492 TLTPLTRRASQSSLESSTGPPCIRS                          516                                                          
						for an edge portion of T09261_P4, comprising an amino acid   	                                                            
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						sequence encoding for corresponding to T09261_P4.            	                                                            

						Comparison report between T09261_P4 and Q9HBA6unique head    	Sequence name: Q9HBA6                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique insertion.1.An isolated chimeric      	Sequence documentation:                                      
						polypeptide encoding for T09261_P4, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9891 x Q9HBA6   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 7054.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     740                Total length:     851                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   86.96      Total Percent Identity:   86.96                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       2                        
						T09261_P4, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QDSELLMLPRAKRGRSAECLHTT                                      	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						homologous to corresponding to amino acids 1 - 263 of Q9HBA6,	                  .         .         .         .         .  
						which also corresponds to amino acids 293 - 555 of T09261_P4,	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						a third amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						290 - 319 of Q9HBA6, which also corresponds to amino acids   	                  .         .         .         .         .  
						556 - 585 of T09261_P4, a fourth amino acid sequence being at	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	                  .         .         .         .         .  
						SSIRTLCSMHHLVPGGSAPPSPLLT                                    	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 586 - 670 of T09261_P4, and a fifth amino acid	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	                  .         .         .         .         .  
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						SEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQP 	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						SRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIG 	                  .         .         .         .         .  
						MEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQ 	     543 AKRGRSAECLHTT..........................SELQPFLDRAR 566                                                          
						QSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLV 	         |||||||||||||                          |||||||||||  
						DPTLTPLTRRASQSSLESSTGPPCIRS                                  	     251 AKRGRSAECLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSELQPFLDRAR 300                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 320 - 766 of Q9HBA6, which also corresponds to   	     567 SASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPTCL 616                                                          
						amino acids 671 - 1117 of T09261_P4, wherein said first amino	         |||||||||||||||||||                                 
						acid sequence, second amino acid sequence, third amino acid  	     301 SASTNCLRPDTSLHSPERE............................... 319                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     617 SRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPS 666                                                          
						isolated polypeptide encoding for a head of T09261_P4,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	     319 .................................................. 319                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     667 PLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEER 716                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	             ||||||||||||||||||||||||||||||||||||||||||||||  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     320 ....RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEER 365                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                  .         .         .         .         .  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     717 TRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSD 766                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence of T09261_P4.3.An       	     366 TRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSD 415                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						T09261_P4, comprising a polypeptide having a length "n",     	     767 SDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTS 816                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     416 SDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTS 465                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     817 GRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAI 866                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TS, having a structure as  	     466 GRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAI 515                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						555-x to 556; and ending at any of amino acid numbers 556+   	     867 VSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 916                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P4,       	     516 VSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTD 565                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     917 GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGD 966                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	     566 GSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGD 615                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLT,                                   	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     967 IQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKK 1016                                                         
						corresponding to T09261_P4.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     616 IQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKK 665                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1017 KTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQI 1066                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     666 KTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQI 715                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1067 LLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIR 1116                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     716 LLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIR 765                                                          
						                                                            	                                                             
						                                                            	    1117 S                                                  1117                                                         
						                                                            	         |                                                   
						                                                            	     766 S                                                  766                                                          

						Comparison report between T09261_P4 and Q9HBA4unique head    	Sequence name: Q9HBA4                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P4, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9891 x Q9HBA4   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 6557.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     700                Total length:     825                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   84.85      Total Percent Identity:   84.85                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P4, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA4,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P4,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P4, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHT        	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						being at least 90 % homologous to corresponding to amino     	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						acids 149 - 261 of Q9HBA4, which also corresponds to amino   	                  .         .         .         .         .  
						acids 442 - 554 of T09261_P4, a fifth amino acid sequence    	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						TSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPT 	                  .         .         .         .         .  
						CLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLL      	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						at least 95% homologous to a polypeptide having the sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 555 - 669 of T09261_P4, a sixth 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						TRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQ 	                  .         .         .         .         .  
						TTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSF 	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						MSEQSERPRGRI                                                 	         ||||||||||||                                        
						amino acid sequence being at least 90 % homologous to        	     250 AKRGRSAECLHT...................................... 261                                                          
						corresponding to amino acids 262 - 393 of Q9HBA4, which also 	                  .         .         .         .         .  
						corresponds to amino acids 670 - 801 of T09261_P4, a seventh 	     593 RSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRS 642                                                          
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	     261 .................................................. 261                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence SSFTPKMQG corresponding to amino acids   	     643 SEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRR 692                                                          
						802 - 810 of T09261_P4, and a eight amino acid sequence being	                                    |||||||||||||||||||||||  
						RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRR 	     262 ...........................TRMHRQRSPTQSPPADTSFSSRR 284                                                          
						SRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIF 	                  .         .         .         .         .  
						PGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQ 	     693 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 742                                                          
						KPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESST 	     285 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 334                                                          
						GPPCIRS                                                      	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 394 	     743 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 792                                                          
						- 700 of Q9HBA4, which also corresponds to amino acids 811 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1117 of T09261_P4, wherein said first amino acid sequence,   	     335 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 384                                                          
						second amino acid sequence, third amino acid sequence, fourth	                  .         .         .         .         .  
						amino acid sequence, fifth amino acid sequence, sixth amino  	     793 QSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 842                                                          
						acid sequence, seventh amino acid sequence and eight amino   	         |||||||||         ||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     385 QSERPRGRI.........RRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 425                                                          
						isolated polypeptide encoding for a head of T09261_P4,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     843 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 892                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     426 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 475                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                  .         .         .         .         .  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     893 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 942                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     476 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 525                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	                  .         .         .         .         .  
						about 95% homologous to the sequence of T09261_P4.3.An       	     943 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 992                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09261_P4, comprising an amino acid sequence being at least  	     526 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 575                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     993 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 1042                                                         
						at least about 95% homologous to the sequence encoding for V,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to T09261_P4.4.An isolated polypeptide encoding	     576 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 625                                                          
						for an edge portion of T09261_P4, comprising an amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least about 80%,  	    1043 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 1092                                                         
						preferably at least about 85%, more preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least about 95% homologous to the 	     626 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 675                                                          
						TSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPT 	                  .         .                                
						CLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLL,     	    1093 TLTPLTRRASQSSLESSTGPPCIRS                          1117                                                         
						sequence encoding for corresponding to T09261_P4.5.An        	         |||||||||||||||||||||||||                           
						isolated polypeptide encoding for an edge portion of         	     676 TLTPLTRRASQSSLESSTGPPCIRS                          700                                                          
						T09261_P4, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						SSFTPKMQG, corresponding to T09261_P4.                       	                                                            

						Comparison report between T09261_P4 and Q9HBA2unique head    	Sequence name: Q9HBA2                                        
						followed by partial WT sequence with a short unique insertion	                                                            
						and a followed by a unique insertion.1.An isolated chimeric  	Sequence documentation:                                      
						polypeptide encoding for T09261_P4, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 9891 x Q9HBA2   ..                             
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                     Quality: 5296.00                      Escore:       0                                               
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	             Matching length:     567                Total length:     825                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	    Total Percent Similarity:   68.73      Total Percent Identity:   68.73                                               
						having the sequence corresponding to amino acids 1 - 292 of  	                        Gaps:       3                        
						T09261_P4, a second amino acid sequence being at least 90 %  	                                                            
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	Alignment:                                                   
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	                  .         .         .         .         .  
						KKLQRSQRISDSDISDYEVDDGIGVVPP                                 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						homologous to corresponding to amino acids 1 - 148 of Q9HBA2,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 293 - 440 of T09261_P4,	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence V corresponding to amino     	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						acids 441 - 441 of T09261_P4, a fourth amino acid sequence   	                  .         .         .         .         .  
						GYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPT 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						RRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 	         |||||||||||||||||||||||||||||||||||||||||||||||| |  
						LDRARSASTNCLRPDTSLHSPERE                                     	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPP.G 149                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 149 - 292 of Q9HBA2, which also corresponds to amino   	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						acids 442 - 585 of T09261_P4, a fifth amino acid sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least 80%, preferably at   	     150 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 199                                                          
						least 85%, more preferably at least 90% and most preferably  	                  .         .         .         .         .  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLT                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     200 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 249                                                          
						corresponding to amino acids 586 - 670 of T09261_P4, a sixth 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ corresponding to amino	         |||||||||||||||||||||||||||||||||||||||||||         
						acids 293 - 330 of Q9HBA2, which also corresponds to amino   	     250 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERE....... 292                                                          
						acids 671 - 708 of T09261_P4, a seventh amino acid sequence  	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     593 RSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRS 642                                                          
						least 85%, more preferably at least 90% and most preferably  	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	     292 .................................................. 292                                                          
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                  .         .         .         .         .  
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT         	     643 SEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRR 692                                                          
						at least 95% homologous to a polypeptide having the sequence 	                                     ||||||||||||||||||||||  
						corresponding to amino acids 709 - 880 of T09261_P4, and a   	     293 ............................RMHRQRSPTQSPPADTSFSSRR 314                                                          
						ESGHKKLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQ 	                  .         .         .         .         .  
						FSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAP 	     693 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 742                                                          
						YVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCF 	         ||||||||||||||||                                    
						MGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS    	     315 GRQLPQVPVRSGSIEQ.................................. 330                                                          
						eight amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 331 - 567 of Q9HBA2, which also 	     743 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 792                                                          
						corresponds to amino acids 881 - 1117 of T09261_P4, wherein  	                                                            
						said first amino acid sequence, second amino acid sequence,  	     330 .................................................. 330                                                          
						third amino acid sequence, fourth amino acid sequence, fifth 	                  .         .         .         .         .  
						amino acid sequence, sixth amino acid sequence, seventh amino	     793 QSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 842                                                          
						acid sequence and eight amino acid sequence are contiguous   	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	     330 .................................................. 330                                                          
						for a head of T09261_P4, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     843 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 892                                                          
						about 85%, more preferably at least about 90% and most       	                                               ||||||||||||  
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	     331 ......................................ESGHKKLKSTIQ 342                                                          
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                  .         .         .         .         .  
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	     893 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 942                                                          
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	     343 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 392                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						T09261_P4.3.An isolated polypeptide encoding for an edge     	     943 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 992                                                          
						portion of T09261_P4, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     393 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 442                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     993 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 1042                                                         
						encoding for V, corresponding to T09261_P4.4.An isolated     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T09261_P4,       	     443 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 492                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1043 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 1092                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	     493 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 542                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLT,                                   	                  .         .                                
						least about 95% homologous to the sequence encoding for      	    1093 TLTPLTRRASQSSLESSTGPPCIRS                          1117                                                         
						corresponding to T09261_P4.5.An isolated polypeptide encoding	         |||||||||||||||||||||||||                           
						for an edge portion of T09261_P4, comprising an amino acid   	     543 TLTPLTRRASQSSLESSTGPPCIRS                          567                                                          
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSD 	                                                            
						VSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSG 	                                                            
						EMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQT,        	                                                            
						sequence encoding for corresponding to T09261_P4.            	                                                            

						Comparison report between T09261_P4 and Q9HBA5unique head    	Sequence name: Q9HBA5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09261_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9891 x Q9HBA5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	Alignment segment 1/1:                                       
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	                                                            
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                     Quality: 7154.00                      Escore:       0                                               
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	             Matching length:     740                Total length:     825                                               
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   89.70      Total Percent Identity:   89.70                                               
						to amino acids 1 - 292 of T09261_P4, a second amino acid     	                        Gaps:       1                        
						RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQ 	                                                            
						PRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSS 	Alignment:                                                   
						KKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVS 	                  .         .         .         .         .  
						PHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSE 	     293 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 342                                                          
						QDSELLMLPRAKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERE        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 RPRNPYVKMYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRE 50                                                           
						amino acids 1 - 293 of Q9HBA5, which also corresponds to     	                  .         .         .         .         .  
						amino acids 293 - 585 of T09261_P4, a third amino acid       	     343 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 392                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 RMLEITVWDQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSL 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	     393 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 442                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLT                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 586 - 670 of	     101 PLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVG 150                                                          
						T09261_P4, and a fourth amino acid sequence being at least 90	                  .         .         .         .         .  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	     443 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 492                                                          
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGA 	     151 YRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQ 200                                                          
						GGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQP 	                  .         .         .         .         .  
						SRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIG 	     493 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 542                                                          
						MEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLV 	     201 RSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPR 250                                                          
						DPTLTPLTRRASQSSLESSTGPPCIRS                                  	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 294 - 740 of    	     543 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSE 592                                                          
						Q9HBA5, which also corresponds to amino acids 671 - 1117 of  	         |||||||||||||||||||||||||||||||||||||||||||         
						T09261_P4, wherein said first amino acid sequence, second    	     251 AKRGRSAECLHTTSELQPFLDRARSASTNCLRPDTSLHSPERE....... 293                                                          
						amino acid sequence, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     593 RSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRS 642                                                          
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						T09261_P4, comprising a polypeptide being at least 70%,      	     293 .................................................. 293                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     643 SEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRR 692                                                          
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                     ||||||||||||||||||||||  
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	     294 ............................RMHRQRSPTQSPPADTSFSSRR 315                                                          
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                  .         .         .         .         .  
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	     693 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 742                                                          
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDG         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of T09261_P4.3.An 	     316 GRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDRE 365                                                          
						isolated polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						T09261_P4, comprising an amino acid sequence being at least  	     743 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 792                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     366 QYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSE 415                                                          
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	                  .         .         .         .         .  
						SSIRTLCSMHHLVPGGSAPPSPLLT,                                   	     793 QSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 842                                                          
						at least about 95% homologous to the sequence encoding for   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to T09261_P4.                                  	     416 QSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSD 465                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     843 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 892                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     466 TAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQ 515                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     893 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 942                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     516 RSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFS 565                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     943 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 992                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     566 DFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKP 615                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     993 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 1042                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     616 GSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGK 665                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1043 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 1092                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     666 VLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDP 715                                                          
						                                                            	                  .         .                                
						                                                            	    1093 TLTPLTRRASQSSLESSTGPPCIRS                          1117                                                         
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     716 TLTPLTRRASQSSLESSTGPPCIRS                          740                                                          

						Comparison report between T09261_P4 and Q8TDY9unique head    	Sequence name: Q8TDY9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09261_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9891 x Q8TDY9   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P4, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 9465.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     987                Total length:    1106                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:   89.24      Total Percent Identity:   89.24                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       2                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTTSELQPFLDRARSASTNCLRPDTSLHSPERE                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						corresponding to amino acids 484 - 1057 of Q8TDY9, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 585 of T09261_P4, a third    	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLT                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 586 - 670 of	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						T09261_P4, a fourth amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQT 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						TGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGA 	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						GGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQP 	                  .         .         .         .         .  
						SRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAM       	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						homologous to corresponding to amino acids 1058 - 1351 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8TDY9, which also corresponds to amino acids 671 - 964 of   	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						T09261_P4, a fifth amino acid sequence being at least 70%,   	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP corresponding to amino    	                  .         .         .         .         .  
						acids 965 - 998 of T09261_P4, and a sixth amino acid sequence	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						APYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS  	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 1352 - 1470 of Q8TDY9, which also corresponds to amino 	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						acids 999 - 1117 of T09261_P4, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						sequence, fourth amino acid sequence, fifth amino acid       	                  .         .         .         .         .  
						sequence and sixth amino acid sequence are contiguous and in 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of T09261_P4, comprising a polypeptide being at least   	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						at least about 95% homologous to the sequence MRKAKREKVET of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09261_P4.3.An isolated polypeptide encoding for an edge     	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						portion of T09261_P4, comprising an amino acid sequence being	                  .         .         .         .         .  
						at least 70%, optionally at least about 80%, preferably at   	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 561                                                          
						least about 85%, more preferably at least about 90% and most 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTTSELQPF 1033                                                         
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	                  .         .         .         .         .  
						SSIRTLCSMHHLVPGGSAPPSPLLT,                                   	     562 LDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERV 611                                                          
						encoding for corresponding to T09261_P4.4.An isolated        	         ||||||||||||||||||||||||                            
						polypeptide encoding for an edge portion of T09261_P4,       	    1034 LDRARSASTNCLRPDTSLHSPERE.......................... 1057                                                         
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     612 LPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGG 661                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	    1057 .................................................. 1057                                                         
						GDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTP, corresponding to         	                  .         .         .         .         .  
						T09261_P4.                                                   	     662 SAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASL 711                                                          
						                                                            	                  |||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1058 .........RMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASL 1098                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     712 VVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVS 761                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1099 VVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVS 1148                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     762 AKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGR 811                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1149 AKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGR 1198                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     812 RMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSA 861                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1199 RMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSA 1248                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     862 KVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPS 911                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1249 KVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPS 1298                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     912 RESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLAT 961                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1299 RESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLAT 1348                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     962 PAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGA 1011                                                         
						                                                            	         |||                                  |||||||||||||  
						                                                            	    1349 PAM..................................APYVKVYLLENGA 1364                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1012 CIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFM 1061                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1365 CIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFM 1414                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1062 GVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTG 1111                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1415 GVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTG 1464                                                         
						                                                            	                                                             
						                                                            	    1112 PPCIRS                                             1117                                                         
						                                                            	         ||||||                                              
						                                                            	    1465 PPCIRS                                             1470                                                         

						Comparison report between T09261_P4 and AAO38848partial WT   	Sequence name: AAO38848                                      
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09261_P4, comprising a first amino 	Sequence documentation:                                      
						MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEY 	                                                            
						TSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILN 	Alignment of: 9891 x AAO38848   ..                           
						KRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKP 	                                                            
						LPGATNEEVYNIILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPS 	Alignment segment 1/1:                                       
						ISVISPTSPGALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 	                                                            
						MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEES 	                     Quality: 10730.00                      Escore:       0                                              
						EFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQR 	             Matching length:    1117                Total length:    1209                                               
						ISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KPRSRLPNVPLQRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLML 	    Total Percent Similarity:   92.39      Total Percent Identity:   92.39                                               
						PRAKRGRSAECLHTT                                              	                        Gaps:       2                        
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 484 - 1038 of AAO38848, which also corresponds	Alignment:                                                   
						to amino acids 1 - 555 of T09261_P4, a second amino acid     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to                   	       1 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 50                                                           
						SELQPFLDRARSASTNCLRPDTSLHSPERE corresponding to amino acids  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1103 - 1132 of AAO38848, which also corresponds to amino     	     484 MRKAKREKVETMLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSS 533                                                          
						acids 556 - 585 of T09261_P4, and a third amino acid sequence	                  .         .         .         .         .  
						RHSRKSERSSIQKQTRKGTASDAERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEH 	      51 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 100                                                          
						SSIRTLCSMHHLVPGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEQASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCDNVSAKSS 	     534 EEEGVSTPEYTSCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSH 583                                                          
						DSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKMQGRRMGTSGRSIMKSTS 	                  .         .         .         .         .  
						VSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSSLSAKVVAIVSRRSRSTSQLSQTESGHK 	     101 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 150                                                          
						KLKSTIQRSTETGMAAEMRKMVRQPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGLGPAQLVGRQTLATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVY 	     584 PVTWQPSKEGDRLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGA 633                                                          
						LLENGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHKCFMGVAQ 	                  .         .         .         .         .  
						ILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLESSTGPPCIRS         	     151 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 200                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 1161 - 1692 of AAO38848, which also corresponds to     	     634 FITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 683                                                          
						amino acids 586 - 1117 of T09261_P4, wherein said first amino	                  .         .         .         .         .  
						acid sequence, second amino acid sequence and third amino    	     201 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 250                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     684 QVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPG 733                                                          
						T09261_P4, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     251 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 300                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     734 ALKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVK 783                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     301 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 350                                                          
						at least two amino acids comprise TS, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     784 MYFLPDRSDKSKRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVW 833                                                          
						555-x to 556; and ending at any of amino acid numbers 556+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     351 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 400                                                          
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09261_P4, comprising a polypeptide having a length "n",     	     834 DQPRVQEEESEFLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPF 883                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     401 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 450                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     884 MPRRHIHGESSSKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARES 933                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise ER, having a structure as  	     451 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 500                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						585-x to 586; and ending at any of amino acid numbers 586+   	     934 KSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHP 983                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     501 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     984 TRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAE 1033                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CLHTT............................................. 555                                                          
						                                                            	         |||||                                               
						                                                            	    1034 CLHTTRHLVRHYKTLPPKMPLLQSSSHWNIYSSILPAHTKTKSVTRQDIS 1083                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     556 ...................SELQPFLDRARSASTNCLRPDTSLHSPERE. 585                                                          
						                                                            	                            ||||||||||||||||||||||||||||||   
						                                                            	    1084 LHHECFNSTVLRFTDEILVSELQPFLDRARSASTNCLRPDTSLHSPERER 1133                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     586 ...........................RHSRKSERSSIQKQTRKGTASDA 608                                                          
						                                                            	                                    |||||||||||||||||||||||  
						                                                            	    1134 GRWSPSLDRRRPPSPRIQIQHASPENDRHSRKSERSSIQKQTRKGTASDA 1183                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     609 ERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLV 658                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1184 ERVLPTCLSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLV 1233                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     659 PGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 708                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1234 PGGSAPPSPLLTRMHRQRSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQ 1283                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     709 ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCD 758                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1284 ASLVVEERTRQMKMKVHRFKQTTGSGSSQELDREQYSKYNIHKDQYRSCD 1333                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     759 NVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKM 808                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1334 NVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSERPRGRISSFTPKM 1383                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     809 QGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSS 858                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1384 QGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKRRSS 1433                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     859 LSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVR 908                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1434 LSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVR 1483                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     909 QPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQT 958                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1484 QPSRESTDGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQT 1533                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     959 LATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLE 1008                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1534 LATPAMGDIQIGMEDKKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLE 1583                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1009 NGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 1058                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1584 NGACIAKKKTRIARKTLDPLYQQSLVFDESPQGKVLQVIVWGDYGRMDHK 1633                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1059 CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLES 1108                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1634 CFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLTPLTRRASQSSLES 1683                                                         
						                                                            	                                                             
						                                                            	    1109 STGPPCIRS                                          1117                                                         
						                                                            	         |||||||||                                           
						                                                            	    1684 STGPPCIRS                                          1692                                                         

						Comparison report between T09261_P4 and Q8TDZ5unique head    	Sequence name: Q8TDZ5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09261_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9891 x Q8TDZ5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MRKAKREKVET  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of T09261_P4, a second   	                                                            
						MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYTSCEDVELESE 	                     Quality: 5365.00                      Escore:       0                                               
						SVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGDRLIGRVILNKRTTMPKDSGA 	             Matching length:     544                Total length:     544                                               
						LLGLKVVGGKMTDLGRLGAFITKVKKGSLADVVGHLRAGDEVLEWNGKPLPGATNEEVYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IILESKSEPQVEIIVSRPIGDIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LKDAPQVLPGQLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 	                        Gaps:       0                        
						KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESEFLGEILIELE 	                                                            
						TALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESSSKKLQRSQRISDSDISDYEV 	Alignment:                                                   
						DDGIGVVPPVGYRSSARESKSTTLTVPEQQRTTHHRSRSVSPHRGNDQGKPRSRLPNVPL 	                  .         .         .         .         .  
						QRSLDEIHPTRRSRSPTRHHDASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAEC 	      12 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 61                                                           
						LHTT                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     484 MLRNDSLSSDQSESVRPSPPKPHRSKRGGKKRQMSVSSSEEEGVSTPEYT 533                                                          
						corresponding to amino acids 484 - 1027 of Q8TDZ5, which also	                  .         .         .         .         .  
						corresponds to amino acids 12 - 555 of T09261_P4, and a third	      62 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 111                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     534 SCEDVELESESVSEKGDLDYYWLDPATWHSRETSPISSHPVTWQPSKEGD 583                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPTC 	     112 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 161                                                          
						LSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 	     584 RLIGRVILNKRTTMPKDSGALLGLKVVGGKMTDLGRLGAFITKVKKGSLA 633                                                          
						SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSE 	                  .         .         .         .         .  
						RPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKR 	     162 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 211                                                          
						RSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSREST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKK 	     634 DVVGHLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVSRPIG 683                                                          
						GQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 	                  .         .         .         .         .  
						DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLT 	     212 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 261                                                          
						PLTRRASQSSLESSTGPPCIRS                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 556 - 1117  	     684 DIPRIPESSHPPLESSSSSFESQKMERPSISVISPTSPGALKDAPQVLPG 733                                                          
						of T09261_P4, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     262 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 311                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T09261_P4, comprising a   	     734 QLSVKLWYDKVGHQLIVNVLQATDLPARVDGRPRNPYVKMYFLPDRSDKS 783                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     312 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 361                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MRKAKREKVET of T09261_P4.3.An isolated       	     784 KRRTKTVKKILEPKWNQTFVYSHVHRRDFRERMLEITVWDQPRVQEEESE 833                                                          
						polypeptide encoding for a tail of T09261_P4, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     362 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 411                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     834 FLGEILIELETALLDDEPHWYKLQTHDESSLPLPQPSPFMPRRHIHGESS 883                                                          
						SELQPFLDRARSASTNCLRPDTSLHSPERERHSRKSERSSIQKQTRKGTASDAERVLPTC 	                  .         .         .         .         .  
						LSRRGHAAPRATDQPVIRGKHPARSRSSEHSSIRTLCSMHHLVPGGSAPPSPLLTRMHRQ 	     412 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 461                                                          
						RSPTQSPPADTSFSSRRGRQLPQVPVRSGSIEQASLVVEERTRQMKMKVHRFKQTTGSGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SQELDREQYSKYNIHKDQYRSCDNVSAKSSDSDVSDVSAISRTSSASRLSSTSFMSEQSE 	     884 SKKLQRSQRISDSDISDYEVDDGIGVVPPVGYRSSARESKSTTLTVPEQQ 933                                                          
						RPRGRISSFTPKMQGRRMGTSGRSIMKSTSVSGEMYTLEHNDGSQSDTAVGTVGAGGKKR 	                  .         .         .         .         .  
						RSSLSAKVVAIVSRRSRSTSQLSQTESGHKKLKSTIQRSTETGMAAEMRKMVRQPSREST 	     462 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 511                                                          
						DGSINSYSSEGNLIFPGVRLGADSQFSDFLDGLGPAQLVGRQTLATPAMGDIQIGMEDKK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVF 	     934 RTTHHRSRSVSPHRGNDQGKPRSRLPNVPLQRSLDEIHPTRRSRSPTRHH 983                                                          
						DESPQGKVLQVIVWGDYGRMDHKCFMGVAQILLEELDLSSMVIGWYKLFPPSSLVDPTLT 	                  .         .         .         .            
						PLTRRASQSSLESSTGPPCIRS                                       	     512 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       555                                                          
						to the sequence in T09261_P4.                                	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     984 DASRSPVDHRTRDVDSQYLSEQDSELLMLPRAKRGRSAECLHTT       1027                                                         

10007	HMR136_T09266_9_tr0_r1_1_gPRT		Comparison report between T09266_P9 and DJC8_HUMANpartial WT 	Sequence name: DJC8_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09266_P9, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to MAASGESGTSGGGGSTEEAFMTFYSEVKQIEKRDSVLTSKNQIERLTRPGSSYFNLNPFE             	                                                            
						corresponding to amino acids 12 - 71 of DJC8_HUMAN, which    	Alignment of: 10007 x DJC8_HUMAN   ..                        
						also corresponds to amino acids 1 - 60 of T09266_P9, and a   	                                                            
						LSILVHPDKNQDDADRAQKAFEAVDKAYKLLLDQEQKKRALDVIQAGKEYVEHTVKERKK 	Alignment segment 1/1:                                       
						QLKKEGKPTIVEEDDPELFKQAVYKQTMKLFAELEIKRKEREAKEMHERKRQREEEIEAQ 	                                                            
						EKAKREREWQKNFEESRDGRVDSWRNFQANTKGKKEKKNRTFLRPPKVKMEQRE       	                     Quality: 2201.00                      Escore:       0                                               
						second amino acid sequence being at least 90 % homologous to 	             Matching length:     234                Total length:     253                                               
						corresponding to amino acids 91 - 264 of DJC8_HUMAN, which   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 61 - 234 of T09266_P9,       	    Total Percent Similarity:   92.49      Total Percent Identity:   92.49                                               
						wherein said first amino acid sequence and second amino acid 	                        Gaps:       1                        
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	Alignment:                                                   
						T09266_P9, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	       1 MAASGESGTSGGGGSTEEAFMTFYSEVKQIEKRDSVLTSKNQIERLTRPG 50                                                           
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	      12 MAASGESGTSGGGGSTEEAFMTFYSEVKQIEKRDSVLTSKNQIERLTRPG 61                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      51 SSYFNLNPFE...................LSILVHPDKNQDDADRAQKAF 81                                                           
						at least two amino acids comprise EL, having a structure as  	         ||||||||||                   |||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	      62 SSYFNLNPFEVLQIDPEVTDEEIKKRFRQLSILVHPDKNQDDADRAQKAF 111                                                          
						60-x to 61; and ending at any of amino acid numbers 61+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      82 EAVDKAYKLLLDQEQKKRALDVIQAGKEYVEHTVKERKKQLKKEGKPTIV 131                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     112 EAVDKAYKLLLDQEQKKRALDVIQAGKEYVEHTVKERKKQLKKEGKPTIV 161                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     132 EEDDPELFKQAVYKQTMKLFAELEIKRKEREAKEMHERKRQREEEIEAQE 181                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     162 EEDDPELFKQAVYKQTMKLFAELEIKRKEREAKEMHERKRQREEEIEAQE 211                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     182 KAKREREWQKNFEESRDGRVDSWRNFQANTKGKKEKKNRTFLRPPKVKME 231                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     212 KAKREREWQKNFEESRDGRVDSWRNFQANTKGKKEKKNRTFLRPPKVKME 261                                                          
						                                                            	                                                             
						                                                            	     232 QRE                                                234                                                          
						                                                            	         |||                                                 
						                                                            	     262 QRE                                                264                                                          

5552	HMR136_T09279_2_tr0_r1_1_gPRT		Comparison report between T09279_P2 and Q8N3T5unique head    	Sequence name: Q8N3T5                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for T09279_P2, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 5552 x Q8N3T5   ..                             
						85%, more preferably at least 90% and most preferably at     	                                                            
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	Alignment segment 1/1:                                       
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	                                                            
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	                     Quality: 2178.00                      Escore:       0                                               
						VPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAG 	             Matching length:     231                Total length:     236                                               
						GTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAG 	 Matching Percent Similarity:   99.57   Matching Percent Identity:   99.57                                               
						SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAH 	    Total Percent Similarity:   97.46      Total Percent Identity:   97.46                                               
						KDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTSMYMNDGYAPPDIT 	                        Gaps:       1                        
						NSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGLGFNI 	                                                            
						VGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVT 	Alignment:                                                   
						IVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGL 	                  .         .         .         .         .  
						PSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLKTVKF 	     681 HVTSNASDSESSY.....HEYGCSKGGQEEYVLSYEPVNQQEVNYTRPVI 725                                                          
						NSKTRDKGEIPDDMGSKGLK                                         	         |||||||||||||      |||||||||||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	       2 HVTSNASDSESSYLILITDEYGCSKGGQEEYVLSYEPVNQQEVNYTRPVI 51                                                           
						corresponding to amino acids 1 - 680 of T09279_P2, a second  	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     726 ILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQ 775                                                          
						HVTSNASDSESSY corresponding to amino acids 2 - 14 of Q8N3T5, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 681 - 693 of T09279_P2,	      52 ILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQ 101                                                          
						a third amino acid sequence bridging amino acid sequence     	                  .         .         .         .         .  
						comprising of H, and a fourth amino acid sequence being at   	     776 MEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRL 825                                                          
						EYGCSKGGQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPKRDYEVDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCI 	     102 MEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRL 151                                                          
						LDVSGNAIKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 	                  .         .         .         .         .  
						FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                        	     826 QIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHF 875                                                          
						least 90 % homologous to corresponding to amino acids 21 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						237 of Q8N3T5, which also corresponds to amino acids 695 -   	     152 QIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHF 201                                                          
						911 of T09279_P2, wherein said first amino acid sequence,    	                  .         .         .                      
						second amino acid sequence, third amino acid sequence and    	     876 TAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL               911                                                          
						fourth amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||                
						order.2.An isolated polypeptide encoding for a head of       	     202 TAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL               237                                                          
						T09279_P2, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	                                                            
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	                                                            
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	                                                            
						VPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAG 	                                                            
						GTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAG 	                                                            
						SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAH 	                                                            
						KDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTSMYMNDGYAPPDIT 	                                                            
						NSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGLGFNI 	                                                            
						VGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVT 	                                                            
						IVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGL 	                                                            
						PSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLKTVKF 	                                                            
						NSKTRDKGEIPDDMGSKGLK                                         	                                                            
						least about 95% homologous to the sequence of T09279_P2.3.An 	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T09279_P2, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise YHE having a structure as  	                                                            
						follows (numbering according to T09279_P2): a sequence       	                                                            
						starting from any of amino acid numbers 693-x to 693; and    	                                                            
						ending at any of amino acid numbers 695 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

5556	HMR136_T09279_22_tr0_r1_1_gPRT		Comparison report between T09279_P22 and Q8N3T5unique head   	Sequence name: Q8N3T5                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for T09279_P22, comprising a first amino acid sequence being 	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 5556 x Q8N3T5   ..                             
						85%, more preferably at least 90% and most preferably at     	                                                            
						MDCLCIVTTKKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSH 	Alignment segment 1/1:                                       
						ISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGT 	                                                            
						DADYEYEEITLERGNSGLGFSIAGGTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCI 	                     Quality: 2104.00                      Escore:       0                                               
						LRVNEVDVRDVTHSKAVEALKEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGG 	             Matching length:     225                Total length:     237                                               
						VGNQHIPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSD 	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.11                                               
						FVYLKVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLG 	    Total Percent Similarity:   94.51      Total Percent Identity:   94.09                                               
						DDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVN 	                        Gaps:       1                        
						SVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSL 	                                                            
						RTSQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESD 	Alignment:                                                   
						EVGVIPSKRRVEKKERARLKTVKFNSKTRDKGQSFNDKRKKNLFSRKFPFYKNKDQSEQE 	                  .         .         .         .         .  
						TSDADQ                                                       	     606 QHVTSNASDSESSY............RGQEEYVLSYEPVNQQEVNYTRPV 643                                                          
						least 95% homologous to a polypeptide having the sequence    	         :|||||||||||||             |||||||||||||||||||||||  
						corresponding to amino acids 1 - 606 of T09279_P22, a second 	       1 EHVTSNASDSESSYLILITDEYGCSKGGQEEYVLSYEPVNQQEVNYTRPV 50                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						HVTSNASDSESSY corresponding to amino acids 2 - 14 of Q8N3T5, 	     644 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 693                                                          
						which also corresponds to amino acids 607 - 619 of           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09279_P22, a third amino acid sequence bridging amino acid  	      51 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 100                                                          
						sequence comprising of R, and a fourth amino acid sequence   	                  .         .         .         .         .  
						GQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYE 	     694 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 743                                                          
						VDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQG 	     101 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 150                                                          
						DTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                               	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     744 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 793                                                          
						acids 28 - 237 of Q8N3T5, which also corresponds to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 621 - 830 of T09279_P22, wherein said first amino acid 	     151 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 200                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .                      
						sequence and fourth amino acid sequence are contiguous and in	     794 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              830                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         |||||||||||||||||||||||||||||||||||||               
						head of T09279_P22, comprising a polypeptide being at least  	     201 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              237                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MDCLCIVTTKKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSH 	                                                            
						ISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGT 	                                                            
						DADYEYEEITLERGNSGLGFSIAGGTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCI 	                                                            
						LRVNEVDVRDVTHSKAVEALKEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGG 	                                                            
						VGNQHIPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSD 	                                                            
						FVYLKVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLG 	                                                            
						DDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVN 	                                                            
						SVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSL 	                                                            
						RTSQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESD 	                                                            
						EVGVIPSKRRVEKKERARLKTVKFNSKTRDKGQSFNDKRKKNLFSRKFPFYKNKDQSEQE 	                                                            
						TSDADQ                                                       	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						T09279_P22.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09279_P22, comprising a polypeptide having a     	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise YRG having a structure as  	                                                            
						follows (numbering according to T09279_P22): a sequence      	                                                            
						starting from any of amino acid numbers 619-x to 619; and    	                                                            
						ending at any of amino acid numbers 621 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

5547	HMR136_T09279_24_tr0_r1_1_gPRT		Comparison report between T09279_P24 and Q8N3T5unique head   	Sequence name: Q8N3T5                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for T09279_P24, comprising a first amino acid sequence being 	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 5547 x Q8N3T5   ..                             
						85%, more preferably at least 90% and most preferably at     	                                                            
						MNYIFGNNTLLYSRGSRGGNTSSSHGSAGPKQKHWAKKGSSDELQAEPEPSRWQQIVAFF 	Alignment segment 1/1:                                       
						TRRHSFIDCISVATSSTQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGF 	                                                            
						SIAGGTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEAL 	                     Quality: 2104.00                      Escore:       0                                               
						KEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEG 	             Matching length:     225                Total length:     237                                               
						GAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTSMYMNDGYAP 	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.11                                               
						PDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGL 	    Total Percent Similarity:   94.51      Total Percent Identity:   94.09                                               
						GFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAG 	                        Gaps:       1                        
						QAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTK 	                                                            
						DSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLK 	Alignment:                                                   
						TVKFNSKTRDKGQSFNDKRKKNLFSRKFPFYKNKDQSEQETSDADQ               	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	     586 QHVTSNASDSESSY............RGQEEYVLSYEPVNQQEVNYTRPV 623                                                          
						corresponding to amino acids 1 - 586 of T09279_P24, a second 	         :|||||||||||||             |||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 EHVTSNASDSESSYLILITDEYGCSKGGQEEYVLSYEPVNQQEVNYTRPV 50                                                           
						HVTSNASDSESSY corresponding to amino acids 2 - 14 of Q8N3T5, 	                  .         .         .         .         .  
						which also corresponds to amino acids 587 - 599 of           	     624 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 673                                                          
						T09279_P24, a third amino acid sequence bridging amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence comprising of R, and a fourth amino acid sequence   	      51 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 100                                                          
						GQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYE 	                  .         .         .         .         .  
						VDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNA 	     674 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 723                                                          
						IKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                               	     101 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 150                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 28 - 237 of Q8N3T5, which also corresponds to amino    	     724 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 773                                                          
						acids 601 - 810 of T09279_P24, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     151 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 200                                                          
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .                      
						a sequential order.2.An isolated polypeptide encoding for a  	     774 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              810                                                          
						head of T09279_P24, comprising a polypeptide being at least  	         |||||||||||||||||||||||||||||||||||||               
						70%, optionally at least about 80%, preferably at least about	     201 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              237                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						MNYIFGNNTLLYSRGSRGGNTSSSHGSAGPKQKHWAKKGSSDELQAEPEPSRWQQIVAFF 	                                                            
						TRRHSFIDCISVATSSTQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGF 	                                                            
						SIAGGTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEAL 	                                                            
						KEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEG 	                                                            
						GAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTSMYMNDGYAP 	                                                            
						PDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGL 	                                                            
						GFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAG 	                                                            
						QAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTK 	                                                            
						DSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLK 	                                                            
						TVKFNSKTRDKGQSFNDKRKKNLFSRKFPFYKNKDQSEQETSDADQ               	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						T09279_P24.3.An isolated polypeptide encoding for an edge    	                                                            
						portion of T09279_P24, comprising a polypeptide having a     	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise YRG having a structure as  	                                                            
						follows (numbering according to T09279_P24): a sequence      	                                                            
						starting from any of amino acid numbers 599-x to 599; and    	                                                            
						ending at any of amino acid numbers 601 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

5545	HMR136_T09279_27_tr0_r1_1_gPRT		Comparison report between T09279_P27 and DLG1_HUMANpartial   	Sequence name: DLG1_HUMAN                                    
						WT sequence followed by mismatch.1.An isolated chimeric      	                                                            
						polypeptide encoding for T09279_P27, comprising a first amino	Sequence documentation:                                      
						MGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLIS 	                                                            
						EFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSV 	Alignment of: 5545 x DLG1_HUMAN   ..                         
						QSVREVA                                                      	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 674 - 800 of DLG1_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 127 of T09279_P27, a bridging 	                     Quality: 2269.00                      Escore:       0                                               
						amino acid E corresponding to amino acid 128 of T09279_P27,  	             Matching length:     231                Total length:     231                                               
						and a second amino acid sequence being at least 90 %         	 Matching Percent Similarity:   99.57   Matching Percent Identity:   99.57                                               
						KGKHCILDVSGNAIKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLE 	    Total Percent Similarity:   99.57      Total Percent Identity:   99.57                                               
						QEFTEHFTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                  	                        Gaps:       0                        
						homologous to corresponding to amino acids 802 - 904 of      	                                                            
						DLG1_HUMAN, which also corresponds to amino acids 129 - 231  	Alignment:                                                   
						of T09279_P27, wherein said first amino acid sequence,       	                  .         .         .         .         .  
						bridging amino acid and second amino acid sequence are       	       1 MGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVIILGPM 50                                                           
						contiguous and in a sequential order.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     674 MGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVIILGPM 723                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     724 KDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDI 773                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRLQIAQL 150                                                          
						                                                            	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						                                                            	     774 QEHKFIEAGQYNNHLYGTSVQSVREVAGKGKHCILDVSGNAIKRLQIAQL 823                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQ 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     824 YPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQ 873                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 GDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                    231                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     874 GDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                    904                                                          

5560	HMR136_T09279_28_tr0_r1_1_gPRT		Comparison report between T09279_P28 and DLG1_HUMANunique    	Sequence name: DLG1_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for T09279_P28, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 5560 x DLG1_HUMAN   ..                         
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment segment 1/1:                                       
						MTSVKRTSFPENSPSTRTRTRVSRKQVMLT corresponding to amino acids 1	                                                            
						- 30 of T09279_P28, a second amino acid sequence being at    	                     Quality: 2319.00                      Escore:       0                                               
						EIPDDMGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRIN 	             Matching length:     236                Total length:     236                                               
						DDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHL 	 Matching Percent Similarity:   99.58   Matching Percent Identity:   99.58                                               
						YGTSVQSVREVA                                                 	    Total Percent Similarity:   99.58      Total Percent Identity:   99.58                                               
						least 90 % homologous to corresponding to amino acids 669 -  	                        Gaps:       0                        
						800 of DLG1_HUMAN, which also corresponds to amino acids 31 -	                                                            
						162 of T09279_P28, a bridging amino acid E corresponding to  	Alignment:                                                   
						amino acid 163 of T09279_P28, and a third amino acid sequence	                  .         .         .         .         .  
						KGKHCILDVSGNAIKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLE 	      31 EIPDDMGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVI 80                                                           
						QEFTEHFTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     669 EIPDDMGSKGLKHVTSNASDSESSYRGQEEYVLSYEPVNQQEVNYTRPVI 718                                                          
						acids 802 - 904 of DLG1_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 164 - 266 of T09279_P28, wherein said first amino	      81 ILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQ 130                                                          
						acid sequence, second amino acid sequence, bridging amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid and third amino acid sequence are contiguous and in a   	     719 ILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQ 768                                                          
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						head of T09279_P28, comprising a polypeptide being at least  	     131 MEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRL 180                                                          
						70%, optionally at least about 80%, preferably at least about	         |||||||||||||||||||||||||||||||| |||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     769 MEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAGKGKHCILDVSGNAIKRL 818                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MTSVKRTSFPENSPSTRTRTRVSRKQVMLT of T09279_P28.                	     181 QIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHF 230                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     819 QIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHF 868                                                          
						                                                            	                  .         .         .                      
						                                                            	     231 TAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL               266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     869 TAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL               904                                                          

5554	HMR136_T09279_37_tr0_r1_1_gPRT		Comparison report between T09279_P37 and DLG1_HUMANpartial   	Sequence name: DLG1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09279_P37, comprising a first amino	Sequence documentation:                                      
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	                                                            
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	Alignment of: 5554 x DLG1_HUMAN   ..                         
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	                                                            
						VPAENTVILPTIPQ                                               	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 194 of DLG1_HUMAN, which also corresponds 	                     Quality: 1901.00                      Escore:       0                                               
						to amino acids 1 - 194 of T09279_P37, and a second amino acid	             Matching length:     194                Total length:     194                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence VFISFFFLYKNFICF corresponding to amino   	                                                            
						acids 195 - 209 of T09279_P37, wherein said first amino acid 	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALI 50                                                           
						tail of T09279_P37, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALI 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence VFISFFFLYKNFICF	      51 DIQEFYEVTLLDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSS 100                                                          
						in T09279_P37.                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 DIQEFYEVTLLDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSS 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LSPSVEKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LSPSVEKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHG 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 FVSHSHISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQ       194                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     151 FVSHSHISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQ       194                                                          

5550	HMR136_T09279_7_tr0_r1_1_gPRT		Comparison report between T09279_P7 and DLG1_HUMANpartial WT 	Sequence name: DLG1_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09279_P7, comprising a first amino acid sequence being at   	                                                            
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	Alignment of: 5550 x DLG1_HUMAN   ..                         
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	                                                            
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	Alignment segment 1/1:                                       
						VPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAG 	                                                            
						GTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCIL                        	                     Quality: 6427.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 1 - 277	             Matching length:     679                Total length:     679                                               
						of DLG1_HUMAN, which also corresponds to amino acids 1 - 277 	 Matching Percent Similarity:   99.12   Matching Percent Identity:   98.67                                               
						of T09279_P7, a bridging amino acid R corresponding to amino 	    Total Percent Similarity:   99.12      Total Percent Identity:   98.67                                               
						acid 278 of T09279_P7, a second amino acid sequence being at 	                        Gaps:       0                        
						VNEVDVRDVTHSKAVEALKEAGSIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVG 	                                                            
						NQHIPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFV 	Alignment:                                                   
						YLKVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPVSKAVLGDD 	                  .         .         .         .         .  
						EITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDRIISVNSV 	       1 MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALI 50                                                           
						DLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEAKIHDLREQMMNSSISSGSGSLRT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEV 	       1 MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALI 50                                                           
						GVIPSKRRVEKKERARLKTVKFNSKTRDKG                               	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 279 -  	      51 DIQEFYEVTLLDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSS 100                                                          
						668 of DLG1_HUMAN, which also corresponds to amino acids 279 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 668 of T09279_P7, and a third amino acid sequence being at 	      51 DIQEFYEVTLLDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSS 100                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	     101 LSPSVEKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHG 150                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSFNDKRKKNLFSRKFPFYKNKDQSEQETSDADRDP corresponding to amino  	     101 LSPSVEKYRYQDEDTPPQEHISPQITNEVIGPELVHVSEKNLSEIENVHG 150                                                          
						acids 669 - 704 of T09279_P7, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, bridging amino acid, second amino acid sequence and	     151 FVSHSHISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQANPPPV 200                                                          
						third amino acid sequence are contiguous and in a sequential 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     151 FVSHSHISPIKPTEAVLPSPPTVPVIPVLPVPAENTVILPTIPQANPPPV 200                                                          
						T09279_P7, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     201 LVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAGGTDNPHIGDD 250                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     201 LVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAGGTDNPHIGDD 250                                                          
						QSFNDKRKKNLFSRKFPFYKNKDQSEQETSDADRDP in T09279_P7.           	                  .         .         .         .         .  
						                                                            	     251 SSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAG 300                                                          
						                                                            	         |||||||||||||||||||||||||||:||||||||||||||||||||||  
						                                                            	     251 SSIFITKIITGGAAAQDGRLRVNDCILQVNEVDVRDVTHSKAVEALKEAG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 TKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 TKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KVAKPTSMYMNDGYAPPDITNSSSQPVDNHVSPSSFLGQTPASPARYSPV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SKAVLGDDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SKAVLGDDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFILAGGPA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 DLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEY 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEY 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SRFEAKIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKK 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PSQGLNFKFGDILHVINASDDEWWQARQVTPDGESDEVGVIPSKRRVEKK 650                                                          
						                                                            	                  .         .                                
						                                                            	     651 ERARLKTVKFNSKTRDKGQSFNDKRKKNL                      679                                                          
						                                                            	         ||||||||||||||||||:  :|   | |                       
						                                                            	     651 ERARLKTVKFNSKTRDKGEIPDDMGSKGL                      679                                                          

5558	HMR136_T09279_8_tr0_r1_1_gPRT		Comparison report between T09279_P8 and Q8N3T5unique head    	Sequence name: Q8N3T5                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for T09279_P8, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 5558 x Q8N3T5   ..                             
						85%, more preferably at least 90% and most preferably at     	                                                            
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	Alignment segment 1/1:                                       
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	                                                            
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	                     Quality: 2104.00                      Escore:       0                                               
						VPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAG 	             Matching length:     225                Total length:     237                                               
						GTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAG 	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.11                                               
						SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAH 	    Total Percent Similarity:   94.51      Total Percent Identity:   94.09                                               
						KDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTTSSQPVDNHVSPSS 	                        Gaps:       1                        
						FLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFIL 	                                                            
						AGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEA 	Alignment:                                                   
						KIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHV 	                  .         .         .         .         .  
						INASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLKTVKFNSKTRDKGQSFNDKR 	     687 QHVTSNASDSESSY............RGQEEYVLSYEPVNQQEVNYTRPV 724                                                          
						KKNLFSRKFPFYKNKDQSEQETSDADQ                                  	         :|||||||||||||             |||||||||||||||||||||||  
						least 95% homologous to a polypeptide having the sequence    	       1 EHVTSNASDSESSYLILITDEYGCSKGGQEEYVLSYEPVNQQEVNYTRPV 50                                                           
						corresponding to amino acids 1 - 687 of T09279_P8, a second  	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     725 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 774                                                          
						HVTSNASDSESSY corresponding to amino acids 2 - 14 of Q8N3T5, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 688 - 700 of T09279_P8,	      51 IILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSRE 100                                                          
						a third amino acid sequence bridging amino acid sequence     	                  .         .         .         .         .  
						comprising of R, and a fourth amino acid sequence being at   	     775 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 824                                                          
						GQEEYVLSYEPVNQQEVNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNA 	     101 QMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKR 150                                                          
						IKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQG 	                  .         .         .         .         .  
						DTLEDIYNQVKQIIEEQSGSYIWVPAKEKL                               	     825 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 874                                                          
						least 90 % homologous to corresponding to amino acids 28 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						237 of Q8N3T5, which also corresponds to amino acids 702 -   	     151 LQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEH 200                                                          
						911 of T09279_P8, wherein said first amino acid sequence,    	                  .         .         .                      
						second amino acid sequence, third amino acid sequence and    	     875 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              911                                                          
						fourth amino acid sequence are contiguous and in a sequential	         |||||||||||||||||||||||||||||||||||||               
						order.2.An isolated polypeptide encoding for a head of       	     201 FTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL              237                                                          
						T09279_P8, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						MPVRKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVINIFQSNLFQALIDIQEFYEVTL 	                                                            
						LDNPKCIDRSKPSEPIQPVNTWEISSLPSSTVTSETLPSSLSPSVEKYRYQDEDTPPQEH 	                                                            
						ISPQITNEVIGPELVHVSEKNLSEIENVHGFVSHSHISPIKPTEAVLPSPPTVPVIPVLP 	                                                            
						VPAENTVILPTIPQANPPPVLVNTDSLETPTYVNGTDADYEYEEITLERGNSGLGFSIAG 	                                                            
						GTDNPHIGDDSSIFITKIITGGAAAQDGRLRVNDCILRVNEVDVRDVTHSKAVEALKEAG 	                                                            
						SIVRLYVKRRKPVSEKIMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAH 	                                                            
						KDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTTSSQPVDNHVSPSS 	                                                            
						FLGQTPASPARYSPVSKAVLGDDEITREPRKVVLHRGSTGLGFNIVGGEDGEGIFISFIL 	                                                            
						AGGPADLSGELRKGDRIISVNSVDLRAASHEQAAAALKNAGQAVTIVAQYRPEEYSRFEA 	                                                            
						KIHDLREQMMNSSISSGSGSLRTSQKRSLYVRALFDYDKTKDSGLPSQGLNFKFGDILHV 	                                                            
						INASDDEWWQARQVTPDGESDEVGVIPSKRRVEKKERARLKTVKFNSKTRDKGQSFNDKR 	                                                            
						KKNLFSRKFPFYKNKDQSEQETSDADQ                                  	                                                            
						least about 95% homologous to the sequence of T09279_P8.3.An 	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T09279_P8, comprising a polypeptide having a length "n",     	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise YRG having a structure as  	                                                            
						follows (numbering according to T09279_P8): a sequence       	                                                            
						starting from any of amino acid numbers 700-x to 700; and    	                                                            
						ending at any of amino acid numbers 702 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.                                	                                                            

11387	HMR136_T09296_1_tr0_r1_1_gPRT		Comparison report between T09296_P1 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P1, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11387 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P1, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P1, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P1, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11395	HMR136_T09296_2_tr0_r1_1_gPRT		Comparison report between T09296_P2 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11395 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P2, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P2, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P2, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11397	HMR136_T09296_4_tr0_r1_1_gPRT		Comparison report between T09296_P4 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11397 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P4, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P4, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P4, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11389	HMR136_T09296_5_tr0_r1_1_gPRT		Comparison report between T09296_P5 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11389 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P5, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P5, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P5, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11391	HMR136_T09296_6_tr0_r1_1_gPRT		Comparison report between T09296_P6 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11391 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P6, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P6, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P6, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11385	HMR136_T09296_7_tr0_r1_1_gPRT		Comparison report between T09296_P7 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11385 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P7, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P7, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P7, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

11393	HMR136_T09296_8_tr0_r1_1_gPRT		Comparison report between T09296_P8 and Q9UPV7partial WT     	Sequence name: Q9UPV7                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09296_P8, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MGVLMSKRQTVEQVQK corresponding to amino acids 28 - 43 of     	Alignment of: 11393 x Q9UPV7   ..                            
						Q9UPV7, which also corresponds to amino acids 1 - 16 of      	                                                            
						T09296_P8, and a second amino acid sequence being at least 90	Alignment segment 1/1:                                       
						EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFTPPAFIRPTRKLDD 	                                                            
						DKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEV 	                     Quality: 3507.00                      Escore:       0                                               
						TEMAHTETGWSCHYCDNINLLLTEEEMYSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKR 	             Matching length:     363                Total length:     400                                               
						GDRDRALSEEQEEQAARQFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ERERARAAFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPASSS 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						SKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG              	                        Gaps:       1                        
						% homologous to corresponding to amino acids 81 - 427 of     	                                                            
						Q9UPV7, which also corresponds to amino acids 17 - 363 of    	Alignment:                                                   
						T09296_P8, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MGVLMSKRQTVEQVQK.................................. 16                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||                                    
						portion of T09296_P8, comprising a polypeptide having a      	      28 MGVLMSKRQTVEQVQKVSLAVSAFKDGLRDRPSIRRTGELPGSRRGTVEG 77                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      17 ...EVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 63                                                           
						preferably at least about 30 amino acids in length, more     	            |||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      78 SVQEVQEEKEAEAGTSVVQEESSAGRAAWERLRDGRGVEPEEFDRTSRFT 127                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise KE, having a structure as  	      64 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 113                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						16-x to 17; and ending at any of amino acid numbers 17+      	     128 PPAFIRPTRKLDDDKPPEICLEPREPVVNDEMCDVCEVWTAESLFPCRVC 177                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     114 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 TRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDNINLLLTEEEM 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 YSLTETFQRCKVIPDCSLTLEDFLRYRHQAAKRGDRDRALSEEQEEQAAR 277                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     278 QFAALDPEHRGHIEWPDFLSHESLLLLQQLRPQNSLLRLLTVKERERARA 327                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     328 AFLARGSGSTVSEAECRRAQHSWFCKRFPEAPSCSVSISHVGPIADSSPA 377                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     378 SSSSKSQDKTLLPTEQESRFVDWPTFLQENVLYILAARPNSAAIHLKPPG 427                                                          

12630	HMR136_T09311_12_tr0_r1_1_gPRT		Comparison report between T09311_P12 and Q96HY6unique head   	Sequence name: Q96HY6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09311_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12630 x Q96HY6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AESRLGNRGGAYEIPASGWTQWFCTEALV corresponding to amino acids 1 	                                                            
						- 29 of T09311_P12, a second amino acid sequence being at    	                     Quality: 2483.00                      Escore:       0                                               
						MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQPGPLEPEEPRA 	             Matching length:     259                Total length:     259                                               
						GGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQEEEGVEKPAETHLSGKIGAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLRKLEEKQARKAQREAEEAEREERKRLESQREAEWKKEEERLRLEEEQKEEEERKAREE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QAQREHEEYLKLKEAFVVEEEGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGL 	                        Gaps:       0                        
						RTQDTINRIQDLLAEGTIT                                          	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 259	Alignment:                                                   
						of Q96HY6, which also corresponds to amino acids 30 - 288 of 	                  .         .         .         .         .  
						T09311_P12, and a third amino acid sequence being at least   	      30 MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQP 79                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQP 50                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						EEKTAVRDGSVGPSKVAQLVRAEPRLRE corresponding to amino acids 289	      80 GPLEPEEPRAGGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQ 129                                                          
						- 316 of T09311_P12, wherein said first amino acid sequence, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 GPLEPEEPRAGGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQ 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09311_P12, comprising a  	     130 EEEGVEKPAETHLSGKIGAKKLRKLEEKQARKAQREAEEAEREERKRLES 179                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 EEEGVEKPAETHLSGKIGAKKLRKLEEKQARKAQREAEEAEREERKRLES 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence AESRLGNRGGAYEIPASGWTQWFCTEALV of             	     180 QREAEWKKEEERLRLEEEQKEEEERKAREEQAQREHEEYLKLKEAFVVEE 229                                                          
						T09311_P12.3.An isolated polypeptide encoding for a tail of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09311_P12, comprising a polypeptide being at least 70%,     	     151 QREAEWKKEEERLRLEEEQKEEEERKAREEQAQREHEEYLKLKEAFVVEE 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     230 EGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGLRTQDTINRIQ 279                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEKTAVRDGSVGPSKVAQLVRAEPRLRE in T09311_P12.                  	     201 EGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGLRTQDTINRIQ 250                                                          
						                                                            	                                                             
						                                                            	     280 DLLAEGTIT                                          288                                                          
						                                                            	         |||||||||                                           
						                                                            	     251 DLLAEGTIT                                          259                                                          

						Comparison report between T09311_P12 and Q9BW47unique head   	Sequence name: Q9BW47                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09311_P12, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12630 x Q9BW47   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						AESRLGNRGGAYEIPASGWTQWFCTEALV corresponding to amino acids 1 	                                                            
						- 29 of T09311_P12, a second amino acid sequence being at    	                     Quality: 2483.00                      Escore:       0                                               
						MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQPGPLEPEEPRA 	             Matching length:     259                Total length:     259                                               
						GGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQEEEGVEKPAETHLSGKIGAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLRKLEEKQARKAQREAEEAEREERKRLESQREAEWKKEEERLRLEEEQKEEEERKAREE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QAQREHEEYLKLKEAFVVEEEGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGL 	                        Gaps:       0                        
						RTQDTINRIQDLLAEGTIT                                          	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 259	Alignment:                                                   
						of Q9BW47, which also corresponds to amino acids 30 - 288 of 	                  .         .         .         .         .  
						T09311_P12, and a third amino acid sequence being at least   	      30 MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQP 79                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MVAPVWYLVAAALLVGFILFLTRSRGRAASAGQEPLHNEELAGAGRVAQP 50                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						EEKTAVRDGSVGPSKVAQLVRAEPRLRE corresponding to amino acids 289	      80 GPLEPEEPRAGGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQ 129                                                          
						- 316 of T09311_P12, wherein said first amino acid sequence, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 GPLEPEEPRAGGRPRRRRDLGSRLQAQRRAQRVAWAEADENEEEAVILAQ 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09311_P12, comprising a  	     130 EEEGVEKPAETHLSGKIGAKKLRKLEEKQARKAQREAEEAEREERKRLES 179                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 EEEGVEKPAETHLSGKIGAKKLRKLEEKQARKAQREAEEAEREERKRLES 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence AESRLGNRGGAYEIPASGWTQWFCTEALV of             	     180 QREAEWKKEEERLRLEEEQKEEEERKAREEQAQREHEEYLKLKEAFVVEE 229                                                          
						T09311_P12.3.An isolated polypeptide encoding for a tail of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09311_P12, comprising a polypeptide being at least 70%,     	     151 QREAEWKKEEERLRLEEEQKEEEERKAREEQAQREHEEYLKLKEAFVVEE 200                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     230 EGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGLRTQDTINRIQ 279                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEKTAVRDGSVGPSKVAQLVRAEPRLRE in T09311_P12.                  	     201 EGVGETMTEEQSQSFLTEFINYIKQSKVVLLEDLASQVGLRTQDTINRIQ 250                                                          
						                                                            	                                                             
						                                                            	     280 DLLAEGTIT                                          288                                                          
						                                                            	         |||||||||                                           
						                                                            	     251 DLLAEGTIT                                          259                                                          

13374	HMR136_T09329_16_tr0_r1_1_gPRT		Comparison report between T09329_P16 and Q9UBP2partial WT    	Sequence name: Q9UBP2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UBP2   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 173 - 521 of Q9UBP2, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     173 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 222                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     223 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 272                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 372                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     373 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 422                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     423 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 472                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     473 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  521                                                          

						Comparison report between T09329_P16 and Q9UIF4partial WT    	Sequence name: Q9UIF4                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UIF4   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 174 - 522 of Q9UIF4, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     174 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 223                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 373                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     374 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 423                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     424 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 473                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     474 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  522                                                          

						Comparison report between T09329_P16 and Q9UIF7partial WT    	Sequence name: Q9UIF7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UIF7   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 198 - 546 of Q9UIF7, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     198 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 247                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     248 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 297                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     298 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 347                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     348 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 397                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     398 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 447                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     448 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 497                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     498 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  546                                                          

						Comparison report between T09329_P16 and Q9UIF5partial WT    	Sequence name: Q9UIF5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UIF5   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 184 - 532 of Q9UIF5, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 283                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 333                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     334 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 383                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     384 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 433                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     434 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 483                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     484 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  532                                                          

						Comparison report between T09329_P16 and Q9UBS7partial WT    	Sequence name: Q9UBS7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UBS7   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 81 - 429 of Q9UBS7, which also corresponds to    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      81 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 130                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     131 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 180                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     181 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 230                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     231 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 280                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     281 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 330                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     331 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 380                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     381 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  429                                                          

						Comparison report between T09329_P16 and Q9UIF6partial WT    	Sequence name: Q9UIF6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q9UIF6   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 188 - 536 of Q9UIF6, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     188 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 237                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     238 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 287                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     288 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 337                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     338 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 387                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     388 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 437                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     438 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 487                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     488 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  536                                                          

						Comparison report between T09329_P16 and Q15830partial WT    	Sequence name: Q15830                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09329_P16, comprising a first amino acid       	                                                            
						MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIGADPSSTLVSQ 	Alignment of: 13374 x Q15830   ..                            
						QLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQCPVESLCRARQRVEQEQLLAS 	                                                            
						GSLSGSPDVEECAPNTGQCHLCLPPSEPWDQTLGVVNFPRKASRKPPREESSATCVLEQP 	Alignment segment 1/1:                                       
						GALGAQILLVQRPNSGLLAGLWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLG 	                                                            
						EVVHTFSHIKLTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 	                     Quality: 3439.00                      Escore:       0                                               
						QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ            	             Matching length:     349                Total length:     349                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 187 - 535 of Q15830, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 349 of T09329_P16.                           	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 MPRTAETLQQLLPGVGRYTAGAIASIAFGQATGVVDGNVARVLCRVRAIG 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 ADPSSTLVSQQLWGLAQQLVDPARPGDFNQAAMELGATVCTPQRPLCSQC 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 PVESLCRARQRVEQEQLLASGSLSGSPDVEECAPNTGQCHLCLPPSEPWD 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 QTLGVVNFPRKASRKPPREESSATCVLEQPGALGAQILLVQRPNSGLLAG 386                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     387 LWEFPSVTWEPSEQLQRKALLQELQRWAGPLPATHLRHLGEVVHTFSHIK 436                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     437 LTYQVYGLALEGQTPVTTVPPGARWLTQEEFHTAAVSTAMKKVFRVYQGQ 486                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     487 QPGTCMGSKRSQVSSPCSRKKPRMGQQVLDNFFRSHISTDAHSLNSAAQ  535                                                          

13679	HMR136_T09337_13_tr0_r1_1_gPRT		Comparison report between T09337_P13 and DDR1_HUMANpartial   	Sequence name: DDR1_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09337_P13, comprising a first amino	Sequence documentation:                                      
						MEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDP 	                                                            
						RARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPG 	Alignment of: 13679 x DDR1_HUMAN   ..                        
						PPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILLLLLIIALMLWRLHWRRLLSK 	                                                            
						AERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGS      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 270 - 504 of DDR1_HUMAN, which also           	                     Quality: 5933.00                      Escore:       0                                               
						corresponds to amino acids 1 - 235 of T09337_P13, and a      	             Matching length:     607                Total length:     644                                               
						AYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDA 	    Total Percent Similarity:   94.25      Total Percent Identity:   94.25                                               
						TKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDK 	                        Gaps:       1                        
						AAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIK 	                                                            
						IADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCR 	Alignment:                                                   
						AQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQL 	                  .         .         .         .         .  
						HRFLAEDALNTV                                                 	       1 MEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMR 50                                                           
						second amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 542 - 913 of DDR1_HUMAN, which  	     270 MEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMR 319                                                          
						also corresponds to amino acids 236 - 607 of T09337_P13,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      51 HNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVV 100                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     320 HNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVV 369                                                          
						T09337_P13, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     101 NNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAIL 150                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     370 NNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAIL 419                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     151 IGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDT 200                                                          
						at least two amino acids comprise SA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     420 IGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDT 469                                                          
						235-x to 236; and ending at any of amino acid numbers 236+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     201 ILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGS............... 235                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     470 ILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLAT 519                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     236 ......................AYSGDYMEPEKPGAPLLPPPPQNSVPHY 263                                                          
						                                                            	                               ||||||||||||||||||||||||||||  
						                                                            	     520 YARPPRGPGPPTPAWAKPTNTQAYSGDYMEPEKPGAPLLPPPPQNSVPHY 569                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 AEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEG 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     570 AEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEG 619                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 QFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDF 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     620 QFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDF 669                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 LKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLE 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     670 LKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLE 719                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     414 DKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLAT 463                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     720 DKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLAT 769                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     464 RNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGK 513                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     770 RNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGK 819                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     514 FTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVY 563                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     820 FTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVY 869                                                          
						                                                            	                  .         .         .         .            
						                                                            	     564 LSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV       607                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     870 LSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV       913                                                          

13677	HMR136_T09337_14_tr0_r1_1_gPRT		Comparison report between T09337_P14 and DDR1_HUMANpartial   	Sequence name: DDR1_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T09337_P14, comprising a first amino	                                                            
						MGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRD 	Alignment of: 13677 x DDR1_HUMAN   ..                        
						GLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRV 	                                                            
						WPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGP 	Alignment segment 1/1:                                       
						AMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVV 	                                                            
						NNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILL 	                     Quality: 7795.00                      Escore:       0                                               
						LLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRP 	             Matching length:     784                Total length:     784                                               
						RGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGPPTPAWAKPTNTQAYSGDYME 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDF 	                        Gaps:       0                        
						LKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGD 	                                                            
						GQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSR 	Alignment:                                                   
						NLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLT 	                  .         .         .         .         .  
						DEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDA 	       1 MGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLR 50                                                           
						LNTV                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     130 MGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLR 179                                                          
						to amino acids 130 - 913 of DDR1_HUMAN, which also           	                  .         .         .         .         .  
						corresponds to amino acids 1 - 784 of T09337_P14.            	      51 VELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     180 VELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLG 229                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 QLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     230 QLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRA 279                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     280 FQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDP 329                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     330 RARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGT 379                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     380 FPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILL 429                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     430 LLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPR 479                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     480 EPPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGP 529                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PTPAWAKPTNTQAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQG 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     530 PTPAWAKPTNTQAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQG 579                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     580 VTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEV 629                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 DSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     630 DSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRL 679                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 KDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     680 KDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGD 729                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 GQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     730 GQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFT 779                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 IKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAF 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     780 IKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAF 829                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQG 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     830 GVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQG 879                                                          
						                                                            	                  .         .         .                      
						                                                            	     751 LYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV                 784                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     880 LYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV                 913                                                          

13681	HMR136_T09337_30_tr0_r1_1_gPRT		Comparison report between T09337_P30 and DDR1_HUMANunique    	Sequence name: DDR1_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09337_P30, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 13681 x DDR1_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MAASGGMDSCLTPPLWGRQCIYLRPCTSTTPPMTDIPWADCSMGVWASWQMVWWGWMTLG 	Alignment segment 1/1:                                       
						RVRSCGSGQAMTI                                                	                                                            
						having the sequence corresponding to amino acids 1 - 73 of   	                     Quality: 1742.00                      Escore:       0                                               
						T09337_P30, and a second amino acid sequence being at least  	             Matching length:     174                Total length:     174                                               
						YPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV       	                        Gaps:       0                        
						90 % homologous to corresponding to amino acids 740 - 913 of 	                                                            
						DDR1_HUMAN, which also corresponds to amino acids 74 - 247 of	Alignment:                                                   
						T09337_P30, wherein said first amino acid sequence and second	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      74 YPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSR 123                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09337_P30, comprising a polypeptide being at least 70%,     	     740 YPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSR 789                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     124 NLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLML 173                                                          
						MAASGGMDSCLTPPLWGRQCIYLRPCTSTTPPMTDIPWADCSMGVWASWQMVWWGWMTLG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVRSCGSGQAMTI                                                	     790 NLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLML 839                                                          
						least about 95% homologous to the sequence of T09337_P30.    	                  .         .         .         .         .  
						                                                            	     174 CRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWS 223                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 CRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWS 889                                                          
						                                                            	                  .         .                                
						                                                            	     224 RESEQRPPFSQLHRFLAEDALNTV                           247                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     890 RESEQRPPFSQLHRFLAEDALNTV                           913                                                          

6604	HMR136_T09341_3_tr0_r1_1_gPRT		Comparison report between T09341_P3 and Q96KU3partial WT     	Sequence name: Q96KU3                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09341_P3, comprising a first amino acid sequence being at   	                                                            
						MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGVLWWLYAKQRR 	Alignment of: 6604 x Q96KU3   ..                             
						SPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIMLVMRKRVALTIALFHVAGKVF 	                                                            
						IHLPLLVFQPFWTFFALVLFWVYWIMTLLFLGTTGSPVQNEQGFVEFKISGPLQYMWWYH 	Alignment segment 1/1:                                       
						VVGLIWISEFILACQQMTVAGAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSF 	                                                            
						IITLVKIPRMILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 	                     Quality: 4290.00                      Escore:       0                                               
						TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIMLLNYQQDYTVW 	             Matching length:     442                Total length:     442                                               
						VLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYNDGSPGREFYMDKVLMEFVEN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						SRKAMKEAGKGGVAD                                              	    Total Percent Similarity:  100.00      Total Percent Identity:   99.77                                               
						least 90 % homologous to corresponding to amino acids 209 -  	                        Gaps:       0                        
						643 of Q96KU3, which also corresponds to amino acids 1 - 435 	                                                            
						of T09341_P3, a bridging amino acid S corresponding to amino 	Alignment:                                                   
						acid 436 of T09341_P3, a second amino acid sequence being at 	                  .         .         .         .         .  
						least 90 % homologous to RELKPM corresponding to amino acids 	       1 MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGV 50                                                           
						645 - 650 of Q96KU3, which also corresponds to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						437 - 442 of T09341_P3, and a third amino acid sequence being	     209 MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGV 258                                                          
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	      51 LWWLYAKQRRSPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIML 100                                                          
						least 95% homologous to a polypeptide having the sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASGASSA corresponding to amino acids 443 - 449 of T09341_P3, 	     259 LWWLYAKQRRSPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIML 308                                                          
						wherein said first amino acid sequence, bridging amino acid, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     101 VMRKRVALTIALFHVAGKVFIHLPLLVFQPFWTFFALVLFWVYWIMTLLF 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09341_P3, comprising a   	     309 VMRKRVALTIALFHVAGKVFIHLPLLVFQPFWTFFALVLFWVYWIMTLLF 358                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 LGTTGSPVQNEQGFVEFKISGPLQYMWWYHVVGLIWISEFILACQQMTVA 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence ASGASSA in T09341_P3.                        	     359 LGTTGSPVQNEQGFVEFKISGPLQYMWWYHVVGLIWISEFILACQQMTVA 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSFIITLVKIPRM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 GAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSFIITLVKIPRM 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 ILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIML 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIML 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 LNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYN 608                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 DGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADSRELKPM         442                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||:||||||          
						                                                            	     609 DGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADARELKPM         650                                                          

						Comparison report between T09341_P3 and Q8WVB0unique head    	Sequence name: Q8WVB0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09341_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 6604 x Q8WVB0   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGVLWWLYAKQRR 	Alignment segment 1/1:                                       
						SPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIMLVMRKRVALTIALFHVAGKVF 	                                                            
						IHLPLLVFQPFWTFFALVLFWVYWIMTLLFLGTTGSPVQNEQGFVEFKISGPLQYMWWYH 	                     Quality: 1753.00                      Escore:       0                                               
						VVGLIWISEFILACQQMTVAGAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSF 	             Matching length:     180                Total length:     180                                               
						IITLVKIPRMILMYIHSQLKGKENACARC                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 269 of  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						T09341_P3, and a second amino acid sequence being at least 90	                        Gaps:       0                        
						VLKSCICCLWCLEKCLNYLNQNAYTATAINSTNFCTSAKDAFVILVENALRVATINTVGD 	                                                            
						FMLFLGKVLIVCSTGLAGIMLLNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVL 	Alignment:                                                   
						FLCFAIDTKYNDGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADSRELKPMASGASSA 	                  .         .         .         .         .  
						% homologous to corresponding to amino acids 1 - 180 of      	     270 VLKSCICCLWCLEKCLNYLNQNAYTATAINSTNFCTSAKDAFVILVENAL 319                                                          
						Q8WVB0, which also corresponds to amino acids 270 - 449 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09341_P3, wherein said first amino acid sequence and second 	       1 VLKSCICCLWCLEKCLNYLNQNAYTATAINSTNFCTSAKDAFVILVENAL 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     320 RVATINTVGDFMLFLGKVLIVCSTGLAGIMLLNYQQDYTVWVLPLIIVCL 369                                                          
						T09341_P3, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 RVATINTVGDFMLFLGKVLIVCSTGLAGIMLLNYQQDYTVWVLPLIIVCL 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGVLWWLYAKQRR 	     370 FAFLVAHCFLSIYEMVVDVLFLCFAIDTKYNDGSPGREFYMDKVLMEFVE 419                                                          
						SPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIMLVMRKRVALTIALFHVAGKVF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IHLPLLVFQPFWTFFALVLFWVYWIMTLLFLGTTGSPVQNEQGFVEFKISGPLQYMWWYH 	     101 FAFLVAHCFLSIYEMVVDVLFLCFAIDTKYNDGSPGREFYMDKVLMEFVE 150                                                          
						VVGLIWISEFILACQQMTVAGAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSF 	                  .         .         .                      
						IITLVKIPRMILMYIHSQLKGKENACARC                                	     420 NSRKAMKEAGKGGVADSRELKPMASGASSA                     449                                                          
						least about 95% homologous to the sequence of T09341_P3.     	         ||||||||||||||||||||||||||||||                      
						                                                            	     151 NSRKAMKEAGKGGVADSRELKPMASGASSA                     180                                                          

						Comparison report between T09341_P3 and Q8WWI5partial WT     	Sequence name: Q8WWI5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09341_P3, comprising a first amino acid        	                                                            
						MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGVLWWLYAKQRR 	Alignment of: 6604 x Q8WWI5   ..                             
						SPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIMLVMRKRVALTIALFHVAGKVF 	                                                            
						IHLPLLVFQPFWTFFALVLFWVYWIMTLLFLGTTGSPVQNEQGFVEFKISGPLQYMWWYH 	Alignment segment 1/1:                                       
						VVGLIWISEFILACQQMTVAGAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSF 	                                                            
						IITLVKIPRMILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 	                     Quality: 4358.00                      Escore:       0                                               
						TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIMLLNYQQDYTVW 	             Matching length:     449                Total length:     449                                               
						VLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYNDGSPGREFYMDKVLMEFVEN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SRKAMKEAGKGGVADSRELKPMASGASSA                                	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 209 - 657 of Q8WWI5, which also corresponds to   	                                                            
						amino acids 1 - 449 of T09341_P3.                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     209 MTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGV 258                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LWWLYAKQRRSPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIML 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     259 LWWLYAKQRRSPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIML 308                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VMRKRVALTIALFHVAGKVFIHLPLLVFQPFWTFFALVLFWVYWIMTLLF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     309 VMRKRVALTIALFHVAGKVFIHLPLLVFQPFWTFFALVLFWVYWIMTLLF 358                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LGTTGSPVQNEQGFVEFKISGPLQYMWWYHVVGLIWISEFILACQQMTVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 LGTTGSPVQNEQGFVEFKISGPLQYMWWYHVVGLIWISEFILACQQMTVA 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSFIITLVKIPRM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 GAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSFIITLVKIPRM 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 ILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINS 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIML 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 TNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIML 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 LNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYN 608                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 DGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADSRELKPMASGASSA  449                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     609 DGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADSRELKPMASGASSA  657                                                          

6754	HMR136_T09352_10_tr0_r1_1_gPRT		Comparison report between T09352_P10 and TR4_HUMANpartial WT 	Sequence name: TR4_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09352_P10, comprising a first amino	Sequence documentation:                                      
						MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG 	                                                            
						TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC 	Alignment of: 6754 x TR4_HUMAN   ..                          
						GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM 	                                                            
						GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL 	Alignment segment 1/1:                                       
						DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 	                                                            
						PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP 	                     Quality: 4418.00                      Escore:       0                                               
						LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR 	             Matching length:     462                Total length:     462                                               
						ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQE                        	 Matching Percent Similarity:   99.35   Matching Percent Identity:   99.13                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:   99.35      Total Percent Identity:   99.13                                               
						to amino acids 1 - 457 of TR4_HUMAN, which also corresponds  	                        Gaps:       0                        
						to amino acids 1 - 457 of T09352_P10, and a second amino acid	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRAQGLGAGVCLGSAWWPWSRAQPPGWRLMSKTPLLTQAGNIANWIASVSHSIHRLREV  	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						corresponding to amino acids 458 - 516 of T09352_P10, wherein	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09352_P10, comprising a  	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						GRAQGLGAGVCLGSAWWPWSRAQPPGWRLMSKTPLLTQAGNIANWIASVSHSIHRLREV  	                  .         .         .         .         .  
						in T09352_P10.                                               	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	                  .                                          
						                                                            	     451 LQNSIQEGRAQG                                       462                                                          
						                                                            	         ||||||| :  |                                        
						                                                            	     451 LQNSIQEDKLSG                                       462                                                          

6758	HMR136_T09352_11_tr0_r1_1_gPRT		Comparison report between T09352_P11 and TR4_HUMANpartial WT 	Sequence name: TR4_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09352_P11, comprising a first amino	Sequence documentation:                                      
						MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG 	                                                            
						TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC 	Alignment of: 6758 x TR4_HUMAN   ..                          
						GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM 	                                                            
						GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL 	Alignment segment 1/1:                                       
						DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 	                                                            
						PEDQSASEITR                                                  	                     Quality: 3000.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     311                Total length:     311                                               
						to amino acids 1 - 311 of TR4_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 311 of T09352_P11, and a second amino acid	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence YEPMRMESPLLAWTPSLYCEGGKQHFGTCAVFN        	                  .         .         .         .         .  
						corresponding to amino acids 312 - 344 of T09352_P11, wherein	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						polypeptide encoding for a tail of T09352_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						to the sequence YEPMRMESPLLAWTPSLYCEGGKQHFGTCAVFN in         	                  .         .         .         .         .  
						T09352_P11.                                                  	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	                  .                                          
						                                                            	     301 PEDQSASEITR                                        311                                                          
						                                                            	         |||||||||||                                         
						                                                            	     301 PEDQSASEITR                                        311                                                          

6760	HMR136_T09352_8_tr0_r1_1_gPRT		Comparison report between T09352_P8 and TR4_HUMANpartial WT  	Sequence name: TR4_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09352_P8, comprising a first amino 	Sequence documentation:                                      
						MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG 	                                                            
						TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC 	Alignment of: 6760 x TR4_HUMAN   ..                          
						GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM 	                                                            
						GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL 	Alignment segment 1/1:                                       
						DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 	                                                            
						PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP 	                     Quality: 5235.00                      Escore:       0                                               
						LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR 	             Matching length:     539                Total length:     539                                               
						ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 539 of TR4_HUMAN, which also corresponds  	                                                            
						to amino acids 1 - 539 of T09352_P8, and a second amino acid 	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNQTTHSFFPKIFLMCSMISLLLLVSTSTRTCSPESGNGKHGAEEKQNSQRTQPQKVVIW 	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						DLLLVAETF                                                    	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 540 - 608 of	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						T09352_P8, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T09352_P8, comprising a polypeptide being at least 70%,      	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						SNQTTHSFFPKIFLMCSMISLLLLVSTSTRTCSPESGNGKHGAEEKQNSQRTQPQKVVIW 	                  .         .         .         .         .  
						DLLLVAETF                                                    	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						least about 95% homologous to the sequence in T09352_P8.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 LQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVL 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 FSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR            539                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     501 FSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR            539                                                          

6762	HMR136_T09352_9_tr0_r1_1_gPRT		Comparison report between T09352_P9 and TR4_HUMANpartial WT  	Sequence name: TR4_HUMAN                                     
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09352_P9, comprising a first amino 	Sequence documentation:                                      
						MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAG 	                                                            
						TGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVC 	Alignment of: 6762 x TR4_HUMAN   ..                          
						GDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEM 	                                                            
						GMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLL 	Alignment segment 1/1:                                       
						DPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 	                                                            
						PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGP 	                     Quality: 5235.00                      Escore:       0                                               
						LLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVR 	             Matching length:     539                Total length:     539                                               
						ACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 539 of TR4_HUMAN, which also corresponds  	                                                            
						to amino acids 1 - 539 of T09352_P9, and a second amino acid 	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence TCSPESGNGKHGAEEKQNSQRTQPQKVVIWDLLLVAETF  	       1 MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQ 50                                                           
						corresponding to amino acids 540 - 578 of T09352_P9, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09352_P9, comprising a   	      51 FILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVE 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence TCSPESGNGKHGAEEKQNSQRTQPQKVVIWDLLLVAETF in   	     101 RLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLT 150                                                          
						T09352_P9.                                                   	                  .         .         .         .         .  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 YSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREK 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQ 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 STPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHW 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNH 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 LQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVL 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVL 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     501 FSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR            539                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     501 FSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYR            539                                                          

6969	HMR136_T09361_4_tr0_r1_1_gPRT		Comparison report between T09361_P4 and Y232_HUMANpartial WT 	Sequence name: Y232_HUMAN                                    
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09361_P4, comprising a first amino acid sequence being at   	                                                            
						MYPICTVVVDGLPSESSSSSYPGPVSVSEMSLLHALGPVQTWLGQELEKCGIDAMIYTRY 	Alignment of: 6969 x Y232_HUMAN   ..                         
						VLSLLLHDSYDYDLQEQENDIFLGWEKGAYKKWGKSKKKCSDLTLEEMKKQAAVQCLRSA 	                                                            
						SDESSGIETLVEELCSRLKDLQSKQEEKIHKKLEGSPSPEAELSPPAKDQVEMYYEAFPP 	Alignment segment 1/1:                                       
						LSEKPVCLQEIMTVWNKSKVCSYSSSSSSSTAPPASTDTSSPKDCNSESEVTKERSSEVP 	                                                            
						TTVHEKTQSKSKNEKENKFSNGTIEEKPALYKKQIRHKPEGKIRPRSWSSGSSEAGSSSS 	                     Quality: 12880.00                      Escore:       0                                              
						GNQGELKASMKYVKVRHKAREIRNKKGRNGQSRLSLKHGEKAERNIHTGSSSSSSSGSVK 	             Matching length:    1303                Total length:    1303                                               
						QLCKRGKRPLKEIGRKDPGSTEGKDLYMENRKDTEYKEEPLWYTEPIAEYFVPLSRKSKL 	 Matching Percent Similarity:   99.92   Matching Percent Identity:   99.92                                               
						ETTYRNRQDTSDLTSEAVEELSESVHGLCISNNNLHKTYLAAGTFIDGHFVEMPAVINED 	    Total Percent Similarity:   99.92      Total Percent Identity:   99.92                                               
						IDLTGTSLCSLPEDNKYLDDIHLSELTHFYEVDIDQSMLDPGASETMQGESRIL       	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 8 - 541	                                                            
						of Y232_HUMAN, which also corresponds to amino acids 1 - 534 	Alignment:                                                   
						of T09361_P4, a bridging amino acid N corresponding to amino 	                  .         .         .         .         .  
						acid 535 of T09361_P4, a second amino acid sequence being at 	       1 MYPICTVVVDGLPSESSSSSYPGPVSVSEMSLLHALGPVQTWLGQELEKC 50                                                           
						MIRQKSKENTDFEAECCIVLDGMELQGERAIWTDSTSSVGAEGLFLQDLGNLAQFWECCS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSSGDADGESFGGDSPVRLSPILDSTVLNSHLLAGNQELFSDINEGSGINSCFSVFEVQC 	       8 MYPICTVVVDGLPSESSSSSYPGPVSVSEMSLLHALGPVQTWLGQELEKC 57                                                           
						SNSVLPFSFETLNLGNENTDSSANMLGKTQSRLLIWTKNSAFEENEHCSNLSTRTCSPWS 	                  .         .         .         .         .  
						HSEETRSDNETLNIQFEESTQFNAEDINYVVPRVSSNYVDEELLDFLQDETCQQNSRTLG 	      51 GIDAMIYTRYVLSLLLHDSYDYDLQEQENDIFLGWEKGAYKKWGKSKKKC 100                                                          
						EIPTLVFKKTSKLESVCGIQLEQKTENKNFETTQVCNESPHGDGYSSGVIKDIWTKMADT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSVATVEIERTDAELFSADVNNYCCCLDAEAELETLQEPDKAVRRSEYHLWEGQKESLEK 	      58 GIDAMIYTRYVLSLLLHDSYDYDLQEQENDIFLGWEKGAYKKWGKSKKKC 107                                                          
						RAFASSELSNVDGGDYTTPSKPWDVAQDKENTFILGGVYGELKTFNSDGEWAVVPPSHTK 	                  .         .         .         .         .  
						GSLLQCAASDVVTIAGTDVFMTPGNSFAPGHRQLWKPFVSFEQNDQPKSGENGLNKGFSF 	     101 SDLTLEEMKKQAAVQCLRSASDESSGIETLVEELCSRLKDLQSKQEEKIH 150                                                          
						IFHEDLLGACGNFQVEDPGLEYSFSSFDLSNPFSQVLHVECSFEPEGIASFSPSFKPKSI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LCSDSDSEVFHPRICGVDRTQYRAIRISPRTHFRPISASELSPGGGSESEFESEKDEANI 	     108 SDLTLEEMKKQAAVQCLRSASDESSGIETLVEELCSRLKDLQSKQEEKIH 157                                                          
						PIPSQVDIFEDPQADLKPLEEDAEKEGHYYGKSELESGKFLPRLKKSGMEKSAQTSLDSQ 	                  .         .         .         .         .  
						EESTGILSVGKQNQCLECSMNESLEIDLESSEANCKIMAQCEEEINNFCGCKAGCQFPAY 	     151 KKLEGSPSPEAELSPPAKDQVEMYYEAFPPLSEKPVCLQEIMTVWNKSKV 200                                                          
						EDNPVSSGQLEEFPVLNTDIQGMNRSQEKQTWWEKALYSPLFPASECE             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 543 -  	     158 KKLEGSPSPEAELSPPAKDQVEMYYEAFPPLSEKPVCLQEIMTVWNKSKV 207                                                          
						1310 of Y232_HUMAN, which also corresponds to amino acids 536	                  .         .         .         .         .  
						- 1303 of T09361_P4, and a third amino acid sequence being at	     201 CSYSSSSSSSTAPPASTDTSSPKDCNSESEVTKERSSEVPTTVHEKTQSK 250                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     208 CSYSSSSSSSTAPPASTDTSSPKDCNSESEVTKERSSEVPTTVHEKTQSK 257                                                          
						homologous to a polypeptide having the sequence GVFCL        	                  .         .         .         .         .  
						corresponding to amino acids 1304 - 1308 of T09361_P4,       	     251 SKNEKENKFSNGTIEEKPALYKKQIRHKPEGKIRPRSWSSGSSEAGSSSS 300                                                          
						wherein said first amino acid sequence, bridging amino acid, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	     258 SKNEKENKFSNGTIEEKPALYKKQIRHKPEGKIRPRSWSSGSSEAGSSSS 307                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of T09361_P4, comprising a   	     301 GNQGELKASMKYVKVRHKAREIRNKKGRNGQSRLSLKHGEKAERNIHTGS 350                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     308 GNQGELKASMKYVKVRHKAREIRNKKGRNGQSRLSLKHGEKAERNIHTGS 357                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence GVFCL in T09361_P4.                          	     351 SSSSSSGSVKQLCKRGKRPLKEIGRKDPGSTEGKDLYMENRKDTEYKEEP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 SSSSSSGSVKQLCKRGKRPLKEIGRKDPGSTEGKDLYMENRKDTEYKEEP 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LWYTEPIAEYFVPLSRKSKLETTYRNRQDTSDLTSEAVEELSESVHGLCI 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 LWYTEPIAEYFVPLSRKSKLETTYRNRQDTSDLTSEAVEELSESVHGLCI 457                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 SNNNLHKTYLAAGTFIDGHFVEMPAVINEDIDLTGTSLCSLPEDNKYLDD 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 SNNNLHKTYLAAGTFIDGHFVEMPAVINEDIDLTGTSLCSLPEDNKYLDD 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IHLSELTHFYEVDIDQSMLDPGASETMQGESRILNMIRQKSKENTDFEAE 550                                                          
						                                                            	         |||||||||||||||||||||||||||||||||| |||||||||||||||  
						                                                            	     508 IHLSELTHFYEVDIDQSMLDPGASETMQGESRILKMIRQKSKENTDFEAE 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 CCIVLDGMELQGERAIWTDSTSSVGAEGLFLQDLGNLAQFWECCSSSSGD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 CCIVLDGMELQGERAIWTDSTSSVGAEGLFLQDLGNLAQFWECCSSSSGD 607                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ADGESFGGDSPVRLSPILDSTVLNSHLLAGNQELFSDINEGSGINSCFSV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     608 ADGESFGGDSPVRLSPILDSTVLNSHLLAGNQELFSDINEGSGINSCFSV 657                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 FEVQCSNSVLPFSFETLNLGNENTDSSANMLGKTQSRLLIWTKNSAFEEN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     658 FEVQCSNSVLPFSFETLNLGNENTDSSANMLGKTQSRLLIWTKNSAFEEN 707                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 EHCSNLSTRTCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPRVS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     708 EHCSNLSTRTCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPRVS 757                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 SNYVDEELLDFLQDETCQQNSRTLGEIPTLVFKKTSKLESVCGIQLEQKT 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     758 SNYVDEELLDFLQDETCQQNSRTLGEIPTLVFKKTSKLESVCGIQLEQKT 807                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ENKNFETTQVCNESPHGDGYSSGVIKDIWTKMADTNSVATVEIERTDAEL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     808 ENKNFETTQVCNESPHGDGYSSGVIKDIWTKMADTNSVATVEIERTDAEL 857                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FSADVNNYCCCLDAEAELETLQEPDKAVRRSEYHLWEGQKESLEKRAFAS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     858 FSADVNNYCCCLDAEAELETLQEPDKAVRRSEYHLWEGQKESLEKRAFAS 907                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 SELSNVDGGDYTTPSKPWDVAQDKENTFILGGVYGELKTFNSDGEWAVVP 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     908 SELSNVDGGDYTTPSKPWDVAQDKENTFILGGVYGELKTFNSDGEWAVVP 957                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 PSHTKGSLLQCAASDVVTIAGTDVFMTPGNSFAPGHRQLWKPFVSFEQND 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     958 PSHTKGSLLQCAASDVVTIAGTDVFMTPGNSFAPGHRQLWKPFVSFEQND 1007                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 QPKSGENGLNKGFSFIFHEDLLGACGNFQVEDPGLEYSFSSFDLSNPFSQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1008 QPKSGENGLNKGFSFIFHEDLLGACGNFQVEDPGLEYSFSSFDLSNPFSQ 1057                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 VLHVECSFEPEGIASFSPSFKPKSILCSDSDSEVFHPRICGVDRTQYRAI 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1058 VLHVECSFEPEGIASFSPSFKPKSILCSDSDSEVFHPRICGVDRTQYRAI 1107                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 RISPRTHFRPISASELSPGGGSESEFESEKDEANIPIPSQVDIFEDPQAD 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1108 RISPRTHFRPISASELSPGGGSESEFESEKDEANIPIPSQVDIFEDPQAD 1157                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 LKPLEEDAEKEGHYYGKSELESGKFLPRLKKSGMEKSAQTSLDSQEESTG 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1158 LKPLEEDAEKEGHYYGKSELESGKFLPRLKKSGMEKSAQTSLDSQEESTG 1207                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 ILSVGKQNQCLECSMNESLEIDLESSEANCKIMAQCEEEINNFCGCKAGC 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1208 ILSVGKQNQCLECSMNESLEIDLESSEANCKIMAQCEEEINNFCGCKAGC 1257                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 QFPAYEDNPVSSGQLEEFPVLNTDIQGMNRSQEKQTWWEKALYSPLFPAS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1258 QFPAYEDNPVSSGQLEEFPVLNTDIQGMNRSQEKQTWWEKALYSPLFPAS 1307                                                         
						                                                            	                                                             
						                                                            	    1301 ECE                                                1303                                                         
						                                                            	         |||                                                 
						                                                            	    1308 ECE                                                1310                                                         

15233	HMR136_T09369_10_tr0_r1_1_gPRT		Comparison report between T09369_P10 and O94888unique head   	Sequence name: O94888                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09369_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15233 x O94888   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EVGEGSPCVSVLLFGGGGGG corresponding to amino acids 1 - 20 of  	                                                            
						T09369_P10, a second amino acid sequence being at least 90 % 	                     Quality:  716.00                      Escore:       0                                               
						KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEP 	             Matching length:      77                Total length:      77                                               
						STSSASVSTVRPHTE                                              	 Matching Percent Similarity:   98.70   Matching Percent Identity:   98.70                                               
						homologous to corresponding to amino acids 1 - 75 of O94888, 	    Total Percent Similarity:   98.70      Total Percent Identity:   98.70                                               
						which also corresponds to amino acids 21 - 95 of T09369_P10, 	                        Gaps:       0                        
						and a third amino acid sequence being at least 70%,          	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence YEFIMCCQELSIA	      21 KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMF 70                                                           
						corresponding to amino acids 96 - 108 of T09369_P10, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMF 50                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .                                
						sequential order.2.An isolated polypeptide encoding for a    	      71 LDGGGIAEEPSTSSASVSTVRPHTEYE                        97                                                           
						head of T09369_P10, comprising a polypeptide being at least  	         ||||||||||||||||||||||||| |                         
						70%, optionally at least about 80%, preferably at least about	      51 LDGGGIAEEPSTSSASVSTVRPHTEEE                        77                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						EVGEGSPCVSVLLFGGGGGG of T09369_P10.3.An isolated polypeptide 	                                                            
						encoding for a tail of T09369_P10, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						YEFIMCCQELSIA in T09369_P10.                                 	                                                            

						Comparison report between T09369_P10 and AAH47420unique head 	Sequence name: AAH47420                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09369_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15233 x AAH47420   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EVGEGSPCVSVLLFGGGGGGK corresponding to amino acids 1 - 21 of 	                                                            
						T09369_P10, a second amino acid sequence being at least 90 % 	                     Quality:  706.00                      Escore:       0                                               
						MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEPS 	             Matching length:      76                Total length:      76                                               
						TSSASVSTVRPHTE                                               	 Matching Percent Similarity:   98.68   Matching Percent Identity:   98.68                                               
						homologous to corresponding to amino acids 1 - 74 of         	    Total Percent Similarity:   98.68      Total Percent Identity:   98.68                                               
						AAH47420, which also corresponds to amino acids 22 - 95 of   	                        Gaps:       0                        
						T09369_P10, and a third amino acid sequence being at least   	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence YEFIMCCQELSIA	      22 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 71                                                           
						corresponding to amino acids 96 - 108 of T09369_P10, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 50                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .                                
						sequential order.2.An isolated polypeptide encoding for a    	      72 DGGGIAEEPSTSSASVSTVRPHTEYE                         97                                                           
						head of T09369_P10, comprising a polypeptide being at least  	         |||||||||||||||||||||||| |                          
						70%, optionally at least about 80%, preferably at least about	      51 DGGGIAEEPSTSSASVSTVRPHTEEE                         76                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						EVGEGSPCVSVLLFGGGGGGK of T09369_P10.3.An isolated polypeptide	                                                            
						encoding for a tail of T09369_P10, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						YEFIMCCQELSIA in T09369_P10.                                 	                                                            

15229	HMR136_T09369_5_tr0_r1_1_gPRT		Comparison report between T09369_P5 and Q8N327unique head    	Sequence name: Q8N327                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids.1.An isolated chimeric polypeptide encoding	Sequence documentation:                                      
						for T09369_P5, comprising a first amino acid sequence being  	                                                            
						at least 70%, optionally at least 80%, preferably at least   	Alignment of: 15229 x Q8N327   ..                            
						85%, more preferably at least 90% and most preferably at     	                                                            
						least 95% homologous to a polypeptide having the sequence    	Alignment segment 1/1:                                       
						MAAHGGSAASSALKGLIQQFTTITGASESVG corresponding to amino acids 	                                                            
						1 - 31 of T09369_P5, a second amino acid sequence being at   	                     Quality: 4200.00                      Escore:       0                                               
						KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEP 	             Matching length:     436                Total length:     458                                               
						EPLFG                                                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						least 90 % homologous to corresponding to amino acids 1 - 65 	    Total Percent Similarity:   95.20      Total Percent Identity:   94.98                                               
						of Q8N327, which also corresponds to amino acids 32 - 96 of  	                        Gaps:       1                        
						T09369_P5, a third amino acid sequence bridging amino acid   	                                                            
						sequence comprising of V, and a fourth amino acid sequence   	Alignment:                                                   
						RQEQELRNGGAIDKKLTTLADLFRPPIDLMHKGSFETAKECGQMQNKWLMINIQNVQDFA 	                  .         .         .         .         .  
						CQCLNRDVWSNEAVKNIIREHFIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKL 	      32 KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPI 81                                                           
						VEWHQLDVSSFLDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ETHFDSTQTKQDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKSPHKDLGHRK 	       1 KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPI 50                                                           
						EENRRPLTEPPVRTDPGTATNHQGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRY 	                  .         .         .         .         .  
						PDGKREQITLPEQAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCP 	      82 PQKQEILVEPEPLFG......................VRQEQELRNGGAI 109                                                          
						QETVFVQERN                                                   	         |||||||||||||||                      :||||||||||||  
						being at least 90 % homologous to corresponding to amino     	      51 PQKQEILVEPEPLFGAPKRRRPARSIFDGFRDFQTETIRQEQELRNGGAI 100                                                          
						acids 89 - 458 of Q8N327, which also corresponds to amino    	                  .         .         .         .         .  
						acids 98 - 467 of T09369_P5, wherein said first amino acid   	     110 DKKLTTLADLFRPPIDLMHKGSFETAKECGQMQNKWLMINIQNVQDFACQ 159                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	     101 DKKLTTLADLFRPPIDLMHKGSFETAKECGQMQNKWLMINIQNVQDFACQ 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of T09369_P5, comprising a polypeptide being at least   	     160 CLNRDVWSNEAVKNIIREHFIFWQVYHDSEEGQRYIQFYKLGDFPYVSIL 209                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 CLNRDVWSNEAVKNIIREHFIFWQVYHDSEEGQRYIQFYKLGDFPYVSIL 200                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MAAHGGSAASSALKGLIQQFTTITGASESVG of T09369_P5.3.An isolated   	     210 DPRTGQKLVEWHQLDVSSFLDQVTGFLGEHGQLDGLSSSPPKKCARSESL 259                                                          
						polypeptide encoding for an edge portion of T09369_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     201 DPRTGQKLVEWHQLDVSSFLDQVTGFLGEHGQLDGLSSSPPKKCARSESL 250                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     260 IDASEDSQLEAAIRASLQETHFDSTQTKQDSRSDEESESELFSGSEEFIS 309                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     251 IDASEDSQLEAAIRASLQETHFDSTQTKQDSRSDEESESELFSGSEEFIS 300                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise GVR having a structure as follows (numbering        	     310 VCGSDEEEEVENLAKSRKSPHKDLGHRKEENRRPLTEPPVRTDPGTATNH 359                                                          
						according to T09369_P5): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 96-x to 96; and ending at any of amino    	     301 VCGSDEEEEVENLAKSRKSPHKDLGHRKEENRRPLTEPPVRTDPGTATNH 350                                                          
						acid numbers 98 + ((n-2) - x), in which x varies from 0 to   	                  .         .         .         .         .  
						n-2.                                                         	     360 QGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRYPDGKREQITLPE 409                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRYPDGKREQITLPE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     410 QAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCPQE 459                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 QAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCPQE 450                                                          
						                                                            	                                                             
						                                                            	     460 TVFVQERN                                           467                                                          
						                                                            	         ||||||||                                            
						                                                            	     451 TVFVQERN                                           458                                                          

						Comparison report between T09369_P5 and O94888partial WT     	Sequence name: O94888                                        
						sequence featuring skipped exon plus extra amino acids.1.An  	                                                            
						isolated chimeric polypeptide encoding for T09369_P5,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEPS 	Alignment of: 15229 x O94888   ..                            
						TSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG                         	                                                            
						homologous to corresponding to amino acids 2 - 97 of O94888, 	Alignment segment 1/1:                                       
						which also corresponds to amino acids 1 - 96 of T09369_P5, a 	                                                            
						second amino acid sequence bridging amino acid sequence      	                     Quality: 4483.00                      Escore:       0                                               
						comprising of V, and a third amino acid sequence being at    	             Matching length:     467                Total length:     489                                               
						RQEQELRNGGAIDKKLTTLADLFRPPIDLMHKGSFETAKECGQMQNKWLMINIQNVQDFA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						CQCLNRDVWSNEAVKNIIREHFIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKL 	    Total Percent Similarity:   95.50      Total Percent Identity:   95.30                                               
						VEWHQLDVSSFLDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQ 	                        Gaps:       1                        
						ETHFDSTQTKQDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKSPHKDLGHRK 	                                                            
						EENRRPLTEPPVRTDPGTATNHQGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRY 	Alignment:                                                   
						PDGKREQITLPEQAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCP 	                  .         .         .         .         .  
						QETVFVQERN                                                   	       1 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 50                                                           
						least 90 % homologous to corresponding to amino acids 121 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						490 of O94888, which also corresponds to amino acids 98 - 467	       2 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 51                                                           
						of T09369_P5, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	      51 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG.... 96                                                           
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||      
						polypeptide encoding for an edge portion of T09369_P5,       	      52 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFGAPKR 101                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	      97 ..................VRQEQELRNGGAIDKKLTTLADLFRPPIDLMH 128                                                          
						about 20 amino acids in length, preferably at least about 30 	                           :|||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     102 RRPARSIFDGFRDFQTETIRQEQELRNGGAIDKKLTTLADLFRPPIDLMH 151                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     129 KGSFETAKECGQMQNKWLMINIQNVQDFACQCLNRDVWSNEAVKNIIREH 178                                                          
						comprise GVR having a structure as follows (numbering        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						according to T09369_P5): a sequence starting from any of     	     152 KGSFETAKECGQMQNKWLMINIQNVQDFACQCLNRDVWSNEAVKNIIREH 201                                                          
						amino acid numbers 96-x to 96; and ending at any of amino    	                  .         .         .         .         .  
						acid numbers 98 + ((n-2) - x), in which x varies from 0 to   	     179 FIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKLVEWHQLDVSSF 228                                                          
						n-2.                                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 FIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKLVEWHQLDVSSF 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     229 LDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQE 278                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 LDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQE 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     279 THFDSTQTKQDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKS 328                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 THFDSTQTKQDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKS 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     329 PHKDLGHRKEENRRPLTEPPVRTDPGTATNHQGLPAVDSEILEMPPEKAD 378                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 PHKDLGHRKEENRRPLTEPPVRTDPGTATNHQGLPAVDSEILEMPPEKAD 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     379 GVVEGIDVNGPKAQLMLRYPDGKREQITLPEQAKLLALVKHVQSKGYPNE 428                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 GVVEGIDVNGPKAQLMLRYPDGKREQITLPEQAKLLALVKHVQSKGYPNE 451                                                          
						                                                            	                  .         .         .                      
						                                                            	     429 RFELLTNFPRRKLSHLDYDITLQEAGLCPQETVFVQERN            467                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     452 RFELLTNFPRRKLSHLDYDITLQEAGLCPQETVFVQERN            490                                                          

						Comparison report between T09369_P5 and AAH47420partial WT   	Sequence name: AAH47420                                      
						sequence featuring skipped exon plus extra amino acids and a 	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for T09369_P5, comprising a first amino acid        	                                                            
						MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEPS 	Alignment of: 15229 x AAH47420   ..                          
						TSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG                         	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 96 of AAH47420, which also corresponds to    	                                                            
						amino acids 1 - 96 of T09369_P5, a second amino acid sequence	                     Quality: 2717.00                      Escore:       0                                               
						bridging amino acid sequence comprising of V, a third amino  	             Matching length:     287                Total length:     309                                               
						RQEQELRNGGAIDKKLTTLADLFRPPIDLMHKGSFETAKECGQMQNKWLMINIQNVQDFA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						CQCLNRDVWSNEAVKNIIREHFIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKL 	    Total Percent Similarity:   92.88      Total Percent Identity:   92.56                                               
						VEWHQLDVSSFLDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQ 	                        Gaps:       1                        
						ETHFDSTQTK                                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment:                                                   
						to amino acids 120 - 309 of AAH47420, which also corresponds 	                  .         .         .         .         .  
						to amino acids 98 - 287 of T09369_P5, and a fourth amino acid	       1 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						QDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKSPHKDLGHRKEENRRPLTEP 	      51 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG.... 96                                                           
						PVRTDPGTATNHQGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRYPDGKREQITL 	         ||||||||||||||||||||||||||||||||||||||||||||||      
						PEQAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCPQETVFVQERN 	      51 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFGAPKR 100                                                          
						having the sequence corresponding to amino acids 288 - 467 of	                  .         .         .         .         .  
						T09369_P5, wherein said first amino acid sequence, second    	      97 ..................VRQEQELRNGGAIDKKLTTLADLFRPPIDLMH 128                                                          
						amino acid sequence, third amino acid sequence and fourth    	                           :|||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     101 RRPARSIFDGFRDFQTETIRQEQELRNGGAIDKKLTTLADLFRPPIDLMH 150                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	                  .         .         .         .         .  
						of T09369_P5, comprising a polypeptide having a length "n",  	     129 KGSFETAKECGQMQNKWLMINIQNVQDFACQCLNRDVWSNEAVKNIIREH 178                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     151 KGSFETAKECGQMQNKWLMINIQNVQDFACQCLNRDVWSNEAVKNIIREH 200                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     179 FIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKLVEWHQLDVSSF 228                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise GVR having a structure as  	     201 FIFWQVYHDSEEGQRYIQFYKLGDFPYVSILDPRTGQKLVEWHQLDVSSF 250                                                          
						follows (numbering according to T09369_P5): a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 96-x to 96; and      	     229 LDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQE 278                                                          
						ending at any of amino acid numbers 98 + ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.3.An isolated polypeptide       	     251 LDQVTGFLGEHGQLDGLSSSPPKKCARSESLIDASEDSQLEAAIRASLQE 300                                                          
						encoding for a tail of T09369_P5, comprising a polypeptide   	                                                             
						being at least 70%, optionally at least about 80%, preferably	     279 THFDSTQTK                                          287                                                          
						at least about 85%, more preferably at least about 90% and   	         |||||||||                                           
						QDSRSDEESESELFSGSEEFISVCGSDEEEEVENLAKSRKSPHKDLGHRKEENRRPLTEP 	     301 THFDSTQTK                                          309                                                          
						PVRTDPGTATNHQGLPAVDSEILEMPPEKADGVVEGIDVNGPKAQLMLRYPDGKREQITL 	                                                            
						PEQAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITLQEAGLCPQETVFVQERN 	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in T09369_P5.                                                	                                                            

15231	HMR136_T09369_9_tr0_r1_1_gPRT		Comparison report between T09369_P9 and Q8N327unique head    	Sequence name: Q8N327                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09369_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15231 x Q8N327   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EVGEGSPCVSVLLFGGGGGGKMAAHGGSAASSALKGLIQQFTTITGASESVG         	                                                            
						corresponding to amino acids 1 - 52 of T09369_P9, a second   	                     Quality:  636.00                      Escore:       0                                               
						KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEP 	             Matching length:      65                Total length:      65                                               
						EPLFG                                                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 65 of Q8N327, which also    	                        Gaps:       0                        
						corresponds to amino acids 53 - 117 of T09369_P9, and a third	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	      53 KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPI 102                                                          
						having the sequence GKFTFFP corresponding to amino acids 118 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 124 of T09369_P9, wherein said first amino acid sequence,  	       1 KHMLEACNNNLEMAVTMFLDGGGIAEEPSTSSASVSTVRPHTEEEVRAPI 50                                                           
						second amino acid sequence and third amino acid sequence are 	                  .                                          
						contiguous and in a sequential order.2.An isolated           	     103 PQKQEILVEPEPLFG                                    117                                                          
						polypeptide encoding for a head of T09369_P9, comprising a   	         |||||||||||||||                                     
						polypeptide being at least 70%, optionally at least about    	      51 PQKQEILVEPEPLFG                                    65                                                           
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence                                              	                                                            
						EVGEGSPCVSVLLFGGGGGGKMAAHGGSAASSALKGLIQQFTTITGASESVG of      	                                                            
						T09369_P9.3.An isolated polypeptide encoding for a tail of   	                                                            
						T09369_P9, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence GKFTFFP in        	                                                            
						T09369_P9.                                                   	                                                            

						Comparison report between T09369_P9 and O94888unique head    	Sequence name: O94888                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09369_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15231 x O94888   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EVGEGSPCVSVLLFGGGGGG corresponding to amino acids 1 - 20 of  	                                                            
						T09369_P9, a second amino acid sequence being at least 90 %  	                     Quality:  929.00                      Escore:       0                                               
						KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEP 	             Matching length:      97                Total length:      97                                               
						STSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 1 - 97 of O94888, 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						which also corresponds to amino acids 21 - 117 of T09369_P9, 	                        Gaps:       0                        
						and a third amino acid sequence being at least 70%,          	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence GKFTFFP      	      21 KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMF 70                                                           
						corresponding to amino acids 118 - 124 of T09369_P9, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 KMAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMF 50                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .            
						sequential order.2.An isolated polypeptide encoding for a    	      71 LDGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG    117                                                          
						head of T09369_P9, comprising a polypeptide being at least   	         |||||||||||||||||||||||||||||||||||||||||||||||     
						70%, optionally at least about 80%, preferably at least about	      51 LDGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG    97                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						EVGEGSPCVSVLLFGGGGGG of T09369_P9.3.An isolated polypeptide  	                                                            
						encoding for a tail of T09369_P9, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						GKFTFFP in T09369_P9.                                        	                                                            

						Comparison report between T09369_P9 and AAH47420unique head  	Sequence name: AAH47420                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09369_P9, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15231 x AAH47420   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						EVGEGSPCVSVLLFGGGGGGK corresponding to amino acids 1 - 21 of 	                                                            
						T09369_P9, a second amino acid sequence being at least 90 %  	                     Quality:  919.00                      Escore:       0                                               
						MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFLDGGGIAEEPS 	             Matching length:      96                Total length:      96                                               
						TSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 1 - 96 of         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AAH47420, which also corresponds to amino acids 22 - 117 of  	                        Gaps:       0                        
						T09369_P9, and a third amino acid sequence being at least    	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence GKFTFFP      	      22 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 71                                                           
						corresponding to amino acids 118 - 124 of T09369_P9, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 MAAHGGSAASSALKGLIQQFTTITGASESVGKHMLEACNNNLEMAVTMFL 50                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .            
						sequential order.2.An isolated polypeptide encoding for a    	      72 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG     117                                                          
						head of T09369_P9, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||      
						70%, optionally at least about 80%, preferably at least about	      51 DGGGIAEEPSTSSASVSTVRPHTEEEVRAPIPQKQEILVEPEPLFG     96                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						EVGEGSPCVSVLLFGGGGGGK of T09369_P9.3.An isolated polypeptide 	                                                            
						encoding for a tail of T09369_P9, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						GKFTFFP in T09369_P9.                                        	                                                            

7122	HMR136_T09370_1_tr0_r1_1_gPRT		Comparison report between T09370_P1 and DUS7_HUMANunique     	Sequence name: DUS7_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09370_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7122 x DUS7_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGAMPCKSAEWL 	Alignment segment 1/1:                                       
						QEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGL                      	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2146.00                      Escore:       0                                               
						to amino acids 1 - 99 of T09370_P1, a second amino acid      	             Matching length:     218                Total length:     218                                               
						MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGAPASVLGLLLQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSSPPTSVLGLGGLRISSDCSDG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ESDRELPSSATESDGSPVPSSQPAFPVQILPYLYLGCAKDSTNLDVLGKYGIKYILNVTP 	                        Gaps:       0                        
						NLPNAFEHGGEFTYKQIPISDHWSQNLSQFFPEAISFI                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 218 of DUS7_HUMAN, which also corresponds to 	                  .         .         .         .         .  
						amino acids 100 - 317 of T09370_P1, and a third amino acid   	     100 MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGA 149                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GSLKEAPP corresponding to amino acids 318	     150 PASVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSS 199                                                          
						- 325 of T09370_P1, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 PASVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSS 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09370_P1, comprising a   	     200 PPTSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQIL 249                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 PPTSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQIL 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGAMPCKSAEWL 	     250 PYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPIS 299                                                          
						QEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGL                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T09370_P1.3.An isolated polypeptide       	     151 PYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPIS 200                                                          
						encoding for a tail of T09370_P1, comprising a polypeptide   	                  .                                          
						being at least 70%, optionally at least about 80%, preferably	     300 DHWSQNLSQFFPEAISFI                                 317                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||                                  
						most preferably at least about 95% homologous to the sequence	     201 DHWSQNLSQFFPEAISFI                                 218                                                          
						GSLKEAPP in T09370_P1.                                       	                                                            

						Comparison report between T09370_P1 and AAH19107unique head  	Sequence name: AAH19107                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09370_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7122 x AAH19107   ..                           
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGAMPCKSAEWL 	Alignment segment 1/1:                                       
						QEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGL                      	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2146.00                      Escore:       0                                               
						to amino acids 1 - 99 of T09370_P1, a second amino acid      	             Matching length:     218                Total length:     218                                               
						MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGAPASVLGLLLQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSSPPTSVLGLGGLRISSDCSDG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ESDRELPSSATESDGSPVPSSQPAFPVQILPYLYLGCAKDSTNLDVLGKYGIKYILNVTP 	                        Gaps:       0                        
						NLPNAFEHGGEFTYKQIPISDHWSQNLSQFFPEAISFI                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 218 of AAH19107, which also corresponds to   	                  .         .         .         .         .  
						amino acids 100 - 317 of T09370_P1, and a third amino acid   	     100 MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGA 149                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MLRRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence GSLKEAPP corresponding to amino acids 318	     150 PASVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSS 199                                                          
						- 325 of T09370_P1, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 PASVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSS 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09370_P1, comprising a   	     200 PPTSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQIL 249                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 PPTSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQIL 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGAMPCKSAEWL 	     250 PYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPIS 299                                                          
						QEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGL                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T09370_P1.3.An isolated polypeptide       	     151 PYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPIS 200                                                          
						encoding for a tail of T09370_P1, comprising a polypeptide   	                  .                                          
						being at least 70%, optionally at least about 80%, preferably	     300 DHWSQNLSQFFPEAISFI                                 317                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||                                  
						most preferably at least about 95% homologous to the sequence	     201 DHWSQNLSQFFPEAISFI                                 218                                                          
						GSLKEAPP in T09370_P1.                                       	                                                            

						Comparison report between T09370_P1 and Q8NFJ0unique head    	Sequence name: Q8NFJ0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09370_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 7122 x Q8NFJ0   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGA          	                                                            
						corresponding to amino acids 1 - 51 of T09370_P1, a second   	                     Quality: 2616.00                      Escore:       0                                               
						MPCKSAEWLQEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGLMLRRLRKGNLPI 	             Matching length:     266                Total length:     266                                               
						RSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGAPASVLGLLLQKLRDDGCQAYYL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QGGFNKFQTEYSEHCETNVDSSSSPSSSPPTSVLGLGGLRISSDCSDGESDRELPSSATE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SDGSPVPSSQPAFPVQILPYLYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEF 	                        Gaps:       0                        
						TYKQIPISDHWSQNLSQFFPEAISFI                                   	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 1 - 266 of Q8NFJ0, which also   	                  .         .         .         .         .  
						corresponds to amino acids 52 - 317 of T09370_P1, and a third	      52 MPCKSAEWLQEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGLML 101                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MPCKSAEWLQEELEARGGASLLLLDCRPHELFESSHIETAINLAIPGLML 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence GSLKEAPP corresponding to amino acids 318	     102 RRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGAPA 151                                                          
						- 325 of T09370_P1, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	      51 RRLRKGNLPIRSIIPNHADKERFATRCKAATVLLYDEATAEWQPEPGAPA 100                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T09370_P1, comprising a   	     152 SVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSSPP 201                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     101 SVLGLLLQKLRDDGCQAYYLQGGFNKFQTEYSEHCETNVDSSSSPSSSPP 150                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     202 TSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQILPY 251                                                          
						MKNQLRGPPARAHMSTSGAAAAGGTRAGSEPGAGSGSGAGTGAGAATGAGA of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09370_P1.3.An isolated polypeptide encoding for a tail of   	     151 TSVLGLGGLRISSDCSDGESDRELPSSATESDGSPVPSSQPAFPVQILPY 200                                                          
						T09370_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     252 LYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPISDH 301                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence GSLKEAPP in       	     201 LYLGCAKDSTNLDVLGKYGIKYILNVTPNLPNAFEHGGEFTYKQIPISDH 250                                                          
						T09370_P1.                                                   	                  .                                          
						                                                            	     302 WSQNLSQFFPEAISFI                                   317                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     251 WSQNLSQFFPEAISFI                                   266                                                          

7330	HMR136_T09375_2_tr0_r1_1_gPRT		Comparison report between T09375_P2 and AAC31938unique head  	Sequence name: AAC31938                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09375_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7330 x AAC31938   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE           	                                                            
						corresponding to amino acids 1 - 50 of T09375_P2, and a      	                     Quality: 1182.00                      Escore:       0                                               
						AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATAAVYSAAILEY 	             Matching length:     127                Total length:     127                                               
						LTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KGQQKTA                                                      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 2 - 128 of AAC31938, which also 	                                                            
						corresponds to amino acids 51 - 177 of T09375_P2, wherein    	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      51 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 100                                                          
						polypeptide encoding for a head of T09375_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       2 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 51                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 150                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE of        	      52 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 101                                                          
						T09375_P2.                                                   	                  .         .                                
						                                                            	     151 KATIAGGGVIPHIHKSLIGKKGQQKTA                        177                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     102 KATIAGGGVIPHIHKSLIGKKGQQKTA                        128                                                          

						Comparison report between T09375_P2 and AAH04274unique head  	Sequence name: AAH04274                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09375_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7330 x AAH04274   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE           	                                                            
						corresponding to amino acids 1 - 50 of T09375_P2, and a      	                     Quality: 1182.00                      Escore:       0                                               
						AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATAAVYSAAILEY 	             Matching length:     127                Total length:     127                                               
						LTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KGQQKTA                                                      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 2 - 128 of AAH04274, which also 	                                                            
						corresponds to amino acids 51 - 177 of T09375_P2, wherein    	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      51 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 100                                                          
						polypeptide encoding for a head of T09375_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       2 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 51                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 150                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE of        	      52 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 101                                                          
						T09375_P2.                                                   	                  .         .                                
						                                                            	     151 KATIAGGGVIPHIHKSLIGKKGQQKTA                        177                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     102 KATIAGGGVIPHIHKSLIGKKGQQKTA                        128                                                          

						Comparison report between T09375_P2 and AAH00098unique head  	Sequence name: AAH00098                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09375_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7330 x AAH00098   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE           	                                                            
						corresponding to amino acids 1 - 50 of T09375_P2, and a      	                     Quality: 1182.00                      Escore:       0                                               
						AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATAAVYSAAILEY 	             Matching length:     127                Total length:     127                                               
						LTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KGQQKTA                                                      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 2 - 128 of AAH00098, which also 	                                                            
						corresponds to amino acids 51 - 177 of T09375_P2, wherein    	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      51 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 100                                                          
						polypeptide encoding for a head of T09375_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       2 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 51                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 150                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE of        	      52 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 101                                                          
						T09375_P2.                                                   	                  .         .                                
						                                                            	     151 KATIAGGGVIPHIHKSLIGKKGQQKTA                        177                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     102 KATIAGGGVIPHIHKSLIGKKGQQKTA                        128                                                          

						Comparison report between T09375_P2 and AAH14885unique head  	Sequence name: AAH14885                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09375_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 7330 x AAH14885   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE           	                                                            
						corresponding to amino acids 1 - 50 of T09375_P2, and a      	                     Quality: 1182.00                      Escore:       0                                               
						AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATAAVYSAAILEY 	             Matching length:     127                Total length:     127                                               
						LTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KGQQKTA                                                      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 2 - 128 of AAH14885, which also 	                                                            
						corresponds to amino acids 51 - 177 of T09375_P2, wherein    	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      51 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 100                                                          
						polypeptide encoding for a head of T09375_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       2 AGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATA 51                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     101 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 150                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVRTSKTSGHWPQQREAGTGYCPAPAAAVGAARAAAAARVGSGRARGRAE of        	      52 AVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLI 101                                                          
						T09375_P2.                                                   	                  .         .                                
						                                                            	     151 KATIAGGGVIPHIHKSLIGKKGQQKTA                        177                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     102 KATIAGGGVIPHIHKSLIGKKGQQKTA                        128                                                          

17259	HMR136_T09399_11_tr0_r1_1_gPRT		Comparison report between T09399_P11 and STX5_HUMANunique    	Sequence name: STX5_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09399_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17259 x STX5_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT       	                                                            
						corresponding to amino acids 1 - 54 of T09399_P11, a second  	                     Quality: 1207.00                      Escore:       0                                               
						MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKDLSNTFAKLEK 	             Matching length:     126                Total length:     126                                               
						LTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQDFVRAKGSQSGRHLQTHSNT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IVVSLQ                                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 1 - 126 of STX5_HUMAN, which    	                                                            
						also corresponds to amino acids 55 - 180 of T09399_P11, and a	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      55 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 104                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	       1 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 50                                                           
						VGPGEEGREAKRKNVEPSLVDPLSFSSSRNWLLCPMTSNRF corresponding to   	                  .         .         .         .         .  
						amino acids 181 - 221 of T09399_P11, wherein said first amino	     105 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 154                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	      51 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 100                                                          
						isolated polypeptide encoding for a head of T09399_P11,      	                  .         .                                
						comprising a polypeptide being at least 70%, optionally at   	     155 DFVRAKGSQSGRHLQTHSNTIVVSLQ                         180                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||                          
						preferably at least about 90% and most preferably at least   	     101 DFVRAKGSQSGRHLQTHSNTIVVSLQ                         126                                                          
						about 95% homologous to the sequence                         	                                                            
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT of    	                                                            
						T09399_P11.3.An isolated polypeptide encoding for a tail of  	                                                            
						T09399_P11, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VGPGEEGREAKRKNVEPSLVDPLSFSSSRNWLLCPMTSNRF in T09399_P11.     	                                                            

17261	HMR136_T09399_4_tr0_r1_1_gPRT		Comparison report between T09399_P4 and STX5_HUMANunique     	Sequence name: STX5_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09399_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17261 x STX5_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT       	                                                            
						corresponding to amino acids 1 - 54 of T09399_P4, and a      	                     Quality: 2876.00                      Escore:       0                                               
						MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKDLSNTFAKLEK 	             Matching length:     301                Total length:     301                                               
						LTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQDFVRAKGSQSGRHLQTHSNT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IVVSLQSKLASMSNDFKSVLEVRTENLKQQRSRREQFSRAPVSALPLAPNHLGGGAVVLG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AESHASKDVAIDMMDSRTSQQLQLIDEQDSYIQSRADTMQNIESTIVELGSIFQQLAHMV 	                        Gaps:       0                        
						KEQEETIQRIDENVLGAQLDVEAAHSEILKYFQSVTSNRWLMVKIFLILIVFFIIFVVFL 	                                                            
						A                                                            	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 1 - 301 of STX5_HUMAN, which    	      55 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 104                                                          
						also corresponds to amino acids 55 - 355 of T09399_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	       1 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T09399_P4,       	     105 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 154                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	      51 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 100                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     155 DFVRAKGSQSGRHLQTHSNTIVVSLQSKLASMSNDFKSVLEVRTENLKQQ 204                                                          
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09399_P4.                                                   	     101 DFVRAKGSQSGRHLQTHSNTIVVSLQSKLASMSNDFKSVLEVRTENLKQQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     205 RSRREQFSRAPVSALPLAPNHLGGGAVVLGAESHASKDVAIDMMDSRTSQ 254                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RSRREQFSRAPVSALPLAPNHLGGGAVVLGAESHASKDVAIDMMDSRTSQ 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     255 QLQLIDEQDSYIQSRADTMQNIESTIVELGSIFQQLAHMVKEQEETIQRI 304                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 QLQLIDEQDSYIQSRADTMQNIESTIVELGSIFQQLAHMVKEQEETIQRI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     305 DENVLGAQLDVEAAHSEILKYFQSVTSNRWLMVKIFLILIVFFIIFVVFL 354                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DENVLGAQLDVEAAHSEILKYFQSVTSNRWLMVKIFLILIVFFIIFVVFL 300                                                          
						                                                            	                                                             
						                                                            	     355 A                                                  355                                                          
						                                                            	         |                                                   
						                                                            	     301 A                                                  301                                                          

17263	HMR136_T09399_8_tr0_r1_1_gPRT		Comparison report between T09399_P8 and STX5_HUMANunique     	Sequence name: STX5_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T09399_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17263 x STX5_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT       	                                                            
						corresponding to amino acids 1 - 54 of T09399_P8, a second   	                     Quality: 1207.00                      Escore:       0                                               
						MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKDLSNTFAKLEK 	             Matching length:     126                Total length:     126                                               
						LTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQDFVRAKGSQSGRHLQTHSNT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IVVSLQ                                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 1 - 126 of STX5_HUMAN, which    	                                                            
						also corresponds to amino acids 55 - 180 of T09399_P8, and a 	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      55 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 104                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	       1 MSCRDRTQEFLSACKSLQTRQNGIQTNKPALRAVRQRSEFTLMAKRIGKD 50                                                           
						VGPGEEGREAKRKNVEPSLVDPLSFSSSRNWLLCPMTSNRF corresponding to   	                  .         .         .         .         .  
						amino acids 181 - 221 of T09399_P8, wherein said first amino 	     105 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 154                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	      51 LSNTFAKLEKLTILAKRKSLFDDKAVEIEELTYIIKQDINSLNKQIAQLQ 100                                                          
						isolated polypeptide encoding for a head of T09399_P8,       	                  .         .                                
						comprising a polypeptide being at least 70%, optionally at   	     155 DFVRAKGSQSGRHLQTHSNTIVVSLQ                         180                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||                          
						preferably at least about 90% and most preferably at least   	     101 DFVRAKGSQSGRHLQTHSNTIVVSLQ                         126                                                          
						about 95% homologous to the sequence                         	                                                            
						MIPRKRYGSKNTDQGVYLGLSKTQVLSPATAGSSSSDIAPLPPPVTLVPPPPDT of    	                                                            
						T09399_P8.3.An isolated polypeptide encoding for a tail of   	                                                            
						T09399_P8, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						VGPGEEGREAKRKNVEPSLVDPLSFSSSRNWLLCPMTSNRF in T09399_P8.      	                                                            

27761	HMR136_T09415_8_tr0_r1_1_gPRT		Comparison report between T09415_P8 and CRK_HUMANpartial WT  	Sequence name: CRK_HUMAN                                     
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for T09415_P8, comprising a first amino 	Sequence documentation:                                      
						MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHY 	                                                            
						IINSSGPRPPVPPSPAQPPPG                                        	Alignment of: 27761 x CRK_HUMAN   ..                         
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 81 of CRK_HUMAN, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 81 of T09415_P8, and a second amino acid     	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality:  809.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:      81                Total length:      81                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence R corresponding to amino acids 82 - 82 of	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						T09415_P8, wherein said first amino acid sequence and second 	                        Gaps:       0                        
						amino acid sequence are contiguous and in a sequential order.	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLS 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLS 50                                                           
						                                                            	                  .         .         .                      
						                                                            	      51 VSENSRVSHYIINSSGPRPPVPPSPAQPPPG                    81                                                           
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	      51 VSENSRVSHYIINSSGPRPPVPPSPAQPPPG                    81                                                           

9239	HMR136_T09419_12_tr0_r1_1_gPRT		Comparison report between T09419_P12 and PDX5_HUMANpartial   	Sequence name: PDX5_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09419_P12, comprising a first amino	Sequence documentation:                                      
						MGLAGVCALRRSAGYILVGGAGGQSAAAAARRCSEGEWASGGVRSFSRAAAAMAPIKVGD 	                                                            
						AIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGV 	Alignment of: 9239 x PDX5_HUMAN   ..                         
						QV                                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 122 of PDX5_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 122 of T09419_P12, and a second amino acid	                     Quality: 1567.00                      Escore:       0                                               
						sequence being at least 90 % homologous to                   	             Matching length:     177                Total length:     214                                               
						ETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 160 - 214 of PDX5_HUMAN, which  	    Total Percent Similarity:   82.71      Total Percent Identity:   82.71                                               
						also corresponds to amino acids 123 - 177 of T09419_P12,     	                        Gaps:       1                        
						wherein said first amino acid sequence and second amino acid 	                                                            
						sequence are contiguous and in a sequential order.2.An       	Alignment:                                                   
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						T09419_P12, comprising a polypeptide having a length "n",    	       1 MGLAGVCALRRSAGYILVGGAGGQSAAAAARRCSEGEWASGGVRSFSRAA 50                                                           
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	       1 MGLAGVCALRRSAGYILVGGAGGQSAAAAARRCSEGEWASGGVRSFSRAA 50                                                           
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	      51 AAMAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGC 100                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise VE, having a structure as  	      51 AAMAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGC 100                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						122-x to 123; and ending at any of amino acid numbers 123+   	     101 SKTHLPGFVEQAEALKAKGVQV............................ 122                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||                              
						                                                            	     101 SKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     123 .........ETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGT 163                                                          
						                                                            	                  |||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGT 200                                                          
						                                                            	                  .                                          
						                                                            	     164 GLTCSLAPNIISQL                                     177                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     201 GLTCSLAPNIISQL                                     214                                                          

6697	HMR136_T09431_6_tr0_r1_1_gPRT		Comparison report between T09431_P6 and DYI1_HUMANpartial WT 	Sequence name: DYI1_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T09431_P6, comprising a first amino 	Sequence documentation:                                      
						MSDKSDLKAELERKKQRLAQIREEKKRKEEERKKKEADMQQKKEPVQDDSDLDRKRRETE 	                                                            
						ALLQSIGISPEPPL                                               	Alignment of: 6697 x DYI1_HUMAN   ..                         
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 74 of DYI1_HUMAN, which also corresponds  	Alignment segment 1/1:                                       
						to amino acids 1 - 74 of T09431_P6, and a second amino acid  	                                                            
						VSTPSEAGSQDSGDLGPLTRTLQWDTDPSVLQLQSDSELGRRLHKLGVSKVTQVDFLPRE 	                     Quality: 6005.00                      Escore:       0                                               
						VVSYSKETQTPLATHQSEEDEEDEEMVESKVGQDSELENQDKKQEVKEAPPRELTEEEKQ 	             Matching length:     617                Total length:     645                                               
						QILHSEEFLIFFDRTIRVIERALAEDSDIFFDYSGRELEEKDGDVQAGANLSFNRQFYDE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HWSKHRVVTCMDWSLQYPELMVASYNNNEDAPHEPDGVALVWNMKFKKTTPEYVFHCQSS 	    Total Percent Similarity:   95.66      Total Percent Identity:   95.66                                               
						VMSVCFARFHPNLVVGGTYSGQIVLWDNRSHRRTPVQRTPLSAAAHTHPVYCVNVVGTQN 	                        Gaps:       1                        
						AHNLITVSTDGKMCSWSLDMLSTPQESMELVYNKSKPVAVTGMAFPTGDVNNFVVGSEEG 	                                                            
						TVYTACRHGSKAGIGEVFEGHQGPVTGINCHMAVGPIDFSHLFVTSSFDWTVKLWTTKHN 	Alignment:                                                   
						KPLYSFEDNADYVYDVMWSPVHPALFACVDGMGRLDLWNLNNDTEVPTASVAIEGASALN 	                  .         .         .         .         .  
						RVRWAQAGKEVAVGDSEGRIWVYDVGELAVPHNDEWTRFARTLVEIRANRADSEEEGTVE 	       1 MSDKSDLKAELERKKQRLAQIREEKKRKEEERKKKEADMQQKKEPVQDDS 50                                                           
						LSA                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MSDKSDLKAELERKKQRLAQIREEKKRKEEERKKKEADMQQKKEPVQDDS 50                                                           
						amino acids 103 - 645 of DYI1_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 75 - 617 of T09431_P6, wherein said first     	      51 DLDRKRRETEALLQSIGISPEPPL.......................... 74                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||                            
						contiguous and in a sequential order.2.An isolated chimeric  	      51 DLDRKRRETEALLQSIGISPEPPLVQPLHFLTWDTCYFHYLVPTPMSPSS 100                                                          
						polypeptide encoding for an edge portion of T09431_P6,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	      75 ..VSTPSEAGSQDSGDLGPLTRTLQWDTDPSVLQLQSDSELGRRLHKLGV 122                                                          
						least about 10 amino acids in length, optionally at least    	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     101 KSVSTPSEAGSQDSGDLGPLTRTLQWDTDPSVLQLQSDSELGRRLHKLGV 150                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     123 SKVTQVDFLPREVVSYSKETQTPLATHQSEEDEEDEEMVESKVGQDSELE 172                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise LV, having a structure as follows: a sequence       	     151 SKVTQVDFLPREVVSYSKETQTPLATHQSEEDEEDEEMVESKVGQDSELE 200                                                          
						starting from any of amino acid numbers 74-x to 75; and      	                  .         .         .         .         .  
						ending at any of amino acid numbers 75+ ((n-2) - x), in which	     173 NQDKKQEVKEAPPRELTEEEKQQILHSEEFLIFFDRTIRVIERALAEDSD 222                                                          
						x varies from 0 to n-2.                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NQDKKQEVKEAPPRELTEEEKQQILHSEEFLIFFDRTIRVIERALAEDSD 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     223 IFFDYSGRELEEKDGDVQAGANLSFNRQFYDEHWSKHRVVTCMDWSLQYP 272                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IFFDYSGRELEEKDGDVQAGANLSFNRQFYDEHWSKHRVVTCMDWSLQYP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     273 ELMVASYNNNEDAPHEPDGVALVWNMKFKKTTPEYVFHCQSSVMSVCFAR 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ELMVASYNNNEDAPHEPDGVALVWNMKFKKTTPEYVFHCQSSVMSVCFAR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 FHPNLVVGGTYSGQIVLWDNRSHRRTPVQRTPLSAAAHTHPVYCVNVVGT 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FHPNLVVGGTYSGQIVLWDNRSHRRTPVQRTPLSAAAHTHPVYCVNVVGT 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 QNAHNLITVSTDGKMCSWSLDMLSTPQESMELVYNKSKPVAVTGMAFPTG 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 QNAHNLITVSTDGKMCSWSLDMLSTPQESMELVYNKSKPVAVTGMAFPTG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 DVNNFVVGSEEGTVYTACRHGSKAGIGEVFEGHQGPVTGINCHMAVGPID 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DVNNFVVGSEEGTVYTACRHGSKAGIGEVFEGHQGPVTGINCHMAVGPID 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     473 FSHLFVTSSFDWTVKLWTTKHNKPLYSFEDNADYVYDVMWSPVHPALFAC 522                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 FSHLFVTSSFDWTVKLWTTKHNKPLYSFEDNADYVYDVMWSPVHPALFAC 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     523 VDGMGRLDLWNLNNDTEVPTASVAIEGASALNRVRWAQAGKEVAVGDSEG 572                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VDGMGRLDLWNLNNDTEVPTASVAIEGASALNRVRWAQAGKEVAVGDSEG 600                                                          
						                                                            	                  .         .         .         .            
						                                                            	     573 RIWVYDVGELAVPHNDEWTRFARTLVEIRANRADSEEEGTVELSA      617                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     601 RIWVYDVGELAVPHNDEWTRFARTLVEIRANRADSEEEGTVELSA      645                                                          

15347	HMR136_T09435_6_tr0_r1_1_gPRT		Comparison report between T09435_P6 and Q13042partial WT     	Sequence name: Q13042                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T09435_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRG corresponding to 	Alignment of: 15347 x Q13042   ..                            
						amino acids 94 - 136 of Q13042, which also corresponds to    	                                                            
						amino acids 1 - 43 of T09435_P6, a bridging amino acid K     	Alignment segment 1/1:                                       
						corresponding to amino acid 44 of T09435_P6, and a second    	                                                            
						IYDALDNRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLCNEEQ 	                     Quality: 5212.00                      Escore:       0                                               
						ELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYNCDFKMCYKLTSVVM 	             Matching length:     526                Total length:     526                                               
						EKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDLYPSNPVSWFAVGCYYLMVGHKNEH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.81                                               
						ARRYLSKATTLEKTYGPAWIAYGHSFAVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEY 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.81                                               
						GLTNNSKLAERFFSQALSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNE 	                        Gaps:       0                        
						VTVDKWEPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGNFENA 	                                                            
						VDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKCYDFDVHTMKTLKNI 	Alignment:                                                   
						ISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRPSLEETFEIEMNESDMMLETSMSDH 	                  .         .         .         .         .  
						ST                                                           	       1 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALD 50                                                           
						amino acid sequence being at least 90 % homologous to        	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						corresponding to amino acids 138 - 619 of Q13042, which also 	      94 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGQIYDALD 143                                                          
						corresponds to amino acids 45 - 526 of T09435_P6, wherein    	                  .         .         .         .         .  
						said first amino acid sequence, bridging amino acid and      	      51 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 100                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	     144 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 193                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     194 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 243                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     244 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 293                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     294 YPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 343                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     344 AVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 393                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     394 LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKW 443                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     444 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 493                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     494 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 543                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     544 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 593                                                          
						                                                            	                  .         .                                
						                                                            	     501 SLEETFEIEMNESDMMLETSMSDHST                         526                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     594 SLEETFEIEMNESDMMLETSMSDHST                         619                                                          

						Comparison report between T09435_P6 and Q96AE6partial WT     	Sequence name: Q96AE6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09435_P6, comprising a first amino acid        	                                                            
						MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALDNRTLATYSYK 	Alignment of: 15347 x Q96AE6   ..                            
						EALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLCNEEQELLRFLFENKLKKYNK 	                                                            
						PSETVIPESVDGLQENLDVVVSLAERHYYNCDFKMCYKLTSVVMEKDPFHASCLPVHIGT 	Alignment segment 1/1:                                       
						LVELNKANELFYLSHKLVDLYPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYG 	                                                            
						PAWIAYGHSFAVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 	                     Quality: 5220.00                      Escore:       0                                               
						LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKWEPLLNNLGHV 	             Matching length:     526                Total length:     526                                               
						CRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGNFENAVDYFHTALGLRRDDTF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SVTMLGHCIEMYIGDSEAYIGADIKDKLKCYDFDVHTMKTLKNIISPPWDFREFEVEKQT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AEETGLTPLETSRKTPDSRPSLEETFEIEMNESDMMLETSMSDHST               	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 95 - 620 of Q96AE6, which also corresponds to    	Alignment:                                                   
						amino acids 1 - 526 of T09435_P6.                            	                  .         .         .         .         .  
						                                                            	       1 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALD 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      95 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALD 144                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     145 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 194                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     195 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 244                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     245 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 294                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 YPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     295 YPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 344                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     345 AVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 394                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKW 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     395 LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKW 444                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     445 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 494                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     495 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 544                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     545 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 594                                                          
						                                                            	                  .         .                                
						                                                            	     501 SLEETFEIEMNESDMMLETSMSDHST                         526                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     595 SLEETFEIEMNESDMMLETSMSDHST                         620                                                          

						Comparison report between T09435_P6 and Q9Y564partial WT     	Sequence name: Q9Y564                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T09435_P6, comprising a first amino acid sequence being at   	                                                            
						MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALDNRTLATYSYK 	Alignment of: 15347 x Q9Y564   ..                            
						EALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLCNEEQELLRFLFENKLKKYNK 	                                                            
						PSETVIPESVDGLQENLDVVVSLAERHYYNCDFKMCYKLTSVVMEKDPFHASCLPVHIGT 	Alignment segment 1/1:                                       
						LVELNKANELFYLSHKLVDLYPSN                                     	                                                            
						least 90 % homologous to corresponding to amino acids 94 -   	                     Quality: 4598.00                      Escore:       0                                               
						297 of Q9Y564, which also corresponds to amino acids 1 - 204 	             Matching length:     475                Total length:     526                                               
						of T09435_P6, a bridging amino acid P corresponding to amino 	 Matching Percent Similarity:   99.79   Matching Percent Identity:   99.79                                               
						acid 205 of T09435_P6, a second amino acid sequence being at 	    Total Percent Similarity:   90.11      Total Percent Identity:   90.11                                               
						VSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSFAVESEHDQAMAAYFT 	                        Gaps:       1                        
						AAQLMKG                                                      	                                                            
						least 90 % homologous to corresponding to amino acids 299 -  	Alignment:                                                   
						365 of Q9Y564, which also corresponds to amino acids 206 -   	                  .         .         .         .         .  
						272 of T09435_P6, a third amino acid sequence being at least 	       1 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALD 50                                                           
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      94 MEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALD 143                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						CHLPMLYIGLEYGLTNNSKLAERFFSQALSIAPEDPFVMHEVGVVAFQNGE          	      51 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 100                                                          
						corresponding to amino acids 273 - 323 of T09435_P6, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WKTAEKWFLDALEKIKAIGNEVTVDKWEPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQ 	     144 NRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLC 193                                                          
						NASTYSAIGYIHSLMGNFENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGAD 	                  .         .         .         .         .  
						IKDKLKCYDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRPSLE 	     101 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 150                                                          
						ETFEIEMNESDMMLETSMSDHST                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	     194 NEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYN 243                                                          
						corresponding to amino acids 366 - 568 of Q9Y564, which also 	                  .         .         .         .         .  
						corresponds to amino acids 324 - 526 of T09435_P6, wherein   	     151 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 200                                                          
						said first amino acid sequence, bridging amino acid, second  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, third amino acid sequence and fourth    	     244 CDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDL 293                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     201 YPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 250                                                          
						of T09435_P6, comprising an amino acid sequence being at     	         |||| |||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     294 YPSNLVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSF 343                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     251 AVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQA 300                                                          
						encoding for                                                 	         ||||||||||||||||||||||                              
						CHLPMLYIGLEYGLTNNSKLAERFFSQALSIAPEDPFVMHEVGVVAFQNGE,         	     344 AVESEHDQAMAAYFTAAQLMKG............................ 365                                                          
						corresponding to T09435_P6.                                  	                  .         .         .         .         .  
						                                                            	     301 LSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKW 350                                                          
						                                                            	                                |||||||||||||||||||||||||||  
						                                                            	     366 .......................WKTAEKWFLDALEKIKAIGNEVTVDKW 392                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     393 EPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGN 442                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     443 FENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKC 492                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     493 YDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRP 542                                                          
						                                                            	                  .         .                                
						                                                            	     501 SLEETFEIEMNESDMMLETSMSDHST                         526                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     543 SLEETFEIEMNESDMMLETSMSDHST                         568                                                          

280	HMR136_T09449_1_tr0_r1_1_gPRT		Comparison report between T09449_P1 and AAAS_HUMANpartial WT 	Sequence name: AAAS_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09449_P1, comprising a first amino acid        	                                                            
						MCSLGLFPPPPPRGQVTLYEHNNELVTGSSYESPPPDFRGQWINLPVLQLTKDPLKTPGR 	Alignment of: 280 x AAAS_HUMAN   ..                          
						LDHGTRTAFIHHREQVWKRCINIWRDVGLFGVLNEIANSEEEVFEWVKTASGWALALCRW 	                                                            
						ASSLHGSLFPHLSLRSEDLIAEFAQVTNWSSCCLRVFAWHPHTNKFAVALLDDSVRVYNA 	Alignment segment 1/1:                                       
						SSTIVPSLKHRLQRNVASLAWKPLSASVLAVACQSCILIWTLDPTSLSTRPSSGCAQVLS 	                                                            
						HPGHTPVTSLAWAPSGGRLLSASPVDAAIRVWDVSTETCVPLPWFRGGGVTNLLWSPDGS 	                     Quality: 3933.00                      Escore:       0                                               
						KILATTPSAVFRVWEAQMWTCERWPTLSGRCQTGCWSPDGSRLLFTVLGEPLIYSLSFPE 	             Matching length:     394                Total length:     394                                               
						RCGEGKGCVGGAKSATIVADLSETTIQTPDGEER                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 394 of AAAS_HUMAN, which also corresponds to 	                        Gaps:       0                        
						amino acids 1 - 394 of T09449_P1.                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MCSLGLFPPPPPRGQVTLYEHNNELVTGSSYESPPPDFRGQWINLPVLQL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MCSLGLFPPPPPRGQVTLYEHNNELVTGSSYESPPPDFRGQWINLPVLQL 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TKDPLKTPGRLDHGTRTAFIHHREQVWKRCINIWRDVGLFGVLNEIANSE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TKDPLKTPGRLDHGTRTAFIHHREQVWKRCINIWRDVGLFGVLNEIANSE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EEVFEWVKTASGWALALCRWASSLHGSLFPHLSLRSEDLIAEFAQVTNWS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EEVFEWVKTASGWALALCRWASSLHGSLFPHLSLRSEDLIAEFAQVTNWS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SCCLRVFAWHPHTNKFAVALLDDSVRVYNASSTIVPSLKHRLQRNVASLA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SCCLRVFAWHPHTNKFAVALLDDSVRVYNASSTIVPSLKHRLQRNVASLA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 WKPLSASVLAVACQSCILIWTLDPTSLSTRPSSGCAQVLSHPGHTPVTSL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 WKPLSASVLAVACQSCILIWTLDPTSLSTRPSSGCAQVLSHPGHTPVTSL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AWAPSGGRLLSASPVDAAIRVWDVSTETCVPLPWFRGGGVTNLLWSPDGS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AWAPSGGRLLSASPVDAAIRVWDVSTETCVPLPWFRGGGVTNLLWSPDGS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KILATTPSAVFRVWEAQMWTCERWPTLSGRCQTGCWSPDGSRLLFTVLGE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KILATTPSAVFRVWEAQMWTCERWPTLSGRCQTGCWSPDGSRLLFTVLGE 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 PLIYSLSFPERCGEGKGCVGGAKSATIVADLSETTIQTPDGEER       394                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     351 PLIYSLSFPERCGEGKGCVGGAKSATIVADLSETTIQTPDGEER       394                                                          

17106	HMR136_T09452_22_tr0_r1_1_gPRT		Comparison report between T09452_P22 and ARI2_HUMANpartial   	Sequence name: ARI2_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09452_P22, comprising a first amino	Sequence documentation:                                      
						MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQGADAFDPEEYQ 	                                                            
						FTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEA 	Alignment of: 17106 x ARI2_HUMAN   ..                        
						RVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVG 	                                                            
						VSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQ 	Alignment segment 1/1:                                       
						EPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 	                                                            
						NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQARE 	                     Quality: 4563.00                      Escore:       0                                               
						ALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKC 	             Matching length:     442                Total length:     442                                               
						RYTLQYTYPYAYYMESGPRKKL                                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 442 of ARI2_HUMAN, which also corresponds 	                        Gaps:       0                        
						to amino acids 1 - 442 of T09452_P22, and a second amino acid	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQG 50                                                           
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALPQPQPTHLLTLLLCLYSLNTSRLSWRLRSKTSHGKWSVQTAMTEGTWRTRCI       	       1 MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQG 50                                                           
						corresponding to amino acids 443 - 496 of T09452_P22, wherein	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      51 ADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHW 100                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09452_P22, comprising a  	      51 ADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHW 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 QVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKEN 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	     101 QVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKEN 150                                                          
						ALPQPQPTHLLTLLLCLYSLNTSRLSWRLRSKTSHGKWSVQTAMTEGTWRTRCI in    	                  .         .         .         .         .  
						T09452_P22.                                                  	     151 LLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNN 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 LGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKL         442                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     401 LGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKL         442                                                          

17102	HMR136_T09452_24_tr0_r1_1_gPRT		Comparison report between T09452_P24 and ARI2_HUMANunique    	Sequence name: ARI2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T09452_P24, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17102 x ARI2_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MLTAISCILPMAL corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 13 of T09452_P24, and a second amino acid sequence 	                                                            
						VSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQF 	                     Quality: 4225.00                      Escore:       0                                               
						VRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEE 	             Matching length:     408                Total length:     408                                               
						LREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						APTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						CLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQT 	                        Gaps:       0                        
						YQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEY 	                                                            
						QQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRTLLKDFHDT             	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 86 - 493 of ARI2_HUMAN, which also corresponds to amino	      14 VSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHP 63                                                           
						acids 14 - 421 of T09452_P24, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      86 VSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHP 135                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of T09452_P24, comprising a polypeptide being at least  	      64 PHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMA 113                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     136 PHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMA 185                                                          
						at least about 95% homologous to the sequence MLTAISCILPMAL  	                  .         .         .         .         .  
						of T09452_P24.                                               	     114 QDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPM 163                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     186 QDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPM 235                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 VIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     236 VIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSE 285                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGS 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     286 TANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGS 335                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 EYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQT 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     336 EYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQT 385                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 YQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYME 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     386 YQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYME 435                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 SGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRT 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     436 SGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRT 485                                                          
						                                                            	                                                             
						                                                            	     414 LLKDFHDT                                           421                                                          
						                                                            	         ||||||||                                            
						                                                            	     486 LLKDFHDT                                           493                                                          

17108	HMR136_T09452_27_tr0_r1_1_gPRT		Comparison report between T09452_P27 and ARI2_HUMANpartial   	Sequence name: ARI2_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T09452_P27, comprising a first amino	Sequence documentation:                                      
						MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQGADAFDPEEYQ 	                                                            
						FTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEA 	Alignment of: 17108 x ARI2_HUMAN   ..                        
						RVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVG 	                                                            
						VSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQ 	Alignment segment 1/1:                                       
						EPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 	                                                            
						NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQARE 	                     Quality: 4563.00                      Escore:       0                                               
						ALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKC 	             Matching length:     442                Total length:     442                                               
						RYTLQYTYPYAYYMESGPRKKL                                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 442 of ARI2_HUMAN, which also corresponds 	                        Gaps:       0                        
						to amino acids 1 - 442 of T09452_P27, and a second amino acid	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQG 50                                                           
						having the sequence                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALPQPQPTHLLTLLLCLYSLNTSRLSWRLRSKTSHGKWSVQTAMTEG corresponding	       1 MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQG 50                                                           
						to amino acids 443 - 489 of T09452_P27, wherein said first   	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	      51 ADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHW 100                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T09452_P27, comprising a  	      51 ADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHW 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     101 QVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKEN 150                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	     101 QVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKEN 150                                                          
						ALPQPQPTHLLTLLLCLYSLNTSRLSWRLRSKTSHGKWSVQTAMTEG in           	                  .         .         .         .         .  
						T09452_P27.                                                  	     151 LLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKC 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 NICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNN 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNN 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 LGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKL         442                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     401 LGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKL         442                                                          

17104	HMR136_T09452_30_tr0_r1_1_gPRT		Comparison report between T09452_P30 and ARI2_HUMANpartial   	Sequence name: ARI2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T09452_P30, comprising a first amino	                                                            
						MQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERW 	Alignment of: 17104 x ARI2_HUMAN   ..                        
						ENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAY 	                                                            
						YMESGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRTLLKDFHD 	Alignment segment 1/1:                                       
						T                                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 1877.00                      Escore:       0                                               
						to amino acids 313 - 493 of ARI2_HUMAN, which also           	             Matching length:     181                Total length:     181                                               
						corresponds to amino acids 1 - 181 of T09452_P30.            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREAL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     313 MQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREAL 362                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     363 KKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQN 412                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     413 AAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVE 462                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 RADSYDRGDLENQMHIAEQRRRTLLKDFHDT                    181                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     463 RADSYDRGDLENQMHIAEQRRRTLLKDFHDT                    493                                                          

17399	HMR136_T09454_7_tr0_r1_1_gPRT		Comparison report between T09454_P7 and Q96BL4unique head    	Sequence name: Q96BL4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09454_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17399 x Q96BL4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAP 	Alignment segment 1/1:                                       
						QNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQ 	                                                            
						QDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVG 	                     Quality: 1528.00                      Escore:       0                                               
						CTKRVGLFHSDRSKLQKAGAATHNRRRASK                               	             Matching length:     156                Total length:     156                                               
						having the sequence corresponding to amino acids 1 - 210 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T09454_P7, and a second amino acid sequence being at least 90	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRR 	                        Gaps:       0                        
						RQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEID 	                                                            
						GQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS                         	Alignment:                                                   
						% homologous to corresponding to amino acids 1 - 156 of      	                  .         .         .         .         .  
						Q96BL4, which also corresponds to amino acids 211 - 366 of   	     211 ASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSP 260                                                          
						T09454_P7, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	       1 ASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSP 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T09454_P7, comprising a polypeptide being at least 70%,      	     261 ISASSSTSRRRQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEF 310                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 ISASSSTSRRRQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEF 100                                                          
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAP 	                  .         .         .         .         .  
						QNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQ 	     311 IRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARI 360                                                          
						QDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CTKRVGLFHSDRSKLQKAGAATHNRRRASK                               	     101 IRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARI 150                                                          
						least about 95% homologous to the sequence of T09454_P7.     	                                                             
						                                                            	     361 SMLKDS                                             366                                                          
						                                                            	         ||||||                                              
						                                                            	     151 SMLKDS                                             156                                                          

						Comparison report between T09454_P7 and Q8N306unique head    	Sequence name: Q8N306                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09454_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17399 x Q8N306   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPG corresponding to 	                                                            
						amino acids 1 - 43 of T09454_P7, and a second amino acid     	                     Quality: 3173.00                      Escore:       0                                               
						MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVG 	             Matching length:     323                Total length:     323                                               
						NLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSKRFCSMACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTKKQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMH 	                        Gaps:       0                        
						MRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLM 	                                                            
						SAMNIKLGPALKIYARISMLKDS                                      	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 323 of Q8N306, which also corresponds to     	      44 MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPF 93                                                           
						amino acids 44 - 366 of T09454_P7, wherein said first amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	       1 MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPF 50                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of T09454_P7, comprising a polypeptide being at   	      94 PVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEG 143                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      51 PVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEG 100                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPG of T09454_P7.    	     144 APLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRS 193                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 APLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     194 KLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQE 243                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 KLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 DSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHH 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 FLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLM 343                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLM 300                                                          
						                                                            	                  .         .                                
						                                                            	     344 SAMNIKLGPALKIYARISMLKDS                            366                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     301 SAMNIKLGPALKIYARISMLKDS                            323                                                          

						Comparison report between T09454_P7 and Q8TAG8unique head    	Sequence name: Q8TAG8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for T09454_P7, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 17399 x Q8TAG8   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment segment 1/1:                                       
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPG corresponding to 	                                                            
						amino acids 1 - 43 of T09454_P7, a second amino acid sequence	                     Quality: 3162.00                      Escore:       0                                               
						MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVG 	             Matching length:     323                Total length:     323                                               
						NLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFK 	 Matching Percent Similarity:   99.69   Matching Percent Identity:   99.69                                               
						RSKRFCSMACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTKKQ 	    Total Percent Similarity:   99.69      Total Percent Identity:   99.69                                               
						PTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMH 	                        Gaps:       0                        
						MRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEI                        	                                                            
						being at least 90 % homologous to corresponding to amino     	Alignment:                                                   
						acids 1 - 277 of Q8TAG8, which also corresponds to amino     	                  .         .         .         .         .  
						acids 44 - 320 of T09454_P7, a bridging amino acid A         	      44 MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPF 93                                                           
						corresponding to amino acid 321 of T09454_P7, and a third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	       1 MTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPF 50                                                           
						EEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS corresponding  	                  .         .         .         .         .  
						to amino acids 279 - 323 of Q8TAG8, which also corresponds to	      94 PVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEG 143                                                          
						amino acids 322 - 366 of T09454_P7, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, bridging amino    	      51 PVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEG 100                                                          
						acid and third amino acid sequence are contiguous and in a   	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     144 APLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRS 193                                                          
						head of T09454_P7, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 APLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRS 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     194 KLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQE 243                                                          
						MERDKLFCVFSSIFRRAFSLLPMPNEETGQGIVHALTDLSSPG of T09454_P7.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 KLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 DSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHH 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 FLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLM 343                                                          
						                                                            	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						                                                            	     251 FLPSEPTKWNVEDVYEFIRSLPGCQEIEEEFRAQEIDGQALLLLKEDHLM 300                                                          
						                                                            	                  .         .                                
						                                                            	     344 SAMNIKLGPALKIYARISMLKDS                            366                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     301 SAMNIKLGPALKIYARISMLKDS                            323                                                          

						Comparison report between T09454_P7 and Q8IXK0unique head    	Sequence name: Q8IXK0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09454_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 17399 x Q8IXK0   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MERDKLFCVFSSIFRRAFSLLPMPNE corresponding 	Alignment segment 1/1:                                       
						to amino acids 1 - 26 of T09454_P7, and a second amino acid  	                                                            
						ETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVI 	                     Quality: 3346.00                      Escore:       0                                               
						QEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEGAPL 	             Matching length:     345                Total length:     345                                               
						KLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRR 	 Matching Percent Similarity:   99.13   Matching Percent Identity:   99.13                                               
						RASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSS 	    Total Percent Similarity:   99.13      Total Percent Identity:   99.13                                               
						TSRRRQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRA 	                        Gaps:       0                        
						QEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS                     	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 519 - 858 of Q8IXK0, which also corresponds to   	                  .         .         .         .         .  
						amino acids 27 - 366 of T09454_P7, wherein said first amino  	      22 PMPNEETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAPQNGENKPPQAI 71                                                           
						acid sequence and second amino acid sequence are contiguous  	         | |  |||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     514 PSPAHETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAPQNGENKPPQAI 563                                                          
						for a head of T09454_P7, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	      72 VKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQQ 121                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     564 VKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQQ 613                                                          
						MERDKLFCVFSSIFRRAFSLLPMPNE of T09454_P7.                     	                  .         .         .         .         .  
						                                                            	     122 DHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSM 171                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     614 DHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSM 663                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     172 ACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTK 221                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     664 ACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTK 713                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     222 KQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRR 271                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     714 KQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRR 763                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     272 QGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIA 321                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     764 QGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIA 813                                                          
						                                                            	                  .         .         .         .            
						                                                            	     322 EEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS      366                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     814 EEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS      858                                                          

18451	HMR136_T09470_4_tr0_r1_1_gPRT		Comparison report between T09470_P4 and TGF3_HUMANpartial WT 	Sequence name: TGF3_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T09470_P4, comprising a first amino 	Sequence documentation:                                      
						MHLQRALVVLALLNFATVSLSLSTCTTLDFGHIKKKRVEAIRGQILSKLRLTSPPEPTVM 	                                                            
						THVPYQVLALYNSTRELLEEMHGEREEGCTQENTESEYYAKEIHKFDMIQGLAEHNELAV 	Alignment of: 18451 x TGF3_HUMAN   ..                        
						CPKGITSKVFRFNVSSVEKNRTNLFRAEFRVLRVPNPSSKRNEQRIELFQILRPDEHIAK 	                                                            
						QRYIGGKNLPTRGTAEWLSFDVTDTVREWLLRRESNLGLEISIHCPCHTFQPNGDILENI 	Alignment segment 1/1:                                       
						HEVMEIKFKGVDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGGQRKKRAL 	                                                            
						DTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLRSADTTHST   	                     Quality: 3580.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     358                Total length:     358                                               
						to amino acids 3 - 360 of TGF3_HUMAN, which also corresponds 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 358 of T09470_P4, and a second amino acid 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence DPQSGAALQHGGEVL corresponding to amino   	                  .         .         .         .         .  
						acids 359 - 373 of T09470_P4, wherein said first amino acid  	       1 MHLQRALVVLALLNFATVSLSLSTCTTLDFGHIKKKRVEAIRGQILSKLR 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       3 MHLQRALVVLALLNFATVSLSLSTCTTLDFGHIKKKRVEAIRGQILSKLR 52                                                           
						tail of T09470_P4, comprising a polypeptide being at least   	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 LTSPPEPTVMTHVPYQVLALYNSTRELLEEMHGEREEGCTQENTESEYYA 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence DPQSGAALQHGGEVL	      53 LTSPPEPTVMTHVPYQVLALYNSTRELLEEMHGEREEGCTQENTESEYYA 102                                                          
						in T09470_P4.                                                	                  .         .         .         .         .  
						                                                            	     101 KEIHKFDMIQGLAEHNELAVCPKGITSKVFRFNVSSVEKNRTNLFRAEFR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     103 KEIHKFDMIQGLAEHNELAVCPKGITSKVFRFNVSSVEKNRTNLFRAEFR 152                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLRVPNPSSKRNEQRIELFQILRPDEHIAKQRYIGGKNLPTRGTAEWLSF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     153 VLRVPNPSSKRNEQRIELFQILRPDEHIAKQRYIGGKNLPTRGTAEWLSF 202                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DVTDTVREWLLRRESNLGLEISIHCPCHTFQPNGDILENIHEVMEIKFKG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     203 DVTDTVREWLLRRESNLGLEISIHCPCHTFQPNGDILENIHEVMEIKFKG 252                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGGQRKKRAL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     253 VDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGGQRKKRAL 302                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     303 DTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLR 352                                                          
						                                                            	                                                             
						                                                            	     351 SADTTHST                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     353 SADTTHST                                           360                                                          

18449	HMR136_T09470_7_tr0_r1_1_gPRT		Comparison report between T09470_P7 and TGF3_HUMANpartial WT 	Sequence name: TGF3_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T09470_P7, comprising a first amino acid        	                                                            
						MEIKFKGVDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGGQRKKRALDTN 	Alignment of: 18449 x TGF3_HUMAN   ..                        
						YCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLRSADTTHSTVLGLY 	                                                            
						NTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQLSNMVVKSCKCS              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 246 - 412 of TGF3_HUMAN, which also corresponds  	                     Quality: 1712.00                      Escore:       0                                               
						to amino acids 1 - 167 of T09470_P7.                         	             Matching length:     167                Total length:     167                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MEIKFKGVDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 MEIKFKGVDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPGQGG 295                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCS 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     296 QRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCS 345                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GPCPYLRSADTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     346 GPCPYLRSADTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRT 395                                                          
						                                                            	                  .                                          
						                                                            	     151 PKVEQLSNMVVKSCKCS                                  167                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     396 PKVEQLSNMVVKSCKCS                                  412                                                          

19028	HMR136_T09476_10_tr0_r1_1_gPRT		Comparison report between T09476_P10 and Q9H5R5unique head   	Sequence name: Q9H5R5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T09476_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 19028 x Q9H5R5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MKPGFWRLQGSTGQQKKYKGVRNISNQLSITTKIAREHPD 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 40 of T09476_P10, and a     	                                                            
						MRNYAKRKGWWDGKKEFDFAAAYSYLDTAKMMTSSGRYCEGYKLLNKHKGNITFETMMEI 	                     Quality: 2219.00                      Escore:       0                                               
						LRDKPSGINMEGEFLTTASMVSILPQDSSLPCIHFFTGTPDPERSVFKPFIFVPHISQLL 	             Matching length:     222                Total length:     222                                               
						DTSSPTFELEDLVKKKSHFKPDRRHPLYQKHQQALEVVNNNEEKAKIMLDNMRKLEKELF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						REMESILQNKHLDVEKIVNLFPQCTKDEIQIYQSNLSVKVSS                   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 1 - 222 of Q9H5R5, which also   	                                                            
						corresponds to amino acids 41 - 262 of T09476_P10, wherein   	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      41 MRNYAKRKGWWDGKKEFDFAAAYSYLDTAKMMTSSGRYCEGYKLLNKHKG 90                                                           
						polypeptide encoding for a head of T09476_P10, comprising a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MRNYAKRKGWWDGKKEFDFAAAYSYLDTAKMMTSSGRYCEGYKLLNKHKG 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      91 NITFETMMEILRDKPSGINMEGEFLTTASMVSILPQDSSLPCIHFFTGTP 140                                                          
						to the sequence MKPGFWRLQGSTGQQKKYKGVRNISNQLSITTKIAREHPD of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T09476_P10.                                                  	      51 NITFETMMEILRDKPSGINMEGEFLTTASMVSILPQDSSLPCIHFFTGTP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     141 DPERSVFKPFIFVPHISQLLDTSSPTFELEDLVKKKSHFKPDRRHPLYQK 190                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 DPERSVFKPFIFVPHISQLLDTSSPTFELEDLVKKKSHFKPDRRHPLYQK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     191 HQQALEVVNNNEEKAKIMLDNMRKLEKELFREMESILQNKHLDVEKIVNL 240                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HQQALEVVNNNEEKAKIMLDNMRKLEKELFREMESILQNKHLDVEKIVNL 200                                                          
						                                                            	                  .         .                                
						                                                            	     241 FPQCTKDEIQIYQSNLSVKVSS                             262                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     201 FPQCTKDEIQIYQSNLSVKVSS                             222                                                          

20793	HMR136_T10010_18_tr0_r1_1_gPRT		Comparison report between T10010_P18 and EP15_HUMANunique    	Sequence name: EP15_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10010_P18, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20793 x EP15_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MYLKSDSGLGGWITIPAVADVLKYSCIVCWSS corresponding to amino acids	                                                            
						1 - 32 of T10010_P18, a second amino acid sequence being at  	                     Quality:  778.00                      Escore:       0                                               
						REKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQKA 	             Matching length:      82                Total length:      82                                               
						QLEEQLKEVRKKCAEEAQL                                          	 Matching Percent Similarity:   98.78   Matching Percent Identity:   97.56                                               
						least 90 % homologous to corresponding to amino acids 347 -  	    Total Percent Similarity:   98.78      Total Percent Identity:   97.56                                               
						425 of EP15_HUMAN, which also corresponds to amino acids 33 -	                        Gaps:       0                        
						111 of T10010_P18, and a third amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment:                                                   
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence VMSGCFL      	      33 REKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQE 82                                                           
						corresponding to amino acids 112 - 118 of T10010_P18, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	     347 REKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQE 396                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .                      
						sequential order.2.An isolated polypeptide encoding for a    	      83 LLDELDEQKAQLEEQLKEVRKKCAEEAQLVMS                   114                                                          
						head of T10010_P18, comprising a polypeptide being at least  	         |||||||||||||||||||||||||||||: |                    
						70%, optionally at least about 80%, preferably at least about	     397 LLDELDEQKAQLEEQLKEVRKKCAEEAQLISS                   428                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MYLKSDSGLGGWITIPAVADVLKYSCIVCWSS of T10010_P18.3.An isolated 	                                                            
						polypeptide encoding for a tail of T10010_P18, comprising a  	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VMSGCFL in T10010_P18.                       	                                                            

20791	HMR136_T10010_4_tr0_r1_1_gPRT		Comparison report between T10010_P4 and EP15_HUMAN_V1partial 	Sequence name: EP15_HUMAN_V1                                 
						WT sequence followed by unique insertion.1.An isolated       	                                                            
						chimeric polypeptide encoding for T10010_P4, comprising a    	Sequence documentation:                                      
						MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPDLILGKIWDLA 	                                                            
						DTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPPPRFHDTSSPLLISGTSAAEL 	Alignment of: 20791 x EP15_HUMAN_V1   ..                     
						PWAVKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGML 	                                                            
						DRDEFAVAMFLVYCALEKEPVPMSLPPALVPPSKRKT                        	Alignment segment 1/1:                                       
						first amino acid sequence being at least 90 % homologous to  	                                                            
						corresponding to amino acids 1 - 217 of EP15_HUMAN_V1, which 	                     Quality: 8632.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 217 of T10010_P4, a      	             Matching length:     896                Total length:     933                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:   96.03      Total Percent Identity:   96.03                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       1                        
						polypeptide having the sequence                              	                                                            
						VSISGSVRLIPSSASAKESYHSLPSVGILPTKAPLRQ corresponding to amino 	Alignment:                                                   
						acids 218 - 254 of T10010_P4, and a third amino acid sequence	                  .         .         .         .         .  
						WVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKL 	       1 MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPD 50                                                           
						SKDQFALAFHLISQKLIKGIDPPHVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LNNEIVDLQREKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQEL 	       1 MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPD 50                                                           
						LDELDEQKAQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELSRL 	                  .         .         .         .         .  
						QQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENHNSQLNWCSSPHS 	      51 LILGKIWDLADTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPP 100                                                          
						ILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIHQESPARSSPELLPSGVTDENEV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTAVTEKVCSELDNNRHSKEEDPFNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFG 	      51 LILGKIWDLADTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPP 100                                                          
						KIDPFGGDPFKGSDPFASDCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPG 	                  .         .         .         .         .  
						GTVVAASDSATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVF 	     101 PRFHDTSSPLLISGTSAAELPWAVKPEDKAKYDAIFDSLSPVNGFLSGDK 150                                                          
						EETSVKSEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDPFQPFPGNDSPKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDMIEWAKRESEREEEQRLARLNQQ 	     101 PRFHDTSSPLLISGTSAAELPWAVKPEDKAKYDAIFDSLSPVNGFLSGDK 150                                                          
						EQEDLELAIALSKSEISEA                                          	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     151 VKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEP 200                                                          
						acids 218 - 896 of EP15_HUMAN_V1, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 255 - 933 of T10010_P4, wherein said first amino 	     151 VKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEP 200                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     201 VPMSLPPALVPPSKRKTVSISGSVRLIPSSASAKESYHSLPSVGILPTKA 250                                                          
						isolated polypeptide encoding for an edge portion of         	         |||||||||||||||||                                   
						T10010_P4, comprising an amino acid sequence being at least  	     201 VPMSLPPALVPPSKRKT................................. 217                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     251 PLRQWVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLA 300                                                          
						at least about 95% homologous to the sequence encoding for   	             ||||||||||||||||||||||||||||||||||||||||||||||  
						VSISGSVRLIPSSASAKESYHSLPSVGILPTKAPLRQ, corresponding to      	     218 ....WVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLA 263                                                          
						T10010_P4.                                                   	                  .         .         .         .         .  
						                                                            	     301 HIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPPHVLTPEMIPPSDR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 HIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPPHVLTPEMIPPSDR 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQDLKEKEDTI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 ASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQDLKEKEDTI 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQKAQLEEQLK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 KQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQKAQLEEQLK 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELSRLQQETAE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 EVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELSRLQQETAE 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENHNSQLNWCS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 LEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENHNSQLNWCS 513                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIHQESPARSS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     514 SPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIHQESPARSS 563                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDPFNVDSSSLTGPVA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     564 PELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDPFNVDSSSLTGPVA 613                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFASDCFFRQST 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     614 DTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFASDCFFRQST 663                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 DPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASDSATDPFAS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     664 DPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASDSATDPFAS 713                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 VFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVFEETSVK 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     714 VFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVFEETSVK 763                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 SEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDPFQPFPGND 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     764 SEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDPFQPFPGND 813                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 SPKEKDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDMIEWAKRES 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     814 SPKEKDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDMIEWAKRES 863                                                          
						                                                            	                  .         .         .                      
						                                                            	     901 EREEEQRLARLNQQEQEDLELAIALSKSEISEA                  933                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     864 EREEEQRLARLNQQEQEDLELAIALSKSEISEA                  896                                                          

20788	HMR136_T10010_7_tr0_r1_1_gPRT		Comparison report between T10010_P7 and EP15_HUMANpartial WT 	Sequence name: EP15_HUMAN                                    
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for T10010_P7, comprising a first amino 	Sequence documentation:                                      
						MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPDLILGKIWDLA 	                                                            
						DTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPPPRFHDTSSPLLISGTSAAEL 	Alignment of: 20788 x EP15_HUMAN   ..                        
						PWAVKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGML 	                                                            
						DRDEFAVAMFLVYCALEKEPVPMSLPPALVPPSKRKTWVVSPAEKAKYDEIFLKTDKDMD 	Alignment segment 1/1:                                       
						GFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPP 	                                                            
						HVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQDLKEKE 	                     Quality: 7638.00                      Escore:       0                                               
						DTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQKAQLEEQLKEVRKKCA 	             Matching length:     786                Total length:     786                                               
						EEAQLISSLKAELTSQESQISTYEEELAKAREELSRLQQETAELEESVESGKAQLEPLQQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HLQDSQQEISSMQMKLMEMKDLENHNSQLNWCSSPHSILVNGATDYCSLSTSSSETANLN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EHVEGQSNLESEPIHQESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDP 	                        Gaps:       0                        
						FNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFASDCFFR 	                                                            
						QSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASDSATDPFASVFGNESF 	Alignment:                                                   
						GGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVFEETSVKSEDEPPALPPKIGTPTR 	                  .         .         .         .         .  
						PCPLPP                                                       	       1 MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPD 50                                                           
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 786 of EP15_HUMAN, which also corresponds 	       1 MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPD 50                                                           
						to amino acids 1 - 786 of T10010_P7, and a second amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      51 LILGKIWDLADTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPP 100                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 LILGKIWDLADTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPP 100                                                          
						having the sequence VSL corresponding to amino acids 787 -   	                  .         .         .         .         .  
						789 of T10010_P7, wherein said first amino acid sequence and 	     101 PRFHDTSSPLLISGTSAAELPWAVKPEDKAKYDAIFDSLSPVNGFLSGDK 150                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.                                                       	     101 PRFHDTSSPLLISGTSAAELPWAVKPEDKAKYDAIFDSLSPVNGFLSGDK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VPMSLPPALVPPSKRKTWVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVRE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VPMSLPPALVPPSKRKTWVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVRE 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 HVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 HVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LDEQKAQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKA 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LDEQKAQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 REELSRLQQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 REELSRLQQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMK 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 DLENHNSQLNWCSSPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DLENHNSQLNWCSSPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SEPIHQESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SEPIHQESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDP 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 FNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 FNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DPFASDCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTV 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 DPFASDCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTV 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VAASDSATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNV 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VAASDSATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNV 750                                                          
						                                                            	                  .         .         .                      
						                                                            	     751 VITKNVFEETSVKSEDEPPALPPKIGTPTRPCPLPP               786                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     751 VITKNVFEETSVKSEDEPPALPPKIGTPTRPCPLPP               786                                                          

20786	HMR136_T10010_8_tr0_r1_1_gPRT		Comparison report between T10010_P8 and EP15_HUMAN_V1unique  	Sequence name: EP15_HUMAN_V1                                 
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T10010_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20786 x EP15_HUMAN_V1   ..                     
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MGCKM        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of T10010_P8, a second    	                                                            
						NGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEPVP 	                     Quality: 7281.00                      Escore:       0                                               
						MSLPPALVPPSKRKT                                              	             Matching length:     754                Total length:     791                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 143 - 217 of EP15_HUMAN_V1,     	    Total Percent Similarity:   95.32      Total Percent Identity:   95.32                                               
						which also corresponds to amino acids 6 - 80 of T10010_P8, a 	                        Gaps:       1                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	       6 NGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 55                                                           
						VSISGSVRLIPSSASAKESYHSLPSVGILPTKAPLRQ corresponding to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 81 - 117 of T10010_P8, and a fourth amino acid sequence	     143 NGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 192                                                          
						WVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKL 	                  .         .         .         .         .  
						SKDQFALAFHLISQKLIKGIDPPHVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDT 	      56 YCALEKEPVPMSLPPALVPPSKRKTVSISGSVRLIPSSASAKESYHSLPS 105                                                          
						LNNEIVDLQREKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQEL 	         |||||||||||||||||||||||||                           
						LDELDEQKAQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELSRL 	     193 YCALEKEPVPMSLPPALVPPSKRKT......................... 217                                                          
						QQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENHNSQLNWCSSPHS 	                  .         .         .         .         .  
						ILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIHQESPARSSPELLPSGVTDENEV 	     106 VGILPTKAPLRQWVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKT 155                                                          
						TTAVTEKVCSELDNNRHSKEEDPFNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFG 	                     ||||||||||||||||||||||||||||||||||||||  
						KIDPFGGDPFKGSDPFASDCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPG 	     218 ............WVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKT 255                                                          
						GTVVAASDSATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVF 	                  .         .         .         .         .  
						EETSVKSEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDPFQPFPGNDSPKE 	     156 GLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPPHVLTP 205                                                          
						KDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDMIEWAKRESEREEEQRLARLNQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQEDLELAIALSKSEISEA                                          	     256 GLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPPHVLTP 305                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 218 - 896 of EP15_HUMAN_V1, which also corresponds to  	     206 EMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQD 255                                                          
						amino acids 118 - 796 of T10010_P8, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, third amino acid  	     306 EMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQD 355                                                          
						sequence and fourth amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     256 LKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQK 305                                                          
						head of T10010_P8, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     356 LKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQK 405                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MGCKM of       	     306 AQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELS 355                                                          
						T10010_P8.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T10010_P8, comprising an amino acid sequence being	     406 AQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELS 455                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     356 RLQQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENH 405                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for VSISGSVRLIPSSASAKESYHSLPSVGILPTKAPLRQ,          	     456 RLQQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENH 505                                                          
						corresponding to T10010_P8.                                  	                  .         .         .         .         .  
						                                                            	     406 NSQLNWCSSPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIH 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     506 NSQLNWCSSPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIH 555                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 QESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDPFNVDS 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     556 QESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDPFNVDS 605                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     506 SSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFAS 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     606 SSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFAS 655                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 DCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASD 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     656 DCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASD 705                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     606 SATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKN 655                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     706 SATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKN 755                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     656 VFEETSVKSEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDP 705                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     756 VFEETSVKSEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDP 805                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     706 FQPFPGNDSPKEKDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDM 755                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     806 FQPFPGNDSPKEKDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDM 855                                                          
						                                                            	                  .         .         .         .            
						                                                            	     756 IEWAKRESEREEEQRLARLNQQEQEDLELAIALSKSEISEA          796                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     856 IEWAKRESEREEEQRLARLNQQEQEDLELAIALSKSEISEA          896                                                          

1544	HMR136_T10028_10_tr0_r1_1_gPRT		Comparison report between T10028_P10 and O75189partial WT    	Sequence name: O75189                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for T10028_P10, comprising a first amino acid       	                                                            
						MNFEGLDPGLAEYAPAMHSALDPVLDAHLNPSLLQNVELDPEGVALEALPVQESVHIMEG 	Alignment of: 1544 x O75189   ..                             
						VYSELHSVVAEVGVPVSVSHFDLHEEMLWVGSHGGHATSFFGPALERYSSFQVNGSDDIR 	                                                            
						QIQSLENGILFLTKNNLKYMARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHI   	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 178 of O75189, which also corresponds to     	                     Quality: 10075.00                      Escore:       0                                              
						amino acids 1 - 178 of T10028_P10, a bridging amino acid I   	             Matching length:    1033                Total length:    1037                                               
						corresponding to amino acid 179 of T10028_P10, a second amino	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.71                                               
						EIDLNTVQETQKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 	    Total Percent Similarity:   99.52      Total Percent Identity:   99.32                                               
						SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAFLRFIPTYTSR 	                        Gaps:       1                        
						LAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVSASKQALAFGDSEGCVHLWTD 	                                                            
						SPEPSFNPYSRETEFALPCLVDSLPPLDWSQDLLPLSLIPVPLTTDTLLSDWPAANSAPA 	Alignment:                                                   
						PRRAPPVDAEILRTMKKVGFIGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGRE 	                  .         .         .         .         .  
						EEPHLHMVSKKYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 	       1 MNFEGLDPGLAEYAPAMHSALDPVLDAHLNPSLLQNVELDPEGVALEALP 50                                                           
						PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPEASALGLILAD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRGAGGSFCSSGDSVIGQLFSCE 	       1 MNFEGLDPGLAEYAPAMHSALDPVLDAHLNPSLLQNVELDPEGVALEALP 50                                                           
						MENCSLCRCGSETVRASSTLLFTLSYPD                                 	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	      51 VQESVHIMEGVYSELHSVVAEVGVPVSVSHFDLHEEMLWVGSHGGHATSF 100                                                          
						to amino acids 180 - 687 of O75189, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 180 - 687 of T10028_P10, a third amino acid      	      51 VQESVHIMEGVYSELHSVVAEVGVPVSVSHFDLHEEMLWVGSHGGHATSF 100                                                          
						DKTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVINCEVNSSKE 	                  .         .         .         .         .  
						ADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNVWLPFS 	     101 FGPALERYSSFQVNGSDDIRQIQSLENGILFLTKNNLKYMARGGLIIFDY 150                                                          
						IRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVVHILDSRTGGSLVAHI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNL 	     101 FGPALERYSSFQVNGSDDIRQIQSLENGILFLTKNNLKYMARGGLIIFDY 150                                                          
						NIKNPIEASVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELR 	                  .         .         .         .         .  
						SDGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQV                  	     151 LLDENEDMHSLLLTDSSTLLVGGLQNHIIEIDLNTVQETQKYAVETPGVT 200                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||:|||||||||||||||||||||  
						amino acids 692 - 1034 of O75189, which also corresponds to  	     151 LLDENEDMHSLLLTDSSTLLVGGLQNHILEIDLNTVQETQKYAVETPGVT 200                                                          
						amino acids 688 - 1030 of T10028_P10, and a fourth amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     201 IMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSLSDFDVHGNLLA 250                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     201 IMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSLSDFDVHGNLLA 250                                                          
						having the sequence                                          	                  .         .         .         .         .  
						LGYGDASEAHPGAYLQCSRTQGRVIGEDSISLPEKGLSFSLFLGGGLLDSILGYKAW    	     251 ACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAFLRFIPTYTSRL 300                                                          
						corresponding to amino acids 1031 - 1087 of T10028_P10,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, bridging amino acid, 	     251 ACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAFLRFIPTYTSRL 300                                                          
						second amino acid sequence, third amino acid sequence and    	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     301 AIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVSASKQALAFGDS 350                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T10028_P10, comprising a polypeptide having a     	     301 AIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVSASKQALAFGDS 350                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     351 EGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWSQDLLPLSLIPV 400                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     351 EGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWSQDLLPLSLIPV 400                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise DD, having a structure as  	     401 PLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGFIGYAPNPRTRL 450                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						687-x to 688; and ending at any of amino acid numbers 688+   	     401 PLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGFIGYAPNPRTRL 450                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of T10028_P10, comprising a  	     451 RNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSKKYRKVTIKYSK 500                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     451 RNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSKKYRKVTIKYSK 500                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	     501 LGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLEPVRCLIQNHLC 550                                                          
						LGYGDASEAHPGAYLQCSRTQGRVIGEDSISLPEKGLSFSLFLGGGLLDSILGYKAW in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10028_P10.                                                  	     501 LGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLEPVRCLIQNHLC 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 QKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPEASALGLILADS 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 QKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPEASALGLILADS 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRGAGGSFCSSGDS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRGAGGSFCSSGDS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPD....DKTGKNYDF 696                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||    |||||||||  
						                                                            	     651 VIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPDGSKSDKTGKNYDF 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     697 AQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVINCEVNSSK 746                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 AQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVINCEVNSSK 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     747 EADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSI 796                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     797 EELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYD 846                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 EELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYD 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     847 LMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPI 896                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPI 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     897 DKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLAR 946                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 DKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLAR 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     947 KQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIK 996                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 KQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIK 1000                                                         
						                                                            	                  .         .         .                      
						                                                            	     997 PSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVLGY              1033                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||: |               
						                                                            	    1001 PSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDY              1037                                                         

1540	HMR136_T10028_15_tr0_r1_1_gPRT		Comparison report between T10028_P15 and O75189partial WT    	Sequence name: O75189                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for T10028_P15, comprising a first amino acid       	                                                            
						sequence being at least 90 % homologous to                   	Alignment of: 1540 x O75189   ..                             
						MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHI corresponding to     	                                                            
						amino acids 140 - 178 of O75189, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 39 of T10028_P15, a bridging amino acid I    	                                                            
						corresponding to amino acid 40 of T10028_P15, a second amino 	                     Quality: 9283.00                      Escore:       0                                               
						EIDLNTVQETQKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 	             Matching length:     951                Total length:     955                                               
						SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAFLRFIPTYTSR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.89                                               
						LAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVSASKQALAFGDSEGCVHLWTD 	    Total Percent Similarity:   99.58      Total Percent Identity:   99.48                                               
						SPEPSFNPYSRETEFALPCLVDSLPPLDWSQDLLPLSLIPVPLTTDTLLSDWPAANSAPA 	                        Gaps:       1                        
						PRRAPPVDAEILRTMKKVGFIGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGRE 	                                                            
						EEPHLHMVSKKYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 	Alignment:                                                   
						PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPEASALGLILAD 	                  .         .         .         .         .  
						SDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRGAGGSFCSSGDSVIGQLFSCE 	       1 MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHIIEIDLNTVQET 50                                                           
						MENCSLCRCGSETVRASSTLLFTLSYPD                                 	         |||||||||||||||||||||||||||||||||||||||:||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     140 MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHILEIDLNTVQET 189                                                          
						to amino acids 180 - 687 of O75189, which also corresponds to	                  .         .         .         .         .  
						amino acids 41 - 548 of T10028_P15, a third amino acid       	      51 QKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 100                                                          
						DKTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVINCEVNSSKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNVWLPFS 	     190 QKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 239                                                          
						IRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVVHILDSRTGGSLVAHI 	                  .         .         .         .         .  
						KVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNL 	     101 SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAF 150                                                          
						NIKNPIEASVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SDGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDA 	     240 SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAF 289                                                          
						KISSKHLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMV                  	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     151 LRFIPTYTSRLAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVS 200                                                          
						amino acids 692 - 1094 of O75189, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 549 - 951 of T10028_P15, and a fourth amino acid 	     290 LRFIPTYTSRLAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVS 339                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     201 ASKQALAFGDSEGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWS 250                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSK 	     340 ASKQALAFGDSEGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWS 389                                                          
						NGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL              	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 952 - 1058  	     251 QDLLPLSLIPVPLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGF 300                                                          
						of T10028_P15, wherein said first amino acid sequence,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid, second amino acid sequence, third amino 	     390 QDLLPLSLIPVPLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGF 439                                                          
						acid sequence and fourth amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated chimeric polypeptide 	     301 IGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSK 350                                                          
						encoding for an edge portion of T10028_P15, comprising a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     440 IGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSK 489                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     351 KYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 400                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     490 KYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 539                                                          
						length, wherein at least two amino acids comprise DD, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     401 PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPE 450                                                          
						acid numbers 548-x to 549; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 549+ ((n-2) - x), in which x varies from 0 to        	     540 PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPE 589                                                          
						n-2.3.An isolated polypeptide encoding for a tail of         	                  .         .         .         .         .  
						T10028_P15, comprising a polypeptide being at least 70%,     	     451 ASALGLILADSDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRG 500                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     590 ASALGLILADSDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRG 639                                                          
						PKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSK 	                  .         .         .         .         .  
						NGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL              	     501 AGGSFCSSGDSVIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPD.. 548                                                          
						least about 95% homologous to the sequence in T10028_P15.    	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     640 AGGSFCSSGDSVIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPDGS 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     549 ..DKTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDI 596                                                          
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 KSDKTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDI 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 LVINCEVNSSKEADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELG 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 LVINCEVNSSKEADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELG 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     647 SPEGVLVCPSIEELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPAR 696                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 SPEGVLVCPSIEELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPAR 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     697 AEEEHGVYVYDLMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQW 746                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 AEEEHGVYVYDLMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQW 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     747 YLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEA 796                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 YLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEA 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     797 SVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAE 846                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 SVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAE 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     847 LRSDGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLT 896                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 LRSDGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLT 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     897 QYSGIKPGDLDAKISSKHLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRV 946                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1040 QYSGIKPGDLDAKISSKHLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRV 1089                                                         
						                                                            	                                                             
						                                                            	     947 INLMV                                              951                                                          
						                                                            	         |||||                                               
						                                                            	    1090 INLMV                                              1094                                                         

						Comparison report between T10028_P15 and Q8IVE1partial WT    	Sequence name: Q8IVE1                                        
						sequence followed by mismatch and a followed by a short      	                                                            
						unique deletion.1.An isolated chimeric polypeptide encoding  	Sequence documentation:                                      
						for T10028_P15, comprising a first amino acid sequence being 	                                                            
						at least 90 % homologous to                                  	Alignment of: 1540 x Q8IVE1   ..                             
						MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHI corresponding to     	                                                            
						amino acids 140 - 178 of Q8IVE1, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 39 of T10028_P15, a bridging amino acid I    	                                                            
						corresponding to amino acid 40 of T10028_P15, a second amino 	                     Quality: 10340.00                      Escore:       0                                              
						EIDLNTVQETQKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 	             Matching length:    1058                Total length:    1059                                               
						SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAFLRFIPTYTSR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.91                                               
						LAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVSASKQALAFGDSEGCVHLWTD 	    Total Percent Similarity:   99.91      Total Percent Identity:   99.81                                               
						SPEPSFNPYSRETEFALPCLVDSLPPLDWSQDLLPLSLIPVPLTTDTLLSDWPAANSAPA 	                        Gaps:       1                        
						PRRAPPVDAEILRTMKKVGFIGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGRE 	                                                            
						EEPHLHMVSKKYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 	Alignment:                                                   
						PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPEASALGLILAD 	                  .         .         .         .         .  
						SDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRGAGG                  	       1 MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHIIEIDLNTVQET 50                                                           
						acid sequence being at least 90 % homologous to corresponding	         |||||||||||||||||||||||||||||||||||||||:||||||||||  
						to amino acids 180 - 642 of Q8IVE1, which also corresponds to	     140 MARGGLIIFDYLLDENEDMHSLLLTDSSTLLVGGLQNHILEIDLNTVQET 189                                                          
						amino acids 41 - 503 of T10028_P15, and a third amino acid   	                  .         .         .         .         .  
						SFCSSGDSVIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPDDKTGKNYDFAQVLKR 	      51 QKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 100                                                          
						SICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVINCEVNSSKEADFWRMQAEVAFKMA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNVWLPFSIRMKMTKNKGLDVCN 	     190 QKYAVETPGVTIMRQTNRFFFCGHTSGKVSLRDLRTFKVEHEFDAFSGSL 239                                                          
						WTDGDEMQWGPARAEEEHGVYVYDLMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTH 	                  .         .         .         .         .  
						QQWYLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEA 	     101 SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAF 150                                                          
						SLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIKPSQMSV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSKHLTTLKSTYL 	     240 SDFDVHGNLLAACGFSSRLTGLACDRFLKVYDLRMMRAITPLQVHVDPAF 289                                                          
						KLRFLIDIGVKFVGHGLQKDFRVINLMVPKDQVLDTVYLFHMPRKRMISLRFLAWYFLDL 	                  .         .         .         .         .  
						KIQGETHDSIEDARTALQLYRKYLELSKNGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQ 	     151 LRFIPTYTSRLAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVS 200                                                          
						TSPKNAAVFSSVLAL                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     290 LRFIPTYTSRLAIISQSGQCQFCEPTGLANPADIFHVNPVGPLLMTFDVS 339                                                          
						amino acids 644 - 1198 of Q8IVE1, which also corresponds to  	                  .         .         .         .         .  
						amino acids 504 - 1058 of T10028_P15, wherein said first     	     201 ASKQALAFGDSEGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWS 250                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     340 ASKQALAFGDSEGCVHLWTDSPEPSFNPYSRETEFALPCLVDSLPPLDWS 389                                                          
						a sequential order.2.An isolated chimeric polypeptide        	                  .         .         .         .         .  
						encoding for an edge portion of T10028_P15, comprising a     	     251 QDLLPLSLIPVPLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGF 300                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     390 QDLLPLSLIPVPLTTDTLLSDWPAANSAPAPRRAPPVDAEILRTMKKVGF 439                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     301 IGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSK 350                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise GS, having 	     440 IGYAPNPRTRLRNQIPYRLKESDSEFDSFSQVTESPVGREEEPHLHMVSK 489                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 504-x to 504; and ending at any of amino acid   	     351 KYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 400                                                          
						numbers 504+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     490 KYRKVTIKYSKLGLEDFDFKHYNKTLFAGLEPHIPNAYCNCMIQVLYFLE 539                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     540 PVRCLIQNHLCQKEFCLACELGFLFHMLDLSRGDPCQGNNFLRAFRTIPE 589                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ASALGLILADSDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     590 ASALGLILADSDEASGKGNLARLIQRWNRFILTQLHQDMQELEIPQAYRG 639                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 AGG.SFCSSGDSVIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPDD 549                                                          
						                                                            	         ||| ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     640 AGGSSFCSSGDSVIGQLFSCEMENCSLCRCGSETVRASSTLLFTLSYPDD 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     550 KTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVI 599                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 KTGKNYDFAQVLKRSICLDQNTQAWCDTCEKYQPTIQTRNIRHLPDILVI 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     600 NCEVNSSKEADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPE 649                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 NCEVNSSKEADFWRMQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPE 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     650 GVLVCPSIEELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEE 699                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 GVLVCPSIEELKNVWLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEE 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     700 EHGVYVYDLMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLF 749                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 EHGVYVYDLMATVVHILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLF 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     750 NDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVL 799                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 NDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVL 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     800 LAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRS 849                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 LAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRS 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     850 DGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYS 899                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DGTKSTIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYS 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     900 GIKPGDLDAKISSKHLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINL 949                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1040 GIKPGDLDAKISSKHLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINL 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     950 MVPKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTA 999                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1090 MVPKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTA 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1000 LQLYRKYLELSKNGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNA 1049                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 LQLYRKYLELSKNGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNA 1189                                                         
						                                                            	                                                             
						                                                            	    1050 AVFSSVLAL                                          1058                                                         
						                                                            	         |||||||||                                           
						                                                            	    1190 AVFSSVLAL                                          1198                                                         

1542	HMR136_T10028_18_tr0_r1_1_gPRT		Comparison report between T10028_P18 and O75189partial WT    	Sequence name: O75189                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10028_P18, comprising a first amino	Sequence documentation:                                      
						MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNVWLPFSIRMKM 	                                                            
						TKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVVHILDSRTGGSLVAHIKVGET 	Alignment of: 1542 x O75189   ..                             
						YHQRKEGVTHQQWYLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNP 	                                                            
						IEASVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTK 	Alignment segment 1/1:                                       
						STIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 	                                                            
						HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMV                       	                     Quality: 3316.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     338                Total length:     338                                               
						to amino acids 757 - 1094 of O75189, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 338 of T10028_P18, and a second amino acid	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						PKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSK 	                  .         .         .         .         .  
						NGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL              	       1 MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNV 50                                                           
						having the sequence corresponding to amino acids 339 - 445 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10028_P18, wherein said first amino acid sequence and second	     757 MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNV 806                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 WLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVV 100                                                          
						T10028_P18, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     807 WLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVV 856                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						PKDQVLDTVYLFHMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSK 	     101 HILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAV 150                                                          
						NGTEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in T10028_P18.    	     857 HILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAV 906                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLARKQRKTH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     907 QFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLARKQRKTH 956                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIKPSQMSV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     957 TTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIKPSQMSV 1006                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1007 ARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 1056                                                         
						                                                            	                  .         .         .                      
						                                                            	     301 HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMV             338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	    1057 HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMV             1094                                                         

						Comparison report between T10028_P18 and Q8IVE1partial WT    	Sequence name: Q8IVE1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10028_P18, comprising a first amino acid       	                                                            
						MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNVWLPFSIRMKM 	Alignment of: 1542 x Q8IVE1   ..                             
						TKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVVHILDSRTGGSLVAHIKVGET 	                                                            
						YHQRKEGVTHQQWYLFNDFLIEPIDKHEAVQFDMNWKVPAILYYVKRNLNSRYNLNIKNP 	Alignment segment 1/1:                                       
						IEASVLLAEASLARKQRKTHTTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTK 	                                                            
						STIKPSQMSVARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 	                     Quality: 4373.00                      Escore:       0                                               
						HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMVPKDQVLDTVYLFHMPRKRMISL 	             Matching length:     445                Total length:     445                                               
						RFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSKNGTEPESFHKVLKGLYEKGRKM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DWKVPEPEGQTSPKNAAVFSSVLAL                                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 754 - 1198 of Q8IVE1, which also corresponds to  	                                                            
						amino acids 1 - 445 of T10028_P18.                           	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     754 MQAEVAFKMAVKKHGGEISKNKEFALADWKELGSPEGVLVCPSIEELKNV 803                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     804 WLPFSIRMKMTKNKGLDVCNWTDGDEMQWGPARAEEEHGVYVYDLMATVV 853                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 HILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     854 HILDSRTGGSLVAHIKVGETYHQRKEGVTHQQWYLFNDFLIEPIDKHEAV 903                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLARKQRKTH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     904 QFDMNWKVPAILYYVKRNLNSRYNLNIKNPIEASVLLAEASLARKQRKTH 953                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIKPSQMSV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     954 TTFIPLMLNEMPQIGDLVGLDAEFVTLNEEEAELRSDGTKSTIKPSQMSV 1003                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1004 ARITCVRGQGPNEGIPFIDDYISTQEQVVDYLTQYSGIKPGDLDAKISSK 1053                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMVPKDQVLDTVYLF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1054 HLTTLKSTYLKLRFLIDIGVKFVGHGLQKDFRVINLMVPKDQVLDTVYLF 1103                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSKNG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1104 HMPRKRMISLRFLAWYFLDLKIQGETHDSIEDARTALQLYRKYLELSKNG 1153                                                         
						                                                            	                  .         .         .         .            
						                                                            	     401 TEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL      445                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1154 TEPESFHKVLKGLYEKGRKMDWKVPEPEGQTSPKNAAVFSSVLAL      1198                                                         

22510	HMR136_T10051_10_tr0_r1_1_gPRT		Comparison report between T10051_P10 and RBM5_HUMANpartial   	Sequence name: RBM5_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10051_P10, comprising a first amino	Sequence documentation:                                      
						MGSDKRVSRTERSGRYGSIIDRDDRDERESRSRRRDSDYKRSSDDRRGDRYDDYRDYDSP 	                                                            
						ERERERRNSDRSEDGYHSDGDYGEHDYRHDISDERESKTIMLRGLPITITESDIREMMES 	Alignment of: 22510 x RBM5_HUMAN   ..                        
						FEGPQPADVRLMKRKTG                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 137 of RBM5_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 137 of T10051_P10, and a second amino acid	                     Quality: 1362.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     139                Total length:     139                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:   99.28   Matching Percent Identity:   99.28                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   99.28      Total Percent Identity:   99.28                                               
						having the sequence ESLLSS corresponding to amino acids 138 -	                        Gaps:       0                        
						143 of T10051_P10, wherein said first amino acid sequence and	                                                            
						second amino acid sequence are contiguous and in a sequential	Alignment:                                                   
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						T10051_P10, comprising a polypeptide being at least 70%,     	       1 MGSDKRVSRTERSGRYGSIIDRDDRDERESRSRRRDSDYKRSSDDRRGDR 50                                                           
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	       1 MGSDKRVSRTERSGRYGSIIDRDDRDERESRSRRRDSDYKRSSDDRRGDR 50                                                           
						least about 95% homologous to the sequence ESLLSS in         	                  .         .         .         .         .  
						T10051_P10.                                                  	      51 YDDYRDYDSPERERERRNSDRSEDGYHSDGDYGEHDYRHDISDERESKTI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 YDDYRDYDSPERERERRNSDRSEDGYHSDGDYGEHDYRHDISDERESKTI 100                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 MLRGLPITITESDIREMMESFEGPQPADVRLMKRKTGES            139                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||| |             
						                                                            	     101 MLRGLPITITESDIREMMESFEGPQPADVRLMKRKTGVS            139                                                          

22514	HMR136_T10051_21_tr0_r1_1_gPRT		Comparison report between T10051_P21 and RBM5_HUMANunique    	Sequence name: RBM5_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T10051_P21, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22514 x RBM5_HUMAN   ..                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FLTWNDCMLDFVFA corresponding to amino    	Alignment segment 1/1:                                       
						acids 1 - 14 of T10051_P21, and a second amino acid sequence 	                                                            
						AVPDTSTYQYDESSGYYYDPTTGLYYDPNSQYYYNSLTQQYLYWDGEKETYVPAAESSSH 	                     Quality: 3575.00                      Escore:       0                                               
						QQSGLPPAKEGKEKKEKPKSKTAQQIAKDMERWAKSLNKQKENFKNSFQPVNSLREEERR 	             Matching length:     361                Total length:     361                                               
						ESAAADAGFALFEKKGALAERQQLIPELVRNGDEENPLKRGLVAAYSGDSDNEEELVERL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ESEEEKLADWKKMACLLCRRQFPNKDALVRHQQLSDLHKQNMDIYRRSRLSEQELEALEL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						REREMKYRDRAAERREKYGIPEPPEPKRKKQFDAGTVNYEQPTKDGIDHSNIGNKMLQAM 	                        Gaps:       0                        
						GWREGSGLGRKCQGITAPIEAQVRLKGAGLGAKGSAYGLSGADSYKDAVRKAMFARFTEM 	                                                            
						E                                                            	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 455 - 815 of RBM5_HUMAN, which also corresponds to     	      15 AVPDTSTYQYDESSGYYYDPTTGLYYDPNSQYYYNSLTQQYLYWDGEKET 64                                                           
						amino acids 15 - 375 of T10051_P21, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence and second amino acid sequence are contiguous  	     455 AVPDTSTYQYDESSGYYYDPTTGLYYDPNSQYYYNSLTQQYLYWDGEKET 504                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of T10051_P21, comprising a polypeptide being at  	      65 YVPAAESSSHQQSGLPPAKEGKEKKEKPKSKTAQQIAKDMERWAKSLNKQ 114                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     505 YVPAAESSSHQQSGLPPAKEGKEKKEKPKSKTAQQIAKDMERWAKSLNKQ 554                                                          
						preferably at least about 95% homologous to the sequence     	                  .         .         .         .         .  
						FLTWNDCMLDFVFA of T10051_P21.                                	     115 KENFKNSFQPVNSLREEERRESAAADAGFALFEKKGALAERQQLIPELVR 164                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     555 KENFKNSFQPVNSLREEERRESAAADAGFALFEKKGALAERQQLIPELVR 604                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     165 NGDEENPLKRGLVAAYSGDSDNEEELVERLESEEEKLADWKKMACLLCRR 214                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     605 NGDEENPLKRGLVAAYSGDSDNEEELVERLESEEEKLADWKKMACLLCRR 654                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     215 QFPNKDALVRHQQLSDLHKQNMDIYRRSRLSEQELEALELREREMKYRDR 264                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     655 QFPNKDALVRHQQLSDLHKQNMDIYRRSRLSEQELEALELREREMKYRDR 704                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     265 AAERREKYGIPEPPEPKRKKQFDAGTVNYEQPTKDGIDHSNIGNKMLQAM 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     705 AAERREKYGIPEPPEPKRKKQFDAGTVNYEQPTKDGIDHSNIGNKMLQAM 754                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 GWREGSGLGRKCQGITAPIEAQVRLKGAGLGAKGSAYGLSGADSYKDAVR 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     755 GWREGSGLGRKCQGITAPIEAQVRLKGAGLGAKGSAYGLSGADSYKDAVR 804                                                          
						                                                            	                  .                                          
						                                                            	     365 KAMFARFTEME                                        375                                                          
						                                                            	         |||||||||||                                         
						                                                            	     805 KAMFARFTEME                                        815                                                          

22512	HMR136_T10051_23_tr0_r1_1_gPRT		Comparison report between T10051_P23 and RBM5_HUMANpartial   	Sequence name: RBM5_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10051_P23, comprising a first amino	                                                            
						MERWAKSLNKQKENFKNSFQPVNSLREEERRESAAADAGFALFEKKGALAERQQLIPELV 	Alignment of: 22512 x RBM5_HUMAN   ..                        
						RNGDEENPLKRGLVAAYSGDSDNEEELVERLESEEEKLADWKKMACLLCRRQFPNKDALV 	                                                            
						RHQQLSDLHKQNMDIYRRSRLSEQELEALELREREMKYRDRAAERREKYGIPEPPEPKRK 	Alignment segment 1/1:                                       
						KQFDAGTVNYEQPTKDGIDHSNIGNKMLQAMGWREGSGLGRKCQGITAPIEAQVRLKGAG 	                                                            
						LGAKGSAYGLSGADSYKDAVRKAMFARFTEME                             	                     Quality: 2673.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     272                Total length:     272                                               
						to amino acids 544 - 815 of RBM5_HUMAN, which also           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 272 of T10051_P23.            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MERWAKSLNKQKENFKNSFQPVNSLREEERRESAAADAGFALFEKKGALA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     544 MERWAKSLNKQKENFKNSFQPVNSLREEERRESAAADAGFALFEKKGALA 593                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ERQQLIPELVRNGDEENPLKRGLVAAYSGDSDNEEELVERLESEEEKLAD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     594 ERQQLIPELVRNGDEENPLKRGLVAAYSGDSDNEEELVERLESEEEKLAD 643                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 WKKMACLLCRRQFPNKDALVRHQQLSDLHKQNMDIYRRSRLSEQELEALE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     644 WKKMACLLCRRQFPNKDALVRHQQLSDLHKQNMDIYRRSRLSEQELEALE 693                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LREREMKYRDRAAERREKYGIPEPPEPKRKKQFDAGTVNYEQPTKDGIDH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     694 LREREMKYRDRAAERREKYGIPEPPEPKRKKQFDAGTVNYEQPTKDGIDH 743                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SNIGNKMLQAMGWREGSGLGRKCQGITAPIEAQVRLKGAGLGAKGSAYGL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     744 SNIGNKMLQAMGWREGSGLGRKCQGITAPIEAQVRLKGAGLGAKGSAYGL 793                                                          
						                                                            	                  .         .                                
						                                                            	     251 SGADSYKDAVRKAMFARFTEME                             272                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     794 SGADSYKDAVRKAMFARFTEME                             815                                                          

22935	HMR136_T10066_5_tr0_r1_1_gPRT		Comparison report between T10066_P5 and Q9UJ54partial WT     	Sequence name: Q9UJ54                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10066_P5, comprising a first amino acid        	                                                            
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	Alignment of: 22935 x Q9UJ54   ..                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESL 	                                                            
						WPFLIDKRWRQTVFH                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 189 - 323 of Q9UJ54, which also corresponds to   	                     Quality: 1368.00                      Escore:       0                                               
						amino acids 1 - 135 of T10066_P5.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 288                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     289 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                323                                                          

						Comparison report between T10066_P5 and Q9BS89partial WT     	Sequence name: Q9BS89                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T10066_P5, comprising a first amino 	Sequence documentation:                                      
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	                                                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRN                            	Alignment of: 22935 x Q9BS89   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 189 - 281 of Q9BS89, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 93 of T10066_P5, a bridging amino acid A     	                                                            
						corresponding to amino acid 94 of T10066_P5, and a second    	                     Quality: 1359.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     135                Total length:     135                                               
						QLDCSKLETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH corresponding to   	 Matching Percent Similarity:   99.26   Matching Percent Identity:   99.26                                               
						amino acids 283 - 323 of Q9BS89, which also corresponds to   	    Total Percent Similarity:   99.26      Total Percent Identity:   99.26                                               
						amino acids 95 - 135 of T10066_P5, wherein said first amino  	                        Gaps:       0                        
						acid sequence, bridging amino acid and second amino acid     	                                                            
						sequence are contiguous and in a sequential order.           	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						                                                            	     239 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNTQLDCSK 288                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     289 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                323                                                          

						Comparison report between T10066_P5 and Q9NZL9partial WT     	Sequence name: Q9NZL9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10066_P5, comprising a first amino acid        	                                                            
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	Alignment of: 22935 x Q9NZL9   ..                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESL 	                                                            
						WPFLIDKRWRQTVFH                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 200 - 334 of Q9NZL9, which also corresponds to   	                     Quality: 1368.00                      Escore:       0                                               
						amino acids 1 - 135 of T10066_P5.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     200 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 249                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     250 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 299                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     300 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                334                                                          

22931	HMR136_T10066_6_tr0_r1_1_gPRT		Comparison report between T10066_P6 and Q9UJ54partial WT     	Sequence name: Q9UJ54                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10066_P6, comprising a first amino acid        	                                                            
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	Alignment of: 22931 x Q9UJ54   ..                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESL 	                                                            
						WPFLIDKRWRQTVFH                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 189 - 323 of Q9UJ54, which also corresponds to   	                     Quality: 1368.00                      Escore:       0                                               
						amino acids 1 - 135 of T10066_P6.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 288                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     289 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                323                                                          

						Comparison report between T10066_P6 and Q9BS89partial WT     	Sequence name: Q9BS89                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T10066_P6, comprising a first amino 	Sequence documentation:                                      
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	                                                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRN                            	Alignment of: 22931 x Q9BS89   ..                            
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 189 - 281 of Q9BS89, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 93 of T10066_P6, a bridging amino acid A     	                                                            
						corresponding to amino acid 94 of T10066_P6, and a second    	                     Quality: 1359.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     135                Total length:     135                                               
						QLDCSKLETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH corresponding to   	 Matching Percent Similarity:   99.26   Matching Percent Identity:   99.26                                               
						amino acids 283 - 323 of Q9BS89, which also corresponds to   	    Total Percent Similarity:   99.26      Total Percent Identity:   99.26                                               
						amino acids 95 - 135 of T10066_P6, wherein said first amino  	                        Gaps:       0                        
						acid sequence, bridging amino acid and second amino acid     	                                                            
						sequence are contiguous and in a sequential order.           	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||| ||||||  
						                                                            	     239 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNTQLDCSK 288                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     289 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                323                                                          

						Comparison report between T10066_P6 and Q9NZL9partial WT     	Sequence name: Q9NZL9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10066_P6, comprising a first amino acid        	                                                            
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	Alignment of: 22931 x Q9NZL9   ..                            
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESL 	                                                            
						WPFLIDKRWRQTVFH                                              	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 200 - 334 of Q9NZL9, which also corresponds to   	                     Quality: 1368.00                      Escore:       0                                               
						amino acids 1 - 135 of T10066_P6.                            	             Matching length:     135                Total length:     135                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     200 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 249                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     250 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 299                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     300 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                334                                                          

22933	HMR136_T10066_7_tr0_r1_1_gPRT		Comparison report between T10066_P7 and Q9UJ54unique head    	Sequence name: Q9UJ54                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10066_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22933 x Q9UJ54   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DLSSFFV corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of T10066_P7, and a second amino acid sequence being at    	                                                            
						AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVLRIPI 	                     Quality: 2074.00                      Escore:       0                                               
						LYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSI 	             Matching length:     210                Total length:     210                                               
						KGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IGQRTPFRIGIKESLWPFLIDKRWRQTVFH                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 114 -  	                        Gaps:       0                        
						323 of Q9UJ54, which also corresponds to amino acids 8 - 217 	                                                            
						of T10066_P7, wherein said first amino acid sequence and     	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	       8 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 57                                                           
						T10066_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     114 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 163                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence DLSSFFV of        	      58 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 107                                                          
						T10066_P7.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     164 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 213                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     108 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 157                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     214 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 263                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 HLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 207                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 HLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 313                                                          
						                                                            	                  .                                          
						                                                            	     208 DKRWRQTVFH                                         217                                                          
						                                                            	         ||||||||||                                          
						                                                            	     314 DKRWRQTVFH                                         323                                                          

						Comparison report between T10066_P7 and Q9H3E1unique head    	Sequence name: Q9H3E1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10066_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22933 x Q9H3E1   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						DLSSFFVAAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGA 	Alignment segment 1/1:                                       
						AVLRIPILYGEVEKLEESAVTV                                       	                                                            
						having the sequence corresponding to amino acids 1 - 82 of   	                     Quality: 1368.00                      Escore:       0                                               
						T10066_P7, and a second amino acid sequence being at least 90	             Matching length:     135                Total length:     135                                               
						MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						WPFLIDKRWRQTVFH                                              	                        Gaps:       0                        
						% homologous to corresponding to amino acids 1 - 135 of      	                                                            
						Q9H3E1, which also corresponds to amino acids 83 - 217 of    	Alignment:                                                   
						T10066_P7, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      83 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 132                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10066_P7, comprising a polypeptide being at least 70%,      	       1 MFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSIKGTFH 50                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     133 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 182                                                          
						DLSSFFVAAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVLRIPILYGEVEKLEESAVTV                                       	      51 WSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSK 100                                                          
						least about 95% homologous to the sequence of T10066_P7.     	                  .         .         .                      
						                                                            	     183 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                217                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     101 LETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH                135                                                          

						Comparison report between T10066_P7 and Q9BS89unique head    	Sequence name: Q9BS89                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for T10066_P7, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 22933 x Q9BS89   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence DLSSFFV corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 7 of T10066_P7, a second amino acid sequence 	                                                            
						AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVLRIPI 	                     Quality: 2065.00                      Escore:       0                                               
						LYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSI 	             Matching length:     210                Total length:     210                                               
						KGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRN             	 Matching Percent Similarity:   99.52   Matching Percent Identity:   99.52                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   99.52      Total Percent Identity:   99.52                                               
						acids 114 - 281 of Q9BS89, which also corresponds to amino   	                        Gaps:       0                        
						acids 8 - 175 of T10066_P7, a bridging amino acid A          	                                                            
						corresponding to amino acid 176 of T10066_P7, and a third    	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						QLDCSKLETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH corresponding to   	       8 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 57                                                           
						amino acids 283 - 323 of Q9BS89, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 177 - 217 of T10066_P7, wherein said first amino 	     114 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 163                                                          
						acid sequence, second amino acid sequence, bridging amino    	                  .         .         .         .         .  
						acid and third amino acid sequence are contiguous and in a   	      58 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 107                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of T10066_P7, comprising a polypeptide being at least   	     164 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 213                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     108 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 157                                                          
						at least about 95% homologous to the sequence DLSSFFV of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10066_P7.                                                   	     214 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 263                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 HLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 207                                                          
						                                                            	         |||||||||||||||||| |||||||||||||||||||||||||||||||  
						                                                            	     264 HLRPITDSPVLGAQRPRNTQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 313                                                          
						                                                            	                  .                                          
						                                                            	     208 DKRWRQTVFH                                         217                                                          
						                                                            	         ||||||||||                                          
						                                                            	     314 DKRWRQTVFH                                         323                                                          

						Comparison report between T10066_P7 and Q9NZL9unique head    	Sequence name: Q9NZL9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10066_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22933 x Q9NZL9   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence DLSSFFV corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of T10066_P7, and a second amino acid sequence being at    	                                                            
						AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVLRIPI 	                     Quality: 2074.00                      Escore:       0                                               
						LYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRMLDPSI 	             Matching length:     210                Total length:     210                                               
						KGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKLETLG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IGQRTPFRIGIKESLWPFLIDKRWRQTVFH                               	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 125 -  	                        Gaps:       0                        
						334 of Q9NZL9, which also corresponds to amino acids 8 - 217 	                                                            
						of T10066_P7, wherein said first amino acid sequence and     	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	       8 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 57                                                           
						T10066_P7, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     125 AAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENN 174                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence DLSSFFV of        	      58 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 107                                                          
						T10066_P7.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     175 LGAAVLRIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHV 224                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     108 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 157                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     225 KDVATVCRQLAEKRMLDPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSS 274                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 HLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 207                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     275 HLRPITDSPVLGAQRPRNAQLDCSKLETLGIGQRTPFRIGIKESLWPFLI 324                                                          
						                                                            	                  .                                          
						                                                            	     208 DKRWRQTVFH                                         217                                                          
						                                                            	         ||||||||||                                          
						                                                            	     325 DKRWRQTVFH                                         334                                                          

2323	HMR136_T10108_4_tr0_r1_1_gPRT		Comparison report between T10108_P4 and Q96L13partial WT     	Sequence name: Q96L13                                        
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for T10108_P4, comprising a first amino 	Sequence documentation:                                      
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	                                                            
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTP                   	Alignment of: 2323 x Q96L13   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 121 - 222 of Q96L13, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 102 of T10108_P4, a second amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1726.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     184                Total length:     185                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence E corresponding to amino acids 103 - 103 	    Total Percent Similarity:   99.46      Total Percent Identity:   99.46                                               
						of T10108_P4, and a third amino acid sequence being at least 	                        Gaps:       1                        
						ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLG 	                                                            
						HETPRAKSPEQLRGDPGLRGSL                                       	Alignment:                                                   
						90 % homologous to corresponding to amino acids 223 - 304 of 	                  .         .         .         .         .  
						Q96L13, which also corresponds to amino acids 104 - 185 of   	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						T10108_P4, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10108_P4,       	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for E,   	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						corresponding to T10108_P4.                                  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TP.ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 269                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     270 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                304                                                          

						Comparison report between T10108_P4 and Q9UJJ9partial WT     	Sequence name: Q9UJJ9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10108_P4, comprising a first amino acid        	                                                            
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	Alignment of: 2323 x Q9UJJ9   ..                             
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTPEENEPTQLEGGPDSLGFE 	                                                            
						TLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLGHETPRAKSPEQLRGDPG 	Alignment segment 1/1:                                       
						LRGSL                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1836.00                      Escore:       0                                               
						amino acids 121 - 305 of Q9UJJ9, which also corresponds to   	             Matching length:     185                Total length:     185                                               
						amino acids 1 - 185 of T10108_P4.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 270                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     271 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                305                                                          

2327	HMR136_T10108_8_tr0_r1_1_gPRT		Comparison report between T10108_P8 and Q96L13partial WT     	Sequence name: Q96L13                                        
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for T10108_P8, comprising a first amino 	Sequence documentation:                                      
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	                                                            
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTP                   	Alignment of: 2327 x Q96L13   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 121 - 222 of Q96L13, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 102 of T10108_P8, a second amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1726.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     184                Total length:     185                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence E corresponding to amino acids 103 - 103 	    Total Percent Similarity:   99.46      Total Percent Identity:   99.46                                               
						of T10108_P8, and a third amino acid sequence being at least 	                        Gaps:       1                        
						ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLG 	                                                            
						HETPRAKSPEQLRGDPGLRGSL                                       	Alignment:                                                   
						90 % homologous to corresponding to amino acids 223 - 304 of 	                  .         .         .         .         .  
						Q96L13, which also corresponds to amino acids 104 - 185 of   	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						T10108_P8, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10108_P8,       	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for E,   	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						corresponding to T10108_P8.                                  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TP.ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 269                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     270 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                304                                                          

						Comparison report between T10108_P8 and Q9UJJ9partial WT     	Sequence name: Q9UJJ9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10108_P8, comprising a first amino acid        	                                                            
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	Alignment of: 2327 x Q9UJJ9   ..                             
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTPEENEPTQLEGGPDSLGFE 	                                                            
						TLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLGHETPRAKSPEQLRGDPG 	Alignment segment 1/1:                                       
						LRGSL                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1836.00                      Escore:       0                                               
						amino acids 121 - 305 of Q9UJJ9, which also corresponds to   	             Matching length:     185                Total length:     185                                               
						amino acids 1 - 185 of T10108_P8.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 270                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     271 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                305                                                          

2325	HMR136_T10108_9_tr0_r1_1_gPRT		Comparison report between T10108_P9 and Q96L13partial WT     	Sequence name: Q96L13                                        
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for T10108_P9, comprising a first amino 	Sequence documentation:                                      
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	                                                            
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTP                   	Alignment of: 2325 x Q96L13   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 121 - 222 of Q96L13, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 102 of T10108_P9, a second amino acid        	                                                            
						sequence being at least 70%, optionally at least 80%,        	                     Quality: 1726.00                      Escore:       0                                               
						preferably at least 85%, more preferably at least 90% and    	             Matching length:     184                Total length:     185                                               
						most preferably at least 95% homologous to a polypeptide     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence E corresponding to amino acids 103 - 103 	    Total Percent Similarity:   99.46      Total Percent Identity:   99.46                                               
						of T10108_P9, and a third amino acid sequence being at least 	                        Gaps:       1                        
						ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLG 	                                                            
						HETPRAKSPEQLRGDPGLRGSL                                       	Alignment:                                                   
						90 % homologous to corresponding to amino acids 223 - 304 of 	                  .         .         .         .         .  
						Q96L13, which also corresponds to amino acids 104 - 185 of   	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						T10108_P9, wherein said first amino acid sequence, second    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10108_P9,       	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for E,   	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						corresponding to T10108_P9.                                  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TP.ENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 269                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     270 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                304                                                          

						Comparison report between T10108_P9 and Q9UJJ9partial WT     	Sequence name: Q9UJJ9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10108_P9, comprising a first amino acid        	                                                            
						MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCHPHALLVYPTL 	Alignment of: 2325 x Q9UJJ9   ..                             
						PEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLKTPEENEPTQLEGGPDSLGFE 	                                                            
						TLENCRKAHKELSKEIKRLKGLLTQHGIPYTRPTETSNLEHLGHETPRAKSPEQLRGDPG 	Alignment segment 1/1:                                       
						LRGSL                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1836.00                      Escore:       0                                               
						amino acids 121 - 305 of Q9UJJ9, which also corresponds to   	             Matching length:     185                Total length:     185                                               
						amino acids 1 - 185 of T10108_P9.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 MWMRDGDACRSRSRQSKVELACGKSNRLAHVSEPSTCVYALTFETPLVCH 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 PHALLVYPTLPEALQRQWDQVEQDLADELITPQGHEKLLRTLFEDAGYLK 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 TPEENEPTQLEGGPDSLGFETLENCRKAHKELSKEIKRLKGLLTQHGIPY 270                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                185                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     271 TRPTETSNLEHLGHETPRAKSPEQLRGDPGLRGSL                305                                                          

2672	HMR136_T10137_14_tr0_r1_1_gPRT		Comparison report between T10137_P14 and GAL2_HUMANpartial   	Sequence name: GAL2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10137_P14, comprising a first amino	                                                            
						MNCLVDGNIPPSSGLSSSSALVCCAGLVTLTVLGRNLSKVELAEICAKSERYIGTEGGGM 	Alignment of: 2672 x GAL2_HUMAN   ..                         
						DQSISFLAEEGTAKLIEFSPLRATDVKLPSGAVFVIANSCVEMNKAATSHFNIRVMECRL 	                                                            
						AAKLLAKYKSLQWDKVLRLEEVQAKLGISLEEMLLVTEDALHPEPYNPEEICRCLGISLE 	Alignment segment 1/1:                                       
						ELRTQILSPNTQDVLIFKLYQRAKHVYSEAARVLQFKKICEEAPENMVQLLGELMNQSHM 	                                                            
						SCRDMYECSCPELDQLVDICRKFGAQGSRLTGAGWGGCTVSMVPADKLPSFLANVHKAYY 	                     Quality: 3193.00                      Escore:       0                                               
						QRSDGSLAPEKQSLFATKPGGGALVLLEA                                	             Matching length:     329                Total length:     329                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 130 - 458 of GAL2_HUMAN, which also           	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 329 of T10137_P14.            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MNCLVDGNIPPSSGLSSSSALVCCAGLVTLTVLGRNLSKVELAEICAKSE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     130 MNCLVDGNIPPSSGLSSSSALVCCAGLVTLTVLGRNLSKVELAEICAKSE 179                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 RYIGTEGGGMDQSISFLAEEGTAKLIEFSPLRATDVKLPSGAVFVIANSC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     180 RYIGTEGGGMDQSISFLAEEGTAKLIEFSPLRATDVKLPSGAVFVIANSC 229                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VEMNKAATSHFNIRVMECRLAAKLLAKYKSLQWDKVLRLEEVQAKLGISL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     230 VEMNKAATSHFNIRVMECRLAAKLLAKYKSLQWDKVLRLEEVQAKLGISL 279                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EEMLLVTEDALHPEPYNPEEICRCLGISLEELRTQILSPNTQDVLIFKLY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     280 EEMLLVTEDALHPEPYNPEEICRCLGISLEELRTQILSPNTQDVLIFKLY 329                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QRAKHVYSEAARVLQFKKICEEAPENMVQLLGELMNQSHMSCRDMYECSC 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     330 QRAKHVYSEAARVLQFKKICEEAPENMVQLLGELMNQSHMSCRDMYECSC 379                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PELDQLVDICRKFGAQGSRLTGAGWGGCTVSMVPADKLPSFLANVHKAYY 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     380 PELDQLVDICRKFGAQGSRLTGAGWGGCTVSMVPADKLPSFLANVHKAYY 429                                                          
						                                                            	                  .         .                                
						                                                            	     301 QRSDGSLAPEKQSLFATKPGGGALVLLEA                      329                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     430 QRSDGSLAPEKQSLFATKPGGGALVLLEA                      458                                                          

25048	HMR136_T10148_3_tr0_r1_1_gPRT		Comparison report between T10148_P3 and Q9H9M7unique head    	Sequence name: Q9H9M7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10148_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 25048 x Q9H9M7   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MQPGWCSGLAGMHLSSASTWRLDSCPRPLCP          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 31 of T10148_P3, and a      	                                                            
						QDRDFIMTFNTSLHRSWWMENGPGCLVTPVLNSRLALEDHHVISVTGCLLDYPYIEALSS 	                     Quality: 1162.00                      Escore:       0                                               
						ALQIFLALFGFVFACYVSKVFLEEEDSFDFIGGFDSYGYQAPQKTSHLQLQPLYTSG    	             Matching length:     117                Total length:     117                                               
						second amino acid sequence being at least 90 % homologous to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 47 - 163 of Q9H9M7, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 32 - 148 of T10148_P3, wherein    	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a head of T10148_P3, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      32 QDRDFIMTFNTSLHRSWWMENGPGCLVTPVLNSRLALEDHHVISVTGCLL 81                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      47 QDRDFIMTFNTSLHRSWWMENGPGCLVTPVLNSRLALEDHHVISVTGCLL 96                                                           
						to the sequence MQPGWCSGLAGMHLSSASTWRLDSCPRPLCP of T10148_P3.	                  .         .         .         .         .  
						                                                            	      82 DYPYIEALSSALQIFLALFGFVFACYVSKVFLEEEDSFDFIGGFDSYGYQ 131                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      97 DYPYIEALSSALQIFLALFGFVFACYVSKVFLEEEDSFDFIGGFDSYGYQ 146                                                          
						                                                            	                  .                                          
						                                                            	     132 APQKTSHLQLQPLYTSG                                  148                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     147 APQKTSHLQLQPLYTSG                                  163                                                          

26997	HMR136_T10228_2_tr0_r1_1_gPRT		Comparison report between T10228_P2 and MPK4_HUMANpartial WT 	Sequence name: MPK4_HUMAN                                    
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10228_P2, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MAAPSPSGGGGSGGGSGSGTPGPVGSPAPGHPAVSSMQG corresponding to     	Alignment of: 26997 x MPK4_HUMAN   ..                        
						amino acids 1 - 39 of MPK4_HUMAN, which also corresponds to  	                                                            
						amino acids 1 - 39 of T10228_P2, a second amino acid sequence	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality: 3840.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:     399                Total length:     410                                               
						FQINFCEKAQS corresponding to amino acids 40 - 50 of          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10228_P2, and a third amino acid sequence being at least 90 	    Total Percent Similarity:   97.32      Total Percent Identity:   97.32                                               
						KRKALKLNFANPPFKSTARFTLNPNPTGVQNPHIERLRTHSIESSGKLKISPEQHWDFTA 	                        Gaps:       1                        
						EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 	                                                            
						YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 	Alignment:                                                   
						KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 	                  .         .         .         .         .  
						SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 	       1 MAAPSPSGGGGSGGGSGSGTPGPVGSPAPGHPAVSSMQGFQINFCEKAQS 50                                                           
						FINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVD 	         |||||||||||||||||||||||||||||||||||||||             
						% homologous to corresponding to amino acids 40 - 399 of     	       1 MAAPSPSGGGGSGGGSGSGTPGPVGSPAPGHPAVSSMQG........... 39                                                           
						MPK4_HUMAN, which also corresponds to amino acids 51 - 410 of	                  .         .         .         .         .  
						T10228_P2, wherein said first amino acid sequence, second    	      51 KRKALKLNFANPPFKSTARFTLNPNPTGVQNPHIERLRTHSIESSGKLKI 100                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	      40 KRKALKLNFANPPFKSTARFTLNPNPTGVQNPHIERLRTHSIESSGKLKI 89                                                           
						polypeptide encoding for an edge portion of T10228_P2,       	                  .         .         .         .         .  
						comprising an amino acid sequence being at least 70%,        	     101 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 150                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      90 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 139                                                          
						least about 95% homologous to the sequence encoding for      	                  .         .         .         .         .  
						FQINFCEKAQS, corresponding to T10228_P2.                     	     151 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     140 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY 189                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     190 KYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 239                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     240 SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 289                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     290 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 339                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     340 FINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMP 389                                                          
						                                                            	                  .                                          
						                                                            	     401 ATPSSPMYVD                                         410                                                          
						                                                            	         ||||||||||                                          
						                                                            	     390 ATPSSPMYVD                                         399                                                          

26995	HMR136_T10228_5_tr0_r1_1_gPRT		Comparison report between T10228_P5 and MPK4_HUMANpartial WT 	Sequence name: MPK4_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10228_P5, comprising a first amino acid        	                                                            
						MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 	Alignment of: 26995 x MPK4_HUMAN   ..                        
						ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 	                                                            
						RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 	Alignment segment 1/1:                                       
						ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 	                                                            
						KELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVD                    	                     Quality: 2783.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     281                Total length:     281                                               
						amino acids 119 - 399 of MPK4_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 281 of T10228_P5.                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     119 MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 168                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     169 FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 218                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     219 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 268                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     269 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 318                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     319 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 368                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 MYEERAVEVACYVCKILDQMPATPSSPMYVD                    281                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     369 MYEERAVEVACYVCKILDQMPATPSSPMYVD                    399                                                          

26999	HMR136_T10228_7_tr0_r1_1_gPRT		Comparison report between T10228_P7 and MPK4_HUMANpartial WT 	Sequence name: MPK4_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10228_P7, comprising a first amino acid        	                                                            
						MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 	Alignment of: 26999 x MPK4_HUMAN   ..                        
						KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 	                                                            
						RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 	Alignment segment 1/1:                                       
						QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 	                                                            
						QMPATPSSPMYVD                                                	                     Quality: 2511.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     253                Total length:     253                                               
						amino acids 147 - 399 of MPK4_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 253 of T10228_P7.                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     147 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 196                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     197 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 246                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     247 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 296                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     297 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 346                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     347 CLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPM 396                                                          
						                                                            	                                                             
						                                                            	     251 YVD                                                253                                                          
						                                                            	         |||                                                 
						                                                            	     397 YVD                                                399                                                          

27126	HMR136_T10232_4_tr0_r1_1_gPRT		Comparison report between T10232_P4 and Q96NJ5unique head    	Sequence name: Q96NJ5                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						T10232_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27126 x Q96NJ5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence LIALLC       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 6 of T10232_P4, a second    	                                                            
						SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHKAVLAACSDYF 	                     Quality: 5522.00                      Escore:       0                                               
						RAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILLEPGVIQDVLAAGSHLQLLEL 	             Matching length:     561                Total length:     561                                               
						LNLCSHYLIQELNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEEVLTLPY 	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.82                                               
						CLLQEVLKSDRLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTLHTVALS 	    Total Percent Similarity:   99.82      Total Percent Identity:   99.82                                               
						HPLVQASETATALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREVCKVKEL 	                        Gaps:       0                        
						RYFNPVDQENALIAAIANWSELA                                      	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 8 - 330 of Q96NJ5, which also   	                  .         .         .         .         .  
						corresponds to amino acids 7 - 329 of T10232_P4, a bridging  	       7 SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHK 56                                                           
						amino acid P corresponding to amino acid 330 of T10232_P4, a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPVGRSHHCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNSWAEIAPMKNCREHF 	       8 SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHK 57                                                           
						VLGAMEEYLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLSCHAGYVADGLLWIS 	                  .         .         .         .         .  
						GGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGGNDLDYNNDRI 	      57 AVLAACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILL 106                                                          
						LVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSIWTNEPLACIQV    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	      58 AVLAACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILL 107                                                          
						corresponding to amino acids 332 - 568 of Q96NJ5, which also 	                  .         .         .         .         .  
						corresponds to amino acids 331 - 567 of T10232_P4, and a     	     107 EPGVIQDVLAAGSHLQLLELLNLCSHYLIQELNSFNYLDLYRLADLFNLT 156                                                          
						fourth amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     108 EPGVIQDVLAAGSHLQLLELLNLCSHYLIQELNSFNYLDLYRLADLFNLT 157                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence SGRSSF corresponding to amino	     157 LLEKAVIDFLVKHLSELLKSRPEEVLTLPYCLLQEVLKSDRLTSLSEEQI 206                                                          
						acids 568 - 573 of T10232_P4, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid,   	     158 LLEKAVIDFLVKHLSELLKSRPEEVLTLPYCLLQEVLKSDRLTSLSEEQI 207                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     207 WQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTLHTVALSHPLVQASETA 256                                                          
						polypeptide encoding for a head of T10232_P4, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     208 WQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTLHTVALSHPLVQASETA 257                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     257 TALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREVCKVKEL 306                                                          
						to the sequence LIALLC of T10232_P4.3.An isolated polypeptide	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of T10232_P4, comprising a polypeptide   	     258 TALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREVCKVKEL 307                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     307 RYFNPVDQENALIAAIANWSELAPMPVGRSHHCVAVMGDFLFVAGGEVEH 356                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||| ||||||||||||||||||||||||||  
						SGRSSF in T10232_P4.                                         	     308 RYFNPVDQENALIAAIANWSELASMPVGRSHHCVAVMGDFLFVAGGEVEH 357                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     357 ASGRTCAVRTACRYDPRSNSWAEIAPMKNCREHFVLGAMEEYLYAVGGRN 406                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 ASGRTCAVRTACRYDPRSNSWAEIAPMKNCREHFVLGAMEEYLYAVGGRN 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     407 ELRQVLPTVERYCPKKNKWTFVQSFDRSLSCHAGYVADGLLWISGGVTNT 456                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 ELRQVLPTVERYCPKKNKWTFVQSFDRSLSCHAGYVADGLLWISGGVTNT 457                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     457 AQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGGNDLDYN 506                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     458 AQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGGNDLDYN 507                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     507 NDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSI 556                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 NDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSI 557                                                          
						                                                            	                  .                                          
						                                                            	     557 WTNEPLACIQV                                        567                                                          
						                                                            	         |||||||||||                                         
						                                                            	     558 WTNEPLACIQV                                        568                                                          

						Comparison report between T10232_P4 and AAH31830unique head  	Sequence name: AAH31830                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10232_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27126 x AAH31830   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence LIALLC       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 6 of T10232_P4, a second    	                                                            
						SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHKAVLAACSDYF 	                     Quality: 1252.00                      Escore:       0                                               
						RAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILLEPGVIQDVLAAGSHLQLLEL 	             Matching length:     130                Total length:     130                                               
						LNLCSHYLIQ                                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 8 - 137 of AAH31830, which also 	                        Gaps:       0                        
						corresponds to amino acids 7 - 136 of T10232_P4, and a third 	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	       7 SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHK 56                                                           
						ELNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEEVLTLPYCLLQEVLKSD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTLHTVALSHPLVQASETA 	       8 SIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHK 57                                                           
						TALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREVCKVKELRYFNPVDQEN 	                  .         .         .         .         .  
						ALIAAIANWSELAPMPVGRSHHCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNS 	      57 AVLAACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILL 106                                                          
						WAEIAPMKNCREHFVLGAMEEYLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CHAGYVADGLLWISGGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLY 	      58 AVLAACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILL 107                                                          
						VLGGNDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSI 	                  .         .         .                      
						WTNEPLACIQVSGRSSF                                            	     107 EPGVIQDVLAAGSHLQLLELLNLCSHYLIQ                     136                                                          
						having the sequence corresponding to amino acids 137 - 573 of	         ||||||||||||||||||||||||||||||                      
						T10232_P4, wherein said first amino acid sequence, second    	     108 EPGVIQDVLAAGSHLQLLELLNLCSHYLIQ                     137                                                          
						amino acid sequence and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of T10232_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence LIALLC of T10232_P4.3.An isolated polypeptide	                                                            
						encoding for a tail of T10232_P4, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						ELNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEEVLTLPYCLLQEVLKSD 	                                                            
						RLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTLHTVALSHPLVQASETA 	                                                            
						TALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREVCKVKELRYFNPVDQEN 	                                                            
						ALIAAIANWSELAPMPVGRSHHCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNS 	                                                            
						WAEIAPMKNCREHFVLGAMEEYLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLS 	                                                            
						CHAGYVADGLLWISGGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLY 	                                                            
						VLGGNDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSI 	                                                            
						WTNEPLACIQVSGRSSF                                            	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in T10232_P4.                                                	                                                            

						Comparison report between T10232_P4 and Q96PY7unique head    	Sequence name: Q96PY7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10232_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27126 x Q96PY7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						LIALLCSIQEMLTGQRLCHSESHNDSVLAALNQQRSD corresponding to amino 	                                                            
						acids 1 - 37 of T10232_P4, a second amino acid sequence being	                     Quality: 5232.00                      Escore:       0                                               
						GILCDITLIAEEQKFHAHKAVLAACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALE 	             Matching length:     530                Total length:     530                                               
						FAYTGQILLEPGVIQDVLAAGSHLQLLELLNLCSHYLIQELNSFNYLDLYRLADLFNLTL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LEKAVIDFLVKHLSELLKSRPEEVLTLPYCLLQEVLKSDRLTSLSEEQIWQLAVRWLEHN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						CHYQYMDELLQYIRFGLMDVDTLHTVALSHPLVQASETATALVNEALEYHQSIYAQPVWQ 	                        Gaps:       0                        
						TRRTKPRFQSDTLYIIGGKKREVCKVKELRYFNPVDQENALIAAIANWSELAPMPVGRSH 	                                                            
						HCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNSWAEIAPMKNCREHFVLGAMEE 	Alignment:                                                   
						YLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLSCHAGYVADGLLWISGGVTNTA 	                  .         .         .         .         .  
						QYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGGNDLDYNNDRILVRHIDS 	      38 GILCDITLIAEEQKFHAHKAVLAACSDYFRAMFSLCMVESGADEVNLHGV 87                                                           
						YNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSIWTNEPLACIQV           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 90 % homologous to corresponding to amino acids 1 - 	       1 GILCDITLIAEEQKFHAHKAVLAACSDYFRAMFSLCMVESGADEVNLHGV 50                                                           
						530 of Q96PY7, which also corresponds to amino acids 38 - 567	                  .         .         .         .         .  
						of T10232_P4, and a third amino acid sequence being at least 	      88 TSLGLKQALEFAYTGQILLEPGVIQDVLAAGSHLQLLELLNLCSHYLIQE 137                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 TSLGLKQALEFAYTGQILLEPGVIQDVLAAGSHLQLLELLNLCSHYLIQE 100                                                          
						homologous to a polypeptide having the sequence SGRSSF       	                  .         .         .         .         .  
						corresponding to amino acids 568 - 573 of T10232_P4, wherein 	     138 LNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEEVLTLPYC 187                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and third amino acid sequence are contiguous and in a        	     101 LNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEEVLTLPYC 150                                                          
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						head of T10232_P4, comprising a polypeptide being at least   	     188 LLQEVLKSDRLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDV 237                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 LLQEVLKSDRLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDV 200                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						LIALLCSIQEMLTGQRLCHSESHNDSVLAALNQQRSD of T10232_P4.3.An      	     238 DTLHTVALSHPLVQASETATALVNEALEYHQSIYAQPVWQTRRTKPRFQS 287                                                          
						isolated polypeptide encoding for a tail of T10232_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     201 DTLHTVALSHPLVQASETATALVNEALEYHQSIYAQPVWQTRRTKPRFQS 250                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     288 DTLYIIGGKKREVCKVKELRYFNPVDQENALIAAIANWSELAPMPVGRSH 337                                                          
						about 95% homologous to the sequence SGRSSF in T10232_P4.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DTLYIIGGKKREVCKVKELRYFNPVDQENALIAAIANWSELAPMPVGRSH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 HCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNSWAEIAPMKNCR 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 HCVAVMGDFLFVAGGEVEHASGRTCAVRTACRYDPRSNSWAEIAPMKNCR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 EHFVLGAMEEYLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLSC 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EHFVLGAMEEYLYAVGGRNELRQVLPTVERYCPKKNKWTFVQSFDRSLSC 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 HAGYVADGLLWISGGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHS 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HAGYVADGLLWISGGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 MAAVQRKLYVLGGNDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQN 537                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MAAVQRKLYVLGGNDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQN 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     538 ESGVAVHNGRIYLVGGYSIWTNEPLACIQV                     567                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     501 ESGVAVHNGRIYLVGGYSIWTNEPLACIQV                     530                                                          

						Comparison report between T10232_P4 and Q8IXH0unique head    	Sequence name: Q8IXH0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10232_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27126 x Q8IXH0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						LIALLCSIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHKAVLA 	Alignment segment 1/1:                                       
						ACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILLEPGVIQDVLAAGSH 	                                                            
						LQLLELLNLCSHYLIQELNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEE 	                     Quality: 1173.00                      Escore:       0                                               
						VLTLPYCLLQEVLKSDRLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTL 	             Matching length:     117                Total length:     117                                               
						HTVALSHPLVQASETATALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CKVKELRYFNPVDQENALIAAIANWSELAPMPVGRSHHCVAVMGDFLFVAGGEVEHASGR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TCAVRTACRYDPRSNSWAEIAPMKNCREHFVLGAMEEYLYAVGGRNELRQVLPTVERYCP 	                        Gaps:       0                        
						KKNKWTFVQSFDRSLSCHAGYVADGLLWIS                               	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 450 of T10232_P4, a second amino acid     	                  .         .         .         .         .  
						GGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGGNDLDYNNDRI 	     451 GGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGG 500                                                          
						LVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYLVGGYSIWTNEPLACIQV    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       8 GGVTNTAQYQNRLMVYEPNQNKWISRSPMLQRRVYHSMAAVQRKLYVLGG 57                                                           
						amino acids 8 - 124 of Q8IXH0, which also corresponds to     	                  .         .         .         .         .  
						amino acids 451 - 567 of T10232_P4, and a third amino acid   	     501 NDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYL 550                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      58 NDLDYNNDRILVRHIDSYNIDTDQWTRCNFNLLTGQNESGVAVHNGRIYL 107                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .                                          
						having the sequence SGRSSF corresponding to amino acids 568 -	     551 VGGYSIWTNEPLACIQV                                  567                                                          
						573 of T10232_P4, wherein said first amino acid sequence,    	         |||||||||||||||||                                   
						second amino acid sequence and third amino acid sequence are 	     108 VGGYSIWTNEPLACIQV                                  124                                                          
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of T10232_P4, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						LIALLCSIQEMLTGQRLCHSESHNDSVLAALNQQRSDGILCDITLIAEEQKFHAHKAVLA 	                                                            
						ACSDYFRAMFSLCMVESGADEVNLHGVTSLGLKQALEFAYTGQILLEPGVIQDVLAAGSH 	                                                            
						LQLLELLNLCSHYLIQELNSFNYLDLYRLADLFNLTLLEKAVIDFLVKHLSELLKSRPEE 	                                                            
						VLTLPYCLLQEVLKSDRLTSLSEEQIWQLAVRWLEHNCHYQYMDELLQYIRFGLMDVDTL 	                                                            
						HTVALSHPLVQASETATALVNEALEYHQSIYAQPVWQTRRTKPRFQSDTLYIIGGKKREV 	                                                            
						CKVKELRYFNPVDQENALIAAIANWSELAPMPVGRSHHCVAVMGDFLFVAGGEVEHASGR 	                                                            
						TCAVRTACRYDPRSNSWAEIAPMKNCREHFVLGAMEEYLYAVGGRNELRQVLPTVERYCP 	                                                            
						KKNKWTFVQSFDRSLSCHAGYVADGLLWIS                               	                                                            
						to the sequence of T10232_P4.3.An isolated polypeptide       	                                                            
						encoding for a tail of T10232_P4, comprising a polypeptide   	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						SGRSSF in T10232_P4.                                         	                                                            

27508	HMR136_T10238_7_tr0_r1_1_gPRT		Comparison report between T10238_P7 and Q96AM8unique head    	Sequence name: Q96AM8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10238_P7, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27508 x Q96AM8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence RSSLATPLVQQLLPGSFMEQAWWQSWRRVPAPVR       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 34 of T10238_P7, and a      	                                                            
						ENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQLEHARQAFAL 	                     Quality: 5483.00                      Escore:       0                                               
						KDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGGSISHQVSFSYFNAFNSLLNN 	             Matching length:     570                Total length:     570                                               
						MELVRKIYSTLAGTRKDVEVTKEEFAQSAIRYGQVTPLEIDILYQLADLYNASGRLTLAD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IERIAPLAEGALPYNLAELQRQQSPGLGRPIWLQIAESAYRFTLGSVAGAVGATAVYPID 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LVKTRMQNQRGSGSVVGELMYKNSFDCFKKVLRYEGFFGLYRGLIPQLIGVAPEKAIKLT 	                        Gaps:       0                        
						VNDFVRDKFTRRDGSVPLPAEVLAGGCAGGSQVIFTNPLEIVKIRLQVAGEITTGPRVSA 	                                                            
						LNVLRDLGIFGLYKGAKACFLRDIPFSAIYFPVYAHCKLLLADENGHVGGLNLLAAGAMA 	Alignment:                                                   
						GVPAASLVTPADVIKTRLQVAARAGQTTYSGVIDCFRKILREEGPSAFWKGTAARVFRSS 	                  .         .         .         .         .  
						PQFGVTLVTYELLQRWFYIDFGGLKPAGSEPTPKSRIADLPPANPDHIGGYRLATATFAG 	      35 ENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQ 84                                                           
						IENKFGLYLPKFKSPSVAVVQPKAAVAATQ                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 90 % homologous to 	     109 ENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQ 158                                                          
						corresponding to amino acids 109 - 678 of Q96AM8, which also 	                  .         .         .         .         .  
						corresponds to amino acids 35 - 604 of T10238_P7, wherein    	      85 LEHARQAFALKDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGG 134                                                          
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	     159 LEHARQAFALKDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGG 208                                                          
						polypeptide encoding for a head of T10238_P7, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     135 SISHQVSFSYFNAFNSLLNNMELVRKIYSTLAGTRKDVEVTKEEFAQSAI 184                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     209 SISHQVSFSYFNAFNSLLNNMELVRKIYSTLAGTRKDVEVTKEEFAQSAI 258                                                          
						to the sequence RSSLATPLVQQLLPGSFMEQAWWQSWRRVPAPVR of        	                  .         .         .         .         .  
						T10238_P7.                                                   	     185 RYGQVTPLEIDILYQLADLYNASGRLTLADIERIAPLAEGALPYNLAELQ 234                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     259 RYGQVTPLEIDILYQLADLYNASGRLTLADIERIAPLAEGALPYNLAELQ 308                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     235 RQQSPGLGRPIWLQIAESAYRFTLGSVAGAVGATAVYPIDLVKTRMQNQR 284                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     309 RQQSPGLGRPIWLQIAESAYRFTLGSVAGAVGATAVYPIDLVKTRMQNQR 358                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     285 GSGSVVGELMYKNSFDCFKKVLRYEGFFGLYRGLIPQLIGVAPEKAIKLT 334                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 GSGSVVGELMYKNSFDCFKKVLRYEGFFGLYRGLIPQLIGVAPEKAIKLT 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     335 VNDFVRDKFTRRDGSVPLPAEVLAGGCAGGSQVIFTNPLEIVKIRLQVAG 384                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 VNDFVRDKFTRRDGSVPLPAEVLAGGCAGGSQVIFTNPLEIVKIRLQVAG 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     385 EITTGPRVSALNVLRDLGIFGLYKGAKACFLRDIPFSAIYFPVYAHCKLL 434                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 EITTGPRVSALNVLRDLGIFGLYKGAKACFLRDIPFSAIYFPVYAHCKLL 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     435 LADENGHVGGLNLLAAGAMAGVPAASLVTPADVIKTRLQVAARAGQTTYS 484                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 LADENGHVGGLNLLAAGAMAGVPAASLVTPADVIKTRLQVAARAGQTTYS 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     485 GVIDCFRKILREEGPSAFWKGTAARVFRSSPQFGVTLVTYELLQRWFYID 534                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 GVIDCFRKILREEGPSAFWKGTAARVFRSSPQFGVTLVTYELLQRWFYID 608                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 FGGLKPAGSEPTPKSRIADLPPANPDHIGGYRLATATFAGIENKFGLYLP 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     609 FGGLKPAGSEPTPKSRIADLPPANPDHIGGYRLATATFAGIENKFGLYLP 658                                                          
						                                                            	                  .         .                                
						                                                            	     585 KFKSPSVAVVQPKAAVAATQ                               604                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     659 KFKSPSVAVVQPKAAVAATQ                               678                                                          

27948	HMR136_T10251_3_tr0_r1_1_gPRT		Comparison report between T10251_P3 and Q9BZZ5unique head    	Sequence name: Q9BZZ5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10251_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 27948 x Q9BZZ5   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	Alignment segment 1/1:                                       
						DSAINAQLDLC                                                  	                                                            
						having the sequence corresponding to amino acids 1 - 71 of   	                     Quality: 4228.00                      Escore:       0                                               
						T10251_P3, and a second amino acid sequence being at least 90	             Matching length:     439                Total length:     439                                               
						EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNALLSIFKMDAKG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFSK 	                        Gaps:       0                        
						NVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLF 	                                                            
						DKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 	Alignment:                                                   
						DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIKDLFHI 	                  .         .         .         .         .  
						PPSYKSTVTLSWKPVQKVEIGQKRASEDTTSGSPPKKSSAGPKRDARQIYNPPSGKYSSN 	      72 EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNAL 121                                                          
						LGNFNYGERFRLGTRNMRD                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 439 of      	       1 EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNAL 50                                                           
						Q9BZZ5, which also corresponds to amino acids 72 - 510 of    	                  .         .         .         .         .  
						T10251_P3, wherein said first amino acid sequence and second 	     122 LSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEV 171                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 LSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEV 100                                                          
						T10251_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     172 EELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQA 221                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	     101 EELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQA 150                                                          
						DSAINAQLDLC                                                  	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10251_P3.     	     222 DLEQTFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLG 271                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DLEQTFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     272 TLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLP 321                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     322 PEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 371                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNI 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     422 NVLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQKRASEDTTSGSPPKKSSA 471                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NVLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQKRASEDTTSGSPPKKSSA 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     472 GPKRDARQIYNPPSGKYSSNLGNFNYGERFRLGTRNMRD            510                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     401 GPKRDARQIYNPPSGKYSSNLGNFNYGERFRLGTRNMRD            439                                                          

						Comparison report between T10251_P3 and Q9Y4J7partial WT     	Sequence name: Q9Y4J7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10251_P3, comprising a first amino 	Sequence documentation:                                      
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	                                                            
						DSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNA 	Alignment of: 27948 x Q9Y4J7   ..                            
						LLSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESK 	                                                            
						KVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQ 	Alignment segment 1/1:                                       
						CTRQAVPLFSKNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 	                                                            
						EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDF 	                     Quality: 4789.00                      Escore:       0                                               
						LTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNN 	             Matching length:     497                Total length:     497                                               
						INVLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQKRASEDTTSGSPPKKSSAGPKRDARQI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						YNPPSGKYSSNLGNFNY                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 1 - 497 of Q9Y4J7, which also corresponds to  	                                                            
						amino acids 1 - 497 of T10251_P3, and a second amino acid    	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIP 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GERFRLGTRNMRD corresponding to amino     	       1 MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIP 50                                                           
						acids 498 - 510 of T10251_P3, wherein said first amino acid  	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	      51 KFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVAD 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T10251_P3, comprising a polypeptide being at least   	      51 KFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVAD 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 ILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRER 150                                                          
						at least about 95% homologous to the sequence GERFRLGTRNMRD  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in T10251_P3.                                                	     101 ILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRER 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 HQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EALKTEENKIKVVALKITNNINVLIKDLFHIPPSYKSTVTLSWKPVQKVE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EALKTEENKIKVVALKITNNINVLIKDLFHIPPSYKSTVTLSWKPVQKVE 450                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 IGQKRASEDTTSGSPPKKSSAGPKRDARQIYNPPSGKYSSNLGNFNY    497                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     451 IGQKRASEDTTSGSPPKKSSAGPKRDARQIYNPPSGKYSSNLGNFNY    497                                                          

27946	HMR136_T10251_4_tr0_r1_1_gPRT		Comparison report between T10251_P4 and Q9BZZ5unique head    	Sequence name: Q9BZZ5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10251_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27946 x Q9BZZ5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	Alignment segment 1/1:                                       
						DSAINAQLDLC                                                  	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 3390.00                      Escore:       0                                               
						to amino acids 1 - 71 of T10251_P4, a second amino acid      	             Matching length:     355                Total length:     355                                               
						EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNALLSIFKMDAKG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFSK 	                        Gaps:       0                        
						NVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLF 	                                                            
						DKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 	Alignment:                                                   
						DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIK      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      72 EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNAL 121                                                          
						amino acids 1 - 355 of Q9BZZ5, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 72 - 426 of T10251_P4, and a third amino acid    	       1 EDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNAL 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     122 LSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEV 171                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence AKESQ corresponding to amino acids 427 - 	      51 LSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEV 100                                                          
						431 of T10251_P4, wherein said first amino acid sequence,    	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     172 EELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQA 221                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T10251_P4, comprising a   	     101 EELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQA 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     222 DLEQTFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLG 271                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	     151 DLEQTFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLG 200                                                          
						DSAINAQLDLC                                                  	                  .         .         .         .         .  
						to the sequence of T10251_P4.3.An isolated polypeptide       	     272 TLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLP 321                                                          
						encoding for a tail of T10251_P4, comprising a polypeptide   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     201 TLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLP 250                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     322 PEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 371                                                          
						AKESQ in T10251_P4.                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNI 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNI 350                                                          
						                                                            	                                                             
						                                                            	     422 NVLIK                                              426                                                          
						                                                            	         |||||                                               
						                                                            	     351 NVLIK                                              355                                                          

						Comparison report between T10251_P4 and Q9Y4J7partial WT     	Sequence name: Q9Y4J7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10251_P4, comprising a first amino 	Sequence documentation:                                      
						MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELA 	                                                            
						DSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNA 	Alignment of: 27946 x Q9Y4J7   ..                            
						LLSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESK 	                                                            
						KVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQ 	Alignment segment 1/1:                                       
						CTRQAVPLFSKNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 	                                                            
						EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDF 	                     Quality: 4080.00                      Escore:       0                                               
						LTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNN 	             Matching length:     426                Total length:     426                                               
						INVLIK                                                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 426 of Q9Y4J7, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 426 of T10251_P4, and a second amino acid    	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIP 50                                                           
						having the sequence AKESQ corresponding to amino acids 427 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						431 of T10251_P4, wherein said first amino acid sequence and 	       1 MPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIP 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 KFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVAD 100                                                          
						T10251_P4, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 KFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVAD 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence AKESQ in          	     101 ILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRER 150                                                          
						T10251_P4.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRER 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDM 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 EKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 HQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 HQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTG 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 EALKTEENKIKVVALKITNNINVLIK                         426                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     401 EALKTEENKIKVVALKITNNINVLIK                         426                                                          

28383	HMR136_T10266_9_tr0_r1_1_gPRT		Comparison report between T10266_P9 and DP1_HUMANpartial WT  	Sequence name: DP1_HUMAN                                     
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10266_P9, comprising a first amino acid        	                                                            
						MAPSPSNGAELLYKRIIRPFFLKHESQMDSVVKDLKDKAKETADAITKEAKKATVNLLGE 	Alignment of: 28383 x DP1_HUMAN   ..                         
						EKKST                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 121 - 185 of DP1_HUMAN, which also corresponds to	                                                            
						amino acids 1 - 65 of T10266_P9.                             	                     Quality:  621.00                      Escore:       0                                               
						                                                            	             Matching length:      65                Total length:      65                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAPSPSNGAELLYKRIIRPFFLKHESQMDSVVKDLKDKAKETADAITKEA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 MAPSPSNGAELLYKRIIRPFFLKHESQMDSVVKDLKDKAKETADAITKEA 170                                                          
						                                                            	                  .                                          
						                                                            	      51 KKATVNLLGEEKKST                                    65                                                           
						                                                            	         |||||||||||||||                                     
						                                                            	     171 KKATVNLLGEEKKST                                    185                                                          

29095	HMR136_T10302_9_tr0_r1_1_gPRT		Comparison report between T10302_P9 and Q9HAR2partial WT     	Sequence name: Q9HAR2                                        
						sequence featuring skipped exon, followed by a unique        	                                                            
						insertion and a followed by a short unique tail.1.An isolated	Sequence documentation:                                      
						chimeric polypeptide encoding for T10302_P9, comprising a    	                                                            
						MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR 	Alignment of: 29095 x Q9HAR2   ..                            
						TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQ 	                                                            
						YECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTD 	Alignment segment 1/1:                                       
						TLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSG 	                                                            
						EAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 	                     Quality: 11729.00                      Escore:       0                                              
						WDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNS 	             Matching length:    1212                Total length:    1278                                               
						YQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIHLDSELE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.92                                               
						RPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRNRSTSTPSPAVEVLDDM 	    Total Percent Similarity:   94.84      Total Percent Identity:   94.76                                               
						TTHLPSASSQIPALEESCEAVEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIW 	                        Gaps:       2                        
						DPQGPDLSNCSSPWVNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVG 	                                                            
						LLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQALNAWRDLTTS 	Alignment:                                                   
						DQLRAATMLLHTVEESAFVLADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMG 	                  .         .         .         .         .  
						HGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSVIVNSP 	       1 MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDV 50                                                           
						VITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFC 	       1 MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDV 50                                                           
						FFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFL 	                  .         .         .         .         .  
						EGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYF 	      51 IMIESANYGRTDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVV 100                                                          
						IWSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDN                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						first amino acid sequence being at least 90 % homologous to  	      51 IMIESANYGRTDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVV 100                                                          
						corresponding to amino acids 1 - 1062 of Q9HAR2, which also  	                  .         .         .         .         .  
						corresponds to amino acids 1 - 1062 of T10302_P9, a second   	     101 AGPDVFPDPCPGTYKYLEVQYECVPYKVEQKVFLCPGLLKGVYQSEHLFE 150                                                          
						IKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFI 	     101 AGPDVFPDPCPGTYKYLEVQYECVPYKVEQKVFLCPGLLKGVYQSEHLFE 150                                                          
						TGDINSSASLNR                                                 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     151 SDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSKDDFIAGRPTTTY 200                                                          
						corresponding to amino acids 1072 - 1203 of Q9HAR2, which    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 1063 - 1194 of T10302_P9, a  	     151 SDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSKDDFIAGRPTTTY 200                                                          
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     201 KLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYH 250                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     201 KLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYH 250                                                          
						GSYLPCIQACVSYLGAMANHLISNALLRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQ    	                  .         .         .         .         .  
						corresponding to amino acids 1195 - 1251 of T10302_P9, a     	     251 DTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 300                                                          
						fourth amino acid sequence being at least 90 % homologous to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPYRETSMGVKLNIAYQ corresponding to amino acids 1204 - 1220 of	     251 DTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 300                                                          
						Q9HAR2, which also corresponds to amino acids 1252 - 1268 of 	                  .         .         .         .         .  
						T10302_P9, and a fifth amino acid sequence being at least    	     301 WDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKD 350                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     301 WDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKD 350                                                          
						homologous to a polypeptide having the sequence M            	                  .         .         .         .         .  
						corresponding to amino acids 1269 - 1269 of T10302_P9,       	     351 SLVDVPFPNSYQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQ 400                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, third amino acid sequence, fourth amino acid       	     351 SLVDVPFPNSYQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQ 400                                                          
						sequence and fifth amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated chimeric polypeptide        	     401 AHHGQVSYISPPIHLDSELERPSVKDISTTGPLGMGSTTTSTTLRTTTLS 450                                                          
						encoding for an edge portion of T10302_P9, comprising a      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having a length "n", wherein n is at least about 	     401 AHHGQVSYISPPIHLDSELERPSVKDISTTGPLGMGSTTTSTTLRTTTLS 450                                                          
						10 amino acids in length, optionally at least about 20 amino 	                  .         .         .         .         .  
						acids in length, preferably at least about 30 amino acids in 	     451 PGRSTTPSVSGRRNRSTSTPSPAVEVLDDMTTHLPSASSQIPALEESCEA 500                                                          
						length, more preferably at least about 40 amino acids in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length and most preferably at least about 50 amino acids in  	     451 PGRSTTPSVSGRRNRSTSTPSPAVEVLDDMTTHLPSASSQIPALEESCEA 500                                                          
						length, wherein at least two amino acids comprise NI, having 	                  .         .         .         .         .  
						a structure as follows: a sequence starting from any of amino	     501 VEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNC 550                                                          
						acid numbers 1062-x to 1063; and ending at any of amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 1063+ ((n-2) - x), in which x varies from 0 to       	     501 VEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNC 550                                                          
						n-2.3.An isolated polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						T10302_P9, comprising an amino acid sequence being at least  	     551 SSPWVNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVG 600                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     551 SSPWVNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVG 600                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						GSYLPCIQACVSYLGAMANHLISNALLRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQ,   	     601 LLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQA 650                                                          
						corresponding to T10302_P9.                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQA 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 LNAWRDLTTSDQLRAATMLLHTVEESAFVLADNLLKTDIVRENTDNIKLE 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LNAWRDLTTSDQLRAATMLLHTVEESAFVLADNLLKTDIVRENTDNIKLE 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 VARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGEIRVAFVLYNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 VARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGEIRVAFVLYNN 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 LGPYLSTENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPV 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LGPYLSTENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPV 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 VFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 VFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCS 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 CNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFC 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 CNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFC 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 FFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFF 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 FFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFF 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 FLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAA 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 FLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAA 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 VDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHT 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 VDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHT 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 AILKPESGCLDN.........IKSWVIGAIALLCLLGLTWAFGLMYINES 1091                                                         
						                                                            	         ||||||||||||         |||||||||||||||||||||||||||||  
						                                                            	    1051 AILKPESGCLDNINYEDNRPFIKSWVIGAIALLCLLGLTWAFGLMYINES 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1092 TVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTES 1141                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 TVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTES 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1142 SIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSAS 1191                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 SIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSAS 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1192 LNRGSYLPCIQACVSYLGAMANHLISNALLRPHGTNNPYNTLLGEPAVCN 1241                                                         
						                                                            	         |||                                                 
						                                                            	    1201 LNR............................................... 1203                                                         
						                                                            	                  .         .                                
						                                                            	    1242 NPSVSMYNAQEPYRETSMGVKLNIAYQM                       1269                                                         
						                                                            	                   |||||||||||||||||:                        
						                                                            	    1204 ..........EPYRETSMGVKLNIAYQI                       1221                                                         

						Comparison report between T10302_P9 and Q9NWK5unique head    	Sequence name: Q9NWK5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10302_P9, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 29095 x Q9NWK5   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR 	                                                            
						TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQ 	                     Quality: 3346.00                      Escore:       0                                               
						YECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTD 	             Matching length:     353                Total length:     366                                               
						TLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 	    Total Percent Similarity:   96.45      Total Percent Identity:   96.45                                               
						WDTAYDKRSASNAF                                               	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 314 of T10302_P9, a second amino acid sequence being at  	Alignment:                                                   
						MICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYIAAVDYNPRDN 	                  .         .         .         .         .  
						LLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIHLDSELERPSVKDISTTGPLG 	     315 MICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYI 364                                                          
						MGSTTTSTTLRTTTLSPGRSTTPSVSGRRNRSTSTPSPAVEVLDDMTTHLPSASSQIPAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EESCEAVEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPW 	       1 MICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYI 50                                                           
						VNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGK 	                  .         .         .         .         .  
						DSAARSLNK                                                    	     365 AAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIH 414                                                          
						least 90 % homologous to corresponding to amino acids 1 - 309	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9NWK5, which also corresponds to amino acids 315 - 623 of	      51 AAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIH 100                                                          
						T10302_P9, a third amino acid sequence being at least 70%,   	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     415 LDSELERPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRN 464                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence LQKRERSCRAYVQ	     101 LDSELERPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRN 150                                                          
						corresponding to amino acids 624 - 636 of T10302_P9, a fourth	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     465 RSTSTPSPAVEVLDDMTTHLPSASSQIPALEESCEAVEAREIMWFKTRQG 514                                                          
						AMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLHTVEESAFVL corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 310 - 353 of Q9NWK5, which also corresponds to   	     151 RSTSTPSPAVEVLDDMTTHLPSASSQIPALEESCEAVEAREIMWFKTRQG 200                                                          
						amino acids 637 - 680 of T10302_P9, and a fifth amino acid   	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     515 QIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKS 564                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     201 QIAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKS 250                                                          
						ADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGE 	                  .         .         .         .         .  
						IRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPV 	     565 GETAANIARELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGK 614                                                          
						VFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISL 	     251 GETAANIARELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGK 300                                                          
						FVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRR 	                  .         .         .         .         .  
						KYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLG 	     615 DSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQALNAWRDLTTSDQLR 664                                                          
						IALYKMFHHTAILKPESGCLDNIKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFT 	         |||||||||             ||||||||||||||||||||||||||||  
						IFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTG 	     301 DSAARSLNK.............AMVETVNNLLQPQALNAWRDLTTSDQLR 337                                                          
						SQSRIRRMWNDTVRKQSESSFITGDINSSASLNRGSYLPCIQACVSYLGAMANHLISNAL 	                  .                                          
						LRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQEPYRETSMGVKLNIAYQM            	     665 AATMLLHTVEESAFVL                                   680                                                          
						having the sequence corresponding to amino acids 681 - 1269  	         ||||||||||||||||                                    
						of T10302_P9, wherein said first amino acid sequence, second 	     338 AATMLLHTVEESAFVL                                   353                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                                                            
						acid sequence and fifth amino acid sequence are contiguous   	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of T10302_P9, comprising a polypeptide being at   	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR 	                                                            
						TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQ 	                                                            
						YECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTD 	                                                            
						TLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSG 	                                                            
						EAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 	                                                            
						WDTAYDKRSASNAF                                               	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						T10302_P9.3.An isolated polypeptide encoding for an edge     	                                                            
						portion of T10302_P9, comprising an amino acid sequence being	                                                            
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for LQKRERSCRAYVQ, corresponding to T10302_P9.4.An  	                                                            
						isolated polypeptide encoding for a tail of T10302_P9,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						ADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGE 	                                                            
						IRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPV 	                                                            
						VFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVL 	                                                            
						MAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISL 	                                                            
						FVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRR 	                                                            
						KYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLG 	                                                            
						IALYKMFHHTAILKPESGCLDNIKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFT 	                                                            
						IFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTG 	                                                            
						SQSRIRRMWNDTVRKQSESSFITGDINSSASLNRGSYLPCIQACVSYLGAMANHLISNAL 	                                                            
						LRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQEPYRETSMGVKLNIAYQM            	                                                            
						about 95% homologous to the sequence in T10302_P9.           	                                                            

						Comparison report between T10302_P9 and O94867unique head    	Sequence name: O94867                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10302_P9, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 29095 x O94867   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR 	                                                            
						TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQ 	                     Quality: 5803.00                      Escore:       0                                               
						YECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTD 	             Matching length:     606                Total length:     619                                               
						TLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 	    Total Percent Similarity:   97.90      Total Percent Identity:   97.90                                               
						WDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNS 	                        Gaps:       1                        
						YQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIHLDSELE 	                                                            
						RPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRNRSTSTPSPAVEVLDDM 	Alignment:                                                   
						TTHLPSASSQIPALEESCEAVEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIW 	                  .         .         .         .         .  
						DPQGPDLSNCSSPWVNHITQKLKSGETAANIAREL                          	     576 AEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNKLQ 625                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						1 - 575 of T10302_P9, a second amino acid sequence being at  	       1 AEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNK.. 48                                                           
						least 90 % homologous to                                     	                  .         .         .         .         .  
						AEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNK             	     626 KRERSCRAYVQAMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLHTVEE 675                                                          
						corresponding to amino acids 1 - 48 of O94867, which also    	                    |||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 576 - 623 of T10302_P9, a third   	      49 ...........AMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLHTVEE 87                                                           
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     676 SAFVLADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMGHGSTI 725                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence LQKRERSCRAYVQ corresponding to amino     	      88 SAFVLADNLLKTDIVRENTDNIKLEVARLSTEGNLEDLKFPENMGHGSTI 137                                                          
						acids 624 - 636 of T10302_P9, a fourth amino acid sequence   	                  .         .         .         .         .  
						AMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLHTVEESAFVLADNLLKTDIVRENTDN 	     726 QLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSV 775                                                          
						IKLEVARLSTEGNLEDLKFPENMGHGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TENASMKLGTEALSTNHSVIVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNP 	     138 QLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEALSTNHSV 187                                                          
						NCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLL 	                  .         .         .         .         .  
						LDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQ 	     776 IVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSK 825                                                          
						PIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPE 	     188 IVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSK 237                                                          
						SGCLDNIKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCV 	                  .         .         .         .         .  
						LQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQ 	     826 RTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDL 875                                                          
						SESSFITGDINSSASLNR                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     238 RTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDL 287                                                          
						acids 49 - 606 of O94867, which also corresponds to amino    	                  .         .         .         .         .  
						acids 637 - 1194 of T10302_P9, and a fifth amino acid        	     876 LLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAEL 925                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     288 LLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAEL 337                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						GSYLPCIQACVSYLGAMANHLISNALLRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQEPY 	     926 LFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFES 975                                                          
						RETSMGVKLNIAYQM                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1195 - 1269 	     338 LFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFES 387                                                          
						of T10302_P9, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, fourth amino 	     976 EHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFI 1025                                                         
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     388 EHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFI 437                                                          
						for a head of T10302_P9, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	    1026 GPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNIKSWVIGAIALLC 1075                                                         
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MWPSQLLIFMMLLAPIIHAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR 	     438 GPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNIKSWVIGAIALLC 487                                                          
						TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQ 	                  .         .         .         .         .  
						YECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTD 	    1076 LLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEY 1125                                                         
						TLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGT 	     488 LLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEY 537                                                          
						WDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNS 	                  .         .         .         .         .  
						YQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGQAHHGQVSYISPPIHLDSELE 	    1126 GKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRK 1175                                                         
						RPSVKDISTTGPLGMGSTTTSTTLRTTTLSPGRSTTPSVSGRRNRSTSTPSPAVEVLDDM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTHLPSASSQIPALEESCEAVEAREIMWFKTRQGQIAKQPCPAGTIGVSTYLCLAPDGIW 	     538 GKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRK 587                                                          
						DPQGPDLSNCSSPWVNHITQKLKSGETAANIAREL                          	                  .                                          
						preferably at least about 95% homologous to the sequence of  	    1176 QSESSFITGDINSSASLNR                                1194                                                         
						T10302_P9.3.An isolated polypeptide encoding for an edge     	         |||||||||||||||||||                                 
						portion of T10302_P9, comprising an amino acid sequence being	     588 QSESSFITGDINSSASLNR                                606                                                          
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						encoding for LQKRERSCRAYVQ, corresponding to T10302_P9.4.An  	                                                            
						isolated polypeptide encoding for a tail of T10302_P9,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						GSYLPCIQACVSYLGAMANHLISNALLRPHGTNNPYNTLLGEPAVCNNPSVSMYNAQEPY 	                                                            
						RETSMGVKLNIAYQM                                              	                                                            
						about 95% homologous to the sequence in T10302_P9.           	                                                            

4311	HMR136_T10306_6_tr0_r1_1_gPRT		Comparison report between T10306_P6 and TMEP_HUMANunique     	Sequence name: TMEP_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T10306_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 4311 x TMEP_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence SHVSLFVSTA corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of T10306_P6, and a second amino acid sequence being at 	                                                            
						ELEFVQIIIIVVVMMVMVVVITCLLSHYKLSARSFISRHSQGRRREDALSSEGCLWPSES 	                     Quality: 2500.00                      Escore:       0                                               
						TVSGNGIPEPQVYAPPRPTDRLAVPPFAQRERFHRFQPTYPYLQHEIDLPPTISLSDGEE 	             Matching length:     250                Total length:     250                                               
						PPPYQGPCTLQLRDPEQQLELNRESVRAPPNRTIFDSDLMDSARLGGPCPPSSNSGISAT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CYGSGGRMEGPPPTYSEVIGHYPGSSFQHQQSSGPPSLLEGTRLHHTHIAPLESAAIWSK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EKDKQKGHPL                                                   	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 38 -   	                                                            
						287 of TMEP_HUMAN, which also corresponds to amino acids 11 -	Alignment:                                                   
						260 of T10306_P6, wherein said first amino acid sequence and 	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      11 ELEFVQIIIIVVVMMVMVVVITCLLSHYKLSARSFISRHSQGRRREDALS 60                                                           
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10306_P6, comprising a polypeptide being at least 70%,      	      38 ELEFVQIIIIVVVMMVMVVVITCLLSHYKLSARSFISRHSQGRRREDALS 87                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	      61 SEGCLWPSESTVSGNGIPEPQVYAPPRPTDRLAVPPFAQRERFHRFQPTY 110                                                          
						least about 95% homologous to the sequence SHVSLFVSTA of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10306_P6.                                                   	      88 SEGCLWPSESTVSGNGIPEPQVYAPPRPTDRLAVPPFAQRERFHRFQPTY 137                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     111 PYLQHEIDLPPTISLSDGEEPPPYQGPCTLQLRDPEQQLELNRESVRAPP 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     138 PYLQHEIDLPPTISLSDGEEPPPYQGPCTLQLRDPEQQLELNRESVRAPP 187                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 NRTIFDSDLMDSARLGGPCPPSSNSGISATCYGSGGRMEGPPPTYSEVIG 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     188 NRTIFDSDLMDSARLGGPCPPSSNSGISATCYGSGGRMEGPPPTYSEVIG 237                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     211 HYPGSSFQHQQSSGPPSLLEGTRLHHTHIAPLESAAIWSKEKDKQKGHPL 260                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     238 HYPGSSFQHQQSSGPPSLLEGTRLHHTHIAPLESAAIWSKEKDKQKGHPL 287                                                          

8076	HMR136_T10314_12_tr0_r1_1_gPRT		Comparison report between T10314_P12 and PMM1_HUMANpartial   	Sequence name: PMM1_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10314_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MAVTAQAARRKERVLCLFDVDGTLTPAR corresponding to amino acids 1 -	Alignment of: 8076 x PMM1_HUMAN   ..                         
						28 of PMM1_HUMAN, which also corresponds to amino acids 1 -  	                                                            
						28 of T10314_P12, and a second amino acid sequence being at  	Alignment segment 1/1:                                       
						QTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEF 	                                                            
						SELDKKEKIREKFVEALKTEFAGKGLRFSRGGMISFDVFPEGWDKRYCLDSLDQDSFDTI 	                     Quality: 1832.00                      Escore:       0                                               
						HFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA            	             Matching length:     197                Total length:     262                                               
						least 90 % homologous to corresponding to amino acids 94 -   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						262 of PMM1_HUMAN, which also corresponds to amino acids 29 -	    Total Percent Similarity:   75.19      Total Percent Identity:   75.19                                               
						197 of T10314_P12, wherein said first amino acid sequence and	                        Gaps:       1                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated chimeric polypeptide encoding for an edge	Alignment:                                                   
						portion of T10314_P12, comprising a polypeptide having a     	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	       1 MAVTAQAARRKERVLCLFDVDGTLTPAR...................... 28                                                           
						length, optionally at least about 20 amino acids in length,  	         ||||||||||||||||||||||||||||                        
						preferably at least about 30 amino acids in length, more     	       1 MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGV 50                                                           
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      29 ...........................................QTIQNHL 35                                                           
						at least two amino acids comprise RQ, having a structure as  	                                                    |||||||  
						follows: a sequence starting from any of amino acid numbers  	      51 VGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHL 100                                                          
						28-x to 29; and ending at any of amino acid numbers 29+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      36 GEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEER 85                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEER 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      86 IEFSELDKKEKIREKFVEALKTEFAGKGLRFSRGGMISFDVFPEGWDKRY 135                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IEFSELDKKEKIREKFVEALKTEFAGKGLRFSRGGMISFDVFPEGWDKRY 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     136 CLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRC 185                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 CLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRC 250                                                          
						                                                            	                  .                                          
						                                                            	     186 REIFFPETAHEA                                       197                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     251 REIFFPETAHEA                                       262                                                          

8078	HMR136_T10314_9_tr0_r1_1_gPRT		Comparison report between T10314_P9 and PMM1_HUMANpartial WT 	Sequence name: PMM1_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10314_P9, comprising a first amino 	Sequence documentation:                                      
						MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIA 	                                                            
						EQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLR 	Alignment of: 8078 x PMM1_HUMAN   ..                         
						LPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLR 	                                                            
						FSRG                                                         	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 184 of PMM1_HUMAN, which also corresponds 	                     Quality: 1768.00                      Escore:       0                                               
						to amino acids 1 - 184 of T10314_P9, and a second amino acid 	             Matching length:     184                Total length:     184                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence LGQALLPG corresponding to amino acids 185	                                                            
						- 192 of T10314_P9, wherein said first amino acid sequence   	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	       1 MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGV 50                                                           
						tail of T10314_P9, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGV 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence LGQALLPG in    	      51 VGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHL 100                                                          
						T10314_P9.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 VGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEER 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEER 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 IEFSELDKKEKIREKFVEALKTEFAGKGLRFSRG                 184                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     151 IEFSELDKKEKIREKFVEALKTEFAGKGLRFSRG                 184                                                          

8268	HMR136_T10318_4_tr0_r1_1_gPRT		Comparison report between T10318_P4 and SYT1_HUMANpartial WT 	Sequence name: SYT1_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10318_P4, comprising a first amino acid        	                                                            
						MGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELGGKTLVMAVYDFD 	Alignment of: 8268 x SYT1_HUMAN   ..                         
						RFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEKEEQEKLGDICFSLRYVPTAGKLTVV 	                                                            
						ILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQI 	Alignment segment 1/1:                                       
						QKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEE 	                                                            
						VDAMLAVKK                                                    	                     Quality: 2449.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     249                Total length:     249                                               
						amino acids 174 - 422 of SYT1_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 249 of T10318_P4.                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELGGK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     174 MGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELGGK 223                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TLVMAVYDFDRFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEKEEQEK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     224 TLVMAVYDFDRFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEKEEQEK 273                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     274 LGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKR 323                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     324 LKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDA 373                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 IGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK  249                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     374 IGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK  422                                                          

4479	HMR136_T10338_11_tr0_r1_1_gPRT		Comparison report between T10338_P11 and Q8N5I2partial WT    	Sequence name: Q8N5I2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10338_P11, comprising a first amino	Sequence documentation:                                      
						MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCGVSNKANDTAW 	                                                            
						VVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSFEGPFGKIVHQVRAAIHTPRF 	Alignment of: 4479 x Q8N5I2   ..                             
						SKDHKCSLVFYILSPLNLNSIPDIEQPNVASATKKFSYKLVKTGSVVLTASTDLRGYVVG 	                                                            
						QALQLHADVENQSGKDTSPVVASLLQKVSYKAKRWIHDVRTIAEVEGAGVKAWRRAQWHE 	Alignment segment 1/1:                                       
						QILVPALPQSALPGCSLIHIDYYLQV                                   	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2577.00                      Escore:       0                                               
						to amino acids 1 - 266 of Q8N5I2, which also corresponds to  	             Matching length:     266                Total length:     266                                               
						amino acids 1 - 266 of T10338_P11, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence WCCWGLGGLRPSGLGPGPSCPTSILSRSL            	Alignment:                                                   
						corresponding to amino acids 267 - 295 of T10338_P11, wherein	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCG 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T10338_P11, comprising a  	       1 MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCG 50                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	      51 VSNKANDTAWVVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSF 100                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence WCCWGLGGLRPSGLGPGPSCPTSILSRSL in T10338_P11. 	      51 VSNKANDTAWVVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSF 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EGPFGKIVHQVRAAIHTPRFSKDHKCSLVFYILSPLNLNSIPDIEQPNVA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EGPFGKIVHQVRAAIHTPRFSKDHKCSLVFYILSPLNLNSIPDIEQPNVA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SATKKFSYKLVKTGSVVLTASTDLRGYVVGQALQLHADVENQSGKDTSPV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SATKKFSYKLVKTGSVVLTASTDLRGYVVGQALQLHADVENQSGKDTSPV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VASLLQKVSYKAKRWIHDVRTIAEVEGAGVKAWRRAQWHEQILVPALPQS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VASLLQKVSYKAKRWIHDVRTIAEVEGAGVKAWRRAQWHEQILVPALPQS 250                                                          
						                                                            	                  .                                          
						                                                            	     251 ALPGCSLIHIDYYLQV                                   266                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     251 ALPGCSLIHIDYYLQV                                   266                                                          

4484	HMR136_T10338_36_tr0_r1_1_gPRT		Comparison report between T10338_P36 and Q8N5I2partial WT    	Sequence name: Q8N5I2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10338_P36, comprising a first amino	Sequence documentation:                                      
						MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCGVSNKANDTAW 	                                                            
						VVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSFEGPFGKIVHQVRAAIHTPRF 	Alignment of: 4484 x Q8N5I2   ..                             
						SKDHKCSLVFYILSPLNLNSIPDIEQPNVASATKKFSYKLVKTGSVVLTASTDLRGYVVG 	                                                            
						QALQLHADVENQS                                                	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 193 of Q8N5I2, which also corresponds to  	                     Quality: 1861.00                      Escore:       0                                               
						amino acids 1 - 193 of T10338_P36, and a second amino acid   	             Matching length:     193                Total length:     193                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence ESVL corresponding to amino acids 194 -  	                                                            
						197 of T10338_P36, wherein said first amino acid sequence and	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCG 50                                                           
						T10338_P36, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MGRVQLFEISLSHGRVVYSPGEPLAGTVRVRLGAPLPFRAIRVTCIGSCG 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence ESVL in           	      51 VSNKANDTAWVVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSF 100                                                          
						T10338_P36.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 VSNKANDTAWVVEEGYFNSSLSLADKGSLPAGEHSFPFQFLLPATAPTSF 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EGPFGKIVHQVRAAIHTPRFSKDHKCSLVFYILSPLNLNSIPDIEQPNVA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EGPFGKIVHQVRAAIHTPRFSKDHKCSLVFYILSPLNLNSIPDIEQPNVA 150                                                          
						                                                            	                  .         .         .         .            
						                                                            	     151 SATKKFSYKLVKTGSVVLTASTDLRGYVVGQALQLHADVENQS        193                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||         
						                                                            	     151 SATKKFSYKLVKTGSVVLTASTDLRGYVVGQALQLHADVENQS        193                                                          

8690	HMR136_T10350_10_tr0_r1_1_gPRT		Comparison report between T10350_P10 and AAH52301unique head 	Sequence name: AAH52301                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10350_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8690 x AAH52301   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						QQLGEESTHQGAERSGSEDRGGSCLRCRPATPELGSSLKKKKRLSQSDEDVIRLIGQHLN 	Alignment segment 1/1:                                       
						G                                                            	                                                            
						having the sequence corresponding to amino acids 1 - 61 of   	                     Quality: 5226.00                      Escore:       0                                               
						T10350_P10, and a second amino acid sequence being at least  	             Matching length:     524                Total length:     524                                               
						LGLNQTVDLLMQESGCRLEHPSATKFRNHVMEGDWDKAENDLNELKPLVHSPHAIVVRGA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LEISQTLLGIIVRMKFLLLQQKYLEYLEDGKVLEALQVLRCELTPLKYNTERIHVLSGYL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MCSHAEDLRAKAEWEGKGTASRSKLLDKLQTYLPPSVMLPPRRLQTLLRQAVELQRDRCL 	                        Gaps:       0                        
						YHNTKLDNNLDSVSLLIDHVCSRRQFPCYTQQILTEHCNEVWFCKFSNDGTKLATGSKDT 	                                                            
						TVIIWQVDPDTHLLKLLKTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGEL 	Alignment:                                                   
						RTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVRVQCLWCLSDG 	                  .         .         .         .         .  
						KTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKNGRLALLNVATQGVHLWDLQD 	      62 LGLNQTVDLLMQESGCRLEHPSATKFRNHVMEGDWDKAENDLNELKPLVH 111                                                          
						RVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHKVYIWHKRSELPIAELTGHTRTVN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CVSWNPQIPSMMASASDDGTVRIWGPAPFIDHQNIEEECSSMDS                 	       1 LGLNQTVDLLMQESGCRLEHPSATKFRNHVMEGDWDKAENDLNELKPLVH 50                                                           
						90 % homologous to corresponding to amino acids 1 - 524 of   	                  .         .         .         .         .  
						AAH52301, which also corresponds to amino acids 62 - 585 of  	     112 SPHAIVVRGALEISQTLLGIIVRMKFLLLQQKYLEYLEDGKVLEALQVLR 161                                                          
						T10350_P10, wherein said first amino acid sequence and second	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 SPHAIVVRGALEISQTLLGIIVRMKFLLLQQKYLEYLEDGKVLEALQVLR 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10350_P10, comprising a polypeptide being at least 70%,     	     162 CELTPLKYNTERIHVLSGYLMCSHAEDLRAKAEWEGKGTASRSKLLDKLQ 211                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 CELTPLKYNTERIHVLSGYLMCSHAEDLRAKAEWEGKGTASRSKLLDKLQ 150                                                          
						QQLGEESTHQGAERSGSEDRGGSCLRCRPATPELGSSLKKKKRLSQSDEDVIRLIGQHLN 	                  .         .         .         .         .  
						G                                                            	     212 TYLPPSVMLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHV 261                                                          
						least about 95% homologous to the sequence of T10350_P10.    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TYLPPSVMLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     262 CSRRQFPCYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPD 311                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 CSRRQFPCYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPD 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     312 THLLKLLKTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGEL 361                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 THLLKLLKTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGEL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     362 RTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVR 411                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     412 VQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKN 461                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     462 GRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIA 511                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     512 SGSEDHKVYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGT 561                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SGSEDHKVYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGT 500                                                          
						                                                            	                  .         .                                
						                                                            	     562 VRIWGPAPFIDHQNIEEECSSMDS                           585                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     501 VRIWGPAPFIDHQNIEEECSSMDS                           524                                                          

						Comparison report between T10350_P10 and Q9H7D7unique head   	Sequence name: Q9H7D7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10350_P10, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8690 x Q9H7D7   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						QQLGEESTHQGAERSGSEDRGGSCLRCRPATPELGSSLKKKKRLSQSDEDVIRLIGQHLN 	Alignment segment 1/1:                                       
						GLGLNQTVDLLMQESGCRLEHPSATKFRNHVMEGDWDKAENDLNELKPLVHSPHAIVVRG 	                                                            
						ALEISQTLLGIIVRMKFLLLQQKYLEYLEDGKVLEALQVLRCELTPLKYNTERIHVLSGY 	                     Quality: 3697.00                      Escore:       0                                               
						LMCSHAEDLRAKAEWEGKGTASRSKLLDKLQTYLPPSV                       	             Matching length:     367                Total length:     367                                               
						having the sequence corresponding to amino acids 1 - 218 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10350_P10, and a second amino acid sequence being at least  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFPCYTQQILTEH 	                        Gaps:       0                        
						CNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLLKTLEGHAYGVSYIAWSPDDN 	                                                            
						YLVACGPDDCSELWLWNVQTGELRTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCD 	Alignment:                                                   
						LDGNLLDSWEGVRVQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTI 	                  .         .         .         .         .  
						SKNGRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 	     219 MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFP 268                                                          
						VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPAPFIDHQNIEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ECSSMDS                                                      	       1 MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFP 50                                                           
						90 % homologous to corresponding to amino acids 1 - 367 of   	                  .         .         .         .         .  
						Q9H7D7, which also corresponds to amino acids 219 - 585 of   	     269 CYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLL 318                                                          
						T10350_P10, wherein said first amino acid sequence and second	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 CYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLL 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10350_P10, comprising a polypeptide being at least 70%,     	     319 KTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGELRTKMSQS 368                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 KTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGELRTKMSQS 150                                                          
						QQLGEESTHQGAERSGSEDRGGSCLRCRPATPELGSSLKKKKRLSQSDEDVIRLIGQHLN 	                  .         .         .         .         .  
						GLGLNQTVDLLMQESGCRLEHPSATKFRNHVMEGDWDKAENDLNELKPLVHSPHAIVVRG 	     369 HEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVRVQCLWCL 418                                                          
						ALEISQTLLGIIVRMKFLLLQQKYLEYLEDGKVLEALQVLRCELTPLKYNTERIHVLSGY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMCSHAEDLRAKAEWEGKGTASRSKLLDKLQTYLPPSV                       	     151 HEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVRVQCLWCL 200                                                          
						least about 95% homologous to the sequence of T10350_P10.    	                  .         .         .         .         .  
						                                                            	     419 SDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKNGRLALLN 468                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKNGRLALLN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     469 VATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 518                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPA 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPA 350                                                          
						                                                            	                  .                                          
						                                                            	     569 PFIDHQNIEEECSSMDS                                  585                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     351 PFIDHQNIEEECSSMDS                                  367                                                          

8688	HMR136_T10350_12_tr0_r1_1_gPRT		Comparison report between T10350_P12 and AAH52301unique head 	Sequence name: AAH52301                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10350_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8688 x AAH52301   ..                           
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FFKISSIKA corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of T10350_P12, and a second amino acid sequence being at 	                                                            
						YLPPSVMLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFPCYTQ 	                     Quality: 3761.00                      Escore:       0                                               
						QILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLLKTLEGHAYGVSYIA 	             Matching length:     376                Total length:     376                                               
						WSPDDNYLVACGPDDCSELWLWNVQTGELRTKMSQSHEDSLTSVAWNPDGKRFVTGGQRG 	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.20                                               
						QFYQCDLDGNLLDSWEGVRVQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHP 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.20                                               
						IMSFTISKNGRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIAS 	                        Gaps:       0                        
						GSEDHKVYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPAPFID 	                                                            
						HQNIEEECSSMDS                                                	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 152 -  	                  .         .         .         .         .  
						524 of AAH52301, which also corresponds to amino acids 10 -  	       7 IKAYLPPSVMLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLID 56                                                           
						382 of T10350_P12, wherein said first amino acid sequence and	         :: |||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     149 LQTYLPPSVMLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLID 198                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10350_P12, comprising a polypeptide being at least 70%,     	      57 HVCSRRQFPCYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVD 106                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     199 HVCSRRQFPCYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVD 248                                                          
						least about 95% homologous to the sequence FFKISSIKA of      	                  .         .         .         .         .  
						T10350_P12.                                                  	     107 PDTHLLKLLKTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTG 156                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     249 PDTHLLKLLKTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTG 298                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     157 ELRTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEG 206                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     299 ELRTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEG 348                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     207 VRVQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTIS 256                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     349 VRVQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTIS 398                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     257 KNGRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDF 306                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     399 KNGRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDF 448                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     307 IASGSEDHKVYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDD 356                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     449 IASGSEDHKVYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDD 498                                                          
						                                                            	                  .         .                                
						                                                            	     357 GTVRIWGPAPFIDHQNIEEECSSMDS                         382                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     499 GTVRIWGPAPFIDHQNIEEECSSMDS                         524                                                          

						Comparison report between T10350_P12 and Q9H7D7unique head   	Sequence name: Q9H7D7                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10350_P12, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 8688 x Q9H7D7   ..                             
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence FFKISSIKAYLPPSV corresponding to amino   	Alignment segment 1/1:                                       
						acids 1 - 15 of T10350_P12, and a second amino acid sequence 	                                                            
						MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFPCYTQQILTEH 	                     Quality: 3697.00                      Escore:       0                                               
						CNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLLKTLEGHAYGVSYIAWSPDDN 	             Matching length:     367                Total length:     367                                               
						YLVACGPDDCSELWLWNVQTGELRTKMSQSHEDSLTSVAWNPDGKRFVTGGQRGQFYQCD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LDGNLLDSWEGVRVQCLWCLSDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SKNGRLALLNVATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 	                        Gaps:       0                        
						VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPAPFIDHQNIEE 	                                                            
						ECSSMDS                                                      	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 1 - 367 of Q9H7D7, which also corresponds to amino     	      16 MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFP 65                                                           
						acids 16 - 382 of T10350_P12, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	       1 MLPPRRLQTLLRQAVELQRDRCLYHNTKLDNNLDSVSLLIDHVCSRRQFP 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of T10350_P12, comprising a polypeptide being at least  	      66 CYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLL 115                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      51 CYTQQILTEHCNEVWFCKFSNDGTKLATGSKDTTVIIWQVDPDTHLLKLL 100                                                          
						at least about 95% homologous to the sequence FFKISSIKAYLPPSV	                  .         .         .         .         .  
						of T10350_P12.                                               	     116 KTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGELRTKMSQS 165                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KTLEGHAYGVSYIAWSPDDNYLVACGPDDCSELWLWNVQTGELRTKMSQS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     166 HEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVRVQCLWCL 215                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 HEDSLTSVAWNPDGKRFVTGGQRGQFYQCDLDGNLLDSWEGVRVQCLWCL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     216 SDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKNGRLALLN 265                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SDGKTVLASDTHQRIRGYNFEDLTDRNIVQEDHPIMSFTISKNGRLALLN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     266 VATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 315                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VATQGVHLWDLQDRVLVRKYQGVTQGFYTIHSCFGGHNEDFIASGSEDHK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     316 VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPA 365                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 VYIWHKRSELPIAELTGHTRTVNCVSWNPQIPSMMASASDDGTVRIWGPA 350                                                          
						                                                            	                  .                                          
						                                                            	     366 PFIDHQNIEEECSSMDS                                  382                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     351 PFIDHQNIEEECSSMDS                                  367                                                          

4775	HMR136_T10354_2_tr0_r1_1_gPRT		Comparison report between T10354_P2 and Q96SN6unique head    	Sequence name: Q96SN6                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						T10354_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4775 x Q96SN6   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNPALAGQRRGSKVVLRLPSPGPALPALEEPARDARGRGRAGGRGSPRLHPAAATVRTHL 	Alignment segment 1/1:                                       
						VLINAEADSSPPSAPQAGAERRRALGSLRRGQGAVPGWAGYVSRYCGSRRRPRPRGSSRV 	                                                            
						RGRRAVRPGPRASRGRAGGAQGPRSPASPPSSRAQPRLGSLPLALVA              	                     Quality: 1912.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     199                Total length:     199                                               
						to amino acids 1 - 167 of T10354_P2, a second amino acid     	 Matching Percent Similarity:   98.99   Matching Percent Identity:   98.99                                               
						MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHAQLSGVEQLLE 	    Total Percent Similarity:   98.99      Total Percent Identity:   98.99                                               
						EFRRQLQQERPQEELELELRAGGGPQEDCPG                              	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 91 of Q96SN6, which also corresponds to amino	Alignment:                                                   
						acids 168 - 258 of T10354_P2, a bridging amino acid R        	                  .         .         .         .         .  
						corresponding to amino acid 259 of T10354_P2, a third amino  	     168 MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHA 217                                                          
						GSGGYSAMPDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRRPA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALAT                	       1 MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHA 50                                                           
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 93 - 197 of Q96SN6, which also corresponds to 	     218 QLSGVEQLLEEFRRQLQQERPQEELELELRAGGGPQEDCPGRGSGGYSAM 267                                                          
						amino acids 260 - 364 of T10354_P2, and a fourth amino acid  	         ||||||||||||||||||||||||||||||||||||||||| ||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 QLSGVEQLLEEFRRQLQQERPQEELELELRAGGGPQEDCPGPGSGGYSAM 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     268 PDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRR 317                                                          
						having the sequence KRMRLHLARLGRMWFCICPQTGWF corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 365 - 388 of T10354_P2, wherein said first amino 	     101 PDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRR 150                                                          
						acid sequence, second amino acid sequence, bridging amino    	                  .         .         .         .            
						acid, third amino acid sequence and fourth amino acid        	     318 PAPPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALATKR  366                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||| |   
						isolated polypeptide encoding for a head of T10354_P2,       	     151 PAPPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALATAR  199                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MNPALAGQRRGSKVVLRLPSPGPALPALEEPARDARGRGRAGGRGSPRLHPAAATVRTHL 	                                                            
						VLINAEADSSPPSAPQAGAERRRALGSLRRGQGAVPGWAGYVSRYCGSRRRPRPRGSSRV 	                                                            
						RGRRAVRPGPRASRGRAGGAQGPRSPASPPSSRAQPRLGSLPLALVA              	                                                            
						about 95% homologous to the sequence of T10354_P2.3.An       	                                                            
						isolated polypeptide encoding for a tail of T10354_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence KRMRLHLARLGRMWFCICPQTGWF	                                                            
						in T10354_P2.                                                	                                                            

						Comparison report between T10354_P2 and AAH43141unique head  	Sequence name: AAH43141                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10354_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4775 x AAH43141   ..                           
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNPALAGQRRGSKVVLRLPSPGPALPALEEPARDARGRGRAGGRGSPRLHPAAATVRTHL 	Alignment segment 1/1:                                       
						VLINAEADSSPPSAPQAGAERRRALGSLRRGQGAVPGWAGYVSRYCGSRRRPRPRGSSRV 	                                                            
						RGRRAVRPGPRASRGRAGGAQGPRSPASPPSSRAQPRLGSLPLALVA              	                     Quality: 1927.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     199                Total length:     199                                               
						to amino acids 1 - 167 of T10354_P2, a second amino acid     	 Matching Percent Similarity:   99.50   Matching Percent Identity:   99.50                                               
						MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHAQLSGVEQLLE 	    Total Percent Similarity:   99.50      Total Percent Identity:   99.50                                               
						EFRRQLQQERPQEELELELRAGGGPQEDCPGRGSGGYSAMPDAIIRTKDSLAAGASFLRA 	                        Gaps:       0                        
						PAAVRGWRQCVAACCSEPRCSVAVVELPRRPAPPAAVLGCYLFNCTARGRNVCKFALHSG 	                                                            
						YSSYSLSRAPDGAALAT                                            	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 197 of AAH43141, which also corresponds to   	     168 MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHA 217                                                          
						amino acids 168 - 364 of T10354_P2, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MASVAQESAGSQRRLPPRHGALRGLLLLCLWLPSGRAALPPAAPLSELHA 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     218 QLSGVEQLLEEFRRQLQQERPQEELELELRAGGGPQEDCPGRGSGGYSAM 267                                                          
						having the sequence KRMRLHLARLGRMWFCICPQTGWF corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 365 - 388 of T10354_P2, wherein said first amino 	      51 QLSGVEQLLEEFRRQLQQERPQEELELELRAGGGPQEDCPGRGSGGYSAM 100                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     268 PDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRR 317                                                          
						isolated polypeptide encoding for a head of T10354_P2,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     101 PDAIIRTKDSLAAGASFLRAPAAVRGWRQCVAACCSEPRCSVAVVELPRR 150                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .            
						preferably at least about 90% and most preferably at least   	     318 PAPPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALATKR  366                                                          
						MNPALAGQRRGSKVVLRLPSPGPALPALEEPARDARGRGRAGGRGSPRLHPAAATVRTHL 	         ||||||||||||||||||||||||||||||||||||||||||||||| |   
						VLINAEADSSPPSAPQAGAERRRALGSLRRGQGAVPGWAGYVSRYCGSRRRPRPRGSSRV 	     151 PAPPAAVLGCYLFNCTARGRNVCKFALHSGYSSYSLSRAPDGAALATAR  199                                                          
						RGRRAVRPGPRASRGRAGGAQGPRSPASPPSSRAQPRLGSLPLALVA              	                                                            
						about 95% homologous to the sequence of T10354_P2.3.An       	                                                            
						isolated polypeptide encoding for a tail of T10354_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence KRMRLHLARLGRMWFCICPQTGWF	                                                            
						in T10354_P2.                                                	                                                            

8983	HMR136_T10356_11_tr0_r1_1_gPRT		Comparison report between T10356_P11 and Q8N8Q7unique head   	Sequence name: Q8N8Q7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10356_P11, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 8983 x Q8N8Q7   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						CTERLRRGFHPPALLTRPERSPEAQGERHIGYRREVI corresponding to amino 	                     Quality: 8027.00                      Escore:       0                                               
						acids 1 - 37 of T10356_P11, a second amino acid sequence     	             Matching length:     824                Total length:     860                                               
						MHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPSAPQSPSYQIQQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSPTSPGFQFSAQPRRFEHGSPSY 	    Total Percent Similarity:   95.81      Total Percent Identity:   95.81                                               
						IQVTSPLSQQVQTQSPTQPSPGPGQALQNVRAGAPGPGLGLCSSSPTGGFVDASVLVRQI 	                        Gaps:       1                        
						SLSPSSGGHFVFQDGSGLTQIAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGPQ 	                                                            
						SPAAAGGAGLQPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPGV 	Alignment:                                                   
						LLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPKKLEEIPPASPE 	                  .         .         .         .         .  
						MAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGNMMDFLAFKKKHYAPLQAYLRQ 	      38 MHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPSA 87                                                           
						NDLDIEEEEEEEEEEEEKSEVINDEQALAGSLVAGAGSTVETDLFKRQQAMPSTGMA    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 MHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPSA 50                                                           
						acids 1 - 477 of Q8N8Q7, which also corresponds to amino     	                  .         .         .         .         .  
						acids 38 - 514 of T10356_P11, a third amino acid sequence    	      88 PQSPSYQIQQLMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSPT 137                                                          
						being at least 70%, optionally at least 80%, preferably at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 85%, more preferably at least 90% and most preferably  	      51 PQSPSYQIQQLMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSPT 100                                                          
						at least 95% homologous to a polypeptide having the sequence 	                  .         .         .         .         .  
						EQSKRPRLEVGHQGVVFQHPGADAGVPLQQLMPTAQ corresponding to amino  	     138 SPGFQFSAQPRRFEHGSPSYIQVTSPLSQQVQTQSPTQPSPGPGQALQNV 187                                                          
						acids 515 - 550 of T10356_P11, a fourth amino acid sequence  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAASLHTPLPQLPGRLPPAGVPTAALSSA 	     101 SPGFQFSAQPRRFEHGSPSYIQVTSPLSQQVQTQSPTQPSPGPGQALQNV 150                                                          
						LQFAQQPQVVEAQTQLQIPVKTQQPNVPIPAPPSSQLPIPPSQPAQLALHVPTPGKVQVQ 	                  .         .         .         .         .  
						ASQLSSLPQMVASTRLPVDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSSPVNRPSSA 	     188 RAGAPGPGLGLCSSSPTGGFVDASVLVRQISLSPSSGGHFVFQDGSGLTQ 237                                                          
						TNKALSPVTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVHQRIAELRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVAAAKKLVRTVVRHHEE 	     151 RAGAPGPGLGLCSSSPTGGFVDASVLVRQISLSPSSGGHFVFQDGSGLTQ 200                                                          
						KQLREERGKKEEQSRLRRIAASTAREIECFWSNIEQVVEIKLRVELE              	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     238 IAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGPQSPAAAGGAGL 287                                                          
						acids 478 - 824 of Q8N8Q7, which also corresponds to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 551 - 897 of T10356_P11, and a fifth amino acid        	     201 IAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGPQSPAAAGGAGL 250                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     288 QPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPGV 337                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKRKKALNLQKVSRRGKELRPKGFDALQESSLDSGMSGRKRKASISLTDDEVDDEEETIE 	     251 QPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPGV 300                                                          
						EEEANEGVVDHQTELSNLAKEAELPLLDLMKLYEGAFLPSSQWPRPKPDGEDTSGEEDAD 	                  .         .         .         .         .  
						DCPGDRESRKDLVLIDSLFIMDQFKAAERMNIGKPNAKDIADVTAVAEAILPKGSARVTT 	     338 LLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPKK 387                                                          
						SVKFNAPSLLYGALRDYQKIGLDWLAKLYRKNLNGILADEAGLGKTVQIIAFFAHLACNE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GNWGPHLVVVRSCNILKWELELKRWCPGLKILSYIGSHRELKAKRQEWAEPNSFHVCITS 	     301 LLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPKK 350                                                          
						YTQFFRGLTAFTRVRWKCLVIDEMQRVKGMTERHWEAVFTLQSQQRLLLIDSPLHNTFLE 	                  .         .         .         .         .  
						LWTMVHFLVPGISRPYLSSPLRAPSEESQDYYHKVVIRLHRVTQPFILRRTKRDVEKQLT 	     388 LEEIPPASPEMAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGNM 437                                                          
						KKYEHVLKCRLSNRQKALYEDVILQPGTQEALKSGHFVNVLSILVRLQRICNHPGLVEPR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HPGSSYVAGPLEYPSASLILKALERDFWKEADLSMFDLIGLENKITRHEAELLSKKKIPR 	     351 LEEIPPASPEMAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGNM 400                                                          
						KLMEEISTSAAPAARPAAAKLKASRLFQPVQYGQKPEGRTVAFPSTHPPRTAAPTTASAA 	                  .         .         .         .         .  
						PQGPLRGRPPIATFSANPEAKGGEVVKIAQLASITGPQSRVAQPETPVTLQFQGSKFTLS 	     438 MDFLAFKKKHYAPLQAYLRQNDLDIEEEEEEEEEEEEKSEVINDEQALAG 487                                                          
						HSQLRQLTAGQPLQLQGSVLQIVSAPGQPYLRAPGPVVMQTVSQAGAVHGALGSKPPAGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSPAPLTPQVGVPGRVAVNALAVGEPGTASKPASPIGGPTQEEKTRLLKERLDQIYLVNE 	     401 MDFLAFKKKHYAPLQAYLRQNDLDIEEEEEEEEEEEEKSEVINDEQALAG 450                                                          
						RRCSQAPVYGRDLLRICALPSHGRVQWRGSLDGRRGKEAGPAHSYTSSSESPSELMLTLC 	                  .         .         .         .         .  
						RCGESLQDVIDRVAFVIPPVVAAPPSLRVPRPPPLYSHRMRILRQGLREHAAPYFQQLRQ 	     488 SLVAGAGSTVETDLFKRQQAMPSTGMAEQSKRPRLEVGHQGVVFQHPGAD 537                                                          
						TTAPRLLQFPELRLVQFDSGKLEALAILLQKLKSEGRRVLILSQMILMLDILEMFLNFHY 	         |||||||||||||||||||||||||||                         
						LTYVRIDENASSEQRQELMRSFNRDRRIFCAILSTHSRTTGINLVEADTVVFYDNDLNPV 	     451 SLVAGAGSTVETDLFKRQQAMPSTGMA....................... 477                                                          
						MDAKAQEWCDRIGRCKDIHIYRLVSGNSIEEKLLKNGTKDLIREVAAQGNDYSMAFLTQR 	                  .         .         .         .         .  
						TIQELFEVYSPMDDAGFPVKAEEFVVLSQEPSVTETIAPKIARPFIEALKSIEYLEEDAQ 	     538 AGVPLQQLMPTAQGGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAASLH 587                                                          
						KSAQEGVLGPHTDALSSDSENMPCDEEPSQLEELADFMEQLTPIEKYALNYLELFHTSIE 	                      |||||||||||||||||||||||||||||||||||||  
						QEKERNSEDAVMTAVRAWEFWNLKTLQEREARLRLEQEEAELLTYTREDAYSMEYVYEDV 	     478 .............GGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAASLH 514                                                          
						DGQTEVMPLWTPPTPPQDDSDIYLDSVMCLMYEATPIPEAKLPPVYVRKERKRHKTDPSA 	                  .         .         .         .         .  
						AGRKKKQRHGEAVVPPRSLFDRATPGLLKIRREGKEQKKNILLKQQVPFAKPLPTFAKPT 	     588 TPLPQLPGRLPPAGVPTAALSSALQFAQQPQVVEAQTQLQIPVKTQQPNV 637                                                          
						AEPGQDNPEWLITEISFSRL                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 898 - 2297  	     515 TPLPQLPGRLPPAGVPTAALSSALQFAQQPQVVEAQTQLQIPVKTQQPNV 564                                                          
						of T10356_P11, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, fourth amino 	     638 PIPAPPSSQLPIPPSQPAQLALHVPTPGKVQVQASQLSSLPQMVASTRLP 687                                                          
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     565 PIPAPPSSQLPIPPSQPAQLALHVPTPGKVQVQASQLSSLPQMVASTRLP 614                                                          
						for a head of T10356_P11, comprising a polypeptide being at  	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     688 VDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSSPVNRPSSATNKALSP 737                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     615 VDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSSPVNRPSSATNKALSP 664                                                          
						CTERLRRGFHPPALLTRPERSPEAQGERHIGYRREVI of T10356_P11.3.An     	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     738 VTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVHQRIAE 787                                                          
						T10356_P11, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     665 VTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVHQRIAE 714                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     788 LRKAGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVAAA 837                                                          
						EQSKRPRLEVGHQGVVFQHPGADAGVPLQQLMPTAQ, corresponding to       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10356_P11.4.An isolated polypeptide encoding for a tail of  	     715 LRKAGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVAAA 764                                                          
						T10356_P11, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     838 KKLVRTVVRHHEEKQLREERGKKEEQSRLRRIAASTAREIECFWSNIEQV 887                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKRKKALNLQKVSRRGKELRPKGFDALQESSLDSGMSGRKRKASISLTDDEVDDEEETIE 	     765 KKLVRTVVRHHEEKQLREERGKKEEQSRLRRIAASTAREIECFWSNIEQV 814                                                          
						EEEANEGVVDHQTELSNLAKEAELPLLDLMKLYEGAFLPSSQWPRPKPDGEDTSGEEDAD 	                  .                                          
						DCPGDRESRKDLVLIDSLFIMDQFKAAERMNIGKPNAKDIADVTAVAEAILPKGSARVTT 	     888 VEIKLRVELE                                         897                                                          
						SVKFNAPSLLYGALRDYQKIGLDWLAKLYRKNLNGILADEAGLGKTVQIIAFFAHLACNE 	         ||||||||||                                          
						GNWGPHLVVVRSCNILKWELELKRWCPGLKILSYIGSHRELKAKRQEWAEPNSFHVCITS 	     815 VEIKLRVELE                                         824                                                          
						YTQFFRGLTAFTRVRWKCLVIDEMQRVKGMTERHWEAVFTLQSQQRLLLIDSPLHNTFLE 	                                                            
						LWTMVHFLVPGISRPYLSSPLRAPSEESQDYYHKVVIRLHRVTQPFILRRTKRDVEKQLT 	                                                            
						KKYEHVLKCRLSNRQKALYEDVILQPGTQEALKSGHFVNVLSILVRLQRICNHPGLVEPR 	                                                            
						HPGSSYVAGPLEYPSASLILKALERDFWKEADLSMFDLIGLENKITRHEAELLSKKKIPR 	                                                            
						KLMEEISTSAAPAARPAAAKLKASRLFQPVQYGQKPEGRTVAFPSTHPPRTAAPTTASAA 	                                                            
						PQGPLRGRPPIATFSANPEAKGGEVVKIAQLASITGPQSRVAQPETPVTLQFQGSKFTLS 	                                                            
						HSQLRQLTAGQPLQLQGSVLQIVSAPGQPYLRAPGPVVMQTVSQAGAVHGALGSKPPAGG 	                                                            
						PSPAPLTPQVGVPGRVAVNALAVGEPGTASKPASPIGGPTQEEKTRLLKERLDQIYLVNE 	                                                            
						RRCSQAPVYGRDLLRICALPSHGRVQWRGSLDGRRGKEAGPAHSYTSSSESPSELMLTLC 	                                                            
						RCGESLQDVIDRVAFVIPPVVAAPPSLRVPRPPPLYSHRMRILRQGLREHAAPYFQQLRQ 	                                                            
						TTAPRLLQFPELRLVQFDSGKLEALAILLQKLKSEGRRVLILSQMILMLDILEMFLNFHY 	                                                            
						LTYVRIDENASSEQRQELMRSFNRDRRIFCAILSTHSRTTGINLVEADTVVFYDNDLNPV 	                                                            
						MDAKAQEWCDRIGRCKDIHIYRLVSGNSIEEKLLKNGTKDLIREVAAQGNDYSMAFLTQR 	                                                            
						TIQELFEVYSPMDDAGFPVKAEEFVVLSQEPSVTETIAPKIARPFIEALKSIEYLEEDAQ 	                                                            
						KSAQEGVLGPHTDALSSDSENMPCDEEPSQLEELADFMEQLTPIEKYALNYLELFHTSIE 	                                                            
						QEKERNSEDAVMTAVRAWEFWNLKTLQEREARLRLEQEEAELLTYTREDAYSMEYVYEDV 	                                                            
						DGQTEVMPLWTPPTPPQDDSDIYLDSVMCLMYEATPIPEAKLPPVYVRKERKRHKTDPSA 	                                                            
						AGRKKKQRHGEAVVPPRSLFDRATPGLLKIRREGKEQKKNILLKQQVPFAKPLPTFAKPT 	                                                            
						AEPGQDNPEWLITEISFSRL                                         	                                                            
						least about 95% homologous to the sequence in T10356_P11.    	                                                            

						Comparison report between T10356_P11 and Q9P230unique head   	Sequence name: Q9P230                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						deletion and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for T10356_P11, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 8983 x Q9P230   ..                             
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence                              	                                                            
						CTERLRRGFHPPALLTRPERSPEAQGERHIGYRREV corresponding to amino  	                     Quality: 16846.00                      Escore:       0                                              
						acids 1 - 36 of T10356_P11, a second amino acid sequence     	             Matching length:    1730                Total length:    1731                                               
						IMHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPSAPQSPSYQIQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QLMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSPTSPGFQFSAQPRRFEHGSPS 	    Total Percent Similarity:   99.94      Total Percent Identity:   99.94                                               
						YIQVTSPLSQQVQTQSPTQPSPGPGQALQNVRAGAPGPGLGLCSSSPTGGFVDASVLVRQ 	                        Gaps:       1                        
						ISLSPSSGGHFVFQDGSGLTQIAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGP 	                                                            
						QSPAAAGGAGLQPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPG 	Alignment:                                                   
						VLLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPKKLEEIPPASP 	                  .         .         .         .         .  
						EMAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGNMMDFLAFKKKHYAPLQAYLR 	      37 IMHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPS 86                                                           
						QNDLDIEEEEEEEEEEEEKSEVINDE                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       1 IMHHGTGPQNVQHQLQRSRACPGSEGEEQPAHPNPPPSPAAPFAPSASPS 50                                                           
						acids 1 - 446 of Q9P230, which also corresponds to amino     	                  .         .         .         .         .  
						acids 37 - 482 of T10356_P11, a third amino acid sequence    	      87 APQSPSYQIQQLMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSP 136                                                          
						QALAGSLVAGAGSTVETDLFKRQQAMPSTGMAEQSKRPRLEVGHQGVVFQHPGADAGVPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQLMPTAQGGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAASLHTPLPQLPGRLPPAGV 	      51 APQSPSYQIQQLMNRSPATGQNVNITLQSVGPVVGGNQQITLAPLPLPSP 100                                                          
						PTAALSSALQFAQQPQVVEAQTQLQIPVKTQQPNVPIPAPPSSQLPIPPSQPAQLALHVP 	                  .         .         .         .         .  
						TPGKVQVQASQLSSLPQMVASTRLPVDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSS 	     137 TSPGFQFSAQPRRFEHGSPSYIQVTSPLSQQVQTQSPTQPSPGPGQALQN 186                                                          
						PVNRPSSATNKALSPVTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QRIAELRKAGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVAAAKKLVR 	     101 TSPGFQFSAQPRRFEHGSPSYIQVTSPLSQQVQTQSPTQPSPGPGQALQN 150                                                          
						TVVRHHEEKQLREERGKKEEQSRLRRIAASTAREIECFWSNIEQVVEIKLRVELEEKRKK 	                  .         .         .         .         .  
						ALNLQKVSRRGKELRPKGFDALQESSLDSGMSGRKRKASISLTDDEVDDEEETIEEEEAN 	     187 VRAGAPGPGLGLCSSSPTGGFVDASVLVRQISLSPSSGGHFVFQDGSGLT 236                                                          
						EGVVDHQTELSNLAKEAELPLLDLMKLYEGAFLPSSQWPRPKPDGEDTSGEEDADDCPGD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RESRKDLVLIDSLFIMDQFKAAERMNIGKPNAKDIADVTAVAEAILPKGSARVTTSVKFN 	     151 VRAGAPGPGLGLCSSSPTGGFVDASVLVRQISLSPSSGGHFVFQDGSGLT 200                                                          
						APSLLYGALRDYQKIGLDWLAKLYRKNLNGILADEAGLGKTVQIIAFFAHLACNEGNWGP 	                  .         .         .         .         .  
						HLVVVRSCNILKWELELKRWCPGLKILSYIGSHRELKAKRQEWAEPNSFHVCITSYTQFF 	     237 QIAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGPQSPAAAGGAG 286                                                          
						RGLTAFTRVRWKCLVIDEMQRVKGMTERHWEAVFTLQSQQRLLLIDSPLHNTFLELWTMV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HFLVPGISRPYLSSPLRAPSEESQDYYHKVVIRLHRVTQPFILRRTKRDVEKQLTKKYEH 	     201 QIAQGAQVQLQHPGTPITVRERRPSQPHTQSGGTIHHLGPQSPAAAGGAG 250                                                          
						VLKCRLSNRQKALYEDVILQPGTQEALKSGHFVNVLSILVRLQRICNHPGLVEPRHPGSS 	                  .         .         .         .         .  
						YVAGPLEYPSASLILKALERDFWKEADLSMFDLIGLENKITRHEAELLSKKKIPRKLMEE 	     287 LQPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPG 336                                                          
						ISTSAAPAARPAAAKLKASRLFQPVQYGQKPEGRTVAFPSTHPPRTAAPTTASAAPQGPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGRPPIATFSANPEAKGGEVVKIAQLASITGPQSRVAQPETPVTLQFQGSKFTLSHSQLR 	     251 LQPLASPSHITTANLPPQISSIIQGQLVQQQQVLQGPPLPRPLGFERTPG 300                                                          
						QLTAGQPLQLQGSVLQIVSAPGQPYLRAPGPVVMQTVSQAGAVHGALGSKPPAGGPSPAP 	                  .         .         .         .         .  
						LTPQVGVPGRVAVNALAVGEPGTASKPASPIGGPTQEEKTRLLKERLDQIYLVNERRCSQ 	     337 VLLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPK 386                                                          
						APVYGRDLLRICALPSHGRVQWRGSLDGRRGKEAGPAHSYTSSSESPSELMLTLCRCGES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQDVIDRVAFVIPPVVAAPPSLRV                                     	     301 VLLPGAGGAAGFGMTSPPPPTSPSRTAVPPGLSSLPLTSVGNTGMKKVPK 350                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 448 - 1731 of Q9P230, which also corresponds to amino  	     387 KLEEIPPASPEMAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGN 436                                                          
						acids 483 - 1766 of T10356_P11, and a fourth amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     351 KLEEIPPASPEMAQMRKQCLDYHYQEMQALKEVFKEYLIELFFLQHFQGN 400                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     437 MMDFLAFKKKHYAPLQAYLRQNDLDIEEEEEEEEEEEEKSEVINDE.QAL 485                                                          
						PRPPPLYSHRMRILRQGLREHAAPYFQQLRQTTAPRLLQFPELRLVQFDSGKLEALAILL 	         |||||||||||||||||||||||||||||||||||||||||||||| |||  
						QKLKSEGRRVLILSQMILMLDILEMFLNFHYLTYVRIDENASSEQRQELMRSFNRDRRIF 	     401 MMDFLAFKKKHYAPLQAYLRQNDLDIEEEEEEEEEEEEKSEVINDEQQAL 450                                                          
						CAILSTHSRTTGINLVEADTVVFYDNDLNPVMDAKAQEWCDRIGRCKDIHIYRLVSGNSI 	                  .         .         .         .         .  
						EEKLLKNGTKDLIREVAAQGNDYSMAFLTQRTIQELFEVYSPMDDAGFPVKAEEFVVLSQ 	     486 AGSLVAGAGSTVETDLFKRQQAMPSTGMAEQSKRPRLEVGHQGVVFQHPG 535                                                          
						EPSVTETIAPKIARPFIEALKSIEYLEEDAQKSAQEGVLGPHTDALSSDSENMPCDEEPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLEELADFMEQLTPIEKYALNYLELFHTSIEQEKERNSEDAVMTAVRAWEFWNLKTLQER 	     451 AGSLVAGAGSTVETDLFKRQQAMPSTGMAEQSKRPRLEVGHQGVVFQHPG 500                                                          
						EARLRLEQEEAELLTYTREDAYSMEYVYEDVDGQTEVMPLWTPPTPPQDDSDIYLDSVMC 	                  .         .         .         .         .  
						LMYEATPIPEAKLPPVYVRKERKRHKTDPSAAGRKKKQRHGEAVVPPRSLFDRATPGLLK 	     536 ADAGVPLQQLMPTAQGGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAAS 585                                                          
						IRREGKEQKKNILLKQQVPFAKPLPTFAKPTAEPGQDNPEWLITEISFSRL          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1767 - 2297 	     501 ADAGVPLQQLMPTAQGGMPPTPQAAQLAGQRQSQQQYDPSTGPPVQNAAS 550                                                          
						of T10356_P11, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence and fourth    	     586 LHTPLPQLPGRLPPAGVPTAALSSALQFAQQPQVVEAQTQLQIPVKTQQP 635                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     551 LHTPLPQLPGRLPPAGVPTAALSSALQFAQQPQVVEAQTQLQIPVKTQQP 600                                                          
						T10356_P11, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     636 NVPIPAPPSSQLPIPPSQPAQLALHVPTPGKVQVQASQLSSLPQMVASTR 685                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     601 NVPIPAPPSSQLPIPPSQPAQLALHVPTPGKVQVQASQLSSLPQMVASTR 650                                                          
						CTERLRRGFHPPALLTRPERSPEAQGERHIGYRREV of T10356_P11.3.An      	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     686 LPVDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSSPVNRPSSATNKAL 735                                                          
						T10356_P11, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     651 LPVDPAPPCPRPLPTSSTSSLAPVSGSGPGPSPARSSPVNRPSSATNKAL 700                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     736 SPVTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVHQRI 785                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     701 SPVTSRTPGVVASAPTKPQSPAQNATSSQDSSQDTLTEQITLENQVHQRI 750                                                          
						at least two amino acids comprise EQ, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     786 AELRKAGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVA 835                                                          
						483-x to 483; and ending at any of amino acid numbers 483+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     751 AELRKAGLWSQRRLPKLQEAPRPKSHWDYLLEEMQWMATDFAQERRWKVA 800                                                          
						polypeptide encoding for a tail of T10356_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     836 AAKKLVRTVVRHHEEKQLREERGKKEEQSRLRRIAASTAREIECFWSNIE 885                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     801 AAKKLVRTVVRHHEEKQLREERGKKEEQSRLRRIAASTAREIECFWSNIE 850                                                          
						PRPPPLYSHRMRILRQGLREHAAPYFQQLRQTTAPRLLQFPELRLVQFDSGKLEALAILL 	                  .         .         .         .         .  
						QKLKSEGRRVLILSQMILMLDILEMFLNFHYLTYVRIDENASSEQRQELMRSFNRDRRIF 	     886 QVVEIKLRVELEEKRKKALNLQKVSRRGKELRPKGFDALQESSLDSGMSG 935                                                          
						CAILSTHSRTTGINLVEADTVVFYDNDLNPVMDAKAQEWCDRIGRCKDIHIYRLVSGNSI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEKLLKNGTKDLIREVAAQGNDYSMAFLTQRTIQELFEVYSPMDDAGFPVKAEEFVVLSQ 	     851 QVVEIKLRVELEEKRKKALNLQKVSRRGKELRPKGFDALQESSLDSGMSG 900                                                          
						EPSVTETIAPKIARPFIEALKSIEYLEEDAQKSAQEGVLGPHTDALSSDSENMPCDEEPS 	                  .         .         .         .         .  
						QLEELADFMEQLTPIEKYALNYLELFHTSIEQEKERNSEDAVMTAVRAWEFWNLKTLQER 	     936 RKRKASISLTDDEVDDEEETIEEEEANEGVVDHQTELSNLAKEAELPLLD 985                                                          
						EARLRLEQEEAELLTYTREDAYSMEYVYEDVDGQTEVMPLWTPPTPPQDDSDIYLDSVMC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMYEATPIPEAKLPPVYVRKERKRHKTDPSAAGRKKKQRHGEAVVPPRSLFDRATPGLLK 	     901 RKRKASISLTDDEVDDEEETIEEEEANEGVVDHQTELSNLAKEAELPLLD 950                                                          
						IRREGKEQKKNILLKQQVPFAKPLPTFAKPTAEPGQDNPEWLITEISFSRL          	                  .         .         .         .         .  
						to the sequence in T10356_P11.                               	     986 LMKLYEGAFLPSSQWPRPKPDGEDTSGEEDADDCPGDRESRKDLVLIDSL 1035                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 LMKLYEGAFLPSSQWPRPKPDGEDTSGEEDADDCPGDRESRKDLVLIDSL 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1036 FIMDQFKAAERMNIGKPNAKDIADVTAVAEAILPKGSARVTTSVKFNAPS 1085                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 FIMDQFKAAERMNIGKPNAKDIADVTAVAEAILPKGSARVTTSVKFNAPS 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1086 LLYGALRDYQKIGLDWLAKLYRKNLNGILADEAGLGKTVQIIAFFAHLAC 1135                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 LLYGALRDYQKIGLDWLAKLYRKNLNGILADEAGLGKTVQIIAFFAHLAC 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1136 NEGNWGPHLVVVRSCNILKWELELKRWCPGLKILSYIGSHRELKAKRQEW 1185                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 NEGNWGPHLVVVRSCNILKWELELKRWCPGLKILSYIGSHRELKAKRQEW 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1186 AEPNSFHVCITSYTQFFRGLTAFTRVRWKCLVIDEMQRVKGMTERHWEAV 1235                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 AEPNSFHVCITSYTQFFRGLTAFTRVRWKCLVIDEMQRVKGMTERHWEAV 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1236 FTLQSQQRLLLIDSPLHNTFLELWTMVHFLVPGISRPYLSSPLRAPSEES 1285                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 FTLQSQQRLLLIDSPLHNTFLELWTMVHFLVPGISRPYLSSPLRAPSEES 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1286 QDYYHKVVIRLHRVTQPFILRRTKRDVEKQLTKKYEHVLKCRLSNRQKAL 1335                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 QDYYHKVVIRLHRVTQPFILRRTKRDVEKQLTKKYEHVLKCRLSNRQKAL 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1336 YEDVILQPGTQEALKSGHFVNVLSILVRLQRICNHPGLVEPRHPGSSYVA 1385                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 YEDVILQPGTQEALKSGHFVNVLSILVRLQRICNHPGLVEPRHPGSSYVA 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1386 GPLEYPSASLILKALERDFWKEADLSMFDLIGLENKITRHEAELLSKKKI 1435                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 GPLEYPSASLILKALERDFWKEADLSMFDLIGLENKITRHEAELLSKKKI 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1436 PRKLMEEISTSAAPAARPAAAKLKASRLFQPVQYGQKPEGRTVAFPSTHP 1485                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 PRKLMEEISTSAAPAARPAAAKLKASRLFQPVQYGQKPEGRTVAFPSTHP 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1486 PRTAAPTTASAAPQGPLRGRPPIATFSANPEAKGGEVVKIAQLASITGPQ 1535                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 PRTAAPTTASAAPQGPLRGRPPIATFSANPEAKGGEVVKIAQLASITGPQ 1500                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1536 SRVAQPETPVTLQFQGSKFTLSHSQLRQLTAGQPLQLQGSVLQIVSAPGQ 1585                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1501 SRVAQPETPVTLQFQGSKFTLSHSQLRQLTAGQPLQLQGSVLQIVSAPGQ 1550                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1586 PYLRAPGPVVMQTVSQAGAVHGALGSKPPAGGPSPAPLTPQVGVPGRVAV 1635                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1551 PYLRAPGPVVMQTVSQAGAVHGALGSKPPAGGPSPAPLTPQVGVPGRVAV 1600                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1636 NALAVGEPGTASKPASPIGGPTQEEKTRLLKERLDQIYLVNERRCSQAPV 1685                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1601 NALAVGEPGTASKPASPIGGPTQEEKTRLLKERLDQIYLVNERRCSQAPV 1650                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1686 YGRDLLRICALPSHGRVQWRGSLDGRRGKEAGPAHSYTSSSESPSELMLT 1735                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1651 YGRDLLRICALPSHGRVQWRGSLDGRRGKEAGPAHSYTSSSESPSELMLT 1700                                                         
						                                                            	                  .         .         .                      
						                                                            	    1736 LCRCGESLQDVIDRVAFVIPPVVAAPPSLRV                    1766                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	    1701 LCRCGESLQDVIDRVAFVIPPVVAAPPSLRV                    1731                                                         

9155	HMR136_T10362_2_tr0_r1_1_gPRT		Comparison report between T10362_P2 and Q9HBW9partial WT     	Sequence name: Q9HBW9                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for T10362_P2, comprising a first amino 	Sequence documentation:                                      
						MHTVEQATLRISQSFQKTTEFDTNSTDIALKVFFFDSYNMKHIHPHMNMDGDYINIFPKR 	                                                            
						KAAYDSNGNVAVAF                                               	Alignment of: 9155 x Q9HBW9   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 142 - 215 of Q9HBW9, which also corresponds to	Alignment segment 1/1:                                       
						amino acids 1 - 74 of T10362_P2, a bridging amino acid V     	                                                            
						corresponding to amino acid 75 of T10362_P2, and a second    	                     Quality: 4583.00                      Escore:       0                                               
						YYKSIGPLLSSSDNFLLKPQNYDNSEEEERVISSVISVSMSSNPPTLYELEKITFTLSHR 	             Matching length:     465                Total length:     465                                               
						KVTDRYRSLCAFWNYSPDTMNGSWSSEGCELTYSNETHTSCRCNHLTHFAILMSSGPSIG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						IKDYNILTRITQLGIIISLICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAELVFLVG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.78                                               
						INTNTNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYNKGFLHKNFYIFGYLS 	                        Gaps:       0                        
						PAVVVGFSAALGYRYYGTTKVCWLSTENNFIWSFIGPACLIILVNLLAFGVIIYKVFRHT 	                                                            
						AGLKPEVSCFENIRSCARGALALLFLLGTTWIFGVLHVVHASVVTAYLFTVSNAFQGMFI 	Alignment:                                                   
						FLFLCVLSRKIQEEYYRLFKNVPCCFGCLR                               	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MHTVEQATLRISQSFQKTTEFDTNSTDIALKVFFFDSYNMKHIHPHMNMD 50                                                           
						corresponding to amino acids 217 - 606 of Q9HBW9, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 76 - 465 of T10362_P2, wherein    	     142 MHTVEQATLRISQSFQKTTEFDTNSTDIALKVFFFDSYNMKHIHPHMNMD 191                                                          
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	      51 GDYINIFPKRKAAYDSNGNVAVAFVYYKSIGPLLSSSDNFLLKPQNYDNS 100                                                          
						order.                                                       	         ||||||||||||||||||||||||:|||||||||||||||||||||||||  
						                                                            	     192 GDYINIFPKRKAAYDSNGNVAVAFLYYKSIGPLLSSSDNFLLKPQNYDNS 241                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EEEERVISSVISVSMSSNPPTLYELEKITFTLSHRKVTDRYRSLCAFWNY 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 EEEERVISSVISVSMSSNPPTLYELEKITFTLSHRKVTDRYRSLCAFWNY 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SPDTMNGSWSSEGCELTYSNETHTSCRCNHLTHFAILMSSGPSIGIKDYN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 SPDTMNGSWSSEGCELTYSNETHTSCRCNHLTHFAILMSSGPSIGIKDYN 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ILTRITQLGIIISLICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 ILTRITQLGIIISLICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAEL 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VFLVGINTNTNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 VFLVGINTNTNKLFCSIIAGLLHYFFLAAFAWMCIEGIHLYLIVVGVIYN 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KGFLHKNFYIFGYLSPAVVVGFSAALGYRYYGTTKVCWLSTENNFIWSFI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 KGFLHKNFYIFGYLSPAVVVGFSAALGYRYYGTTKVCWLSTENNFIWSFI 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 GPACLIILVNLLAFGVIIYKVFRHTAGLKPEVSCFENIRSCARGALALLF 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 GPACLIILVNLLAFGVIIYKVFRHTAGLKPEVSCFENIRSCARGALALLF 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LLGTTWIFGVLHVVHASVVTAYLFTVSNAFQGMFIFLFLCVLSRKIQEEY 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 LLGTTWIFGVLHVVHASVVTAYLFTVSNAFQGMFIFLFLCVLSRKIQEEY 591                                                          
						                                                            	                  .                                          
						                                                            	     451 YRLFKNVPCCFGCLR                                    465                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     592 YRLFKNVPCCFGCLR                                    606                                                          

5562	HMR136_T10382_10_tr0_r1_1_gPRT		Comparison report between T10382_P10 and Q9H3E4unique head   	Sequence name: Q9H3E4                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10382_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 5562 x Q9H3E4   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	Alignment segment 1/1:                                       
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	                                                            
						TIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFT 	                     Quality: 1505.00                      Escore:       0                                               
						LVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRP 	             Matching length:     152                Total length:     152                                               
						VSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ILSEM                                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 305 of T10382_P10, a second amino acid    	                                                            
						GEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLLFTFNV 	Alignment:                                                   
						PGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKLTHVQR 	                  .         .         .         .         .  
						QEAAQSRREEKKRAEKERIMNEEDPEKQRRLE                             	     306 GEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDT 355                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 14 - 165 of Q9H3E4, which also corresponds to    	      14 GEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDT 63                                                           
						amino acids 306 - 457 of T10382_P10, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     356 KRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQK 405                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      64 KRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQK 113                                                          
						having the sequence V corresponding to amino acids 458 - 458 	                  .         .         .         .         .  
						of T10382_P10, wherein said first amino acid sequence, second	     406 ADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRR 455                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     114 ADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRR 163                                                          
						polypeptide encoding for a head of T10382_P10, comprising a  	                                                             
						polypeptide being at least 70%, optionally at least about    	     456 LE                                                 457                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||                                                  
						about 90% and most preferably at least about 95% homologous  	     164 LE                                                 165                                                          
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	                                                            
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	                                                            
						TIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFT 	                                                            
						LVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRP 	                                                            
						VSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 	                                                            
						ILSEM                                                        	                                                            
						to the sequence of T10382_P10.                               	                                                            

						Comparison report between T10382_P10 and Q96D00unique head   	Sequence name: Q96D00                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10382_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 5562 x Q96D00   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	Alignment segment 1/1:                                       
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	                                                            
						TIVDVPAHLQNSWESYYLEIL                                        	                     Quality: 3118.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     316                Total length:     316                                               
						to amino acids 1 - 141 of T10382_P10, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQEN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVTMNDEDMDTYVF 	                        Gaps:       0                        
						AVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLAILSEMGEVTDGMMDTKMVHFL 	                                                            
						THYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLLFTFNVPGSGNTYPKDMEALLP 	Alignment:                                                   
						LMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEK 	                  .         .         .         .         .  
						ERIMNEEDPEKQRRLE                                             	     142 MVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEA 191                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 316 of Q96D00, which also corresponds to     	       1 MVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEA 50                                                           
						amino acids 142 - 457 of T10382_P10, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     192 TSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPV 241                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 TSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPV 100                                                          
						having the sequence V corresponding to amino acids 458 - 458 	                  .         .         .         .         .  
						of T10382_P10, wherein said first amino acid sequence, second	     242 SDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGA 291                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 SDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGA 150                                                          
						polypeptide encoding for a head of T10382_P10, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     292 KYGLPDSLAILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPK 341                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 KYGLPDSLAILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPK 200                                                          
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	                  .         .         .         .         .  
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	     342 IMQEEGQPLKLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSID 391                                                          
						TIVDVPAHLQNSWESYYLEIL                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T10382_P10.                               	     201 IMQEEGQPLKLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSID 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     392 KAKKFRLNREGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEK 441                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KAKKFRLNREGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEK 300                                                          
						                                                            	                  .                                          
						                                                            	     442 ERIMNEEDPEKQRRLE                                   457                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     301 ERIMNEEDPEKQRRLE                                   316                                                          

						Comparison report between T10382_P10 and Q96JZ7partial WT    	Sequence name: Q96JZ7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10382_P10, comprising a first amino acid       	                                                            
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	Alignment of: 5562 x Q96JZ7   ..                             
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	                                                            
						TIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFT 	Alignment segment 1/1:                                       
						LVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRP 	                                                            
						VSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 	                     Quality: 4515.00                      Escore:       0                                               
						ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLL 	             Matching length:     458                Total length:     458                                               
						FTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						THVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRRLEV                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 458 of Q96JZ7, which also corresponds to     	                                                            
						amino acids 1 - 458 of T10382_P10.                           	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	                                                             
						                                                            	     451 EKQRRLEV                                           458                                                          
						                                                            	         ||||||||                                            
						                                                            	     451 EKQRRLEV                                           458                                                          

						Comparison report between T10382_P10 and Q96A33partial WT    	Sequence name: Q96A33                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for T10382_P10, comprising a first amino	Sequence documentation:                                      
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	                                                            
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	Alignment of: 5562 x Q96A33   ..                             
						TIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFT 	                                                            
						LVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRP 	Alignment segment 1/1:                                       
						VSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 	                                                            
						ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLL 	                     Quality: 4507.00                      Escore:       0                                               
						FTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKL 	             Matching length:     457                Total length:     457                                               
						THVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRRLE                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 457 of Q96A33, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 457 of T10382_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						having the sequence V corresponding to amino acids 458 - 458 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T10382_P10, wherein said first amino acid sequence and    	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	                                                             
						                                                            	     451 EKQRRLE                                            457                                                          
						                                                            	         |||||||                                             
						                                                            	     451 EKQRRLE                                            457                                                          

						Comparison report between T10382_P10 and Q9NRG3partial WT    	Sequence name: Q9NRG3                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for T10382_P10, comprising a first amino	Sequence documentation:                                      
						MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSVTESPQRVIIT 	                                                            
						EDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDEEFEGYEDKPDTSSSKNKDPI 	Alignment of: 5562 x Q9NRG3   ..                             
						TIVDVPAHLQNSWESYYLEILMVTGLLAYIMNYIIGKNKNSRLAQAWFNTHRELLESNFT 	                                                            
						LVGDDGTNKEATSTGKLNQENEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRP 	Alignment segment 1/1:                                       
						VSDQVQIKVTMNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 	                                                            
						ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPLKLPDTKRTLL 	                     Quality: 4507.00                      Escore:       0                                               
						FTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNREGKQKADKNRARVEENFLKL 	             Matching length:     457                Total length:     457                                               
						THVQRQEAAQSRREEKKRAEKERIMNEEDPEKQRRLE                        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acid sequence being at least 90 % homologous to corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 457 of Q9NRG3, which also corresponds to  	                        Gaps:       0                        
						amino acids 1 - 457 of T10382_P10, and a second amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment:                                                   
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						having the sequence V corresponding to amino acids 458 - 458 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T10382_P10, wherein said first amino acid sequence and    	       1 MKAFHTFCVVLLVFGSVSEAKFDDFEDEEDIVEYDDNDFAEFEDVMEDSV 50                                                           
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TESPQRVIITEDDEDETTVELEGQDENQEGDFEDADTQEGDTESEPYDDE 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 EFEGYEDKPDTSSSKNKDPITIVDVPAHLQNSWESYYLEILMVTGLLAYI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MNYIIGKNKNSRLAQAWFNTHRELLESNFTLVGDDGTNKEATSTGKLNQE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 NEHIYNLWCSGRVCCEGMLIQLRFLKRQDLLNVLARMMRPVSDQVQIKVT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MNDEDMDTYVFAVGTRKALVRLQKEMQDLSEFCSDKPKSGAKYGLPDSLA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ILSEMGEVTDGMMDTKMVHFLTHYADKIESVHFSDQFSGPKIMQEEGQPL 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 KLPDTKRTLLFTFNVPGSGNTYPKDMEALLPLMNMVIYSIDKAKKFRLNR 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EGKQKADKNRARVEENFLKLTHVQRQEAAQSRREEKKRAEKERIMNEEDP 450                                                          
						                                                            	                                                             
						                                                            	     451 EKQRRLE                                            457                                                          
						                                                            	         |||||||                                             
						                                                            	     451 EKQRRLE                                            457                                                          

11399	HMR136_T10391_8_tr0_r1_1_gPRT		Comparison report between T10391_P8 and Q8NAZ8unique head    	Sequence name: Q8NAZ8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion, a mismatch and a followed by a unique tail.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T10391_P8,        	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 11399 x Q8NAZ8   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGS corresponding to amino 	                     Quality: 5544.00                      Escore:       0                                               
						acids 1 - 37 of T10391_P8, a second amino acid sequence being	             Matching length:     581                Total length:     703                                               
						MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDASCSVLGPSAP 	 Matching Percent Similarity:   99.83   Matching Percent Identity:   99.66                                               
						GSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPHMGVGRQQRGPFQGVRVKNSV 	    Total Percent Similarity:   82.50      Total Percent Identity:   82.36                                               
						KELLLHIRSHKQKASGQAVDDFKTQGVNIEQFRELKNTVSYSGKRKGPDSLSDGPACKRP 	                        Gaps:       1                        
						ALLHSQFLTPPQTPTPGESMEDVHLNEPKQESSADLLQNIINIKNECSPVSLNTV      	                                                            
						at least 90 % homologous to corresponding to amino acids 1 - 	Alignment:                                                   
						235 of Q8NAZ8, which also corresponds to amino acids 38 - 272	                  .         .         .         .         .  
						of T10391_P8, a third amino acid sequence being at least 70%,	      38 MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDA 87                                                           
						optionally at least 80%, preferably at least 85%, more       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDA 50                                                           
						QVSWLNPVVVPQSSPAEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQH 	                  .         .         .         .         .  
						VEQQPHYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRESENIAN 	      88 SCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPH 137                                                          
						PM                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	      51 SCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPH 100                                                          
						to amino acids 273 - 394 of T10391_P8, a fourth amino acid   	                  .         .         .         .         .  
						QTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLPFSNMGNPMNTTQLGKSL 	     138 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 187                                                          
						FQWQVEQEESKLANISQDQFLSKDADGDTFLHIAVAQGRRALSYVLARKMNALHMLDIKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HNGQSAFQVAVAANQHLIVQDLVNIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAV 	     101 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 150                                                          
						GSNQFVDLEATNYDGLTPLHCAVIAHNAV                                	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     188 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 237                                                          
						amino acids 236 - 444 of Q8NAZ8, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 395 - 603 of T10391_P8, a bridging amino acid V  	     151 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 200                                                          
						corresponding to amino acid 604 of T10391_P8, a fifth amino  	                  .         .         .         .         .  
						HELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQMGAAVEAKDRKSGRTALHLAAEEANLE 	     238 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWLNPVVVPQSSP 287                                                          
						LIRLFLELPSCLSFVNAKAYNGNTALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENE 	         |||||||||||||||||||||||||||||||||||                 
						QPVHLVPDGPVGEQ                                               	     201 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTV............... 235                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 446 - 579 of Q8NAZ8, which also corresponds to	     288 AEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 337                                                          
						amino acids 605 - 738 of T10391_P8, and a sixth amino acid   	                                                            
						sequence being at least 70%, optionally at least 80%,        	     235 .................................................. 235                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     338 HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRES 387                                                          
						having the sequence VRGTGGRGSIFWHCSLKQKGR corresponding to   	                                                            
						amino acids 739 - 759 of T10391_P8, wherein said first amino 	     235 .................................................. 235                                                          
						acid sequence, second amino acid sequence, third amino acid  	                  .         .         .         .         .  
						sequence, fourth amino acid sequence, bridging amino acid,   	     388 ENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 437                                                          
						fifth amino acid sequence and sixth amino acid sequence are  	                |||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     236 .......QTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 278                                                          
						polypeptide encoding for a head of T10391_P8, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     438 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 487                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     279 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 328                                                          
						to the sequence WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGS of     	                  .         .         .         .         .  
						T10391_P8.3.An isolated polypeptide encoding for an edge     	     488 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 537                                                          
						portion of T10391_P8, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     329 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 378                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     538 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 587                                                          
						QVSWLNPVVVPQSSPAEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEQQPHYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRESENIAN 	     379 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 428                                                          
						PM,                                                          	                  .         .         .         .         .  
						encoding for corresponding to T10391_P8.4.An isolated        	     588 DGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 637                                                          
						polypeptide encoding for a tail of T10391_P8, comprising a   	         |||||||||||||||| |||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     429 DGLTPLHCAVIAHNAVFHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 478                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     638 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 687                                                          
						to the sequence VRGTGGRGSIFWHCSLKQKGR in T10391_P8.          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 528                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     688 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 737                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     529 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 578                                                          
						                                                            	                                                             
						                                                            	     738 QVR                                                740                                                          
						                                                            	         |:|                                                 
						                                                            	     579 QIR                                                581                                                          

						Comparison report between T10391_P8 and Q9BYH8unique head    	Sequence name: Q9BYH8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10391_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 11399 x Q9BYH8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGS corresponding to amino 	                                                            
						acids 1 - 37 of T10391_P8, a second amino acid sequence being	                     Quality: 6924.00                      Escore:       0                                               
						MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDASCSVLGPSAP 	             Matching length:     703                Total length:     703                                               
						GSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPHMGVGRQQRGPFQGVRVKNSV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.86                                               
						KELLLHIRSHKQKASGQAVDDFKTQGVNIEQFRELKNTVSYSGKRKGPDSLSDGPACKRP 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.86                                               
						ALLHSQFLTPPQTPTPGESMEDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWL 	                        Gaps:       0                        
						NPVVVPQSSPAEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 	                                                            
						HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRESENIANPMQTS 	Alignment:                                                   
						SSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLPFSNMGNPMNTTQLGKSLFQW 	                  .         .         .         .         .  
						QVEQEESKLANISQDQFLSKDADGDTFLHIAVAQGRRALSYVLARKMNALHMLDIKEHNG 	      38 MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDA 87                                                           
						QSAFQVAVAANQHLIVQDLVNIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QFVDLEATNYDGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 	       1 MIVDKLLDDSRGGEGLRDAAGGCGLMTSPLNLSYFYGASPPAAAPGACDA 50                                                           
						MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGNTALHVAASLQ 	                  .         .         .         .         .  
						YRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGEQ                    	      88 SCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPH 137                                                          
						at least 90 % homologous to corresponding to amino acids 1 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						701 of Q9BYH8, which also corresponds to amino acids 38 - 738	      51 SCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVESRSRGGARAERQPVEPH 100                                                          
						of T10391_P8, and a third amino acid sequence being at least 	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	     138 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 187                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     101 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 150                                                          
						VRGTGGRGSIFWHCSLKQKGR corresponding to amino acids 739 - 759 	                  .         .         .         .         .  
						of T10391_P8, wherein said first amino acid sequence, second 	     188 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 237                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     151 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 200                                                          
						polypeptide encoding for a head of T10391_P8, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     238 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWLNPVVVPQSSP 287                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     201 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWLNPVVVPQSSP 250                                                          
						to the sequence WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGS of     	                  .         .         .         .         .  
						T10391_P8.3.An isolated polypeptide encoding for a tail of   	     288 AEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 337                                                          
						T10391_P8, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 AEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     338 HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRES 387                                                          
						VRGTGGRGSIFWHCSLKQKGR in T10391_P8.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRES 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     388 ENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 437                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     438 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 487                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 537                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     538 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 587                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     588 DGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 637                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     638 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 687                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     688 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 737                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 700                                                          
						                                                            	                                                             
						                                                            	     738 QVR                                                740                                                          
						                                                            	         |:|                                                 
						                                                            	     701 QIR                                                703                                                          

						Comparison report between T10391_P8 and Q8IUL4unique head    	Sequence name: Q8IUL4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10391_P8, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 11399 x Q8IUL4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGSMIVDKLLDDSRGGEGLRDAAGGC 	Alignment segment 1/1:                                       
						GLMTSPLNLSYFYGASPPAAAPGACDASCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVE 	                                                            
						SRSRGGARAERQPVEPH                                            	                     Quality: 5961.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     603                Total length:     603                                               
						to amino acids 1 - 137 of T10391_P8, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIEQFRELKNTVS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						YSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESMEDVHLNEPKQESSADLLQNI 	                        Gaps:       0                        
						INIKNECSPVSLNTVQVSWLNPVVVPQSSPAEQCQDFHGGQVFSPPQKCQPFQVRGSQQM 	                                                            
						IDQASLYQYSPQNQHVEQQPHYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSL 	Alignment:                                                   
						VSLLGDQRESENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 	                  .         .         .         .         .  
						FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHIAVAQGRRALS 	     138 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 187                                                          
						YVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLVNIGAQVNTTDCWGRTPLHVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEKGHSQVLQAIQKGAVGSNQFVDLEATNYDGLTPLHCAVIAHNAVVHELQRNQQPHSPE 	       1 MGVGRQQRGPFQGVRVKNSVKELLLHIRSHKQKASGQAVDDFKTQGVNIE 50                                                           
						VQELLLKNKSLVDTIKCLIQMGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLS 	                  .         .         .         .         .  
						FVNAKAYNGNTALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 	     188 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 237                                                          
						Q                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 QFRELKNTVSYSGKRKGPDSLSDGPACKRPALLHSQFLTPPQTPTPGESM 100                                                          
						amino acids 1 - 601 of Q8IUL4, which also corresponds to     	                  .         .         .         .         .  
						amino acids 138 - 738 of T10391_P8, and a third amino acid   	     238 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWLNPVVVPQSSP 287                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 EDVHLNEPKQESSADLLQNIINIKNECSPVSLNTVQVSWLNPVVVPQSSP 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VRGTGGRGSIFWHCSLKQKGR corresponding to   	     288 AEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 337                                                          
						amino acids 739 - 759 of T10391_P8, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	     151 AEQCQDFHGGQVFSPPQKCQPFQVRGSQQMIDQASLYQYSPQNQHVEQQP 200                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T10391_P8,       	     338 HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRES 387                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     201 HYTHKPTLEYSPFPIPPQSPAYEPNLFDGPESQFCPNQSLVSLLGDQRES 250                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						WPAPSARRQLPEPAREAAARSEPVAQVSGSSSAQPGSMIVDKLLDDSRGGEGLRDAAGGC 	     388 ENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 437                                                          
						GLMTSPLNLSYFYGASPPAAAPGACDASCSVLGPSAPGSPGSDSSDFSSASSVSSCGAVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRSRGGARAERQPVEPH                                            	     251 ENIANPMQTSSSVQQQNDAHLHSFSMMPSSACEAMVGHEMASDSSNTSLP 300                                                          
						about 95% homologous to the sequence of T10391_P8.3.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of T10391_P8,       	     438 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 487                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     301 FSNMGNPMNTTQLGKSLFQWQVEQEESKLANISQDQFLSKDADGDTFLHI 350                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence VRGTGGRGSIFWHCSLKQKGR in	     488 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 537                                                          
						T10391_P8.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AVAQGRRALSYVLARKMNALHMLDIKEHNGQSAFQVAVAANQHLIVQDLV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     538 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 587                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NIGAQVNTTDCWGRTPLHVCAEKGHSQVLQAIQKGAVGSNQFVDLEATNY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     588 DGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 637                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DGLTPLHCAVIAHNAVVHELQRNQQPHSPEVQELLLKNKSLVDTIKCLIQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     638 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 687                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 MGAAVEAKDRKSGRTALHLAAEEANLELIRLFLELPSCLSFVNAKAYNGN 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     688 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 737                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TALHVAASLQYRLTQLDAVRLLMRKGADPSTRNLENEQPVHLVPDGPVGE 600                                                          
						                                                            	                                                             
						                                                            	     738 QVR                                                740                                                          
						                                                            	         |:|                                                 
						                                                            	     601 QIR                                                603                                                          

11545	HMR136_T10392_6_tr0_r1_1_gPRT		Comparison report between T10392_P6 and Q8TE35unique head    	Sequence name: Q8TE35                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for T10392_P6, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 11545 x Q8TE35   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MSLIR corresponding to amino 	Alignment segment 1/1:                                       
						acids 1 - 5 of T10392_P6, a second amino acid sequence being 	                                                            
						LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDAGAGLLAAAMI 	                     Quality: 6014.00                      Escore:       0                                               
						AVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGSICWAAKCALAYFYMVSSWGG 	             Matching length:     614                Total length:     614                                               
						YVFLINLIPLHVLVLMLTGRFSHRIYVAYCTVYCLGTILSMQISFVGFQPVLSSEHMAAF 	 Matching Percent Similarity:   99.84   Matching Percent Identity:   99.84                                               
						GVFGLCQIHAFVDYLRSKLNPQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFY 	    Total Percent Similarity:   99.84      Total Percent Identity:   99.84                                               
						SLLDPSYAKNNIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 	                        Gaps:       0                        
						YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKKSKKQQDSTYP 	                                                            
						IKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLSAR                   	Alignment:                                                   
						at least 90 % homologous to corresponding to amino acids 92 -	                  .         .         .         .         .  
						493 of Q8TE35, which also corresponds to amino acids 6 - 407 	       6 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 55                                                           
						of T10392_P6, a bridging amino acid G corresponding to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 408 of T10392_P6, and a third amino acid sequence being 	      92 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 141                                                          
						GDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTILVDNNTWNNTHISR 	                  .         .         .         .         .  
						VGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSDDINKFLWMVRIGGSTDTGKHIKE 	      56 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 105                                                          
						NDYYTPTGEFRVDREGSPVLLNCLMYKMCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDVLEEAYTTEHWLVRIYKVKDLDNRGLSRT                              	     142 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 191                                                          
						at least 90 % homologous to corresponding to amino acids 495 	                  .         .         .         .         .  
						- 705 of Q8TE35, which also corresponds to amino acids 409 - 	     106 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 155                                                          
						619 of T10392_P6, wherein said first amino acid sequence,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, bridging amino acid and third    	     192 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 241                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     156 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 205                                                          
						T10392_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     242 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 291                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence MSLIR of          	     206 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 255                                                          
						T10392_P6.                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 ARGGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 455                                                          
						                                                            	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 ARDGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 591                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     506 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     592 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 641                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     642 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 691                                                          
						                                                            	                  .                                          
						                                                            	     606 YKVKDLDNRGLSRT                                     619                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     692 YKVKDLDNRGLSRT                                     705                                                          

						Comparison report between T10392_P6 and AAH48348unique head  	Sequence name: AAH48348                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10392_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11545 x AAH48348   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MSLIR corresponding to amino acids 1 - 5 	Alignment segment 1/1:                                       
						of T10392_P6, and a second amino acid sequence being at least	                                                            
						LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDAGAGLLAAAMI 	                     Quality: 6027.00                      Escore:       0                                               
						AVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGSICWAAKCALAYFYMVSSWGG 	             Matching length:     614                Total length:     614                                               
						YVFLINLIPLHVLVLMLTGRFSHRIYVAYCTVYCLGTILSMQISFVGFQPVLSSEHMAAF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GVFGLCQIHAFVDYLRSKLNPQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SLLDPSYAKNNIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 	                        Gaps:       0                        
						YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKKSKKQQDSTYP 	                                                            
						IKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLSARGGDGSRIIFDDFREAYYW 	Alignment:                                                   
						LRHNTPEDAKVMSWWDYGYQITAMANRTILVDNNTWNNTHISRVGQAMASTEEKAYEIMR 	                  .         .         .         .         .  
						ELDVSYVLVIFGGLTGYSSDDINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGS 	       6 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 55                                                           
						PVLLNCLMYKMCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YKVKDLDNRGLSRT                                               	     107 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 156                                                          
						90 % homologous to corresponding to amino acids 107 - 720 of 	                  .         .         .         .         .  
						AAH48348, which also corresponds to amino acids 6 - 619 of   	      56 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 105                                                          
						T10392_P6, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     157 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 206                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10392_P6, comprising a polypeptide being at least 70%,      	     106 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 155                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     207 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 256                                                          
						least about 95% homologous to the sequence MSLIR of          	                  .         .         .         .         .  
						T10392_P6.                                                   	     156 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 406                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     407 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 456                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     457 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 506                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 ARGGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     507 ARGGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 556                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     557 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 606                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     506 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     607 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 656                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     657 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 706                                                          
						                                                            	                  .                                          
						                                                            	     606 YKVKDLDNRGLSRT                                     619                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     707 YKVKDLDNRGLSRT                                     720                                                          

						Comparison report between T10392_P6 and Q8WUB4unique head    	Sequence name: Q8WUB4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10392_P6, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 11545 x Q8WUB4   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MSLIR corresponding to amino acids 1 - 5 	Alignment segment 1/1:                                       
						of T10392_P6, and a second amino acid sequence being at least	                                                            
						LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDAGAGLLAAAMI 	                     Quality: 6027.00                      Escore:       0                                               
						AVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGSICWAAKCALAYFYMVSSWGG 	             Matching length:     614                Total length:     614                                               
						YVFLINLIPLHVLVLMLTGRFSHRIYVAYCTVYCLGTILSMQISFVGFQPVLSSEHMAAF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GVFGLCQIHAFVDYLRSKLNPQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SLLDPSYAKNNIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 	                        Gaps:       0                        
						YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKKSKKQQDSTYP 	                                                            
						IKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLSARGGDGSRIIFDDFREAYYW 	Alignment:                                                   
						LRHNTPEDAKVMSWWDYGYQITAMANRTILVDNNTWNNTHISRVGQAMASTEEKAYEIMR 	                  .         .         .         .         .  
						ELDVSYVLVIFGGLTGYSSDDINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGS 	       6 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 55                                                           
						PVLLNCLMYKMCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YKVKDLDNRGLSRT                                               	      92 LMITSAAIYHVLHFFHITIDIRNVCVFLAPLFSSFTTIVTYHLTKELKDA 141                                                          
						90 % homologous to corresponding to amino acids 92 - 705 of  	                  .         .         .         .         .  
						Q8WUB4, which also corresponds to amino acids 6 - 619 of     	      56 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 105                                                          
						T10392_P6, wherein said first amino acid sequence and second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     142 GAGLLAAAMIAVVPGYISRSVAGSYDNEGIAIFCMLLTYYMWIKAVKTGS 191                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10392_P6, comprising a polypeptide being at least 70%,      	     106 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 155                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     192 ICWAAKCALAYFYMVSSWGGYVFLINLIPLHVLVLMLTGRFSHRIYVAYC 241                                                          
						least about 95% homologous to the sequence MSLIR of          	                  .         .         .         .         .  
						T10392_P6.                                                   	     156 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     242 TVYCLGTILSMQISFVGFQPVLSSEHMAAFGVFGLCQIHAFVDYLRSKLN 291                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     292 PQQFEVLFRSVISLVGFVLLTVGALLMLTGKISPWTGRFYSLLDPSYAKN 341                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     342 NIPIIASVSEHQPTTWSSYYFDLQLLVFMFPVGLYYCFSNLSDARIFIIM 391                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     392 YGVTSMYFSAVMVRLMLVLAPVMCILSGIGVSQVLSTYMKNLDISRPDKK 441                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     442 SKKQQDSTYPIKNEVASGMILVMAFFLITYTFHSTWVTSEAYSSPSIVLS 491                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     406 ARGGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 455                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     492 ARGGDGSRIIFDDFREAYYWLRHNTPEDAKVMSWWDYGYQITAMANRTIL 541                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     456 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 505                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     542 VDNNTWNNTHISRVGQAMASTEEKAYEIMRELDVSYVLVIFGGLTGYSSD 591                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     506 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     592 DINKFLWMVRIGGSTDTGKHIKENDYYTPTGEFRVDREGSPVLLNCLMYK 641                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     642 MCYYRFGQVYTEAKRPPGFDRVRNAEIGNKDFELDVLEEAYTTEHWLVRI 691                                                          
						                                                            	                  .                                          
						                                                            	     606 YKVKDLDNRGLSRT                                     619                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     692 YKVKDLDNRGLSRT                                     705                                                          

11761	HMR136_T10398_3_tr0_r1_1_gPRT		Comparison report between T10398_P3 and Q9Y6C9partial WT     	Sequence name: Q9Y6C9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10398_P3, comprising a first amino acid        	                                                            
						MIARSAATLITHPFHVITLRSMVQFIGRESKYCGLCDSIITIYREEGILGFFAGLVPRLL 	Alignment of: 11761 x Q9Y6C9   ..                            
						GDILSLWLCNSLAYLVNTYALDSGVSTMNEMKSYSQAVTGFFASMLTYPFVLVSNLMAVN 	                                                            
						NCGLAGGCPPYSPIYTSWIDCWCMLQKEGNMSRGNSLFFRKVPFGKTYCCDLKMLI     	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 128 - 303 of Q9Y6C9, which also corresponds to   	                     Quality: 1748.00                      Escore:       0                                               
						amino acids 1 - 176 of T10398_P3.                            	             Matching length:     176                Total length:     176                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MIARSAATLITHPFHVITLRSMVQFIGRESKYCGLCDSIITIYREEGILG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     128 MIARSAATLITHPFHVITLRSMVQFIGRESKYCGLCDSIITIYREEGILG 177                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 FFAGLVPRLLGDILSLWLCNSLAYLVNTYALDSGVSTMNEMKSYSQAVTG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     178 FFAGLVPRLLGDILSLWLCNSLAYLVNTYALDSGVSTMNEMKSYSQAVTG 227                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FFASMLTYPFVLVSNLMAVNNCGLAGGCPPYSPIYTSWIDCWCMLQKEGN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     228 FFASMLTYPFVLVSNLMAVNNCGLAGGCPPYSPIYTSWIDCWCMLQKEGN 277                                                          
						                                                            	                  .         .                                
						                                                            	     151 MSRGNSLFFRKVPFGKTYCCDLKMLI                         176                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     278 MSRGNSLFFRKVPFGKTYCCDLKMLI                         303                                                          

12713	HMR136_T10408_7_tr0_r1_1_gPRT		Comparison report between T10408_P7 and Q9Y424unique head    	Sequence name: Q9Y424                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for T10408_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12713 x Q9Y424   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MASEELYEVERIVDKRKNKKGKTEYLVRWKGYDSEDDTWEPEQHLVNCEEYIHDFNRRHT 	Alignment segment 1/1:                                       
						EKQKESTLTRTNRTSPNNARKQISRSTNSNFSKTSPKALVIGKDHESKNSQLFAASQKFR 	                                                            
						KNTAPSLSSRKNMDLAKSGIKILVPKSPVKSRTAVDGFQSESPEKLDPVEQGQEDTVAPE 	                     Quality:  903.00                      Escore:       0                                               
						VAAEKPVGALLGPGAERARMGSRPRIHPLVPQVPGPVTAAMATGLAVNGKGTSPFMDALT 	             Matching length:     100                Total length:     136                                               
						ANGTTNIQTSVTGVTASKRKFIDDRRDQPFDKRLRFSVRQTESAYRYRDIVVRKQDGFTH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ILLSTKSSENNSLNPEVMREVQSALSTAAADDSKLVLLSAVGSVFCCGLDFIYFIRRLTD 	    Total Percent Similarity:   73.53      Total Percent Identity:   73.53                                               
						DRKRESTKMAEAIRNFVNTFIQFKKPIIVAVNGPAIGLGASILPLCDV             	                        Gaps:       1                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 408 of T10408_P7, a second amino acid     	Alignment:                                                   
						VWANEKAWFQTPYTTFGQSPDGCSTVMFPKIMGGASANEMLLSGRKLTAQEACGKGLVSQ 	                  .         .         .         .         .  
						VFWPGTFTQEVMVRIKELASCNPV                                     	     409 VWANEKAWFQTPYTTFGQSPDGCSTVMFPKIMGGASANEMLLSGRKLTAQ 458                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 8 - 91 of Q9Y424, which also corresponds to amino	       8 VWANEKAWFQTPYTTFGQSPDGCSTVMFPKIMGGASANEMLLSGRKLTAQ 57                                                           
						acids 409 - 492 of T10408_P7, and a third amino acid sequence	                  .         .         .         .         .  
						being at least 90 % homologous to GMDSMLKYLQRKIDEF           	     459 EACGKGLVSQVFWPGTFTQEVMVRIKELASCNPV................ 492                                                          
						corresponding to amino acids 128 - 143 of Q9Y424, which also 	         ||||||||||||||||||||||||||||||||||                  
						corresponds to amino acids 493 - 508 of T10408_P7, wherein   	      58 EACGKGLVSQVFWPGTFTQEVMVRIKELASCNPVVLEESKALVRCNMKME 107                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .                      
						and third amino acid sequence are contiguous and in a        	     493 ....................GMDSMLKYLQRKIDEF               508                                                          
						sequential order.2.An isolated polypeptide encoding for a    	                             ||||||||||||||||                
						head of T10408_P7, comprising a polypeptide being at least   	     108 LEQANERECEVLKKIWGSAQGMDSMLKYLQRKIDEF               143                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MASEELYEVERIVDKRKNKKGKTEYLVRWKGYDSEDDTWEPEQHLVNCEEYIHDFNRRHT 	                                                            
						EKQKESTLTRTNRTSPNNARKQISRSTNSNFSKTSPKALVIGKDHESKNSQLFAASQKFR 	                                                            
						KNTAPSLSSRKNMDLAKSGIKILVPKSPVKSRTAVDGFQSESPEKLDPVEQGQEDTVAPE 	                                                            
						VAAEKPVGALLGPGAERARMGSRPRIHPLVPQVPGPVTAAMATGLAVNGKGTSPFMDALT 	                                                            
						ANGTTNIQTSVTGVTASKRKFIDDRRDQPFDKRLRFSVRQTESAYRYRDIVVRKQDGFTH 	                                                            
						ILLSTKSSENNSLNPEVMREVQSALSTAAADDSKLVLLSAVGSVFCCGLDFIYFIRRLTD 	                                                            
						DRKRESTKMAEAIRNFVNTFIQFKKPIIVAVNGPAIGLGASILPLCDV             	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						T10408_P7.3.An isolated chimeric polypeptide encoding for an 	                                                            
						edge portion of T10408_P7, comprising a polypeptide having a 	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise VG, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						492-x to 493; and ending at any of amino acid numbers 493+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

						Comparison report between T10408_P7 and Q9Y232unique head    	Sequence name: Q9Y232                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for T10408_P7,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 12713 x Q9Y232   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence MASEELYE     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of T10408_P7, a second    	                                                            
						VERIVDKRKNKKGKTEYLVRWKGYDSEDDTWEPEQHLVNCEEYIHDFNRRHTEKQKESTL 	                     Quality: 4772.00                      Escore:       0                                               
						TRTNRTSPNNARKQISRSTNSNFSKTSPKALVIGKDHESKNSQLFAASQKFRKNTAPSLS 	             Matching length:     501                Total length:     537                                               
						SRKNMDLAKSGIKILVPKSPVKSRTAVDGFQSESPEKLDPVEQGQEDTVAPEVAAEKPVG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.80                                               
						ALLGPGAERARMGSRPRIHPLVPQVPGPVTAAMATGLAVNGKGTSPFMDALTANGTTNIQ 	    Total Percent Similarity:   93.30      Total Percent Identity:   93.11                                               
						TSVTGVTASKRKFIDDRRDQPFDKRLRFSVRQTESAYRYRDIVVRKQDGFTHILLSTKSS 	                        Gaps:       1                        
						ENNSLNPEVMREVQSALSTAAADDSKLVLLSAVGSVFCCGLDFIYFIRRLTDDRKRESTK 	                                                            
						MAEAIRNFVNTFIQFKKPIIVAVNGPAIGLGASILPLCDVVWANEKAWFQTPYTTFGQSP 	Alignment:                                                   
						DGCSTVMFPKIMGGASANEMLLSGRKLTAQEACGKGLVSQVFWPGTFTQEVMVRIKELAS 	                  .         .         .         .         .  
						CNPV                                                         	       8 EVERIVDKRKNKKGKTEYLVRWKGYDSEDDTWEPEQHLVNCEEYIHDFNR 57                                                           
						amino acid sequence being at least 90 % homologous to        	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 63 - 546 of Q9Y232, which also  	      62 QVERIVDKRKNKKGKTEYLVRWKGYDSEDDTWEPEQHLVNCEEYIHDFNR 111                                                          
						corresponds to amino acids 9 - 492 of T10408_P7, and a third 	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      58 RHTEKQKESTLTRTNRTSPNNARKQISRSTNSNFSKTSPKALVIGKDHES 107                                                          
						GMDSMLKYLQRKIDEF corresponding to amino acids 583 - 598 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q9Y232, which also corresponds to amino acids 493 - 508 of   	     112 RHTEKQKESTLTRTNRTSPNNARKQISRSTNSNFSKTSPKALVIGKDHES 161                                                          
						T10408_P7, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     108 KNSQLFAASQKFRKNTAPSLSSRKNMDLAKSGIKILVPKSPVKSRTAVDG 157                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T10408_P7, comprising a   	     162 KNSQLFAASQKFRKNTAPSLSSRKNMDLAKSGIKILVPKSPVKSRTAVDG 211                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     158 FQSESPEKLDPVEQGQEDTVAPEVAAEKPVGALLGPGAERARMGSRPRIH 207                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MASEELYE of T10408_P7.3.An isolated chimeric 	     212 FQSESPEKLDPVEQGQEDTVAPEVAAEKPVGALLGPGAERARMGSRPRIH 261                                                          
						polypeptide encoding for an edge portion of T10408_P7,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     208 PLVPQVPGPVTAAMATGLAVNGKGTSPFMDALTANGTTNIQTSVTGVTAS 257                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     262 PLVPQVPGPVTAAMATGLAVNGKGTSPFMDALTANGTTNIQTSVTGVTAS 311                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     258 KRKFIDDRRDQPFDKRLRFSVRQTESAYRYRDIVVRKQDGFTHILLSTKS 307                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise VG, having a structure as follows: a sequence       	     312 KRKFIDDRRDQPFDKRLRFSVRQTESAYRYRDIVVRKQDGFTHILLSTKS 361                                                          
						starting from any of amino acid numbers 492-x to 493; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 493+ ((n-2) - x), in     	     308 SENNSLNPEVMREVQSALSTAAADDSKLVLLSAVGSVFCCGLDFIYFIRR 357                                                          
						which x varies from 0 to n-2.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     362 SENNSLNPEVMREVQSALSTAAADDSKLVLLSAVGSVFCCGLDFIYFIRR 411                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     358 LTDDRKRESTKMAEAIRNFVNTFIQFKKPIIVAVNGPAIGLGASILPLCD 407                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     412 LTDDRKRESTKMAEAIRNFVNTFIQFKKPIIVAVNGPAIGLGASILPLCD 461                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     408 VVWANEKAWFQTPYTTFGQSPDGCSTVMFPKIMGGASANEMLLSGRKLTA 457                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     462 VVWANEKAWFQTPYTTFGQSPDGCSTVMFPKIMGGASANEMLLSGRKLTA 511                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     458 QEACGKGLVSQVFWPGTFTQEVMVRIKELASCNPV............... 492                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     512 QEACGKGLVSQVFWPGTFTQEVMVRIKELASCNPVVLEESKALVRCNMKM 561                                                          
						                                                            	                  .         .         .                      
						                                                            	     493 .....................GMDSMLKYLQRKIDEF              508                                                          
						                                                            	                              ||||||||||||||||               
						                                                            	     562 ELEQANERECEVLKKIWGSAQGMDSMLKYLQRKIDEF              598                                                          

13210	HMR136_T10425_14_tr0_r1_1_gPRT		Comparison report between T10425_P14 and Q9BVZ1partial WT    	Sequence name: Q9BVZ1                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 130 - 147 of 	Alignment of: 13210 x Q9BVZ1   ..                            
						Q9BVZ1, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P14, a second amino acid sequence being at least 70%, 	Alignment segment 1/1:                                       
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	                     Quality:  958.00                      Escore:       0                                               
						WHRSDSAPRNKISRFQAPISAPEYTVTPSPQQARVCPPHMLPEDGANLSSARGILSLIQS 	             Matching length:     109                Total length:     187                                               
						STRRAYQQILDVLDENRR                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   58.29      Total Percent Identity:   58.29                                               
						to amino acids 19 - 96 of T10425_P14, and a third amino acid 	                        Gaps:       1                        
						PVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLE 	                                                            
						EENKERAKREMVMYSITVAFWLLNSWLWFRR                              	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 148 - 238 of Q9BVZ1, which also corresponds to   	       1 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 50                                                           
						amino acids 97 - 187 of T10425_P14, wherein said first amino 	         ||||||||||||||||||                                  
						acid sequence, second amino acid sequence and third amino    	     130 MSENAVRQNGQLVRNDSL................................ 147                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	      51 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 100                                                          
						T10425_P14, comprising an amino acid sequence being at least 	                                                       ||||  
						70%, optionally at least about 80%, preferably at least about	     148 ..............................................PVLR 151                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						WHRSDSAPRNKISRFQAPISAPEYTVTPSPQQARVCPPHMLPEDGANLSSARGILSLIQS 	     101 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 150                                                          
						STRRAYQQILDVLDENRR,                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     152 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 201                                                          
						corresponding to T10425_P14.                                 	                  .         .         .                      
						                                                            	     151 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     202 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              238                                                          

						Comparison report between T10425_P14 and Q9H690partial WT    	Sequence name: Q9H690                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 130 - 147 of 	Alignment of: 13210 x Q9H690   ..                            
						Q9H690, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P14, a second amino acid sequence being at least 70%, 	Alignment segment 1/1:                                       
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	                     Quality: 1474.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence              	             Matching length:     162                Total length:     187                                               
						WHRSDSAPRNKISRFQAPISAPEYT corresponding to amino acids 19 -  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						43 of T10425_P14, and a third amino acid sequence being at   	    Total Percent Similarity:   86.63      Total Percent Identity:   86.63                                               
						VTPSPQQARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLRGGS 	                        Gaps:       1                        
						AAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERA 	                                                            
						KREMVMYSITVAFWLLNSWLWFRR                                     	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 148 -  	                  .         .         .         .         .  
						291 of Q9H690, which also corresponds to amino acids 44 - 187	       1 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 50                                                           
						of T10425_P14, wherein said first amino acid sequence, second	         ||||||||||||||||||                         |||||||  
						amino acid sequence and third amino acid sequence are        	     130 MSENAVRQNGQLVRNDSL.........................VTPSPQQ 154                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10425_P14,      	      51 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 100                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     155 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 204                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     101 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 150                                                          
						WHRSDSAPRNKISRFQAPISAPEYT, corresponding to T10425_P14.      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 254                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     255 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              291                                                          

						Comparison report between T10425_P14 and Q9GZY8partial WT    	Sequence name: Q9GZY8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10425_P14, comprising a first amino acid       	                                                            
						MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQARVCPPHMLP 	Alignment of: 13210 x Q9GZY8   ..                            
						EDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLRGGSAAATSNPHHDNVRYGIS 	                                                            
						NIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLN 	Alignment segment 1/1:                                       
						SWLWFRR                                                      	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1830.00                      Escore:       0                                               
						amino acids 156 - 342 of Q9GZY8, which also corresponds to   	             Matching length:     187                Total length:     187                                               
						amino acids 1 - 187 of T10425_P14.                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     156 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 305                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     306 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              342                                                          

						Comparison report between T10425_P14 and Q9NRG8partial WT    	Sequence name: Q9NRG8                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 130 - 147 of 	Alignment of: 13210 x Q9NRG8   ..                            
						Q9NRG8, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P14, a second amino acid sequence being at least 70%, 	Alignment segment 1/1:                                       
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	                     Quality:  763.00                      Escore:       0                                               
						WHRSDSAPRNKISRFQAPISAPEYTVTPSPQQARVCPPHMLPEDGANLSSARGILSLIQS 	             Matching length:      89                Total length:     187                                               
						STRRAYQQILDVLDENRRPVLRGGSAAATSNPHHDNVR                       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   47.59      Total Percent Identity:   47.59                                               
						to amino acids 19 - 116 of T10425_P14, and a third amino acid	                        Gaps:       1                        
						YGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAF 	                                                            
						WLLNSWLWFRR                                                  	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 148 - 218 of Q9NRG8, which also corresponds to   	       1 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 50                                                           
						amino acids 117 - 187 of T10425_P14, wherein said first amino	         ||||||||||||||||||                                  
						acid sequence, second amino acid sequence and third amino    	     130 MSENAVRQNGQLVRNDSL................................ 147                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	      51 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 100                                                          
						T10425_P14, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	     147 .................................................. 147                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						WHRSDSAPRNKISRFQAPISAPEYTVTPSPQQARVCPPHMLPEDGANLSSARGILSLIQS 	     101 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 150                                                          
						STRRAYQQILDVLDENRRPVLRGGSAAATSNPHHDNVR,                      	                         ||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     148 ................YGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 181                                                          
						corresponding to T10425_P14.                                 	                  .         .         .                      
						                                                            	     151 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              187                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     182 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              218                                                          

13212	HMR136_T10425_17_tr0_r1_1_gPRT		Comparison report between T10425_P17 and Q9BVZ1partial WT    	Sequence name: Q9BVZ1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10425_P17, comprising a first amino acid       	                                                            
						MSENAVRQNGQLVRNDSLPVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDA 	Alignment of: 13212 x Q9BVZ1   ..                            
						ASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR            	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 130 - 238 of Q9BVZ1, which also corresponds to   	                                                            
						amino acids 1 - 109 of T10425_P17.                           	                     Quality: 1058.00                      Escore:       0                                               
						                                                            	             Matching length:     109                Total length:     109                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSENAVRQNGQLVRNDSLPVLRGGSAAATSNPHHDNVRYGISNIDTTIEG 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     130 MSENAVRQNGQLVRNDSLPVLRGGSAAATSNPHHDNVRYGISNIDTTIEG 179                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 TSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     180 TSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWL 229                                                          
						                                                            	                                                             
						                                                            	     101 LNSWLWFRR                                          109                                                          
						                                                            	         |||||||||                                           
						                                                            	     230 LNSWLWFRR                                          238                                                          

						Comparison report between T10425_P17 and Q9H690partial WT    	Sequence name: Q9H690                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10425_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 130 - 147 of 	Alignment of: 13212 x Q9H690   ..                            
						Q9H690, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P17, and a second amino acid sequence being at least  	Alignment segment 1/1:                                       
						PVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLE 	                                                            
						EENKERAKREMVMYSITVAFWLLNSWLWFRR                              	                     Quality:  958.00                      Escore:       0                                               
						90 % homologous to corresponding to amino acids 201 - 291 of 	             Matching length:     109                Total length:     162                                               
						Q9H690, which also corresponds to amino acids 19 - 109 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10425_P17, wherein said first amino acid sequence and second	    Total Percent Similarity:   67.28      Total Percent Identity:   67.28                                               
						amino acid sequence are contiguous and in a sequential       	                        Gaps:       1                        
						order.2.An isolated chimeric polypeptide encoding for an edge	                                                            
						portion of T10425_P17, comprising a polypeptide having a     	Alignment:                                                   
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	       1 MSENAVRQNGQLVRNDSL................................ 18                                                           
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||                                  
						preferably at least about 40 amino acids in length and most  	     130 MSENAVRQNGQLVRNDSLVTPSPQQARVCPPHMLPEDGANLSSARGILSL 179                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise LP, having a structure as  	      19 .....................PVLRGGSAAATSNPHHDNVRYGISNIDTT 47                                                           
						follows: a sequence starting from any of amino acid numbers  	                              |||||||||||||||||||||||||||||  
						18-x to 19; and ending at any of amino acid numbers 19+      	     180 IQSSTRRAYQQILDVLDENRRPVLRGGSAAATSNPHHDNVRYGISNIDTT 229                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	      48 IEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVA 97                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     230 IEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVA 279                                                          
						                                                            	                  .                                          
						                                                            	      98 FWLLNSWLWFRR                                       109                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     280 FWLLNSWLWFRR                                       291                                                          

						Comparison report between T10425_P17 and Q9GZY8partial WT    	Sequence name: Q9GZY8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10425_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 156 - 173 of 	Alignment of: 13212 x Q9GZY8   ..                            
						Q9GZY8, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P17, and a second amino acid sequence being at least  	Alignment segment 1/1:                                       
						PVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLE 	                                                            
						EENKERAKREMVMYSITVAFWLLNSWLWFRR                              	                     Quality:  958.00                      Escore:       0                                               
						90 % homologous to corresponding to amino acids 252 - 342 of 	             Matching length:     109                Total length:     187                                               
						Q9GZY8, which also corresponds to amino acids 19 - 109 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10425_P17, wherein said first amino acid sequence and second	    Total Percent Similarity:   58.29      Total Percent Identity:   58.29                                               
						amino acid sequence are contiguous and in a sequential       	                        Gaps:       1                        
						order.2.An isolated chimeric polypeptide encoding for an edge	                                                            
						portion of T10425_P17, comprising a polypeptide having a     	Alignment:                                                   
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	       1 MSENAVRQNGQLVRNDSL................................ 18                                                           
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||                                  
						preferably at least about 40 amino acids in length and most  	     156 MSENAVRQNGQLVRNDSLWHRSDSAPRNKISRFQAPISAPEYTVTPSPQQ 205                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise LP, having a structure as  	      19 ..............................................PVLR 22                                                           
						follows: a sequence starting from any of amino acid numbers  	                                                       ||||  
						18-x to 19; and ending at any of amino acid numbers 19+      	     206 ARVCPPHMLPEDGANLSSARGILSLIQSSTRRAYQQILDVLDENRRPVLR 255                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	      23 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 72                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 GGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNR 305                                                          
						                                                            	                  .         .         .                      
						                                                            	      73 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              109                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     306 RLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR              342                                                          

						Comparison report between T10425_P17 and Q9NRG8partial WT    	Sequence name: Q9NRG8                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MSENAVRQNGQLVRNDSL corresponding to amino acids 130 - 147 of 	Alignment of: 13212 x Q9NRG8   ..                            
						Q9NRG8, which also corresponds to amino acids 1 - 18 of      	                                                            
						T10425_P17, a second amino acid sequence being at least 70%, 	Alignment segment 1/1:                                       
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	                     Quality:  763.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence              	             Matching length:      89                Total length:     109                                               
						PVLRGGSAAATSNPHHDNVR corresponding to amino acids 19 - 38 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10425_P17, and a third amino acid sequence being at least 90	    Total Percent Similarity:   81.65      Total Percent Identity:   81.65                                               
						YGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAF 	                        Gaps:       1                        
						WLLNSWLWFRR                                                  	                                                            
						% homologous to corresponding to amino acids 148 - 218 of    	Alignment:                                                   
						Q9NRG8, which also corresponds to amino acids 39 - 109 of    	                  .         .         .         .         .  
						T10425_P17, wherein said first amino acid sequence, second   	       1 MSENAVRQNGQLVRNDSLPVLRGGSAAATSNPHHDNVRYGISNIDTTIEG 50                                                           
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||                    ||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     130 MSENAVRQNGQLVRNDSL....................YGISNIDTTIEG 159                                                          
						polypeptide encoding for an edge portion of T10425_P17,      	                  .         .         .         .         .  
						comprising an amino acid sequence being at least 70%,        	      51 TSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWL 100                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     160 TSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWL 209                                                          
						least about 95% homologous to the sequence encoding for      	                                                             
						PVLRGGSAAATSNPHHDNVR, corresponding to T10425_P17.           	     101 LNSWLWFRR                                          109                                                          
						                                                            	         |||||||||                                           
						                                                            	     210 LNSWLWFRR                                          218                                                          

13214	HMR136_T10425_6_tr0_r1_1_gPRT		Comparison report between T10425_P6 and Q9BVZ1partial WT     	Sequence name: Q9BVZ1                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P6, comprising a first amino 	Sequence documentation:                                      
						MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVIMQVPERIVVA 	                                                            
						GNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERPLDFLDLERPPTTPQNEEIRA 	Alignment of: 13214 x Q9BVZ1   ..                            
						VGRLKRERSMSENAVRQNGQLVRNDSL                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 147 of Q9BVZ1, which also corresponds to  	                                                            
						amino acids 1 - 147 of T10425_P6, a second amino acid        	                     Quality: 2211.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     238                Total length:     249                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   95.58      Total Percent Identity:   95.58                                               
						having the sequence VRRQNEIRCER corresponding to amino acids 	                        Gaps:       1                        
						148 - 158 of T10425_P6, and a third amino acid sequence being	                                                            
						PVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLE 	Alignment:                                                   
						EENKERAKREMVMYSITVAFWLLNSWLWFRR                              	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 148 	       1 MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVI 50                                                           
						- 238 of Q9BVZ1, which also corresponds to amino acids 159 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						249 of T10425_P6, wherein said first amino acid sequence,    	       1 MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVI 50                                                           
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 MQVPERIVVAGNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERP 100                                                          
						polypeptide encoding for an edge portion of T10425_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	      51 MQVPERIVVAGNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERP 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 LDFLDLERPPTTPQNEEIRAVGRLKRERSMSENAVRQNGQLVRNDSLVRR 150                                                          
						least about 95% homologous to the sequence encoding for      	         |||||||||||||||||||||||||||||||||||||||||||||||     
						VRRQNEIRCER, corresponding to T10425_P6.                     	     101 LDFLDLERPPTTPQNEEIRAVGRLKRERSMSENAVRQNGQLVRNDSL... 147                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 QNEIRCERPVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDA 200                                                          
						                                                            	                 ||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     148 ........PVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDA 189                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 ASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR  249                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     190 ASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR  238                                                          

						Comparison report between T10425_P6 and Q9NRG8partial WT     	Sequence name: Q9NRG8                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10425_P6, comprising a first amino 	Sequence documentation:                                      
						MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVIMQVPERIVVA 	                                                            
						GNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERPLDFLDLERPPTTPQNEEIRA 	Alignment of: 13214 x Q9NRG8   ..                            
						VGRLKRERSMSENAVRQNGQLVRNDSL                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 147 of Q9NRG8, which also corresponds to  	                                                            
						amino acids 1 - 147 of T10425_P6, a second amino acid        	                     Quality: 2016.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     218                Total length:     249                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:   87.55      Total Percent Identity:   87.55                                               
						having the sequence VRRQNEIRCERPVLRGGSAAATSNPHHDNVR          	                        Gaps:       1                        
						corresponding to amino acids 148 - 178 of T10425_P6, and a   	                                                            
						YGISNIDTTIEGTSDDLTVVDAASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAF 	Alignment:                                                   
						WLLNSWLWFRR                                                  	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	       1 MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVI 50                                                           
						corresponding to amino acids 148 - 218 of Q9NRG8, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 179 - 249 of T10425_P6, wherein   	       1 MAEISRIQYEMEYTEGISQRMRVPEKLKVAPPNADLEQGFQEGVPNASVI 50                                                           
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	      51 MQVPERIVVAGNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERP 100                                                          
						sequential order.2.An isolated polypeptide encoding for an   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of T10425_P6, comprising an amino acid sequence 	      51 MQVPERIVVAGNNEDVSFSRPADLDLIQSTPFKPLALKTPPRVLTLSERP 100                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     101 LDFLDLERPPTTPQNEEIRAVGRLKRERSMSENAVRQNGQLVRNDSLVRR 150                                                          
						most preferably at least about 95% homologous to the sequence	         |||||||||||||||||||||||||||||||||||||||||||||||     
						encoding for VRRQNEIRCERPVLRGGSAAATSNPHHDNVR, corresponding  	     101 LDFLDLERPPTTPQNEEIRAVGRLKRERSMSENAVRQNGQLVRNDSL... 147                                                          
						to T10425_P6.                                                	                  .         .         .         .         .  
						                                                            	     151 QNEIRCERPVLRGGSAAATSNPHHDNVRYGISNIDTTIEGTSDDLTVVDA 200                                                          
						                                                            	                                     ||||||||||||||||||||||  
						                                                            	     148 ............................YGISNIDTTIEGTSDDLTVVDA 169                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 ASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR  249                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     170 ASLRRQIIKLNRRLQLLEEENKERAKREMVMYSITVAFWLLNSWLWFRR  218                                                          

6519	HMR136_T10426_1_tr0_r1_1_gPRT		Comparison report between T10426_P1 and Q9NRD8partial WT     	Sequence name: Q9NRD8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10426_P1, comprising a first amino 	Sequence documentation:                                      
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                                                            
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	Alignment of: 6519 x Q9NRD8   ..                             
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                                                            
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	Alignment segment 1/1:                                       
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                                                            
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKG 	                     Quality: 14896.00                      Escore:       0                                              
						FQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKF 	             Matching length:    1520                Total length:    1548                                               
						SRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTL 	    Total Percent Similarity:   98.19      Total Percent Identity:   98.19                                               
						RDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 	                        Gaps:       1                        
						TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSS 	                                                            
						PIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLF 	Alignment:                                                   
						SSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVL 	                  .         .         .         .         .  
						DINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLS 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						FREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNI 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						SCRVSFITRTPGER                                               	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						to amino acids 1 - 974 of Q9NRD8, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 974 of T10426_P1, and a second amino acid    	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	                  .         .         .         .         .  
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	                  .         .         .         .         .  
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	                  .         .         .         .         .  
						HHYENF                                                       	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1003 - 1548 of Q9NRD8, which also corresponds to 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						amino acids 975 - 1520 of T10426_P1, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of T10426_P1, comprising a      	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise RA, having 	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 974-x to 975; and ending at any of amino acid   	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						numbers 975+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P1 and Q9NR02partial WT     	Sequence name: Q9NR02                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10426_P1, comprising a first amino acid sequence being at   	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment of: 6519 x Q9NR02   ..                             
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGD                                            	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 137	                                                            
						of Q9NR02, which also corresponds to amino acids 1 - 137 of  	                     Quality: 14877.00                      Escore:       0                                              
						T10426_P1, a bridging amino acid P corresponding to amino    	             Matching length:    1520                Total length:    1548                                               
						acid 138 of T10426_P1, a second amino acid sequence being at 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						VFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSF 	    Total Percent Similarity:   98.13      Total Percent Identity:   98.13                                               
						SGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPFLQALGLLW 	                        Gaps:       1                        
						FRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYEWLPSFLQKTLPEYTGYRP 	                                                            
						FLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIREN 	Alignment:                                                   
						PNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 	                  .         .         .         .         .  
						PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGP 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						LFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGV 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						VAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRH 	                  .         .         .         .         .  
						LTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPED 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						KSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEE 	                  .         .         .         .         .  
						LTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER     	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						least 90 % homologous to corresponding to amino acids 139 -  	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						974 of Q9NR02, which also corresponds to amino acids 139 -   	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDLVFDPDQRGDVVL 150                                                          
						974 of T10426_P1, and a third amino acid sequence being at   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1003 - 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						1548 of Q9NR02, which also corresponds to amino acids 975 -  	                  .         .         .         .         .  
						1520 of T10426_P1, wherein said first amino acid sequence,   	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						bridging amino acid, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of T10426_P1, comprising a polypeptide having a      	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise RA, having a structure as  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						974-x to 975; and ending at any of amino acid numbers 975+   	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPVPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P1 and Q9UHF9unique head    	Sequence name: Q9UHF9                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for T10426_P1,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6519 x Q9UHF9   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment segment 1/1:                                       
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                     Quality: 11522.00                      Escore:       0                                              
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	             Matching length:    1182                Total length:    1210                                               
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	    Total Percent Similarity:   97.69      Total Percent Identity:   97.69                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 338 of T10426_P1, a second amino acid     	                                                            
						MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQI 	Alignment:                                                   
						SELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSD 	                  .         .         .         .         .  
						LNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYW 	     339 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 388                                                          
						FENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 	       1 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 50                                                           
						KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILS 	                  .         .         .         .         .  
						NNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKA 	     389 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 438                                                          
						VTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKD 	      51 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 100                                                          
						EFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 	                  .         .         .         .         .  
						QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER                         	     439 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 488                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 636 of Q9UHF9, which also corresponds to     	     101 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 150                                                          
						amino acids 339 - 974 of T10426_P1, and a third amino acid   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     489 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 538                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     539 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 588                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     589 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 638                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 300                                                          
						amino acids 665 - 1210 of Q9UHF9, which also corresponds to  	                  .         .         .         .         .  
						amino acids 975 - 1520 of T10426_P1, wherein said first amino	     639 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 688                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     301 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 350                                                          
						isolated polypeptide encoding for a head of T10426_P1,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     689 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 738                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     351 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 400                                                          
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                  .         .         .         .         .  
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	     739 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 788                                                          
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	     401 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 450                                                          
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                  .         .         .         .         .  
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	     789 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 838                                                          
						about 95% homologous to the sequence of T10426_P1.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     451 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 500                                                          
						T10426_P1, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     839 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 888                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     501 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 550                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     889 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 938                                                          
						at least two amino acids comprise RA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     551 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 600                                                          
						974-x to 975; and ending at any of amino acid numbers 975+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     939 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER.............. 974                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     601 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..............AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 1010                                                         
						                                                            	                       ||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1011 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 1060                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1061 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 1110                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1111 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 1160                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1161 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 1210                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1211 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 1260                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1261 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1310                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1311 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1360                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1361 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1410                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1411 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1460                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1461 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1510                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1200                                                         
						                                                            	                  .                                          
						                                                            	    1511 AHFMHHYENF                                         1520                                                         
						                                                            	         ||||||||||                                          
						                                                            	    1201 AHFMHHYENF                                         1210                                                         

6521	HMR136_T10426_2_tr0_r1_1_gPRT		Comparison report between T10426_P2 and Q9NRD8partial WT     	Sequence name: Q9NRD8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10426_P2, comprising a first amino 	Sequence documentation:                                      
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                                                            
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	Alignment of: 6521 x Q9NRD8   ..                             
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                                                            
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	Alignment segment 1/1:                                       
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                                                            
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKG 	                     Quality: 14896.00                      Escore:       0                                              
						FQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKF 	             Matching length:    1520                Total length:    1548                                               
						SRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTL 	    Total Percent Similarity:   98.19      Total Percent Identity:   98.19                                               
						RDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 	                        Gaps:       1                        
						TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSS 	                                                            
						PIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLF 	Alignment:                                                   
						SSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVL 	                  .         .         .         .         .  
						DINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLS 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						FREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNI 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						SCRVSFITRTPGER                                               	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						to amino acids 1 - 974 of Q9NRD8, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 974 of T10426_P2, and a second amino acid    	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	                  .         .         .         .         .  
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	                  .         .         .         .         .  
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	                  .         .         .         .         .  
						HHYENF                                                       	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1003 - 1548 of Q9NRD8, which also corresponds to 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						amino acids 975 - 1520 of T10426_P2, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of T10426_P2, comprising a      	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise RA, having 	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 974-x to 975; and ending at any of amino acid   	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						numbers 975+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P2 and Q9NR02partial WT     	Sequence name: Q9NR02                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10426_P2, comprising a first amino acid sequence being at   	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment of: 6521 x Q9NR02   ..                             
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGD                                            	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 137	                                                            
						of Q9NR02, which also corresponds to amino acids 1 - 137 of  	                     Quality: 14877.00                      Escore:       0                                              
						T10426_P2, a bridging amino acid P corresponding to amino    	             Matching length:    1520                Total length:    1548                                               
						acid 138 of T10426_P2, a second amino acid sequence being at 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						VFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSF 	    Total Percent Similarity:   98.13      Total Percent Identity:   98.13                                               
						SGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPFLQALGLLW 	                        Gaps:       1                        
						FRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYEWLPSFLQKTLPEYTGYRP 	                                                            
						FLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIREN 	Alignment:                                                   
						PNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 	                  .         .         .         .         .  
						PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGP 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						LFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGV 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						VAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRH 	                  .         .         .         .         .  
						LTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPED 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						KSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEE 	                  .         .         .         .         .  
						LTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER     	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						least 90 % homologous to corresponding to amino acids 139 -  	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						974 of Q9NR02, which also corresponds to amino acids 139 -   	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDLVFDPDQRGDVVL 150                                                          
						974 of T10426_P2, and a third amino acid sequence being at   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1003 - 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						1548 of Q9NR02, which also corresponds to amino acids 975 -  	                  .         .         .         .         .  
						1520 of T10426_P2, wherein said first amino acid sequence,   	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						bridging amino acid, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of T10426_P2, comprising a polypeptide having a      	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise RA, having a structure as  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						974-x to 975; and ending at any of amino acid numbers 975+   	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPVPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P2 and Q9UHF9unique head    	Sequence name: Q9UHF9                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for T10426_P2,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6521 x Q9UHF9   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment segment 1/1:                                       
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                     Quality: 11522.00                      Escore:       0                                              
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	             Matching length:    1182                Total length:    1210                                               
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	    Total Percent Similarity:   97.69      Total Percent Identity:   97.69                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 338 of T10426_P2, a second amino acid     	                                                            
						MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQI 	Alignment:                                                   
						SELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSD 	                  .         .         .         .         .  
						LNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYW 	     339 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 388                                                          
						FENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 	       1 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 50                                                           
						KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILS 	                  .         .         .         .         .  
						NNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKA 	     389 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 438                                                          
						VTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKD 	      51 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 100                                                          
						EFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 	                  .         .         .         .         .  
						QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER                         	     439 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 488                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 636 of Q9UHF9, which also corresponds to     	     101 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 150                                                          
						amino acids 339 - 974 of T10426_P2, and a third amino acid   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     489 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 538                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     539 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 588                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     589 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 638                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 300                                                          
						amino acids 665 - 1210 of Q9UHF9, which also corresponds to  	                  .         .         .         .         .  
						amino acids 975 - 1520 of T10426_P2, wherein said first amino	     639 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 688                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     301 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 350                                                          
						isolated polypeptide encoding for a head of T10426_P2,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     689 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 738                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     351 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 400                                                          
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                  .         .         .         .         .  
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	     739 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 788                                                          
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	     401 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 450                                                          
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                  .         .         .         .         .  
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	     789 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 838                                                          
						about 95% homologous to the sequence of T10426_P2.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     451 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 500                                                          
						T10426_P2, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     839 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 888                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     501 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 550                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     889 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 938                                                          
						at least two amino acids comprise RA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     551 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 600                                                          
						974-x to 975; and ending at any of amino acid numbers 975+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     939 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER.............. 974                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     601 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..............AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 1010                                                         
						                                                            	                       ||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1011 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 1060                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1061 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 1110                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1111 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 1160                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1161 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 1210                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1211 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 1260                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1261 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1310                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1311 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1360                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1361 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1410                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1411 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1460                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1461 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1510                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1200                                                         
						                                                            	                  .                                          
						                                                            	    1511 AHFMHHYENF                                         1520                                                         
						                                                            	         ||||||||||                                          
						                                                            	    1201 AHFMHHYENF                                         1210                                                         

6523	HMR136_T10426_3_tr0_r1_1_gPRT		Comparison report between T10426_P3 and Q9NRD8partial WT     	Sequence name: Q9NRD8                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10426_P3, comprising a first amino 	Sequence documentation:                                      
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                                                            
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	Alignment of: 6523 x Q9NRD8   ..                             
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                                                            
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	Alignment segment 1/1:                                       
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                                                            
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKG 	                     Quality: 14896.00                      Escore:       0                                              
						FQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKF 	             Matching length:    1520                Total length:    1548                                               
						SRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTL 	    Total Percent Similarity:   98.19      Total Percent Identity:   98.19                                               
						RDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 	                        Gaps:       1                        
						TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSS 	                                                            
						PIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLF 	Alignment:                                                   
						SSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVL 	                  .         .         .         .         .  
						DINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLS 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						FREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNI 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						SCRVSFITRTPGER                                               	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						to amino acids 1 - 974 of Q9NRD8, which also corresponds to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 974 of T10426_P3, and a second amino acid    	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	                  .         .         .         .         .  
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	                  .         .         .         .         .  
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	                  .         .         .         .         .  
						HHYENF                                                       	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1003 - 1548 of Q9NRD8, which also corresponds to 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						amino acids 975 - 1520 of T10426_P3, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of T10426_P3, comprising a      	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise RA, having 	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 974-x to 975; and ending at any of amino acid   	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						numbers 975+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P3 and Q9NR02partial WT     	Sequence name: Q9NR02                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10426_P3, comprising a first amino acid sequence being at   	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment of: 6523 x Q9NR02   ..                             
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGD                                            	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 137	                                                            
						of Q9NR02, which also corresponds to amino acids 1 - 137 of  	                     Quality: 14877.00                      Escore:       0                                              
						T10426_P3, a bridging amino acid P corresponding to amino    	             Matching length:    1520                Total length:    1548                                               
						acid 138 of T10426_P3, a second amino acid sequence being at 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						VFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSF 	    Total Percent Similarity:   98.13      Total Percent Identity:   98.13                                               
						SGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPFLQALGLLW 	                        Gaps:       1                        
						FRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYEWLPSFLQKTLPEYTGYRP 	                                                            
						FLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIREN 	Alignment:                                                   
						PNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 	                  .         .         .         .         .  
						PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGP 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						LFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGV 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						VAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRH 	                  .         .         .         .         .  
						LTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPED 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						KSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEE 	                  .         .         .         .         .  
						LTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER     	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						least 90 % homologous to corresponding to amino acids 139 -  	         ||||||||||||||||||||||||||||||||||||| ||||||||||||  
						974 of Q9NR02, which also corresponds to amino acids 139 -   	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDLVFDPDQRGDVVL 150                                                          
						974 of T10426_P3, and a third amino acid sequence being at   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1003 - 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						1548 of Q9NR02, which also corresponds to amino acids 975 -  	                  .         .         .         .         .  
						1520 of T10426_P3, wherein said first amino acid sequence,   	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						bridging amino acid, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of T10426_P3, comprising a polypeptide having a      	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise RA, having a structure as  	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						974-x to 975; and ending at any of amino acid numbers 975+   	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGER.......................... 974                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPVPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1022                                                         
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1023 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1072                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1073 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1122                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1123 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVPGMTGVLLLLVLA 1200                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1173 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1222                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1201 IMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQLPTFHIYF 1250                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1223 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1272                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1251 LVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSG 1300                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1273 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1322                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1301 QWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSP 1350                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1323 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1372                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1351 KGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLV 1400                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1373 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1422                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1401 FKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEENDHQDLVSVHIY 1450                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1423 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1472                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1451 VTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSITHFGRPPFEPFFN 1500                                                         
						                                                            	                  .         .         .         .            
						                                                            	    1473 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1520                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1501 SLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFMHHYENF   1548                                                         

						Comparison report between T10426_P3 and Q9UHF9unique head    	Sequence name: Q9UHF9                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for T10426_P3,        	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6523 x Q9UHF9   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment segment 1/1:                                       
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                     Quality: 11522.00                      Escore:       0                                              
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	             Matching length:    1182                Total length:    1210                                               
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	    Total Percent Similarity:   97.69      Total Percent Identity:   97.69                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 338 of T10426_P3, a second amino acid     	                                                            
						MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQI 	Alignment:                                                   
						SELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSD 	                  .         .         .         .         .  
						LNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYW 	     339 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 388                                                          
						FENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 	       1 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 50                                                           
						KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILS 	                  .         .         .         .         .  
						NNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKA 	     389 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 438                                                          
						VTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKD 	      51 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 100                                                          
						EFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 	                  .         .         .         .         .  
						QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER                         	     439 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 488                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 636 of Q9UHF9, which also corresponds to     	     101 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 150                                                          
						amino acids 339 - 974 of T10426_P3, and a third amino acid   	                  .         .         .         .         .  
						AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYY 	     489 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 538                                                          
						YGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWW 	     151 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 200                                                          
						FFQTVPGMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSYALIQ 	                  .         .         .         .         .  
						LPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQFQRPQGFEYKSGQW 	     539 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 588                                                          
						VRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGPWTTRLREIYSSPKGNGCAGYPKLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDGPFGEGHQEWHKFEVSVLVGGGIGVTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRT 	     201 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 250                                                          
						QRQFEWLADIIQEVEENDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFT 	                  .         .         .         .         .  
						GLRSITHFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDRAHFM 	     589 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 638                                                          
						HHYENF                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     251 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 300                                                          
						amino acids 665 - 1210 of Q9UHF9, which also corresponds to  	                  .         .         .         .         .  
						amino acids 975 - 1520 of T10426_P3, wherein said first amino	     639 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 688                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	     301 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 350                                                          
						isolated polypeptide encoding for a head of T10426_P3,       	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     689 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 738                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     351 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 400                                                          
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                  .         .         .         .         .  
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	     739 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 788                                                          
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	     401 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 450                                                          
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                  .         .         .         .         .  
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	     789 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 838                                                          
						about 95% homologous to the sequence of T10426_P3.3.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     451 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 500                                                          
						T10426_P3, comprising a polypeptide having a length "n",     	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     839 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 888                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     501 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 550                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     889 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 938                                                          
						at least two amino acids comprise RA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     551 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 600                                                          
						974-x to 975; and ending at any of amino acid numbers 975+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     939 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGER.............. 974                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     601 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     975 ..............AAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 1010                                                         
						                                                            	                       ||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1011 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 1060                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1061 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 1110                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1111 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 1160                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDGSKLPQKFYWWFFQTVP 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1161 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 1210                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 GMTGVLLLLVLAIMYVFASHHFRRRSFRGFWLTHHLYILLYALLIIHGSY 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1211 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 1260                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 ALIQLPTFHIYFLVPAIIYGGDKLVSLSRKKVEISVVKAELLPSGVTYLQ 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1261 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1310                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 FQRPQGFEYKSGQWVRIACLALGTTEYHPFTLTSAPHEDTLSLHIRAVGP 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1311 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1360                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 WTTRLREIYSSPKGNGCAGYPKLYLDGPFGEGHQEWHKFEVSVLVGGGIG 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1361 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1410                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 VTPFASILKDLVFKSSLGSQMLCKKIYFIWVTRTQRQFEWLADIIQEVEE 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1411 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1460                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 NDHQDLVSVHIYVTQLAEKFDLRTTMLYICERHFQKVLNRSLFTGLRSIT 1150                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1461 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1510                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1151 HFGRPPFEPFFNSLQEVHPQVRKIGVFSCGPPGMTKNVEKACQLVNRQDR 1200                                                         
						                                                            	                  .                                          
						                                                            	    1511 AHFMHHYENF                                         1520                                                         
						                                                            	         ||||||||||                                          
						                                                            	    1201 AHFMHHYENF                                         1210                                                         

6525	HMR136_T10426_4_tr0_r1_1_gPRT		Comparison report between T10426_P4 and Q9NRD8partial WT     	Sequence name: Q9NRD8                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10426_P4, comprising a first amino 	Sequence documentation:                                      
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	                                                            
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	Alignment of: 6525 x Q9NRD8   ..                             
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                                                            
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	Alignment segment 1/1:                                       
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	                                                            
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNASCHFRKVLNKG 	                     Quality: 11530.00                      Escore:       0                                              
						FQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISELEDNIVVEDLRDYWPGPGKF 	             Matching length:    1172                Total length:    1172                                               
						SRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 	                        Gaps:       0                        
						TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAMEWPGPKERSS 	                                                            
						PIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNNRGCRTLLLKIPKEYDLVLLF 	Alignment:                                                   
						SSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVL 	                  .         .         .         .         .  
						DINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLS 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						FREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGNGIRDIFKQNI 	       1 MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHER 50                                                           
						SCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQ 	                  .         .         .         .         .  
						RGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGI 	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						ILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAIL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSAGHAVNVYIFSVSPLSLLACIFPNVFVNDG                             	      51 GAVGCRLQRRVPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHN 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1172 of Q9NRD8, which also corresponds to 	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						amino acids 1 - 1172 of T10426_P4, and a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     101 RTVLGVFFGYHVLSDVVSVETPGCPAEFLNIRIPPGDPVFDPDQRGDVVL 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						YDRCASAPGPGHHVCLRLPPLPPPQLPGLLADPPPLHPALCPAHHPWQLCSDPAAHFPHL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPGPGNHLWR                                                   	     151 PFQRSRWDPETGRSPSNPRDLANQVTGWLDGSAIYGSSHSWSDALRSFSG 200                                                          
						having the sequence corresponding to amino acids 1173 - 1242 	                  .         .         .         .         .  
						of T10426_P4, wherein said first amino acid sequence and     	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     201 GQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAFGAERGNREPF 250                                                          
						T10426_P4, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YDRCASAPGPGHHVCLRLPPLPPPQLPGLLADPPPLHPALCPAHHPWQLCSDPAAHFPHL 	     251 LQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 300                                                          
						LPGPGNHLWR                                                   	                  .         .         .         .         .  
						least about 95% homologous to the sequence in T10426_P4.     	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFSTMVPPGVYMRNAS 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 CHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQISE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLF 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNTTLRDVLVAVINI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 DPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVLDFFEGSSPGFAI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESVKKEAAKDGVPAM 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 EWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILSNN 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMS 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 EKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVRE 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 ALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGYLSFREFLDILVV 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 FMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFIEISNNCLSKAQL 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     901 AEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFTQLCVKGGGGGGN 950                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFG 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     951 GIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKRFG 1000                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1001 KKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSA 1050                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1051 ICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLT 1100                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1101 MCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLAILHSAGHAVNVY 1150                                                         
						                                                            	                  .         .                                
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDG                             1172                                                         
						                                                            	         ||||||||||||||||||||||                              
						                                                            	    1151 IFSVSPLSLLACIFPNVFVNDG                             1172                                                         

						Comparison report between T10426_P4 and Q9UHF9unique head    	Sequence name: Q9UHF9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10426_P4, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6525 x Q9UHF9   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	Alignment segment 1/1:                                       
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	                                                            
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	                     Quality: 8156.00                      Escore:       0                                               
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	             Matching length:     834                Total length:     834                                               
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 338 of T10426_P4, a second amino acid     	                                                            
						MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVNELLLGMASQI 	Alignment:                                                   
						SELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGLPSYSQALLAFGLDIPRNWSD 	                  .         .         .         .         .  
						LNPNVDPQVLEATAALYNQDLSQLELLLGGLLESHGDPGPLFSAIVLDQFVRLRDGDRYW 	     339 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 388                                                          
						FENTRNGLFSKKEIEDIRNTTLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQCAPLTVLDFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 	       1 MVPPGVYMRNASCHFRKVLNKGFQSSQALRVCNNYWIRENPNLNSTQEVN 50                                                           
						KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQPLQQVNLILS 	                  .         .         .         .         .  
						NNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCVRWALGLHVAEMSEKELFRKA 	     389 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 438                                                          
						VTKQQRERILEIFFRHLFAQVLDINQADAGTLPLDSSQKVREALTCELSRAEFAESLGLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PQDMFVESMFSLADKDGNGYLSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKD 	      51 ELLLGMASQISELEDNIVVEDLRDYWPGPGKFSRTDYVASSIQRGRDMGL 100                                                          
						EFFTMMRSFIEISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 	                  .         .         .         .         .  
						QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAPELGGPGLKKR 	     439 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 488                                                          
						FGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENYRRHIVCVAIFSAICVGVFAD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RAYYYGFALPPSDIAQTTLVGIILSRGTAASVSFMFSYILLTMCRNLITFLRETFLNRYV 	     101 PSYSQALLAFGLDIPRNWSDLNPNVDPQVLEATAALYNQDLSQLELLLGG 150                                                          
						PFDAAVDFHRWIAMAAVVLAILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDG       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     489 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 538                                                          
						amino acids 1 - 834 of Q9UHF9, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 339 - 1172 of T10426_P4, and a third amino acid  	     151 LLESHGDPGPLFSAIVLDQFVRLRDGDRYWFENTRNGLFSKKEIEDIRNT 200                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     539 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 588                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YDRCASAPGPGHHVCLRLPPLPPPQLPGLLADPPPLHPALCPAHHPWQLCSDPAAHFPHL 	     201 TLRDVLVAVINIDPSALQPNVFVWHKGAPCPQPKQLTTDGLPQCAPLTVL 250                                                          
						LPGPGNHLWR                                                   	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1173 - 1242 	     589 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 638                                                          
						of T10426_P4, wherein said first amino acid sequence, second 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     251 DFFEGSSPGFAITIIALCCLPLVSLLLSGVVAYFRGREHKKLQKKLKESV 300                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T10426_P4, comprising a   	     639 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 688                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     301 KKEAAKDGVPAMEWPGPKERSSPIIIQLLSDRCLQVLNRHLTVLRVVQLQ 350                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MLRARPEALMLLGALLTGSLGPSGSQDALSLPWEVQRYDGWFNNLRHHERGAVGCRLQRR 	     689 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 738                                                          
						VPANYADGVYQALEEPQLPNPRRLSNAATRGIAGLPSLHNRTVLGVFFGYHVLSDVVSVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPGCPAEFLNIRIPPGDPVFDPDQRGDVVLPFQRSRWDPETGRSPSNPRDLANQVTGWLD 	     351 PLQQVNLILSNNRGCRTLLLKIPKEYDLVLLFSSEEERGAFVQQLWDFCV 400                                                          
						GSAIYGSSHSWSDALRSFSGGQLASGPDPAFPRDSQNPLLMWAAPDPATGQNGPRGLYAF 	                  .         .         .         .         .  
						GAERGNREPFLQALGLLWFRYHNLWAQRLARQHPDWEDEELFQHARKRVIATYQNIAVYE 	     739 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 788                                                          
						WLPSFLQKTLPEYTGYRPFLDPSISPEFVVASEQFFST                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T10426_P4.3.An isolated polypeptide       	     401 RWALGLHVAEMSEKELFRKAVTKQQRERILEIFFRHLFAQVLDINQADAG 450                                                          
						encoding for a tail of T10426_P4, comprising a polypeptide   	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     789 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 838                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YDRCASAPGPGHHVCLRLPPLPPPQLPGLLADPPPLHPALCPAHHPWQLCSDPAAHFPHL 	     451 TLPLDSSQKVREALTCELSRAEFAESLGLKPQDMFVESMFSLADKDGNGY 500                                                          
						LPGPGNHLWR                                                   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     839 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 888                                                          
						in T10426_P4.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LSFREFLDILVVFMKGSPEDKSRLMFTMYDLDENGFLSKDEFFTMMRSFI 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     889 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 938                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 EISNNCLSKAQLAEVVESMFRESGFQDKEELTWEDFHFMLRDHDSELRFT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     939 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAP 988                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 QLCVKGGGGGGNGIRDIFKQNISCRVSFITRTPGERSHPQGLGPPAPEAP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     989 ELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 1038                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ELGGPGLKKRFGKKAAVPTPRLYTEALQEKMQRGFLAQKLQQYKRFVENY 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1039 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 1088                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 RRHIVCVAIFSAICVGVFADRAYYYGFALPPSDIAQTTLVGIILSRGTAA 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1089 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 1138                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 SVSFMFSYILLTMCRNLITFLRETFLNRYVPFDAAVDFHRWIAMAAVVLA 800                                                          
						                                                            	                  .         .         .                      
						                                                            	    1139 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDG                 1172                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     801 ILHSAGHAVNVYIFSVSPLSLLACIFPNVFVNDG                 834                                                          

14561	HMR136_T10442_17_tr0_r1_1_gPRT		Comparison report between T10442_P17 and GALE_HUMAN_V1unique 	Sequence name: GALE_HUMAN_V1                                 
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T10442_P17, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 14561 x GALE_HUMAN_V1   ..                     
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MPSLHGQ corresponding to amino acids 1 - 	Alignment segment 1/1:                                       
						7 of T10442_P17, and a second amino acid sequence being at   	                                                            
						IMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKT 	                     Quality: 2293.00                      Escore:       0                                               
						WNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTG 	             Matching length:     232                Total length:     232                                               
						VRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.57                                               
						ARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA          	    Total Percent Similarity:  100.00      Total Percent Identity:   99.57                                               
						least 90 % homologous to corresponding to amino acids 118 -  	                        Gaps:       0                        
						348 of GALE_HUMAN_V1, which also corresponds to amino acids 8	                                                            
						- 238 of T10442_P17, wherein said first amino acid sequence  	Alignment:                                                   
						and second amino acid sequence are contiguous and in a       	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	       7 QIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEE 56                                                           
						head of T10442_P17, comprising a polypeptide being at least  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     117 EIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEE 166                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MPSLHGQ of     	      57 MIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVA 106                                                          
						T10442_P17.                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     167 MIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVA 216                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     107 IGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRI 156                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 IGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRI 266                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     157 YNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQE 206                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 YNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQE 316                                                          
						                                                            	                  .         .         .                      
						                                                            	     207 ELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA                   238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     317 ELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA                   348                                                          

15111	HMR136_T10447_2_tr0_r1_1_gPRT		Comparison report between T10447_P2 and BAC77387partial WT   	Sequence name: BAC77387                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10447_P2, comprising a first amino acid        	                                                            
						MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEWQESRTEGEHS 	Alignment of: 15111 x BAC77387   ..                          
						KEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKLKAREQIKFFEEVLLFEDELH 	                                                            
						DHGVSSLSVKIRVMPSSFFLLLRFFLRIDGVLIRMNDTRLYHEADKTYMLREYTSRESKI 	Alignment segment 1/1:                                       
						SSLMHVPPSLFTEPNEISQYLPIKEAVCEKLIFPERIDPNPADSQKSTQVE          	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2279.00                      Escore:       0                                               
						amino acids 42 - 272 of BAC77387, which also corresponds to  	             Matching length:     231                Total length:     231                                               
						amino acids 1 - 231 of T10447_P2.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      42 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 91                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      92 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 141                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KAREQIKFFEEVLLFEDELHDHGVSSLSVKIRVMPSSFFLLLRFFLRIDG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     142 KAREQIKFFEEVLLFEDELHDHGVSSLSVKIRVMPSSFFLLLRFFLRIDG 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLFTEPNEISQY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 VLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLFTEPNEISQY 241                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 LPIKEAVCEKLIFPERIDPNPADSQKSTQVE                    231                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     242 LPIKEAVCEKLIFPERIDPNPADSQKSTQVE                    272                                                          

						Comparison report between T10447_P2 and Q8IZ86partial WT     	Sequence name: Q8IZ86                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10447_P2, comprising a first amino 	Sequence documentation:                                      
						MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEWQESRTEGEHS 	                                                            
						KEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKLKAREQIKFFEEVLLFEDELH 	Alignment of: 15111 x Q8IZ86   ..                            
						DHGVSSLSVKI                                                  	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 42 - 172 of Q8IZ86, which also corresponds to 	                                                            
						amino acids 1 - 131 of T10447_P2, and a second amino acid    	                     Quality: 1293.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     131                Total length:     131                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RVMPSSFFLLLRFFLRIDGVLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLF 	                        Gaps:       0                        
						TEPNEISQYLPIKEAVCEKLIFPERIDPNPADSQKSTQVE                     	                                                            
						having the sequence corresponding to amino acids 132 - 231 of	Alignment:                                                   
						T10447_P2, wherein said first amino acid sequence and second 	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	       1 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 50                                                           
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10447_P2, comprising a polypeptide being at least 70%,      	      42 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 91                                                           
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	      51 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 100                                                          
						RVMPSSFFLLLRFFLRIDGVLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEPNEISQYLPIKEAVCEKLIFPERIDPNPADSQKSTQVE                     	      92 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 141                                                          
						least about 95% homologous to the sequence in T10447_P2.     	                  .         .         .                      
						                                                            	     101 KAREQIKFFEEVLLFEDELHDHGVSSLSVKI                    131                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     142 KAREQIKFFEEVLLFEDELHDHGVSSLSVKI                    172                                                          

						Comparison report between T10447_P2 and O75663partial WT     	Sequence name: O75663                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10447_P2, comprising a first amino acid        	                                                            
						MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEWQESRTEGEHS 	Alignment of: 15111 x O75663   ..                            
						KEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKLKAREQIKFFEEVLLFEDELH 	                                                            
						DHGVSSLSVKIRVMPSSFFLLLRFFLRIDGVLIRMNDTRLYHEADKTYMLREYTSRESKI 	Alignment segment 1/1:                                       
						SSLMHVPPSLFTEPNEISQYLPIKEAVCEKLIFPERIDPNPADSQKSTQVE          	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2279.00                      Escore:       0                                               
						amino acids 42 - 272 of O75663, which also corresponds to    	             Matching length:     231                Total length:     231                                               
						amino acids 1 - 231 of T10447_P2.                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      42 MPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEW 91                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      92 QESRTEGEHSKEVIKPYDWTYTTDYKGTLLGESLKLKVVPTTDHIDTEKL 141                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KAREQIKFFEEVLLFEDELHDHGVSSLSVKIRVMPSSFFLLLRFFLRIDG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     142 KAREQIKFFEEVLLFEDELHDHGVSSLSVKIRVMPSSFFLLLRFFLRIDG 191                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLFTEPNEISQY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     192 VLIRMNDTRLYHEADKTYMLREYTSRESKISSLMHVPPSLFTEPNEISQY 241                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 LPIKEAVCEKLIFPERIDPNPADSQKSTQVE                    231                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     242 LPIKEAVCEKLIFPERIDPNPADSQKSTQVE                    272                                                          

15462	HMR136_T10451_3_tr0_r1_1_gPRT		Comparison report between T10451_P3 and Q9Y3W8unique head    	Sequence name: Q9Y3W8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10451_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15462 x Q9Y3W8   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	Alignment segment 1/1:                                       
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                     Quality: 6144.00                      Escore:       0                                               
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	             Matching length:     633                Total length:     633                                               
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	                        Gaps:       0                        
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	                                                            
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	Alignment:                                                   
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	     860 ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLE 909                                                          
						IFPLSPDPRWQSSSPRPVALALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GALVMSMHRSHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLR 	       8 ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLE 57                                                           
						AQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEP 	                  .         .         .         .         .  
						DLISKVLQGLIEVRSPHLE                                          	     910 AVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFR 959                                                          
						having the sequence corresponding to amino acids 1 - 859 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10451_P3, and a second amino acid sequence being at least 90	      58 AVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFR 107                                                          
						ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGL 	                  .         .         .         .         .  
						LVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 	     960 PYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPSASLDFLWACIHVPRI 1009                                                         
						RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGR 	     108 PYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPSASLDFLWACIHVPRI 157                                                          
						RCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 	                  .         .         .         .         .  
						RGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLEL 	    1010 WQGRDQRTPQKRREELVLRVQGPELISLVELILAEAETRSQDGDTAACSL 1059                                                         
						LQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVS 	     158 WQGRDQRTPQKRREELVLRVQGPELISLVELILAEAETRSQDGDTAACSL 207                                                          
						LFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEE 	                  .         .         .         .         .  
						CCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAV 	    1060 IQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGRRCRDLLLQLY 1109                                                         
						LLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 8 - 640 of      	     208 IQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGRRCRDLLLQLY 257                                                          
						Q9Y3W8, which also corresponds to amino acids 860 - 1492 of  	                  .         .         .         .         .  
						T10451_P3, wherein said first amino acid sequence and second 	    1110 LQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 1159                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     258 LQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 307                                                          
						T10451_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1160 RGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSC 1209                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	     308 RGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSC 357                                                          
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                  .         .         .         .         .  
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	    1210 FLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFIN 1259                                                         
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	     358 FLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFIN 407                                                          
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	                  .         .         .         .         .  
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	    1260 KFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDNSDLVMLKSLLAGLSL 1309                                                         
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	     408 KFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDNSDLVMLKSLLAGLSL 457                                                          
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	    1310 PSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPLTAAEMAPYMKRLSRG 1359                                                         
						IFPLSPDPRWQSSSPRPVALALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GALVMSMHRSHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLR 	     458 PSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPLTAAEMAPYMKRLSRG 507                                                          
						AQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEP 	                  .         .         .         .         .  
						DLISKVLQGLIEVRSPHLE                                          	    1360 QTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRNLAFSLA 1409                                                         
						least about 95% homologous to the sequence of T10451_P3.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     508 QTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRNLAFSLA 557                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1410 LRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAV 1459                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     558 LRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAV 607                                                          
						                                                            	                  .         .         .                      
						                                                            	    1460 LLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                  1492                                                         
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     608 LLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                  640                                                          

						Comparison report between T10451_P3 and Q8WV40unique head    	Sequence name: Q8WV40                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10451_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15462 x Q8WV40   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	Alignment segment 1/1:                                       
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                     Quality: 6742.00                      Escore:       0                                               
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	             Matching length:     698                Total length:     698                                               
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	                        Gaps:       0                        
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	                                                            
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	Alignment:                                                   
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	     795 RLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLIS 844                                                          
						IFPLSPDPRWQSSSPRPVALALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GALVMSMHRSHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLR 	       1 RLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLIS 50                                                           
						AQLRMLASQASAGR                                               	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 794 of  	     845 KVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVVVVSSLLLQEEE 894                                                          
						T10451_P3, and a second amino acid sequence being at least 90	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLISKVLQGLIEVR 	      51 KVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVVVVSSLLLQEEE 100                                                          
						SPHLEELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLG 	                  .         .         .         .         .  
						PSSGLLVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPT 	     895 PLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLF 944                                                          
						LHQCIRVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISLVELILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGD 	     101 PLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLF 150                                                          
						SVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDS 	                  .         .         .         .         .  
						RALENRGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVL 	     945 SRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPS 994                                                          
						GLLELLQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAISFLQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLP 	     151 SRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPS 200                                                          
						LVSVSLFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLM 	                  .         .         .         .         .  
						SSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQ 	     995 ASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVELILAE 1044                                                         
						EHAAVLLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 1 - 698 of      	     201 ASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVELILAE 250                                                          
						Q8WV40, which also corresponds to amino acids 795 - 1492 of  	                  .         .         .         .         .  
						T10451_P3, wherein said first amino acid sequence and second 	    1045 AETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGD 1094                                                         
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     251 AETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGD 300                                                          
						T10451_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    1095 SVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRF 1144                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	     301 SVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRF 350                                                          
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                  .         .         .         .         .  
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	    1145 ITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHLPMIAALLHGRT 1194                                                         
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	     351 ITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHLPMIAALLHGRT 400                                                          
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	                  .         .         .         .         .  
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	    1195 HLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLL 1244                                                         
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	     401 HLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLL 450                                                          
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	    1245 LNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDN 1294                                                         
						IFPLSPDPRWQSSSPRPVALALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GALVMSMHRSHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLR 	     451 LNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDN 500                                                          
						AQLRMLASQASAGR                                               	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10451_P3.     	    1295 SDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPL 1344                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1345 TAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLM 1394                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 TAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLM 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1395 SSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALR 1444                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALR 650                                                          
						                                                            	                  .         .         .         .            
						                                                            	    1445 NLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEALRILHMEAVM   1492                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     651 NLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEALRILHMEAVM   698                                                          

						Comparison report between T10451_P3 and Q9P2A8unique head    	Sequence name: Q9P2A8                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for T10451_P3, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15462 x Q9P2A8   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	Alignment segment 1/1:                                       
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                     Quality: 10754.00                      Escore:       0                                              
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	             Matching length:    1113                Total length:    1113                                               
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	 Matching Percent Similarity:   99.91   Matching Percent Identity:   99.91                                               
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	    Total Percent Similarity:   99.91      Total Percent Identity:   99.91                                               
						KEVRLLAVQKLEMWLQNPK                                          	                        Gaps:       0                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 379 of T10451_P3, a second amino acid sequence being at  	Alignment:                                                   
						EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRYVRRMRQSKEG 	                  .         .         .         .         .  
						EEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGPPRADDSEFQALLDIWFPEE 	     380 EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRY 429                                                          
						KPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQDLEPQQLLLFVQSFGIPVSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRD 	     265 EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRY 314                                                          
						STEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 	                  .         .         .         .         .  
						LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFLACPLLR 	     430 VRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLG 479                                                          
						QLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQLRMLASQASAGRRLSDV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLE 	     315 VRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLG 364                                                          
						ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGL 	                  .         .         .         .         .  
						LVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 	     480 PPRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSE 529                                                          
						RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGR 	     365 PPRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSE 414                                                          
						RCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 	                  .         .         .         .         .  
						RGAD                                                         	     530 VLRLVDAALQDLEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLE 579                                                          
						least 90 % homologous to corresponding to amino acids 265 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1048 of Q9P2A8, which also corresponds to amino acids 380 -  	     415 VLRLVDAALQDLEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLE 464                                                          
						1163 of T10451_P3, a bridging amino acid A corresponding to  	                  .         .         .         .         .  
						amino acid 1164 of T10451_P3, and a third amino acid sequence	     580 QNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRDSTEAPKPKSS 629                                                          
						SMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKHA 	     465 QNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRDSTEAPKPKSS 514                                                          
						DPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPL 	                  .         .         .         .         .  
						TAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRNL 	     630 PEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 679                                                          
						AFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHRA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLVGMYGQMDPSAQISEALRILHMEAVM                                 	     515 PEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 564                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 1050 - 1377 of Q9P2A8, which also corresponds to amino 	     680 LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHR 729                                                          
						acids 1165 - 1492 of T10451_P3, wherein said first amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	     565 LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHR 614                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     730 SHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPL 779                                                          
						T10451_P3, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     615 SHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPL 664                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	     780 RAQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIAT 829                                                          
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	     665 RAQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIAT 714                                                          
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	                  .         .         .         .         .  
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	     830 LRSGEQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPAC 879                                                          
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEVRLLAVQKLEMWLQNPK                                          	     715 LRSGEQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPAC 764                                                          
						least about 95% homologous to the sequence of T10451_P3.     	                  .         .         .         .         .  
						                                                            	     880 KPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDP 929                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     765 KPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDP 814                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     930 EVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 979                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     815 EVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 864                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     980 RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRV 1029                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     865 RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRV 914                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1030 QGPELISLVELILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVR 1079                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     915 QGPELISLVELILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVR 964                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1080 KVTEHLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGA 1129                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     965 KVTEHLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGA 1014                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1130 ASSSVCKLDGLIHRFITLLADTSDSRALENRGADASMACRKLAVAHPLLL 1179                                                         
						                                                            	         |||||||||||||||||||||||||||||||||| |||||||||||||||  
						                                                            	    1015 ASSSVCKLDGLIHRFITLLADTSDSRALENRGADGSMACRKLAVAHPLLL 1064                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1180 LRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEH 1229                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1065 LRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEH 1114                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1230 QGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISF 1279                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1115 QGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISF 1164                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1280 LQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESS 1329                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1165 LQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESS 1214                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1330 AGSLPLVSVSLFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRR 1379                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1215 AGSLPLVSVSLFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRR 1264                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1380 PEILSFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMY 1429                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1265 PEILSFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMY 1314                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1430 CLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQI 1479                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1315 CLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQI 1364                                                         
						                                                            	                  .                                          
						                                                            	    1480 SEALRILHMEAVM                                      1492                                                         
						                                                            	         |||||||||||||                                       
						                                                            	    1365 SEALRILHMEAVM                                      1377                                                         

						Comparison report between T10451_P3 and Q9BT91unique head    	Sequence name: Q9BT91                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						T10451_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15462 x Q9BT91   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	Alignment segment 1/1:                                       
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                     Quality: 4272.00                      Escore:       0                                               
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	             Matching length:     445                Total length:     445                                               
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	    Total Percent Similarity:   99.78      Total Percent Identity:   99.78                                               
						KEVRLLAVQKLEMWLQNPK                                          	                        Gaps:       0                        
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1 - 379 of T10451_P3, a second amino acid     	Alignment:                                                   
						EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRYVRRMRQSKEG 	                  .         .         .         .         .  
						EEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGPPRADDSEFQALLDIWFPEE 	     380 EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRY 429                                                          
						KPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQDLEPQQLLLFVQSFGIPVSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRD 	     220 EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRY 269                                                          
						STEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLS               	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     430 VRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLG 479                                                          
						amino acids 220 - 505 of Q9BT91, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 380 - 665 of T10451_P3, a bridging amino acid P  	     270 VRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLG 319                                                          
						corresponding to amino acid 666 of T10451_P3, a third amino  	                  .         .         .         .         .  
						DPRWQSSSPRPVALALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMS 	     480 PPRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSE 529                                                          
						MHRSHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQLRML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVR                       	     320 PPRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSE 369                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 507 - 664 of Q9BT91, which also corresponds to	     530 VLRLVDAALQDLEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLE 579                                                          
						amino acids 667 - 824 of T10451_P3, and a fourth amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     370 VLRLVDAALQDLEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLE 419                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     580 QNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRDSTEAPKPKSS 629                                                          
						AVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVVV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLF 	     420 QNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRDSTEAPKPKSS 469                                                          
						SRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPSASLDFLWACI 	                  .         .         .         .         .  
						HVPRIWQGRDQRTPQKRREELVLRVQGPELISLVELILAEAETRSQDGDTAACSLIQARL 	     630 PEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 679                                                          
						PLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLL 	         |||||||||||||||||||||||||||||||||||| |||||||||||||  
						HSEGAASSSVCKLDGLIHRFITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHLP 	     470 PEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSLDPRWQSSSPRPVA 519                                                          
						MIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLL 	                  .         .         .         .         .  
						LNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDNSDLVMLKSLL 	     680 LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHR 729                                                          
						AGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPLTAAEMAPYMKRLSRGQTVED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFL 	     520 LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHR 569                                                          
						PTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEALR 	                  .         .         .         .         .  
						ILHMEAVM                                                     	     730 SHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPL 779                                                          
						having the sequence corresponding to amino acids 825 - 1492  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T10451_P3, wherein said first amino acid sequence, second 	     570 SHFLACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPL 619                                                          
						amino acid sequence, bridging amino acid, third amino acid   	                  .         .         .         .            
						sequence and fourth amino acid sequence are contiguous and in	     780 RAQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVR      824                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         |||||||||||||||||||||||||||||||||||||||||||||       
						head of T10451_P3, comprising a polypeptide being at least   	     620 RAQLRMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVR      664                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	                                                            
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                                                            
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	                                                            
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	                                                            
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	                                                            
						KEVRLLAVQKLEMWLQNPK                                          	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						T10451_P3.3.An isolated polypeptide encoding for a tail of   	                                                            
						T10451_P3, comprising a polypeptide being at least 70%,      	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						AVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVVV 	                                                            
						VSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVSSCPDLQLRLLF 	                                                            
						SRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLLGKSREQRFDPSASLDFLWACI 	                                                            
						HVPRIWQGRDQRTPQKRREELVLRVQGPELISLVELILAEAETRSQDGDTAACSLIQARL 	                                                            
						PLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLL 	                                                            
						HSEGAASSSVCKLDGLIHRFITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHLP 	                                                            
						MIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGALWDCLLSFIRLL 	                                                            
						LNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKHADPLHDLSFDNSDLVMLKSLL 	                                                            
						AGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTPLTAAEMAPYMKRLSRGQTVED 	                                                            
						LLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFL 	                                                            
						PTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEALR 	                                                            
						ILHMEAVM                                                     	                                                            
						least about 95% homologous to the sequence in T10451_P3.     	                                                            

						Comparison report between T10451_P3 and Q96D36unique head    	Sequence name: Q96D36                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10451_P3, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 15462 x Q96D36   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	Alignment segment 1/1:                                       
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                                                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                     Quality: 7816.00                      Escore:       0                                               
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	             Matching length:     809                Total length:     809                                               
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	                        Gaps:       0                        
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	                                                            
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	Alignment:                                                   
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	     684 QALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFL 733                                                          
						IFPLSPDPRWQSSSPRPVALALQ                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 683 of  	       4 QALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFL 53                                                           
						T10451_P3, and a second amino acid sequence being at least 90	                  .         .         .         .         .  
						QALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFLACPLLRQLCQ 	     734 ACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQL 783                                                          
						YQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQLRMLASQASAGRRLSDVRGGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLEELLT 	      54 ACPLLRQLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQL 103                                                          
						AFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDW 	                  .         .         .         .         .  
						LEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLL 	     784 RMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSG 833                                                          
						GKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVELILA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGRRCRD 	     104 RMLASQASAGRRLSDVRGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSG 153                                                          
						LLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALENRGAD 	                  .         .         .         .         .  
						ASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPH 	     834 EQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVV 883                                                          
						VFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVSLFTP 	     154 EQCSVEPDLISKVLQGLIEVRSPHLEELLTAFFSATADAASPFPACKPVV 203                                                          
						LTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEECCRN 	                  .         .         .         .         .  
						LAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAVLLHR 	     884 VVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVS 933                                                          
						AFLVGMYGQMDPSAQISEALRILHMEAVM                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 4 - 812 of      	     204 VVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGLLVDWLEMLDPEVVS 253                                                          
						Q96D36, which also corresponds to amino acids 684 - 1492 of  	                  .         .         .         .         .  
						T10451_P3, wherein said first amino acid sequence and second 	     934 SCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLL 983                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     254 SCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCIRVLL 303                                                          
						T10451_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     984 GKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPE 1033                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	     304 GKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPE 353                                                          
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	                  .         .         .         .         .  
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	    1034 LISLVELILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTE 1083                                                         
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	     354 LISLVELILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTE 403                                                          
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	                  .         .         .         .         .  
						KEVRLLAVQKLEMWLQNPKEQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLS 	    1084 HLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSS 1133                                                         
						ALLSIFSRYVRRMRQSKEGEEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRADDSEFQALLDIWFPEEKPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQD 	     404 HLSGCIQQWGDSVLGRRCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSS 453                                                          
						LEPQQLLLFVQSFGIPVSSMSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGA 	                  .         .         .         .         .  
						SGGQTFHSLLTASLPPRRDSTEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQ 	    1134 VCKLDGLIHRFITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHL 1183                                                         
						IFPLSPDPRWQSSSPRPVALALQ                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of T10451_P3.     	     454 VCKLDGLIHRFITLLADTSDSRALENRGADASMACRKLAVAHPLLLLRHL 503                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1184 PMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGAL 1233                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     504 PMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLELLQPHVFRSEHQGAL 553                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1234 WDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKH 1283                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     554 WDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISFLQKH 603                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1284 ADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSL 1333                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     604 ADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSL 653                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1334 PLVSVSLFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEIL 1383                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     654 PLVSVSLFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEIL 703                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1384 SFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGS 1433                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     704 SFFSTNLQRLMSSAEECCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGS 753                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1434 QDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEAL 1483                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     754 QDFEVVQTALRNLPEYALLCQEHAAVLLHRAFLVGMYGQMDPSAQISEAL 803                                                          
						                                                            	                                                             
						                                                            	    1484 RILHMEAVM                                          1492                                                         
						                                                            	         |||||||||                                           
						                                                            	     804 RILHMEAVM                                          812                                                          

						Comparison report between T10451_P3 and Q8N201partial WT     	Sequence name: Q8N201                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10451_P3, comprising a first amino 	Sequence documentation:                                      
						MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAPSGLPSERKRD 	                                                            
						AAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEKRAISPSIKEPSVVPIEVLPT 	Alignment of: 15462 x Q8N201   ..                            
						VLLDEIEAAELEGNDDRIEGVLCGAVKQLKVTRAKPDSTLYLSLMYLAKIKPNIFATEGV 	                                                            
						IEALCSLLRRDASINFKAKGNSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIW 	Alignment segment 1/1:                                       
						VDSPHCKTFVDNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 	                                                            
						IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNLLRLLTSTCGY 	                     Quality: 3630.00                      Escore:       0                                               
						KEVRLLAVQKLEMWLQNPK                                          	             Matching length:     379                Total length:     379                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 379 of Q8N201, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 379 of T10451_P3, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRYVRRMRQSKEG 	       1 MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAP 50                                                           
						EEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGPPRADDSEFQALLDIWFPEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQDLEPQQLLLFVQSFGIPVSS 	       1 MNRAKPTTVRRPSAAAKPSGHPPPGDFIALGSKGQANESKTASTLLKPAP 50                                                           
						MSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRD 	                  .         .         .         .         .  
						STEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 	      51 SGLPSERKRDAAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEK 100                                                          
						LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFLACPLLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQLRMLASQASAGRRLSDV 	      51 SGLPSERKRDAAAALSSASALTGLTKRPKLSSTPPLSALGRLAEAAVAEK 100                                                          
						RGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLE 	                  .         .         .         .         .  
						ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGL 	     101 RAISPSIKEPSVVPIEVLPTVLLDEIEAAELEGNDDRIEGVLCGAVKQLK 150                                                          
						LVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVE 	     101 RAISPSIKEPSVVPIEVLPTVLLDEIEAAELEGNDDRIEGVLCGAVKQLK 150                                                          
						LILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGR 	                  .         .         .         .         .  
						RCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 	     151 VTRAKPDSTLYLSLMYLAKIKPNIFATEGVIEALCSLLRRDASINFKAKG 200                                                          
						RGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISF 	     151 VTRAKPDSTLYLSLMYLAKIKPNIFATEGVIEALCSLLRRDASINFKAKG 200                                                          
						LQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVS 	                  .         .         .         .         .  
						LFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEE 	     201 NSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIWVDSPHCKTFV 250                                                          
						CCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                            	     201 NSLVSVLACNLLMAAYEEDENWPEIFVKVYIEDSLGERIWVDSPHCKTFV 250                                                          
						having the sequence corresponding to amino acids 380 - 1492  	                  .         .         .         .         .  
						of T10451_P3, wherein said first amino acid sequence and     	     251 DNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 300                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	     251 DNIQTAFNTRMPPRSVLLQGEAGRVAGDLGAGSSPHPSLTEEEDSQTELL 300                                                          
						T10451_P3, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     301 IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNL 350                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EQAQHSDLALDVARLVVERSTIMSHLFSKLSPSAASDAVLSALLSIFSRYVRRMRQSKEG 	     301 IAEEKLSPEQEGQLMPRYEELAESVEEYVLDMLRDQLNRRQPIDNVSRNL 350                                                          
						EEVYSWSESQDQVFLRWSSGETATMHILVVHAMVILLTLGPPRADDSEFQALLDIWFPEE 	                  .         .                                
						KPLPTAFLVDTSEEALLLPDWLKLRMIRSEVLRLVDAALQDLEPQQLLLFVQSFGIPVSS 	     351 LRLLTSTCGYKEVRLLAVQKLEMWLQNPK                      379                                                          
						MSKLLQFLDQAVAHDPQTLEQNIMDKNYMAHLVEVQHERGASGGQTFHSLLTASLPPRRD 	         |||||||||||||||||||||||||||||                       
						STEAPKPKSSPEQPIGQGRIRVGTQLRVLGPEDDLAGMFLQIFPLSPDPRWQSSSPRPVA 	     351 LRLLTSTCGYKEVRLLAVQKLEMWLQNPK                      379                                                          
						LALQQALGQELARVVQGSPEVPGITVRVLQALATLLSSPHGGALVMSMHRSHFLACPLLR 	                                                            
						QLCQYQRCVPQDTGFSSLFLKVLLQMLQWLDSPGVEGGPLRAQLRMLASQASAGRRLSDV 	                                                            
						RGGLLRLAEALAFRQDLEVVSSTVRAVIATLRSGEQCSVEPDLISKVLQGLIEVRSPHLE 	                                                            
						ELLTAFFSATADAASPFPACKPVVVVSSLLLQEEEPLAGGKPGADGGSLEAVRLGPSSGL 	                                                            
						LVDWLEMLDPEVVSSCPDLQLRLLFSRRKGKGQAQVPSFRPYLLTLFTHQSSWPTLHQCI 	                                                            
						RVLLGKSREQRFDPSASLDFLWACIHVPRIWQGRDQRTPQKRREELVLRVQGPELISLVE 	                                                            
						LILAEAETRSQDGDTAACSLIQARLPLLLSCCCGDDESVRKVTEHLSGCIQQWGDSVLGR 	                                                            
						RCRDLLLQLYLQRPELRVPVPEVLLHSEGAASSSVCKLDGLIHRFITLLADTSDSRALEN 	                                                            
						RGADASMACRKLAVAHPLLLLRHLPMIAALLHGRTHLNFQEFRQQNHLSCFLHVLGLLEL 	                                                            
						LQPHVFRSEHQGALWDCLLSFIRLLLNYRKSSRHLAAFINKFVQFIHKYITYNAPAAISF 	                                                            
						LQKHADPLHDLSFDNSDLVMLKSLLAGLSLPSRDDRTDRGLDEEGEEESSAGSLPLVSVS 	                                                            
						LFTPLTAAEMAPYMKRLSRGQTVEDLLEVLSDIDEMSRRRPEILSFFSTNLQRLMSSAEE 	                                                            
						CCRNLAFSLALRSMQNSPSIAAAFLPTFMYCLGSQDFEVVQTALRNLPEYALLCQEHAAV 	                                                            
						LLHRAFLVGMYGQMDPSAQISEALRILHMEAVM                            	                                                            
						least about 95% homologous to the sequence in T10451_P3.     	                                                            

15815	HMR136_T10456_1_tr0_r1_1_gPRT		Comparison report between T10456_P1 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by unique insertion, a mismatch and a      	                                                            
						followed by a unique insertion with extra amino acids.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T10456_P1,        	                                                            
						comprising a first amino acid sequence being at least 90 %   	Alignment of: 15815 x R3HD_HUMAN   ..                        
						homologous to                                                	                                                            
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDL       	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 56 of R3HD_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 54 of T10456_P1, a second     	                     Quality: 9400.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     969                Total length:    1131                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.79                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   85.59      Total Percent Identity:   85.50                                               
						having the sequence                                          	                        Gaps:       3                        
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN corresponding to	                                                            
						amino acids 55 - 98 of T10456_P1, a third amino acid sequence	Alignment:                                                   
						QEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNT 	                  .         .         .         .         .  
						LKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSG 	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						KSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						acids 57 - 225 of R3HD_HUMAN, which also corresponds to amino	                  .         .         .         .         .  
						acids 99 - 267 of T10456_P1, a bridging amino acid M         	      51 NIDLQRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQENQE 100                                                          
						corresponding to amino acid 268 of T10456_P1, a fourth amino 	         ||||                                            ||  
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	      53 NIDL............................................QE 58                                                           
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                  .         .         .         .         .  
						GDSSGSSKSIGRLSK                                              	     101 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 150                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 227 - 361 of R3HD_HUMAN, which also           	      59 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 108                                                          
						corresponds to amino acids 269 - 403 of T10456_P1, a fifth   	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     151 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 200                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     109 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 158                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	                  .         .         .         .         .  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     201 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 250                                                          
						having the sequence corresponding to amino acids 404 - 488 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P1, a sixth amino acid sequence being at least 90 %   	     159 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 208                                                          
						homologous to                                                	                  .         .         .         .         .  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     251 RYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 300                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 489 - 539 of T10456_P1, a    	     209 RYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 258                                                          
						seventh amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     301 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 350                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     259 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 308                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	                  .         .         .         .         .  
						acids 540 - 573 of T10456_P1, and a eight amino acid sequence	     351 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 400                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     309 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 358                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	                  .         .         .         .         .  
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     401 LSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSS 450                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	         |||                                                 
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     359 LSK............................................... 361                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	                  .         .         .         .         .  
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     451 LSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSILINPQTGQPFINPDGSP 500                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                                               ||||||||||||  
						RTSKKHYDFHILERASSQ                                           	     362 ......................................TGQPFINPDGSP 373                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     501 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQPVHPLQSSSQP 550                                                          
						amino acids 574 - 1131 of T10456_P1, wherein said first amino	         |||||||||||||||||||||||||||||||||||||||             
						acid sequence, second amino acid sequence, third amino acid  	     374 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQQ.......... 413                                                          
						sequence, bridging amino acid, fourth amino acid sequence,   	                  .         .         .         .         .  
						fifth amino acid sequence, sixth amino acid sequence, seventh	     551 VQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHMSLARQPSADGSDPHAAM 600                                                          
						amino acid sequence and eight amino acid sequence are        	                                |||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     414 .......................DNLGSQFSHMSLARQPSADGSDPHAAM 440                                                          
						polypeptide encoding for an edge portion of T10456_P1,       	                  .         .         .         .         .  
						comprising an amino acid sequence being at least 70%,        	     601 FQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYP 650                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     441 FQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYP 490                                                          
						least about 95% homologous to the sequence encoding for      	                  .         .         .         .         .  
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN, corresponding  	     651 ASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYN 700                                                          
						to T10456_P1.3.An isolated polypeptide encoding for an edge  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T10456_P1, comprising an amino acid sequence being	     491 ASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYN 540                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     701 SHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGN 750                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     541 SHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGN 590                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	                  .         .         .         .         .  
						encoding for corresponding to T10456_P1.4.An isolated        	     751 QIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTG 800                                                          
						polypeptide encoding for an edge portion of T10456_P1,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     591 QIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTG 640                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     801 MPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQC 850                                                          
						least about 95% homologous to the sequence encoding for      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	     641 MPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQC 690                                                          
						T10456_P1.5.A bridge portion of T10456_P1, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	     851 TAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVE 900                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     691 TAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVE 740                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     901 FSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFS 950                                                          
						length, wherein at least two amino acids comprise QP, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows (numbering according to T10456_P1): a 	     741 FSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFS 790                                                          
						sequence starting from any of amino acid numbers 412-x to    	                  .         .         .         .         .  
						412; and ending at any of amino acid numbers 540 + ((n-2) -  	     951 RPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQA 1000                                                         
						x), in which x varies from 0 to n-2.                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     791 RPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQA 840                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWL 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     841 KKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWL 890                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 RDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNA 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     891 RDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNA 940                                                          
						                                                            	                  .         .         .                      
						                                                            	    1101 LKKQINSVNKFKLRTSKKHYDFHILERASSQ                    1131                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     941 LKKQINSVNKFKLRTSKKHYDFHILERASSQ                    971                                                          

15823	HMR136_T10456_10_tr0_r1_1_gPRT		Comparison report between T10456_P10 and R3HD_HUMANunique    	Sequence name: R3HD_HUMAN                                    
						head followed by partial WT sequence a mismatch, followed by 	                                                            
						a unique insertion and a followed by a unique insertion with 	Sequence documentation:                                      
						extra amino acids.1.An isolated chimeric polypeptide encoding	                                                            
						for T10456_P10, comprising a first amino acid sequence being 	Alignment of: 15823 x R3HD_HUMAN   ..                        
						at least 70%, optionally at least 80%, preferably at least   	                                                            
						85%, more preferably at least 90% and most preferably at     	Alignment segment 1/1:                                       
						least 95% homologous to a polypeptide having the sequence    	                                                            
						ALNQWCYGCQQPSVHWGVSMEREVGDYRAVNSGIYKRMR corresponding to     	                     Quality: 7672.00                      Escore:       0                                               
						amino acids 1 - 39 of T10456_P10, a second amino acid        	             Matching length:     782                Total length:     900                                               
						sequence being at least 90 % homologous to                   	 Matching Percent Similarity:   99.87   Matching Percent Identity:   99.74                                               
						PDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ corresponding to amino  	    Total Percent Similarity:   86.78      Total Percent Identity:   86.67                                               
						acids 190 - 225 of R3HD_HUMAN, which also corresponds to     	                        Gaps:       2                        
						amino acids 40 - 75 of T10456_P10, a bridging amino acid M   	                                                            
						corresponding to amino acid 76 of T10456_P10, a third amino  	Alignment:                                                   
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	                  .         .         .         .         .  
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	      40 PDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQMRIRLKDDRRSKSI 89                                                           
						GDSSGSSKSIGRLSK                                              	         ||||||||||||||||||||||||||||||||||||:|||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     190 PDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQVRIRLKDDRRSKSI 239                                                          
						to amino acids 227 - 361 of R3HD_HUMAN, which also           	                  .         .         .         .         .  
						corresponds to amino acids 77 - 211 of T10456_P10, a fourth  	      90 EEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVN 139                                                          
						amino acid sequence being at least 70%, optionally at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least 85%, more preferably at least 90%   	     240 EEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVN 289                                                          
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     140 KDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFS 189                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 212 - 296 of	     290 KDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFS 339                                                          
						T10456_P10, a fifth amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						homologous to                                                	     190 GISVLTRGDSSGSSKSIGRLSKTGSESSGSVGSSTGSLSHIQQPLPGTAL 239                                                          
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	         ||||||||||||||||||||||                              
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	     340 GISVLTRGDSSGSSKSIGRLSK............................ 361                                                          
						also corresponds to amino acids 297 - 347 of T10456_P10, a   	                  .         .         .         .         .  
						sixth amino acid sequence being at least 70%, optionally at  	     240 SQSSHGAPVVYPTVSTHSSLSFDGGLNGQVASPSTSFFLLPLEAAGIPPG 289                                                          
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	     361 .................................................. 361                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	     290 SILINPQTGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQP 339                                                          
						acids 348 - 381 of T10456_P10, and a seventh amino acid      	                |||||||||||||||||||||||||||||||||||||||||||  
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	     362 .......TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQP 404                                                          
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	                  .         .         .         .         .  
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	     340 AANHIFSQPVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSVDNLGSQFS 389                                                          
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	         ||||||||                                  ||||||||  
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	     405 AANHIFSQQ.................................DNLGSQFS 421                                                          
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	                  .         .         .         .         .  
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	     390 HMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPP 439                                                          
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	     422 HMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPP 471                                                          
						RTSKKHYDFHILERASSQ                                           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     440 PPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAP 489                                                          
						amino acids 414 - 971 of R3HD_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 382 - 939 of T10456_P10, wherein said first   	     472 PPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAP 521                                                          
						amino acid sequence, second amino acid sequence, bridging    	                  .         .         .         .         .  
						amino acid, third amino acid sequence, fourth amino acid     	     490 GHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVG 539                                                          
						sequence, fifth amino acid sequence, sixth amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and seventh amino acid sequence are contiguous and  	     522 GHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVG 571                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						a head of T10456_P10, comprising a polypeptide being at least	     540 VQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTY 589                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     572 VQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTY 621                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						ALNQWCYGCQQPSVHWGVSMEREVGDYRAVNSGIYKRMR of T10456_P10.3.An   	     590 QQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQV 639                                                          
						isolated polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P10, comprising an amino acid sequence being at least 	     622 QQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQV 671                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     640 QFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPP 689                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	     672 QFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPP 721                                                          
						at least about 95% homologous to the sequence encoding for   	                  .         .         .         .         .  
						corresponding to T10456_P10.4.An isolated polypeptide        	     690 QWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLS 739                                                          
						encoding for an edge portion of T10456_P10, comprising an    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 70%, optionally at least  	     722 QWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLS 771                                                          
						about 80%, preferably at least about 85%, more preferably at 	                  .         .         .         .         .  
						least about 90% and most preferably at least about 95%       	     740 TLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHI 789                                                          
						homologous to the sequence encoding for                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	     772 TLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHI 821                                                          
						T10456_P10.5.A bridge portion of T10456_P10, comprising a    	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	     790 PNQQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRM 839                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     822 PNQQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRM 871                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     840 EAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDL 889                                                          
						length, wherein at least two amino acids comprise QP, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows (numbering according to T10456_P10): a	     872 EAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDL 921                                                          
						sequence starting from any of amino acid numbers 412-x to    	                  .         .         .         .         .  
						412; and ending at any of amino acid numbers 348 + ((n-2) -  	     890 ASTYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ 939                                                          
						x), in which x varies from 0 to n-2.                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     922 ASTYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ 971                                                          

15813	HMR136_T10456_13_tr0_r1_1_gPRT		Comparison report between T10456_P13 and R3HD_HUMANpartial   	Sequence name: R3HD_HUMAN                                    
						WT sequence followed by unique insertion, a mismatch,        	                                                            
						followed by a unique insertion with extra amino acids and a  	Sequence documentation:                                      
						followed by a unique tail.1.An isolated chimeric polypeptide 	                                                            
						encoding for T10456_P13, comprising a first amino acid       	Alignment of: 15813 x R3HD_HUMAN   ..                        
						sequence being at least 90 % homologous to                   	                                                            
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDL       	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 56 of R3HD_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 54 of T10456_P13, a second    	                     Quality: 4045.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     443                Total length:     605                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.55                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   73.06      Total Percent Identity:   72.89                                               
						having the sequence                                          	                        Gaps:       3                        
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN corresponding to	                                                            
						amino acids 55 - 98 of T10456_P13, a third amino acid        	Alignment:                                                   
						QEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNT 	                  .         .         .         .         .  
						LKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSG 	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						KSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						amino acids 57 - 225 of R3HD_HUMAN, which also corresponds to	                  .         .         .         .         .  
						amino acids 99 - 267 of T10456_P13, a bridging amino acid M  	      51 NIDLQRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQENQE 100                                                          
						corresponding to amino acid 268 of T10456_P13, a fourth amino	         ||||                                            ||  
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	      53 NIDL............................................QE 58                                                           
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                  .         .         .         .         .  
						GDSSGSSKSIGRLSK                                              	     101 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 150                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 227 - 361 of R3HD_HUMAN, which also           	      59 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 108                                                          
						corresponds to amino acids 269 - 403 of T10456_P13, a fifth  	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     151 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 200                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     109 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 158                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	                  .         .         .         .         .  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     201 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 250                                                          
						having the sequence corresponding to amino acids 404 - 488 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P13, a sixth amino acid sequence being at least 90 %  	     159 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 208                                                          
						homologous to                                                	                  .         .         .         .         .  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     251 RYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 300                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 489 - 539 of T10456_P13, a   	     209 RYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 258                                                          
						seventh amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     301 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 350                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     259 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 308                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	                  .         .         .         .         .  
						acids 540 - 573 of T10456_P13, a eight amino acid sequence   	     351 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 400                                                          
						being at least 90 % homologous to                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTV corresponding to amino acids	     309 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 358                                                          
						414 - 445 of R3HD_HUMAN, which also corresponds to amino     	                  .         .         .         .         .  
						acids 574 - 605 of T10456_P13, and a ninth amino acid        	     401 LSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSS 450                                                          
						sequence being at least 70%, optionally at least 80%,        	         |||                                                 
						preferably at least 85%, more preferably at least 90% and    	     359 LSK............................................... 361                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						LFSRLPATSRIRTSTISSNHFTMQFPAASRPPMYSWTTTATWWGDGDDAAQCTKQSTILC 	     451 LSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSILINPQTGQPFINPDGSP 500                                                          
						PLTPAVETKQILL                                                	                                               ||||||||||||  
						having the sequence corresponding to amino acids 606 - 678 of	     362 ......................................TGQPFINPDGSP 373                                                          
						T10456_P13, wherein said first amino acid sequence, second   	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, bridging     	     501 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQPVHPLQSSSQP 550                                                          
						amino acid, fourth amino acid sequence, fifth amino acid     	         |||||||||||||||||||||||||||||||||||||||             
						sequence, sixth amino acid sequence, seventh amino acid      	     374 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQQ.......... 413                                                          
						sequence, eight amino acid sequence and ninth amino acid     	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     551 VQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHMSLARQPSADGSDPHAAM 600                                                          
						isolated polypeptide encoding for an edge portion of         	                                |||||||||||||||||||||||||||  
						T10456_P13, comprising an amino acid sequence being at least 	     414 .......................DNLGSQFSHMSLARQPSADGSDPHAAM 440                                                          
						70%, optionally at least about 80%, preferably at least about	                                                             
						85%, more preferably at least about 90% and most preferably  	     601 FQSTV                                              605                                                          
						at least about 95% homologous to the sequence encoding for   	         |||||                                               
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN, corresponding  	     441 FQSTV                                              445                                                          
						to T10456_P13.3.An isolated polypeptide encoding for an edge 	                                                            
						portion of T10456_P13, comprising an amino acid sequence     	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	                                                            
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	                                                            
						encoding for corresponding to T10456_P13.4.An isolated       	                                                            
						polypeptide encoding for an edge portion of T10456_P13,      	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	                                                            
						T10456_P13.5.A bridge portion of T10456_P13, comprising a    	                                                            
						polypeptide having a length "n", wherein n is at least about 	                                                            
						10 amino acids in length, optionally at least about 20 amino 	                                                            
						acids in length, preferably at least about 30 amino acids in 	                                                            
						length, more preferably at least about 40 amino acids in     	                                                            
						length and most preferably at least about 50 amino acids in  	                                                            
						length, wherein at least two amino acids comprise QP, having 	                                                            
						a structure as follows (numbering according to T10456_P13): a	                                                            
						sequence starting from any of amino acid numbers 412-x to    	                                                            
						412; and ending at any of amino acid numbers 540 + ((n-2) -  	                                                            
						x), in which x varies from 0 to n-2.6.An isolated polypeptide	                                                            
						encoding for a tail of T10456_P13, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						LFSRLPATSRIRTSTISSNHFTMQFPAASRPPMYSWTTTATWWGDGDDAAQCTKQSTILC 	                                                            
						PLTPAVETKQILL                                                	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in T10456_P13.                                               	                                                            

15811	HMR136_T10456_2_tr0_r1_1_gPRT		Comparison report between T10456_P2 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by mismatch, followed by a unique insertion	                                                            
						and a followed by a unique insertion with extra amino        	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						T10456_P2, comprising a first amino acid sequence being at   	Alignment of: 15811 x R3HD_HUMAN   ..                        
						MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPM 	                                                            
						TSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYI 	Alignment segment 1/1:                                       
						LKRDNSSFDKDDNQ                                               	                                                            
						least 90 % homologous to corresponding to amino acids 92 -   	                     Quality: 8638.00                      Escore:       0                                               
						225 of R3HD_HUMAN, which also corresponds to amino acids 1 - 	             Matching length:     880                Total length:     998                                               
						134 of T10456_P2, a bridging amino acid M corresponding to   	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.77                                               
						amino acid 135 of T10456_P2, a second amino acid sequence    	    Total Percent Similarity:   88.08      Total Percent Identity:   87.98                                               
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	                        Gaps:       2                        
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                                                            
						GDSSGSSKSIGRLSK                                              	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 227 - 361 of R3HD_HUMAN, which also corresponds to     	       1 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 50                                                           
						amino acids 136 - 270 of T10456_P2, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      92 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 141                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 100                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     142 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 191                                                          
						having the sequence corresponding to amino acids 271 - 355 of	                  .         .         .         .         .  
						T10456_P2, a fourth amino acid sequence being at least 90 %  	     101 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEE 150                                                          
						homologous to                                                	         ||||||||||||||||||||||||||||||||||:|||||||||||||||  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     192 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEE 241                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 356 - 406 of T10456_P2, a    	     151 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 200                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     242 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 291                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	     201 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 250                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 407 - 440 of T10456_P2, and a sixth amino acid sequence	     292 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 341                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	                  .         .         .         .         .  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     251 SVLTRGDSSGSSKSIGRLSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQ 300                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	         ||||||||||||||||||||                                
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     342 SVLTRGDSSGSSKSIGRLSK.............................. 361                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	                  .         .         .         .         .  
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     301 SSHGAPVVYPTVSTHSSLSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSI 350                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	                                                            
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     361 .................................................. 361                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                  .         .         .         .         .  
						RTSKKHYDFHILERASSQ                                           	     351 LINPQTGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 400                                                          
						being at least 90 % homologous to corresponding to amino     	              |||||||||||||||||||||||||||||||||||||||||||||  
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     362 .....TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 406                                                          
						amino acids 441 - 998 of T10456_P2, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, bridging amino acid, second amino acid        	     401 NHIFSQPVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHM 450                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||                                  ||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     407 NHIFSQQ.................................DNLGSQFSHM 423                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     451 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 500                                                          
						T10456_P2, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     424 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 473                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     501 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 550                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     474 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 523                                                          
						corresponding to T10456_P2.3.An isolated polypeptide encoding	                  .         .         .         .         .  
						for an edge portion of T10456_P2, comprising an amino acid   	     551 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 600                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     524 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 573                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV,    	     601 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 650                                                          
						corresponding to T10456_P2.4.A bridge portion of T10456_P2,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     574 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 623                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     651 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 700                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     624 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 673                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QP, having a structure as follows (numbering        	     701 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 750                                                          
						according to T10456_P2): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 412-x to 412; and ending at any of amino  	     674 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 723                                                          
						acid numbers 407 + ((n-2) - x), in which x varies from 0 to  	                  .         .         .         .         .  
						n-2.                                                         	     751 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     724 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 773                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     774 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 823                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     824 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 873                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     874 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 923                                                          
						                                                            	                  .         .         .         .            
						                                                            	     951 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   998                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     924 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   971                                                          

15821	HMR136_T10456_3_tr0_r1_1_gPRT		Comparison report between T10456_P3 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by mismatch, followed by a unique insertion	                                                            
						and a followed by a unique insertion with extra amino        	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						T10456_P3, comprising a first amino acid sequence being at   	Alignment of: 15821 x R3HD_HUMAN   ..                        
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDLQEKIQI 	                                                            
						QLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNTLKNNPR 	Alignment segment 1/1:                                       
						DRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVN 	                                                            
						KTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ                  	                     Quality: 9500.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 3 - 225	             Matching length:     969                Total length:    1087                                               
						of R3HD_HUMAN, which also corresponds to amino acids 1 - 223 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.79                                               
						of T10456_P3, a bridging amino acid M corresponding to amino 	    Total Percent Similarity:   89.05      Total Percent Identity:   88.96                                               
						acid 224 of T10456_P3, a second amino acid sequence being at 	                        Gaps:       2                        
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	                                                            
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	Alignment:                                                   
						GDSSGSSKSIGRLSK                                              	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 227 -  	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						361 of R3HD_HUMAN, which also corresponds to amino acids 225 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 359 of T10456_P3, a third amino acid sequence being at     	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      51 NIDLQEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYT 100                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	      53 NIDLQEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYT 102                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 360 - 444 of T10456_P3, a fourth amino acid   	     101 DSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMT 150                                                          
						sequence being at least 90 % homologous to                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     103 DSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMT 152                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 445 - 495 of T10456_P3, a    	     151 SYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDK 200                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     153 SYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDK 202                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	     201 GEDFQKRYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEEREEEYQRARDR 250                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	         |||||||||||||||||||||||:||||||||||||||||||||||||||  
						acids 496 - 529 of T10456_P3, and a sixth amino acid sequence	     203 GEDFQKRYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEEREEEYQRARDR 252                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	                  .         .         .         .         .  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     251 IFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQS 300                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     253 IFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQS 302                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	                  .         .         .         .         .  
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     301 STENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGS 350                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     303 STENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGS 352                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                  .         .         .         .         .  
						RTSKKHYDFHILERASSQ                                           	     351 SKSIGRLSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPT 400                                                          
						being at least 90 % homologous to corresponding to amino     	         |||||||||                                           
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     353 SKSIGRLSK......................................... 361                                                          
						amino acids 530 - 1087 of T10456_P3, wherein said first amino	                  .         .         .         .         .  
						acid sequence, bridging amino acid, second amino acid        	     401 VSTHSSLSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSILINPQTGQPFI 450                                                          
						sequence, third amino acid sequence, fourth amino acid       	                                                     ||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     362 ............................................TGQPFI 367                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     451 NPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQPVHPL 500                                                          
						T10456_P3, comprising an amino acid sequence being at least  	         |||||||||||||||||||||||||||||||||||||||||||||       
						70%, optionally at least about 80%, preferably at least about	     368 NPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQQ.... 413                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     501 QSSSQPVQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHMSLARQPSADGS 550                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	                                      |||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     414 .............................DNLGSQFSHMSLARQPSADGS 434                                                          
						corresponding to T10456_P3.3.An isolated polypeptide encoding	                  .         .         .         .         .  
						for an edge portion of T10456_P3, comprising an amino acid   	     551 DPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPV 600                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     435 DPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPV 484                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV,    	     601 PTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPV 650                                                          
						corresponding to T10456_P3.4.A bridge portion of T10456_P3,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     485 PTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPV 534                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     651 PSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQ 700                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     535 PSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQ 584                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QP, having a structure as follows (numbering        	     701 PNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQG 750                                                          
						according to T10456_P3): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 412-x to 412; and ending at any of amino  	     585 PNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQG 634                                                          
						acid numbers 496 + ((n-2) - x), in which x varies from 0 to  	                  .         .         .         .         .  
						n-2.                                                         	     751 SMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQ 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     635 SMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQ 684                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 LQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQR 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     685 LQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQR 734                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 GQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLS 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     735 GQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLS 784                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 IMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGN 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     785 IMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGN 834                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 RGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIG 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     835 RGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIG 884                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 AKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSI 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     885 AKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSI 934                                                          
						                                                            	                  .         .         .                      
						                                                            	    1051 SAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ              1087                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     935 SAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ              971                                                          

15819	HMR136_T10456_5_tr0_r1_1_gPRT		Comparison report between T10456_P5 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by unique insertion, a mismatch and a      	                                                            
						followed by a unique insertion with extra amino acids.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T10456_P5,        	                                                            
						comprising a first amino acid sequence being at least 90 %   	Alignment of: 15819 x R3HD_HUMAN   ..                        
						homologous to                                                	                                                            
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDL       	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 56 of R3HD_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 54 of T10456_P5, a second     	                     Quality: 9400.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     969                Total length:    1117                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.79                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   86.66      Total Percent Identity:   86.57                                               
						having the sequence QSSSKLKLVRSLAVCEESPPPPAPEISQEN           	                        Gaps:       3                        
						corresponding to amino acids 55 - 84 of T10456_P5, a third   	                                                            
						QEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNT 	Alignment:                                                   
						LKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSG 	                  .         .         .         .         .  
						KSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ            	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 57 - 225 of R3HD_HUMAN, which   	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						also corresponds to amino acids 85 - 253 of T10456_P5, a     	                  .         .         .         .         .  
						bridging amino acid M corresponding to amino acid 254 of     	      51 NIDLQSSSKLKLVRSLAVCEESPPPPAPEISQENQEKIQIQLTQSFEKEE 100                                                          
						T10456_P5, a fourth amino acid sequence being at least 90 %  	         ||||                              ||||||||||||||||  
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	      53 NIDL..............................QEKIQIQLTQSFEKEE 72                                                           
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                  .         .         .         .         .  
						GDSSGSSKSIGRLSK                                              	     101 KPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNTLKNNPR 150                                                          
						homologous to corresponding to amino acids 227 - 361 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						R3HD_HUMAN, which also corresponds to amino acids 255 - 389  	      73 KPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNTLKNNPR 122                                                          
						of T10456_P5, a fifth amino acid sequence being at least 70%,	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     151 DRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNV 200                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     123 DRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNV 172                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     201 DQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKD 250                                                          
						to amino acids 390 - 474 of T10456_P5, a sixth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to                   	     173 DQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKD 222                                                          
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	                  .         .         .         .         .  
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	     251 DNQMRIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQ 300                                                          
						also corresponds to amino acids 475 - 525 of T10456_P5, a    	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						seventh amino acid sequence being at least 70%, optionally at	     223 DNQVRIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQ 272                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     301 DEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSD 350                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	     273 DEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSD 322                                                          
						acids 526 - 559 of T10456_P5, and a eight amino acid sequence	                  .         .         .         .         .  
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	     351 SSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGRLSKTGSESSGSVGS 400                                                          
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	         |||||||||||||||||||||||||||||||||||||||             
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	     323 SSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGRLSK........... 361                                                          
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	                  .         .         .         .         .  
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	     401 STGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVASP 450                                                          
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	                                                            
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	     361 .................................................. 361                                                          
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	                  .         .         .         .         .  
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	     451 STSFFLLPLEAAGIPPGSILINPQTGQPFINPDGSPVVYNPPMTQQPVRS 500                                                          
						RTSKKHYDFHILERASSQ                                           	                                 ||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     362 ........................TGQPFINPDGSPVVYNPPMTQQPVRS 387                                                          
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 1117 of T10456_P5, wherein said first amino	     501 QVPGPPQPPLPAPPQQPAANHIFSQPVHPLQSSSQPVQYSTAPYPSPFLP 550                                                          
						acid sequence, second amino acid sequence, third amino acid  	         |||||||||||||||||||||||||                           
						sequence, bridging amino acid, fourth amino acid sequence,   	     388 QVPGPPQPPLPAPPQQPAANHIFSQQ........................ 413                                                          
						fifth amino acid sequence, sixth amino acid sequence, seventh	                  .         .         .         .         .  
						amino acid sequence and eight amino acid sequence are        	     551 VSPTQQYSVDNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSG 600                                                          
						contiguous and in a sequential order.2.An isolated           	                  |||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T10456_P5,       	     414 .........DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSG 454                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     601 YIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQ 650                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence encoding for      	     455 YIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQ 504                                                          
						QSSSKLKLVRSLAVCEESPPPPAPEISQEN, corresponding to             	                  .         .         .         .         .  
						T10456_P5.3.An isolated polypeptide encoding for an edge     	     651 GYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQT 700                                                          
						portion of T10456_P5, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     505 GYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQT 554                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     701 GYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPT 750                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	     555 GYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPT 604                                                          
						encoding for corresponding to T10456_P5.4.An isolated        	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10456_P5,       	     751 YQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQN 800                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     605 YQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQN 654                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     801 NLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVM 850                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P5.5.A bridge portion of T10456_P5, comprising a      	     655 NLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVM 704                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     851 MQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQL 900                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     705 MQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQL 754                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise QP, having 	     901 SSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPL 950                                                          
						a structure as follows (numbering according to T10456_P5): a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence starting from any of amino acid numbers 412-x to    	     755 SSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPL 804                                                          
						412; and ending at any of amino acid numbers 526 + ((n-2) -  	                  .         .         .         .         .  
						x), in which x varies from 0 to n-2.                         	     951 LGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQAKKAASTDLGAGETV 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     805 LGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQAKKAASTDLGAGETV 854                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 VGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCC 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     855 VGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCC 904                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 GSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKLR 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     905 GSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKLR 954                                                          
						                                                            	                  .                                          
						                                                            	    1101 TSKKHYDFHILERASSQ                                  1117                                                         
						                                                            	         |||||||||||||||||                                   
						                                                            	     955 TSKKHYDFHILERASSQ                                  971                                                          

15817	HMR136_T10456_6_tr0_r1_1_gPRT		Comparison report between T10456_P6 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by mismatch, followed by a unique insertion	                                                            
						and a followed by a unique insertion with extra amino        	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						T10456_P6, comprising a first amino acid sequence being at   	Alignment of: 15817 x R3HD_HUMAN   ..                        
						MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPM 	                                                            
						TSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYI 	Alignment segment 1/1:                                       
						LKRDNSSFDKDDNQ                                               	                                                            
						least 90 % homologous to corresponding to amino acids 92 -   	                     Quality: 8638.00                      Escore:       0                                               
						225 of R3HD_HUMAN, which also corresponds to amino acids 1 - 	             Matching length:     880                Total length:     998                                               
						134 of T10456_P6, a bridging amino acid M corresponding to   	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.77                                               
						amino acid 135 of T10456_P6, a second amino acid sequence    	    Total Percent Similarity:   88.08      Total Percent Identity:   87.98                                               
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	                        Gaps:       2                        
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                                                            
						GDSSGSSKSIGRLSK                                              	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 227 - 361 of R3HD_HUMAN, which also corresponds to     	       1 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 50                                                           
						amino acids 136 - 270 of T10456_P6, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      92 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 141                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 100                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     142 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 191                                                          
						having the sequence corresponding to amino acids 271 - 355 of	                  .         .         .         .         .  
						T10456_P6, a fourth amino acid sequence being at least 90 %  	     101 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEE 150                                                          
						homologous to                                                	         ||||||||||||||||||||||||||||||||||:|||||||||||||||  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     192 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEE 241                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 356 - 406 of T10456_P6, a    	     151 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 200                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     242 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 291                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	     201 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 250                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 407 - 440 of T10456_P6, and a sixth amino acid sequence	     292 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 341                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	                  .         .         .         .         .  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     251 SVLTRGDSSGSSKSIGRLSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQ 300                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	         ||||||||||||||||||||                                
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     342 SVLTRGDSSGSSKSIGRLSK.............................. 361                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	                  .         .         .         .         .  
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     301 SSHGAPVVYPTVSTHSSLSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSI 350                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	                                                            
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     361 .................................................. 361                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                  .         .         .         .         .  
						RTSKKHYDFHILERASSQ                                           	     351 LINPQTGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 400                                                          
						being at least 90 % homologous to corresponding to amino     	              |||||||||||||||||||||||||||||||||||||||||||||  
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     362 .....TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 406                                                          
						amino acids 441 - 998 of T10456_P6, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, bridging amino acid, second amino acid        	     401 NHIFSQPVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHM 450                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||                                  ||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     407 NHIFSQQ.................................DNLGSQFSHM 423                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     451 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 500                                                          
						T10456_P6, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     424 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 473                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     501 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 550                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     474 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 523                                                          
						corresponding to T10456_P6.3.An isolated polypeptide encoding	                  .         .         .         .         .  
						for an edge portion of T10456_P6, comprising an amino acid   	     551 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 600                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     524 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 573                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV,    	     601 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 650                                                          
						corresponding to T10456_P6.4.A bridge portion of T10456_P6,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     574 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 623                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     651 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 700                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     624 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 673                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QP, having a structure as follows (numbering        	     701 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 750                                                          
						according to T10456_P6): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 412-x to 412; and ending at any of amino  	     674 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 723                                                          
						acid numbers 407 + ((n-2) - x), in which x varies from 0 to  	                  .         .         .         .         .  
						n-2.                                                         	     751 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     724 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 773                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     774 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 823                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     824 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 873                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     874 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 923                                                          
						                                                            	                  .         .         .         .            
						                                                            	     951 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   998                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     924 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   971                                                          

15827	HMR136_T10456_7_tr0_r1_1_gPRT		Comparison report between T10456_P7 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by unique insertion, a mismatch and a      	                                                            
						followed by a unique insertion with extra amino acids.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T10456_P7,        	                                                            
						comprising a first amino acid sequence being at least 90 %   	Alignment of: 15827 x R3HD_HUMAN   ..                        
						homologous to                                                	                                                            
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDL       	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 56 of R3HD_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 54 of T10456_P7, a second     	                     Quality: 9400.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     969                Total length:    1117                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.79                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   86.66      Total Percent Identity:   86.57                                               
						having the sequence QSSSKLKLVRSLAVCEESPPPPAPEISQEN           	                        Gaps:       3                        
						corresponding to amino acids 55 - 84 of T10456_P7, a third   	                                                            
						QEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNT 	Alignment:                                                   
						LKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSG 	                  .         .         .         .         .  
						KSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ            	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 57 - 225 of R3HD_HUMAN, which   	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						also corresponds to amino acids 85 - 253 of T10456_P7, a     	                  .         .         .         .         .  
						bridging amino acid M corresponding to amino acid 254 of     	      51 NIDLQSSSKLKLVRSLAVCEESPPPPAPEISQENQEKIQIQLTQSFEKEE 100                                                          
						T10456_P7, a fourth amino acid sequence being at least 90 %  	         ||||                              ||||||||||||||||  
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	      53 NIDL..............................QEKIQIQLTQSFEKEE 72                                                           
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                  .         .         .         .         .  
						GDSSGSSKSIGRLSK                                              	     101 KPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNTLKNNPR 150                                                          
						homologous to corresponding to amino acids 227 - 361 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						R3HD_HUMAN, which also corresponds to amino acids 255 - 389  	      73 KPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNTLKNNPR 122                                                          
						of T10456_P7, a fifth amino acid sequence being at least 70%,	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     151 DRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNV 200                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     123 DRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNV 172                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     201 DQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKD 250                                                          
						to amino acids 390 - 474 of T10456_P7, a sixth amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to                   	     173 DQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKD 222                                                          
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	                  .         .         .         .         .  
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	     251 DNQMRIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQ 300                                                          
						also corresponds to amino acids 475 - 525 of T10456_P7, a    	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						seventh amino acid sequence being at least 70%, optionally at	     223 DNQVRIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQ 272                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     301 DEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSD 350                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	     273 DEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSD 322                                                          
						acids 526 - 559 of T10456_P7, and a eight amino acid sequence	                  .         .         .         .         .  
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	     351 SSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGRLSKTGSESSGSVGS 400                                                          
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	         |||||||||||||||||||||||||||||||||||||||             
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	     323 SSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGRLSK........... 361                                                          
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	                  .         .         .         .         .  
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	     401 STGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVASP 450                                                          
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	                                                            
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	     361 .................................................. 361                                                          
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	                  .         .         .         .         .  
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	     451 STSFFLLPLEAAGIPPGSILINPQTGQPFINPDGSPVVYNPPMTQQPVRS 500                                                          
						RTSKKHYDFHILERASSQ                                           	                                 ||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     362 ........................TGQPFINPDGSPVVYNPPMTQQPVRS 387                                                          
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	                  .         .         .         .         .  
						amino acids 560 - 1117 of T10456_P7, wherein said first amino	     501 QVPGPPQPPLPAPPQQPAANHIFSQPVHPLQSSSQPVQYSTAPYPSPFLP 550                                                          
						acid sequence, second amino acid sequence, third amino acid  	         |||||||||||||||||||||||||                           
						sequence, bridging amino acid, fourth amino acid sequence,   	     388 QVPGPPQPPLPAPPQQPAANHIFSQQ........................ 413                                                          
						fifth amino acid sequence, sixth amino acid sequence, seventh	                  .         .         .         .         .  
						amino acid sequence and eight amino acid sequence are        	     551 VSPTQQYSVDNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSG 600                                                          
						contiguous and in a sequential order.2.An isolated           	                  |||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T10456_P7,       	     414 .........DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSG 454                                                          
						comprising an amino acid sequence being at least 70%,        	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     601 YIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQ 650                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence encoding for      	     455 YIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYPASGHPVSQPVLQQQ 504                                                          
						QSSSKLKLVRSLAVCEESPPPPAPEISQEN, corresponding to             	                  .         .         .         .         .  
						T10456_P7.3.An isolated polypeptide encoding for an edge     	     651 GYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQT 700                                                          
						portion of T10456_P7, comprising an amino acid sequence being	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 70%, optionally at least about 80%, preferably at   	     505 GYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYNSHLNQPLPQPAQQT 554                                                          
						least about 85%, more preferably at least about 90% and most 	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     701 GYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPT 750                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	     555 GYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQGVVIPYTSVPT 604                                                          
						encoding for corresponding to T10456_P7.4.An isolated        	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10456_P7,       	     751 YQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQN 800                                                          
						comprising an amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     605 YQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQN 654                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence encoding for      	     801 NLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVM 850                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P7.5.A bridge portion of T10456_P7, comprising a      	     655 NLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVM 704                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     851 MQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQL 900                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     705 MQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQL 754                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise QP, having 	     901 SSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPL 950                                                          
						a structure as follows (numbering according to T10456_P7): a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence starting from any of amino acid numbers 412-x to    	     755 SSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFSRPFVPGQGDSRYPL 804                                                          
						412; and ending at any of amino acid numbers 526 + ((n-2) -  	                  .         .         .         .         .  
						x), in which x varies from 0 to n-2.                         	     951 LGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQAKKAASTDLGAGETV 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     805 LGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQAKKAASTDLGAGETV 854                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 VGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCC 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     855 VGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDPQSQPRRHPLCC 904                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 GSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKLR 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     905 GSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKLR 954                                                          
						                                                            	                  .                                          
						                                                            	    1101 TSKKHYDFHILERASSQ                                  1117                                                         
						                                                            	         |||||||||||||||||                                   
						                                                            	     955 TSKKHYDFHILERASSQ                                  971                                                          

15825	HMR136_T10456_8_tr0_r1_1_gPRT		Comparison report between T10456_P8 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by unique insertion, a mismatch and a      	                                                            
						followed by a unique insertion with extra amino acids.1.An   	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for T10456_P8,        	                                                            
						comprising a first amino acid sequence being at least 90 %   	Alignment of: 15825 x R3HD_HUMAN   ..                        
						homologous to                                                	                                                            
						MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIENNIDL       	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 56 of R3HD_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 54 of T10456_P8, a second     	                     Quality: 9400.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     969                Total length:    1131                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.79                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   85.59      Total Percent Identity:   85.50                                               
						having the sequence                                          	                        Gaps:       3                        
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN corresponding to	                                                            
						amino acids 55 - 98 of T10456_P8, a third amino acid sequence	Alignment:                                                   
						QEKIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGIDLHEFLVNT 	                  .         .         .         .         .  
						LKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSG 	       1 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 50                                                           
						KSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQ            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	       3 MSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVEKNEHCIEN 52                                                           
						acids 57 - 225 of R3HD_HUMAN, which also corresponds to amino	                  .         .         .         .         .  
						acids 99 - 267 of T10456_P8, a bridging amino acid M         	      51 NIDLQRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQENQE 100                                                          
						corresponding to amino acid 268 of T10456_P8, a fourth amino 	         ||||                                            ||  
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	      53 NIDL............................................QE 58                                                           
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                  .         .         .         .         .  
						GDSSGSSKSIGRLSK                                              	     101 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 150                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 227 - 361 of R3HD_HUMAN, which also           	      59 KIQIQLTQSFEKEEKPSKDEAEKEKASDKLPRKMLSRDSSQEYTDSTGID 108                                                          
						corresponds to amino acids 269 - 403 of T10456_P8, a fifth   	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     151 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 200                                                          
						80%, preferably at least 85%, more preferably at least 90%   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and most preferably at least 95% homologous to a polypeptide 	     109 LHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPMTSYHRML 158                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	                  .         .         .         .         .  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     201 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 250                                                          
						having the sequence corresponding to amino acids 404 - 488 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10456_P8, a sixth amino acid sequence being at least 90 %   	     159 LHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQK 208                                                          
						homologous to                                                	                  .         .         .         .         .  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     251 RYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 300                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	         |||||||||||||||||:||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 489 - 539 of T10456_P8, a    	     209 RYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEEREEEYQRARDRIFSQDS 258                                                          
						seventh amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     301 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 350                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	     259 LCSQENYIIDKRLQDEDASSTQQRRQIFRVNKDASGRSTNSHQSSTENEL 308                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	                  .         .         .         .         .  
						acids 540 - 573 of T10456_P8, and a eight amino acid sequence	     351 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 400                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     309 KYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTRGDSSGSSKSIGR 358                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	                  .         .         .         .         .  
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     401 LSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSS 450                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	         |||                                                 
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     359 LSK............................................... 361                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	                  .         .         .         .         .  
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     451 LSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSILINPQTGQPFINPDGSP 500                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                                               ||||||||||||  
						RTSKKHYDFHILERASSQ                                           	     362 ......................................TGQPFINPDGSP 373                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     501 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQPVHPLQSSSQP 550                                                          
						amino acids 574 - 1131 of T10456_P8, wherein said first amino	         |||||||||||||||||||||||||||||||||||||||             
						acid sequence, second amino acid sequence, third amino acid  	     374 VVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQQ.......... 413                                                          
						sequence, bridging amino acid, fourth amino acid sequence,   	                  .         .         .         .         .  
						fifth amino acid sequence, sixth amino acid sequence, seventh	     551 VQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHMSLARQPSADGSDPHAAM 600                                                          
						amino acid sequence and eight amino acid sequence are        	                                |||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     414 .......................DNLGSQFSHMSLARQPSADGSDPHAAM 440                                                          
						polypeptide encoding for an edge portion of T10456_P8,       	                  .         .         .         .         .  
						comprising an amino acid sequence being at least 70%,        	     601 FQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYP 650                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     441 FQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPPPPPPLPPGQPVPTAGYP 490                                                          
						least about 95% homologous to the sequence encoding for      	                  .         .         .         .         .  
						QRPLQSFGQTGKRSKSSSKLKLVRSLAVCEESPPPPAPEISQEN, corresponding  	     651 ASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYN 700                                                          
						to T10456_P8.3.An isolated polypeptide encoding for an edge  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of T10456_P8, comprising an amino acid sequence being	     491 ASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRPVPSVHYN 540                                                          
						at least 70%, optionally at least about 80%, preferably at   	                  .         .         .         .         .  
						least about 85%, more preferably at least about 90% and most 	     701 SHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGN 750                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     541 SHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGN 590                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	                  .         .         .         .         .  
						encoding for corresponding to T10456_P8.4.An isolated        	     751 QIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTG 800                                                          
						polypeptide encoding for an edge portion of T10456_P8,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     591 QIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTG 640                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     801 MPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQC 850                                                          
						least about 95% homologous to the sequence encoding for      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV, corresponding to         	     641 MPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQC 690                                                          
						T10456_P8.5.A bridge portion of T10456_P8, comprising a      	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	     851 TAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVE 900                                                          
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     691 TAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQWKQNKYYCDHQRGQKCVE 740                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	     901 FSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFS 950                                                          
						length, wherein at least two amino acids comprise QP, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows (numbering according to T10456_P8): a 	     741 FSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTLKTVRPSGPPLSIMPQFS 790                                                          
						sequence starting from any of amino acid numbers 412-x to    	                  .         .         .         .         .  
						412; and ending at any of amino acid numbers 540 + ((n-2) -  	     951 RPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQA 1000                                                         
						x), in which x varies from 0 to n-2.                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     791 RPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHGNRGRRQA 840                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 KKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWL 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     841 KKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWL 890                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 RDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNA 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     891 RDPQSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNA 940                                                          
						                                                            	                  .         .         .                      
						                                                            	    1101 LKKQINSVNKFKLRTSKKHYDFHILERASSQ                    1131                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     941 LKKQINSVNKFKLRTSKKHYDFHILERASSQ                    971                                                          

15809	HMR136_T10456_9_tr0_r1_1_gPRT		Comparison report between T10456_P9 and R3HD_HUMANpartial WT 	Sequence name: R3HD_HUMAN                                    
						sequence followed by mismatch, followed by a unique insertion	                                                            
						and a followed by a unique insertion with extra amino        	Sequence documentation:                                      
						acids.1.An isolated chimeric polypeptide encoding for        	                                                            
						T10456_P9, comprising a first amino acid sequence being at   	Alignment of: 15809 x R3HD_HUMAN   ..                        
						MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNNESPRKKFPPM 	                                                            
						TSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPDQKFNEHIKDDKGEDFQKRYI 	Alignment segment 1/1:                                       
						LKRDNSSFDKDDNQ                                               	                                                            
						least 90 % homologous to corresponding to amino acids 92 -   	                     Quality: 8638.00                      Escore:       0                                               
						225 of R3HD_HUMAN, which also corresponds to amino acids 1 - 	             Matching length:     880                Total length:     998                                               
						134 of T10456_P9, a bridging amino acid M corresponding to   	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.77                                               
						amino acid 135 of T10456_P9, a second amino acid sequence    	    Total Percent Similarity:   88.08      Total Percent Identity:   87.98                                               
						RIRLKDDRRSKSIEEREEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIF 	                        Gaps:       2                        
						RVNKDASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGISVLTR 	                                                            
						GDSSGSSKSIGRLSK                                              	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 227 - 361 of R3HD_HUMAN, which also corresponds to     	       1 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 50                                                           
						amino acids 136 - 270 of T10456_P9, a third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      92 MLSRDSSQEYTDSTGIDLHEFLVNTLKNNPRDRMMLLKLEQEILDFIGNN 141                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      51 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 100                                                          
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSTSFFLLPLEAAGIPPGSILINPQ                                    	     142 ESPRKKFPPMTSYHRMLLHRVAAYFGLDHNVDQSGKSVIVNKTSNTRIPD 191                                                          
						having the sequence corresponding to amino acids 271 - 355 of	                  .         .         .         .         .  
						T10456_P9, a fourth amino acid sequence being at least 90 %  	     101 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQMRIRLKDDRRSKSIEE 150                                                          
						homologous to                                                	         ||||||||||||||||||||||||||||||||||:|||||||||||||||  
						TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAANHIFSQ          	     192 QKFNEHIKDDKGEDFQKRYILKRDNSSFDKDDNQVRIRLKDDRRSKSIEE 241                                                          
						corresponding to amino acids 362 - 412 of R3HD_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 356 - 406 of T10456_P9, a    	     151 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 200                                                          
						fifth amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     242 REEEYQRARDRIFSQDSLCSQENYIIDKRLQDEDASSTQQRRQIFRVNKD 291                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	     201 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 250                                                          
						PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 407 - 440 of T10456_P9, and a sixth amino acid sequence	     292 ASGRSTNSHQSSTENELKYSEPRPWSSTDSDSSLRNLKPAVTKASSFSGI 341                                                          
						DNLGSQFSHMSLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 	                  .         .         .         .         .  
						PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGHYHSSQPQYRP 	     251 SVLTRGDSSGSSKSIGRLSKTGSESSGSVGSSTGSLSHIQQPLPGTALSQ 300                                                          
						VPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQQPQSQSLVSGQPNSIGNQIQ 	         ||||||||||||||||||||                                
						GVVIPYTSVPTYQVSLPQGSQGIPHQTYQQPVMFPNQSNQGSMPTTGMPVYYSVIPPGQQ 	     342 SVLTRGDSSGSSKSIGRLSK.............................. 361                                                          
						NNLSSSVGYLQHPGSEQVQFPRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNP 	                  .         .         .         .         .  
						QSCAHSPPQWKQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 	     301 SSHGAPVVYPTVSTHSSLSFDGGLNGQVASPSTSFFLLPLEAAGIPPGSI 350                                                          
						KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPNQQGQPGSRHG 	                                                            
						NRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEAEKLFGELFKIGAKIRWLRDP 	     361 .................................................. 361                                                          
						QSQPRRHPLCCGSGDNTANPERSKPSDLASTYTVLATFPSISAAQNALKKQINSVNKFKL 	                  .         .         .         .         .  
						RTSKKHYDFHILERASSQ                                           	     351 LINPQTGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 400                                                          
						being at least 90 % homologous to corresponding to amino     	              |||||||||||||||||||||||||||||||||||||||||||||  
						acids 414 - 971 of R3HD_HUMAN, which also corresponds to     	     362 .....TGQPFINPDGSPVVYNPPMTQQPVRSQVPGPPQPPLPAPPQQPAA 406                                                          
						amino acids 441 - 998 of T10456_P9, wherein said first amino 	                  .         .         .         .         .  
						acid sequence, bridging amino acid, second amino acid        	     401 NHIFSQPVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSVDNLGSQFSHM 450                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||                                  ||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     407 NHIFSQQ.................................DNLGSQFSHM 423                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     451 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 500                                                          
						T10456_P9, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     424 SLARQPSADGSDPHAAMFQSTVVLQSPQQSGYIMTAAPPPHPPPPPPPPP 473                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						TGSESSGSVGSSTGSLSHIQQPLPGTALSQSSHGAPVVYPTVSTHSSLSFDGGLNGQVAS 	     501 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 550                                                          
						PSTSFFLLPLEAAGIPPGSILINPQ,                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence encoding for   	     474 PPPPLPPGQPVPTAGYPASGHPVSQPVLQQQGYIQQPSPQMPACYCAPGH 523                                                          
						corresponding to T10456_P9.3.An isolated polypeptide encoding	                  .         .         .         .         .  
						for an edge portion of T10456_P9, comprising an amino acid   	     551 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 600                                                          
						sequence being at least 70%, optionally at least about 80%,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 85%, more preferably at least about	     524 YHSSQPQYRPVPSVHYNSHLNQPLPQPAQQTGYQVIPNQQQNYQGIVGVQ 573                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for PVHPLQSSSQPVQYSTAPYPSPFLPVSPTQQYSV,    	     601 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 650                                                          
						corresponding to T10456_P9.4.A bridge portion of T10456_P9,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     574 QPQSQSLVSGQPNSIGNQIQGVVIPYTSVPTYQVSLPQGSQGIPHQTYQQ 623                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     651 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 700                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     624 PVMFPNQSNQGSMPTTGMPVYYSVIPPGQQNNLSSSVGYLQHPGSEQVQF 673                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise QP, having a structure as follows (numbering        	     701 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 750                                                          
						according to T10456_P9): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 412-x to 412; and ending at any of amino  	     674 PRTTSPCSSQQLQGHQCTAGPPPPPGGGMVMMQLSVPNNPQSCAHSPPQW 723                                                          
						acid numbers 407 + ((n-2) - x), in which x varies from 0 to  	                  .         .         .         .         .  
						n-2.                                                         	     751 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     724 KQNKYYCDHQRGQKCVEFSSVDNIVQHSPQLSSPIISPAQSPAPAQLSTL 773                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     774 KTVRPSGPPLSIMPQFSRPFVPGQGDSRYPLLGQPLQYNPPAVLHGHIPN 823                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     824 QQGQPGSRHGNRGRRQAKKAASTDLGAGETVVGKVLEITELPDGITRMEA 873                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     874 EKLFGELFKIGAKIRWLRDPQSQPRRHPLCCGSGDNTANPERSKPSDLAS 923                                                          
						                                                            	                  .         .         .         .            
						                                                            	     951 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   998                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     924 TYTVLATFPSISAAQNALKKQINSVNKFKLRTSKKHYDFHILERASSQ   971                                                          

1645	HMR136_T10474_12_tr0_r1_1_gPRT		Comparison report between T10474_P12 and Q9NZC3partial WT    	Sequence name: Q9NZC3                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10474_P12, comprising a first amino	Sequence documentation:                                      
						MWLWEDQGGLLGPFSFLLLVLLLVTRSPVNACLLTGSLFVLLRVFSFEPVPSCRALQVLK 	                                                            
						PRDRISAIAHRGGSHDAPENTLAAIRQ                                  	Alignment of: 1645 x Q9NZC3   ..                             
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 87 of Q9NZC3, which also corresponds to   	Alignment segment 1/1:                                       
						amino acids 1 - 87 of T10474_P12, and a second amino acid    	                                                            
						MRQTDRDVITALTHRPWSLSHTGDGKPRYDTFWKHFIFVMMDILLDWSMHNILWYLCGIS 	                     Quality: 1961.00                      Escore:       0                                               
						AFLMQKDFVSPAYLKKWSAKGIQVVGWTVNTFDEKSYYESHLGSSYITDSMVEDCEPHF  	             Matching length:     206                Total length:     331                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 213 - 331 of Q9NZC3, which also corresponds to   	    Total Percent Similarity:   62.24      Total Percent Identity:   62.24                                               
						amino acids 88 - 206 of T10474_P12, wherein said first amino 	                        Gaps:       1                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated chimeric polypeptide 	Alignment:                                                   
						encoding for an edge portion of T10474_P12, comprising a     	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	       1 MWLWEDQGGLLGPFSFLLLVLLLVTRSPVNACLLTGSLFVLLRVFSFEPV 50                                                           
						10 amino acids in length, optionally at least about 20 amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	       1 MWLWEDQGGLLGPFSFLLLVLLLVTRSPVNACLLTGSLFVLLRVFSFEPV 50                                                           
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      51 PSCRALQVLKPRDRISAIAHRGGSHDAPENTLAAIRQ............. 87                                                           
						length, wherein at least two amino acids comprise QM, having 	         |||||||||||||||||||||||||||||||||||||               
						a structure as follows: a sequence starting from any of amino	      51 PSCRALQVLKPRDRISAIAHRGGSHDAPENTLAAIRQAAKNGATGVELDI 100                                                          
						acid numbers 87-x to 88; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 88+ ((n-2) - x), in which x varies from 0 to n-2.    	      87 .................................................. 87                                                           
						                                                            	                                                            
						                                                            	     101 EFTSDGIPVLMHDNTVDRTTDGTGRLCDLTFEQIRKLNPAANHRLRNDFP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      87 .................................................. 87                                                           
						                                                            	                                                            
						                                                            	     151 DEKIPTLREAVAECLNHNLTIFFDVKGHAHKATEALKKMYMEFPQLYNNS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      88 ............MRQTDRDVITALTHRPWSLSHTGDGKPRYDTFWKHFIF 125                                                          
						                                                            	                     ||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VVCSFLPEVIYKMRQTDRDVITALTHRPWSLSHTGDGKPRYDTFWKHFIF 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     126 VMMDILLDWSMHNILWYLCGISAFLMQKDFVSPAYLKKWSAKGIQVVGWT 175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VMMDILLDWSMHNILWYLCGISAFLMQKDFVSPAYLKKWSAKGIQVVGWT 300                                                          
						                                                            	                  .         .         .                      
						                                                            	     176 VNTFDEKSYYESHLGSSYITDSMVEDCEPHF                    206                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     301 VNTFDEKSYYESHLGSSYITDSMVEDCEPHF                    331                                                          

22012	HMR136_T10476_14_tr0_r1_1_gPRT		Comparison report between T10476_P14 and Q14997partial WT    	Sequence name: Q14997                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10476_P14, comprising a first amino acid       	                                                            
						MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIH 	Alignment of: 22012 x Q14997   ..                            
						FEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMN 	                                                            
						LSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSPCYYA     	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1623 - 1798 of Q14997, which also corresponds to 	                     Quality: 1751.00                      Escore:       0                                               
						amino acids 1 - 176 of T10476_P14.                           	             Matching length:     176                Total length:     176                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1623 MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNF 1672                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1673 LTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLG 1722                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1723 ACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNW 1772                                                         
						                                                            	                  .         .                                
						                                                            	     151 QEHKQQFTDDQLLVLTDLLVSPCYYA                         176                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	    1773 QEHKQQFTDDQLLVLTDLLVSPCYYA                         1798                                                         

						Comparison report between T10476_P14 and AAH43602partial WT  	Sequence name: AAH43602                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10476_P14, comprising a first amino acid       	                                                            
						MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIH 	Alignment of: 22012 x AAH43602   ..                          
						FEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMN 	                                                            
						LSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSPCYYA     	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 284 - 459 of AAH43602, which also corresponds to 	                     Quality: 1751.00                      Escore:       0                                               
						amino acids 1 - 176 of T10476_P14.                           	             Matching length:     176                Total length:     176                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 MVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNF 333                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     334 LTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLG 383                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNW 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     384 ACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNW 433                                                          
						                                                            	                  .         .                                
						                                                            	     151 QEHKQQFTDDQLLVLTDLLVSPCYYA                         176                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     434 QEHKQQFTDDQLLVLTDLLVSPCYYA                         459                                                          

22010	HMR136_T10476_22_tr0_r1_1_gPRT		Comparison report between T10476_P22 and Q14997unique head   	Sequence name: Q14997                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion with extra amino acids and a followed by a unique  	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						T10476_P22, comprising a first amino acid sequence being at  	Alignment of: 22010 x Q14997   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						PGRVRVGGGGGGVPGLMEPAERAGVGEPPEPGGRPEPGPRGFVPQKEIVYNKLLPYAERL 	                                                            
						D                                                            	                     Quality: 7732.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     794                Total length:     816                                               
						to amino acids 1 - 61 of T10476_P22, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						AESDLQLAQIKCNLGRAVQLQELWPGGLFWTRKLSTYIRLYGRKFSKEDHVLFIKLLYEL 	    Total Percent Similarity:   97.30      Total Percent Identity:   97.18                                               
						VSIPKLEISMMQGFARLLINLLKKKELLSRADLELPWRPLYDMVERILYSKTEHLGLNWF 	                        Gaps:       1                        
						P                                                            	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 121 of Q14997, which also corresponds to     	                  .         .         .         .         .  
						amino acids 62 - 182 of T10476_P22, a third amino acid       	      62 AESDLQLAQIKCNLGRAVQLQELWPGGLFWTRKLSTYIRLYGRKFSKEDH 111                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 AESDLQLAQIKCNLGRAVQLQELWPGGLFWTRKLSTYIRLYGRKFSKEDH 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence KNIVPFILRDYKNHKRSLYRYHS corresponding to 	     112 VLFIKLLYELVSIPKLEISMMQGFARLLINLLKKKELLSRADLELPWRPL 161                                                          
						amino acids 183 - 205 of T10476_P22, a fourth amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SVENILKTLVKSCRPYFPADATAEMLEEWRPLMCPFDVTMQKAITYFEIFLPTSLPPELH 	      51 VLFIKLLYELVSIPKLEISMMQGFARLLINLLKKKELLSRADLELPWRPL 100                                                          
						HKGFKLWFDELIGLWVSVQNLPQWEGQLVNLFARLATDNIGYIDWDPYVPKIFTRILRSL 	                  .         .         .         .         .  
						NLPVGSSQVLVPRFLTNAYDIGHAVIWITAMMGGPSKLVQKHLAGLFNSITSFYHPSNNG 	     162 YDMVERILYSKTEHLGLNWFPKNIVPFILRDYKNHKRSLYRYHSSVENIL 211                                                          
						RWLNKLMKLLQRLPNSVVRRLHRERYKKPSWLTPVPDSHKLTDQDVTDFVQCIIQPVLLA 	         |||||||||||||||||||||                      :||||||  
						MFSKTGSLEAAQALQNLALMRPELVIPPVLERTYPALETLTEPHQLTATLSCVIGVARSL 	     101 YDMVERILYSKTEHLGLNWFP......................NSVENIL 128                                                          
						VSGGRWFPEGPTHMLPLLMRALPGVDPNDFSKCMITFQFIATFSTLVPLVDCSSVLQERN 	                  .         .         .         .         .  
						DLTEVERELCSATAEFEDFVLQFMDRCFGLIESSTLEQTREETETEKMTHLESLVELGLS 	     212 KTLVKSCRPYFPADATAEMLEEWRPLMCPFDVTMQKAITYFEIFLPTSLP 261                                                          
						STFSTILTQCSKEIFMVALQKVFNFSTSHIFETRVAGRMVADMCRAAVKCCPEESLKLFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PHCCSVITQLTMNDDVLNDEELDKELLWNLQLLSEITRVDGRKLLLYREQLVKILQRTLH 	     129 KTLVKSCRPYFPADATAEMLEEWRPLMCPFDVTMQKAITYFEIFLPTSLP 178                                                          
						LTCKQGYTLSCNLLHHLLRSTTLIYPTEYCSVPGGFDKPPSEYFPIKDWGKPGDLWNLGI 	                  .         .         .         .         .  
						QWHVPSSEEVSFAFYLLDSFLQPELVKLQHCGDGKLEMSRDDILQSLTIVHNCLIGSGNL 	     262 PELHHKGFKLWFDELIGLWVSVQNLPQWEGQLVNLFARLATDNIGYIDWD 311                                                          
						LPPLKGEPVTNL                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     179 PELHHKGFKLWFDELIGLWVSVQNLPQWEGQLVNLFARLATDNIGYIDWD 228                                                          
						amino acids 123 - 794 of Q14997, which also corresponds to   	                  .         .         .         .         .  
						amino acids 206 - 877 of T10476_P22, and a fifth amino acid  	     312 PYVPKIFTRILRSLNLPVGSSQVLVPRFLTNAYDIGHAVIWITAMMGGPS 361                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     229 PYVPKIFTRILRSLNLPVGSSQVLVPRFLTNAYDIGHAVIWITAMMGGPS 278                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence KLPSSAGGAAHRKGNSYYST corresponding to    	     362 KLVQKHLAGLFNSITSFYHPSNNGRWLNKLMKLLQRLPNSVVRRLHRERY 411                                                          
						amino acids 878 - 897 of T10476_P22, wherein said first amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence, third amino acid  	     279 KLVQKHLAGLFNSITSFYHPSNNGRWLNKLMKLLQRLPNSVVRRLHRERY 328                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     412 KKPSWLTPVPDSHKLTDQDVTDFVQCIIQPVLLAMFSKTGSLEAAQALQN 461                                                          
						isolated polypeptide encoding for a head of T10476_P22,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     329 KKPSWLTPVPDSHKLTDQDVTDFVQCIIQPVLLAMFSKTGSLEAAQALQN 378                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     462 LALMRPELVIPPVLERTYPALETLTEPHQLTATLSCVIGVARSLVSGGRW 511                                                          
						PGRVRVGGGGGGVPGLMEPAERAGVGEPPEPGGRPEPGPRGFVPQKEIVYNKLLPYAERL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						D                                                            	     379 LALMRPELVIPPVLERTYPALETLTEPHQLTATLSCVIGVARSLVSGGRW 428                                                          
						about 95% homologous to the sequence of T10476_P22.3.An      	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     512 FPEGPTHMLPLLMRALPGVDPNDFSKCMITFQFIATFSTLVPLVDCSSVL 561                                                          
						T10476_P22, comprising an amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     429 FPEGPTHMLPLLMRALPGVDPNDFSKCMITFQFIATFSTLVPLVDCSSVL 478                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     562 QERNDLTEVERELCSATAEFEDFVLQFMDRCFGLIESSTLEQTREETETE 611                                                          
						KNIVPFILRDYKNHKRSLYRYHS, corresponding to T10476_P22.4.A     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridge portion of T10476_P22, comprising a polypeptide having	     479 QERNDLTEVERELCSATAEFEDFVLQFMDRCFGLIESSTLEQTREETETE 528                                                          
						a length "n", wherein n is at least about 10 amino acids in  	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     612 KMTHLESLVELGLSSTFSTILTQCSKEIFMVALQKVFNFSTSHIFETRVA 661                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     529 KMTHLESLVELGLSSTFSTILTQCSKEIFMVALQKVFNFSTSHIFETRVA 578                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise P, having a structure as   	     662 GRMVADMCRAAVKCCPEESLKLFVPHCCSVITQLTMNDDVLNDEELDKEL 711                                                          
						follows (numbering according to T10476_P22): a sequence      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 121-x to 121; and    	     579 GRMVADMCRAAVKCCPEESLKLFVPHCCSVITQLTMNDDVLNDEELDKEL 628                                                          
						ending at any of amino acid numbers 183 + ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.5.An isolated polypeptide       	     712 LWNLQLLSEITRVDGRKLLLYREQLVKILQRTLHLTCKQGYTLSCNLLHH 761                                                          
						encoding for a tail of T10476_P22, comprising a polypeptide  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     629 LWNLQLLSEITRVDGRKLLLYREQLVKILQRTLHLTCKQGYTLSCNLLHH 678                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     762 LLRSTTLIYPTEYCSVPGGFDKPPSEYFPIKDWGKPGDLWNLGIQWHVPS 811                                                          
						KLPSSAGGAAHRKGNSYYST in T10476_P22.                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     679 LLRSTTLIYPTEYCSVPGGFDKPPSEYFPIKDWGKPGDLWNLGIQWHVPS 728                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     812 SEEVSFAFYLLDSFLQPELVKLQHCGDGKLEMSRDDILQSLTIVHNCLIG 861                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     729 SEEVSFAFYLLDSFLQPELVKLQHCGDGKLEMSRDDILQSLTIVHNCLIG 778                                                          
						                                                            	                  .                                          
						                                                            	     862 SGNLLPPLKGEPVTNL                                   877                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     779 SGNLLPPLKGEPVTNL                                   794                                                          

22008	HMR136_T10476_4_tr0_r1_1_gPRT		Comparison report between T10476_P4 and Q14997unique head    	Sequence name: Q14997                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10476_P4, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 22008 x Q14997   ..                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MQALLFLYR corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of T10476_P4, and a second amino acid sequence being at  	                                                            
						VPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKSLFLIIKIIGD 	                     Quality: 9892.00                      Escore:       0                                               
						LLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRALLIDRVMLQHELRTLTVEGCE 	             Matching length:    1004                Total length:    1004                                               
						YKKIHQDMIRDLLRLSTSSYSQVRNKAQQTFFAALGAYNFCCRDIIPLVLEFLRPDRQGV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TQQQFKGALYCLLGNHSGVCLANLHDWDCIVQTWPAIVSSGLSQAMSLEKPSIVRLFDDL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AEKIHRQYETIGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIKRQQEKNADA 	                        Gaps:       0                        
						LRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFFVENLNHDAIV 	                                                            
						VRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQIIAGDRPDNHWLHYDSKTIPRT 	Alignment:                                                   
						KKEWESSCFVEKTHWGYYTWPKNMVVYAGVEEQPKLGRSREDMTEAEQIIFDHFSDPKFV 	                  .         .         .         .         .  
						EQLITFLSLEDRKGKDKFNPRRFCLFKGIFRNFDDAFLPVLKPHLEHLVADSHESTQRCV 	      10 VPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKS 59                                                           
						AEIIAGLIRGSKHWTFEKVEKLWELLCPLLRTALSNITVETYNDWGACIATSCESRDPRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLHRLLKYLEPKLTQVYK 	     795 VPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKS 844                                                          
						NVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFTARILEKLKPLMDVDEEIQNHVMEEN 	                  .         .         .         .         .  
						GIGEEDERTQGIKLLKTILKWLMASAGRSFSTAVTEQLQLLPLFFKIAPVENDNSYDELK 	      60 LFLIIKIIGDLLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRAL 109                                                          
						RDAKLCLSLMSQGLLYPHQVPLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKTKLPKK 	     845 LFLIIKIIGDLLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRAL 894                                                          
						RKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIE 	                  .         .         .         .         .  
						MTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSPCYYA                 	     110 LIDRVMLQHELRTLTVEGCEYKKIHQDMIRDLLRLSTSSYSQVRNKAQQT 159                                                          
						least 90 % homologous to corresponding to amino acids 795 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1798 of Q14997, which also corresponds to amino acids 10 -   	     895 LIDRVMLQHELRTLTVEGCEYKKIHQDMIRDLLRLSTSSYSQVRNKAQQT 944                                                          
						1013 of T10476_P4, wherein said first amino acid sequence and	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     160 FFAALGAYNFCCRDIIPLVLEFLRPDRQGVTQQQFKGALYCLLGNHSGVC 209                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10476_P4, comprising a polypeptide being at least 70%,      	     945 FFAALGAYNFCCRDIIPLVLEFLRPDRQGVTQQQFKGALYCLLGNHSGVC 994                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     210 LANLHDWDCIVQTWPAIVSSGLSQAMSLEKPSIVRLFDDLAEKIHRQYET 259                                                          
						least about 95% homologous to the sequence MQALLFLYR of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10476_P4.                                                   	     995 LANLHDWDCIVQTWPAIVSSGLSQAMSLEKPSIVRLFDDLAEKIHRQYET 1044                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     260 IGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIKRQQEKNADA 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1045 IGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIKRQQEKNADA 1094                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     310 LRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFF 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1095 LRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFF 1144                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     360 VENLNHDAIVVRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQII 409                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1145 VENLNHDAIVVRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQII 1194                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     410 AGDRPDNHWLHYDSKTIPRTKKEWESSCFVEKTHWGYYTWPKNMVVYAGV 459                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1195 AGDRPDNHWLHYDSKTIPRTKKEWESSCFVEKTHWGYYTWPKNMVVYAGV 1244                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     460 EEQPKLGRSREDMTEAEQIIFDHFSDPKFVEQLITFLSLEDRKGKDKFNP 509                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1245 EEQPKLGRSREDMTEAEQIIFDHFSDPKFVEQLITFLSLEDRKGKDKFNP 1294                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     510 RRFCLFKGIFRNFDDAFLPVLKPHLEHLVADSHESTQRCVAEIIAGLIRG 559                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1295 RRFCLFKGIFRNFDDAFLPVLKPHLEHLVADSHESTQRCVAEIIAGLIRG 1344                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     560 SKHWTFEKVEKLWELLCPLLRTALSNITVETYNDWGACIATSCESRDPRK 609                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1345 SKHWTFEKVEKLWELLCPLLRTALSNITVETYNDWGACIATSCESRDPRK 1394                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     610 LHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLHRLLKY 659                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1395 LHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLHRLLKY 1444                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     660 LEPKLTQVYKNVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFTARILE 709                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1445 LEPKLTQVYKNVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFTARILE 1494                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     710 KLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWLMASAGRSF 759                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1495 KLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWLMASAGRSF 1544                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     760 STAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLLYPHQV 809                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1545 STAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLLYPHQV 1594                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     810 PLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVKDIRWL 859                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1595 PLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVKDIRWL 1644                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     860 VISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKTKLPKK 909                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1645 VISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKTKLPKK 1694                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     910 RKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMNLS 959                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1695 RKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMNLS 1744                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     960 AHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSP 1009                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1745 AHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSP 1794                                                         
						                                                            	                                                             
						                                                            	    1010 CYYA                                               1013                                                         
						                                                            	         ||||                                                
						                                                            	    1795 CYYA                                               1798                                                         

						Comparison report between T10476_P4 and AAH43602unique head  	Sequence name: AAH43602                                      
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for T10476_P4, comprising a    	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 22008 x AAH43602   ..                          
						90% and most preferably at least 95% homologous to a         	                                                            
						MQALLFLYRVPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKSL 	Alignment segment 1/1:                                       
						FLIIKIIGDLLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRALLIDRVMLQHEL 	                                                            
						RTLTVEGCEYKKIHQDMIRDLLRLSTSSYSQVRNKAQQTFFAALGAYNFCCRDIIPLVLE 	                     Quality: 4516.00                      Escore:       0                                               
						FLRPDRQGVTQQQFKGALYCLLGNHSGVCLANLHDWDCIVQTWPAIVSSGLSQAMSLEKP 	             Matching length:     459                Total length:     459                                               
						SIVRLFDDLAEKIHRQYETIGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.78                                               
						RQQEKNADALRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFFV 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.78                                               
						ENLNHDAIVVRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQIIAGDRPDNHWLH 	                        Gaps:       0                        
						YDSKTIPRTKKEWESSCFVEKTHWGYYTWPKNMVVYAGVEEQPKLGRSREDMTEAEQIIF 	                                                            
						DHFSDPKFVEQLITFLSLEDRKGKDKFNPRRFCLFKGIFRNFDDAFLPVLKPHLEHLVAD 	Alignment:                                                   
						SHESTQRCVAEIIA                                               	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     555 GLIRGSKHWTFEKVEKLWELLCPLLRTALSNITVETYNDWGACIATSCES 604                                                          
						1 - 554 of T10476_P4, a second amino acid sequence being at  	         ||||||||||||||||:|||||||||||||||||||||||||||||||||  
						least 90 % homologous to GLIRGSKHWTFEKVEK corresponding to   	       1 GLIRGSKHWTFEKVEKFWELLCPLLRTALSNITVETYNDWGACIATSCES 50                                                           
						amino acids 1 - 16 of AAH43602, which also corresponds to    	                  .         .         .         .         .  
						amino acids 555 - 570 of T10476_P4, a bridging amino acid L  	     605 RDPRKLHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLH 654                                                          
						corresponding to amino acid 571 of T10476_P4, and a third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WELLCPLLRTALSNITVETYNDWGACIATSCESRDPRKLHWLFELLLESPLSGEGGSFVD 	      51 RDPRKLHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLH 100                                                          
						ACRLYVLQGGLAQQEWRVPELLHRLLKYLEPKLTQVYKNVRERIGSVLTYIFMIDVSLPN 	                  .         .         .         .         .  
						TTPTISPHVPEFTARILEKLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWL 	     655 RLLKYLEPKLTQVYKNVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFT 704                                                          
						MASAGRSFSTAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLLYPHQVPL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEV 	     101 RLLKYLEPKLTQVYKNVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFT 150                                                          
						REMAATTLSGLLQCNFLTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHA 	                  .         .         .         .         .  
						GVLGLGACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHK 	     705 ARILEKLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWLMAS 754                                                          
						QQFTDDQLLVLTDLLVSPCYYA                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     151 ARILEKLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWLMAS 200                                                          
						corresponding to amino acids 18 - 459 of AAH43602, which also	                  .         .         .         .         .  
						corresponds to amino acids 572 - 1013 of T10476_P4, wherein  	     755 AGRSFSTAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLL 804                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid and third amino acid sequence are        	     201 AGRSFSTAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLL 250                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T10476_P4, comprising a   	     805 YPHQVPLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVK 854                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     251 YPHQVPLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVK 300                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MQALLFLYRVPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKSL 	     855 DIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKT 904                                                          
						FLIIKIIGDLLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRALLIDRVMLQHEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTLTVEGCEYKKIHQDMIRDLLRLSTSSYSQVRNKAQQTFFAALGAYNFCCRDIIPLVLE 	     301 DIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKT 350                                                          
						FLRPDRQGVTQQQFKGALYCLLGNHSGVCLANLHDWDCIVQTWPAIVSSGLSQAMSLEKP 	                  .         .         .         .         .  
						SIVRLFDDLAEKIHRQYETIGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIK 	     905 KLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQL 954                                                          
						RQQEKNADALRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENLNHDAIVVRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQIIAGDRPDNHWLH 	     351 KLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQL 400                                                          
						YDSKTIPRTKKEWESSCFVEKTHWGYYTWPKNMVVYAGVEEQPKLGRSREDMTEAEQIIF 	                  .         .         .         .         .  
						DHFSDPKFVEQLITFLSLEDRKGKDKFNPRRFCLFKGIFRNFDDAFLPVLKPHLEHLVAD 	     955 LMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTD 1004                                                         
						SHESTQRCVAEIIA                                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T10476_P4.                                	     401 LMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTD 450                                                          
						                                                            	                                                             
						                                                            	    1005 LLVSPCYYA                                          1013                                                         
						                                                            	         |||||||||                                           
						                                                            	     451 LLVSPCYYA                                          459                                                          

9241	HMR136_T10490_16_tr0_r1_1_gPRT		Comparison report between T10490_P16 and TD54_HUMANpartial   	Sequence name: TD54_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10490_P16, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MDSAGQDINLNSPNKGLLSDSMTDVPVDTGVAARTPAVEGLTEAEEEELRAELTK      	Alignment of: 9241 x TD54_HUMAN   ..                         
						corresponding to amino acids 1 - 55 of TD54_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 55 of T10490_P16, and a second	Alignment segment 1/1:                                       
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	                     Quality:  517.00                      Escore:       0                                               
						and most preferably at least 95% homologous to a polypeptide 	             Matching length:      55                Total length:      55                                               
						having the sequence ELCDLQVV corresponding to amino acids 56 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						- 63 of T10490_P16, wherein said first amino acid sequence   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						and second amino acid sequence are contiguous and in a       	                        Gaps:       0                        
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						tail of T10490_P16, comprising a polypeptide being at least  	Alignment:                                                   
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	       1 MDSAGQDINLNSPNKGLLSDSMTDVPVDTGVAARTPAVEGLTEAEEEELR 50                                                           
						at least about 95% homologous to the sequence ELCDLQVV in    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10490_P16.                                                  	       1 MDSAGQDINLNSPNKGLLSDSMTDVPVDTGVAARTPAVEGLTEAEEEELR 50                                                           
						                                                            	                                                             
						                                                            	      51 AELTK                                              55                                                           
						                                                            	         |||||                                               
						                                                            	      51 AELTK                                              55                                                           

105	HMR136_T10499_2_tr0_r1_1_gPRT		Comparison report between T10499_P2 and Q8WXZ8partial WT     	Sequence name: Q8WXZ8                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10499_P2, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MAKAGDKS corresponding to amino     	Alignment of: 105 x Q8WXZ8   ..                              
						acids 1 - 8 of Q8WXZ8, which also corresponds to amino acids 	                                                            
						1 - 8 of T10499_P2, a bridging amino acid G corresponding to 	Alignment segment 1/1:                                       
						amino acid 9 of T10499_P2, a second amino acid sequence being	                                                            
						SSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPPGFSISEIKNKQRRHLMFTR 	                     Quality: 1987.00                      Escore:       0                                               
						WKQQQRKEKLAAKKKLKKEREALGDKAPPKPVPKTIDNQRVYDETTVDPNDEEVAYDEAT 	             Matching length:     205                Total length:     205                                               
						DEFASYFNKQTSPKILITTSDRPHGRTVRLCEQLSTVIPNSHVYYRRGLALKKIIPQCIA 	 Matching Percent Similarity:   99.51   Matching Percent Identity:   99.51                                               
						RDFTDLIVINEDRKTP                                             	    Total Percent Similarity:   99.51      Total Percent Identity:   99.51                                               
						at least 90 % homologous to corresponding to amino acids 10 -	                        Gaps:       0                        
						205 of Q8WXZ8, which also corresponds to amino acids 10 - 205	                                                            
						of T10499_P2, and a third amino acid sequence being at least 	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       1 MAKAGDKSGSSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPP 50                                                           
						homologous to a polypeptide having the sequence              	         |||||||| |||||||||||||||||||||||||||||||||||||||||  
						SILFFFKEVFLSSP corresponding to amino acids 206 - 219 of     	       1 MAKAGDKSSSSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPP 50                                                           
						T10499_P2, wherein said first amino acid sequence, bridging  	                  .         .         .         .         .  
						amino acid, second amino acid sequence and third amino acid  	      51 GFSISEIKNKQRRHLMFTRWKQQQRKEKLAAKKKLKKEREALGDKAPPKP 100                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a tail of T10499_P2,       	      51 GFSISEIKNKQRRHLMFTRWKQQQRKEKLAAKKKLKKEREALGDKAPPKP 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     101 VPKTIDNQRVYDETTVDPNDEEVAYDEATDEFASYFNKQTSPKILITTSD 150                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence SILFFFKEVFLSSP in       	     101 VPKTIDNQRVYDETTVDPNDEEVAYDEATDEFASYFNKQTSPKILITTSD 150                                                          
						T10499_P2.                                                   	                  .         .         .         .         .  
						                                                            	     151 RPHGRTVRLCEQLSTVIPNSHVYYRRGLALKKIIPQCIARDFTDLIVINE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RPHGRTVRLCEQLSTVIPNSHVYYRRGLALKKIIPQCIARDFTDLIVINE 200                                                          
						                                                            	                                                             
						                                                            	     201 DRKTP                                              205                                                          
						                                                            	         |||||                                               
						                                                            	     201 DRKTP                                              205                                                          

						Comparison report between T10499_P2 and Q9H9Y2partial WT     	Sequence name: Q9H9Y2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10499_P2, comprising a first amino 	Sequence documentation:                                      
						MAKAGDKSGSSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPPGFSISEIKNK 	                                                            
						QRRHLMFTRWKQQQRKEKLAAKKKLKKEREALGDKAPPKPVPKTIDNQRVYDETTVDPND 	Alignment of: 105 x Q9H9Y2   ..                              
						EEVAYDEATDEFASYFNKQTSPKILITTSDRPHGRTVRLCEQLSTVIPNSHVYYRRGLAL 	                                                            
						KKIIPQCIARDFTDLIVINEDRKTP                                    	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 205 of Q9H9Y2, which also corresponds to  	                     Quality: 1998.00                      Escore:       0                                               
						amino acids 1 - 205 of T10499_P2, and a second amino acid    	             Matching length:     205                Total length:     205                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						having the sequence SILFFFKEVFLSSP corresponding to amino    	                                                            
						acids 206 - 219 of T10499_P2, wherein said first amino acid  	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MAKAGDKSGSSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPP 50                                                           
						tail of T10499_P2, comprising a polypeptide being at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MAKAGDKSGSSGKKSLKRKAAAEELQEAAGAGDGATENGVQPPKAAAFPP 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence SILFFFKEVFLSSP 	      51 GFSISEIKNKQRRHLMFTRWKQQQRKEKLAAKKKLKKEREALGDKAPPKP 100                                                          
						in T10499_P2.                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GFSISEIKNKQRRHLMFTRWKQQQRKEKLAAKKKLKKEREALGDKAPPKP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VPKTIDNQRVYDETTVDPNDEEVAYDEATDEFASYFNKQTSPKILITTSD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VPKTIDNQRVYDETTVDPNDEEVAYDEATDEFASYFNKQTSPKILITTSD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RPHGRTVRLCEQLSTVIPNSHVYYRRGLALKKIIPQCIARDFTDLIVINE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RPHGRTVRLCEQLSTVIPNSHVYYRRGLALKKIIPQCIARDFTDLIVINE 200                                                          
						                                                            	                                                             
						                                                            	     201 DRKTP                                              205                                                          
						                                                            	         |||||                                               
						                                                            	     201 DRKTP                                              205                                                          

214	HMR136_T10502_5_tr0_r1_1_gPRT		Comparison report between T10502_P5 and Q96AB6partial WT     	Sequence name: Q96AB6                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10502_P5, comprising a first amino 	Sequence documentation:                                      
						acid sequence being at least 90 % homologous to              	                                                            
						MPLLVEGRRVRLPQSAGDLVRAHPPLEERARLLR corresponding to amino    	Alignment of: 214 x Q96AB6   ..                              
						acids 1 - 34 of Q96AB6, which also corresponds to amino acids	                                                            
						1 - 34 of T10502_P5, and a second amino acid sequence being  	Alignment segment 1/1:                                       
						GSISILGSDDATTCHIVVLRHTGNGATCLTHCDGTDTKAEVPLIMNSIKSFSDHAQCGRL 	                                                            
						EVHLVGGFSDDRQLSQKLTHQLLSEFDRQEDDIHLVTLCVTELNDREENENHFPVIYGIA 	                     Quality: 2682.00                      Escore:       0                                               
						VNIKTAEIYRASFQDRGPEEQLRAARTLAGGPMISIYDAETEQLRIGPYSWTPFPHVDFW 	             Matching length:     283                Total length:     310                                               
						LHQDDKQILENLSTSPLAEPPHFVEHIRSTLMFLKKHPSPAHTLFSGNKALLYKKNEDGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WEKISSPGS                                                    	    Total Percent Similarity:   91.29      Total Percent Identity:   91.29                                               
						at least 90 % homologous to corresponding to amino acids 62 -	                        Gaps:       1                        
						310 of Q96AB6, which also corresponds to amino acids 35 - 283	                                                            
						of T10502_P5, wherein said first amino acid sequence and     	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated chimeric polypeptide encoding for an edge	       1 MPLLVEGRRVRLPQSAGDLVRAHPPLEERARLLR................ 34                                                           
						portion of T10502_P5, comprising a polypeptide having a      	         ||||||||||||||||||||||||||||||||||                  
						length "n", wherein n is at least about 10 amino acids in    	       1 MPLLVEGRRVRLPQSAGDLVRAHPPLEERARLLRGQSVQQVGPQGLLYVQ 50                                                           
						length, optionally at least about 20 amino acids in length,  	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      35 ...........GSISILGSDDATTCHIVVLRHTGNGATCLTHCDGTDTKA 73                                                           
						preferably at least about 40 amino acids in length and most  	                    |||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	      51 QRELAVTSPKDGSISILGSDDATTCHIVVLRHTGNGATCLTHCDGTDTKA 100                                                          
						at least two amino acids comprise RG, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	      74 EVPLIMNSIKSFSDHAQCGRLEVHLVGGFSDDRQLSQKLTHQLLSEFDRQ 123                                                          
						34-x to 35; and ending at any of amino acid numbers 35+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     101 EVPLIMNSIKSFSDHAQCGRLEVHLVGGFSDDRQLSQKLTHQLLSEFDRQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     124 EDDIHLVTLCVTELNDREENENHFPVIYGIAVNIKTAEIYRASFQDRGPE 173                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EDDIHLVTLCVTELNDREENENHFPVIYGIAVNIKTAEIYRASFQDRGPE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     174 EQLRAARTLAGGPMISIYDAETEQLRIGPYSWTPFPHVDFWLHQDDKQIL 223                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EQLRAARTLAGGPMISIYDAETEQLRIGPYSWTPFPHVDFWLHQDDKQIL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     224 ENLSTSPLAEPPHFVEHIRSTLMFLKKHPSPAHTLFSGNKALLYKKNEDG 273                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ENLSTSPLAEPPHFVEHIRSTLMFLKKHPSPAHTLFSGNKALLYKKNEDG 300                                                          
						                                                            	                  .                                          
						                                                            	     274 LWEKISSPGS                                         283                                                          
						                                                            	         ||||||||||                                          
						                                                            	     301 LWEKISSPGS                                         310                                                          

17110	HMR136_T10511_8_tr0_r1_1_gPRT		Comparison report between T10511_P8 and FBX3_HUMAN_V1partial 	Sequence name: FBX3_HUMAN_V1                                 
						WT sequence featuring skipped exon plus extra amino          	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						T10511_P8, comprising a first amino acid sequence being at   	                                                            
						least 90 % homologous to MAAMETETAPLTLESLPTDPLLLILSFLDYRDLI  	Alignment of: 17110 x FBX3_HUMAN_V1   ..                     
						corresponding to amino acids 1 - 34 of FBX3_HUMAN_V1, which  	                                                            
						also corresponds to amino acids 1 - 34 of T10511_P8, a second	Alignment segment 1/1:                                       
						amino acid sequence bridging amino acid sequence comprising  	                                                            
						of K, and a third amino acid sequence being at least 90 %    	                     Quality: 4269.00                      Escore:       0                                               
						EEKTQKNQCWKSLFIDTYSDVGRYIDHYAAIKKAWDDLKKYLEPRCPRMVLSLKEGAREE 	             Matching length:     441                Total length:     471                                               
						DLDAVEAQIGCKLPDDYRCSYRIHNGQKLVVPGLLGSMALSNHYRSEDLLDVDTAAGGFQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						QRQGLKYCLPLTFCIHTGLSQYIAVEAAEGRNKNEVFYQCPDQMARNPAAIDMFIIGATF 	    Total Percent Similarity:   93.63      Total Percent Identity:   93.42                                               
						TDWFTSYVKNVVSGGFPIIRDQIFRYVHDPECVATTGDITVSVSTSFLPELSSVHPPHYF 	                        Gaps:       1                        
						FTYRIRIEMSKDALPEKACQLDSRYWRITNAKGDVEEVQGPGVVGEFPIISPGRVYEYTS 	                                                            
						CTTFSTTSGYMEGYYTFHFLYFKDKIFNVAIPRFHMACPTFRVSIARLEMGPDEYEEMEE 	Alignment:                                                   
						EEEEEEEEDEDDDSADMDESDEDDEEERRRRVFDVPIRRRRCSRLF               	                  .         .         .         .         .  
						homologous to corresponding to amino acids 66 - 471 of       	       1 MAAMETETAPLTLESLPTDPLLLILSFLDYRDLI................ 34                                                           
						FBX3_HUMAN_V1, which also corresponds to amino acids 36 - 441	         ||||||||||||||||||||||||||||||||||                  
						of T10511_P8, wherein said first amino acid sequence, second 	       1 MAAMETETAPLTLESLPTDPLLLILSFLDYRDLINCCYVSRRLSQLSSHD 50                                                           
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      35 ..............KEEKTQKNQCWKSLFIDTYSDVGRYIDHYAAIKKAW 70                                                           
						polypeptide encoding for an edge portion of T10511_P8,       	                       :|||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	      51 PLWRRHCKKYWLISEEEKTQKNQCWKSLFIDTYSDVGRYIDHYAAIKKAW 100                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      71 DDLKKYLEPRCPRMVLSLKEGAREEDLDAVEAQIGCKLPDDYRCSYRIHN 120                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     101 DDLKKYLEPRCPRMVLSLKEGAREEDLDAVEAQIGCKLPDDYRCSYRIHN 150                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise IKE having a structure as follows (numbering        	     121 GQKLVVPGLLGSMALSNHYRSEDLLDVDTAAGGFQQRQGLKYCLPLTFCI 170                                                          
						according to T10511_P8): a sequence starting from any of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid numbers 34-x to 34; and ending at any of amino    	     151 GQKLVVPGLLGSMALSNHYRSEDLLDVDTAAGGFQQRQGLKYCLPLTFCI 200                                                          
						acid numbers 36 + ((n-2) - x), in which x varies from 0 to   	                  .         .         .         .         .  
						n-2.                                                         	     171 HTGLSQYIAVEAAEGRNKNEVFYQCPDQMARNPAAIDMFIIGATFTDWFT 220                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 HTGLSQYIAVEAAEGRNKNEVFYQCPDQMARNPAAIDMFIIGATFTDWFT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     221 SYVKNVVSGGFPIIRDQIFRYVHDPECVATTGDITVSVSTSFLPELSSVH 270                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SYVKNVVSGGFPIIRDQIFRYVHDPECVATTGDITVSVSTSFLPELSSVH 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     271 PPHYFFTYRIRIEMSKDALPEKACQLDSRYWRITNAKGDVEEVQGPGVVG 320                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PPHYFFTYRIRIEMSKDALPEKACQLDSRYWRITNAKGDVEEVQGPGVVG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     321 EFPIISPGRVYEYTSCTTFSTTSGYMEGYYTFHFLYFKDKIFNVAIPRFH 370                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EFPIISPGRVYEYTSCTTFSTTSGYMEGYYTFHFLYFKDKIFNVAIPRFH 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     371 MACPTFRVSIARLEMGPDEYEEMEEEEEEEEEEDEDDDSADMDESDEDDE 420                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MACPTFRVSIARLEMGPDEYEEMEEEEEEEEEEDEDDDSADMDESDEDDE 450                                                          
						                                                            	                  .         .                                
						                                                            	     421 EERRRRVFDVPIRRRRCSRLF                              441                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     451 EERRRRVFDVPIRRRRCSRLF                              471                                                          

17401	HMR136_T10512_10_tr0_r1_1_gPRT		Comparison report between T10512_P10 and Q9H710unique head   	Sequence name: Q9H710                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10512_P10, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17401 x Q9H710   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MWTLVGRGWGCARALAPRATGAALLVAPGPRSAPTLGAAPESWATDRLYSSAEFKEKLDM 	Alignment segment 1/1:                                       
						SRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVKA 	                                                            
						QTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANFF 	                     Quality: 2342.00                      Escore:       0                                               
						LAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAII 	             Matching length:     244                Total length:     244                                               
						ERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						GVLNPNEQPTHKL                                                	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 313 of T10512_P10, a second amino acid    	                                                            
						LGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQFP 	Alignment:                                                   
						DKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFIDQNRVMLKYLFPLNEI 	                  .         .         .         .         .  
						VVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMDILLNGNTVEELVTVVHKDKAHSIGKA 	     314 LGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKE 363                                                          
						ICERLKDSLPRQLFEIAIQAAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKKK                                                         	      47 LGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKE 96                                                           
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 47 - 290 of Q9H710, which also corresponds to    	     364 ITIINPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKN 413                                                          
						amino acids 314 - 557 of T10512_P10, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      97 ITIINPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKN 146                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     414 MIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAEL 463                                                          
						having the sequence LRKIGNVEVPKDAFIKVLKTQSSK corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 558 - 581 of T10512_P10, wherein said first amino	     147 MIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAEL 196                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	     464 VKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQA 513                                                          
						isolated polypeptide encoding for a head of T10512_P10,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     197 VKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQA 246                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .            
						preferably at least about 90% and most preferably at least   	     514 AIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKK       557                                                          
						MWTLVGRGWGCARALAPRATGAALLVAPGPRSAPTLGAAPESWATDRLYSSAEFKEKLDM 	         ||||||||||||||||||||||||||||||||||||||||||||        
						SRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVKA 	     247 AIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKK       290                                                          
						QTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANFF 	                                                            
						LAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAII 	                                                            
						ERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEV 	                                                            
						GVLNPNEQPTHKL                                                	                                                            
						about 95% homologous to the sequence of T10512_P10.3.An      	                                                            
						isolated polypeptide encoding for a tail of T10512_P10,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence LRKIGNVEVPKDAFIKVLKTQSSK	                                                            
						in T10512_P10.                                               	                                                            

						Comparison report between T10512_P10 and Q8N442partial WT    	Sequence name: Q8N442                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10512_P10, comprising a first amino	Sequence documentation:                                      
						MWTLVGRGWGCARALAPRATGAALLVAPGPRSAPTLGAAPESWATDRLYSSAEFKEKLDM 	                                                            
						SRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVKA 	Alignment of: 17401 x Q8N442   ..                            
						QTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANFF 	                                                            
						LAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAII 	Alignment segment 1/1:                                       
						ERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEV 	                                                            
						GVLNPNEQPTHKL                                                	                     Quality: 5474.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     581                Total length:     669                                               
						to amino acids 1 - 313 of Q8N442, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 313 of T10512_P10, and a second amino acid   	    Total Percent Similarity:   86.85      Total Percent Identity:   86.85                                               
						LGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQFP 	                        Gaps:       1                        
						DKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFIDQNRVMLKYLFPLNEI 	                                                            
						VVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMDILLNGNTVEELVTVVHKDKAHSIGKA 	Alignment:                                                   
						ICERLKDSLPRQLFEIAIQAAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAE 	                  .         .         .         .         .  
						GKKKLRKIGNVEVPKDAFIKVLKTQSSK                                 	       1 MWTLVGRGWGCARALAPRATGAALLVAPGPRSAPTLGAAPESWATDRLYS 50                                                           
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 402 - 669 of Q8N442, which also corresponds to   	       1 MWTLVGRGWGCARALAPRATGAALLVAPGPRSAPTLGAAPESWATDRLYS 50                                                           
						amino acids 314 - 581 of T10512_P10, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      51 SAEFKEKLDMSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKN 100                                                          
						and in a sequential order.2.An isolated chimeric polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of T10512_P10, comprising a     	      51 SAEFKEKLDMSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKN 100                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     101 NKQVLDKLQVERERGITVKAQTASLFYNCEGKQYLLNLIDTPGHVDFSYE 150                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     101 NKQVLDKLQVERERGITVKAQTASLFYNCEGKQYLLNLIDTPGHVDFSYE 150                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .         .         .  
						length, wherein at least two amino acids comprise LL, having 	     151 VSRSLSACQGVLLVVDANEGIQAQTVANFFLAFEAQLSVIPVINKIDLKN 200                                                          
						a structure as follows: a sequence starting from any of amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 313-x to 314; and ending at any of amino acid   	     151 VSRSLSACQGVLLVVDANEGIQAQTVANFFLAFEAQLSVIPVINKIDLKN 200                                                          
						numbers 314+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     201 ADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAIIERIPPPKVHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAIIERIPPPKVHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GVLNPNEQPTHKL..................................... 313                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     301 GVLNPNEQPTHKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGF 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     313 .................................................. 313                                                          
						                                                            	                                                            
						                                                            	     351 KSAKPMVFAGMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGW 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 .LGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREK 362                                                          
						                                                            	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 RLGFLGLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     363 EITIINPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQK 412                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EITIINPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQK 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     413 NMIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAE 462                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NMIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAE 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     463 LVKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQ 512                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LVKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     513 AAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKKLRKIG 562                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKKLRKIG 650                                                          
						                                                            	                  .                                          
						                                                            	     563 NVEVPKDAFIKVLKTQSSK                                581                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     651 NVEVPKDAFIKVLKTQSSK                                669                                                          

17403	HMR136_T10512_3_tr0_r1_1_gPRT		Comparison report between T10512_P3 and Q9H710unique head    	Sequence name: Q9H710                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10512_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17403 x Q9H710   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVK 	Alignment segment 1/1:                                       
						AQTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANF 	                                                            
						FLAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAI 	                     Quality: 2788.00                      Escore:       0                                               
						IERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNE 	             Matching length:     290                Total length:     290                                               
						VGVLNPNEQPTHKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGFKSAKP     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 1 - 296 of T10512_P3, a second amino acid     	                        Gaps:       0                        
						MVFAGMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFLGLLHMEVFNQ 	                                                            
						RLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQFPDKSKVTEYLEPVVL 	Alignment:                                                   
						GTIITPDEYTGKIMMLCEARRAVQKNMIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSG 	                  .         .         .         .         .  
						YASFDYEDAGYQTAELVKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLF 	     297 MVFAGMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFL 346                                                          
						EIAIQAAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKK           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MVFAGMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFL 50                                                           
						amino acids 1 - 290 of Q9H710, which also corresponds to     	                  .         .         .         .         .  
						amino acids 297 - 586 of T10512_P3, and a third amino acid   	     347 GLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITII 396                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 GLLHMEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITII 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence LRKIGNVEVPKDAFIKVLKTQSSK corresponding to	     397 NPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFI 446                                                          
						amino acids 587 - 610 of T10512_P3, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	     101 NPAQFPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFI 150                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T10512_P3,       	     447 DQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMD 496                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 DQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMD 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVK 	     497 ILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQAAIGS 546                                                          
						AQTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAI 	     201 ILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQAAIGS 250                                                          
						IERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNE 	                  .         .         .         .            
						VGVLNPNEQPTHKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGFKSAKP     	     547 KIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKK           586                                                          
						about 95% homologous to the sequence of T10512_P3.3.An       	         ||||||||||||||||||||||||||||||||||||||||            
						isolated polypeptide encoding for a tail of T10512_P3,       	     251 KIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKK           290                                                          
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence LRKIGNVEVPKDAFIKVLKTQSSK	                                                            
						in T10512_P3.                                                	                                                            

						Comparison report between T10512_P3 and Q8N442partial WT     	Sequence name: Q8N442                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10512_P3, comprising a first amino acid        	                                                            
						MSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQVERERGITVK 	Alignment of: 17403 x Q8N442   ..                            
						AQTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQGVLLVVDANEGIQAQTVANF 	                                                            
						FLAFEAQLSVIPVINKIDLKNADPERVENQIEKVFDIPSDECIKISAKLGTNVESVLQAI 	Alignment segment 1/1:                                       
						IERIPPPKVHRKNPLRALVFDSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNE 	                                                            
						VGVLNPNEQPTHKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGFKSAKPMVFA 	                     Quality: 5857.00                      Escore:       0                                               
						GMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFLGLLHMEVFNQRLEQ 	             Matching length:     610                Total length:     610                                               
						EYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQFPDKSKVTEYLEPVVLGTII 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TPDEYTGKIMMLCEARRAVQKNMIFIDQNRVMLKYLFPLNEIVVDFYDSLKSLSSGYASF 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DYEDAGYQTAELVKMDILLNGNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAI 	                        Gaps:       0                        
						QAAIGSKIIARETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKKLRKIGNVEVPKDAF 	                                                            
						IKVLKTQSSK                                                   	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 60 - 669 of Q8N442, which also corresponds to    	       1 MSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQ 50                                                           
						amino acids 1 - 610 of T10512_P3.                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      60 MSRFPVENIRNFSIVAHVDHGKSTLADRLLELTGTIDKTKNNKQVLDKLQ 109                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VERERGITVKAQTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     110 VERERGITVKAQTASLFYNCEGKQYLLNLIDTPGHVDFSYEVSRSLSACQ 159                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GVLLVVDANEGIQAQTVANFFLAFEAQLSVIPVINKIDLKNADPERVENQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     160 GVLLVVDANEGIQAQTVANFFLAFEAQLSVIPVINKIDLKNADPERVENQ 209                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IEKVFDIPSDECIKISAKLGTNVESVLQAIIERIPPPKVHRKNPLRALVF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     210 IEKVFDIPSDECIKISAKLGTNVESVLQAIIERIPPPKVHRKNPLRALVF 259                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEVGVLNPNEQP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     260 DSTFDQYRGVIANVALFDGVVSKGDKIVSAHTQKTYEVNEVGVLNPNEQP 309                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 THKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGFKSAKPMVFA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     310 THKLYAGQVGYLIAGMKDVTEAQIGDTLCLHKQPVEPLPGFKSAKPMVFA 359                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFLGLLH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     360 GMYPLDQSEYNNLKSAIEKLTLNDSSVTVHRDSSLALGAGWRLGFLGLLH 409                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 MEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     410 MEVFNQRLEQEYNASVILTTPTVPYKAVLSSSKLIKEHREKEITIINPAQ 459                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 FPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFIDQNR 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     460 FPDKSKVTEYLEPVVLGTIITPDEYTGKIMMLCEARRAVQKNMIFIDQNR 509                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMDILLN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     510 VMLKYLFPLNEIVVDFYDSLKSLSSGYASFDYEDAGYQTAELVKMDILLN 559                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 GNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQAAIGSKIIA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     560 GNTVEELVTVVHKDKAHSIGKAICERLKDSLPRQLFEIAIQAAIGSKIIA 609                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 RETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKKLRKIGNVEVPKDAF 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     610 RETVKAYRKNVLAKCYGGDITRKMKLLKRQAEGKKKLRKIGNVEVPKDAF 659                                                          
						                                                            	                  .                                          
						                                                            	     601 IKVLKTQSSK                                         610                                                          
						                                                            	         ||||||||||                                          
						                                                            	     660 IKVLKTQSSK                                         669                                                          

17679	HMR136_T10522_19_tr0_r1_1_gPRT		Comparison report between T10522_P19 and DPSD_HUMANshort     	Sequence name: DPSD_HUMAN                                    
						unique head followed by partial WT sequence featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						T10522_P19, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17679 x DPSD_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of T10522_P19, a second   	                                                            
						VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVEDLHHYRNLSE 	                     Quality: 2930.00                      Escore:       0                                               
						FFRRKLKPQARPVCGLHSV                                          	             Matching length:     302                Total length:     361                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 108 - 186 of DPSD_HUMAN, which  	    Total Percent Similarity:   83.66      Total Percent Identity:   83.66                                               
						also corresponds to amino acids 2 - 80 of T10522_P19, and a  	                        Gaps:       1                        
						ISPSDGRILNFGQVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTR 	                                                            
						EGNELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKELFCHNERVV 	Alignment:                                                   
						LTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGSYNDFSFVTHTNREGVPMR 	                  .         .         .         .         .  
						KGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQKIRFGEALGSL                  	       2 VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVE 51                                                           
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 246 - 468 of DPSD_HUMAN, which  	     108 VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVE 157                                                          
						also corresponds to amino acids 81 - 303 of T10522_P19,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      52 DLHHYRNLSEFFRRKLKPQARPVCGLHSV..................... 80                                                           
						sequence and third amino acid sequence are contiguous and in 	         |||||||||||||||||||||||||||||                       
						a sequential order.2.An isolated chimeric polypeptide        	     158 DLHHYRNLSEFFRRKLKPQARPVCGLHSVVRPDPFLLQETGLFPASPAQP 207                                                          
						encoding for an edge portion of T10522_P19, comprising a     	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	      81 ......................................ISPSDGRILNFG 92                                                           
						10 amino acids in length, optionally at least about 20 amino 	                                               ||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     208 PWSPAYLEGAGMTRGGGGCLLGGGDPALPGSKPLLPFQISPSDGRILNFG 257                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      93 QVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTREG 142                                                          
						length, wherein at least two amino acids comprise VI, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     258 QVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTREG 307                                                          
						acid numbers 80-x to 81; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 81+ ((n-2) - x), in which x varies from 0 to n-2.    	     143 NELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKEL 192                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     308 NELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKEL 357                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     193 FCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGS 242                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 FCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGS 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     243 YNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQ 292                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 YNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQ 457                                                          
						                                                            	                  .                                          
						                                                            	     293 KIRFGEALGSL                                        303                                                          
						                                                            	         |||||||||||                                         
						                                                            	     458 KIRFGEALGSL                                        468                                                          

17677	HMR136_T10522_25_tr0_r1_1_gPRT		Comparison report between T10522_P25 and DPSD_HUMANshort     	Sequence name: DPSD_HUMAN                                    
						unique head followed by partial WT sequence featuring a      	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						T10522_P25, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 17677 x DPSD_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of T10522_P25, a second   	                                                            
						VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVEDLHHYRNLSE 	                     Quality: 2790.00                      Escore:       0                                               
						FFRRK                                                        	             Matching length:     288                Total length:     361                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 108 - 172 of DPSD_HUMAN, which  	    Total Percent Similarity:   79.78      Total Percent Identity:   79.78                                               
						also corresponds to amino acids 2 - 66 of T10522_P25, and a  	                        Gaps:       1                        
						ISPSDGRILNFGQVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTR 	                                                            
						EGNELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKELFCHNERVV 	Alignment:                                                   
						LTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGSYNDFSFVTHTNREGVPMR 	                  .         .         .         .         .  
						KGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQKIRFGEALGSL                  	       2 VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVE 51                                                           
						third amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 246 - 468 of DPSD_HUMAN, which  	     108 VALYKSVPTRLLSRAWGRLNQVELPHWLRRPVYSLYIWTFGVNMKEAAVE 157                                                          
						also corresponds to amino acids 67 - 289 of T10522_P25,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      52 DLHHYRNLSEFFRRK................................... 66                                                           
						sequence and third amino acid sequence are contiguous and in 	         |||||||||||||||                                     
						a sequential order.2.An isolated chimeric polypeptide        	     158 DLHHYRNLSEFFRRKLKPQARPVCGLHSVVRPDPFLLQETGLFPASPAQP 207                                                          
						encoding for an edge portion of T10522_P25, comprising a     	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	      67 ......................................ISPSDGRILNFG 78                                                           
						10 amino acids in length, optionally at least about 20 amino 	                                               ||||||||||||  
						acids in length, preferably at least about 30 amino acids in 	     208 PWSPAYLEGAGMTRGGGGCLLGGGDPALPGSKPLLPFQISPSDGRILNFG 257                                                          
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      79 QVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTREG 128                                                          
						length, wherein at least two amino acids comprise KI, having 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	     258 QVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTREG 307                                                          
						acid numbers 66-x to 67; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 67+ ((n-2) - x), in which x varies from 0 to n-2.    	     129 NELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKEL 178                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     308 NELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKEL 357                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     179 FCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGS 228                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     358 FCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGS 407                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     229 YNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQ 278                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 YNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQ 457                                                          
						                                                            	                  .                                          
						                                                            	     279 KIRFGEALGSL                                        289                                                          
						                                                            	         |||||||||||                                         
						                                                            	     458 KIRFGEALGSL                                        468                                                          

17675	HMR136_T10522_26_tr0_r1_1_gPRT		Comparison report between T10522_P26 and DPSD_HUMANshort     	Sequence name: DPSD_HUMAN                                    
						unique head followed by partial WT sequence1.An isolated     	                                                            
						chimeric polypeptide encoding for T10522_P26, comprising a   	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 17675 x DPSD_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence M corresponding to amino     	Alignment segment 1/1:                                       
						acids 1 - 1 of T10522_P26, and a second amino acid sequence  	                                                            
						ISPSDGRILNFGQVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASCDSFKNQLVTR 	                     Quality: 2235.00                      Escore:       0                                               
						EGNELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMSVNPGMARWIKELFCHNERVV 	             Matching length:     223                Total length:     223                                               
						LTGDWKHGFFSLTAVGATNVGSIRIYFDRDLHTNSPRHSKGSYNDFSFVTHTNREGVPMR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KGEHLGEFNLGSTIVLIFEAPKDFNFQLKTGQKIRFGEALGSL                  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       0                        
						acids 246 - 468 of DPSD_HUMAN, which also corresponds to     	                                                            
						amino acids 2 - 224 of T10522_P26, wherein said first amino  	Alignment:                                                   
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.                                   	       2 ISPSDGRILNFGQVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASC 51                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     246 ISPSDGRILNFGQVKNCEVEQVKGVTYSLESFLGPRMCTEDLPFPPAASC 295                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      52 DSFKNQLVTREGNELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMS 101                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     296 DSFKNQLVTREGNELYHCVIYLAPGDYHCFHSPTDWTVSHRRHFPGSLMS 345                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     102 VNPGMARWIKELFCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRD 151                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     346 VNPGMARWIKELFCHNERVVLTGDWKHGFFSLTAVGATNVGSIRIYFDRD 395                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     152 LHTNSPRHSKGSYNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEA 201                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     396 LHTNSPRHSKGSYNDFSFVTHTNREGVPMRKGEHLGEFNLGSTIVLIFEA 445                                                          
						                                                            	                  .         .                                
						                                                            	     202 PKDFNFQLKTGQKIRFGEALGSL                            224                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     446 PKDFNFQLKTGQKIRFGEALGSL                            468                                                          

17875	HMR136_T10525_8_tr0_r1_1_gPRT		Comparison report between T10525_P8 and CT45_HUMANpartial WT 	Sequence name: CT45_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10525_P8, comprising a first amino acid        	                                                            
						MELKSTNISFTNMVSVDERLIYKPHPQDPEKTVLTQEAIITVKGVSLSSYLEGLMASTIS 	Alignment of: 17875 x CT45_HUMAN   ..                        
						SNASKGREAMEWVIHKLNAEIEELTASARGTIRTPMAAAAFAEK                 	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 91 - 194 of CT45_HUMAN, which also corresponds to	                                                            
						amino acids 1 - 104 of T10525_P8.                            	                     Quality:  991.00                      Escore:       0                                               
						                                                            	             Matching length:     104                Total length:     104                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MELKSTNISFTNMVSVDERLIYKPHPQDPEKTVLTQEAIITVKGVSLSSY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      91 MELKSTNISFTNMVSVDERLIYKPHPQDPEKTVLTQEAIITVKGVSLSSY 140                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LEGLMASTISSNASKGREAMEWVIHKLNAEIEELTASARGTIRTPMAAAA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     141 LEGLMASTISSNASKGREAMEWVIHKLNAEIEELTASARGTIRTPMAAAA 190                                                          
						                                                            	                                                             
						                                                            	     101 FAEK                                               104                                                          
						                                                            	         ||||                                                
						                                                            	     191 FAEK                                               194                                                          

18301	HMR136_T10535_2_tr0_r1_1_gPRT		Comparison report between T10535_P2 and NFL2_HUMANpartial WT 	Sequence name: NFL2_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10535_P2, comprising a first amino 	Sequence documentation:                                      
						MDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQ 	                                                            
						LQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQ 	Alignment of: 18301 x NFL2_HUMAN   ..                        
						LLAQTFPFVDDNE                                                	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 2 - 134 of NFL2_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 133 of T10535_P2, and a second amino acid 	                     Quality: 5768.00                      Escore:       0                                               
						SLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLN 	             Matching length:     597                Total length:     604                                               
						IENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSD 	    Total Percent Similarity:   98.84      Total Percent Identity:   98.84                                               
						LSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEEL 	                        Gaps:       1                        
						DSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPF 	                                                            
						TKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDI 	Alignment:                                                   
						RRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLY 	                  .         .         .         .         .  
						LEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN                 	       1 MDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQ 50                                                           
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 142 - 605 of NFL2_HUMAN, which also corresponds  	       2 MDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQ 51                                                           
						to amino acids 134 - 597 of T10535_P2, wherein said first    	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	      51 KKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSAN 100                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of T10535_P2,       	      52 KKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSAN 101                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     101 YSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNE.......SLVPDIPGHI 143                                                          
						about 20 amino acids in length, preferably at least about 30 	         |||||||||||||||||||||||||||||||||       ||||||||||  
						amino acids in length, more preferably at least about 40     	     102 YSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHI 151                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     144 ESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLN 193                                                          
						comprise ES, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 133-x to 134; and    	     152 ESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLN 201                                                          
						ending at any of amino acid numbers 134+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     194 IENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFE 243                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 IENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFE 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 DSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPS 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 DSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPS 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 PATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTS 343                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 PATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTS 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     344 PSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSG 393                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 PSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSG 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     394 DMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLE 443                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 DMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLE 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 AHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDI 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 AHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDI 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     494 RRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLH 543                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 RRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLH 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     544 LLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPD 593                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 LLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPD 601                                                          
						                                                            	                                                             
						                                                            	     594 VKKN                                               597                                                          
						                                                            	         ||||                                                
						                                                            	     602 VKKN                                               605                                                          

19038	HMR136_T10540_1_tr0_r1_1_gPRT		Comparison report between T10540_P1 and RBPL_HUMANpartial WT 	Sequence name: RBPL_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10540_P1, comprising a first amino 	Sequence documentation:                                      
						MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHTTILRGGVRRC 	                                                            
						LQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPGWRVKPGQDQAHQAGETGPTV 	Alignment of: 19038 x RBPL_HUMAN   ..                        
						CGYMGLDSASGSATETQKLNFEQQPDSREFGCAKTLYISDADKRKHFRLVLRLVLRGGRE 	                                                            
						LGTFHSRLIK                                                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 190 of RBPL_HUMAN, which also corresponds 	                     Quality: 1906.00                      Escore:       0                                               
						to amino acids 1 - 190 of T10540_P1, and a second amino acid 	             Matching length:     201                Total length:     201                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:   97.01   Matching Percent Identity:   96.02                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   97.01      Total Percent Identity:   96.02                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						CAYPPAQRSPSSTACALRRSPHATSLWRMGPLWPVHDSGLPSRSTWLMGTLPKETSHRER 	                                                            
						ATFAMAPWCSSSARSPASHYLP                                       	Alignment:                                                   
						having the sequence corresponding to amino acids 191 - 272 of	                  .         .         .         .         .  
						T10540_P1, wherein said first amino acid sequence and second 	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						T10540_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CAYPPAQRSPSSTACALRRSPHATSLWRMGPLWPVHDSGLPSRSTWLMGTLPKETSHRER 	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						ATFAMAPWCSSSARSPASHYLP                                       	                  .         .         .         .         .  
						least about 95% homologous to the sequence in T10540_P1.     	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSREF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSREF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GCAKTLYISDADKRKHFRLVLRLVLRGGRELGTFHSRLIKCAYPPAQRSP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||    |:|:    
						                                                            	     151 GCAKTLYISDADKRKHFRLVLRLVLRGGRELGTFHSRLIKVISKPSQKKQ 200                                                          
						                                                            	                                                             
						                                                            	     201 S                                                  201                                                          
						                                                            	         |                                                   
						                                                            	     201 S                                                  201                                                          

19036	HMR136_T10540_4_tr0_r1_1_gPRT		Comparison report between T10540_P4 and RBPL_HUMANpartial WT 	Sequence name: RBPL_HUMAN                                    
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for T10540_P4, comprising a first amino 	Sequence documentation:                                      
						MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQFQASPCPKEA 	                                                            
						NRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLISTLELSGGGDVATLELHGEN 	Alignment of: 19036 x RBPL_HUMAN   ..                        
						FHAGLKVWFGDVEAETMY                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 289 - 426 of RBPL_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 138 of T10540_P4, a second    	                     Quality: 2150.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     228                Total length:     229                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   99.56      Total Percent Identity:   99.56                                               
						having the sequence R corresponding to amino acids 139 - 139 	                        Gaps:       1                        
						of T10540_P4, and a third amino acid sequence being at least 	                                                            
						SPRSLVCVVPDVAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPG 	Alignment:                                                   
						VPEPATDADALLESIHQEFTRTNFHLFIQT                               	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 427 - 516 of 	       1 MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQ 50                                                           
						RBPL_HUMAN, which also corresponds to amino acids 140 - 229  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T10540_P4, wherein said first amino acid sequence, second 	     289 MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQ 338                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 FQASPCPKEANRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLI 100                                                          
						polypeptide encoding for an edge portion of T10540_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     339 FQASPCPKEANRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLI 388                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 STLELSGGGDVATLELHGENFHAGLKVWFGDVEAETMYRSPRSLVCVVPD 150                                                          
						least about 95% homologous to the sequence encoding for R,   	         |||||||||||||||||||||||||||||||||||||| |||||||||||  
						corresponding to T10540_P4.                                  	     389 STLELSGGGDVATLELHGENFHAGLKVWFGDVEAETMY.SPRSLVCVVPD 437                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPGV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     438 VAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPGV 487                                                          
						                                                            	                  .         .                                
						                                                            	     201 PEPATDADALLESIHQEFTRTNFHLFIQT                      229                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     488 PEPATDADALLESIHQEFTRTNFHLFIQT                      516                                                          

19034	HMR136_T10540_5_tr0_r1_1_gPRT		Comparison report between T10540_P5 and RBPL_HUMANpartial WT 	Sequence name: RBPL_HUMAN                                    
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for T10540_P5, comprising a first amino 	Sequence documentation:                                      
						MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQFQASPCPKEA 	                                                            
						NRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLISTLELSGGGDVATLELHGEN 	Alignment of: 19034 x RBPL_HUMAN   ..                        
						FHAGLKVWFGDVEAETMY                                           	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 289 - 426 of RBPL_HUMAN, which also           	                                                            
						corresponds to amino acids 1 - 138 of T10540_P5, a second    	                     Quality: 2150.00                      Escore:       0                                               
						amino acid sequence being at least 70%, optionally at least  	             Matching length:     228                Total length:     229                                               
						80%, preferably at least 85%, more preferably at least 90%   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						and most preferably at least 95% homologous to a polypeptide 	    Total Percent Similarity:   99.56      Total Percent Identity:   99.56                                               
						having the sequence R corresponding to amino acids 139 - 139 	                        Gaps:       1                        
						of T10540_P5, and a third amino acid sequence being at least 	                                                            
						SPRSLVCVVPDVAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPG 	Alignment:                                                   
						VPEPATDADALLESIHQEFTRTNFHLFIQT                               	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 427 - 516 of 	       1 MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQ 50                                                           
						RBPL_HUMAN, which also corresponds to amino acids 140 - 229  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of T10540_P5, wherein said first amino acid sequence, second 	     289 MIIRKVAKQCALLDVDEPISQLHKCAFQFPGSPPGGGGTYLCLATEKVVQ 338                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      51 FQASPCPKEANRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLI 100                                                          
						polypeptide encoding for an edge portion of T10540_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     339 FQASPCPKEANRALLNDSSCWTIIGTESVEFSFSTSLACTLEPVTPVPLI 388                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     101 STLELSGGGDVATLELHGENFHAGLKVWFGDVEAETMYRSPRSLVCVVPD 150                                                          
						least about 95% homologous to the sequence encoding for R,   	         |||||||||||||||||||||||||||||||||||||| |||||||||||  
						corresponding to T10540_P5.                                  	     389 STLELSGGGDVATLELHGENFHAGLKVWFGDVEAETMY.SPRSLVCVVPD 437                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPGV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     438 VAAFCSDWRWLRAPITIPMSLVRADGLFYPSAFSFTYTPEYSVRPGHPGV 487                                                          
						                                                            	                  .         .                                
						                                                            	     201 PEPATDADALLESIHQEFTRTNFHLFIQT                      229                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     488 PEPATDADALLESIHQEFTRTNFHLFIQT                      516                                                          

19040	HMR136_T10540_6_tr0_r1_1_gPRT		Comparison report between T10540_P6 and RBPL_HUMANpartial WT 	Sequence name: RBPL_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10540_P6, comprising a first amino 	Sequence documentation:                                      
						MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHTTILRGGVRRC 	                                                            
						LQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPGWRVKPGQDQAHQAGETGPTV 	Alignment of: 19040 x RBPL_HUMAN   ..                        
						CGYMGLDSASGSATETQKLNFEQQPDSR                                 	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 148 of RBPL_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 148 of T10540_P6, and a second amino acid 	                     Quality: 1490.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     148                Total length:     148                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VRAHGKGSDSCSHPCLSWERRAPLLPSESQEIGGETGRPGSCLKAEPESLDGGASGHLRR 	                        Gaps:       0                        
						GGRPISGRGWFIRRGRAGMRWPCTCEPPRNSAAPRPCTSQMQTRGSTFGWCCGWCCAGAG 	                                                            
						SWVPSTAALSRSSRSPRRRSSR                                       	Alignment:                                                   
						having the sequence corresponding to amino acids 149 - 290 of	                  .         .         .         .         .  
						T10540_P6, wherein said first amino acid sequence and second 	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						T10540_P6, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRAHGKGSDSCSHPCLSWERRAPLLPSESQEIGGETGRPGSCLKAEPESLDGGASGHLRR 	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						GGRPISGRGWFIRRGRAGMRWPCTCEPPRNSAAPRPCTSQMQTRGSTFGWCCGWCCAGAG 	                  .         .         .         .            
						SWVPSTAALSRSSRSPRRRSSR                                       	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSR   148                                                          
						least about 95% homologous to the sequence in T10540_P6.     	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSR   148                                                          

19032	HMR136_T10540_7_tr0_r1_1_gPRT		Comparison report between T10540_P7 and RBPL_HUMANpartial WT 	Sequence name: RBPL_HUMAN                                    
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10540_P7, comprising a first amino 	Sequence documentation:                                      
						MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHTTILRGGVRRC 	                                                            
						LQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPGWRVKPGQDQAHQAGETGPTV 	Alignment of: 19032 x RBPL_HUMAN   ..                        
						CGYMGLDSASGSATETQKLNFEQQPDSR                                 	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 148 of RBPL_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 148 of T10540_P7, and a second amino acid 	                     Quality: 1490.00                      Escore:       0                                               
						sequence being at least 70%, optionally at least 80%,        	             Matching length:     148                Total length:     148                                               
						preferably at least 85%, more preferably at least 90% and    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VRAHGKGSDSCSHPCLSWERRAPLLPSESQEIGGETGRPGSCLKAEPESLDGGASGHLRR 	                        Gaps:       0                        
						GGRPISGRGWFIRRGRAGMRWPCTCEPPRNSAAPRPCTSQMQTRGSTFGWCCGWCCAGAG 	                                                            
						SWVPSTAALSRSSRSPRRRSSR                                       	Alignment:                                                   
						having the sequence corresponding to amino acids 149 - 290 of	                  .         .         .         .         .  
						T10540_P7, wherein said first amino acid sequence and second 	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDPAGAADPSVPPNPLTHLSLQDRSEMQLQSEADRRSLPGTWTRSSPEHT 50                                                           
						T10540_P7, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VRAHGKGSDSCSHPCLSWERRAPLLPSESQEIGGETGRPGSCLKAEPESLDGGASGHLRR 	      51 TILRGGVRRCLQQQCEQTVRILHAKVAQKSYGNEKRFFCPPPCVYLSGPG 100                                                          
						GGRPISGRGWFIRRGRAGMRWPCTCEPPRNSAAPRPCTSQMQTRGSTFGWCCGWCCAGAG 	                  .         .         .         .            
						SWVPSTAALSRSSRSPRRRSSR                                       	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSR   148                                                          
						least about 95% homologous to the sequence in T10540_P7.     	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     101 WRVKPGQDQAHQAGETGPTVCGYMGLDSASGSATETQKLNFEQQPDSR   148                                                          

19263	HMR136_T10545_2_tr0_r1_1_gPRT		Comparison report between T10545_P2 and Q9H600partial WT     	Sequence name: Q9H600                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10545_P2, comprising a first amino 	Sequence documentation:                                      
						MVSIPEYYEGKNVLLTGATGFLGKVLLEKLLRSCPKVNSVYVLVRQKAGQTPQERVEEVL 	                                                            
						SGKLFDRLRDENPDFREKIIAINSELTQPKLALSEEDKEVIIDSTNIIFHCAATVRFNEN 	Alignment of: 19263 x Q9H600   ..                            
						LRDAVQLNVIATRQLILLAQQMKNLEVFMHVSTAYAYCNRKHIDEVVYPPPVDPKKLIDS 	                                                            
						LEWMDDGLVNDITPKLIGDRPNTYIYTKALAEYVVQQEGAKLNVAIVRPSIVGASWKEPF 	Alignment segment 1/1:                                       
						PGWIDNFNGPSGLFIAAGKGILRTIRASNNALADLVPVDVVVNMSLAAAWYSGVNRPRNI 	                                                            
						MVYNCTTGSTNPFHWGEVG                                          	                     Quality: 3097.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     319                Total length:     319                                               
						to amino acids 1 - 319 of Q9H600, which also corresponds to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 319 of T10545_P2, and a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						YYVSHSFKMNPLNQVFRCPSFKFNSNSLSHHYRKGVSHRVSALLLDCTHVDRSETADDEN 	                  .         .         .         .         .  
						NNSSSQSYGVS                                                  	       1 MVSIPEYYEGKNVLLTGATGFLGKVLLEKLLRSCPKVNSVYVLVRQKAGQ 50                                                           
						having the sequence corresponding to amino acids 320 - 390 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10545_P2, wherein said first amino acid sequence and second 	       1 MVSIPEYYEGKNVLLTGATGFLGKVLLEKLLRSCPKVNSVYVLVRQKAGQ 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a tail of       	      51 TPQERVEEVLSGKLFDRLRDENPDFREKIIAINSELTQPKLALSEEDKEV 100                                                          
						T10545_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      51 TPQERVEEVLSGKLFDRLRDENPDFREKIIAINSELTQPKLALSEEDKEV 100                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						YYVSHSFKMNPLNQVFRCPSFKFNSNSLSHHYRKGVSHRVSALLLDCTHVDRSETADDEN 	     101 IIDSTNIIFHCAATVRFNENLRDAVQLNVIATRQLILLAQQMKNLEVFMH 150                                                          
						NNSSSQSYGVS                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence in T10545_P2.     	     101 IIDSTNIIFHCAATVRFNENLRDAVQLNVIATRQLILLAQQMKNLEVFMH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VSTAYAYCNRKHIDEVVYPPPVDPKKLIDSLEWMDDGLVNDITPKLIGDR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VSTAYAYCNRKHIDEVVYPPPVDPKKLIDSLEWMDDGLVNDITPKLIGDR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PNTYIYTKALAEYVVQQEGAKLNVAIVRPSIVGASWKEPFPGWIDNFNGP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PNTYIYTKALAEYVVQQEGAKLNVAIVRPSIVGASWKEPFPGWIDNFNGP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SGLFIAAGKGILRTIRASNNALADLVPVDVVVNMSLAAAWYSGVNRPRNI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SGLFIAAGKGILRTIRASNNALADLVPVDVVVNMSLAAAWYSGVNRPRNI 300                                                          
						                                                            	                  .                                          
						                                                            	     301 MVYNCTTGSTNPFHWGEVG                                319                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     301 MVYNCTTGSTNPFHWGEVG                                319                                                          

19838	HMR136_T10552_16_tr0_r1_1_gPRT		Comparison report between T10552_P16 and SCD1_HUMANunique    	Sequence name: SCD1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10552_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19838 x SCD1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						FGKLTPCAKMKLLLQAPLHQRARVGVETGAEAVVRPPFQVLVFLPSAWGRPLTRPLYCRA 	Alignment segment 1/1:                                       
						LLYGFPSRTVKAGGRGQHAFSASRPALSHSLAALSLPCRPAGRGNRRALGGRSGGGGSSG 	                                                            
						SGSLCGCIGGSGKMAARAGFQSVAPSGGAGASGGAGAAAALGPGGTPGPPVR         	                     Quality: 2722.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     275                Total length:     275                                               
						to amino acids 1 - 172 of T10552_P16, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MGPAPGQGLYRSPMPGAAYPRPGMLPGSRMTPQGPSMGPPGYGGNPSVRPGLAQSGMDQS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RKRPAPQQIQQVQQQAVQNRNHNAKKKKMADKILPQRIRELVPESQAYMDLLAFERKLDQ 	                        Gaps:       0                        
						TIMRKRLDIQEALKRPIKQKRKLRIFISNTFNPAKSDAEDGEGTVASWELRVEGRLLEDS 	                                                            
						ALSKYDATKQKRKFSSFFKSLVIELDKDLYGPDNHLVEWHRTATTQETDGFQVKRPGDVN 	Alignment:                                                   
						VRCTVLLMLDYQPPQFKLDPRLARLLGIHTQTRPV                          	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     173 MGPAPGQGLYRSPMPGAAYPRPGMLPGSRMTPQGPSMGPPGYGGNPSVRP 222                                                          
						amino acids 1 - 275 of SCD1_HUMAN, which also corresponds to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 173 - 447 of T10552_P16, and a third amino acid  	       1 MGPAPGQGLYRSPMPGAAYPRPGMLPGSRMTPQGPSMGPPGYGGNPSVRP 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     223 GLAQSGMDQSRKRPAPQQIQQVQQQAVQNRNHNAKKKKMADKILPQRIRE 272                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence DTGQPWGS corresponding to amino acids 448	      51 GLAQSGMDQSRKRPAPQQIQQVQQQAVQNRNHNAKKKKMADKILPQRIRE 100                                                          
						- 455 of T10552_P16, wherein said first amino acid sequence, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     273 LVPESQAYMDLLAFERKLDQTIMRKRLDIQEALKRPIKQKRKLRIFISNT 322                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T10552_P16, comprising a  	     101 LVPESQAYMDLLAFERKLDQTIMRKRLDIQEALKRPIKQKRKLRIFISNT 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     323 FNPAKSDAEDGEGTVASWELRVEGRLLEDSALSKYDATKQKRKFSSFFKS 372                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FGKLTPCAKMKLLLQAPLHQRARVGVETGAEAVVRPPFQVLVFLPSAWGRPLTRPLYCRA 	     151 FNPAKSDAEDGEGTVASWELRVEGRLLEDSALSKYDATKQKRKFSSFFKS 200                                                          
						LLYGFPSRTVKAGGRGQHAFSASRPALSHSLAALSLPCRPAGRGNRRALGGRSGGGGSSG 	                  .         .         .         .         .  
						SGSLCGCIGGSGKMAARAGFQSVAPSGGAGASGGAGAAAALGPGGTPGPPVR         	     373 LVIELDKDLYGPDNHLVEWHRTATTQETDGFQVKRPGDVNVRCTVLLMLD 422                                                          
						to the sequence of T10552_P16.3.An isolated polypeptide      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of T10552_P16, comprising a polypeptide  	     201 LVIELDKDLYGPDNHLVEWHRTATTQETDGFQVKRPGDVNVRCTVLLMLD 250                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .                                
						at least about 85%, more preferably at least about 90% and   	     423 YQPPQFKLDPRLARLLGIHTQTRPV                          447                                                          
						most preferably at least about 95% homologous to the sequence	         |||||||||||||||||||||||||                           
						DTGQPWGS in T10552_P16.                                      	     251 YQPPQFKLDPRLARLLGIHTQTRPV                          275                                                          

						Comparison report between T10552_P16 and AAH09368unique head 	Sequence name: AAH09368                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10552_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19838 x AAH09368   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						FGKLTPCAKMKLLLQAPLHQRARVGVETGAEAVVRPPFQVLVFLPSAWGRPLTRPLYCRA 	Alignment segment 1/1:                                       
						LLYGFPSRTVKAGGRGQHAFSASRPALSHSLAALSLPCRPAGRGNRRALGGRSGGGGSSG 	                                                            
						SGSLCGCIGGSGK                                                	                     Quality: 3083.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     314                Total length:     314                                               
						to amino acids 1 - 133 of T10552_P16, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MAARAGFQSVAPSGGAGASGGAGAAAALGPGGTPGPPVRMGPAPGQGLYRSPMPGAAYPR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PGMLPGSRMTPQGPSMGPPGYGGNPSVRPGLAQSGMDQSRKRPAPQQIQQVQQQAVQNRN 	                        Gaps:       0                        
						HNAKKKKMADKILPQRIRELVPESQAYMDLLAFERKLDQTIMRKRLDIQEALKRPIKQKR 	                                                            
						KLRIFISNTFNPAKSDAEDGEGTVASWELRVEGRLLEDSALSKYDATKQKRKFSSFFKSL 	Alignment:                                                   
						VIELDKDLYGPDNHLVEWHRTATTQETDGFQVKRPGDVNVRCTVLLMLDYQPPQFKLDPR 	                  .         .         .         .         .  
						LARLLGIHTQTRPV                                               	     134 MAARAGFQSVAPSGGAGASGGAGAAAALGPGGTPGPPVRMGPAPGQGLYR 183                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 314 of AAH09368, which also corresponds to   	       1 MAARAGFQSVAPSGGAGASGGAGAAAALGPGGTPGPPVRMGPAPGQGLYR 50                                                           
						amino acids 134 - 447 of T10552_P16, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     184 SPMPGAAYPRPGMLPGSRMTPQGPSMGPPGYGGNPSVRPGLAQSGMDQSR 233                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 SPMPGAAYPRPGMLPGSRMTPQGPSMGPPGYGGNPSVRPGLAQSGMDQSR 100                                                          
						having the sequence DTGQPWGS corresponding to amino acids 448	                  .         .         .         .         .  
						- 455 of T10552_P16, wherein said first amino acid sequence, 	     234 KRPAPQQIQQVQQQAVQNRNHNAKKKKMADKILPQRIRELVPESQAYMDL 283                                                          
						second amino acid sequence and third amino acid sequence are 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 KRPAPQQIQQVQQQAVQNRNHNAKKKKMADKILPQRIRELVPESQAYMDL 150                                                          
						polypeptide encoding for a head of T10552_P16, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     284 LAFERKLDQTIMRKRLDIQEALKRPIKQKRKLRIFISNTFNPAKSDAEDG 333                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 LAFERKLDQTIMRKRLDIQEALKRPIKQKRKLRIFISNTFNPAKSDAEDG 200                                                          
						FGKLTPCAKMKLLLQAPLHQRARVGVETGAEAVVRPPFQVLVFLPSAWGRPLTRPLYCRA 	                  .         .         .         .         .  
						LLYGFPSRTVKAGGRGQHAFSASRPALSHSLAALSLPCRPAGRGNRRALGGRSGGGGSSG 	     334 EGTVASWELRVEGRLLEDSALSKYDATKQKRKFSSFFKSLVIELDKDLYG 383                                                          
						SGSLCGCIGGSGK                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T10552_P16.3.An isolated polypeptide      	     201 EGTVASWELRVEGRLLEDSALSKYDATKQKRKFSSFFKSLVIELDKDLYG 250                                                          
						encoding for a tail of T10552_P16, comprising a polypeptide  	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     384 PDNHLVEWHRTATTQETDGFQVKRPGDVNVRCTVLLMLDYQPPQFKLDPR 433                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     251 PDNHLVEWHRTATTQETDGFQVKRPGDVNVRCTVLLMLDYQPPQFKLDPR 300                                                          
						DTGQPWGS in T10552_P16.                                      	                  .                                          
						                                                            	     434 LARLLGIHTQTRPV                                     447                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     301 LARLLGIHTQTRPV                                     314                                                          

1288	HMR136_T10558_12_tr0_r1_1_gPRT		Comparison report between T10558_P12 and                     	Sequence name: BA1A_HUMAN_V4                                 
						BA1A_HUMAN_V4partial WT sequence (truncation of last part or 	                                                            
						first part of sequence, no other amino acids)1.An isolated   	Sequence documentation:                                      
						chimeric polypeptide encoding for T10558_P12, comprising a   	                                                            
						MVLCDGCDRGHHTYCVRPKLKTVPEGDWFCPECRPKQRSRRLSSRQRPSLESDEDVEDSM 	Alignment of: 1288 x BA1A_HUMAN_V4   ..                      
						GGEDDEVDGDEEEGQSEEEEYEVEQDEDDSQEEEEVSLPKRGRPQVRLPVKTRGKLSSSF 	                                                            
						SSRGQQQEPGRYPSRSQQSTPKTTVSSKTGRSLRKINSAPPTETKSLRIASRSTRHSHGP 	Alignment segment 1/1:                                       
						LQADVFVELLSPRRKRRGRKSANNTPENSPNFPNFRVIATKSSEQSRSVNIASKLSLQES 	                                                            
						ESKRRCRKRQSPEPSPVTLGRRSSGRQGGVHELSAFEQLVVELVRHDDSWPFLKLVSKIQ 	                     Quality: 3887.00                      Escore:       0                                               
						VPDYYDIIKKPIALNIIREKVNKCEYKLASEFIDDIELMFSNCFEYNPRNTSEAKAGTRL 	             Matching length:     394                Total length:     394                                               
						QAFFHIQAQKLGLHVTPSNVDQVSTPPAAKKSRI                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1163 - 1556 of BA1A_HUMAN_V4,   	                        Gaps:       0                        
						which also corresponds to amino acids 1 - 394 of T10558_P12. 	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVLCDGCDRGHHTYCVRPKLKTVPEGDWFCPECRPKQRSRRLSSRQRPSL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1163 MVLCDGCDRGHHTYCVRPKLKTVPEGDWFCPECRPKQRSRRLSSRQRPSL 1212                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ESDEDVEDSMGGEDDEVDGDEEEGQSEEEEYEVEQDEDDSQEEEEVSLPK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1213 ESDEDVEDSMGGEDDEVDGDEEEGQSEEEEYEVEQDEDDSQEEEEVSLPK 1262                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RGRPQVRLPVKTRGKLSSSFSSRGQQQEPGRYPSRSQQSTPKTTVSSKTG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1263 RGRPQVRLPVKTRGKLSSSFSSRGQQQEPGRYPSRSQQSTPKTTVSSKTG 1312                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RSLRKINSAPPTETKSLRIASRSTRHSHGPLQADVFVELLSPRRKRRGRK 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1313 RSLRKINSAPPTETKSLRIASRSTRHSHGPLQADVFVELLSPRRKRRGRK 1362                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SANNTPENSPNFPNFRVIATKSSEQSRSVNIASKLSLQESESKRRCRKRQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1363 SANNTPENSPNFPNFRVIATKSSEQSRSVNIASKLSLQESESKRRCRKRQ 1412                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SPEPSPVTLGRRSSGRQGGVHELSAFEQLVVELVRHDDSWPFLKLVSKIQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1413 SPEPSPVTLGRRSSGRQGGVHELSAFEQLVVELVRHDDSWPFLKLVSKIQ 1462                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 VPDYYDIIKKPIALNIIREKVNKCEYKLASEFIDDIELMFSNCFEYNPRN 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1463 VPDYYDIIKKPIALNIIREKVNKCEYKLASEFIDDIELMFSNCFEYNPRN 1512                                                         
						                                                            	                  .         .         .         .            
						                                                            	     351 TSEAKAGTRLQAFFHIQAQKLGLHVTPSNVDQVSTPPAAKKSRI       394                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	    1513 TSEAKAGTRLQAFFHIQAQKLGLHVTPSNVDQVSTPPAAKKSRI       1556                                                         

1286	HMR136_T10558_3_tr0_r1_1_gPRT		Comparison report between T10558_P3 and BA1A_HUMAN_V4partial 	Sequence name: BA1A_HUMAN_V4                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10558_P3, comprising a first amino 	                                                            
						MELRLSNPSLVKKLSSTSVYDLTPGEKMKILHALCGKLLTLVSTRDFIEDYVDILRQAKQ 	Alignment of: 1286 x BA1A_HUMAN_V4   ..                      
						EFRELKAEQHRKEREEAAARIRKRKEEKLKEQEQKMKEKQEKLKEDEQRNSTADISIGEE 	                                                            
						EREDFDTSIESKDTEQKELDQDMVTEDEDDPGSHKRGRRGKRGQNGFKEFTRQEQINCVT 	Alignment segment 1/1:                                       
						REPLTADEEEALKQEHQRKEKELLEKIQSAIACTNIFPLGRDRMYRRYWIFPSIPGLFIE 	                                                            
						EDYSGLTEDMLLPRPSSFQNNVQSQDPQVSTKTGEPLMSESTSNIDQGPRDHSVQLPKPV 	                     Quality: 9528.00                      Escore:       0                                               
						HKPNRWCFYSSCEQLDQLIEALNSRGHRESALKETLLQEKSRICAQLARFSEEKFHFSDK 	             Matching length:     970                Total length:     970                                               
						PQPDSKPTYSRGRSSNAYDPSQMCAEKQLELRLRDFLLDIEDRIYQGTLGAIKVTDRHIW 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSALESGRYELLSEENKENGIIKTVNEDVEEMEIDEQTKVIVKDRLLGIKTETPSTVSTN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ASTPQSVSSVVHYLAMALFQIEQGIERRFLKAPLDASDSGRSYKTVLDRWRESLLSSASL 	                        Gaps:       0                        
						SQVFLHLSTLDRSVIWSKSILNARCKICRKKGDAENMVLCDGCDRGHHTYCVRPKLKTVP 	                                                            
						EGDWFCPECRPKQRSRRLSSRQRPSLESDEDVEDSMGGEDDEVDGDEEEGQSEEEEYEVE 	Alignment:                                                   
						QDEDDSQEEEEVSLPKRGRPQVRLPVKTRGKLSSSFSSRGQQQEPGRYPSRSQQSTPKTT 	                  .         .         .         .         .  
						VSSKTGRSLRKINSAPPTETKSLRIASRSTRHSHGPLQADVFVELLSPRRKRRGRKSANN 	       1 MELRLSNPSLVKKLSSTSVYDLTPGEKMKILHALCGKLLTLVSTRDFIED 50                                                           
						TPENSPNFPNFRVIATKSSEQSRSVNIASKLSLQESESKRRCRKRQSPEPSPVTLGRRSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRQGGVHELSAFEQLVVELVRHDDSWPFLKLVSKIQVPDYYDIIKKPIALNIIREKVNKC 	     587 MELRLSNPSLVKKLSSTSVYDLTPGEKMKILHALCGKLLTLVSTRDFIED 636                                                          
						EYKLASEFIDDIELMFSNCFEYNPRNTSEAKAGTRLQAFFHIQAQKLGLHVTPSNVDQVS 	                  .         .         .         .         .  
						TPPAAKKSRI                                                   	      51 YVDILRQAKQEFRELKAEQHRKEREEAAARIRKRKEEKLKEQEQKMKEKQ 100                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 587 - 1556 of BA1A_HUMAN_V4, which also       	     637 YVDILRQAKQEFRELKAEQHRKEREEAAARIRKRKEEKLKEQEQKMKEKQ 686                                                          
						corresponds to amino acids 1 - 970 of T10558_P3.             	                  .         .         .         .         .  
						                                                            	     101 EKLKEDEQRNSTADISIGEEEREDFDTSIESKDTEQKELDQDMVTEDEDD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     687 EKLKEDEQRNSTADISIGEEEREDFDTSIESKDTEQKELDQDMVTEDEDD 736                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PGSHKRGRRGKRGQNGFKEFTRQEQINCVTREPLTADEEEALKQEHQRKE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     737 PGSHKRGRRGKRGQNGFKEFTRQEQINCVTREPLTADEEEALKQEHQRKE 786                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KELLEKIQSAIACTNIFPLGRDRMYRRYWIFPSIPGLFIEEDYSGLTEDM 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     787 KELLEKIQSAIACTNIFPLGRDRMYRRYWIFPSIPGLFIEEDYSGLTEDM 836                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LLPRPSSFQNNVQSQDPQVSTKTGEPLMSESTSNIDQGPRDHSVQLPKPV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     837 LLPRPSSFQNNVQSQDPQVSTKTGEPLMSESTSNIDQGPRDHSVQLPKPV 886                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 HKPNRWCFYSSCEQLDQLIEALNSRGHRESALKETLLQEKSRICAQLARF 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     887 HKPNRWCFYSSCEQLDQLIEALNSRGHRESALKETLLQEKSRICAQLARF 936                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SEEKFHFSDKPQPDSKPTYSRGRSSNAYDPSQMCAEKQLELRLRDFLLDI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     937 SEEKFHFSDKPQPDSKPTYSRGRSSNAYDPSQMCAEKQLELRLRDFLLDI 986                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EDRIYQGTLGAIKVTDRHIWRSALESGRYELLSEENKENGIIKTVNEDVE 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     987 EDRIYQGTLGAIKVTDRHIWRSALESGRYELLSEENKENGIIKTVNEDVE 1036                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 EMEIDEQTKVIVKDRLLGIKTETPSTVSTNASTPQSVSSVVHYLAMALFQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1037 EMEIDEQTKVIVKDRLLGIKTETPSTVSTNASTPQSVSSVVHYLAMALFQ 1086                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IEQGIERRFLKAPLDASDSGRSYKTVLDRWRESLLSSASLSQVFLHLSTL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1087 IEQGIERRFLKAPLDASDSGRSYKTVLDRWRESLLSSASLSQVFLHLSTL 1136                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 DRSVIWSKSILNARCKICRKKGDAENMVLCDGCDRGHHTYCVRPKLKTVP 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1137 DRSVIWSKSILNARCKICRKKGDAENMVLCDGCDRGHHTYCVRPKLKTVP 1186                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 EGDWFCPECRPKQRSRRLSSRQRPSLESDEDVEDSMGGEDDEVDGDEEEG 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1187 EGDWFCPECRPKQRSRRLSSRQRPSLESDEDVEDSMGGEDDEVDGDEEEG 1236                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 QSEEEEYEVEQDEDDSQEEEEVSLPKRGRPQVRLPVKTRGKLSSSFSSRG 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1237 QSEEEEYEVEQDEDDSQEEEEVSLPKRGRPQVRLPVKTRGKLSSSFSSRG 1286                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 QQQEPGRYPSRSQQSTPKTTVSSKTGRSLRKINSAPPTETKSLRIASRST 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1287 QQQEPGRYPSRSQQSTPKTTVSSKTGRSLRKINSAPPTETKSLRIASRST 1336                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     751 RHSHGPLQADVFVELLSPRRKRRGRKSANNTPENSPNFPNFRVIATKSSE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1337 RHSHGPLQADVFVELLSPRRKRRGRKSANNTPENSPNFPNFRVIATKSSE 1386                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     801 QSRSVNIASKLSLQESESKRRCRKRQSPEPSPVTLGRRSSGRQGGVHELS 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1387 QSRSVNIASKLSLQESESKRRCRKRQSPEPSPVTLGRRSSGRQGGVHELS 1436                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 AFEQLVVELVRHDDSWPFLKLVSKIQVPDYYDIIKKPIALNIIREKVNKC 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1437 AFEQLVVELVRHDDSWPFLKLVSKIQVPDYYDIIKKPIALNIIREKVNKC 1486                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 EYKLASEFIDDIELMFSNCFEYNPRNTSEAKAGTRLQAFFHIQAQKLGLH 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1487 EYKLASEFIDDIELMFSNCFEYNPRNTSEAKAGTRLQAFFHIQAQKLGLH 1536                                                         
						                                                            	                  .         .                                
						                                                            	     951 VTPSNVDQVSTPPAAKKSRI                               970                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	    1537 VTPSNVDQVSTPPAAKKSRI                               1556                                                         

20544	HMR136_T10559_11_tr0_r1_1_gPRT		Comparison report between T10559_P11 and FBW4_HUMANunique    	Sequence name: FBW4_HUMAN                                    
						head followed by partial WT sequence followed by a short     	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						T10559_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20544 x FBW4_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	Alignment segment 1/1:                                       
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	                                                            
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	                     Quality: 2743.00                      Escore:       0                                               
						A                                                            	             Matching length:     278                Total length:     278                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 181 of T10559_P11, a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGRLAQVCRWLRR 	                        Gaps:       0                        
						FTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVSQNWRLGRCREGILLKWRCSQ 	                                                            
						MPWMQLEDDSLYISQANFILAYQFRPDGASLNRRPLGVFAGHDEDVCHFVLANSHIVSAG 	Alignment:                                                   
						GDGKIGIHKIHSTFTVKYSAHEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHT 	                  .         .         .         .         .  
						IQTEDRVWSIAISPLLSSFVTGTACCGHFSPLRIWDLN                       	     182 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 231                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 278 of FBW4_HUMAN, which also corresponds to 	       1 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 50                                                           
						amino acids 182 - 459 of T10559_P11, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     232 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 281                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 100                                                          
						having the sequence R corresponding to amino acids 460 - 460 	                  .         .         .         .         .  
						of T10559_P11, wherein said first amino acid sequence, second	     282 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 331                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 150                                                          
						polypeptide encoding for a head of T10559_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     332 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 381                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 200                                                          
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	                  .         .         .         .         .  
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	     382 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 431                                                          
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						A                                                            	     201 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 250                                                          
						to the sequence of T10559_P11.                               	                  .         .                                
						                                                            	     432 AISPLLSSFVTGTACCGHFSPLRIWDLN                       459                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     251 AISPLLSSFVTGTACCGHFSPLRIWDLN                       278                                                          

20540	HMR136_T10559_13_tr0_r1_1_gPRT		Comparison report between T10559_P13 and FBW4_HUMANunique    	Sequence name: FBW4_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10559_P13, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20540 x FBW4_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	Alignment segment 1/1:                                       
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	                                                            
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	                     Quality: 3224.00                      Escore:       0                                               
						A                                                            	             Matching length:     327                Total length:     327                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.69                                               
						to amino acids 1 - 181 of T10559_P13, a second amino acid    	    Total Percent Similarity:  100.00      Total Percent Identity:   99.69                                               
						MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGRLAQVCRWLRR 	                        Gaps:       0                        
						FTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVSQNWRLGRCREGILLKWRCSQ 	                                                            
						MPWMQLEDDSLYISQANFILAYQFRPDGASLNRRPLGVFAGHDEDVCHFVLANSHIVSAG 	Alignment:                                                   
						GDGKIGIHKIHSTFTVKYSAHEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHT 	                  .         .         .         .         .  
						IQTEDRVWSIAISPLLSSFVTGTACCGHFSPLRIWDLNSGQLMTHLGSDFPPGAGVLDVM 	     182 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 231                                                          
						YESPFTLLSCGYDTYVRYWDLRTSVR                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 50                                                           
						amino acids 1 - 326 of FBW4_HUMAN, which also corresponds to 	                  .         .         .         .         .  
						amino acids 182 - 507 of T10559_P13, and a third amino acid  	     232 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 281                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence QMATTCWPQVPPTTVLYGCGTGVKGPACTPSR         	     282 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 331                                                          
						corresponding to amino acids 508 - 539 of T10559_P13, wherein	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	     101 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 150                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     332 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 381                                                          
						head of T10559_P13, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     151 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 200                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	     382 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 431                                                          
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	     201 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 250                                                          
						A                                                            	                  .         .         .         .         .  
						at least about 95% homologous to the sequence of             	     432 AISPLLSSFVTGTACCGHFSPLRIWDLNSGQLMTHLGSDFPPGAGVLDVM 481                                                          
						T10559_P13.3.An isolated polypeptide encoding for a tail of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10559_P13, comprising a polypeptide being at least 70%,     	     251 AISPLLSSFVTGTACCGHFSPLRIWDLNSGQLMTHLGSDFPPGAGVLDVM 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .                                
						more preferably at least about 90% and most preferably at    	     482 YESPFTLLSCGYDTYVRYWDLRTSVRQ                        508                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||:                         
						QMATTCWPQVPPTTVLYGCGTGVKGPACTPSR in T10559_P13.              	     301 YESPFTLLSCGYDTYVRYWDLRTSVRK                        327                                                          

20546	HMR136_T10559_15_tr0_r1_1_gPRT		Comparison report between T10559_P15 and FBW4_HUMANunique    	Sequence name: FBW4_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10559_P15, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20546 x FBW4_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	Alignment segment 1/1:                                       
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	                                                            
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	                     Quality: 3525.00                      Escore:       0                                               
						A                                                            	             Matching length:     365                Total length:     412                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 181 of T10559_P15, a second amino acid    	    Total Percent Similarity:   88.59      Total Percent Identity:   88.59                                               
						MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGRLAQVCRWLRR 	                        Gaps:       1                        
						FTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVSQNWRLGRCREGILLKWRCSQ 	                                                            
						MPWMQLEDDSLYISQANFILAYQFRPDGASLNRRPLGVFAGHDEDVCHFVLANSHIVSAG 	Alignment:                                                   
						GDGKIGIHKIHSTFTVKYSAHEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHT 	                  .         .         .         .         .  
						IQTEDRVWSIAISPLLSSFVTGTACCGHFSPLRIWDLN                       	     182 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 231                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 278 of FBW4_HUMAN, which also corresponds to 	       1 MAAAAGEEEEEEEAARESAARPAAGPALWRLPEELLLLICSYLDMRALGR 50                                                           
						amino acids 182 - 459 of T10559_P15, and a third amino acid  	                  .         .         .         .         .  
						RKCVMEWEEPHDSTLYCLQTDGNHLLATGSSYYGVVRLWDRRQRACLHAFPLTSTPLSSP 	     232 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 281                                                          
						VYCLRLTTKHLYAALSYNLHVLDFQNP                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LAQVCRWLRRFTSCDLLWRRIARASLNSGFTRLGTDLMTSVPVKERVKVS 100                                                          
						amino acids 326 - 412 of FBW4_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 460 - 546 of T10559_P15, wherein said first   	     282 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 331                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     101 QNWRLGRCREGILLKWRCSQMPWMQLEDDSLYISQANFILAYQFRPDGAS 150                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						T10559_P15, comprising a polypeptide being at least 70%,     	     332 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 381                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     151 LNRRPLGVFAGHDEDVCHFVLANSHIVSAGGDGKIGIHKIHSTFTVKYSA 200                                                          
						MVSPPPGAAAVAARAGLRVGPAPRPLMGSQGRSGPPGNGGPGEGEGGEARKLQEGRVARG 	                  .         .         .         .         .  
						KRRKGKGKGKARAGQGGRGSGAEGKPGPQTAKEAAGPGADAGARACPREEAEGGRSVEEG 	     382 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 431                                                          
						ARGIVKGVEGSAGAGKEAQGREYGKKEEWRVRARRREGARPGRAQGRGGQAWADIAGTGV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						A                                                            	     201 HEQEVNCVDCKGGIIVSGSRDRTAKVWPLASGRLGQCLHTIQTEDRVWSI 250                                                          
						least about 95% homologous to the sequence of T10559_P15.3.An	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     432 AISPLLSSFVTGTACCGHFSPLRIWDLN...................... 459                                                          
						T10559_P15, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||                        
						wherein n is at least about 10 amino acids in length,        	     251 AISPLLSSFVTGTACCGHFSPLRIWDLNSGQLMTHLGSDFPPGAGVLDVM 300                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     460 .........................RKCVMEWEEPHDSTLYCLQTDGNHL 484                                                          
						preferably at least about 40 amino acids in length and most  	                                  |||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     301 YESPFTLLSCGYDTYVRYWDLRTSVRKCVMEWEEPHDSTLYCLQTDGNHL 350                                                          
						at least two amino acids comprise NR, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     485 LATGSSYYGVVRLWDRRQRACLHAFPLTSTPLSSPVYCLRLTTKHLYAAL 534                                                          
						459-x to 460; and ending at any of amino acid numbers 460+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     351 LATGSSYYGVVRLWDRRQRACLHAFPLTSTPLSSPVYCLRLTTKHLYAAL 400                                                          
						                                                            	                  .                                          
						                                                            	     535 SYNLHVLDFQNP                                       546                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     401 SYNLHVLDFQNP                                       412                                                          

1481	HMR136_T10566_5_tr0_r1_1_gPRT		Comparison report between T10566_P5 and TDEL_HUMANpartial WT 	Sequence name: TDEL_HUMAN                                    
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for T10566_P5, comprising a first amino 	Sequence documentation:                                      
						MGSVLGLCSMASWIPCLCGSAPCLLCRCCPSGNNSTVTRLIYALFLLVGVCVACVMLIPG 	                                                            
						MEEQLNKIPGFCENEKGVVPCNILVGYKAVYRLCFGLAMFYLLLSLLMIKVKSSSDPRAA 	Alignment of: 1481 x TDEL_HUMAN   ..                         
						VHNGFWFFKFAAAIAIIIGAFFIPEGTFTT                               	                                                            
						acid sequence being at least 90 % homologous to corresponding	Alignment segment 1/1:                                       
						to amino acids 1 - 150 of TDEL_HUMAN, which also corresponds 	                                                            
						to amino acids 1 - 150 of T10566_P5, and a second amino acid 	                     Quality: 3996.00                      Escore:       0                                               
						EGNSRCWYAALLSATALNYLLSLVAIVLFFVYYTHPASCSENKAFISVNMLLCVGASVMS 	             Matching length:     416                Total length:     453                                               
						ILPKIQESQPRSGLLQSSVITVYTMYLTWSAMTNEPETNCNPSLLSIIGYNTTSTVPKEG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QSVQWWHAQGIIGLILFLLCVFYSSIRTSNNSQVNKLTLTSDESTLIEDGGARSDGSLED 	    Total Percent Similarity:   91.83      Total Percent Identity:   91.83                                               
						GDDVHRAVDNERDGVTYSYSFFHFMLFLASLYIMMTLTNWYRYEPSREMKSQWTAVWVKI 	                        Gaps:       1                        
						SSSWIGIVLYVWTLVAPLVLTNRDFD                                   	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 188 - 453 of TDEL_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 151 - 416 of T10566_P5, wherein said first    	       1 MGSVLGLCSMASWIPCLCGSAPCLLCRCCPSGNNSTVTRLIYALFLLVGV 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	       1 MGSVLGLCSMASWIPCLCGSAPCLLCRCCPSGNNSTVTRLIYALFLLVGV 50                                                           
						polypeptide encoding for an edge portion of T10566_P5,       	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	      51 CVACVMLIPGMEEQLNKIPGFCENEKGVVPCNILVGYKAVYRLCFGLAMF 100                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	      51 CVACVMLIPGMEEQLNKIPGFCENEKGVVPCNILVGYKAVYRLCFGLAMF 100                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     101 YLLLSLLMIKVKSSSDPRAAVHNGFWFFKFAAAIAIIIGAFFIPEGTFTT 150                                                          
						amino acids in length, wherein at least two amino acids      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprise TE, having a structure as follows: a sequence       	     101 YLLLSLLMIKVKSSSDPRAAVHNGFWFFKFAAAIAIIIGAFFIPEGTFTT 150                                                          
						starting from any of amino acid numbers 150-x to 151; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 151+ ((n-2) - x), in     	     151 .....................................EGNSRCWYAALLS 163                                                          
						which x varies from 0 to n-2.                                	                                              |||||||||||||  
						                                                            	     151 VWFYVGMAGAFCFILIQLVLLIDFAHSWNESWVEKMEEGNSRCWYAALLS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     164 ATALNYLLSLVAIVLFFVYYTHPASCSENKAFISVNMLLCVGASVMSILP 213                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ATALNYLLSLVAIVLFFVYYTHPASCSENKAFISVNMLLCVGASVMSILP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     214 KIQESQPRSGLLQSSVITVYTMYLTWSAMTNEPETNCNPSLLSIIGYNTT 263                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KIQESQPRSGLLQSSVITVYTMYLTWSAMTNEPETNCNPSLLSIIGYNTT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     264 STVPKEGQSVQWWHAQGIIGLILFLLCVFYSSIRTSNNSQVNKLTLTSDE 313                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 STVPKEGQSVQWWHAQGIIGLILFLLCVFYSSIRTSNNSQVNKLTLTSDE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     314 STLIEDGGARSDGSLEDGDDVHRAVDNERDGVTYSYSFFHFMLFLASLYI 363                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 STLIEDGGARSDGSLEDGDDVHRAVDNERDGVTYSYSFFHFMLFLASLYI 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     364 MMTLTNWYRYEPSREMKSQWTAVWVKISSSWIGIVLYVWTLVAPLVLTNR 413                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 MMTLTNWYRYEPSREMKSQWTAVWVKISSSWIGIVLYVWTLVAPLVLTNR 450                                                          
						                                                            	                                                             
						                                                            	     414 DFD                                                416                                                          
						                                                            	         |||                                                 
						                                                            	     451 DFD                                                453                                                          

1479	HMR136_T10566_6_tr0_r1_1_gPRT		Comparison report between T10566_P6 and TDEL_HUMANpartial WT 	Sequence name: TDEL_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10566_P6, comprising a first amino acid        	                                                            
						MAGAFCFILIQLVLLIDFAHSWNESWVEKMEEGNSRCWYAALLSATALNYLLSLVAIVLF 	Alignment of: 1479 x TDEL_HUMAN   ..                         
						FVYYTHPASCSENKAFISVNMLLCVGASVMSILPKIQESQPRSGLLQSSVITVYTMYLTW 	                                                            
						SAMTNEPETNCNPSLLSIIGYNTTSTVPKEGQSVQWWHAQGIIGLILFLLCVFYSSIRTS 	Alignment segment 1/1:                                       
						NNSQVNKLTLTSDESTLIEDGGARSDGSLEDGDDVHRAVDNERDGVTYSYSFFHFMLFLA 	                                                            
						SLYIMMTLTNWYRYEPSREMKSQWTAVWVKISSSWIGIVLYVWTLVAPLVLTNRDFD    	                     Quality: 2928.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     297                Total length:     297                                               
						amino acids 157 - 453 of TDEL_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 297 of T10566_P6.                         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAGAFCFILIQLVLLIDFAHSWNESWVEKMEEGNSRCWYAALLSATALNY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     157 MAGAFCFILIQLVLLIDFAHSWNESWVEKMEEGNSRCWYAALLSATALNY 206                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LLSLVAIVLFFVYYTHPASCSENKAFISVNMLLCVGASVMSILPKIQESQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     207 LLSLVAIVLFFVYYTHPASCSENKAFISVNMLLCVGASVMSILPKIQESQ 256                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PRSGLLQSSVITVYTMYLTWSAMTNEPETNCNPSLLSIIGYNTTSTVPKE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     257 PRSGLLQSSVITVYTMYLTWSAMTNEPETNCNPSLLSIIGYNTTSTVPKE 306                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GQSVQWWHAQGIIGLILFLLCVFYSSIRTSNNSQVNKLTLTSDESTLIED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     307 GQSVQWWHAQGIIGLILFLLCVFYSSIRTSNNSQVNKLTLTSDESTLIED 356                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GGARSDGSLEDGDDVHRAVDNERDGVTYSYSFFHFMLFLASLYIMMTLTN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     357 GGARSDGSLEDGDDVHRAVDNERDGVTYSYSFFHFMLFLASLYIMMTLTN 406                                                          
						                                                            	                  .         .         .         .            
						                                                            	     251 WYRYEPSREMKSQWTAVWVKISSSWIGIVLYVWTLVAPLVLTNRDFD    297                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     407 WYRYEPSREMKSQWTAVWVKISSSWIGIVLYVWTLVAPLVLTNRDFD    453                                                          

21897	HMR136_T10602_18_tr0_r1_1_gPRT		Comparison report between T10602_P18 and WS22_HUMANpartial   	Sequence name: WS22_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10602_P18, comprising a first amino	Sequence documentation:                                      
						MASRGRRPEHGGPPELFYDETEARKYVRNSRMIDIQTRMAGRALELLYLPENKPCYLLDI 	                                                            
						GCGTGLSGSYLSDEGHYWVGLDISPAMLDEAVDREIEGDLLLGDMGQGIPFKPGTFDGCI 	Alignment of: 21897 x WS22_HUMAN   ..                        
						SISAVQWLCNANKKSENPAKRLYCFFASLFSVLVRGSRAVLQLYPENSEQLELITTQATK 	                                                            
						AGFSGGMVVDYPNSAKAKK                                          	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 199 of WS22_HUMAN, which also corresponds 	                     Quality: 2327.00                      Escore:       0                                               
						to amino acids 1 - 199 of T10602_P18, and a second amino acid	             Matching length:     246                Total length:     281                                               
						sequence being at least 90 % homologous to                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPLRMSRRGMVRKSRAWVLEKKERHRRQGREVRPDTQYTGRKRKPRF corresponding	    Total Percent Similarity:   87.54      Total Percent Identity:   87.54                                               
						to amino acids 235 - 281 of WS22_HUMAN, which also           	                        Gaps:       1                        
						corresponds to amino acids 200 - 246 of T10602_P18, wherein  	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	       1 MASRGRRPEHGGPPELFYDETEARKYVRNSRMIDIQTRMAGRALELLYLP 50                                                           
						T10602_P18, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	       1 MASRGRRPEHGGPPELFYDETEARKYVRNSRMIDIQTRMAGRALELLYLP 50                                                           
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      51 ENKPCYLLDIGCGTGLSGSYLSDEGHYWVGLDISPAMLDEAVDREIEGDL 100                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	      51 ENKPCYLLDIGCGTGLSGSYLSDEGHYWVGLDISPAMLDEAVDREIEGDL 100                                                          
						at least two amino acids comprise KF, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     101 LLGDMGQGIPFKPGTFDGCISISAVQWLCNANKKSENPAKRLYCFFASLF 150                                                          
						199-x to 200; and ending at any of amino acid numbers 200+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     101 LLGDMGQGIPFKPGTFDGCISISAVQWLCNANKKSENPAKRLYCFFASLF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SVLVRGSRAVLQLYPENSEQLELITTQATKAGFSGGMVVDYPNSAKAKK. 199                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     151 SVLVRGSRAVLQLYPENSEQLELITTQATKAGFSGGMVVDYPNSAKAKKF 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     200 ..................................FPLRMSRRGMVRKSRA 215                                                          
						                                                            	                                           ||||||||||||||||  
						                                                            	     201 YLCLFSGPSTFIPEGLSENQDEVEPRESVFTNERFPLRMSRRGMVRKSRA 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     216 WVLEKKERHRRQGREVRPDTQYTGRKRKPRF                    246                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     251 WVLEKKERHRRQGREVRPDTQYTGRKRKPRF                    281                                                          

21899	HMR136_T10602_7_tr0_r1_1_gPRT		Comparison report between T10602_P7 and WS22_HUMANpartial WT 	Sequence name: WS22_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10602_P7, comprising a first amino acid        	                                                            
						MIDIQTRMAGRALELLYLPENKPCYLLDIGCGTGLSGSYLSDEGHYWVGLDISPAMLDEA 	Alignment of: 21899 x WS22_HUMAN   ..                        
						VDREIEGDLLLGDMGQGIPFKPGTFDGCISISAVQWLCNANKKSENPAKRLYCFFASLFS 	                                                            
						VLVRGSRAVLQLYPENSEQLELITTQATKAGFSGGMVVDYPNSAKAKKFYLCLFSGPSTF 	Alignment segment 1/1:                                       
						IPEGLSENQDEVEPRESVFTNERFPLRMSRRGMVRKSRAWVLEKKERHRRQGREVRPDTQ 	                                                            
						YTGRKRKPRF                                                   	                     Quality: 2463.00                      Escore:       0                                               
						sequence being at least 90 % homologous to corresponding to  	             Matching length:     250                Total length:     250                                               
						amino acids 32 - 281 of WS22_HUMAN, which also corresponds to	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 250 of T10602_P7.                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MIDIQTRMAGRALELLYLPENKPCYLLDIGCGTGLSGSYLSDEGHYWVGL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      32 MIDIQTRMAGRALELLYLPENKPCYLLDIGCGTGLSGSYLSDEGHYWVGL 81                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DISPAMLDEAVDREIEGDLLLGDMGQGIPFKPGTFDGCISISAVQWLCNA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      82 DISPAMLDEAVDREIEGDLLLGDMGQGIPFKPGTFDGCISISAVQWLCNA 131                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NKKSENPAKRLYCFFASLFSVLVRGSRAVLQLYPENSEQLELITTQATKA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     132 NKKSENPAKRLYCFFASLFSVLVRGSRAVLQLYPENSEQLELITTQATKA 181                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GFSGGMVVDYPNSAKAKKFYLCLFSGPSTFIPEGLSENQDEVEPRESVFT 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     182 GFSGGMVVDYPNSAKAKKFYLCLFSGPSTFIPEGLSENQDEVEPRESVFT 231                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NERFPLRMSRRGMVRKSRAWVLEKKERHRRQGREVRPDTQYTGRKRKPRF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     232 NERFPLRMSRRGMVRKSRAWVLEKKERHRRQGREVRPDTQYTGRKRKPRF 281                                                          

1840	HMR136_T10619_0_tr0_r1_1_gPRT		Comparison report between T10619_P0 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10619_P0, comprising a first amino 	                                                            
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	Alignment of: 1840 x IKAP_HUMAN_V5   ..                      
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	                                                            
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	Alignment segment 1/1:                                       
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	                                                            
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                     Quality: 7783.00                      Escore:       0                                               
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	             Matching length:     795                Total length:     795                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	                        Gaps:       0                        
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                                                            
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	Alignment:                                                   
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	                  .         .         .         .         .  
						AFEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIP 	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						PKINRRTQWKLSLLD                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						to amino acids 538 - 1332 of IKAP_HUMAN_V5, which also       	                  .         .         .         .         .  
						corresponds to amino acids 1 - 795 of T10619_P0.             	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                  .         .         .         .            
						                                                            	     751 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      795                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1288 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      1332                                                         

1842	HMR136_T10619_1_tr0_r1_1_gPRT		Comparison report between T10619_P1 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10619_P1, comprising a first amino 	                                                            
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	Alignment of: 1842 x IKAP_HUMAN_V5   ..                      
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	                                                            
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	Alignment segment 1/1:                                       
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	                                                            
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                     Quality: 7783.00                      Escore:       0                                               
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	             Matching length:     795                Total length:     795                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	                        Gaps:       0                        
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                                                            
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	Alignment:                                                   
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	                  .         .         .         .         .  
						AFEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIP 	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						PKINRRTQWKLSLLD                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						to amino acids 538 - 1332 of IKAP_HUMAN_V5, which also       	                  .         .         .         .         .  
						corresponds to amino acids 1 - 795 of T10619_P1.             	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                  .         .         .         .            
						                                                            	     751 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      795                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1288 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      1332                                                         

1848	HMR136_T10619_14_tr0_r1_1_gPRT		Comparison report between T10619_P14 and IKAP_HUMANunique    	Sequence name: IKAP_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for T10619_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 1848 x IKAP_HUMAN   ..                         
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence MILVKASLSLLDGVGRRHSSMA corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 22 of T10619_P14, and a second amino acid    	                                                            
						HGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNRRKAERKKHSLKEGSPLEDLAL 	                     Quality: 1689.00                      Escore:       0                                               
						LEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTY 	             Matching length:     174                Total length:     174                                               
						QQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD       	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1159 - 1332 of IKAP_HUMAN, which also corresponds	                        Gaps:       0                        
						to amino acids 23 - 196 of T10619_P14, wherein said first    	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of T10619_P14, comprising a  	      23 HGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNRRKAERKKHSLK 72                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	    1159 HGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNRRKAERKKHSLK 1208                                                         
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MILVKASLSLLDGVGRRHSSMA of T10619_P14.        	      73 EGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQKA 122                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1209 EGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQKA 1258                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     123 FEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVP 172                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1259 FEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVP 1308                                                         
						                                                            	                  .         .                                
						                                                            	     173 VLDAELFIPPKINRRTQWKLSLLD                           196                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	    1309 VLDAELFIPPKINRRTQWKLSLLD                           1332                                                         

1838	HMR136_T10619_2_tr0_r1_1_gPRT		Comparison report between T10619_P2 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10619_P2, comprising a first amino 	                                                            
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	Alignment of: 1838 x IKAP_HUMAN_V5   ..                      
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	                                                            
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	Alignment segment 1/1:                                       
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	                                                            
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                     Quality: 7783.00                      Escore:       0                                               
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	             Matching length:     795                Total length:     795                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	                        Gaps:       0                        
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                                                            
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	Alignment:                                                   
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	                  .         .         .         .         .  
						AFEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIP 	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						PKINRRTQWKLSLLD                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						to amino acids 538 - 1332 of IKAP_HUMAN_V5, which also       	                  .         .         .         .         .  
						corresponds to amino acids 1 - 795 of T10619_P2.             	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                  .         .         .         .            
						                                                            	     751 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      795                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1288 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      1332                                                         

1844	HMR136_T10619_3_tr0_r1_1_gPRT		Comparison report between T10619_P3 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10619_P3, comprising a first amino 	                                                            
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	Alignment of: 1844 x IKAP_HUMAN_V5   ..                      
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	                                                            
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	Alignment segment 1/1:                                       
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	                                                            
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                     Quality: 7783.00                      Escore:       0                                               
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	             Matching length:     795                Total length:     795                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	                        Gaps:       0                        
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                                                            
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	Alignment:                                                   
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	                  .         .         .         .         .  
						AFEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIP 	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						PKINRRTQWKLSLLD                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						to amino acids 538 - 1332 of IKAP_HUMAN_V5, which also       	                  .         .         .         .         .  
						corresponds to amino acids 1 - 795 of T10619_P3.             	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                  .         .         .         .            
						                                                            	     751 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      795                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1288 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      1332                                                         

1846	HMR136_T10619_5_tr0_r1_1_gPRT		Comparison report between T10619_P5 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for T10619_P5, comprising a first amino 	                                                            
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	Alignment of: 1846 x IKAP_HUMAN_V5   ..                      
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	                                                            
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	Alignment segment 1/1:                                       
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	                                                            
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                     Quality: 7783.00                      Escore:       0                                               
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	             Matching length:     795                Total length:     795                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	                        Gaps:       0                        
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                                                            
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	Alignment:                                                   
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	                  .         .         .         .         .  
						AFEDTLQLMERSLPEIWTLTYQQNSATPVLGPNSTANSIMASYQQQKTSVPVLDAELFIP 	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						PKINRRTQWKLSLLD                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						to amino acids 538 - 1332 of IKAP_HUMAN_V5, which also       	                  .         .         .         .         .  
						corresponds to amino acids 1 - 795 of T10619_P5.             	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                  .         .         .         .            
						                                                            	     751 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      795                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	    1288 GPNSTANSIMASYQQQKTSVPVLDAELFIPPKINRRTQWKLSLLD      1332                                                         

1852	HMR136_T10619_6_tr0_r1_1_gPRT		Comparison report between T10619_P6 and IKAP_HUMAN_V5partial 	Sequence name: IKAP_HUMAN_V5                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10619_P6, comprising a first amino 	Sequence documentation:                                      
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	                                                            
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	Alignment of: 1852 x IKAP_HUMAN_V5   ..                      
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	                                                            
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	Alignment segment 1/1:                                       
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                                                            
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	                     Quality: 7328.00                      Escore:       0                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	             Matching length:     751                Total length:     751                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYE 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						EAVLLLLEGAAWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 	                        Gaps:       0                        
						LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNSRISARSSKNR 	                                                            
						RKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVYHILKVLFLFEFDEQGRELQK 	Alignment:                                                   
						AFEDTLQLMERSLPEIWTLTYQQNSATP                                 	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						to amino acids 538 - 1285 of IKAP_HUMAN_V5, which also       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 1 - 748 of T10619_P6, and a second	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence TWGEGVLLCCPSWS corresponding to amino    	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						acids 749 - 762 of T10619_P6, wherein said first amino acid  	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T10619_P6, comprising a polypeptide being at least   	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						at least about 95% homologous to the sequence TWGEGVLLCCPSWS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in T10619_P6.                                                	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQDYEEAVLLLLEGA 1087                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     551 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1088 AWEEALRLVYKYNRLDIIETNVKPSILEAQKNYMAFLDSQTATFSRHKKR 1137                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1138 LLVVRELKEQAQQAGLDDEVPHGQESDLFSETSSVVSGSEMSGKYSHSNS 1187                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     651 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1188 RISARSSKNRRKAERKKHSLKEGSPLEDLALLEALSEVVQNTENLKDEVY 1237                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     701 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPTW 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	    1238 HILKVLFLFEFDEQGRELQKAFEDTLQLMERSLPEIWTLTYQQNSATPVL 1287                                                         
						                                                            	                                                             
						                                                            	     751 G                                                  751                                                          
						                                                            	         |                                                   
						                                                            	    1288 G                                                  1288                                                         

1850	HMR136_T10619_9_tr0_r1_1_gPRT		Comparison report between T10619_P9 and IKAP_HUMAN_V6partial 	Sequence name: IKAP_HUMAN_V6                                 
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10619_P9, comprising a first amino 	Sequence documentation:                                      
						MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPSLAIKPWKNSG 	                                                            
						GFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEVASNITSFAVYDEFLLLTTHS 	Alignment of: 1850 x IKAP_HUMAN_V6   ..                      
						HTCQCFCLRDASFKTLQAGLSSNHVSHGEVLRKVERGSRIVTVVPQDTKLVLQMPRGNLE 	                                                            
						VVHHRALVLAQIRKWLDKLMFKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSV 	Alignment segment 1/1:                                       
						NHINLFFTELKEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 	                                                            
						SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDVNELYDHSLGT 	                     Quality: 5273.00                      Escore:       0                                               
						YDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTIDKYLKRYEKAIGHLSKCGPEY 	             Matching length:     537                Total length:     537                                               
						FPECLNLIKDKNLYNEALKLYSPSSQQYQDISIAYGEHLMQEHMYEPAGLMFARCGAHEK 	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.81                                               
						ALSAFLTCGNWKQALCVAAQLNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEE       	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						acid sequence being at least 90 % homologous to corresponding	                        Gaps:       0                        
						to amino acids 538 - 1071 of IKAP_HUMAN_V6, which also       	                                                            
						corresponds to amino acids 1 - 534 of T10619_P9, and a second	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence CAQRWGVTSCPRWSETPGLK corresponding to    	     538 MDEEHGQLNVSSSAAVDGVIISLCCNSKTKSVVLQLADGQIFKYLWESPS 587                                                          
						amino acids 535 - 554 of T10619_P9, wherein said first amino 	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      51 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 100                                                          
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a tail of T10619_P9, comprising a polypeptide being at   	     588 LAIKPWKNSGGFPVRFPYPCTQTELAMIGEEECVLGLTDRCRFFINDIEV 637                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     101 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 150                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CAQRWGVTSCPRWSETPGLK in T10619_P9.                           	     638 ASNITSFAVYDEFLLLTTHSHTCQCFCLRDASFKTLQAGLSSNHVSHGEV 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 LRKVERGSRIVTVVPQDTKLVLQMPRGNLEVVHHRALVLAQIRKWLDKLM 737                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     738 FKEAFECMRKLRINLNLIYDHNPKVFLGNVETFIKQIDSVNHINLFFTEL 787                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     788 KEEDVTKTMYPAPVTSSVYLSRDPDGNKIDLVCDAMRAVMESINPHKYCL 837                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     838 SILTSHVKKTTPELEIVLQKVHELQGNAPSDPDAVSAEEALKYLLHLVDV 887                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     888 NELYDHSLGTYDFDLVLMVAEKSQKDPKEYLPFLNTLKKMETNYQRFTID 937                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     938 KYLKRYEKAIGHLSKCGPEYFPECLNLIKDKNLYNEALKLYSPSSQQYQD 987                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     988 ISIAYGEHLMQEHMYEPAGLMFARCGAHEKALSAFLTCGNWKQALCVAAQ 1037                                                         
						                                                            	                  .         .         .                      
						                                                            	     501 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEECAQ              537                                                          
						                                                            	         |||||||||||||||||||||||||||||||||| ||               
						                                                            	    1038 LNFTKDQLVGLGRTLAGKLVEQRKHIDAAMVLEESAQ              1074                                                         

22282	HMR136_T10620_0_tr0_r1_1_gPRT		Comparison report between T10620_P0 and Q8N989partial WT     	Sequence name: Q8N989                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10620_P0, comprising a first amino acid sequence being at   	                                                            
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	Alignment of: 22282 x Q8N989   ..                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	                                                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	Alignment segment 1/1:                                       
						YEFHYENNNVDKDKPLSGGLPDICESFLE                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 209	                     Quality: 2103.00                      Escore:       0                                               
						of Q8N989, which also corresponds to amino acids 1 - 209 of  	             Matching length:     214                Total length:     214                                               
						T10620_P0, a bridging amino acid K corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.53                                               
						acid 210 of T10620_P0, a second amino acid sequence being at 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.53                                               
						least 90 % homologous to WLRK corresponding to amino acids   	                        Gaps:       0                        
						211 - 214 of Q8N989, which also corresponds to amino acids   	                                                            
						211 - 214 of T10620_P0, and a third amino acid sequence being	Alignment:                                                   
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						KVRQTPCNCRA                                                  	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						corresponding to amino acids 215 - 345 of T10620_P0, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid, second  	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						polypeptide encoding for a tail of T10620_P0, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						KVRQTPCNCRA                                                  	                  .                                          
						to the sequence in T10620_P0.                                	     201 PDICESFLEKWLRK                                     214                                                          
						                                                            	         |||||||||:||||                                      
						                                                            	     201 PDICESFLERWLRK                                     214                                                          

						Comparison report between T10620_P0 and Q96BT7partial WT     	Sequence name: Q96BT7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10620_P0, comprising a first amino 	Sequence documentation:                                      
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	                                                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	Alignment of: 22282 x Q96BT7   ..                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	                                                            
						YEFHYENNNVDKDKPLSGGLPDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ        	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 233 of Q96BT7, which also corresponds to  	                     Quality: 2310.00                      Escore:       0                                               
						amino acids 1 - 233 of T10620_P0, and a second amino acid    	             Matching length:     233                Total length:     233                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	                                                            
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	Alignment:                                                   
						having the sequence corresponding to amino acids 234 - 345 of	                  .         .         .         .         .  
						T10620_P0, wherein said first amino acid sequence and second 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						T10620_P0, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	                  .         .         .         .         .  
						least about 95% homologous to the sequence in T10620_P0.     	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          

22284	HMR136_T10620_1_tr0_r1_1_gPRT		Comparison report between T10620_P1 and Q8N989partial WT     	Sequence name: Q8N989                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10620_P1, comprising a first amino acid sequence being at   	                                                            
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	Alignment of: 22284 x Q8N989   ..                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	                                                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	Alignment segment 1/1:                                       
						YEFHYENNNVDKDKPLSGGLPDICESFLE                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 209	                     Quality: 2103.00                      Escore:       0                                               
						of Q8N989, which also corresponds to amino acids 1 - 209 of  	             Matching length:     214                Total length:     214                                               
						T10620_P1, a bridging amino acid K corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.53                                               
						acid 210 of T10620_P1, a second amino acid sequence being at 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.53                                               
						least 90 % homologous to WLRK corresponding to amino acids   	                        Gaps:       0                        
						211 - 214 of Q8N989, which also corresponds to amino acids   	                                                            
						211 - 214 of T10620_P1, and a third amino acid sequence being	Alignment:                                                   
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						KVRQTPCNCRA                                                  	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						corresponding to amino acids 215 - 345 of T10620_P1, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid, second  	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						polypeptide encoding for a tail of T10620_P1, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						KVRQTPCNCRA                                                  	                  .                                          
						to the sequence in T10620_P1.                                	     201 PDICESFLEKWLRK                                     214                                                          
						                                                            	         |||||||||:||||                                      
						                                                            	     201 PDICESFLERWLRK                                     214                                                          

						Comparison report between T10620_P1 and Q96BT7partial WT     	Sequence name: Q96BT7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10620_P1, comprising a first amino 	Sequence documentation:                                      
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	                                                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	Alignment of: 22284 x Q96BT7   ..                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	                                                            
						YEFHYENNNVDKDKPLSGGLPDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ        	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 233 of Q96BT7, which also corresponds to  	                     Quality: 2310.00                      Escore:       0                                               
						amino acids 1 - 233 of T10620_P1, and a second amino acid    	             Matching length:     233                Total length:     233                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	                                                            
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	Alignment:                                                   
						having the sequence corresponding to amino acids 234 - 345 of	                  .         .         .         .         .  
						T10620_P1, wherein said first amino acid sequence and second 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						T10620_P1, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	                  .         .         .         .         .  
						least about 95% homologous to the sequence in T10620_P1.     	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          

22286	HMR136_T10620_2_tr0_r1_1_gPRT		Comparison report between T10620_P2 and Q8N989partial WT     	Sequence name: Q8N989                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10620_P2, comprising a first amino acid sequence being at   	                                                            
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	Alignment of: 22286 x Q8N989   ..                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	                                                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	Alignment segment 1/1:                                       
						YEFHYENNNVDKDKPLSGGLPDICESFLE                                	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 209	                     Quality: 2103.00                      Escore:       0                                               
						of Q8N989, which also corresponds to amino acids 1 - 209 of  	             Matching length:     214                Total length:     214                                               
						T10620_P2, a bridging amino acid K corresponding to amino    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.53                                               
						acid 210 of T10620_P2, a second amino acid sequence being at 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.53                                               
						least 90 % homologous to WLRK corresponding to amino acids   	                        Gaps:       0                        
						211 - 214 of Q8N989, which also corresponds to amino acids   	                                                            
						211 - 214 of T10620_P2, and a third amino acid sequence being	Alignment:                                                   
						at least 70%, optionally at least 80%, preferably at least   	                  .         .         .         .         .  
						85%, more preferably at least 90% and most preferably at     	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						KVRQTPCNCRA                                                  	                  .         .         .         .         .  
						least 95% homologous to a polypeptide having the sequence    	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						corresponding to amino acids 215 - 345 of T10620_P2, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, bridging amino acid, second  	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						polypeptide encoding for a tail of T10620_P2, comprising a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						GYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVML 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFR 	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						KVRQTPCNCRA                                                  	                  .                                          
						to the sequence in T10620_P2.                                	     201 PDICESFLEKWLRK                                     214                                                          
						                                                            	         |||||||||:||||                                      
						                                                            	     201 PDICESFLERWLRK                                     214                                                          

						Comparison report between T10620_P2 and Q96BT7partial WT     	Sequence name: Q96BT7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10620_P2, comprising a first amino 	Sequence documentation:                                      
						MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQ 	                                                            
						LLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFV 	Alignment of: 22286 x Q96BT7   ..                            
						EKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFG 	                                                            
						YEFHYENNNVDKDKPLSGGLPDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ        	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 233 of Q96BT7, which also corresponds to  	                     Quality: 2310.00                      Escore:       0                                               
						amino acids 1 - 233 of T10620_P2, and a second amino acid    	             Matching length:     233                Total length:     233                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       0                        
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	                                                            
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	Alignment:                                                   
						having the sequence corresponding to amino acids 234 - 345 of	                  .         .         .         .         .  
						T10620_P2, wherein said first amino acid sequence and second 	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a tail of       	       1 MDSNHQSNYKLSKTEKKFLRKQIKAKHTLLRHEGIETVSYATQSLVVANG 50                                                           
						T10620_P2, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHG 	      51 GLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTL 100                                                          
						ITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCRA         	                  .         .         .         .         .  
						least about 95% homologous to the sequence in T10620_P2.     	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEK 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGL 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     201 PDICESFLEKWLRKGYIKHKPDQMTINQYEPGQ                  233                                                          

22642	HMR136_T10625_11_tr0_r1_1_gPRT		Comparison report between T10625_P11 and PSDC_HUMANunique    	Sequence name: PSDC_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10625_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22642 x PSDC_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						SFAWAPDGLPERVRGQLPVWVTSGGRSRGTARDAQAGT corresponding to amino	                                                            
						acids 1 - 38 of T10625_P11, a second amino acid sequence     	                     Quality: 3957.00                      Escore:       0                                               
						being at least 90 % homologous to MADGGSERADGRIVKME          	             Matching length:     417                Total length:     456                                               
						corresponding to amino acids 1 - 17 of PSDC_HUMAN, which also	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 39 - 55 of T10625_P11, and a third	    Total Percent Similarity:   91.45      Total Percent Identity:   91.45                                               
						ASDMVSTSRILVAVVKMCYEAKEWDLLNENIMLLSKRRSQLKQAVAKMVQQCCTYVEEIT 	                        Gaps:       1                        
						DLPIKLRLIDTLRMVTEGKIYVEIERARLTKTLATIKEQNGDVKEAASILQELQVETYGS 	                                                            
						MEKKERVEFILEQMRLCLAVKDYIRTQIISKKINTKFFQEENTEKLKLKYYNLMIQLDQH 	Alignment:                                                   
						EGSYLSICKHYRAIYDTPCIQAESEKWQQALKSVVLYVILAPFDNEQSDLVHRISGDKKL 	                  .         .         .         .         .  
						EEIPKYKDLLKLFTTMELMRWSTLVEDYGMELRKGSLESPATDVFGSTEEGEKRWKDLKN 	      39 MADGGSERADGRIVKME................................. 55                                                           
						RVVEHNIRIMAKYYTRITMKRMAQLLDLSVDESEAFLSNLVVNKTIFAKVDRLAGIINFQ 	         |||||||||||||||||                                   
						RPKDPNNLLNDWSQKLNSLMSLVNKTTHLIAKEEMIHNLQ                     	       1 MADGGSERADGRIVKMEVDYSATVDQRLPECAKLAKEGRLQEVIETLLSL 50                                                           
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 57 - 456 of PSDC_HUMAN, which   	      56 ......ASDMVSTSRILVAVVKMCYEAKEWDLLNENIMLLSKRRSQLKQA 99                                                           
						also corresponds to amino acids 56 - 455 of T10625_P11,      	               ||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	      51 EKQTRTASDMVSTSRILVAVVKMCYEAKEWDLLNENIMLLSKRRSQLKQA 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     100 VAKMVQQCCTYVEEITDLPIKLRLIDTLRMVTEGKIYVEIERARLTKTLA 149                                                          
						head of T10625_P11, comprising a polypeptide being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 VAKMVQQCCTYVEEITDLPIKLRLIDTLRMVTEGKIYVEIERARLTKTLA 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     150 TIKEQNGDVKEAASILQELQVETYGSMEKKERVEFILEQMRLCLAVKDYI 199                                                          
						SFAWAPDGLPERVRGQLPVWVTSGGRSRGTARDAQAGT of T10625_P11.3.An    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     151 TIKEQNGDVKEAASILQELQVETYGSMEKKERVEFILEQMRLCLAVKDYI 200                                                          
						T10625_P11, comprising a polypeptide having a length "n",    	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     200 RTQIISKKINTKFFQEENTEKLKLKYYNLMIQLDQHEGSYLSICKHYRAI 249                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     201 RTQIISKKINTKFFQEENTEKLKLKYYNLMIQLDQHEGSYLSICKHYRAI 250                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     250 YDTPCIQAESEKWQQALKSVVLYVILAPFDNEQSDLVHRISGDKKLEEIP 299                                                          
						at least two amino acids comprise EA, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     251 YDTPCIQAESEKWQQALKSVVLYVILAPFDNEQSDLVHRISGDKKLEEIP 300                                                          
						55-x to 56; and ending at any of amino acid numbers 56+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     300 KYKDLLKLFTTMELMRWSTLVEDYGMELRKGSLESPATDVFGSTEEGEKR 349                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KYKDLLKLFTTMELMRWSTLVEDYGMELRKGSLESPATDVFGSTEEGEKR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     350 WKDLKNRVVEHNIRIMAKYYTRITMKRMAQLLDLSVDESEAFLSNLVVNK 399                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 WKDLKNRVVEHNIRIMAKYYTRITMKRMAQLLDLSVDESEAFLSNLVVNK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     400 TIFAKVDRLAGIINFQRPKDPNNLLNDWSQKLNSLMSLVNKTTHLIAKEE 449                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TIFAKVDRLAGIINFQRPKDPNNLLNDWSQKLNSLMSLVNKTTHLIAKEE 450                                                          
						                                                            	                                                             
						                                                            	     450 MIHNLQ                                             455                                                          
						                                                            	         ||||||                                              
						                                                            	     451 MIHNLQ                                             456                                                          

23123	HMR136_T10640_0_tr0_r1_1_gPRT		Comparison report between T10640_P0 and Q8NCW9unique head    	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P0, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23123 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P0, a second amino acid     	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 490 - 760 of T10640_P0, and a third amino acid   	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						to amino acids 761 - 787 of T10640_P0, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     690 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 739                                                          
						T10640_P0, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     740 ITDELKQCKNNLKLLREKGNN                              760                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P0.3.An 	                                                            
						isolated polypeptide encoding for a tail of T10640_P0,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P0.                    	                                                            

						Comparison report between T10640_P0 and Q9Y681unique head    	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P0, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23123 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     421                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   95.25      Total Percent Identity:   95.25                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P0, a second amino acid sequence being at  	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P0, a third   	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P0, a fourth amino acid      	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						NNPSILQPVPA                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 31 - 401 of Q9Y681, which also corresponds to    	                  .         .         .         .         .  
						amino acids 399 - 769 of T10640_P0, and a fifth amino acid   	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						acids 770 - 787 of T10640_P0, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						isolated polypeptide encoding for a head of T10640_P0,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     699 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 748                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     331 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 380                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                  .         .                                
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	     749 NNLKLLREKGNNPSILQPVPA                              769                                                          
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	         |||||||||||||||||||||                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	     381 NNLKLLREKGNNPSILQPVPA                              401                                                          
						about 95% homologous to the sequence of T10640_P0.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P0, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P0.4.An        	                                                            
						isolated polypeptide encoding for a tail of T10640_P0,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VFIGLFLAFLFWCFGPLW in   	                                                            
						T10640_P0.                                                   	                                                            

						Comparison report between T10640_P0 and Q9HCH1unique head    	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P0, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23123 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6065.00                      Escore:       0                                               
						I                                                            	             Matching length:     639                Total length:     660                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P0, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   96.82      Total Percent Identity:   96.82                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of T10640_P0,	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	                  .         .         .         .         .  
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	                  .         .         .         .         .  
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						ITDELKQCKNNLKLLREKGNN                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 90 % homologous to	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						corresponding to amino acids 280 - 660 of Q9HCH1, which also 	                  .         .         .         .         .  
						corresponds to amino acids 380 - 760 of T10640_P0, and a     	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						fourth amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW  	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						corresponding to amino acids 761 - 787 of T10640_P0, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						polypeptide encoding for a head of T10640_P0, comprising a   	         ||||||||                     |||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						I                                                            	                  .         .         .         .         .  
						to the sequence of T10640_P0.3.An isolated chimeric          	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						polypeptide encoding for an edge portion of T10640_P0,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise EK, having a structure as follows: a sequence       	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						starting from any of amino acid numbers 379-x to 380; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 380+ ((n-2) - x), in     	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of T10640_P0, comprising a polypeptide   	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P0.                    	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 650                                                          
						                                                            	                  .                                          
						                                                            	     751 LKLLREKGNN                                         760                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 LKLLREKGNN                                         660                                                          

23121	HMR136_T10640_11_tr0_r1_1_gPRT		Comparison report between T10640_P11 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P11, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23121 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2182.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     226                Total length:     226                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P11, a second amino acid    	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKE               	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 226 of Q8NCW9, which also corresponds to     	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 490 - 715 of T10640_P11, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	                  .         .         .         .         .  
						to amino acids 716 - 742 of T10640_P11, wherein said first   	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .                                
						T10640_P11, comprising a polypeptide being at least 70%,     	     690 QHLRDSADLKTLLSKAENQAKDVQKE                         715                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||                          
						more preferably at least about 90% and most preferably at    	     201 QHLRDSADLKTLLSKAENQAKDVQKE                         226                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                                                            
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P11.3.An	                                                            
						isolated polypeptide encoding for a tail of T10640_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P11.                   	                                                            

						Comparison report between T10640_P11 and Q9Y681unique head   	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P11, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23121 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3245.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     347                Total length:     367                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   94.55      Total Percent Identity:   94.55                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P11, a second amino acid sequence being at 	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P11, a third  	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P11, a fourth amino acid     	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKE                                            	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 31 - 347 of Q9Y681, which also corresponds to    	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 399 - 715 of T10640_P11, and a fifth amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	                  .         .         .         .         .  
						to amino acids 716 - 742 of T10640_P11, wherein said first   	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						amino acid sequence, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, fourth amino acid sequence and fifth amino    	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T10640_P11,      	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						preferably at least about 90% and most preferably at least   	                  .                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     699 KTLLSKAENQAKDVQKE                                  715                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||                                   
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     331 KTLLSKAENQAKDVQKE                                  347                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                                                            
						about 95% homologous to the sequence of T10640_P11.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P11, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P11.4.An       	                                                            
						isolated polypeptide encoding for a tail of T10640_P11,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P11.                   	                                                            

						Comparison report between T10640_P11 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P11, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23121 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 5623.00                      Escore:       0                                               
						I                                                            	             Matching length:     594                Total length:     615                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P11, a second amino acid sequence being at least 90 % 	    Total Percent Similarity:   96.59      Total Percent Identity:   96.59                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of           	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P11, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	                  .         .         .         .         .  
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKE                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 280 - 615 of      	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						Q9HCH1, which also corresponds to amino acids 380 - 715 of   	                  .         .         .         .         .  
						T10640_P11, and a fourth amino acid sequence being at least  	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding to amino acids 716 	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						- 742 of T10640_P11, wherein said first amino acid sequence, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						T10640_P11, comprising a polypeptide being at least 70%,     	         ||||||||                     |||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						I                                                            	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						least about 95% homologous to the sequence of T10640_P11.3.An	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						T10640_P11, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						at least two amino acids comprise EK, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						379-x to 380; and ending at any of amino acid numbers 380+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						polypeptide encoding for a tail of T10640_P11, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						to the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P11.   	                  .         .         .         .         .  
						                                                            	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .                                          
						                                                            	     701 LLSKAENQAKDVQKE                                    715                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 LLSKAENQAKDVQKE                                    615                                                          

23109	HMR136_T10640_13_tr0_r1_1_gPRT		Comparison report between T10640_P13 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P13, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23109 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQAL 	Alignment segment 1/1:                                       
						L                                                            	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2624.00                      Escore:       0                                               
						to amino acids 1 - 61 of T10640_P13, a second amino acid     	             Matching length:     271                Total length:     271                                               
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                        Gaps:       0                        
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	                                                            
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	      62 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 111                                                          
						amino acids 62 - 332 of T10640_P13, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     112 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 161                                                          
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 333 - 359 of T10640_P13, wherein said first   	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     162 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 211                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P13, comprising a polypeptide being at least 70%,     	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     212 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 261                                                          
						MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						L                                                            	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						least about 95% homologous to the sequence of T10640_P13.3.An	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of T10640_P13,      	     262 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 311                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						preferably at least about 90% and most preferably at least   	                  .         .                                
						about 95% homologous to the sequence                         	     312 ITDELKQCKNNLKLLREKGNN                              332                                                          
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P13.                   	         |||||||||||||||||||||                               
						                                                            	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          

						Comparison report between T10640_P13 and Q9Y681partial WT    	Sequence name: Q9Y681                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10640_P13, comprising a first amino	Sequence documentation:                                      
						MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQAL 	                                                            
						LEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 	Alignment of: 23109 x Q9Y681   ..                            
						LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCED 	                                                            
						QQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTS 	Alignment segment 1/1:                                       
						DLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 	                                                            
						KFEMTEQEKQSITDELKQCKNNLKLLREKGNNPSILQPVPA                    	                     Quality: 3296.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     341                Total length:     341                                               
						to amino acids 61 - 401 of Q9Y681, which also corresponds to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 341 of T10640_P13, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	                  .         .         .         .         .  
						acids 342 - 359 of T10640_P13, wherein said first amino acid 	       1 MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTS 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      61 MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTS 110                                                          
						tail of T10640_P13, comprising a polypeptide being at least  	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 KQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEK 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     111 KQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEK 160                                                          
						VFIGLFLAFLFWCFGPLW in T10640_P13.                            	                  .         .         .         .         .  
						                                                            	     101 DSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     161 DSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 210                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEW 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     211 ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEW 260                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     261 NALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRK 310                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     311 ELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 360                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 KFEMTEQEKQSITDELKQCKNNLKLLREKGNNPSILQPVPA          341                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     361 KFEMTEQEKQSITDELKQCKNNLKLLREKGNNPSILQPVPA          401                                                          

						Comparison report between T10640_P13 and Q9HCH1partial WT    	Sequence name: Q9HCH1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10640_P13, comprising a first amino	Sequence documentation:                                      
						MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQAL 	                                                            
						LEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 	Alignment of: 23109 x Q9HCH1   ..                            
						LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCED 	                                                            
						QQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTS 	Alignment segment 1/1:                                       
						DLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 	                                                            
						KFEMTEQEKQSITDELKQCKNNLKLLREKGNN                             	                     Quality: 3208.00                      Escore:       0                                               
						acid sequence being at least 90 % homologous to corresponding	             Matching length:     332                Total length:     332                                               
						to amino acids 329 - 660 of Q9HCH1, which also corresponds to	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 1 - 332 of T10640_P13, and a second amino acid   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	                        Gaps:       0                        
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment:                                                   
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	                  .         .         .         .         .  
						to amino acids 333 - 359 of T10640_P13, wherein said first   	       1 MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTS 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     329 MDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTS 378                                                          
						polypeptide encoding for a tail of T10640_P13, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 KQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEK 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     379 KQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEK 428                                                          
						to the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P13.   	                  .         .         .         .         .  
						                                                            	     101 DSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 DSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 478                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEW 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEW 528                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     529 NALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRK 578                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 ELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     579 ELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKL 628                                                          
						                                                            	                  .         .         .                      
						                                                            	     301 KFEMTEQEKQSITDELKQCKNNLKLLREKGNN                   332                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     629 KFEMTEQEKQSITDELKQCKNNLKLLREKGNN                   660                                                          

23127	HMR136_T10640_14_tr0_r1_1_gPRT		Comparison report between T10640_P14 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23127 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P14, a second amino acid    	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 490 - 760 of T10640_P14, and a third amino acid  	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						to amino acids 761 - 787 of T10640_P14, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     690 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 739                                                          
						T10640_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     740 ITDELKQCKNNLKLLREKGNN                              760                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P14.3.An	                                                            
						isolated polypeptide encoding for a tail of T10640_P14,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P14.                   	                                                            

						Comparison report between T10640_P14 and Q9Y681unique head   	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P14, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23127 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     421                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   95.25      Total Percent Identity:   95.25                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P14, a second amino acid sequence being at 	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P14, a third  	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P14, a fourth amino acid     	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						NNPSILQPVPA                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 31 - 401 of Q9Y681, which also corresponds to    	                  .         .         .         .         .  
						amino acids 399 - 769 of T10640_P14, and a fifth amino acid  	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						acids 770 - 787 of T10640_P14, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						isolated polypeptide encoding for a head of T10640_P14,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     699 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 748                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     331 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 380                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                  .         .                                
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	     749 NNLKLLREKGNNPSILQPVPA                              769                                                          
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	         |||||||||||||||||||||                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	     381 NNLKLLREKGNNPSILQPVPA                              401                                                          
						about 95% homologous to the sequence of T10640_P14.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P14, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P14.4.An       	                                                            
						isolated polypeptide encoding for a tail of T10640_P14,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VFIGLFLAFLFWCFGPLW in   	                                                            
						T10640_P14.                                                  	                                                            

						Comparison report between T10640_P14 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P14, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23127 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6065.00                      Escore:       0                                               
						I                                                            	             Matching length:     639                Total length:     660                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P14, a second amino acid sequence being at least 90 % 	    Total Percent Similarity:   96.82      Total Percent Identity:   96.82                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of           	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P14, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	                  .         .         .         .         .  
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITDELKQCKNNLKLLREKGNN                                        	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						homologous to corresponding to amino acids 280 - 660 of      	                  .         .         .         .         .  
						Q9HCH1, which also corresponds to amino acids 380 - 760 of   	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						T10640_P14, and a fourth amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding to amino acids 761 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 787 of T10640_P14, wherein said first amino acid sequence, 	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						second amino acid sequence, third amino acid sequence and    	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||                     |||||||||||||||||||||  
						T10640_P14, comprising a polypeptide being at least 70%,     	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						I                                                            	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10640_P14.3.An	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P14, comprising a polypeptide having a length "n",    	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EK, having a structure as  	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						379-x to 380; and ending at any of amino acid numbers 380+   	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of T10640_P14, comprising a  	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P14.   	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 650                                                          
						                                                            	                  .                                          
						                                                            	     751 LKLLREKGNN                                         760                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 LKLLREKGNN                                         660                                                          

23129	HMR136_T10640_16_tr0_r1_1_gPRT		Comparison report between T10640_P16 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P16, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23129 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P16, a second amino acid    	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 490 - 760 of T10640_P16, and a third amino acid  	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						to amino acids 761 - 787 of T10640_P16, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     690 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 739                                                          
						T10640_P16, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     740 ITDELKQCKNNLKLLREKGNN                              760                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P16.3.An	                                                            
						isolated polypeptide encoding for a tail of T10640_P16,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P16.                   	                                                            

						Comparison report between T10640_P16 and Q9Y681unique head   	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P16, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23129 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     421                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   95.25      Total Percent Identity:   95.25                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P16, a second amino acid sequence being at 	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P16, a third  	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P16, a fourth amino acid     	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						NNPSILQPVPA                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 31 - 401 of Q9Y681, which also corresponds to    	                  .         .         .         .         .  
						amino acids 399 - 769 of T10640_P16, and a fifth amino acid  	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						acids 770 - 787 of T10640_P16, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						isolated polypeptide encoding for a head of T10640_P16,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     699 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 748                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     331 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 380                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                  .         .                                
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	     749 NNLKLLREKGNNPSILQPVPA                              769                                                          
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	         |||||||||||||||||||||                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	     381 NNLKLLREKGNNPSILQPVPA                              401                                                          
						about 95% homologous to the sequence of T10640_P16.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P16, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P16.4.An       	                                                            
						isolated polypeptide encoding for a tail of T10640_P16,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VFIGLFLAFLFWCFGPLW in   	                                                            
						T10640_P16.                                                  	                                                            

						Comparison report between T10640_P16 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P16, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23129 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6065.00                      Escore:       0                                               
						I                                                            	             Matching length:     639                Total length:     660                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P16, a second amino acid sequence being at least 90 % 	    Total Percent Similarity:   96.82      Total Percent Identity:   96.82                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of           	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P16, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	                  .         .         .         .         .  
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITDELKQCKNNLKLLREKGNN                                        	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						homologous to corresponding to amino acids 280 - 660 of      	                  .         .         .         .         .  
						Q9HCH1, which also corresponds to amino acids 380 - 760 of   	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						T10640_P16, and a fourth amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding to amino acids 761 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 787 of T10640_P16, wherein said first amino acid sequence, 	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						second amino acid sequence, third amino acid sequence and    	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||                     |||||||||||||||||||||  
						T10640_P16, comprising a polypeptide being at least 70%,     	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						I                                                            	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10640_P16.3.An	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P16, comprising a polypeptide having a length "n",    	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EK, having a structure as  	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						379-x to 380; and ending at any of amino acid numbers 380+   	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of T10640_P16, comprising a  	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P16.   	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 650                                                          
						                                                            	                  .                                          
						                                                            	     751 LKLLREKGNN                                         760                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 LKLLREKGNN                                         660                                                          

23117	HMR136_T10640_2_tr0_r1_1_gPRT		Comparison report between T10640_P2 and Q8NCW9unique head    	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P2, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23117 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEKLIVEGH 	                        Gaps:       0                        
						LTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKD 	                                                            
						DLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALL                  	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 523 of T10640_P2, a second amino acid     	     524 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 573                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     574 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 623                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 524 - 794 of T10640_P2, and a third amino acid   	     624 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 673                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     674 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 723                                                          
						to amino acids 795 - 821 of T10640_P2, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     724 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 773                                                          
						T10640_P2, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     774 ITDELKQCKNNLKLLREKGNN                              794                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEKLIVEGH 	                                                            
						LTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKD 	                                                            
						DLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALL                  	                                                            
						least about 95% homologous to the sequence of T10640_P2.3.An 	                                                            
						isolated polypeptide encoding for a tail of T10640_P2,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P2.                    	                                                            

						Comparison report between T10640_P2 and Q9Y681unique head    	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P2, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23117 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     455                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   88.13      Total Percent Identity:   88.13                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P2, a second amino acid sequence being at  	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQ 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P2, a third   	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 VDDFLPKINGSTEKEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLS 448                                                          
						having the sequence                                          	                                           ||||||||||||||||  
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEKLIVEGHLTKAVEETKLSK       	      31 ..................................ENQTRAKESDFSDTLS 46                                                           
						corresponding to amino acids 379 - 432 of T10640_P2, a fourth	                  .         .         .         .         .  
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	     449 PSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHL 498                                                          
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	      47 PSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHL 96                                                           
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	                  .         .         .         .         .  
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	     499 RKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQL 548                                                          
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NNPSILQPVPA                                                  	      97 RKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQL 146                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 31 - 401 of Q9Y681, which also  	     549 QRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDI 598                                                          
						corresponds to amino acids 433 - 803 of T10640_P2, and a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fifth amino acid sequence being at least 70%, optionally at  	     147 QRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDI 196                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     599 ASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEA 648                                                          
						polypeptide having the sequence VFIGLFLAFLFWCFGPLW           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 804 - 821 of T10640_P2, wherein 	     197 ASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEA 246                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence, fourth amino acid sequence and    	     649 TRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSL 698                                                          
						fifth amino acid sequence are contiguous and in a sequential 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     247 TRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSL 296                                                          
						T10640_P2, comprising a polypeptide being at least 70%,      	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     699 ELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQK 748                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     297 ELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQK 346                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                  .         .         .         .         .  
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     749 EYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNNPSIL 798                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	     347 EYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNNPSIL 396                                                          
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                                                             
						least about 95% homologous to the sequence of T10640_P2.3.An 	     799 QPVPA                                              803                                                          
						isolated polypeptide encoding for an edge portion of         	         |||||                                               
						T10640_P2, comprising an amino acid sequence being at least  	     397 QPVPA                                              401                                                          
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEKLIVEGHLTKAVEETKLSK,      	                                                            
						corresponding to T10640_P2.4.An isolated polypeptide encoding	                                                            
						for a tail of T10640_P2, comprising a polypeptide being at   	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						VFIGLFLAFLFWCFGPLW in T10640_P2.                             	                                                            

23119	HMR136_T10640_22_tr0_r1_1_gPRT		Comparison report between T10640_P22 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P22, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23119 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P22, a second amino acid    	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 490 - 760 of T10640_P22, and a third amino acid  	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						to amino acids 761 - 787 of T10640_P22, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     690 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 739                                                          
						T10640_P22, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     740 ITDELKQCKNNLKLLREKGNN                              760                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P22.3.An	                                                            
						isolated polypeptide encoding for a tail of T10640_P22,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P22.                   	                                                            

						Comparison report between T10640_P22 and Q9Y681unique head   	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P22, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23119 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     421                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   95.25      Total Percent Identity:   95.25                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P22, a second amino acid sequence being at 	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P22, a third  	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P22, a fourth amino acid     	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						NNPSILQPVPA                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 31 - 401 of Q9Y681, which also corresponds to    	                  .         .         .         .         .  
						amino acids 399 - 769 of T10640_P22, and a fifth amino acid  	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						acids 770 - 787 of T10640_P22, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						isolated polypeptide encoding for a head of T10640_P22,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     699 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 748                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     331 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 380                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                  .         .                                
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	     749 NNLKLLREKGNNPSILQPVPA                              769                                                          
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	         |||||||||||||||||||||                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	     381 NNLKLLREKGNNPSILQPVPA                              401                                                          
						about 95% homologous to the sequence of T10640_P22.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P22, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P22.4.An       	                                                            
						isolated polypeptide encoding for a tail of T10640_P22,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VFIGLFLAFLFWCFGPLW in   	                                                            
						T10640_P22.                                                  	                                                            

						Comparison report between T10640_P22 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P22, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23119 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6065.00                      Escore:       0                                               
						I                                                            	             Matching length:     639                Total length:     660                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P22, a second amino acid sequence being at least 90 % 	    Total Percent Similarity:   96.82      Total Percent Identity:   96.82                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of           	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P22, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	                  .         .         .         .         .  
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ITDELKQCKNNLKLLREKGNN                                        	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						homologous to corresponding to amino acids 280 - 660 of      	                  .         .         .         .         .  
						Q9HCH1, which also corresponds to amino acids 380 - 760 of   	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						T10640_P22, and a fourth amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding to amino acids 761 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 787 of T10640_P22, wherein said first amino acid sequence, 	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						second amino acid sequence, third amino acid sequence and    	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||                     |||||||||||||||||||||  
						T10640_P22, comprising a polypeptide being at least 70%,     	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						I                                                            	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10640_P22.3.An	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P22, comprising a polypeptide having a length "n",    	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EK, having a structure as  	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						379-x to 380; and ending at any of amino acid numbers 380+   	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                  .         .         .         .         .  
						polypeptide encoding for a tail of T10640_P22, comprising a  	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P22.   	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 650                                                          
						                                                            	                  .                                          
						                                                            	     751 LKLLREKGNN                                         760                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 LKLLREKGNN                                         660                                                          

23115	HMR136_T10640_23_tr0_r1_1_gPRT		Comparison report between T10640_P23 and Q8NCW9unique head   	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P23, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23115 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2182.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     226                Total length:     226                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P23, a second amino acid    	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKE               	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 226 of Q8NCW9, which also corresponds to     	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 490 - 715 of T10640_P23, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						having the sequence VKRKDIMSPIMVGLKAKSKSDIHAS corresponding  	                  .         .         .         .         .  
						to amino acids 716 - 740 of T10640_P23, wherein said first   	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .                                
						T10640_P23, comprising a polypeptide being at least 70%,     	     690 QHLRDSADLKTLLSKAENQAKDVQKE                         715                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||                          
						more preferably at least about 90% and most preferably at    	     201 QHLRDSADLKTLLSKAENQAKDVQKE                         226                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                                                            
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P23.3.An	                                                            
						isolated polypeptide encoding for a tail of T10640_P23,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						VKRKDIMSPIMVGLKAKSKSDIHAS in T10640_P23.                     	                                                            

						Comparison report between T10640_P23 and Q9Y681unique head   	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P23, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23115 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3245.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     347                Total length:     367                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   94.55      Total Percent Identity:   94.55                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P23, a second amino acid sequence being at 	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P23, a third  	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P23, a fourth amino acid     	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKE                                            	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 31 - 347 of Q9Y681, which also corresponds to    	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 399 - 715 of T10640_P23, and a fifth amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						having the sequence VKRKDIMSPIMVGLKAKSKSDIHAS corresponding  	                  .         .         .         .         .  
						to amino acids 716 - 740 of T10640_P23, wherein said first   	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						amino acid sequence, second amino acid sequence, third amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, fourth amino acid sequence and fifth amino    	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of T10640_P23,      	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						preferably at least about 90% and most preferably at least   	                  .                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     699 KTLLSKAENQAKDVQKE                                  715                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||                                   
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     331 KTLLSKAENQAKDVQKE                                  347                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                                                            
						about 95% homologous to the sequence of T10640_P23.3.An      	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P23, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P23.4.An       	                                                            
						isolated polypeptide encoding for a tail of T10640_P23,      	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						VKRKDIMSPIMVGLKAKSKSDIHAS in T10640_P23.                     	                                                            

						Comparison report between T10640_P23 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P23, comprising a first amino	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23115 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 5623.00                      Escore:       0                                               
						I                                                            	             Matching length:     594                Total length:     615                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P23, a second amino acid sequence being at least 90 % 	    Total Percent Similarity:   96.59      Total Percent Identity:   96.59                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of           	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P23, a third amino acid sequence being at least 90 %  	                  .         .         .         .         .  
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	                  .         .         .         .         .  
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKE                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 280 - 615 of      	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						Q9HCH1, which also corresponds to amino acids 380 - 715 of   	                  .         .         .         .         .  
						T10640_P23, and a fourth amino acid sequence being at least  	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						VKRKDIMSPIMVGLKAKSKSDIHAS corresponding to amino acids 716 - 	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						740 of T10640_P23, wherein said first amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence, third amino acid sequence and    	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						T10640_P23, comprising a polypeptide being at least 70%,     	         ||||||||                     |||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						I                                                            	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						least about 95% homologous to the sequence of T10640_P23.3.An	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						T10640_P23, comprising a polypeptide having a length "n",    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						at least two amino acids comprise EK, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						379-x to 380; and ending at any of amino acid numbers 380+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						polypeptide encoding for a tail of T10640_P23, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						to the sequence VKRKDIMSPIMVGLKAKSKSDIHAS in T10640_P23.     	                  .         .         .         .         .  
						                                                            	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .                                          
						                                                            	     701 LLSKAENQAKDVQKE                                    715                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     601 LLSKAENQAKDVQKE                                    615                                                          

23131	HMR136_T10640_24_tr0_r1_1_gPRT		Comparison report between T10640_P24 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P24, comprising a   	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23131 x Q9HCH1   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3235.00                      Escore:       0                                               
						I                                                            	             Matching length:     345                Total length:     379                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 121 of T10640_P24, a second amino acid sequence being at 	    Total Percent Similarity:   91.03      Total Percent Identity:   91.03                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQ                                            	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						least 90 % homologous to corresponding to amino acids 1 - 257	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9HCH1, which also corresponds to amino acids 122 - 378 of	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P24, a third amino acid sequence being at least 70%,  	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEK corresponding to amino    	                  .         .         .         .         .  
						acids 379 - 412 of T10640_P24, a fourth amino acid sequence  	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						EHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKSSDDTTDAQMDEQDLNEPLAKVSLLK                                 	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 258 - 345 of Q9HCH1, which also corresponds to amino   	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						acids 413 - 500 of T10640_P24, and a fifth amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						having the sequence GTLTCFYDIVNQGIKSPFAIKSVLDIM corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 501 - 527 of T10640_P24, wherein said first   	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence, fourth amino acid sequence and fifth amino    	     372 ERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSGG 421                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         |||||||                                  |||||||||  
						isolated polypeptide encoding for a head of T10640_P24,      	     251 ERLTALQ..................................EHLLSKSGG 266                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     422 DCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPS 471                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     267 DCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPS 316                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                  .         .                                
						I                                                            	     472 KEKSSDDTTDAQMDEQDLNEPLAKVSLLK                      500                                                          
						about 95% homologous to the sequence of T10640_P24.3.An      	         |||||||||||||||||||||||||||||                       
						isolated polypeptide encoding for an edge portion of         	     317 KEKSSDDTTDAQMDEQDLNEPLAKVSLLK                      345                                                          
						T10640_P24, comprising an amino acid sequence being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEK, corresponding to         	                                                            
						T10640_P24.4.An isolated polypeptide encoding for a tail of  	                                                            
						T10640_P24, comprising a polypeptide being at least 70%,     	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						GTLTCFYDIVNQGIKSPFAIKSVLDIM in T10640_P24.                   	                                                            

23107	HMR136_T10640_25_tr0_r1_1_gPRT		Comparison report between T10640_P25 and Q9HCH1unique head   	Sequence name: Q9HCH1                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P25, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23107 x Q9HCH1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						I                                                            	                     Quality: 2482.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     257                Total length:     257                                               
						to amino acids 1 - 121 of T10640_P25, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                        Gaps:       0                        
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	                                                            
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	Alignment:                                                   
						ALQADNDFTNERLTALQ                                            	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						amino acids 1 - 257 of Q9HCH1, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 122 - 378 of T10640_P25, and a third amino acid  	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GK corresponding to amino acids 379 - 380	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						of T10640_P25, wherein said first amino acid sequence, second	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T10640_P25, comprising a  	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                  .         .         .         .         .  
						I                                                            	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						to the sequence of T10640_P25.                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						                                                            	                                                             
						                                                            	     372 ERLTALQ                                            378                                                          
						                                                            	         |||||||                                             
						                                                            	     251 ERLTALQ                                            257                                                          

23111	HMR136_T10640_3_tr0_r1_1_gPRT		Comparison report between T10640_P3 and Q9HCH1unique head    	Sequence name: Q9HCH1                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23111 x Q9HCH1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						I                                                            	                     Quality: 2482.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     257                Total length:     257                                               
						to amino acids 1 - 121 of T10640_P3, a second amino acid     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                        Gaps:       0                        
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	                                                            
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	Alignment:                                                   
						ALQADNDFTNERLTALQ                                            	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						amino acids 1 - 257 of Q9HCH1, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 122 - 378 of T10640_P3, and a third amino acid   	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GK corresponding to amino acids 379 - 380	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						of T10640_P3, wherein said first amino acid sequence, second 	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of T10640_P3, comprising a   	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                  .         .         .         .         .  
						I                                                            	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						to the sequence of T10640_P3.                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						                                                            	                                                             
						                                                            	     372 ERLTALQ                                            378                                                          
						                                                            	         |||||||                                             
						                                                            	     251 ERLTALQ                                            257                                                          

23113	HMR136_T10640_5_tr0_r1_1_gPRT		Comparison report between T10640_P5 and Q8NCW9unique head    	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23113 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSG 	                        Gaps:       0                        
						GDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTT 	                                                            
						DAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFEL 	Alignment:                                                   
						QALL                                                         	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     545 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 594                                                          
						to amino acids 1 - 544 of T10640_P5, a second amino acid     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	                  .         .         .         .         .  
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	     595 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 644                                                          
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	     645 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 694                                                          
						amino acids 545 - 815 of T10640_P5, and a third amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     695 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 744                                                          
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 816 - 842 of T10640_P5, wherein said first    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     745 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 794                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P5, comprising a polypeptide being at least 70%,      	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .                                
						more preferably at least about 90% and most preferably at    	     795 ITDELKQCKNNLKLLREKGNN                              815                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         |||||||||||||||||||||                               
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                                                            
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSG 	                                                            
						GDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTT 	                                                            
						DAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFEL 	                                                            
						QALL                                                         	                                                            
						least about 95% homologous to the sequence of T10640_P5.3.An 	                                                            
						isolated polypeptide encoding for a tail of T10640_P5,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P5.                    	                                                            

						Comparison report between T10640_P5 and Q9Y681unique head    	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P5, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23113 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     476                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   84.24      Total Percent Identity:   84.24                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P5, a second amino acid sequence being at  	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQVRLEHLQEKTLKECSSLGIQ 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P5, a third   	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 VDDFLPKINGSTEKEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEE 448                                                          
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSGGDCTFIHQFIECQKKLIV 	                                                            
						EGHLTKAVEETKLSK                                              	      30 .................................................. 30                                                           
						having the sequence corresponding to amino acids 379 - 453 of	                  .         .         .         .         .  
						T10640_P5, a fourth amino acid sequence being at least 90 %  	     449 TKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSL 498                                                          
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	              |||||||||||||||||||||||||||||||||||||||||||||  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	      31 .....ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSL 75                                                           
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	                  .         .         .         .         .  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	     499 LKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEER 548                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	      76 LKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEER 125                                                          
						NNPSILQPVPA                                                  	                  .         .         .         .         .  
						homologous to corresponding to amino acids 31 - 401 of       	     549 KAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSAR 598                                                          
						Q9Y681, which also corresponds to amino acids 454 - 824 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P5, and a fifth amino acid sequence being at least    	     126 KAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSAR 175                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     599 DEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEIT 648                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFIGLFLAFLFWCFGPLW corresponding to amino acids 825 - 842 of 	     176 DEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEIT 225                                                          
						T10640_P5, wherein said first amino acid sequence, second    	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, fourth amino 	     649 SLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENV 698                                                          
						acid sequence and fifth amino acid sequence are contiguous   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     226 SLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENV 275                                                          
						for a head of T10640_P5, comprising a polypeptide being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     699 LLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLR 748                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     276 LLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLR 325                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                  .         .         .         .         .  
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     749 DSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDE 798                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	     326 DSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDE 375                                                          
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                  .         .                                
						preferably at least about 95% homologous to the sequence of  	     799 LKQCKNNLKLLREKGNNPSILQPVPA                         824                                                          
						T10640_P5.3.An isolated polypeptide encoding for an edge     	         ||||||||||||||||||||||||||                          
						portion of T10640_P5, comprising an amino acid sequence being	     376 LKQCKNNLKLLREKGNNPSILQPVPA                         401                                                          
						at least 70%, optionally at least about 80%, preferably at   	                                                            
						least about 85%, more preferably at least about 90% and most 	                                                            
						preferably at least about 95% homologous to the sequence     	                                                            
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSGGDCTFIHQFIECQKKLIV 	                                                            
						EGHLTKAVEETKLSK,                                             	                                                            
						encoding for corresponding to T10640_P5.4.An isolated        	                                                            
						polypeptide encoding for a tail of T10640_P5, comprising a   	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VFIGLFLAFLFWCFGPLW in T10640_P5.             	                                                            

						Comparison report between T10640_P5 and Q9HCH1unique head    	Sequence name: Q9HCH1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P5, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23113 x Q9HCH1   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6280.00                      Escore:       0                                               
						I                                                            	             Matching length:     660                Total length:     694                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						1 - 121 of T10640_P5, a second amino acid sequence being at  	    Total Percent Similarity:   95.10      Total Percent Identity:   95.10                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQ                                            	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						least 90 % homologous to corresponding to amino acids 1 - 257	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of Q9HCH1, which also corresponds to amino acids 122 - 378 of	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						T10640_P5, a third amino acid sequence being at least 70%,   	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEK corresponding to amino    	                  .         .         .         .         .  
						acids 379 - 412 of T10640_P5, a fourth amino acid sequence   	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						EHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELART 	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						SKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRD 	                  .         .         .         .         .  
						ELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQN 	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						SFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYE 	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						KTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNN                  	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						acids 258 - 660 of Q9HCH1, which also corresponds to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 413 - 815 of T10640_P5, and a fifth amino acid sequence	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     372 ERLTALQVRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEKEHLLSKSGG 421                                                          
						at least 95% homologous to a polypeptide having the sequence 	         |||||||                                  |||||||||  
						PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding to amino acids 816 	     251 ERLTALQ..................................EHLLSKSGG 266                                                          
						- 842 of T10640_P5, wherein said first amino acid sequence,  	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence, fourth	     422 DCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPS 471                                                          
						amino acid sequence and fifth amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     267 DCTFIHQFIECQKKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPS 316                                                          
						polypeptide encoding for a head of T10640_P5, comprising a   	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     472 KEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRK 521                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     317 KEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRK 366                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                  .         .         .         .         .  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     522 ELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQR 571                                                          
						I                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of T10640_P5.3.An isolated polypeptide       	     367 ELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQR 416                                                          
						encoding for an edge portion of T10640_P5, comprising an     	                  .         .         .         .         .  
						amino acid sequence being at least 70%, optionally at least  	     572 LHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIAS 621                                                          
						about 80%, preferably at least about 85%, more preferably at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 90% and most preferably at least about 95%       	     417 LHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIAS 466                                                          
						homologous to the sequence encoding for                      	                  .         .         .         .         .  
						VRLEHLQEKTLKECSSLGIQVDDFLPKINGSTEK, corresponding to         	     622 LQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATR 671                                                          
						T10640_P5.4.An isolated polypeptide encoding for a tail of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10640_P5, comprising a polypeptide being at least 70%,      	     467 LQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATR 516                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     672 LQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLEL 721                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P5.                    	     517 LQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLEL 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     722 TSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEY 771                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 TSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEY 616                                                          
						                                                            	                  .         .         .         .            
						                                                            	     772 EKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNN       815                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     617 EKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNN       660                                                          

23125	HMR136_T10640_6_tr0_r1_1_gPRT		Comparison report between T10640_P6 and Q8NCW9unique head    	Sequence name: Q8NCW9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10640_P6, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23125 x Q8NCW9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	Alignment segment 1/1:                                       
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                                                            
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                     Quality: 2624.00                      Escore:       0                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	             Matching length:     271                Total length:     271                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                        Gaps:       0                        
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 489 of T10640_P6, a second amino acid     	     490 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 539                                                          
						EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQ 	       1 EEERKAYRNQVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDEL 50                                                           
						QREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSD 	                  .         .         .         .         .  
						LSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLK 	     540 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 589                                                          
						FEMTEQEKQSITDELKQCKNNLKLLREKGNN                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 LSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYE 100                                                          
						amino acids 1 - 271 of Q8NCW9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 490 - 760 of T10640_P6, and a third amino acid   	     590 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 639                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 KEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLK 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW corresponding	     640 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 689                                                          
						to amino acids 761 - 787 of T10640_P6, wherein said first    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 RENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKE 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     690 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 739                                                          
						T10640_P6, comprising a polypeptide being at least 70%,      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 QHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	     740 ITDELKQCKNNLKLLREKGNN                              760                                                          
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	         |||||||||||||||||||||                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	     251 ITDELKQCKNNLKLLREKGNN                              271                                                          
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	                                                            
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	                                                            
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKI 	                                                            
						EALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKS 	                                                            
						SDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQ 	                                                            
						KCFELQALL                                                    	                                                            
						least about 95% homologous to the sequence of T10640_P6.3.An 	                                                            
						isolated polypeptide encoding for a tail of T10640_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P6.                    	                                                            

						Comparison report between T10640_P6 and Q9Y681unique head    	Sequence name: Q9Y681                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a followed by a unique tail.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for T10640_P6, comprising a    	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 23125 x Q9Y681   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 3775.00                      Escore:       0                                               
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	             Matching length:     401                Total length:     421                                               
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	    Total Percent Similarity:   95.25      Total Percent Identity:   95.25                                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	                        Gaps:       1                        
						polypeptide having the sequence corresponding to amino acids 	                                                            
						1 - 348 of T10640_P6, a second amino acid sequence being at  	Alignment:                                                   
						least 90 % homologous to MEEKEQELQAKIEALQADNDFTNERLTALQ      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 30 of Q9Y681, which also    	     349 MEEKEQELQAKIEALQADNDFTNERLTALQEKLIVEGHLTKAVEETKLSK 398                                                          
						corresponds to amino acids 349 - 378 of T10640_P6, a third   	         ||||||||||||||||||||||||||||||                      
						amino acid sequence being at least 70%, optionally at least  	       1 MEEKEQELQAKIEALQADNDFTNERLTALQ.................... 30                                                           
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	     399 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 448                                                          
						having the sequence EKLIVEGHLTKAVEETKLSK corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 379 - 398 of T10640_P6, a fourth amino acid      	      31 ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDL 80                                                           
						ENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQGAQSEIEAK 	                  .         .         .         .         .  
						QEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQVEESTKQIQVLQAQLQRLH 	     449 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 498                                                          
						IDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASERDTDIASLQEELKKVRAEL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSL 	      81 QGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRN 130                                                          
						KRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 	                  .         .         .         .         .  
						KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKG 	     499 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 548                                                          
						NNPSILQPVPA                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     131 QVEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILL 180                                                          
						amino acids 31 - 401 of Q9Y681, which also corresponds to    	                  .         .         .         .         .  
						amino acids 399 - 769 of T10640_P6, and a fifth amino acid   	     549 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 598                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     181 LHQAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNS 230                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence VFIGLFLAFLFWCFGPLW corresponding to amino	     599 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 648                                                          
						acids 770 - 787 of T10640_P6, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, third amino acid       	     231 FQLRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSE 280                                                          
						sequence, fourth amino acid sequence and fifth amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	     649 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 698                                                          
						isolated polypeptide encoding for a head of T10640_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     281 LQRQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADL 330                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     699 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 748                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     331 KTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCK 380                                                          
						IVSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQ 	                  .         .                                
						MLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKEL 	     749 NNLKLLREKGNNPSILQPVPA                              769                                                          
						IALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEEL 	         |||||||||||||||||||||                               
						RELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDE             	     381 NNLKLLREKGNNPSILQPVPA                              401                                                          
						about 95% homologous to the sequence of T10640_P6.3.An       	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						T10640_P6, comprising an amino acid sequence being at least  	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						EKLIVEGHLTKAVEETKLSK, corresponding to T10640_P6.4.An        	                                                            
						isolated polypeptide encoding for a tail of T10640_P6,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence VFIGLFLAFLFWCFGPLW in   	                                                            
						T10640_P6.                                                   	                                                            

						Comparison report between T10640_P6 and Q9HCH1unique head    	Sequence name: Q9HCH1                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for T10640_P6, comprising a first amino 	                                                            
						acid sequence being at least 70%, optionally at least 80%,   	Alignment of: 23125 x Q9HCH1   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	                                                            
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	                     Quality: 6065.00                      Escore:       0                                               
						I                                                            	             Matching length:     639                Total length:     660                                               
						having the sequence corresponding to amino acids 1 - 121 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						T10640_P6, a second amino acid sequence being at least 90 %  	    Total Percent Similarity:   96.82      Total Percent Identity:   96.82                                               
						VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQYLQEALHREQM 	                        Gaps:       1                        
						LEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMGNQLQACSKNQTEDSLRKELI 	                                                            
						ALQEDKHNYETTAKESLRRVLQEKIEVVRKLSEVERSLSNTEDECTHLKEMNERTQEELR 	Alignment:                                                   
						ELANKYNGAVNEIKDLSDKLKVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIE 	                  .         .         .         .         .  
						ALQADNDFTNERLTALQE                                           	     122 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 171                                                          
						homologous to corresponding to amino acids 1 - 258 of Q9HCH1,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which also corresponds to amino acids 122 - 379 of T10640_P6,	       1 VSTIKLFLPDGMEARLRSDVIHAPLPSPVDKVAANTPSMYSQELFQLSQY 50                                                           
						KLIVEGHLTKAVEETKLSKENQTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLA 	                  .         .         .         .         .  
						KVSLLKDDLQGAQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQ 	     172 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 221                                                          
						VEESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLHQAAAKVASE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQLRCQQCEDQQREEATRLQG 	      51 LQEALHREQMLEQKLATLQRLLAITQEASDTSWQALIDEDRLLSRLEVMG 100                                                          
						ELEKLRKEWNALETECHSLKRENVLLSSELQRQEKELHNSQKQSLELTSDLSILQMSRKE 	                  .         .         .         .         .  
						LENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQS 	     222 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 271                                                          
						ITDELKQCKNNLKLLREKGNN                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 90 % homologous to	     101 NQLQACSKNQTEDSLRKELIALQEDKHNYETTAKESLRRVLQEKIEVVRK 150                                                          
						corresponding to amino acids 280 - 660 of Q9HCH1, which also 	                  .         .         .         .         .  
						corresponds to amino acids 380 - 760 of T10640_P6, and a     	     272 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 321                                                          
						fourth amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     151 LSEVERSLSNTEDECTHLKEMNERTQEELRELANKYNGAVNEIKDLSDKL 200                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence PSILQPVPAVFIGLFLAFLFWCFGPLW  	     322 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 371                                                          
						corresponding to amino acids 761 - 787 of T10640_P6, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     201 KVAEGKQEEIQQKGQAEKKELQHKIDEMEEKEQELQAKIEALQADNDFTN 250                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     372 ERLTALQE.....................KLIVEGHLTKAVEETKLSKEN 400                                                          
						polypeptide encoding for a head of T10640_P6, comprising a   	         ||||||||                     |||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     251 ERLTALQEHLLSKSGGDCTFIHQFIECQKKLIVEGHLTKAVEETKLSKEN 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     401 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 450                                                          
						MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGC 	     301 QTRAKESDFSDTLSPSKEKSSDDTTDAQMDEQDLNEPLAKVSLLKDDLQG 350                                                          
						I                                                            	                  .         .         .         .         .  
						to the sequence of T10640_P6.3.An isolated chimeric          	     451 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 500                                                          
						polypeptide encoding for an edge portion of T10640_P6,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     351 AQSEIEAKQEIQHLRKELIEAQELARTSKQKCFELQALLEEERKAYRNQV 400                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     501 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 550                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     401 EESTKQIQVLQAQLQRLHIDTENLREEKDSEITSTRDELLSARDEILLLH 450                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise EK, having a structure as follows: a sequence       	     551 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 600                                                          
						starting from any of amino acid numbers 379-x to 380; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 380+ ((n-2) - x), in     	     451 QAAAKVASERDTDIASLQEELKKVRAELERWRKAASEYEKEITSLQNSFQ 500                                                          
						which x varies from 0 to n-2.4.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of T10640_P6, comprising a polypeptide   	     601 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 650                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     501 LRCQQCEDQQREEATRLQGELEKLRKEWNALETECHSLKRENVLLSSELQ 550                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						PSILQPVPAVFIGLFLAFLFWCFGPLW in T10640_P6.                    	     651 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 RQEKELHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKT 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 LLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNN 650                                                          
						                                                            	                  .                                          
						                                                            	     751 LKLLREKGNN                                         760                                                          
						                                                            	         ||||||||||                                          
						                                                            	     651 LKLLREKGNN                                         660                                                          

23279	HMR136_T10647_14_tr0_r1_1_gPRT		Comparison report between T10647_P14 and Q9UPZ8partial WT    	Sequence name: Q9UPZ8                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10647_P14, comprising a first amino	Sequence documentation:                                      
						MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 	                                                            
						IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 	Alignment of: 23279 x Q9UPZ8   ..                            
						GDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKG 	                                                            
						QDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTV 	Alignment segment 1/1:                                       
						ISLLLEAGANVDAQNIK                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2544.00                      Escore:       0                                               
						to amino acids 36 - 292 of Q9UPZ8, which also corresponds to 	             Matching length:     257                Total length:     257                                               
						amino acids 1 - 257 of T10647_P14, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence AILRCHMAL corresponding to amino acids   	Alignment:                                                   
						258 - 266 of T10647_P14, wherein said first amino acid       	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRK 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T10647_P14, comprising a polypeptide being at least  	      36 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRK 85                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 100                                                          
						at least about 95% homologous to the sequence AILRCHMAL in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10647_P14.                                                  	      86 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 135                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     136 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 185                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     186 SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYR 235                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 THSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     236 THSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 285                                                          
						                                                            	                                                             
						                                                            	     251 VDAQNIK                                            257                                                          
						                                                            	         |||||||                                             
						                                                            	     286 VDAQNIK                                            292                                                          

						Comparison report between T10647_P14 and O75407short unique  	Sequence name: O75407                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10647_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23279 x O75407   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MQ           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of T10647_P14, a second   	                                                            
						REEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWDIV 	                     Quality: 1790.00                      Escore:       0                                               
						KATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGD 	             Matching length:     180                Total length:     180                                               
						LNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQD 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 180 of O75407, which also   	                        Gaps:       0                        
						corresponds to amino acids 3 - 182 of T10647_P14, and a third	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	       3 REEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTH 52                                                           
						VDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVIS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLLEAGANVDAQNIKAILRCHMAL                                     	       1 REEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTH 50                                                           
						having the sequence corresponding to amino acids 183 - 266 of	                  .         .         .         .         .  
						T10647_P14, wherein said first amino acid sequence, second   	      53 IDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNR 102                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	      51 IDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNR 100                                                          
						polypeptide encoding for a tail of T10647_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     103 IDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSL 152                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     101 IDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSL 150                                                          
						VDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVIS 	                  .         .         .                      
						LLLEAGANVDAQNIKAILRCHMAL                                     	     153 IDGEGCSCIHLAAQFGHTSIVAYLIAKGQD                     182                                                          
						to the sequence in T10647_P14.                               	         ||||||||||||||||||||||||||||||                      
						                                                            	     151 IDGEGCSCIHLAAQFGHTSIVAYLIAKGQD                     180                                                          

						Comparison report between T10647_P14 and AAH30990unique head 	Sequence name: AAH30990                                      
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for T10647_P14, comprising a first amino	Sequence documentation:                                      
						acid sequence being at least 70%, optionally at least 80%,   	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment of: 23279 x AAH30990   ..                          
						most preferably at least 95% homologous to a polypeptide     	                                                            
						MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 	Alignment segment 1/1:                                       
						IVKATQ                                                       	                                                            
						having the sequence corresponding to amino acids 1 - 66 of   	                     Quality: 1957.00                      Escore:       0                                               
						T10647_P14, and a second amino acid sequence being at least  	             Matching length:     200                Total length:     200                                               
						YGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMM 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						DQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLE 	                        Gaps:       0                        
						AGANVDAQNIKAILRCHMAL                                         	                                                            
						90 % homologous to corresponding to amino acids 77 - 276 of  	Alignment:                                                   
						AAH30990, which also corresponds to amino acids 67 - 266 of  	                  .         .         .         .         .  
						T10647_P14, wherein said first amino acid sequence and second	      67 YGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIV 116                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      77 YGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIV 126                                                          
						T10647_P14, comprising a polypeptide being at least 70%,     	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     117 DQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQ 166                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 	     127 DQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQ 176                                                          
						IVKATQ                                                       	                  .         .         .         .         .  
						least about 95% homologous to the sequence of T10647_P14.    	     167 FGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVS 216                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     177 FGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVS 226                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     217 VNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKAILRCHMAL 266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     227 VNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKAILRCHMAL 276                                                          

						Comparison report between T10647_P14 and Q9P088unique head   	Sequence name: Q9P088                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10647_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23279 x Q9P088   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MQR          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of T10647_P14, a second   	                                                            
						EEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWDIVK 	                     Quality: 1772.00                      Escore:       0                                               
						ATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDL 	             Matching length:     179                Total length:     179                                               
						NSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQ   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.44                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:   99.44                                               
						corresponding to amino acids 2 - 179 of Q9P088, which also   	                        Gaps:       0                        
						corresponds to amino acids 4 - 181 of T10647_P14, and a third	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment:                                                   
						80%, preferably at least 85%, more preferably at least 90%   	                  .         .         .         .         .  
						and most preferably at least 95% homologous to a polypeptide 	       4 EEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHI 53                                                           
						DVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLLLEAGANVDAQNIKAILRCHMAL                                    	       2 EEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHI 51                                                           
						having the sequence corresponding to amino acids 182 - 266 of	                  .         .         .         .         .  
						T10647_P14, wherein said first amino acid sequence, second   	      54 DDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRI 103                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	      52 DDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRI 101                                                          
						polypeptide encoding for a head of T10647_P14, comprising a  	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     104 DLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 153                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     102 DLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 151                                                          
						to the sequence MQR of T10647_P14.3.An isolated polypeptide  	                  .         .                                
						encoding for a tail of T10647_P14, comprising a polypeptide  	     154 DGEGCSCIHLAAQFGHTSIVAYLIAKGQD                      182                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||:                       
						at least about 85%, more preferably at least about 90% and   	     152 DGEGCSCIHLAAQFGHTSIVAYLIAKGQE                      180                                                          
						DVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVI 	                                                            
						SLLLEAGANVDAQNIKAILRCHMAL                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in T10647_P14.                                               	                                                            

						Comparison report between T10647_P14 and AAH50324partial WT  	Sequence name: AAH50324                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10647_P14, comprising a first amino	Sequence documentation:                                      
						MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 	                                                            
						IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 	Alignment of: 23279 x AAH50324   ..                          
						GDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKG 	                                                            
						QDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTV 	Alignment segment 1/1:                                       
						ISLLLEAGANVDAQNIK                                            	                                                            
						acid sequence being at least 90 % homologous to corresponding	                     Quality: 2544.00                      Escore:       0                                               
						to amino acids 1 - 257 of AAH50324, which also corresponds to	             Matching length:     257                Total length:     257                                               
						amino acids 1 - 257 of T10647_P14, and a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 70%, optionally at least 80%,        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	                        Gaps:       0                        
						most preferably at least 95% homologous to a polypeptide     	                                                            
						having the sequence AILRCHMAL corresponding to amino acids   	Alignment:                                                   
						258 - 266 of T10647_P14, wherein said first amino acid       	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRK 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of T10647_P14, comprising a polypeptide being at least  	       1 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRK 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 100                                                          
						at least about 95% homologous to the sequence AILRCHMAL in   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10647_P14.                                                  	      51 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 THSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 THSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 250                                                          
						                                                            	                                                             
						                                                            	     251 VDAQNIK                                            257                                                          
						                                                            	         |||||||                                             
						                                                            	     251 VDAQNIK                                            257                                                          

						Comparison report between T10647_P14 and BAC77366unique head 	Sequence name: BAC77366                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10647_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23279 x BAC77366   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MQREEGFNTK   	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 10 of T10647_P14, a second  	                                                            
						MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWDIVKATQYGIY 	                     Quality: 2441.00                      Escore:       0                                               
						ERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHW 	             Matching length:     247                Total length:     247                                               
						ATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VDAQNIK                                                      	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 247 of BAC77366, which also 	Alignment:                                                   
						corresponds to amino acids 11 - 257 of T10647_P14, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	      11 MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 60                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 50                                                           
						polypeptide having the sequence AILRCHMAL corresponding to   	                  .         .         .         .         .  
						amino acids 258 - 266 of T10647_P14, wherein said first amino	      61 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYI 110                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	      51 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYI 100                                                          
						isolated polypeptide encoding for a head of T10647_P14,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     111 SKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSC 160                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     101 SKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSC 150                                                          
						about 95% homologous to the sequence MQREEGFNTK of           	                  .         .         .         .         .  
						T10647_P14.3.An isolated polypeptide encoding for a tail of  	     161 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLL 210                                                          
						T10647_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLL 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						least about 95% homologous to the sequence AILRCHMAL in      	     211 LTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIK    257                                                          
						T10647_P14.                                                  	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     201 LTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIK    247                                                          

						Comparison report between T10647_P14 and BAC77388unique head 	Sequence name: BAC77388                                      
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10647_P14, comprising a first amino acid sequence being at  	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23279 x BAC77388   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MQREEGFNTK   	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 10 of T10647_P14, a second  	                                                            
						MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWDIVKATQYGIY 	                     Quality: 2441.00                      Escore:       0                                               
						ERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHW 	             Matching length:     247                Total length:     247                                               
						ATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGAN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VDAQNIK                                                      	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 247 of BAC77388, which also 	Alignment:                                                   
						corresponds to amino acids 11 - 257 of T10647_P14, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	      11 MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 60                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWD 50                                                           
						polypeptide having the sequence AILRCHMAL corresponding to   	                  .         .         .         .         .  
						amino acids 258 - 266 of T10647_P14, wherein said first amino	      61 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYI 110                                                          
						acid sequence, second amino acid sequence and third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence are contiguous and in a sequential order.2.An  	      51 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYI 100                                                          
						isolated polypeptide encoding for a head of T10647_P14,      	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     111 SKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSC 160                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     101 SKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSC 150                                                          
						about 95% homologous to the sequence MQREEGFNTK of           	                  .         .         .         .         .  
						T10647_P14.3.An isolated polypeptide encoding for a tail of  	     161 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLL 210                                                          
						T10647_P14, comprising a polypeptide being at least 70%,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLL 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						least about 95% homologous to the sequence AILRCHMAL in      	     211 LTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIK    257                                                          
						T10647_P14.                                                  	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     201 LTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIK    247                                                          

						Comparison report between T10647_P14 and Q8IUH5partial WT    	Sequence name: Q8IUH5                                        
						sequence followed by mismatch, followed by a short unique    	                                                            
						deletion and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for T10647_P14, comprising a   	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment of: 23279 x Q8IUH5   ..                            
						MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSH corresponding to amino	                                                            
						acids 1 - 38 of Q8IUH5, which also corresponds to amino acids	Alignment segment 1/1:                                       
						1 - 38 of T10647_P14, a bridging amino acid Y corresponding  	                                                            
						to amino acid 39 of T10647_P14, a second amino acid sequence 	                     Quality: 2436.00                      Escore:       0                                               
						NHGYGEPLGRKTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAI 	             Matching length:     257                Total length:     258                                               
						NNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.61                                               
						CIHLAAQFGHTSI                                                	    Total Percent Similarity:   99.61      Total Percent Identity:   99.22                                               
						being at least 90 % homologous to corresponding to amino     	                        Gaps:       1                        
						acids 40 - 172 of Q8IUH5, which also corresponds to amino    	                                                            
						acids 40 - 172 of T10647_P14, a third amino acid sequence    	Alignment:                                                   
						VAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWA 	                  .         .         .         .         .  
						VLAGNTTVISLLLEAGANVDAQNIK                                    	       1 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRK 50                                                           
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||:|||||||||||  
						acids 174 - 258 of Q8IUH5, which also corresponds to amino   	       1 MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHFNHGYGEPLGRK 50                                                           
						acids 173 - 257 of T10647_P14, and a fourth amino acid       	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      51 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 100                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAIN 100                                                          
						having the sequence AILRCHMAL corresponding to amino acids   	                  .         .         .         .         .  
						258 - 266 of T10647_P14, wherein said first amino acid       	     101 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 150                                                          
						sequence, bridging amino acid, second amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     101 NRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADP 150                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of T10647_P14,      	     151 SLIDGEGCSCIHLAAQFGHTSI.VAYLIAKGQDVDMMDQNGMTPLMWAAY 199                                                          
						comprising a polypeptide having a length "n", wherein n is at	         |||||||||||||||||||||| |||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     151 SLIDGEGCSCIHLAAQFGHTSIVVAYLIAKGQDVDMMDQNGMTPLMWAAY 200                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     200 RTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 249                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     201 RTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 250                                                          
						comprise IV, having a structure as follows: a sequence       	                                                             
						starting from any of amino acid numbers 173-x to 173; and    	     250 NVDAQNIK                                           257                                                          
						ending at any of amino acid numbers 173+ ((n-2) - x), in     	         ||||||||                                            
						which x varies from 0 to n-2.3.An isolated polypeptide       	     251 NVDAQNIK                                           258                                                          
						encoding for a tail of T10647_P14, comprising a polypeptide  	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						AILRCHMAL in T10647_P14.                                     	                                                            

23417	HMR136_T10653_1_tr0_r1_1_gPRT		Comparison report between T10653_P1 and Q9NVT5partial WT     	Sequence name: Q9NVT5                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10653_P1, comprising a first amino acid sequence being at   	                                                            
						MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYFESMEDVEVEN 	Alignment of: 23417 x Q9NVT5   ..                            
						ETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAIISRVQCRIVALDLRSHGETKV 	                                                            
						KNPEDLSAETMAKDVGNVVEAMYGDLPPPIMLIGHSMGGAIAVHTASSNLVPSLLGLCMI 	Alignment segment 1/1:                                       
						DVVEGTAMDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEG 	                                                            
						ITSPEGSKSIVEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 	                     Quality: 3716.00                      Escore:       0                                               
						WFRGLSNL                                                     	             Matching length:     381                Total length:     381                                               
						least 90 % homologous to corresponding to amino acids 1 - 308	 Matching Percent Similarity:   99.74   Matching Percent Identity:   99.74                                               
						of Q9NVT5, which also corresponds to amino acids 1 - 308 of  	    Total Percent Similarity:   99.74      Total Percent Identity:   99.74                                               
						T10653_P1, a bridging amino acid F corresponding to amino    	                        Gaps:       0                        
						acid 309 of T10653_P1, a second amino acid sequence being at 	                                                            
						LSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHAVHEDAPDKVAEAVATFLIR 	Alignment:                                                   
						HRFAEPIGGFQC                                                 	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 310 -  	       1 MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYF 50                                                           
						381 of Q9NVT5, which also corresponds to amino acids 310 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						381 of T10653_P1, and a third amino acid sequence being at   	       1 MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYF 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      51 ESMEDVEVENETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAII 100                                                          
						homologous to a polypeptide having the sequence DLLSTPPQHRALL	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 382 - 394 of T10653_P1, wherein 	      51 ESMEDVEVENETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAII 100                                                          
						said first amino acid sequence, bridging amino acid, second  	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     101 SRVQCRIVALDLRSHGETKVKNPEDLSAETMAKDVGNVVEAMYGDLPPPI 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of T10653_P1, comprising a   	     101 SRVQCRIVALDLRSHGETKVKNPEDLSAETMAKDVGNVVEAMYGDLPPPI 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 MLIGHSMGGAIAVHTASSNLVPSLLGLCMIDVVEGTAMDALNSMQNFLRG 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence DLLSTPPQHRALL in T10653_P1.                  	     151 MLIGHSMGGAIAVHTASSNLVPSLLGLCMIDVVEGTAMDALNSMQNFLRG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGSKSI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGSKSI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 WFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHA 350                                                          
						                                                            	         |||||||| |||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 WFRGLSNLSLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHA 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 VHEDAPDKVAEAVATFLIRHRFAEPIGGFQC                    381                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     351 VHEDAPDKVAEAVATFLIRHRFAEPIGGFQC                    381                                                          

						Comparison report between T10653_P1 and Q9UI18unique head    	Sequence name: Q9UI18                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10653_P1, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23417 x Q9UI18   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYFESMEDVEVEN 	Alignment segment 1/1:                                       
						ETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAIISRVQCRIVALDLRSHGETKV 	                                                            
						KNPEDLSAETMAKDVGNVVEAMYGDLPPPIMLIGHSMGGAIAVHTASSNLVPSLLGLCMI 	                     Quality: 1917.00                      Escore:       0                                               
						DVVEGTA                                                      	             Matching length:     194                Total length:     194                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 187 of T10653_P1, a second amino acid     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGS 	                        Gaps:       0                        
						KSIVEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDGWFRGLSN 	                                                            
						LFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHAVHEDAPDKVAEAVATFL 	Alignment:                                                   
						IRHRFAEPIGGFQC                                               	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     188 MDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQ 237                                                          
						amino acids 1 - 194 of Q9UI18, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 188 - 381 of T10653_P1, and a third amino acid   	       1 MDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQ 50                                                           
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     238 CEGITSPEGSKSIVEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTW 287                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence DLLSTPPQHRALL corresponding to amino     	      51 CEGITSPEGSKSIVEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTW 100                                                          
						acids 382 - 394 of T10653_P1, wherein said first amino acid  	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	     288 RIELAKTEKYWDGWFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQG 337                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of T10653_P1,       	     101 RIELAKTEKYWDGWFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQG 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .            
						least about 80%, preferably at least about 85%, more         	     338 KFQMQVLPQCGHAVHEDAPDKVAEAVATFLIRHRFAEPIGGFQC       381                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||        
						MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYFESMEDVEVEN 	     151 KFQMQVLPQCGHAVHEDAPDKVAEAVATFLIRHRFAEPIGGFQC       194                                                          
						ETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAIISRVQCRIVALDLRSHGETKV 	                                                            
						KNPEDLSAETMAKDVGNVVEAMYGDLPPPIMLIGHSMGGAIAVHTASSNLVPSLLGLCMI 	                                                            
						DVVEGTA                                                      	                                                            
						about 95% homologous to the sequence of T10653_P1.3.An       	                                                            
						isolated polypeptide encoding for a tail of T10653_P1,       	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence DLLSTPPQHRALL in        	                                                            
						T10653_P1.                                                   	                                                            

						Comparison report between T10653_P1 and Q9Y570partial WT     	Sequence name: Q9Y570                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for T10653_P1, comprising a first amino 	Sequence documentation:                                      
						MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYFESMEDVEVEN 	                                                            
						ETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAIISRVQCRIVALDLRSHGETKV 	Alignment of: 23417 x Q9Y570   ..                            
						KNPEDLSAETMAKDVGNVVEAMYGDLPPPIMLIGHSMGGAIAVHTASSNLVPSLLGLCMI 	                                                            
						DVVEGTAMDALNSMQNFLRGRPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEG 	Alignment segment 1/1:                                       
						ITSPEGSKSIVEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 	                                                            
						WFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHAVHEDAPDKVA 	                     Quality: 3732.00                      Escore:       0                                               
						EAVATFLIRHRFAEPIGGFQC                                        	             Matching length:     381                Total length:     381                                               
						acid sequence being at least 90 % homologous to corresponding	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 1 - 381 of Q9Y570, which also corresponds to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 381 of T10653_P1, and a second amino acid    	                        Gaps:       0                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment:                                                   
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence DLLSTPPQHRALL corresponding to amino     	       1 MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYF 50                                                           
						acids 382 - 394 of T10653_P1, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	       1 MSALEKSMHLGRLPSRPPLPGSGGSQSGAKMRMGPGRKRDFSPVPWSQYF 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of T10653_P1, comprising a polypeptide being at least   	      51 ESMEDVEVENETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAII 100                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      51 ESMEDVEVENETGKDTFRVYKSGSEGPVLLLLHGGGHSALSWAVFTAAII 100                                                          
						at least about 95% homologous to the sequence DLLSTPPQHRALL  	                  .         .         .         .         .  
						in T10653_P1.                                                	     101 SRVQCRIVALDLRSHGETKVKNPEDLSAETMAKDVGNVVEAMYGDLPPPI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SRVQCRIVALDLRSHGETKVKNPEDLSAETMAKDVGNVVEAMYGDLPPPI 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MLIGHSMGGAIAVHTASSNLVPSLLGLCMIDVVEGTAMDALNSMQNFLRG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MLIGHSMGGAIAVHTASSNLVPSLLGLCMIDVVEGTAMDALNSMQNFLRG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGSKSI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RPKTFKSLENAIEWSVKSGQIRNLESARVSMVGQVKQCEGITSPEGSKSI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 VEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VEGIIEEEEEDEEGSESISKRKKEDDMETKKDHPYTWRIELAKTEKYWDG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 WFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 WFRGLSNLFLSCPIPKLLLLAGVDRLDKDLTIGQMQGKFQMQVLPQCGHA 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     351 VHEDAPDKVAEAVATFLIRHRFAEPIGGFQC                    381                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     351 VHEDAPDKVAEAVATFLIRHRFAEPIGGFQC                    381                                                          

24237	HMR136_T10687_3_tr0_r1_1_gPRT		Comparison report between T10687_P3 and SEH1_HUMANunique     	Sequence name: SEH1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						T10687_P3, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24237 x SEH1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						QGRCGGVGSTSRALPGCEVWLGYGPRAAAAAAATVLFGGAGPTET corresponding  	                                                            
						to amino acids 1 - 45 of T10687_P3, a second amino acid      	                     Quality: 3554.00                      Escore:       0                                               
						MFVARSIAADHKDLIHDVSFDFHGRRMATCSSDQSVKVWDKSESGDWHCTASWKTHSGSV 	             Matching length:     357                Total length:     357                                               
						WRVTWAHPEFGQVLASCSFDRTAAVWEEIVGESNDKLRGQSHWVKRTTLVDSRTSVTDVK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FAPKHMGLMLATCSADGIVRIYEAPDVMNLSQWSLQHEISCKLSCSCISWNPSSSRAHSP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MIAVGSDDSSPNAMAKVQIFEYNENTRKYAKAETLMTVTDPVHDIAFAPNLGRSFHILAI 	                        Gaps:       0                        
						ATKDVRIFTLKPVRKELTSSGGPTKFEIHIVAQFDNHNSQVWRVSWNITGTVLASSGDDG 	                                                            
						CVRLWKANYMDNWKCTGILKGNGSPVNGSSQQGTSNPSLGSTIPSLQNSLNGSSAGR    	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 357 of SEH1_HUMAN, which also corresponds to 	      46 MFVARSIAADHKDLIHDVSFDFHGRRMATCSSDQSVKVWDKSESGDWHCT 95                                                           
						amino acids 46 - 402 of T10687_P3, and a third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 MFVARSIAADHKDLIHDVSFDFHGRRMATCSSDQSVKVWDKSESGDWHCT 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	      96 ASWKTHSGSVWRVTWAHPEFGQVLASCSFDRTAAVWEEIVGESNDKLRGQ 145                                                          
						having the sequence NGKRAPFPLPQRRLTSPKIHQQPAYY corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 403 - 428 of T10687_P3, wherein said first    	      51 ASWKTHSGSVWRVTWAHPEFGQVLASCSFDRTAAVWEEIVGESNDKLRGQ 100                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     146 SHWVKRTTLVDSRTSVTDVKFAPKHMGLMLATCSADGIVRIYEAPDVMNL 195                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						T10687_P3, comprising a polypeptide being at least 70%,      	     101 SHWVKRTTLVDSRTSVTDVKFAPKHMGLMLATCSADGIVRIYEAPDVMNL 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     196 SQWSLQHEISCKLSCSCISWNPSSSRAHSPMIAVGSDDSSPNAMAKVQIF 245                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGRCGGVGSTSRALPGCEVWLGYGPRAAAAAAATVLFGGAGPTET of             	     151 SQWSLQHEISCKLSCSCISWNPSSSRAHSPMIAVGSDDSSPNAMAKVQIF 200                                                          
						T10687_P3.3.An isolated polypeptide encoding for a tail of   	                  .         .         .         .         .  
						T10687_P3, comprising a polypeptide being at least 70%,      	     246 EYNENTRKYAKAETLMTVTDPVHDIAFAPNLGRSFHILAIATKDVRIFTL 295                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     201 EYNENTRKYAKAETLMTVTDPVHDIAFAPNLGRSFHILAIATKDVRIFTL 250                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						NGKRAPFPLPQRRLTSPKIHQQPAYY in T10687_P3.                     	     296 KPVRKELTSSGGPTKFEIHIVAQFDNHNSQVWRVSWNITGTVLASSGDDG 345                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 KPVRKELTSSGGPTKFEIHIVAQFDNHNSQVWRVSWNITGTVLASSGDDG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     346 CVRLWKANYMDNWKCTGILKGNGSPVNGSSQQGTSNPSLGSTIPSLQNSL 395                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CVRLWKANYMDNWKCTGILKGNGSPVNGSSQQGTSNPSLGSTIPSLQNSL 350                                                          
						                                                            	                                                             
						                                                            	     396 NGSSAGR                                            402                                                          
						                                                            	         |||||||                                             
						                                                            	     351 NGSSAGR                                            357                                                          

2623	HMR136_T10689_5_tr0_r1_1_gPRT		Comparison report between T10689_P5 and Q9NR47unique head    	Sequence name: Q9NR47                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						T10689_P5, comprising a first amino acid sequence being at   	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 2623 x Q9NR47   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MNI          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 3 of T10689_P5, a second    	                                                            
						MDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIMKQT 	                     Quality: 3394.00                      Escore:       0                                               
						EVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCGE 	             Matching length:     362                Total length:     399                                               
						TQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AAETRNS                                                      	    Total Percent Similarity:   90.73      Total Percent Identity:   90.73                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       1                        
						corresponding to amino acids 1 - 187 of Q9NR47, which also   	                                                            
						corresponds to amino acids 4 - 190 of T10689_P5, a third     	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       4 MDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTK 53                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence QLNSARLEGDNIMVNFSYMLNFLHVKWLKIWAEEVTK    	       1 MDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTK 50                                                           
						corresponding to amino acids 191 - 227 of T10689_P5, and a   	                  .         .         .         .         .  
						SEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQK 	      54 IWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMID 103                                                          
						QLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN      	      51 IWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMID 100                                                          
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 188 - 362 of Q9NR47, which also 	     104 AGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEG 153                                                          
						corresponds to amino acids 228 - 402 of T10689_P5, wherein   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     101 AGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEG 150                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     154 DYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSQLNSARLEGDNIM 203                                                          
						polypeptide encoding for a head of T10689_P5, comprising a   	         |||||||||||||||||||||||||||||||||||||               
						polypeptide being at least 70%, optionally at least about    	     151 DYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNS............. 187                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     204 VNFSYMLNFLHVKWLKIWAEEVTKSEQELRITQSEFDRQAEITRLLLEGI 253                                                          
						to the sequence MNI of T10689_P5.3.An isolated polypeptide   	                                 ||||||||||||||||||||||||||  
						encoding for an edge portion of T10689_P5, comprising an     	     188 ........................SEQELRITQSEFDRQAEITRLLLEGI 213                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						about 80%, preferably at least about 85%, more preferably at 	     254 SSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQT 303                                                          
						least about 90% and most preferably at least about 95%       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to the sequence encoding for                      	     214 SSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQT 263                                                          
						QLNSARLEGDNIMVNFSYMLNFLHVKWLKIWAEEVTK, corresponding to      	                  .         .         .         .         .  
						T10689_P5.                                                   	     304 SVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDY 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 SVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDY 313                                                          
						                                                            	                  .         .         .         .            
						                                                            	     354 DAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN  402                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     314 DAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN  362                                                          

						Comparison report between T10689_P5 and Q9NYA9partial WT     	Sequence name: Q9NYA9                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10689_P5, comprising a first amino 	Sequence documentation:                                      
						MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIM 	                                                            
						KQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIK 	Alignment of: 2623 x Q9NYA9   ..                             
						CGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLK 	                                                            
						KAKAAETRNSQLNSARLEGDNIM                                      	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 203 of Q9NYA9, which also corresponds to  	                     Quality: 3630.00                      Escore:       0                                               
						amino acids 1 - 203 of T10689_P5, a second amino acid        	             Matching length:     386                Total length:     402                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   96.02      Total Percent Identity:   96.02                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       1                        
						having the sequence VNFSYMLNFLHVKWLK corresponding to amino  	                                                            
						acids 204 - 219 of T10689_P5, and a third amino acid sequence	Alignment:                                                   
						IWAEEVTKSEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCY 	                  .         .         .         .         .  
						QYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLK 	       1 MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAE 50                                                           
						ECSGSRKARVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLN                                                          	       1 MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAE 50                                                           
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 204 - 386 of Q9NYA9, which also corresponds to amino   	      51 CTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQY 100                                                          
						acids 220 - 402 of T10689_P5, wherein said first amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	      51 CTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQY 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	     101 MIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNF 150                                                          
						T10689_P5, comprising an amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 MIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNF 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     151 IEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSQLNSARLEGD 200                                                          
						VNFSYMLNFLHVKWLK, corresponding to T10689_P5.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSQLNSARLEGD 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIMVNFSYMLNFLHVKWLKIWAEEVTKSEQELRITQSEFDRQAEITRLLL 250                                                          
						                                                            	         |||                |||||||||||||||||||||||||||||||  
						                                                            	     201 NIM................IWAEEVTKSEQELRITQSEFDRQAEITRLLL 234                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     235 EGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNN 284                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     285 NQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVL 334                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLEL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 YDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLEL 384                                                          
						                                                            	                                                             
						                                                            	     401 LN                                                 402                                                          
						                                                            	         ||                                                  
						                                                            	     385 LN                                                 386                                                          

						Comparison report between T10689_P5 and Q9Y371partial WT     	Sequence name: Q9Y371                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for T10689_P5, comprising a first amino 	Sequence documentation:                                      
						MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIM 	                                                            
						KQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIK 	Alignment of: 2623 x Q9Y371   ..                             
						CGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLK 	                                                            
						KAKAAETRNS                                                   	Alignment segment 1/1:                                       
						acid sequence being at least 90 % homologous to corresponding	                                                            
						to amino acids 1 - 190 of Q9Y371, which also corresponds to  	                     Quality: 3425.00                      Escore:       0                                               
						amino acids 1 - 190 of T10689_P5, a second amino acid        	             Matching length:     365                Total length:     402                                               
						sequence being at least 70%, optionally at least 80%,        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						preferably at least 85%, more preferably at least 90% and    	    Total Percent Similarity:   90.80      Total Percent Identity:   90.80                                               
						most preferably at least 95% homologous to a polypeptide     	                        Gaps:       1                        
						having the sequence QLNSARLEGDNIMVNFSYMLNFLHVKWLKIWAEEVTK    	                                                            
						corresponding to amino acids 191 - 227 of T10689_P5, and a   	Alignment:                                                   
						SEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQK 	                  .         .         .         .         .  
						QLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKA 	       1 MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAE 50                                                           
						RVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 90 % homologous to  	       1 MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAE 50                                                           
						corresponding to amino acids 191 - 365 of Q9Y371, which also 	                  .         .         .         .         .  
						corresponds to amino acids 228 - 402 of T10689_P5, wherein   	      51 CTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQY 100                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and third amino acid sequence are contiguous and in a        	      51 CTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQY 100                                                          
						sequential order.2.An isolated polypeptide encoding for an   	                  .         .         .         .         .  
						edge portion of T10689_P5, comprising an amino acid sequence 	     101 MIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNF 150                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     101 MIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNF 150                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						encoding for QLNSARLEGDNIMVNFSYMLNFLHVKWLKIWAEEVTK,          	     151 IEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSQLNSARLEGD 200                                                          
						corresponding to T10689_P5.                                  	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     151 IEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNS.......... 190                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 NIMVNFSYMLNFLHVKWLKIWAEEVTKSEQELRITQSEFDRQAEITRLLL 250                                                          
						                                                            	                                    |||||||||||||||||||||||  
						                                                            	     191 ...........................SEQELRITQSEFDRQAEITRLLL 213                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     214 EGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNN 263                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 NQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 NQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVL 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLEL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 YDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLEL 363                                                          
						                                                            	                                                             
						                                                            	     401 LN                                                 402                                                          
						                                                            	         ||                                                  
						                                                            	     364 LN                                                 365                                                          

25158	HMR136_T10706_5_tr0_r1_1_gPRT		Comparison report between T10706_P5 and GME1_HUMANpartial WT 	Sequence name: GME1_HUMAN                                    
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10706_P5, comprising a first amino acid        	                                                            
						MANAEVSVPVGDVVVVPTEGNEGENPEDTKTQVILQLQPVQQGLFIDGHFYNRIYEAGSE 	Alignment of: 25158 x GME1_HUMAN   ..                        
						NNTAVVAVETHTIHKIEEGIDTGTIEANEDMEIAYPITCGESKAILLWKKFVCPGINVKC 	                                                            
						VKFNDQLISPKHFVHLAGKSTLKDWKRAIRLGGIMLR                        	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 157 of GME1_HUMAN, which also corresponds to 	                     Quality: 1529.00                      Escore:       0                                               
						amino acids 1 - 157 of T10706_P5.                            	             Matching length:     157                Total length:     157                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MANAEVSVPVGDVVVVPTEGNEGENPEDTKTQVILQLQPVQQGLFIDGHF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MANAEVSVPVGDVVVVPTEGNEGENPEDTKTQVILQLQPVQQGLFIDGHF 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YNRIYEAGSENNTAVVAVETHTIHKIEEGIDTGTIEANEDMEIAYPITCG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 YNRIYEAGSENNTAVVAVETHTIHKIEEGIDTGTIEANEDMEIAYPITCG 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ESKAILLWKKFVCPGINVKCVKFNDQLISPKHFVHLAGKSTLKDWKRAIR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ESKAILLWKKFVCPGINVKCVKFNDQLISPKHFVHLAGKSTLKDWKRAIR 150                                                          
						                                                            	                                                             
						                                                            	     151 LGGIMLR                                            157                                                          
						                                                            	         |||||||                                             
						                                                            	     151 LGGIMLR                                            157                                                          

25342	HMR136_T10707_0_tr0_r1_1_gPRT		Comparison report between T10707_P0 and AAH51351partial WT   	Sequence name: AAH51351                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for T10707_P0, comprising a first amino acid        	                                                            
						MDEDEKDRAKRASRNKSEKKRRDQFNVLIKELSSMLPGNTRKMDKTTVLEKVIGFLQKHN 	Alignment of: 25342 x AAH51351   ..                          
						EVSAQTEICDIQQDWKPSFLSNEEFTQLMLEALDGFIIAVTTDGSIIYVSDSITPLLGHL 	                                                            
						PSDVMDQNLLNFLPEQEHSEVYKILSSHMLVTDSPSPEYLKSDSDLEFYCHLLRGSLNPK 	Alignment segment 1/1:                                       
						EFPTYEYIKFVGNFRSYNNVPSPSCNGFDNTLSRPCRVPLGKEVCFIATVRLATPQFLKE 	                                                            
						MCIVDEPLEEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHIDDLELLARCH 	                     Quality: 8192.00                      Escore:       0                                               
						QHLMQFGKGKSCCYRFLTKGQQWIWLQTHYYITYHQWNSKPEFIVCTHSVVSYADVRVER 	             Matching length:     824                Total length:     824                                               
						RQELALEDPPSEALHSSALKDKGSSLEPRQHFNALDVGASGLNTSHSPSASSRSSHKSSH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TAMSEPTSTPTKLMAEASTPALPRSATLPQELPVPGLSQAATMPAPLPSPSSCDLTQQLL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PQTVLQSTPAPMAQFSAQFSMFQTIKDQLEQRTRILQANIRWQQEELHKIQEQLCLVQDS 	                        Gaps:       0                        
						NVQMFLQQPAVSLSFSSTQRPEAQQQLQQRSAAVTQPQLGAGPQLPGQISSAQVTSQHLL 	                                                            
						RESSVISTQGPKPMRSSQLMQSSGRSGSSLVSPFSSATAALPPSLNLTTPASTSQDASQC 	Alignment:                                                   
						QPSPDFSHDRQLRLLLSQPIQPMMPGSCDARQPSEVSRTGRQVKYAQSQTVFQNPDAHPA 	                  .         .         .         .         .  
						NSSSAPMPVLLMGQAVLHPSFPASQPSPLQPAQARQQPPQHYLQVQAPTSLHSEQQDSLL 	       1 MDEDEKDRAKRASRNKSEKKRRDQFNVLIKELSSMLPGNTRKMDKTTVLE 50                                                           
						LSTYSQQPGTLGYPQPPPAQPQPLRPPRRVSSLSESSGLQQPPR                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      84 MDEDEKDRAKRASRNKSEKKRRDQFNVLIKELSSMLPGNTRKMDKTTVLE 133                                                          
						amino acids 84 - 907 of AAH51351, which also corresponds to  	                  .         .         .         .         .  
						amino acids 1 - 824 of T10707_P0.                            	      51 KVIGFLQKHNEVSAQTEICDIQQDWKPSFLSNEEFTQLMLEALDGFIIAV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     134 KVIGFLQKHNEVSAQTEICDIQQDWKPSFLSNEEFTQLMLEALDGFIIAV 183                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TTDGSIIYVSDSITPLLGHLPSDVMDQNLLNFLPEQEHSEVYKILSSHML 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     184 TTDGSIIYVSDSITPLLGHLPSDVMDQNLLNFLPEQEHSEVYKILSSHML 233                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 VTDSPSPEYLKSDSDLEFYCHLLRGSLNPKEFPTYEYIKFVGNFRSYNNV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     234 VTDSPSPEYLKSDSDLEFYCHLLRGSLNPKEFPTYEYIKFVGNFRSYNNV 283                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSPSCNGFDNTLSRPCRVPLGKEVCFIATVRLATPQFLKEMCIVDEPLEE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     284 PSPSCNGFDNTLSRPCRVPLGKEVCFIATVRLATPQFLKEMCIVDEPLEE 333                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHIDDLELLARCH 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     334 FTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHIDDLELLARCH 383                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QHLMQFGKGKSCCYRFLTKGQQWIWLQTHYYITYHQWNSKPEFIVCTHSV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     384 QHLMQFGKGKSCCYRFLTKGQQWIWLQTHYYITYHQWNSKPEFIVCTHSV 433                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 VSYADVRVERRQELALEDPPSEALHSSALKDKGSSLEPRQHFNALDVGAS 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     434 VSYADVRVERRQELALEDPPSEALHSSALKDKGSSLEPRQHFNALDVGAS 483                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GLNTSHSPSASSRSSHKSSHTAMSEPTSTPTKLMAEASTPALPRSATLPQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     484 GLNTSHSPSASSRSSHKSSHTAMSEPTSTPTKLMAEASTPALPRSATLPQ 533                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ELPVPGLSQAATMPAPLPSPSSCDLTQQLLPQTVLQSTPAPMAQFSAQFS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     534 ELPVPGLSQAATMPAPLPSPSSCDLTQQLLPQTVLQSTPAPMAQFSAQFS 583                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 MFQTIKDQLEQRTRILQANIRWQQEELHKIQEQLCLVQDSNVQMFLQQPA 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     584 MFQTIKDQLEQRTRILQANIRWQQEELHKIQEQLCLVQDSNVQMFLQQPA 633                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 VSLSFSSTQRPEAQQQLQQRSAAVTQPQLGAGPQLPGQISSAQVTSQHLL 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     634 VSLSFSSTQRPEAQQQLQQRSAAVTQPQLGAGPQLPGQISSAQVTSQHLL 683                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 RESSVISTQGPKPMRSSQLMQSSGRSGSSLVSPFSSATAALPPSLNLTTP 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     684 RESSVISTQGPKPMRSSQLMQSSGRSGSSLVSPFSSATAALPPSLNLTTP 733                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ASTSQDASQCQPSPDFSHDRQLRLLLSQPIQPMMPGSCDARQPSEVSRTG 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     734 ASTSQDASQCQPSPDFSHDRQLRLLLSQPIQPMMPGSCDARQPSEVSRTG 783                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 RQVKYAQSQTVFQNPDAHPANSSSAPMPVLLMGQAVLHPSFPASQPSPLQ 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     784 RQVKYAQSQTVFQNPDAHPANSSSAPMPVLLMGQAVLHPSFPASQPSPLQ 833                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 PAQARQQPPQHYLQVQAPTSLHSEQQDSLLLSTYSQQPGTLGYPQPPPAQ 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     834 PAQARQQPPQHYLQVQAPTSLHSEQQDSLLLSTYSQQPGTLGYPQPPPAQ 883                                                          
						                                                            	                  .         .                                
						                                                            	     801 PQPLRPPRRVSSLSESSGLQQPPR                           824                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     884 PQPLRPPRRVSSLSESSGLQQPPR                           907                                                          

